data_1ajw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ajw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' CB ' ' CB ' ' A' ' 120' ' ' ARG . 17.0 p-10 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 86.0 t -125.51 119.15 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.9 t -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.35 110.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.726 . . . . 0.0 109.142 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.8 p -76.2 -41.27 50.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -167.38 163.76 15.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.287 -0.883 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -121.44 125.93 48.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 85' ' ' PRO . 12.8 m -109.97 154.78 22.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 111.032 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -138.71 92.02 2.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.35 130.8 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.713 -0.617 . . . . 0.0 110.654 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.7 m -128.05 -3.13 5.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.713 -0.617 . . . . 0.0 111.145 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.83 18.7 3.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.951 -1.093 . . . . 0.0 111.29 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.5 p -142.26 -45.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.757 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 202' ' ' TRP . . . -57.77 -179.18 0.11 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.749 -0.594 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -73.85 -17.31 22.81 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.531 1.279 . . . . 0.0 110.238 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.7 171.61 35.45 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.924 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' ' CG2' ' A' ' 76' ' ' THR . 46.8 Cg_endo -72.56 122.26 8.11 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.778 1.409 . . . . 0.0 110.728 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.66 117.66 10.67 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.149 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.99 112.8 25.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.633 -0.667 . . . . 0.0 110.64 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 1.3 tt -101.07 101.66 12.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.554 -0.716 . . . . 0.0 109.988 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.6 t0 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.553 -0.717 . . . . 0.0 110.33 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 192' ' ' TRP . 96.0 mt -135.87 54.77 1.89 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 110.062 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 p -135.87 -42.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.783 -0.573 . . . . 0.0 110.422 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.33 -103.61 2.45 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.22 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.632 -0.923 . . . . 0.0 110.687 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.55 -26.74 15.67 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.638 -0.663 . . . . 0.0 110.395 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.94 0.2 36.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.495 -0.753 . . . . 0.0 111.523 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 t -85.9 0.25 53.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.099 -1.0 . . . . 0.0 111.208 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.439 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 34.3 m-85 -93.14 -29.42 15.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.165 -0.959 . . . . 0.0 110.045 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -12.57 60.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -86.47 -26.62 24.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.253 -0.904 . . . . 0.0 110.33 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -132.62 -172.11 2.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.5 -0.75 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.4 p -152.59 169.64 22.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.549 -0.719 . . . . 0.0 110.102 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -96.7 119.85 35.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.58 -0.7 . . . . 0.0 109.997 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.51 116.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 109.62 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 166.38 11.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.463 ' HE3' ' CG ' ' A' ' 202' ' ' TRP . 0.2 OUTLIER -96.14 148.02 23.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.593 -0.692 . . . . 0.0 111.542 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -23.46 -46.81 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.04 36.4 0.12 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.818 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 105' ' ' LYS . 27.0 m -60.41 148.31 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.235 -1.156 . . . . 0.0 110.309 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.09 93.96 5.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 163' ' ' GLU . 32.5 p90 -109.7 151.35 27.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.469 -0.77 . . . . 0.0 111.562 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.3 156.44 18.14 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.98 135.93 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.314 -0.866 . . . . 0.0 110.42 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -122.51 120.45 33.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.587 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.1 mm -97.65 134.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.701 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 p -108.67 150.12 27.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.134 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.445 ' CG ' ' HE3' ' A' ' 126' ' ' MET . 3.1 p90 -162.51 139.13 7.74 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 135.06 35.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.625 . . . . 0.0 111.126 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.26 102.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -128.63 43.89 3.06 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.781 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -155.96 -65.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.0 166.06 23.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.375 -0.828 . . . . 0.0 111.413 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.7 mt -80.25 145.97 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.3 t -114.8 74.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.673 -0.642 . . . . 0.0 109.428 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 85.4 p -64.82 85.04 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 110.474 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.18 51.76 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.445 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -75.26 131.92 40.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -1.007 . . . . 0.0 109.312 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -130.7 159.57 36.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 111.085 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -138.08 126.52 23.32 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.06 166.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -168.58 111.45 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.4 m-70 -98.39 109.26 22.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.56 -0.713 . . . . 0.0 109.979 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.5 m -68.62 79.07 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.8 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.45 ' CZ ' ' CG ' ' A' ' 138' ' ' LYS . 2.8 m-85 -69.28 124.62 24.33 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.611 -0.681 . . . . 0.0 110.021 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -127.03 130.46 50.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.552 -0.717 . . . . 0.0 110.243 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 52.74 28.56 6.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.464 -0.772 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.48 -18.78 47.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.18 152.89 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -1.198 . . . . 0.0 110.328 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -85.24 134.52 34.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 110.268 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.6 -19.61 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.2 115.76 0.96 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 110.69 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 3.3 pttm -143.49 121.15 11.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.601 -0.687 . . . . 0.0 109.891 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.5 m -143.63 169.29 18.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.452 -0.78 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.42 157.56 16.83 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.722 -0.611 . . . . 0.0 109.92 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -122.92 103.23 8.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 110.427 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ttt -65.6 120.32 12.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.515 -0.741 . . . . 0.0 109.584 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 158' ' ' PHE . 50.6 t -96.9 -69.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.47 -0.769 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.87 -162.4 31.65 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -93.89 126.04 38.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.622 -0.928 . . . . 0.0 110.27 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.425 ' CE1' HG13 ' A' ' 146' ' ' VAL . 9.9 m-85 -113.45 137.74 51.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.695 . . . . 0.0 110.487 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.89 150.61 17.58 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.48 114.41 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.419 1.221 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -106.6 -58.18 1.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.572 -0.705 . . . . 0.0 110.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -170.55 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.523 -0.736 . . . . 0.0 110.744 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.88 -154.38 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.414 -0.804 . . . . 0.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -101.56 166.33 10.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.849 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.43 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 92.8 m-85 -115.74 -166.06 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.744 -0.598 . . . . 0.0 109.388 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -148.54 110.91 4.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.666 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 146' ' ' VAL . 39.8 t80 -70.81 165.76 22.46 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.08 109.12 4.61 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.814 . . . . 0.0 110.792 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 158' ' ' PHE . 72.2 p -87.58 145.91 38.25 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.57 -171.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.658 1.346 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -54.03 158.1 2.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 5.7 tt0 -159.95 93.44 1.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.74 -0.6 . . . . 0.0 109.77 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.13 133.14 49.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.628 -0.67 . . . . 0.0 110.519 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.88 166.78 36.95 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.84 117.47 5.16 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.377 1.198 . . . . 0.0 110.118 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -108.03 172.36 6.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.514 -0.741 . . . . 0.0 110.709 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.81 155.29 8.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.1 ttm -59.28 -27.73 66.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.582 -0.952 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 170' ' ' LEU . 4.2 mm? -93.48 -28.79 15.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.655 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.58 -22.01 54.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.936 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -62.36 138.56 58.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.339 -0.85 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.35 177.3 19.11 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 p -88.62 131.59 34.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.939 . . . . 0.0 110.354 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -112.68 108.49 17.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.511 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -66.6 137.91 57.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 0.0 109.403 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.413 HD13 ' CH2' ' A' ' 194' ' ' TRP . 16.4 mt -128.69 135.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.358 -0.839 . . . . 0.0 110.828 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -108.42 105.04 14.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.738 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.414 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 2.5 p -106.45 129.28 54.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.532 -0.73 . . . . 0.0 110.593 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -126.5 91.61 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.673 -0.642 . . . . 0.0 109.886 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.82 103.66 5.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 109.7 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 69.6 p -122.37 165.81 15.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.707 . . . . 0.0 110.201 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.404 ' HB3' ' CD2' ' A' ' 189' ' ' HIS . 46.7 p-10 . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.624 -0.673 . . . . 0.0 109.39 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.46 118.8 34.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.419 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 36.3 m-70 -56.93 -49.98 73.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 110.791 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.1 tp -168.25 153.74 6.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -154.28 140.96 19.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.419 ' CE2' HD12 ' A' ' 90' ' ' LEU . 16.0 p90 -145.57 -154.63 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.787 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.7 129.5 6.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.362 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 14.3 p-90 -137.82 146.9 44.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.574 -0.704 . . . . 0.0 109.901 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -96.79 158.08 15.6 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 21.1 tp -127.0 111.55 14.21 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.7 m -91.53 117.66 29.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.53 -0.731 . . . . 0.0 110.774 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 198' ' ' ILE . 48.5 mm -90.03 139.86 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -134.55 -155.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.467 -0.771 . . . . 0.0 110.494 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -93.83 -63.05 1.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -153.15 113.86 4.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.52 -0.737 . . . . 0.0 111.496 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.467 ' CZ2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -80.05 7.13 9.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.618 -0.676 . . . . 0.0 111.901 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -169.03 38.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.349 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.194 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 31.6 t30 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.941 0.4 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 57.2 t -122.48 33.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.712 0.767 . . . . 0.0 109.684 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.24 153.38 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.291 0.567 . . . . 0.0 109.986 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 57.8 t -69.03 136.84 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.669 -0.645 . . . . 0.0 109.487 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.1 p -95.44 -41.85 8.77 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -164.19 169.01 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 110.253 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.64 134.9 43.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.6 m -122.03 158.35 29.36 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.578 -0.702 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.81 93.73 3.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.75 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -81.69 140.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.746 -0.596 . . . . 0.0 110.161 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.2 m -142.41 -162.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.642 -0.661 . . . . 0.0 110.063 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.7 p -111.34 -72.55 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 110.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 p -96.63 32.54 2.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.447 ' HB3' ' CZ3' ' A' ' 202' ' ' TRP . . . -90.56 -174.62 0.45 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.652 -0.655 . . . . 0.0 110.237 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 48.2 Cg_endo -79.93 -28.87 2.99 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 123.203 1.107 . . . . 0.0 110.156 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.55 -179.22 33.45 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.44 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.87 108.35 2.42 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.587 1.309 . . . . 0.0 110.511 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 37.7 mt -71.72 107.39 4.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.829 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.15 146.29 27.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.656 . . . . 0.0 110.247 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -130.91 140.82 50.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.698 . . . . 0.0 110.095 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.25 130.08 39.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.506 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mt -137.73 56.14 1.77 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -149.37 -45.64 0.14 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -0.758 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.14 -89.02 1.13 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.75 124.14 49.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.916 . . . . 0.0 110.282 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 97' ' ' PHE . 89.4 mt -92.84 -24.16 18.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.581 -0.699 . . . . 0.0 110.392 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -23.1 6.31 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.218 -0.926 . . . . 0.0 111.295 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -57.78 -19.72 30.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 111.081 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.1 m-30 -62.56 -55.24 29.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.163 -0.961 . . . . 0.0 110.47 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -20.03 39.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.498 -0.751 . . . . 0.0 110.835 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -96.26 26.86 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -168.95 163.33 11.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.389 -0.82 . . . . 0.0 110.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 p -163.29 131.14 3.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.615 -0.678 . . . . 0.0 110.032 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 26.9 m-85 -73.79 126.6 30.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.614 -0.679 . . . . 0.0 110.094 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.1 t -87.35 122.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.71 . . . . 0.0 110.128 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.445 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 41.1 mt -114.89 -169.67 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 110.151 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 16.3 tttm -126.4 157.5 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.716 0.769 . . . . 0.0 109.868 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -41.19 117.35 0.86 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 43.44 66.2 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.127 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 35.0 m -98.44 152.21 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -1.111 . . . . 0.0 110.244 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -95.48 117.11 29.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 109.486 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 110' ' ' TYR . 33.0 p90 -142.58 149.27 38.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.387 -0.821 . . . . 0.0 111.277 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.62 166.01 11.52 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 112' ' ' ILE . 70.0 mt -126.15 148.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.022 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -123.25 92.09 3.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 109.547 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.419 HD13 ' CZ ' ' A' ' 128' ' ' TYR . 46.9 mm -73.32 135.71 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 110.322 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.1 m -117.94 136.99 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.467 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 37.9 p90 -156.71 148.9 23.11 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.413 -0.804 . . . . 0.0 110.695 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.88 138.01 35.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.716 -0.615 . . . . 0.0 110.509 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 84.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.643 . . . . 0.0 109.482 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.17 48.59 2.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.567 -0.708 . . . . 0.0 111.25 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -70.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.376 -0.827 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.22 156.81 36.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.555 -0.716 . . . . 0.0 110.416 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 122' ' ' ILE . 84.3 mt -80.17 103.4 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 110.292 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.56 99.48 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.632 -0.667 . . . . 0.0 109.497 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.431 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 83.6 p -89.39 117.72 28.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.512 -0.742 . . . . 0.0 110.758 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.92 48.94 1.12 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.467 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 1.3 ttt -73.09 125.09 26.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 109.906 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -119.69 143.71 47.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.167 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CZ ' HD13 ' A' ' 114' ' ' ILE . 30.9 t80 -120.54 106.57 11.91 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.15 163.2 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.569 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -153.25 139.56 18.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.738 -0.601 . . . . 0.0 109.944 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -117.93 132.65 56.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 m -87.55 71.1 9.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 109.543 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 7.3 m-85 -74.08 151.46 40.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.714 -0.616 . . . . 0.0 110.822 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.454 ' NE ' ' CE2' ' A' ' 175' ' ' TYR . 2.8 tpt180 -120.17 -150.96 0.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.836 -0.54 . . . . 0.0 109.735 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 66.43 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 110.848 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.3 34.66 35.97 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.9 t -144.84 95.09 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.655 -0.909 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -59.55 115.6 3.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.508 -0.745 . . . . 0.0 110.197 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 139' ' ' ILE . 95.2 mt -89.8 -58.7 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.474 -0.766 . . . . 0.0 110.115 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.29 -171.8 1.36 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.51 -0.744 . . . . 0.0 110.944 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.85 167.6 22.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.777 -0.577 . . . . 0.0 110.269 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.1 m -137.11 147.81 46.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.356 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.28 127.8 54.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.662 -0.648 . . . . 0.0 110.012 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -117.32 139.05 51.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.495 -0.753 . . . . 0.0 110.614 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.348 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 58.4 t -79.57 -69.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 0.0 110.411 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.79 171.84 20.61 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.431 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 38.7 m -94.71 150.8 19.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.609 -0.936 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 156' ' ' TYR . 63.6 m-85 -149.35 129.01 13.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.55 -0.719 . . . . 0.0 110.388 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.01 169.95 34.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.24 -165.94 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.339 1.179 . . . . 0.0 110.354 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 37.7 34.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.153 0.501 . . . . 0.0 112.234 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.29 26.9 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.711 -0.618 . . . . 0.0 110.49 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.9 -159.56 0.21 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.581 -0.7 . . . . 0.0 110.386 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -100.18 150.96 21.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.39 -0.819 . . . . 0.0 110.8 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 149' ' ' TYR . 84.7 m-85 -105.69 -165.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.726 -0.609 . . . . 0.0 109.543 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.14 123.03 1.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.422 -0.799 . . . . 0.0 110.548 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 146' ' ' VAL . 33.3 t80 -87.48 167.88 13.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.77 88.29 1.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.417 HG21 ' CE2' ' A' ' 158' ' ' PHE . 82.1 p -62.87 146.79 94.82 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 149.56 77.33 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.408 1.215 . . . . 0.0 110.621 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.73 106.28 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.558 -0.714 . . . . 0.0 110.787 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.66 159.53 14.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -91.0 148.0 22.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.0 110.547 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.19 178.95 1.84 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.659 -0.651 . . . . 0.0 110.021 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.85 132.23 18.18 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.222 1.117 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -113.28 165.32 12.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.76 161.22 17.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.3 ttp -60.85 -39.48 89.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.669 -0.9 . . . . 0.0 110.141 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -72.3 -5.47 36.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.604 -0.685 . . . . 0.0 111.687 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.3 -29.51 57.38 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -65.08 127.51 31.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.59 -179.24 21.94 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 p -88.09 134.96 33.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.994 . . . . 0.0 110.3 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CE2' ' NE ' ' A' ' 134' ' ' ARG . 24.8 m-85 -122.57 111.54 16.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.691 -0.631 . . . . 0.0 110.001 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.22 130.64 47.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.531 -0.731 . . . . 0.0 110.334 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.456 ' CG2' ' CZ2' ' A' ' 194' ' ' TRP . 49.9 mm -114.26 98.55 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.646 -0.659 . . . . 0.0 110.029 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 119.04 31.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.111 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 36.8 t -118.44 143.41 46.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.735 -0.603 . . . . 0.0 110.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -84.48 130.6 34.74 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.2 t -171.62 -171.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.536 -0.727 . . . . 0.0 110.201 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.642 179.414 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.501 2.082 0 CA-C-O 121.181 0.515 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 119.69 37.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.707 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.408 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 10.1 m-70 -75.7 -60.31 2.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 110.789 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -169.82 152.06 4.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 t -149.42 135.56 19.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.533 -0.729 . . . . 0.0 110.362 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.83 -155.69 0.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.685 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -167.87 128.07 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.981 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.456 ' CZ2' ' CG2' ' A' ' 177' ' ' ILE . 24.7 p-90 -132.74 150.6 52.14 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.0 109.719 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.52 151.58 23.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.493 -0.755 . . . . 0.0 111.137 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.53 105.09 8.78 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -81.77 138.33 35.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.604 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 198' ' ' ILE . 49.3 mm -114.57 164.04 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 109.461 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -153.94 -159.23 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -122.32 -10.65 8.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.651 -0.655 . . . . 0.0 111.346 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.06 69.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.136 -0.978 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.02 -4.56 33.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.555 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -154.44 46.17 0.56 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.126 -0.984 . . . . 0.0 110.136 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.249 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 189' ' ' HIS . 85.0 t -141.1 119.39 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.2 t -142.85 139.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.487 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 59.4 t -64.29 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.4 p -74.8 -66.96 0.69 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.873 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -131.35 170.82 14.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.529 -0.732 . . . . 0.0 110.73 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -142.7 136.88 29.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.659 -0.651 . . . . 0.0 109.889 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -109.42 163.99 12.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 0.0 110.076 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -145.98 110.19 4.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.13 114.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 110.042 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.3 m -115.62 78.55 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 110.1 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.3 p 45.94 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.905 -0.497 . . . . 0.0 112.061 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 73.4 p -84.11 56.75 3.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 110.219 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.432 ' HA ' ' CZ2' ' A' ' 202' ' ' TRP . . . -90.72 151.89 44.26 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 110.695 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.2 -18.49 23.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.514 1.271 . . . . 0.0 110.228 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.98 152.77 7.37 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.01 98.55 0.91 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.436 1.229 . . . . 0.0 110.369 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 6.0 mt -64.72 131.46 46.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 109.879 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -103.87 113.02 26.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.542 -0.723 . . . . 0.0 110.31 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 1.2 tt -89.13 131.36 35.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.567 -0.708 . . . . 0.0 110.03 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.13 126.45 34.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.681 -0.637 . . . . 0.0 110.052 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.42 HD22 ' CE2' ' A' ' 192' ' ' TRP . 1.1 mp -130.28 52.99 1.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -129.39 -48.4 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.703 -0.623 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.4 -116.25 4.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.88 114.61 3.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.567 -0.96 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 65.4 mt -93.87 -39.12 10.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.638 -0.664 . . . . 0.0 110.058 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.86 -18.62 34.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.2 t -55.09 -20.65 10.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.24 -0.913 . . . . 0.0 111.335 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.449 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 4.6 m-30 -59.99 -31.57 70.04 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -63.3 -16.27 59.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 111.207 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -86.73 -25.48 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.906 . . . . 0.0 110.601 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.54 137.66 47.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -121.26 149.82 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 29.4 m-85 -85.46 123.04 30.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.504 -0.747 . . . . 0.0 110.105 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.71 152.61 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 109.988 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.43 HD22 ' CH2' ' A' ' 202' ' ' TRP . 1.6 mt -153.63 172.66 16.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.672 -0.643 . . . . 0.0 110.052 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.405 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -93.85 153.87 18.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.509 -0.744 . . . . 0.0 109.843 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -20.52 -55.57 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.88 69.72 0.24 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.577 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 ' CG1' ' CB ' ' A' ' 105' ' ' LYS . 20.9 m -82.63 -161.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.489 -1.006 . . . . 0.0 109.869 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.58 145.77 26.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.416 ' CZ ' ' CD1' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -109.29 111.08 22.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 112.213 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.46 98.63 6.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.64 144.88 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.464 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -120.15 107.25 12.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.428 HG22 ' CE1' ' A' ' 181' ' ' PHE . 48.2 mm -83.24 148.16 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.422 -0.798 . . . . 0.0 110.608 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -130.14 137.21 50.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 25.5 p90 -157.7 159.32 36.79 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.874 -0.731 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -98.54 138.68 35.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.382 0.611 . . . . 0.0 111.054 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 91.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -129.13 48.11 2.4 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.91 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -69.62 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.226 -0.921 . . . . 0.0 110.582 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -139.02 165.83 26.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.775 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.86 105.33 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.654 -0.653 . . . . 0.0 109.708 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.49 80.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 110.094 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.95 116.86 22.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.604 -0.685 . . . . 0.0 110.144 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.55 27.54 3.28 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -64.24 135.65 56.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.508 -0.996 . . . . 0.0 109.589 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -126.31 167.37 15.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -138.02 78.16 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.22 157.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.54 -0.725 . . . . 0.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -162.16 126.52 3.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.709 -0.619 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 15.1 m-70 -109.82 119.43 39.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.512 -0.742 . . . . 0.0 110.288 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.4 m -72.14 68.66 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.656 . . . . 0.0 109.411 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 5.5 m-85 -61.63 144.91 53.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 110.765 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -126.99 100.68 6.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.59 37.28 28.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.561 -0.712 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.65 -15.35 61.06 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.081 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.46 167.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.179 -1.189 . . . . 0.0 110.203 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 1.8 mppt? -113.66 130.9 56.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.76 -23.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.735 . . . . 0.0 111.035 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -165.39 119.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.159 -0.963 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -144.41 132.62 21.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -0.75 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.2 m -146.32 165.78 28.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.665 -0.647 . . . . 0.0 110.499 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -100.06 136.31 40.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.669 . . . . 0.0 110.038 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -111.54 154.45 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.558 -0.713 . . . . 0.0 110.454 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 12.3 ttm -101.73 112.16 24.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.606 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 57.8 t -79.49 -48.76 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.529 -0.732 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.46 165.6 10.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 65.4 p -85.77 143.75 28.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.68 -0.894 . . . . 0.0 109.403 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 148' ' ' SER . 50.2 m-85 -140.68 125.93 18.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.543 -0.723 . . . . 0.0 110.384 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.58 154.37 32.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.54 85.51 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.476 1.25 . . . . 0.0 110.378 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -85.45 -89.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.63 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.927 -1.108 . . . . 0.0 110.998 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -162.5 -163.43 0.9 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.82 . . . . 0.0 110.935 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -100.28 167.54 10.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.606 . . . . 0.0 110.092 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.439 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 27.7 m-85 -113.79 171.51 7.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.663 . . . . 0.0 109.787 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -138.36 95.33 2.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.523 -0.735 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 49.0 t80 -81.36 169.83 16.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.82 111.37 5.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.745 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 64.0 p -77.67 140.01 63.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.75 . . . . 0.0 109.064 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.11 163.28 29.43 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.75 1.395 . . . . 0.0 111.401 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.176 0.512 . . . . 0.0 111.478 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -79.39 -171.5 2.77 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.54 155.92 39.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 110.649 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.62 160.61 26.4 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.702 -0.624 . . . . 0.0 109.8 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.45 117.02 4.9 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.411 1.216 . . . . 0.0 110.777 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -113.97 -170.38 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.09 28.27 3.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 65.81 -68.51 0.12 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.452 -1.028 . . . . 0.0 110.75 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -29.22 61.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.61 -21.79 41.43 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.642 -0.661 . . . . 0.0 110.671 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -60.69 136.86 58.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 142.02 -173.52 23.64 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 p -91.6 137.99 31.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.623 -0.927 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -128.23 115.07 17.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 110.271 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.45 151.85 27.19 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.509 -0.744 . . . . 0.0 110.09 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.419 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 49.4 mm -131.51 97.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.463 -0.773 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 133' ' ' TYR . 4.3 ttpt -82.4 102.44 11.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 109.733 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.41 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.4 p -109.34 137.1 47.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.725 . . . . 0.0 110.482 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.41 99.51 5.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.781 -0.575 . . . . 0.0 110.007 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.449 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -78.77 120.42 23.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.688 -0.633 . . . . 0.0 109.75 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.0 t -142.95 -164.77 1.92 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.53 -0.731 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 13.0 p-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.906 -0.496 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.232 0.539 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.67 126.22 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.538 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 17.0 m-70 -73.48 -47.86 37.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 110.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -168.39 152.21 5.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.3 t -148.43 152.15 36.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.692 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CE2' HD22 ' A' ' 90' ' ' LEU . 15.4 p90 -142.97 -161.24 1.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.0 109.947 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.09 122.86 3.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.446 -0.784 . . . . 0.0 110.759 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.419 ' CZ2' HG22 ' A' ' 177' ' ' ILE . 37.6 p-90 -132.28 149.31 52.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.601 -0.687 . . . . 0.0 109.713 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.21 152.3 22.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.549 -0.719 . . . . 0.0 111.303 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 25.7 tp -122.04 108.84 13.84 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.9 m -85.74 140.31 30.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.528 -0.733 . . . . 0.0 110.581 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.6 mm -119.72 160.51 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.752 -0.592 . . . . 0.0 109.651 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.13 -153.23 0.33 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.212 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -3.65 6.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.448 -0.783 . . . . 0.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -160.05 43.96 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -54.04 -23.11 12.44 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.239 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.04 47.2 0.91 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.589 -0.695 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.265 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.142 0.496 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 189' ' ' HIS . 96.1 t -126.91 128.74 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.95 142.03 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.792 -0.567 . . . . 0.0 109.804 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.85 112.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.0 p -78.23 -35.53 48.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.0 111.062 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -159.31 176.89 11.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.367 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -145.82 113.67 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.798 -0.564 . . . . 0.0 109.665 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -109.8 164.55 12.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.445 -0.785 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -139.23 101.67 4.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.0 167.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.717 -0.614 . . . . 0.0 110.127 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.36 -162.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.759 . . . . 0.0 110.098 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -108.84 -40.65 4.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -122.62 35.12 4.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' HB3' ' CH2' ' A' ' 202' ' ' TRP . . . -90.09 165.02 25.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.547 -0.721 . . . . 0.0 110.263 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 -26.8 25.01 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.385 1.203 . . . . 0.0 110.256 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.26 174.03 32.66 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.96 96.08 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.55 1.289 . . . . 0.0 110.293 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 23.6 mt -64.8 106.24 1.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.629 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.24 135.08 41.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.586 -0.696 . . . . 0.0 110.652 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.18 168.02 10.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.608 -0.682 . . . . 0.0 109.866 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.73 128.87 54.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.715 . . . . 0.0 110.111 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -128.07 50.24 2.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 110.078 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.7 p -141.0 -43.79 0.38 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.155 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.14 -92.01 2.03 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.68 98.79 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -1.021 . . . . 0.0 110.557 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -95.45 -36.92 11.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 0.0 110.089 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.36 -13.0 57.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 0.0 111.273 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 p -55.1 -28.01 49.31 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 28.7 m-85 -61.96 -39.47 92.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.46 -0.775 . . . . 0.0 109.985 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -57.92 -24.37 57.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.685 . . . . 0.0 110.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -118.67 45.41 2.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.561 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -168.35 136.13 2.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.791 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.2 p -143.41 127.88 17.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.657 . . . . 0.0 109.544 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 11.9 m-85 -76.42 115.37 16.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.369 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.77 121.14 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 109.179 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.451 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 1.0 OUTLIER -113.76 -159.31 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.618 -0.676 . . . . 0.0 110.3 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 47.0 tttm -140.94 158.79 43.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.572 -0.705 . . . . 0.0 110.555 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' CG ' ' NH1' ' A' ' 172' ' ' ARG . 22.3 mt-10 -38.36 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 33.32 70.34 0.13 Allowed Glycine 0 N--CA 1.505 3.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.863 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 33.0 m -90.83 147.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -1.14 . . . . 0.0 109.749 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.26 93.39 4.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 108.814 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 163' ' ' GLU . 31.8 p90 -113.45 146.31 39.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 111.894 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -108.38 157.49 18.35 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.66 164.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.855 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' CG ' ' CD1' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -142.67 87.15 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.87 -0.519 . . . . 0.0 109.612 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.55 150.92 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.411 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -127.02 153.02 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.705 -0.622 . . . . 0.0 109.739 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.495 ' CD2' ' CZ ' ' A' ' 181' ' ' PHE . 1.0 OUTLIER -172.09 159.32 4.9 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.576 -0.703 . . . . 0.0 110.576 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -113.94 154.54 27.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.11 97.83 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -128.98 48.93 2.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.513 -0.742 . . . . 0.0 111.291 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -70.6 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.27 -0.894 . . . . 0.0 110.777 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -135.56 172.61 12.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.671 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 122' ' ' ILE . 82.1 mt -80.35 108.76 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.726 -0.609 . . . . 0.0 110.419 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.61 86.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -78.13 59.29 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.677 -0.639 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.48 60.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.704 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.4 OUTLIER -70.25 128.67 37.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -1.058 . . . . 0.0 108.566 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -125.99 145.42 50.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.248 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.14 96.04 3.12 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.15 162.46 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.087 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -151.46 135.33 16.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.598 -0.688 . . . . 0.0 110.185 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.6 m-70 -109.55 149.1 30.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.715 . . . . 0.0 109.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.13 80.84 1.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.6 -0.687 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 11.6 m-85 -86.05 140.37 30.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 111.071 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -119.83 79.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.685 . . . . 0.0 110.399 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt 52.09 55.61 8.98 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.406 -0.809 . . . . 0.0 111.339 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.84 -19.33 52.3 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.1 t -98.73 89.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.181 -1.188 . . . . 0.0 109.829 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 5.1 pttm -66.92 122.73 18.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.575 -0.703 . . . . 0.0 110.562 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 mt -89.74 -54.03 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.15 -167.97 0.37 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.505 -0.747 . . . . 0.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -157.93 153.46 26.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.632 -0.668 . . . . 0.0 109.92 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.5 m -118.29 146.1 44.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -125.19 118.4 25.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -111.56 147.09 36.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.404 -0.81 . . . . 0.0 110.855 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.0 ttp -104.12 118.19 36.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.753 -0.592 . . . . 0.0 109.463 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 158' ' ' PHE . 49.1 t -79.87 -66.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.59 -0.694 . . . . 0.0 110.263 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.23 -148.87 20.17 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 92.5 p -108.59 136.64 47.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.543 -0.975 . . . . 0.0 110.427 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.42 ' CE1' HG13 ' A' ' 146' ' ' VAL . 23.3 m-85 -122.82 147.01 47.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 110.396 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.14 152.29 18.03 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -75.5 -174.25 1.93 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.362 1.19 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 52.01 70.11 0.59 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.5 -0.75 . . . . 0.0 111.079 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.1 -94.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.484 -0.76 . . . . 0.0 110.364 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.54 -155.17 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.838 -1.164 . . . . 0.0 109.897 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 88.73 6.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.91 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -59.75 -168.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.506 -0.746 . . . . 0.0 109.94 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.61 134.83 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.475 -0.766 . . . . 0.0 110.726 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 146' ' ' VAL . 29.9 t80 -107.09 156.86 18.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.401 ' CD1' ' CG ' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -137.93 114.0 10.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.446 -0.784 . . . . 0.0 110.595 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -78.61 154.53 78.69 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.21 154.96 72.11 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.628 1.331 . . . . 0.0 110.806 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 ttm -59.83 124.17 19.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.699 -0.626 . . . . 0.0 110.438 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.5 pt-20 -124.49 141.59 51.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.633 -0.667 . . . . 0.0 109.921 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.19 140.31 31.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.586 -0.696 . . . . 0.0 110.417 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.62 -179.27 1.34 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.637 . . . . 0.0 110.098 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.41 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 47.7 Cg_endo -75.29 125.47 9.15 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.237 1.125 . . . . 0.0 110.297 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -115.26 -176.68 2.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.656 -0.653 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.93 153.98 19.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 9.2 ttm -60.19 -28.12 67.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.644 -0.915 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 26.2 4.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 110.116 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.31 22.46 8.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.529 -0.732 . . . . 0.0 110.387 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -100.03 147.9 25.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.835 . . . . 0.0 109.94 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.83 179.97 16.77 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.6 p -81.14 140.76 34.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.67 -0.9 . . . . 0.0 110.761 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 13.4 m-85 -118.35 106.19 12.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.787 -0.571 . . . . 0.0 109.919 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -71.08 121.45 18.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.584 -0.697 . . . . 0.0 110.055 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.84 145.42 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -114.02 114.43 26.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.976 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.421 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.0 m -106.23 151.36 24.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.65 -0.656 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -149.12 93.73 2.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 116' ' ' PHE . 18.1 t80 -75.33 107.55 7.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.591 -0.693 . . . . 0.0 109.628 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.8 p -121.71 168.49 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.524 -0.735 . . . . 0.0 110.38 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 189' ' ' HIS . 7.0 p-10 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.783 -0.573 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.003 0.43 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.32 108.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.378 -0.826 . . . . 0.0 110.088 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 183' ' ' ASP . 25.8 m-70 -59.57 -55.12 38.45 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.471 -0.768 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 tp -168.56 153.87 6.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.5 t -148.26 155.73 41.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 110.142 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.421 ' CD2' HD22 ' A' ' 90' ' ' LEU . 23.1 p90 -148.6 -152.99 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -164.08 139.91 6.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 14.1 p-90 -147.89 147.82 30.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.213 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -92.73 148.88 21.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.503 -0.748 . . . . 0.0 111.224 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.05 115.72 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.0 m -87.41 152.49 22.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.477 -0.764 . . . . 0.0 110.947 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.8 mm -130.28 159.21 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -160.32 -158.51 0.63 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.284 -0.885 . . . . 0.0 111.243 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -64.31 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.61 -0.681 . . . . 0.0 111.096 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.59 103.67 3.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.0 110.93 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -72.95 -3.13 23.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.556 -0.715 . . . . 0.0 111.644 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -136.49 57.61 1.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.059 -1.026 . . . . 0.0 110.133 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.228 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.212 0.53 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.95 122.07 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.0 t -148.89 137.15 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.302 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 58.4 t -66.12 108.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.0 p -70.62 -62.63 1.32 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.607 -0.683 . . . . 0.0 110.543 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -145.07 167.9 21.6 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.774 . . . . 0.0 110.802 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.61 136.28 53.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.717 -0.615 . . . . 0.0 109.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.4 m -125.82 149.17 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 110.638 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -133.9 103.66 5.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 109.947 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.14 166.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.616 -0.677 . . . . 0.0 110.178 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.25 -164.3 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 110.009 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -44.77 4.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 p -108.98 27.19 9.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.453 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.84 162.37 33.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.594 -0.691 . . . . 0.0 110.609 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 45.7 Cg_endo -71.78 -25.49 20.23 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.524 1.276 . . . . 0.0 110.078 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.03 176.22 33.89 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.63 104.45 1.6 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.567 1.298 . . . . 0.0 110.444 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 23.5 mt -64.88 108.75 1.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.655 -0.653 . . . . 0.0 109.634 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -86.77 139.66 30.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -120.06 149.42 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 110.085 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -103.19 118.4 36.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.715 . . . . 0.0 110.222 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 2.8 mt -128.98 50.04 2.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -96.93 -73.52 0.6 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.599 -0.688 . . . . 0.0 110.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -52.37 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.78 88.09 4.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.917 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 96.1 mt -87.82 -25.23 23.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.724 . . . . 0.0 110.405 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.85 -21.75 12.36 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.245 -0.909 . . . . 0.0 111.093 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.2 t -54.43 -22.6 13.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.347 -0.846 . . . . 0.0 111.127 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.4 m-30 -61.95 -48.03 82.2 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.802 . . . . 0.0 109.943 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -59.51 -24.8 63.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.62 -0.675 . . . . 0.0 110.659 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -86.85 -26.42 24.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 0.0 110.509 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -132.76 129.86 39.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.643 -0.661 . . . . 0.0 110.379 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -106.99 -175.03 2.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.645 -0.659 . . . . 0.0 110.093 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.434 ' CE1' ' HG ' ' A' ' 88' ' ' LEU . 2.6 m-85 -113.58 96.03 5.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.596 -0.69 . . . . 0.0 110.174 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.18 142.88 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 109.837 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.439 HD22 ' CH2' ' A' ' 202' ' ' TRP . 1.2 mt -157.32 172.51 18.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.06 157.57 17.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -20.04 -50.86 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.54 63.54 0.15 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.392 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -75.37 137.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -1.025 . . . . 0.0 110.322 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.81 105.32 8.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.67 -0.644 . . . . 0.0 109.431 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.426 ' CD1' HD21 ' A' ' 77' ' ' LEU . 18.1 p90 -121.56 171.07 9.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.317 -0.864 . . . . 0.0 111.512 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -117.18 145.61 43.75 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.61 139.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.417 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 90.59 3.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.695 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.42 147.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.569 -0.707 . . . . 0.0 110.368 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 m -130.49 134.72 47.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.461 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 25.6 p90 -154.61 160.67 41.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.441 -0.787 . . . . 0.0 111.093 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -108.29 131.44 54.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.327 0.584 . . . . 0.0 110.716 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -120.23 93.1 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -129.35 50.23 2.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.348 -0.845 . . . . 0.0 111.569 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.12 -65.26 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 110.421 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.82 169.54 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.58 101.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.717 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.9 75.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.65 -0.656 . . . . 0.0 109.743 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -83.14 110.95 18.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.718 . . . . 0.0 110.387 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.47 30.16 2.51 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.7 OUTLIER -62.24 112.11 2.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.434 -1.039 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 163.71 12.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.594 -0.692 . . . . 0.0 110.936 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -138.13 112.08 8.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.73 -0.606 . . . . 0.0 109.64 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.41 161.29 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 0.0 110.034 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -167.42 117.98 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.546 -0.721 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -110.4 131.02 55.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.597 -0.689 . . . . 0.0 110.242 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 m -86.16 93.04 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.718 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.19 127.44 32.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.718 . . . . 0.0 110.471 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 11.2 ttp180 -125.74 130.95 52.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.37 28.69 7.7 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.27 47.13 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.56 146.33 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.214 . . . . 0.0 110.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.61 138.76 40.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.597 -0.689 . . . . 0.0 110.126 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.85 -24.22 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -173.28 134.96 0.55 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.028 . . . . 0.0 110.829 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 175.57 7.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.627 -0.671 . . . . 0.0 109.438 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.3 m -154.26 144.7 22.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 111.1 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -115.15 122.51 46.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.93 130.59 56.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.442 -0.787 . . . . 0.0 111.23 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.48 119.01 17.11 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.425 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 6.4 t -79.7 -58.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.505 -0.747 . . . . 0.0 110.293 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.11 165.07 11.0 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.935 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 59.2 p -92.91 151.76 19.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.614 -0.933 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 148' ' ' SER . 12.7 m-85 -139.15 169.49 17.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.469 -0.769 . . . . 0.0 110.573 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.05 141.96 17.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.51 178.36 5.72 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.214 1.113 . . . . 0.0 110.777 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.06 71.32 0.5 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.54 -0.725 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -166.55 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.458 -0.776 . . . . 0.0 110.408 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.74 -153.94 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.028 -1.045 . . . . 0.0 110.026 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.28 168.85 10.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.427 -0.796 . . . . 0.0 110.02 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 32.2 m-85 -127.17 -176.58 3.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -150.68 113.32 4.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.493 -0.754 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 35.2 t80 -87.24 168.51 13.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.529 -0.732 . . . . 0.0 110.022 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.07 109.8 4.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 0.0 110.738 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.8 p -83.33 151.13 62.07 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.392 -0.817 . . . . 0.0 109.121 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.72 -175.13 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.524 1.276 . . . . 0.0 110.892 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.0 ptm -56.64 145.1 29.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.653 -0.655 . . . . 0.0 110.915 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.04 93.92 2.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.718 -0.614 . . . . 0.0 109.731 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -63.91 121.83 15.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.43 175.12 0.27 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.724 -0.61 . . . . 0.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 112.51 3.52 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.248 1.131 . . . . 0.0 110.85 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -172.82 2.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.886 -0.509 . . . . 0.0 110.544 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.34 31.67 1.8 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.5 mtp 63.71 -70.75 0.07 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.62 -0.929 . . . . 0.0 111.213 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 170' ' ' LEU . 1.1 pt? -69.81 -7.03 36.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.179 -0.951 . . . . 0.0 111.71 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.54 -5.13 41.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.293 -0.879 . . . . 0.0 110.94 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -67.86 140.68 56.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.86 -174.65 24.16 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.6 p -91.49 124.46 35.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.605 -0.938 . . . . 0.0 110.211 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 24.0 m-85 -112.11 112.87 24.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.358 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -62.59 143.32 57.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.592 -0.693 . . . . 0.0 109.801 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.426 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 50.5 mm -119.33 94.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.533 -0.729 . . . . 0.0 110.41 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.23 107.96 10.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.512 -0.743 . . . . 0.0 109.47 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 5.2 p -113.45 160.4 18.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -147.89 83.79 1.52 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.682 -0.636 . . . . 0.0 109.82 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.447 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -69.68 110.85 5.09 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -141.33 -168.21 2.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.521 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 p30 . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.316 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 120.957 0.408 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.36 125.24 37.86 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 18.9 p80 -91.56 -17.69 25.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.474 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 43.5 tp -171.39 155.05 4.07 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.034 -1.041 . . . . 0.0 111.018 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -164.96 140.27 5.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.72 -0.613 . . . . 0.0 109.677 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 90' ' ' LEU . 14.7 p90 -146.95 -153.53 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.412 -0.805 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -167.16 127.33 1.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.701 -0.625 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.426 ' CZ2' HG22 ' A' ' 177' ' ' ILE . 20.0 p-90 -130.63 145.94 52.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.25 152.1 23.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.681 -0.637 . . . . 0.0 110.989 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 13.1 tp -123.75 92.06 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.734 -0.604 . . . . 0.0 109.544 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.8 m -67.73 129.5 40.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.571 -0.705 . . . . 0.0 110.186 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.1 mm -109.73 150.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.807 -0.558 . . . . 0.0 109.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.73 -153.01 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.665 -0.647 . . . . 0.0 109.949 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 -4.87 6.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.655 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -159.98 46.7 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.982 -1.074 . . . . 0.0 110.986 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -56.06 -22.16 26.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.344 -0.848 . . . . 0.0 111.131 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.64 51.54 1.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -0.815 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.194 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.059 0.457 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -115.82 134.52 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.582 -0.699 . . . . 0.0 110.15 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.0 t -148.34 152.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.608 -0.683 . . . . 0.0 109.92 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.458 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 60.3 t -71.61 112.33 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -70.81 -51.3 27.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.306 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -151.3 179.77 8.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 tt -146.39 121.24 9.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.629 -0.669 . . . . 0.0 110.075 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -109.75 163.42 13.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.416 HD12 ' CD2' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -148.61 113.89 5.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.468 -0.77 . . . . 0.0 110.531 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.87 167.23 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.654 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 52.5 t -153.05 -71.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.554 -0.717 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.0 p -171.89 -71.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 p -103.99 33.59 3.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.609 -0.682 . . . . 0.0 109.928 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -79.65 172.78 8.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 110.32 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.22 -27.73 16.28 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.455 1.24 . . . . 0.0 110.046 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.57 170.44 25.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.04 97.76 0.86 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.544 1.286 . . . . 0.0 110.292 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 1.5 mp -64.67 122.68 17.42 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.523 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.22 112.93 26.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 110.678 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.449 ' CD1' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt -95.26 131.23 41.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 5.4 t70 -75.64 135.25 40.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.704 . . . . 0.0 110.614 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.61 54.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.619 -0.675 . . . . 0.0 109.71 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.7 p -130.21 49.84 2.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 110.7 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.52 -55.62 0.74 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.26 64.32 0.56 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.592 -0.946 . . . . 0.0 110.073 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 97' ' ' PHE . 29.4 mt -95.14 -0.09 53.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 111.207 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.18 -24.37 58.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.106 -0.996 . . . . 0.0 110.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.77 -6.55 45.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.42 -0.8 . . . . 0.0 111.227 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 13.9 m-85 -81.28 -38.71 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -69.95 -20.2 63.34 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.511 -0.743 . . . . 0.0 110.858 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.37 38.25 3.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -168.96 151.62 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.447 -0.783 . . . . 0.0 110.55 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -128.76 -169.53 2.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.555 -0.716 . . . . 0.0 109.989 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CE1' ' CD1' ' A' ' 88' ' ' LEU . 1.1 m-85 -125.17 111.57 15.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 109.93 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.22 147.47 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.547 -0.72 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.424 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 0.9 OUTLIER -167.38 145.05 4.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.788 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -78.59 155.6 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.454 -0.779 . . . . 0.0 109.75 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -17.24 -87.59 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.81 67.29 0.55 Allowed Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.163 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 8.6 m -75.96 157.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.467 -1.02 . . . . 0.0 110.156 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -85.5 89.53 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 46.2 p90 -109.27 138.86 44.99 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.662 0.744 . . . . 0.0 112.095 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 164.98 11.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.35 150.01 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.218 -0.926 . . . . 0.0 111.216 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -125.42 108.01 11.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.7 153.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 0.0 110.522 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.3 m -131.02 140.95 50.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.806 -0.559 . . . . 0.0 109.582 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.45 ' CD1' ' CE ' ' A' ' 126' ' ' MET . 27.8 p90 -164.47 147.58 9.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.469 -0.77 . . . . 0.0 110.505 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 161.56 17.91 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.439 -0.788 . . . . 0.0 111.195 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.1 t -133.08 117.23 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.779 -0.575 . . . . 0.0 109.593 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -128.66 46.73 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.995 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 -67.89 0.25 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -143.69 179.07 7.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.819 . . . . 0.0 110.562 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.19 109.34 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.666 -0.646 . . . . 0.0 109.981 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.5 t -91.46 83.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.9 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.5 p -85.07 107.78 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.621 -0.675 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.41 39.98 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.45 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -81.46 137.89 35.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -1.043 . . . . 0.0 109.957 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -139.39 171.87 13.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -129.52 117.84 21.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 109.73 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.32 165.74 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.736 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -168.29 124.05 1.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.284 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -113.95 117.82 32.44 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.731 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.6 m -71.89 84.58 0.95 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.717 -0.615 . . . . 0.0 109.921 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 138' ' ' LYS . 2.7 m-85 -87.41 136.39 32.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.497 -0.752 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.401 ' HD2' ' CE2' ' A' ' 175' ' ' TYR . 3.3 ttp180 -120.42 110.58 16.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 110.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 29.63 43.47 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 34.18 6.99 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.6 t -149.21 82.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.959 . . . . 0.0 110.071 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 133' ' ' TYR . 2.4 ttpm? -62.29 121.87 14.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -104.32 -31.52 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.534 -0.729 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -174.23 149.71 1.43 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.14 -0.975 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 150.71 51.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.64 . . . . 0.0 109.505 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.4 HG23 ' CE1' ' A' ' 144' ' ' TYR . 11.9 m -132.84 159.81 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 110.729 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.98 138.83 53.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.631 -0.668 . . . . 0.0 110.122 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.4 ' CE1' HG23 ' A' ' 142' ' ' THR . 24.8 m-85 -122.63 113.15 18.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.9 ttt -68.72 137.87 54.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.523 -0.736 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.426 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 60.6 t -98.11 -68.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.552 -0.717 . . . . 0.0 110.151 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.28 176.02 26.14 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.4 p -87.4 152.47 22.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.693 -0.887 . . . . 0.0 109.963 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 81.3 m-85 -148.18 144.39 27.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 110.415 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.5 154.01 19.68 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.23 65.35 5.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.377 1.199 . . . . 0.0 110.474 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -170.93 37.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 110.337 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -144.31 15.02 1.65 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.522 -0.736 . . . . 0.0 111.06 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 54.66 -148.1 0.49 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.173 -0.954 . . . . 0.0 110.734 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.95 157.06 38.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.373 -0.829 . . . . 0.0 110.84 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 153' ' ' ALA . 57.4 m-85 -115.87 177.45 4.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.737 -0.602 . . . . 0.0 109.669 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.95 92.84 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.51 -0.744 . . . . 0.0 110.355 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 28.5 t80 -80.81 168.23 19.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.009 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.4 100.63 2.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.0 p -76.02 155.87 84.39 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 109.252 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.76 153.02 76.91 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.615 1.324 . . . . 0.0 110.978 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.0 ptm -58.0 113.47 1.91 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.679 -0.638 . . . . 0.0 110.49 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.25 161.42 13.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.094 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -104.84 141.44 36.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.484 -0.76 . . . . 0.0 110.512 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.426 ' CB ' ' HD2' ' A' ' 166' ' ' PRO . . . -96.15 179.66 1.1 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.629 -0.67 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 165' ' ' ALA . 41.8 Cg_endo -66.44 -153.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.201 1.106 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -107.0 -162.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.061 -1.024 . . . . 0.0 110.689 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -98.86 -66.79 0.87 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.6 mtt -60.79 145.94 47.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.959 . . . . 0.0 109.233 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.93 -61.32 0.33 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.639 -0.663 . . . . 0.0 110.535 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.85 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.4 -0.812 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 150.36 48.93 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.918 -1.114 . . . . 0.0 110.136 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.56 -177.82 17.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.7 p -91.99 129.78 37.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.696 -0.885 . . . . 0.0 110.219 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.401 ' CE2' ' HD2' ' A' ' 134' ' ' ARG . 12.3 m-85 -108.01 101.12 10.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.594 -0.691 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.96 125.06 23.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.96 132.14 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -0.851 . . . . 0.0 110.506 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.8 106.51 17.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.4 m -99.09 140.6 33.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.646 -0.659 . . . . 0.0 109.728 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.44 90.07 2.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.595 -0.691 . . . . 0.0 110.393 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.458 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 3.7 t80 -64.38 131.66 47.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 109.648 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.411 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.9 t -171.0 -169.06 0.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.8 p30 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.482 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 121.234 0.54 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -115.35 118.02 32.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.782 -0.574 . . . . 0.0 109.503 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.411 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.2 m-70 -75.07 -67.44 0.65 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.457 -0.777 . . . . 0.0 110.666 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.0 tp -165.74 160.29 17.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.461 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.8 p -155.94 144.91 20.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.586 -0.696 . . . . 0.0 110.403 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -138.7 -155.76 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.606 -0.684 . . . . 0.0 109.734 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.46 129.31 7.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.323 -0.86 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.5 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 4.4 p-90 -140.01 147.9 41.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -99.31 154.97 17.76 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.756 0.789 . . . . 0.0 112.452 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.454 ' CD2' ' CZ3' ' A' ' 194' ' ' TRP . 0.9 OUTLIER -111.74 103.47 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -80.21 101.12 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.753 . . . . 0.0 110.434 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 198' ' ' ILE . 49.3 mm -78.93 145.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 109.689 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -142.6 -154.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.647 -0.658 . . . . 0.0 110.401 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -108.71 -32.46 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.758 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.11 93.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.448 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -77.21 -0.2 24.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.571 -0.706 . . . . 0.0 111.307 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -127.79 43.2 3.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 92.8 t -130.68 125.24 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.778 -0.577 . . . . 0.0 110.132 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -148.59 138.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.775 -0.578 . . . . 0.0 109.962 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 58.2 t -64.51 104.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.4 p -70.8 -63.3 1.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.668 -0.645 . . . . 0.0 110.41 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -138.61 173.21 11.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 tt -142.85 124.92 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.648 -0.658 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.0 m -114.91 157.37 23.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.442 -0.786 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -137.46 106.39 5.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.74 166.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 110.42 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.33 -154.49 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.1 p -115.03 -26.42 7.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.436 -0.79 . . . . 0.0 110.397 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.7 p -140.12 34.67 1.92 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.21 173.41 5.76 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.352 -0.843 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.36 -26.52 17.17 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.286 1.15 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.72 177.31 34.68 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.45 102.76 1.32 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.487 1.256 . . . . 0.0 110.317 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 102' ' ' PHE . 37.5 mt -64.85 112.74 3.4 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.503 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -99.67 113.67 26.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 5.6 mt -98.75 137.45 37.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.604 -0.685 . . . . 0.0 109.739 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 14.6 t0 -86.57 128.61 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.506 -0.746 . . . . 0.0 110.679 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.426 HD22 ' CE2' ' A' ' 192' ' ' TRP . 1.0 OUTLIER -128.52 51.44 2.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.466 -0.771 . . . . 0.0 109.982 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.6 p -115.16 -58.73 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 110.346 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.67 -57.25 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 75.64 0.96 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.548 -0.972 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.413 HD22 ' CE1' ' A' ' 97' ' ' PHE . 6.5 mt -95.01 0.03 54.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 111.213 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -70.51 -33.14 70.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.037 -1.039 . . . . 0.0 110.659 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 m -57.47 -20.82 33.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.456 -0.777 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 3.7 m-85 -55.33 -42.2 73.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.246 -0.909 . . . . 0.0 110.388 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -63.59 -26.27 68.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 0.0 109.944 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 52.5 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.015 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -158.26 30.16 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.392 -0.817 . . . . 0.0 110.657 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -55.9 121.58 9.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.77 -0.581 . . . . 0.0 110.557 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 86' ' ' LEU . 23.6 m-85 -85.21 122.73 29.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.544 -0.722 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.03 152.84 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.436 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 0.7 OUTLIER -154.54 128.04 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.424 -0.798 . . . . 0.0 110.75 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 24.3 tttm -60.57 146.34 45.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.105 0.955 . . . . 0.0 110.431 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -61.15 128.57 37.07 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.63 40.54 97.61 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.862 -0.524 . . . . 0.0 112.862 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 31.9 m -83.38 178.09 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 118.861 1.33 . . . . 0.0 110.044 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -120.27 96.38 5.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -118.93 157.54 27.49 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.887 0.851 . . . . 0.0 112.407 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -116.67 157.3 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 112' ' ' ILE . 71.8 mt -116.46 154.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -137.87 122.17 18.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.809 -0.557 . . . . 0.0 109.507 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 mm -106.54 147.09 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 110.648 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 m -127.42 134.83 49.86 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.463 ' CZ ' ' CB ' ' A' ' 156' ' ' TYR . 41.1 p90 -152.18 140.78 20.77 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.0 111.203 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 142.33 27.81 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.436 0.636 . . . . 0.0 110.946 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.96 95.49 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -129.41 48.27 2.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.0 111.687 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 -67.08 0.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.294 -0.879 . . . . 0.0 110.764 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -143.1 178.07 7.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.3 mp -80.15 107.83 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 109.735 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.9 82.02 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 p -84.64 113.4 21.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.667 -0.646 . . . . 0.0 110.438 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.68 37.07 0.8 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -79.51 145.32 33.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.498 -1.001 . . . . 0.0 109.797 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -143.82 141.23 30.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 110.958 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -109.0 109.05 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.4 mt -96.66 161.46 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 110.117 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -159.34 118.9 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.69 -0.631 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 17.8 m-70 -106.41 134.7 49.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.726 . . . . 0.0 109.899 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.8 m -90.11 113.42 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.646 -0.659 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 2.3 m-85 -111.38 119.32 38.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.679 . . . . 0.0 109.947 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -120.88 129.14 53.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.656 -0.652 . . . . 0.0 110.348 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt 52.68 39.25 28.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.35 -0.844 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.88 30.43 72.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.5 t -143.11 119.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.997 . . . . 0.0 109.881 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -77.22 138.88 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.137 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -26.87 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.492 -0.755 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -169.67 144.97 3.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HD3' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -142.42 139.88 31.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.5 m -120.51 160.8 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.824 . . . . 0.0 111.061 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -126.21 73.81 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.088 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.89 141.67 58.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.708 . . . . 0.0 110.613 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 ttt -94.37 124.27 38.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.427 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 26.3 t -79.75 -58.86 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.26 175.75 14.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.1 p -86.29 147.88 25.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.922 . . . . 0.0 109.853 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.419 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 67.3 m-85 -146.31 135.73 22.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.44 161.03 30.92 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.66 62.58 5.57 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.41 1.216 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -170.52 54.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.469 -0.77 . . . . 0.0 110.418 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.455 ' CB ' ' CZ ' ' A' ' 156' ' ' TYR . . . -155.99 23.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.499 -0.751 . . . . 0.0 111.244 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 40.46 -150.16 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.862 -0.524 . . . . 0.0 112.269 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.41 114.42 6.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.28 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 116' ' ' PHE . 3.9 m-85 -73.37 -173.34 1.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.606 -0.684 . . . . 0.0 109.755 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.96 82.53 1.44 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.571 -0.706 . . . . 0.0 110.727 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 42.7 t80 -80.97 161.99 24.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.392 -0.817 . . . . 0.0 109.384 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.51 117.54 5.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.952 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.413 HG21 ' CE2' ' A' ' 158' ' ' PHE . 24.5 p -81.05 156.7 71.9 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.434 -0.791 . . . . 0.0 108.877 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 166.3 20.03 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.711 1.374 . . . . 0.0 110.979 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 135.62 56.31 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.417 0.627 . . . . 0.0 110.948 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.64 127.49 42.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.412 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -79.2 139.65 37.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.48 -0.762 . . . . 0.0 110.883 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.33 170.52 11.19 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.733 -0.605 . . . . 0.0 110.41 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.37 132.76 21.35 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 O-C-N 123.434 1.228 . . . . 0.0 110.405 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 -171.83 2.08 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.653 -0.655 . . . . 0.0 110.571 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.55 -157.15 15.19 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.45 -38.91 6.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.626 -0.926 . . . . 0.0 109.573 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tt -86.68 -22.68 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.761 -0.587 . . . . 0.0 110.235 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.21 20.02 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -0.848 . . . . 0.0 110.778 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -62.22 147.6 47.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 110.171 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 138.17 -171.95 23.15 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.6 p -96.26 137.06 35.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.6 -0.941 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.32 108.76 14.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.629 -0.669 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.76 131.71 42.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.442 -0.786 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.2 mt -121.27 147.99 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.32 -0.863 . . . . 0.0 110.725 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -112.23 111.01 21.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 3.1 m -103.39 125.0 49.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 110.135 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -113.92 114.55 26.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 110.315 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.442 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -96.11 130.54 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 109.938 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 t -156.2 -163.45 1.47 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.528 -0.733 . . . . 0.0 110.473 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 8.6 p-10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.651 -0.655 . . . . 0.0 109.932 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.103 0.478 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.28 96.46 5.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.422 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 1.6 m-70 -60.14 -47.33 86.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 109.805 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 23.3 tp -170.89 107.81 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.709 -0.619 . . . . 0.0 109.963 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -113.31 131.0 56.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.629 -0.67 . . . . 0.0 110.124 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.426 ' CE2' HD22 ' A' ' 90' ' ' LEU . 25.1 p90 -133.92 -154.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.761 . . . . 0.0 109.938 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -167.91 130.74 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 16.6 p-90 -133.14 146.23 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.681 . . . . 0.0 109.829 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.75 149.25 21.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.695 -0.628 . . . . 0.0 110.627 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.3 tp -121.33 108.76 14.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.689 -0.632 . . . . 0.0 109.391 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.5 m -78.22 136.8 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.6 mm -111.1 151.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.712 -0.618 . . . . 0.0 109.87 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.35 -160.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.659 -0.65 . . . . 0.0 109.721 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -119.62 -30.79 4.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -135.73 59.9 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 111.493 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -66.09 -11.3 47.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.305 -0.872 . . . . 0.0 111.338 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -157.02 51.22 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.02 . . . . 0.0 110.205 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' CG ' ' A' ' 189' ' ' HIS . 46.5 t -140.37 30.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.612 0.72 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 138.04 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.203 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.5 t -63.07 124.39 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.4 p -87.03 -63.5 1.3 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.258 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -135.99 172.16 13.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.357 -0.84 . . . . 0.0 111.119 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.08 124.51 14.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.712 -0.618 . . . . 0.0 109.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m -109.89 158.47 18.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.787 . . . . 0.0 110.455 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 102' ' ' PHE . 1.7 mt -142.3 103.22 4.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.53 166.95 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.497 -0.752 . . . . 0.0 110.34 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -157.92 0.58 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.961 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -101.97 -29.41 11.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 0.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.4 p -138.17 41.78 2.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.675 -0.641 . . . . 0.0 110.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.449 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.39 163.43 31.06 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.592 -0.692 . . . . 0.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.27 -25.2 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.491 1.258 . . . . 0.0 110.244 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.04 167.57 25.84 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.44 100.07 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.515 1.271 . . . . 0.0 110.243 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.55 115.51 5.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.665 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -97.82 101.23 12.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.447 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.457 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -82.63 125.49 31.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.534 -0.729 . . . . 0.0 109.913 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.0 134.36 35.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.652 -0.655 . . . . 0.0 110.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.406 HD22 ' CD1' ' A' ' 192' ' ' TRP . 6.4 mt -135.27 55.15 1.9 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.66 -0.65 . . . . 0.0 109.923 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -106.34 -72.98 0.7 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.692 . . . . 0.0 110.524 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.4 -77.99 0.78 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.05 92.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.451 -1.029 . . . . 0.0 110.41 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 44.2 mt -92.34 -37.69 12.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.663 -0.648 . . . . 0.0 110.046 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -18.84 36.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.511 -0.743 . . . . 0.0 110.879 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.1 p -53.89 -22.51 10.15 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.299 -0.876 . . . . 0.0 111.153 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.457 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 7.0 m-30 -60.84 -30.24 69.98 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 109.87 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -60.78 -26.7 67.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.672 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.49 22.7 5.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.596 -0.69 . . . . 0.0 110.707 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -171.19 128.64 0.71 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 p -113.21 179.58 3.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.665 -0.647 . . . . 0.0 110.185 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.421 ' CD2' HD11 ' A' ' 77' ' ' LEU . 7.1 m-85 -111.59 104.96 13.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.7 139.74 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.48 -0.762 . . . . 0.0 110.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 0.8 OUTLIER -154.33 161.45 41.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.706 -0.621 . . . . 0.0 110.263 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.4 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 1.1 mtpm? -76.47 152.16 36.22 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.523 -0.735 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -20.61 -74.31 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.61 69.56 0.46 Allowed Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.415 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' A' ' 105' ' ' LYS . 33.9 m -80.27 -176.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.524 -0.986 . . . . 0.0 110.071 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.25 96.93 6.04 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 163' ' ' GLU . 44.6 p90 -113.26 149.23 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.505 -0.747 . . . . 0.0 111.987 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -107.32 155.48 19.93 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -121.43 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.008 -1.058 . . . . 0.0 111.197 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -120.83 107.29 12.54 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.28 151.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.44 -0.787 . . . . 0.0 111.073 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -131.32 152.1 50.89 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.496 ' CD2' ' CE2' ' A' ' 181' ' ' PHE . 2.1 p90 -167.84 159.05 11.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 111.15 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 155' ' ' GLU . 3.0 mmm180 -93.06 135.92 33.8 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.202 0.525 . . . . 0.0 111.377 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.06 85.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.21 48.38 2.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.535 -0.728 . . . . 0.0 111.998 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -68.51 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 171.51 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 0.0 110.586 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 122' ' ' ILE . 77.1 mt -70.96 108.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.666 -0.646 . . . . 0.0 110.264 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.99 75.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.646 -0.658 . . . . 0.0 109.501 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.436 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 69.8 p -64.68 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.657 -0.652 . . . . 0.0 110.358 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.92 49.38 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.448 ' HE3' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -79.78 120.7 24.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.257 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -132.88 148.2 52.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 111.1 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -125.38 113.37 17.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.47 146.71 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.625 -0.672 . . . . 0.0 110.511 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.67 141.83 43.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.556 -0.715 . . . . 0.0 110.08 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.8 m-70 -101.07 164.72 11.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.684 . . . . 0.0 109.634 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.6 m -119.7 61.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.951 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.88 118.75 7.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.741 . . . . 0.0 110.417 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.92 138.26 54.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.619 -0.675 . . . . 0.0 110.017 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? 53.35 28.74 7.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.412 -0.805 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.37 -11.46 63.34 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.196 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.55 148.02 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.024 -1.28 . . . . 0.0 110.765 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 135.92 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.284 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.68 -26.26 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.752 . . . . 0.0 111.049 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -176.3 146.02 0.62 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -133.67 143.13 48.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.535 -0.728 . . . . 0.0 109.76 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.2 m -109.9 151.83 26.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.604 -0.685 . . . . 0.0 111.043 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -126.05 136.39 52.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.63 -0.669 . . . . 0.0 109.836 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -123.41 129.02 50.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.451 -0.781 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.7 ttm -91.75 107.97 19.58 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.455 ' CG1' ' CE1' ' A' ' 149' ' ' TYR . 61.8 t -79.68 -44.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.309 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.68 -173.82 19.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.436 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 31.9 m -84.84 126.32 33.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.604 -0.939 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CE1' ' CG1' ' A' ' 146' ' ' VAL . 8.8 m-85 -113.51 131.46 56.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.725 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -118.19 145.09 18.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.81 142.77 35.97 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.382 1.201 . . . . 0.0 110.186 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.61 -39.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.566 -0.709 . . . . 0.0 110.774 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.6 -81.85 0.46 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 111.416 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.28 -136.31 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 110.424 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -79.78 166.01 22.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.887 -1.133 . . . . 0.0 110.819 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 33.5 m-85 -121.31 -175.99 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -133.78 114.96 13.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.447 -0.783 . . . . 0.0 111.019 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.423 ' CD1' HG12 ' A' ' 146' ' ' VAL . 34.4 t80 -100.41 159.97 14.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.725 . . . . 0.0 109.202 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.81 118.79 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.459 -0.776 . . . . 0.0 110.946 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.42 HG21 ' CE2' ' A' ' 158' ' ' PHE . 30.6 p -89.78 156.41 47.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.094 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.53 169.53 12.58 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.652 1.343 . . . . 0.0 110.83 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 129.47 41.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.406 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 7.2 mm-40 -116.33 127.27 54.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.626 -0.671 . . . . 0.0 109.631 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -83.2 133.61 35.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.79 165.15 43.32 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.765 -0.585 . . . . 0.0 110.188 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.2 123.69 8.97 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.401 1.211 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 169.2 8.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.654 -0.653 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.01 160.82 10.76 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.78 -43.54 97.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.969 . . . . 0.0 110.151 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.67 -27.35 40.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.647 -0.658 . . . . 0.0 110.216 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.97 -22.18 59.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.499 -0.751 . . . . 0.0 110.645 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -68.23 131.17 44.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.478 -0.764 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 151.71 179.4 27.34 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.2 p -87.44 130.16 34.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.524 -0.986 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.03 113.88 26.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 110.641 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.86 125.33 29.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.458 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.7 mt -117.61 137.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.379 -0.825 . . . . 0.0 110.959 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -103.31 96.86 7.04 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.412 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 1.4 p -94.25 125.39 38.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.683 . . . . 0.0 110.671 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -127.6 96.83 4.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.681 . . . . 0.0 109.997 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -83.14 91.27 7.2 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.586 -0.696 . . . . 0.0 110.087 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.9 t -116.98 -171.77 2.09 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 p30 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.364 179.151 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.502 2.143 0 CA-C-O 121.242 0.544 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.07 120.01 38.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 16.3 m-70 -82.75 -73.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.779 . . . . 0.0 110.864 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.1 tp -156.05 151.19 26.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.669 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 t -153.86 139.69 18.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.663 . . . . 0.0 109.786 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.412 ' CE2' ' OG ' ' A' ' 179' ' ' SER . 21.9 p90 -135.19 -153.57 0.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.99 132.01 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.452 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 17.0 p-90 -139.33 147.1 41.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.678 -0.639 . . . . 0.0 109.614 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.78 152.05 20.95 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.518 0.675 . . . . 0.0 111.26 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -126.16 91.54 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -67.9 137.2 55.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.608 -0.682 . . . . 0.0 110.436 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -114.53 145.3 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 109.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -144.16 -153.07 0.45 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 109.84 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -132.06 1.41 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.399 -0.813 . . . . 0.0 111.661 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -160.23 46.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.942 -1.099 . . . . 0.0 111.122 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.449 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -59.15 -18.63 37.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 111.197 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -152.47 48.24 0.75 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.219 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' CG1' ' CE ' ' A' ' 126' ' ' MET . 93.3 t -141.92 117.76 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.507 0.67 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.0 t -139.66 144.05 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.899 -0.501 . . . . 0.0 109.775 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.408 HG23 ' CD2' ' A' ' 181' ' ' PHE . 60.0 t -64.27 99.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.1 p -70.83 -44.63 66.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.715 -0.616 . . . . 0.0 111.228 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -154.97 158.0 38.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.32 152.57 36.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.724 -0.61 . . . . 0.0 109.757 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -139.77 152.64 46.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -0.765 . . . . 0.0 110.631 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -136.67 83.52 2.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.574 -0.704 . . . . 0.0 109.973 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.85 149.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.634 . . . . 0.0 110.14 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.8 m -146.07 -164.96 2.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.693 -0.629 . . . . 0.0 110.037 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.6 p -103.53 -76.9 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.775 . . . . 0.0 110.758 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 p -96.26 32.59 1.93 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.826 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' CZ3' ' A' ' 202' ' ' TRP . . . -90.28 178.99 1.63 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.652 -0.655 . . . . 0.0 110.087 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.25 -26.85 12.1 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.342 1.18 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 156.63 -179.42 32.48 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.72 111.4 3.13 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.488 1.257 . . . . 0.0 110.416 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' CD2' ' CD1' ' A' ' 102' ' ' PHE . 13.8 mt -65.76 115.66 6.14 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.99 137.78 34.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 3.9 mt -132.71 119.67 20.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 0.0 109.717 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.49 141.95 50.17 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -138.51 56.3 1.72 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.753 . . . . 0.0 110.059 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -105.99 -66.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.265 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.57 -46.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.91 65.15 1.94 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.574 -0.956 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.418 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 13.4 mt -84.19 0.1 50.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.575 -0.703 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.61 -27.29 64.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.029 . . . . 0.0 110.787 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.8 m -65.42 -13.77 59.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.463 -0.773 . . . . 0.0 111.065 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 10.7 m-85 -72.19 -52.51 16.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.286 -0.883 . . . . 0.0 110.711 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -57.68 -20.24 32.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.521 -0.737 . . . . 0.0 111.007 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -115.0 44.96 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.4 -0.812 . . . . 0.0 110.393 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -168.66 146.55 4.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 p -150.98 131.39 13.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 109.82 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 86' ' ' LEU . 15.1 m-85 -77.12 122.99 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 110.189 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.65 113.17 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 109.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HG ' ' CZ3' ' A' ' 202' ' ' TRP . 4.1 tt -113.62 156.81 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.421 ' HB2' ' CG ' ' A' ' 202' ' ' TRP . 31.8 tttt -80.9 161.8 24.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -40.82 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.73 66.77 0.11 Allowed Glycine 0 N--CA 1.507 3.372 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.777 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 30.5 m -79.01 -160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.224 -1.162 . . . . 0.0 109.201 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.09 117.11 27.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.464 -0.773 . . . . 0.0 109.54 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.441 ' CD1' HD21 ' A' ' 77' ' ' LEU . 10.8 p90 -137.67 152.13 48.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.306 -0.872 . . . . 0.0 111.916 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -109.67 150.27 28.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.39 151.56 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.133 -0.979 . . . . 0.0 111.703 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 93.28 3.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.456 ' CG2' ' CE2' ' A' ' 181' ' ' PHE . 47.8 mm -81.18 142.6 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.743 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.8 m -122.08 135.94 54.86 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 116' ' ' PHE . 15.5 p90 -153.06 145.34 23.95 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.333 -0.854 . . . . 0.0 111.158 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -88.52 128.25 35.55 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.39 84.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.75 48.88 2.32 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 111.86 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -145.42 -66.32 0.31 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.237 -0.914 . . . . 0.0 110.904 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.74 168.92 17.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.339 -0.851 . . . . 0.0 110.412 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.29 108.37 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.99 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.4 86.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 109.798 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.3 p -88.11 88.48 7.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.616 -0.677 . . . . 0.0 110.384 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 137.94 44.64 0.08 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.446 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -80.99 121.07 25.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 109.793 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -129.5 137.42 50.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.728 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.502 ' CD1' ' CD2' ' A' ' 181' ' ' PHE . 14.0 t80 -111.62 139.02 47.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.723 . . . . 0.0 109.678 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.0 mt -136.79 144.45 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.541 -0.725 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.52 144.28 37.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 110.057 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 14.9 m-70 -117.23 116.92 28.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.596 -0.69 . . . . 0.0 110.156 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 29.3 m -68.04 77.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 0.0 110.202 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 4.2 m-85 -76.39 125.99 30.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.403 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 7.9 tpt180 -120.75 120.89 36.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt 52.89 38.59 27.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.488 -0.757 . . . . 0.0 110.754 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.8 35.56 58.47 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.5 t -147.1 109.14 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.955 . . . . 0.0 109.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 4.9 pttm -63.02 128.9 37.99 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.637 -0.664 . . . . 0.0 110.232 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.53 -23.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.635 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.43 132.18 0.29 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.89 149.99 49.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.683 . . . . 0.0 109.634 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -127.56 154.89 44.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.514 -0.741 . . . . 0.0 110.838 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -126.01 121.44 33.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.63 -0.669 . . . . 0.0 110.052 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -110.99 145.7 37.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.703 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -92.08 119.33 31.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.228 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.431 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 58.9 t -79.58 -52.43 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 110.304 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.7 175.81 14.2 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 30.8 t -99.02 139.37 34.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.927 . . . . 0.0 110.063 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.492 ' CD1' ' CE2' ' A' ' 156' ' ' TYR . 47.0 m-85 -142.04 126.89 18.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.694 . . . . 0.0 110.308 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.25 164.78 28.56 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.08 92.97 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.447 1.235 . . . . 0.0 110.342 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -169.49 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 0.0 110.447 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -92.43 19.33 7.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.542 -0.724 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 38.1 mt-10 56.2 -143.88 0.7 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 152.35 45.5 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.05 -1.031 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 149' ' ' TYR . 42.0 m-85 -116.13 -176.31 2.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 109.546 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -147.49 104.31 3.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.509 -0.744 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 146' ' ' VAL . 34.9 t80 -77.85 165.81 23.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.87 97.57 2.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.396 -0.815 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.43 HG21 ' CE2' ' A' ' 158' ' ' PHE . 75.0 p -72.79 149.17 90.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.46 157.55 54.28 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.415 1.218 . . . . 0.0 110.702 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.71 93.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.606 -0.684 . . . . 0.0 110.976 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -79.87 167.71 20.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.416 -0.803 . . . . 0.0 109.862 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.69 123.32 48.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.504 -0.747 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 177.03 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.45 127.73 12.09 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.298 1.157 . . . . 0.0 111.112 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -115.63 174.97 5.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 110.121 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.65 156.5 10.66 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 15.2 ttt -62.33 -46.61 87.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.734 -0.862 . . . . 0.0 109.998 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.89 -26.42 60.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.645 . . . . 0.0 110.182 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.93 -20.7 39.44 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.421 -0.799 . . . . 0.0 110.719 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.7 mtp-105 -58.5 125.22 22.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.304 -0.872 . . . . 0.0 110.411 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.75 175.4 27.65 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.4 p -84.86 134.7 34.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.594 -0.945 . . . . 0.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.403 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 32.3 m-85 -115.59 101.41 8.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.607 -0.683 . . . . 0.0 110.693 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.18 121.37 17.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.714 . . . . 0.0 109.112 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.42 HD13 ' CZ2' ' A' ' 194' ' ' TRP . 42.6 mt -110.09 126.61 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.53 -0.732 . . . . 0.0 110.99 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -87.4 92.52 9.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.685 -0.634 . . . . 0.0 109.879 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.0 p -84.98 140.94 30.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.658 -0.651 . . . . 0.0 110.674 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.82 83.62 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.892 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.502 ' CD2' ' CD1' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.26 128.66 34.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.668 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -162.72 -169.88 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.672 . . . . 0.0 110.52 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.878 -0.514 . . . . 0.0 109.762 179.686 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 121.105 0.479 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.35 110.99 20.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.48 -55.04 13.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.464 -0.773 . . . . 0.0 110.665 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -166.54 164.19 17.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 190' ' ' LEU . 17.6 p -168.23 134.73 1.99 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.853 -0.529 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.422 ' CG ' HD22 ' A' ' 90' ' ' LEU . 14.5 p90 -147.0 -155.21 0.6 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 110.442 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -157.81 127.68 6.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 12.3 p-90 -134.79 146.21 49.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.697 -0.627 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.91 136.11 40.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.656 -0.653 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.7 tp -110.36 98.55 7.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.6 m -73.14 121.07 19.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.651 -0.656 . . . . 0.0 110.515 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.7 mm -90.24 149.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.592 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 -155.82 0.64 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 110.456 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -120.22 -21.3 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.504 -0.747 . . . . 0.0 111.268 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -155.04 81.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.441 ' CZ3' ' HB3' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -79.74 3.21 20.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.478 -0.764 . . . . 0.0 111.501 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 44.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.086 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.7 t -110.15 140.09 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.662 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.3 t -149.43 144.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.731 -0.606 . . . . 0.0 109.616 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.4 100.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.0 p -70.23 -44.46 68.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -159.29 173.92 15.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tt -144.3 164.41 30.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.688 -0.632 . . . . 0.0 109.544 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.4 m -151.55 163.01 39.98 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.432 -0.792 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -143.36 84.19 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.604 -0.685 . . . . 0.0 109.895 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.98 143.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.731 -0.606 . . . . 0.0 110.106 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.67 -163.13 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.592 -0.693 . . . . 0.0 110.077 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.9 p -110.53 -72.68 0.71 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.466 -0.772 . . . . 0.0 110.677 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -95.75 27.66 3.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.565 -0.709 . . . . 0.0 110.639 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.443 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.27 -176.52 0.65 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.28 -25.04 10.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.311 1.163 . . . . 0.0 110.016 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.07 -177.08 30.91 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.484 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 91.55 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.556 1.292 . . . . 0.0 110.558 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.83 111.41 2.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.696 . . . . 0.0 109.386 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.86 159.83 14.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.0 110.872 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.426 HD23 ' CE2' ' A' ' 97' ' ' PHE . 4.4 mt -132.18 128.16 37.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.722 -0.611 . . . . 0.0 109.912 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 133.46 40.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 192' ' ' TRP . 0.9 OUTLIER -132.09 51.79 2.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.3 p -123.82 -65.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.391 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.92 -53.18 0.21 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.99 71.97 0.4 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.541 -0.976 . . . . 0.0 110.158 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -33.84 13.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.009 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.29 -26.99 65.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.591 -0.693 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.4 t -60.34 -23.68 64.44 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 110.472 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.426 ' CE2' HD23 ' A' ' 88' ' ' LEU . 5.3 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -73.63 -26.96 61.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.64 -0.663 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -105.08 28.91 6.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.453 -0.779 . . . . 0.0 110.284 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -158.46 139.82 13.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.716 . . . . 0.0 110.127 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -126.24 -175.8 3.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 110.4 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.445 ' CE2' ' CB ' ' A' ' 86' ' ' LEU . 1.7 m-85 -116.65 109.31 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.673 -0.642 . . . . 0.0 109.99 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.11 105.73 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -0.779 . . . . 0.0 109.793 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.441 ' HG ' ' CZ3' ' A' ' 202' ' ' TRP . 3.8 tt -122.43 158.62 29.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.627 -0.67 . . . . 0.0 110.077 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 106' ' ' GLU . 2.2 tttt -87.22 161.56 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.472 -0.767 . . . . 0.0 110.385 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 105' ' ' LYS . 33.9 mt-10 -18.58 -71.63 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.27 63.26 0.4 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.699 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.5 m -73.29 127.41 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.442 -1.034 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -71.71 94.77 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.43 ' CD1' HD21 ' A' ' 77' ' ' LEU . 14.6 p90 -109.49 154.87 22.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 111.838 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.3 131.1 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.04 142.28 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.261 -0.9 . . . . 0.0 110.533 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -117.85 102.69 9.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.412 HG22 ' CE1' ' A' ' 181' ' ' PHE . 47.7 mm -88.11 127.92 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.755 . . . . 0.0 110.685 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -113.06 137.89 50.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 116' ' ' PHE . 19.5 p90 -151.05 174.84 12.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 110.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -127.64 150.83 49.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 111.322 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.67 111.32 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -128.66 48.39 2.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.472 -0.767 . . . . 0.0 111.472 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -69.71 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.0 110.646 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -137.93 171.98 13.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.431 -0.793 . . . . 0.0 110.472 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.9 mt -80.0 109.84 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.615 . . . . 0.0 109.966 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.9 t -84.65 82.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.848 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 p -81.21 77.58 8.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.637 -0.664 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.97 46.08 0.04 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 1.3 tpp -79.54 137.68 37.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.546 -0.973 . . . . 0.0 109.489 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -126.11 158.15 36.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -134.31 109.9 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.74 166.22 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.496 -0.753 . . . . 0.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -154.96 127.89 8.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.665 -0.647 . . . . 0.0 109.602 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 12.9 m-70 -110.32 117.19 32.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.3 m -68.51 78.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 0.0 109.902 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 2.7 m-85 -78.25 105.1 9.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.191 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HD3' ' CD2' ' A' ' 175' ' ' TYR . 11.0 tpt180 -120.76 153.76 36.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.683 -0.636 . . . . 0.0 109.686 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 52.91 36.22 21.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.33 -0.857 . . . . 0.0 110.786 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.32 23.91 66.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.3 149.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.306 -1.114 . . . . 0.0 110.181 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 21.8 ttmt -80.1 136.31 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.0 110.247 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -118.5 -25.19 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.456 -0.778 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -174.69 143.29 0.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.104 -0.998 . . . . 0.0 110.248 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 2.9 pttt -137.76 166.45 23.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.234 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.1 m -145.0 156.56 44.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.586 -0.696 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.91 132.65 52.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 110.335 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -123.08 121.92 37.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.709 . . . . 0.0 110.576 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.406 ' O ' ' CZ ' ' A' ' 158' ' ' PHE . 23.6 mtp -65.15 122.08 16.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -0.786 . . . . 0.0 109.29 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 48.8 t -79.27 -56.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 110.298 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 137.41 174.04 13.17 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 p -84.99 150.31 24.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.701 -0.882 . . . . 0.0 109.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 147' ' ' GLY . 69.8 m-85 -146.7 161.32 40.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.357 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -110.07 154.55 16.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 50.5 Cg_endo -72.64 -156.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.713 1.375 . . . . 0.0 110.321 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 25.4 mtp-105 73.09 51.23 0.14 Allowed 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 50.64 23.69 1.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.428 -0.795 . . . . 0.0 111.852 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 tt0 -79.38 103.43 9.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.56 112.91 24.8 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.615 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 78.5 m-85 -96.75 -175.3 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.738 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -141.02 112.51 7.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 160' ' ' THR . 30.8 t80 -83.82 160.46 21.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.226 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.05 100.82 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 111.459 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.431 HG21 ' CE2' ' A' ' 158' ' ' PHE . 52.4 p -69.56 149.35 97.01 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.35 -179.45 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.591 1.311 . . . . 0.0 111.077 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptm -53.73 144.88 16.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.685 -0.634 . . . . 0.0 111.232 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.407 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 12.3 mt-10 -140.54 96.35 3.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.73 -0.606 . . . . 0.0 109.673 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.76 121.76 17.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.625 -0.672 . . . . 0.0 110.595 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 104' ' ' LEU . . . -55.0 176.49 0.15 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.723 -0.611 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.08 118.38 5.66 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.367 1.193 . . . . 0.0 110.299 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.75 165.85 13.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.605 -0.684 . . . . 0.0 110.712 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.82 143.64 14.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.438 ' HA ' ' CD ' ' A' ' 172' ' ' ARG . 30.6 mtp -60.26 -42.24 94.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.521 -0.988 . . . . 0.0 109.511 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.55 -22.23 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.869 -0.519 . . . . 0.0 109.938 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.72 23.06 4.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.438 ' CD ' ' HA ' ' A' ' 169' ' ' MET . 45.9 mtm180 -100.37 176.85 5.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.257 -0.902 . . . . 0.0 110.029 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 105.63 -173.99 20.64 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.9 p -86.04 131.05 34.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.924 . . . . 0.0 110.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.406 ' CD2' ' HD3' ' A' ' 134' ' ' ARG . 24.7 m-85 -116.67 108.5 15.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.688 -0.633 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -73.85 121.2 20.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.533 -0.73 . . . . 0.0 109.128 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.3 mt -110.09 129.61 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.4 -0.812 . . . . 0.0 111.061 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 108.54 20.41 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.698 -0.626 . . . . 0.0 109.729 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.3 p -113.16 135.15 54.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.8 118.43 23.71 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.604 0.716 . . . . 0.0 110.361 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -91.41 94.64 9.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.535 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -116.82 -172.5 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 111.092 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.88 -0.512 . . . . 0.0 109.904 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 121.239 0.543 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.89 118.62 34.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.728 -0.607 . . . . 0.0 109.757 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -57.87 -50.79 72.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.483 -0.761 . . . . 0.0 110.697 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.0 tp -169.4 151.12 4.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.498 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 65.3 p -147.74 161.29 41.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.431 ' CD2' ' CD2' ' A' ' 90' ' ' LEU . 16.9 p90 -146.58 -156.23 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.766 . . . . 0.0 110.232 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.94 131.45 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.621 -0.674 . . . . 0.0 110.562 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.466 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.86 146.31 41.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.652 -0.655 . . . . 0.0 109.799 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.69 146.59 24.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.699 . . . . 0.0 111.079 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 53.2 tp -116.23 97.43 6.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.4 m -72.11 111.9 7.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 0.0 110.081 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.5 mm -90.41 146.94 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.625 -0.672 . . . . 0.0 109.811 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -138.25 -156.91 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.684 -0.635 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -115.85 -24.31 8.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 110.72 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.79 94.89 1.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.611 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.443 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -84.95 12.19 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.606 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -153.65 40.1 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 110.18 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.116 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.079 0.466 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG13 ' CE1' ' A' ' 189' ' ' HIS . 95.7 t -119.96 126.51 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.792 -0.567 . . . . 0.0 110.164 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -149.02 132.55 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.832 -0.542 . . . . 0.0 109.879 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.18 108.64 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.7 p -71.2 -62.05 1.54 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.66 . . . . 0.0 110.728 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -141.03 169.01 18.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.944 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -130.64 124.49 31.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.648 -0.657 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 m -109.9 159.71 17.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -0.782 . . . . 0.0 110.486 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mt -139.76 84.15 1.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.539 -0.726 . . . . 0.0 109.978 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.21 166.68 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.685 -0.634 . . . . 0.0 110.344 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.24 -152.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.607 -0.683 . . . . 0.0 109.847 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.04 -36.24 2.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 111.068 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -126.7 26.25 6.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.348 -0.845 . . . . 0.0 110.8 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.455 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.36 -175.51 0.54 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.403 -0.811 . . . . 0.0 110.235 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 48.7 Cg_endo -80.14 -30.97 1.91 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.313 1.165 . . . . 0.0 109.97 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.61 175.54 36.24 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.521 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.4 104.67 1.73 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.521 1.274 . . . . 0.0 110.506 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 102' ' ' PHE . 2.4 mp -69.41 112.42 5.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 109.493 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.72 146.53 23.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.629 -0.67 . . . . 0.0 110.749 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -132.42 153.88 50.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 109.81 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.86 133.76 47.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.478 -0.764 . . . . 0.0 110.508 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.407 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -132.02 51.93 2.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.501 -0.75 . . . . 0.0 110.103 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.9 p -113.52 -69.57 0.85 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.94 -47.3 0.15 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -72.48 64.9 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.639 -0.919 . . . . 0.0 109.987 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.424 HD22 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -90.24 -23.16 21.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.397 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.37 -30.67 62.98 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.29 -0.881 . . . . 0.0 110.767 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -58.08 -20.23 38.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.486 -0.759 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 6.0 m-85 -60.02 -30.39 69.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.92 -22.7 66.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.743 -0.598 . . . . 0.0 110.931 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -121.92 60.11 0.98 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.697 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.61 125.03 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.374 -0.829 . . . . 0.0 110.363 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.4 p -135.04 127.18 29.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 86' ' ' LEU . 22.8 m-85 -73.98 139.05 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.537 -0.727 . . . . 0.0 109.881 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.16 108.27 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.485 -0.76 . . . . 0.0 110.449 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 58.0 mt -113.87 165.73 12.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.55 -0.718 . . . . 0.0 109.69 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.437 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 15.1 tttm -94.46 160.93 14.43 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -18.28 -108.86 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.99 75.4 0.39 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.33 -1.481 . . . . 0.0 110.144 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m -85.26 143.76 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.536 -0.979 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -88.92 89.25 7.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -110.0 131.09 55.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 111.917 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.02 159.64 14.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.2 145.3 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.053 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -118.06 102.35 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.2 127.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.522 -0.736 . . . . 0.0 110.851 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.18 145.98 31.92 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.467 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 27.8 p90 -162.43 149.16 13.25 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.363 -0.835 . . . . 0.0 111.009 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -101.57 133.16 46.68 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.361 0.601 . . . . 0.0 111.282 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.06 96.43 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.52 48.64 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.344 -0.847 . . . . 0.0 111.742 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -146.76 -69.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.224 -0.923 . . . . 0.0 110.794 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.9 158.16 40.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.19 102.9 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.565 -0.709 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.72 94.99 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.616 -0.677 . . . . 0.0 109.826 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.13 97.83 8.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.617 -0.677 . . . . 0.0 110.294 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.17 41.03 0.38 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.467 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -78.86 126.19 30.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.942 . . . . 0.0 109.78 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -137.2 146.87 45.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.13 137.84 48.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 129' ' ' ILE . 81.0 mt -123.19 156.45 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.516 -0.74 . . . . 0.0 110.231 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -154.64 131.88 11.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.793 -0.567 . . . . 0.0 109.74 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.403 ' ND1' ' CB ' ' A' ' 141' ' ' LYS . 23.8 m-70 -110.64 131.56 54.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.547 -0.721 . . . . 0.0 110.098 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 31.3 m -81.87 67.3 7.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.615 -0.678 . . . . 0.0 109.837 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 6.4 m-85 -61.57 136.92 58.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.498 -0.751 . . . . 0.0 110.104 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -120.84 110.53 16.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.75 35.91 22.56 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.471 -0.768 . . . . 0.0 110.588 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.31 14.96 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.13 113.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -1.041 . . . . 0.0 110.143 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -67.64 123.92 21.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.649 -0.657 . . . . 0.0 110.189 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.65 -22.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.486 -0.759 . . . . 0.0 110.8 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -169.36 123.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.403 ' CB ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -130.86 154.15 48.36 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.697 . . . . 0.0 109.468 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.5 m -142.45 146.03 34.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -109.33 120.51 42.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.695 -0.628 . . . . 0.0 109.462 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -104.37 117.68 34.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.443 -0.786 . . . . 0.0 110.946 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 124.9 23.92 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.423 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 21.7 t -90.53 -56.5 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 110.25 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.33 166.68 10.76 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 79.5 p -81.0 140.63 35.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.637 -0.92 . . . . 0.0 109.558 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.408 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 43.9 m-85 -139.45 130.04 25.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.425 -0.797 . . . . 0.0 110.36 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.23 166.84 14.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.24 68.89 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.486 1.256 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.96 27.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.459 ' CB ' ' CZ ' ' A' ' 156' ' ' TYR . . . -147.3 12.54 1.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 111.676 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 52.21 -145.08 0.57 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.956 -1.09 . . . . 0.0 111.09 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.1 122.4 20.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.39 -0.819 . . . . 0.0 110.948 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 116' ' ' PHE . 6.5 m-85 -84.17 -173.51 4.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.724 . . . . 0.0 109.911 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -153.9 104.45 2.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 22.3 t80 -85.18 162.61 19.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -140.44 87.1 2.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.403 -0.811 . . . . 0.0 111.305 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 158' ' ' PHE . 65.5 p -67.19 148.27 98.83 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.37 -0.831 . . . . 0.0 108.965 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.26 157.73 60.57 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.392 1.206 . . . . 0.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.2 ptt? -54.61 108.67 0.41 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.574 -0.704 . . . . 0.0 110.659 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -88.55 155.97 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.38 -0.825 . . . . 0.0 110.296 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.73 137.7 44.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.284 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -94.16 172.15 6.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.323 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.18 179.77 5.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.382 1.201 . . . . 0.0 110.529 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -170.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.439 -0.788 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.06 -44.14 0.09 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.7 mtt -56.2 -75.27 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -1.102 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -2.55 36.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.982 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.26 28.75 6.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -0.946 . . . . 0.0 110.082 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 163.98 27.22 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.517 -0.739 . . . . 0.0 109.985 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.18 -167.78 14.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.1 p -107.23 130.46 54.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.663 -0.904 . . . . 0.0 110.661 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.61 129.72 50.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.671 -0.643 . . . . 0.0 109.954 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.27 143.04 47.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.745 . . . . 0.0 109.851 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.413 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -121.43 130.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.51 -0.744 . . . . 0.0 110.199 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -110.92 98.89 7.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.534 -0.729 . . . . 0.0 109.307 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.43 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 10.0 m -100.82 133.66 44.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.648 -0.658 . . . . 0.0 110.422 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -139.54 90.51 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.706 -0.621 . . . . 0.0 109.39 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 189' ' ' HIS . 0.3 OUTLIER -75.77 116.47 16.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.837 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 t -129.1 -175.38 3.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.755 -0.59 . . . . 0.0 109.803 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.294 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 121.201 0.524 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.59 115.75 30.12 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 31.8 p80 -74.36 -15.21 60.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 0.0 111.31 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.1 tp -168.83 156.22 7.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.124 -0.985 . . . . 0.0 110.853 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.0 p -168.38 143.79 3.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.739 -0.6 . . . . 0.0 109.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 179' ' ' SER . 40.4 p90 -151.19 -156.15 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 110.095 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.6 132.88 3.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 111.085 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 8.9 p-90 -139.33 165.44 27.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.79 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -102.19 159.68 15.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 111.291 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.48 109.75 11.31 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.1 m -85.28 130.11 34.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.696 . . . . 0.0 110.85 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.98 152.14 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.63 -0.669 . . . . 0.0 109.402 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -145.13 -151.83 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 110.605 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -107.43 -39.49 5.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 111.302 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -144.6 98.08 3.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.21 -0.931 . . . . 0.0 111.207 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.455 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -89.09 35.1 0.79 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.191 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -169.71 34.13 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.27 -0.894 . . . . 0.0 110.136 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.904 -1.045 . . . . 0.0 110.173 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 120.84 0.352 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -130.06 112.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.623 . . . . 0.0 110.461 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -138.64 149.5 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.926 -0.484 . . . . 0.0 109.885 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.423 HG23 ' CD2' ' A' ' 181' ' ' PHE . 59.7 t -65.68 103.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -72.02 -35.94 69.55 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.146 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -167.31 173.09 9.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 110.4 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tt -142.68 124.59 15.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.577 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -109.7 167.19 10.33 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.56 -0.713 . . . . 0.0 110.843 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.03 80.98 1.54 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.62 -0.675 . . . . 0.0 109.39 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.0 t -77.49 166.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 110.157 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.17 -166.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.691 -0.63 . . . . 0.0 110.192 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.8 p -116.55 -33.13 4.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -124.17 20.21 9.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.708 . . . . 0.0 110.856 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.453 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.62 -174.83 0.47 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 47.5 Cg_endo -81.02 -30.87 1.51 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.27 1.142 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.19 173.17 34.36 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.89 -1.147 . . . . 0.0 110.55 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.56 96.32 0.74 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.665 1.35 . . . . 0.0 110.372 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 3.6 mt -64.81 123.87 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.652 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -103.52 122.76 45.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.501 -0.749 . . . . 0.0 110.802 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -102.6 119.17 38.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -67.58 141.0 56.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.587 -0.695 . . . . 0.0 110.688 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.416 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -140.35 56.83 1.6 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.471 -0.768 . . . . 0.0 110.073 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.8 p -128.53 -56.22 1.23 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.684 -0.635 . . . . 0.0 110.3 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.89 -51.9 0.04 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.39 69.94 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.597 -0.943 . . . . 0.0 110.147 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -94.23 -22.69 18.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.51 -0.744 . . . . 0.0 110.579 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -22.17 12.88 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.373 -0.83 . . . . 0.0 111.08 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.26 63.38 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 0.0 110.548 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 5.5 m-85 -58.97 -60.34 4.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.362 -0.836 . . . . 0.0 110.667 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -13.45 47.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.482 -0.761 . . . . 0.0 111.231 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -86.36 -15.99 38.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.16 -0.962 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.68 162.23 34.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -132.4 167.74 19.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 86' ' ' LEU . 3.9 m-85 -103.18 113.13 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.636 -0.665 . . . . 0.0 109.874 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.89 117.27 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 110.787 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.452 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 37.0 mt -127.6 145.02 51.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 26.9 tttm -65.21 142.08 58.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.213 -0.93 . . . . 0.0 108.848 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.0 pt-20 -57.13 110.64 0.87 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.404 -0.81 . . . . 0.0 111.523 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.2 39.73 3.68 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.762 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 27.6 m -99.12 133.08 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.128 -1.219 . . . . 0.0 110.653 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.27 98.11 11.15 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.05 144.74 40.91 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.616 0.722 . . . . 0.0 111.611 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -106.55 150.87 25.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.8 mt -119.86 148.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -130.08 93.2 3.44 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.88 150.37 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.567 0.699 . . . . 0.0 110.652 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -124.82 145.22 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 116' ' ' PHE . 31.2 p90 -166.28 136.68 3.39 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.523 -0.735 . . . . 0.0 110.501 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -87.26 144.16 26.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.776 -0.578 . . . . 0.0 111.158 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -131.03 83.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.577 -0.702 . . . . 0.0 109.415 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.34 48.7 2.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.515 -0.741 . . . . 0.0 111.738 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -147.79 -66.39 0.25 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.287 -0.883 . . . . 0.0 111.126 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.08 169.9 16.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.935 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 91.5 mt -78.4 124.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.63 . . . . 0.0 110.115 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.11 80.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.2 p -79.77 112.11 16.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.749 -0.595 . . . . 0.0 110.705 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.75 45.35 0.51 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 1.8 mmt -61.98 132.56 53.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -1.097 . . . . 0.0 109.098 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.16 148.76 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.923 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.96 87.4 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 109.533 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 129' ' ' ILE . 85.5 mt -81.46 169.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.648 . . . . 0.0 110.072 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.18 120.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.445 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.2 m-70 -103.4 124.88 49.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.0 110.083 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.7 m -85.25 68.32 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.373 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -65.96 154.31 39.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.425 -0.797 . . . . 0.0 110.201 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -130.72 86.29 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.598 -0.689 . . . . 0.0 110.602 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 53.63 61.96 2.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.381 -0.825 . . . . 0.0 110.857 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.76 36.58 57.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.01 146.95 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.991 . . . . 0.0 109.793 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.11 121.0 43.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.44 -26.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.759 . . . . 0.0 111.145 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -161.82 153.08 18.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.888 -1.133 . . . . 0.0 111.201 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.423 ' HE3' ' CE1' ' A' ' 131' ' ' HIS . 5.9 ptmt -175.79 135.91 0.31 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.708 . . . . 0.0 109.229 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.8 m -146.23 168.82 20.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -108.39 151.0 26.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.723 -0.611 . . . . 0.0 110.005 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -119.86 128.42 53.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.509 -0.744 . . . . 0.0 110.676 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 ttp -87.77 109.0 19.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.451 -0.781 . . . . 0.0 109.382 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.43 HG12 ' CG ' ' A' ' 158' ' ' PHE . 80.2 t -86.43 -71.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 110.709 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.59 -165.57 38.0 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.7 p -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.676 -0.896 . . . . 0.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' A' ' 126' ' ' MET . 11.8 m-85 -126.22 -173.95 2.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.837 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.69 162.94 26.23 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.83 66.25 2.41 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.314 1.165 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.13 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.555 -0.716 . . . . 0.0 109.895 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -178.35 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.005 -1.06 . . . . 0.0 110.709 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -94.02 -171.09 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.444 -0.785 . . . . 0.0 111.563 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.4 144.31 30.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.367 0.604 . . . . 0.0 110.601 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 60.4 m-85 -107.96 154.64 21.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -128.84 135.28 48.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.331 -0.856 . . . . 0.0 111.371 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.43 ' CG ' HG12 ' A' ' 146' ' ' VAL . 28.0 t80 -103.44 136.18 43.67 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.77 116.45 25.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 110.778 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.42 HG21 ' CE2' ' A' ' 158' ' ' PHE . 43.1 p -86.54 153.05 55.55 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 162.56 37.54 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.628 1.331 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.41 123.36 15.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.567 -0.708 . . . . 0.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.45 114.15 27.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.687 -0.633 . . . . 0.0 109.999 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -69.85 127.08 31.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.646 -0.658 . . . . 0.0 110.288 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.71 172.75 4.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.8 -0.562 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.82 147.54 56.28 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 O-C-N 123.427 1.225 . . . . 0.0 110.131 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 35.7 mtmt -115.92 175.57 5.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.514 -0.741 . . . . 0.0 110.461 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.57 147.17 17.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -52.74 43.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.541 -0.976 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.48 -27.93 62.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.463 -0.773 . . . . 0.0 110.34 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.29 38.25 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 mtp-105 -67.71 126.98 31.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.511 -0.743 . . . . 0.0 109.9 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.32 177.88 28.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 p -91.8 135.81 33.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.918 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -128.56 114.68 17.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 110.054 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.98 148.4 47.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.768 . . . . 0.0 110.132 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.421 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 46.2 mm -124.09 101.67 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 0.0 110.172 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -91.67 104.0 16.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 14.9 m -113.88 142.94 45.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.516 -0.74 . . . . 0.0 110.939 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -123.49 95.28 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.777 -0.577 . . . . 0.0 109.455 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 6.6 t80 -80.61 73.56 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.711 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.1 t -116.56 -168.84 1.52 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.665 . . . . 0.0 109.319 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.541 -0.725 . . . . 0.0 109.814 179.521 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -115.18 109.61 18.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.63 -0.669 . . . . 0.0 109.807 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -77.9 -67.76 0.7 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.451 -0.781 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -143.9 164.61 30.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 110.123 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.433 ' N ' ' CD1' ' A' ' 190' ' ' LEU . 7.4 t -168.82 135.38 1.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 16.4 p90 -145.23 -172.83 3.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.65 125.88 7.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.513 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.0 p-90 -134.48 145.25 48.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.688 -0.633 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.62 146.79 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.2 tp -120.28 94.37 4.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.731 -0.606 . . . . 0.0 109.793 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.6 m -73.23 148.58 43.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.56 -0.712 . . . . 0.0 110.017 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.9 mm -124.27 135.95 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.604 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -128.76 -156.09 0.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.569 -0.707 . . . . 0.0 110.491 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -30.45 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 111.103 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -138.22 56.7 1.72 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.368 -0.832 . . . . 0.0 111.122 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -60.87 -16.04 37.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.0 111.327 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 35.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 110.455 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.186 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.182 0.515 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.04 111.45 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.628 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -142.03 152.78 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.2 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.454 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 58.0 t -68.81 102.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 -53.57 11.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.597 -0.69 . . . . 0.0 110.065 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -150.02 165.68 31.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.74 -0.6 . . . . 0.0 110.001 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.06 165.21 19.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.728 -0.608 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -155.04 156.13 35.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.59 -0.694 . . . . 0.0 110.81 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -136.17 96.91 3.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.0 109.737 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.26 167.88 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.852 -0.53 . . . . 0.0 110.188 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -171.7 -28.03 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.483 -0.761 . . . . 0.0 111.672 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 p 62.58 17.43 9.64 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -140.63 -46.55 0.41 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.507 -0.746 . . . . 0.0 109.224 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.463 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -59.34 -174.84 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.765 -0.584 . . . . 0.0 110.025 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 82' ' ' ALA . 43.8 Cg_endo -73.11 -23.59 18.0 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.167 1.088 . . . . 0.0 110.345 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.66 176.73 40.21 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.83 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.15 102.87 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.639 1.336 . . . . 0.0 110.452 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 30.5 mt -65.38 102.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -98.29 161.44 13.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.639 -0.663 . . . . 0.0 111.234 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.448 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 4.3 mt -130.94 167.53 18.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.822 -0.548 . . . . 0.0 109.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.419 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 11.0 t70 -111.05 131.22 55.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.578 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.415 HD22 ' CD2' ' A' ' 192' ' ' TRP . 1.5 mp -136.95 55.39 1.83 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 109.899 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -135.94 36.0 2.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.609 -0.682 . . . . 0.0 110.66 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.11 -86.65 0.22 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.97 81.18 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.694 -0.886 . . . . 0.0 110.197 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -95.12 -26.36 16.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.63 -0.669 . . . . 0.0 110.379 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -57.86 -26.64 62.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.443 -0.786 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -22.44 30.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.423 -0.798 . . . . 0.0 110.389 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.448 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 3.2 m-85 -56.47 -22.06 29.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.434 -0.791 . . . . 0.0 110.526 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -81.86 -20.18 39.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -0.783 . . . . 0.0 110.523 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -86.55 -22.15 26.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.935 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -132.4 134.81 45.59 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 110.689 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -105.83 -168.53 1.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.655 -0.653 . . . . 0.0 109.921 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CE1' ' HG ' ' A' ' 88' ' ' LEU . 1.6 m-85 -116.98 96.62 5.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.42 108.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.715 -0.616 . . . . 0.0 109.854 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.458 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 5.1 mt -113.87 -170.85 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.6 -0.687 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.432 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 31.1 tttm -134.64 157.23 47.15 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.994 0.902 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -47.54 124.46 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 45.51 60.18 4.35 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.905 -0.497 . . . . 0.0 113.097 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.7 m -96.15 119.83 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.239 -1.153 . . . . 0.0 110.596 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.43 96.0 2.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.42 ' CD1' HD21 ' A' ' 77' ' ' LEU . 14.3 p90 -115.44 148.79 38.98 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.573 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -102.0 138.14 39.36 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.73 161.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.247 -0.908 . . . . 0.0 110.521 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.59 82.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mm -75.15 143.78 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.708 -0.62 . . . . 0.0 110.49 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.07 132.21 54.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 48.6 p90 -154.2 144.71 22.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.779 . . . . 0.0 111.082 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -97.17 138.27 34.92 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.261 0.553 . . . . 0.0 110.858 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.89 87.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.633 -0.667 . . . . 0.0 109.324 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.25 47.17 2.52 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.426 -0.796 . . . . 0.0 112.164 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -139.08 -64.09 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.34 160.95 37.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.479 -0.763 . . . . 0.0 110.277 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.79 112.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.58 120.74 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.583 -0.698 . . . . 0.0 109.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.6 p -116.84 114.87 24.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.455 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.99 30.77 2.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.2 ttt -63.45 120.06 10.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.402 -1.057 . . . . 0.0 109.625 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.22 156.22 25.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.411 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 35.0 t80 -132.16 101.06 5.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.8 mt -94.27 165.67 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.295 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -158.84 134.66 8.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 0.0 110.023 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -113.96 118.23 33.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.681 -0.637 . . . . 0.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 m -75.42 74.59 2.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.533 -0.73 . . . . 0.0 109.781 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -62.27 154.64 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.518 -0.739 . . . . 0.0 110.515 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -120.22 39.26 3.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.703 -0.623 . . . . 0.0 110.27 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.46 61.34 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.253 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 149.45 -37.06 0.99 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.88 127.18 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.968 . . . . 0.0 110.297 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.38 131.34 50.68 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 139' ' ' ILE . 20.2 mt -89.79 -52.73 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.679 -0.638 . . . . 0.0 109.312 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -169.17 165.09 11.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 174.68 10.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.618 -0.676 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 m -154.65 146.25 23.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -102.38 137.46 40.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.578 -0.701 . . . . 0.0 110.109 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -120.97 129.94 53.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.431 -0.793 . . . . 0.0 110.537 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -80.44 112.5 17.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 109.389 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.425 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 49.4 t -79.72 -67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.55 171.64 19.64 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.7 p -95.4 154.93 16.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.972 . . . . 0.0 110.02 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -147.92 128.04 13.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.366 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.55 153.21 28.49 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.24 76.84 2.97 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.454 1.239 . . . . 0.0 110.435 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -169.0 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 110.34 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -142.44 -111.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 110.162 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -171.95 -148.65 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.593 -1.317 . . . . 0.0 109.739 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 91.13 1.03 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.427 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 22.7 m-85 -59.87 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.415 -0.803 . . . . 0.0 110.008 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.09 114.77 3.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 110.987 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 39.0 t80 -95.34 169.46 10.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.1 124.9 7.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.858 . . . . 0.0 111.145 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.0 p -93.75 159.92 33.72 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.31 152.77 80.04 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.63 1.332 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -57.28 116.33 3.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.746 -0.596 . . . . 0.0 111.121 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -113.11 149.35 33.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.71 -0.619 . . . . 0.0 109.617 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.44 127.35 44.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.539 -0.726 . . . . 0.0 110.934 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.421 ' CB ' ' HD2' ' A' ' 166' ' ' PRO . . . -62.72 -176.06 0.14 Allowed Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 165' ' ' ALA . 44.8 Cg_endo -73.6 127.7 11.95 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 O-C-N 123.066 1.035 . . . . 0.0 110.204 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -116.17 159.02 22.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 110.868 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.65 162.18 30.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -60.06 173.07 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -1.044 . . . . 0.0 109.556 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 tt 67.9 -60.65 0.4 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.372 -0.83 . . . . 0.0 110.625 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 175' ' ' TYR . . . -52.08 -23.25 5.03 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.15 155.57 38.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.344 -0.847 . . . . 0.0 110.101 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.23 -175.3 19.92 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -91.89 118.17 30.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.94 . . . . 0.0 110.363 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' A' ' 171' ' ' ALA . 55.3 m-85 -112.48 124.39 52.4 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 140.06 47.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.646 -0.659 . . . . 0.0 110.637 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.418 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 46.9 mm -113.53 94.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.647 -0.658 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 109.22 18.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.23 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.411 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 28.6 t -113.64 144.38 43.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.393 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.02 105.97 10.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.682 -0.637 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.7 t80 -81.62 132.63 35.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.72 -0.613 . . . . 0.0 109.852 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -171.03 -172.7 1.17 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.649 -0.657 . . . . 0.0 110.222 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.738 -0.601 . . . . 0.0 109.524 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 121.23 0.538 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.23 117.1 29.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.658 . . . . 0.0 109.666 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.1 m-70 -68.9 -62.5 1.35 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.508 -0.745 . . . . 0.0 110.68 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.7 tp -168.43 159.53 10.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.382 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.2 t -153.71 138.53 17.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.53 -0.732 . . . . 0.0 110.196 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.415 ' CD2' HD22 ' A' ' 90' ' ' LEU . 19.0 p90 -142.02 -155.43 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 110.083 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -169.01 128.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.377 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 8.9 p-90 -130.45 145.0 51.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.613 -0.68 . . . . 0.0 109.982 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.44 158.83 28.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.474 0.654 . . . . 0.0 110.941 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 21.9 tp -133.38 95.41 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.1 m -80.63 104.34 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.626 -0.672 . . . . 0.0 110.78 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.76 147.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -138.29 -158.83 0.89 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.424 -0.797 . . . . 0.0 110.809 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -53.13 4.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.691 -0.631 . . . . 0.0 110.928 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -147.1 94.06 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.0 110.818 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.463 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -74.97 -0.78 19.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.644 -0.66 . . . . 0.0 111.336 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.69 34.92 2.79 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 110.249 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.189 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.237 0.541 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.9 t -114.05 130.76 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 0.0 110.078 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.2 t -148.1 137.75 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.786 -0.572 . . . . 0.0 110.284 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 57.5 t -69.44 106.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 p -73.35 -58.37 3.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.728 -0.608 . . . . 0.0 110.498 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.23 164.28 30.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.49 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 tt -132.13 124.19 28.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.673 -0.642 . . . . 0.0 109.695 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -109.87 152.04 26.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.754 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.61 114.19 9.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.612 -0.68 . . . . 0.0 110.149 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.44 165.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.712 . . . . 0.0 110.26 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.97 -156.64 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 109.956 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.1 p -97.38 -35.88 10.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 p -138.79 47.53 1.94 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.617 -0.677 . . . . 0.0 110.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.452 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.23 172.01 7.66 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.664 -0.647 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -29.12 14.11 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.442 1.233 . . . . 0.0 109.855 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.38 175.12 33.07 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.9 100.63 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.393 1.207 . . . . 0.0 110.204 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 102' ' ' PHE . 53.1 mt -65.03 113.31 3.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.631 -0.668 . . . . 0.0 109.932 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.11 116.2 29.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.758 -0.589 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -101.87 128.03 48.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.587 -0.696 . . . . 0.0 109.983 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.05 126.85 31.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.546 -0.721 . . . . 0.0 110.007 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 52.21 2.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.672 . . . . 0.0 110.062 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -101.37 -73.75 0.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.4 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.09 -42.66 0.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.33 77.66 8.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.689 -0.889 . . . . 0.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 86.9 mt -87.33 -20.87 26.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -13.71 36.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.0 111.477 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -6.2 39.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.06 -1.025 . . . . 0.0 111.567 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.423 ' CE1' HD21 ' A' ' 88' ' ' LEU . 12.4 m-30 -75.27 -55.53 5.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -58.21 -17.55 19.79 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.489 -0.757 . . . . 0.0 111.407 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -86.0 -19.85 29.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.265 -0.897 . . . . 0.0 110.89 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.62 147.08 37.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.216 -0.928 . . . . 0.0 110.582 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 160.9 37.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.449 -0.782 . . . . 0.0 109.931 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 86' ' ' LEU . 29.3 m-85 -90.98 166.08 13.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.99 128.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 88.2 mt -129.5 164.62 23.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.63 -0.669 . . . . 0.0 109.686 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 2.5 ttpt -77.2 166.54 23.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -29.24 -66.77 0.08 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.82 72.98 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.44 ' CG1' ' CB ' ' A' ' 105' ' ' LYS . 32.7 m -88.0 139.12 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.412 -1.052 . . . . 0.0 110.661 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -85.32 95.98 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 48.5 p90 -109.68 135.93 49.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.533 -0.729 . . . . 0.0 111.745 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -89.2 157.39 18.28 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.89 132.56 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.422 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -115.36 121.48 42.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.88 146.82 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.506 0.669 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -129.37 133.29 47.32 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.453 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 33.4 p90 -154.73 157.98 38.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.383 -0.823 . . . . 0.0 110.847 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.76 129.46 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.51 110.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 109.351 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -128.53 48.23 2.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 111.382 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 -67.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.295 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.66 165.67 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.509 -0.745 . . . . 0.0 110.474 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 122' ' ' ILE . 84.8 mt -69.12 106.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.691 -0.63 . . . . 0.0 109.974 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.83 95.02 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.653 -0.655 . . . . 0.0 109.966 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.1 p -88.87 74.97 8.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.322 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.63 53.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -82.69 151.38 26.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.988 . . . . 0.0 109.605 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -146.69 151.63 37.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.873 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -128.15 97.49 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.758 -0.588 . . . . 0.0 109.499 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.23 134.6 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 110.055 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.405 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 18.5 tt0 -129.06 138.07 51.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -113.6 138.39 50.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.444 -0.785 . . . . 0.0 110.089 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.7 m -96.6 85.92 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.707 -0.621 . . . . 0.0 109.824 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 138' ' ' LYS . 5.4 m-85 -89.84 129.26 36.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 110.398 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 3.5 tmm_? -145.52 151.43 38.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 51.49 31.23 7.2 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.452 -0.78 . . . . 0.0 111.166 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.41 60.33 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.314 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.36 149.67 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.322 . . . . 0.0 110.398 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 16.7 tttp -85.66 119.76 26.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.8 -67.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.56 -0.713 . . . . 0.0 109.914 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.73 157.45 6.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.506 -0.746 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 165.72 19.0 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.4 m -128.74 137.31 51.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.562 -0.711 . . . . 0.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -101.7 105.24 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.712 . . . . 0.0 110.077 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -96.2 148.07 23.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.75 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.05 117.2 33.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 158' ' ' PHE . 48.1 t -80.86 -55.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.48 -0.762 . . . . 0.0 110.196 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.75 -179.69 17.68 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 22.3 m -89.65 151.29 21.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.66 -0.906 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.3 129.55 14.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 0.0 110.369 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.03 152.08 30.95 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.71 90.24 0.95 Allowed 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.425 1.224 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 26.42 7.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.584 -0.698 . . . . 0.0 110.226 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 53.42 22.81 3.02 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.376 -0.827 . . . . 0.0 111.268 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -133.04 178.22 7.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.17 157.93 16.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.705 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.16 177.56 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.539 -0.726 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -148.81 91.67 1.9 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 146' ' ' VAL . 40.1 t80 -79.56 163.94 24.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.0 110.002 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -139.72 119.28 13.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.565 -0.709 . . . . 0.0 110.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 158' ' ' PHE . 66.8 p -102.26 157.09 34.37 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.522 -0.736 . . . . 0.0 109.714 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.68 159.83 46.41 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.707 1.372 . . . . 0.0 110.997 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 149.87 27.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.408 0.623 . . . . 0.0 110.872 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.409 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 16.6 tt0 -129.24 106.44 8.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.712 -0.617 . . . . 0.0 109.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.09 126.0 26.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.31 173.09 7.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.793 -0.567 . . . . 0.0 110.003 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.96 123.92 9.25 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.338 1.178 . . . . 0.0 110.362 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -118.12 -160.93 0.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 110.572 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.71 47.9 13.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 54.79 175.65 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.567 -0.961 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -61.38 0.32 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.285 -0.885 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -49.43 -24.66 2.09 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.382 -0.824 . . . . 0.0 111.407 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -58.74 128.35 36.78 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.18 -178.84 25.5 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.8 p -86.79 142.75 27.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.517 -0.99 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 38.1 m-85 -131.11 105.0 7.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.671 -0.643 . . . . 0.0 110.356 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -70.35 120.14 15.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.612 -0.68 . . . . 0.0 109.349 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 44.8 mt -109.72 148.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.982 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -114.84 118.88 34.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.748 -0.595 . . . . 0.0 109.79 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.8 m -110.53 122.48 47.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.585 -0.697 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -111.01 103.62 12.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t80 -83.26 116.79 22.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.548 -0.72 . . . . 0.0 110.071 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.3 t -131.97 -155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.746 . . . . 0.0 110.166 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.055 -179.822 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.048 0.451 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.11 88.09 2.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -60.27 -40.62 91.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.522 -0.736 . . . . 0.0 109.973 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tp -170.35 148.21 3.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 110.032 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -159.65 136.96 9.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.654 -0.654 . . . . 0.0 110.025 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.424 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 23.9 p90 -136.48 -157.39 0.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.613 -0.68 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.742 . . . . 0.0 110.55 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 18.1 p-90 -144.13 153.27 41.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.561 -0.712 . . . . 0.0 109.987 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -94.34 153.49 17.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.536 -0.727 . . . . 0.0 111.042 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.78 90.05 3.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.1 m -67.98 145.09 54.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.0 110.94 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.6 156.89 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.707 -0.621 . . . . 0.0 109.392 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -151.91 -153.27 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.493 -0.754 . . . . 0.0 110.068 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -129.88 -0.7 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 111.624 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -160.08 47.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.085 -1.01 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.463 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -57.44 -19.85 26.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.525 -0.734 . . . . 0.0 111.292 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 56.91 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.165 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.33 119.2 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.624 -0.673 . . . . 0.0 110.338 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.52 136.74 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 181' ' ' PHE . 59.3 t -61.24 103.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.518 -0.739 . . . . 0.0 109.115 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.0 p -73.45 -56.37 5.14 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.889 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -141.99 168.35 19.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.812 . . . . 0.0 110.724 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.66 124.57 31.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.65 -0.657 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -110.4 156.22 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.621 -0.674 . . . . 0.0 110.277 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.55 82.2 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.577 -0.702 . . . . 0.0 109.879 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.49 143.93 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.725 -0.609 . . . . 0.0 110.088 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.2 m -140.82 -163.54 1.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.041 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 p -115.87 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.4 p -95.87 24.9 5.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.447 ' HB3' ' CZ3' ' A' ' 202' ' ' TRP . . . -90.5 -177.38 0.77 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.509 -0.744 . . . . 0.0 110.29 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 82' ' ' ALA . 45.2 Cg_endo -73.99 -23.59 15.97 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.359 1.189 . . . . 0.0 110.131 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.68 -175.46 29.67 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.07 104.8 1.58 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.503 1.264 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.89 114.45 4.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.722 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -90.19 146.61 24.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 3.7 tt -128.08 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.52 127.35 40.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.517 -0.739 . . . . 0.0 110.161 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.26 55.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.654 -0.654 . . . . 0.0 109.878 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -104.81 -73.63 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.728 -0.607 . . . . 0.0 110.474 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.22 -74.77 0.49 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.41 94.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.683 -0.893 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 61.0 mt -92.78 -33.41 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.492 -0.755 . . . . 0.0 110.149 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -57.57 -19.31 24.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.502 -0.749 . . . . 0.0 111.065 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.56 -24.5 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.16 -0.963 . . . . 0.0 111.263 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.456 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 8.1 m-85 -62.0 -19.24 62.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.507 -0.745 . . . . 0.0 110.309 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.9 -25.98 61.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -86.94 -25.24 24.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.494 -0.754 . . . . 0.0 110.855 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.35 151.47 51.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.392 -0.818 . . . . 0.0 110.619 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -123.81 -170.27 2.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.543 -0.723 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.416 ' CZ ' HD11 ' A' ' 88' ' ' LEU . 6.5 m-85 -115.37 102.08 9.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.641 -0.662 . . . . 0.0 110.052 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.39 147.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.65 -0.656 . . . . 0.0 110.203 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.401 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 3.8 tt -159.34 148.17 18.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.664 -0.647 . . . . 0.0 109.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.425 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 63.7 tttt -83.54 158.29 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -39.96 107.5 0.07 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 32.24 68.64 0.14 Allowed Glycine 0 N--CA 1.506 3.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.736 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 21.5 m -88.78 167.55 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -1.141 . . . . 0.0 109.647 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.38 97.94 11.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.202 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -128.42 134.28 48.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.0 111.581 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -89.46 167.53 12.92 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.0 mt -125.35 137.94 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 0.0 110.358 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -115.68 109.34 17.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.645 -0.66 . . . . 0.0 109.541 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.0 mm -93.38 126.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.583 -0.698 . . . . 0.0 110.773 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.9 p -108.59 148.55 30.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 156' ' ' TYR . 2.5 p90 -164.78 146.37 8.02 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.235 -0.916 . . . . 0.0 111.884 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -81.49 125.26 30.26 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.276 0.56 . . . . 0.0 110.748 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 156' ' ' TYR . 72.4 t -126.36 82.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.54 48.73 2.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.442 -0.786 . . . . 0.0 111.93 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -138.34 -65.97 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.104 -0.997 . . . . 0.0 111.089 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -142.67 175.98 9.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.393 -0.817 . . . . 0.0 110.86 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.58 113.28 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 110.152 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -95.76 88.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.664 -0.647 . . . . 0.0 109.8 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 77.6 p -82.97 88.06 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.632 -0.668 . . . . 0.0 110.516 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.0 46.55 0.07 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.434 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 3.0 ttt -81.22 128.48 33.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.514 -0.992 . . . . 0.0 109.597 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -140.62 167.0 23.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.507 -0.745 . . . . 0.0 110.849 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -135.75 120.12 17.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.7 -0.625 . . . . 0.0 109.733 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.57 130.25 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.583 -0.698 . . . . 0.0 110.3 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -128.1 135.61 50.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.611 -0.681 . . . . 0.0 109.862 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.1 m-70 -104.2 114.64 29.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -70.68 77.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.698 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 3.4 m-85 -80.79 141.99 34.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.985 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -119.35 -155.4 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -64.66 81.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.58 -0.7 . . . . 0.0 110.608 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.9 23.73 61.75 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -148.78 89.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -1.079 . . . . 0.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 149.84 49.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.726 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 140' ' ' ASP . 44.2 pt -118.89 -37.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.406 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.6 t70 -175.86 167.2 3.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.0 -1.063 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -126.86 -168.3 1.85 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.4 m -159.74 126.96 4.61 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.47 136.84 52.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -123.17 127.44 48.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.576 -0.703 . . . . 0.0 110.845 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.7 tpp -81.18 106.01 12.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.451 ' CG1' ' CE1' ' A' ' 149' ' ' TYR . 40.8 t -79.96 -36.4 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.547 -0.721 . . . . 0.0 110.279 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.69 -176.87 16.81 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 3.1 t -82.52 135.73 35.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.599 -0.942 . . . . 0.0 110.03 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.451 ' CE1' ' CG1' ' A' ' 146' ' ' VAL . 9.3 m-85 -118.35 128.99 55.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.633 . . . . 0.0 110.939 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.79 153.05 16.91 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.79 85.14 1.36 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.369 1.194 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -62.28 1.48 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.67 127.01 0.9 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 111.17 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.03 -156.92 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.498 -0.751 . . . . 0.0 111.545 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.81 174.79 7.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.554 -0.716 . . . . 0.0 111.26 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.437 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 44.4 m-85 -119.31 -174.63 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.657 -0.652 . . . . 0.0 109.461 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.87 100.41 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 146' ' ' VAL . 54.6 t80 -81.39 170.35 16.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.124 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -155.68 109.42 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 110.513 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.8 p -75.6 146.88 81.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 109.168 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.43 -177.97 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.706 1.371 . . . . 0.0 111.021 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -58.37 145.17 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.482 0.658 . . . . 0.0 110.872 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.47 119.86 3.1 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.82 146.14 37.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 111.019 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.76 -178.09 0.88 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.748 -0.595 . . . . 0.0 109.723 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.9 123.61 8.56 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.104 1.055 . . . . 0.0 110.355 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 171.36 7.78 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.459 -0.776 . . . . 0.0 110.539 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.84 161.91 11.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.99 -61.0 2.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.574 -0.956 . . . . 0.0 109.291 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.63 -29.76 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.725 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.9 -23.98 61.77 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.501 -0.749 . . . . 0.0 110.538 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -64.2 129.08 38.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.788 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.4 -177.94 30.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.6 p -86.72 133.99 33.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.949 . . . . 0.0 110.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -116.81 106.74 13.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.272 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.76 121.12 19.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.599 -0.688 . . . . 0.0 109.547 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -111.81 124.33 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.451 -0.78 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.4 ' CB ' ' HB2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -86.76 96.69 10.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.0 109.451 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.412 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.3 p -90.55 134.89 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.632 -0.667 . . . . 0.0 110.802 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -133.41 82.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.66 -0.65 . . . . 0.0 109.618 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.402 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 4.0 t80 -79.1 111.84 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.617 -0.677 . . . . 0.0 110.06 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -136.19 -166.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.31 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.789 -0.569 . . . . 0.0 109.992 179.814 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.084 0.469 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.46 108.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 110.003 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -65.92 -56.2 12.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.543 -0.723 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -168.3 142.85 3.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.584 -0.698 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 81.0 p -142.63 147.75 36.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.532 -0.73 . . . . 0.0 109.989 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.412 ' CE2' ' OG ' ' A' ' 179' ' ' SER . 16.4 p90 -144.68 -155.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 109.975 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.99 126.04 3.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 110.613 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.426 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 23.2 p-90 -133.29 147.55 51.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.589 -0.694 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.93 135.06 35.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 111.145 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.4 tp -104.96 95.46 5.87 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.9 m -72.42 117.97 14.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.555 -0.716 . . . . 0.0 110.992 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.3 mm -91.03 153.33 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -142.89 -167.63 2.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.394 -0.816 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 -46.66 6.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.704 -0.622 . . . . 0.0 110.568 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.89 106.27 4.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.33 36.56 0.88 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.607 -0.683 . . . . 0.0 111.285 179.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -169.37 37.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.316 -0.865 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.16 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 59.2 t -138.87 135.34 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.8 t -147.73 142.1 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 0.0 109.582 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 62.1 t -63.02 105.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.1 p -70.52 -52.88 18.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 110.361 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 mtm105 -158.68 151.84 22.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.556 -0.715 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 tt -110.67 126.54 54.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.721 -0.612 . . . . 0.0 109.701 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m -109.4 152.37 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -139.74 109.04 6.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.271 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.54 167.07 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.667 -0.645 . . . . 0.0 109.887 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 -158.38 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.532 -0.73 . . . . 0.0 110.017 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 p -95.07 -34.48 12.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p -140.24 48.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.462 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.51 168.01 15.2 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -26.48 14.69 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.454 1.239 . . . . 0.0 110.07 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.07 169.13 28.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.97 103.04 1.41 Allowed 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.442 1.233 . . . . 0.0 110.209 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 15.4 mt -64.7 116.16 5.98 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.756 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.83 106.04 17.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.395 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -84.98 127.97 34.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.666 -0.646 . . . . 0.0 109.938 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.28 122.6 25.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.569 -0.707 . . . . 0.0 110.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.417 HD23 ' CG ' ' A' ' 192' ' ' TRP . 3.9 mt -128.59 51.03 2.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 109.933 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -109.89 -70.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -60.88 0.15 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.93 88.66 0.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.6 -0.941 . . . . 0.0 110.316 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 92.1 mt -94.98 -25.93 16.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.378 -0.826 . . . . 0.0 110.5 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -52.35 -23.3 5.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -18.48 35.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.431 -0.793 . . . . 0.0 111.325 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.453 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 13.3 m-30 -61.96 -56.01 23.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.199 -0.938 . . . . 0.0 110.59 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.98 25.1 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 0.0 111.132 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -86.89 9.82 18.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 111.25 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -171.6 148.0 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.166 -0.959 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.2 p -125.3 159.41 31.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.781 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 86' ' ' LEU . 7.3 m-85 -82.15 117.97 22.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 110.261 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.08 154.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.623 -0.673 . . . . 0.0 109.802 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.44 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 1.7 mt -164.76 179.0 6.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.571 -0.706 . . . . 0.0 110.328 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 152.32 24.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -19.56 -69.44 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -143.26 74.21 0.33 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.922 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.47 -173.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 110.116 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -120.79 93.63 4.09 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.413 ' CE2' ' O ' ' A' ' 163' ' ' GLU . 40.5 p90 -109.81 145.72 36.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.367 -0.833 . . . . 0.0 112.329 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 mtt85 -105.33 165.19 11.29 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.41 135.35 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.664 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 100.53 8.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.826 -0.546 . . . . 0.0 109.579 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 114' ' ' ILE . 46.2 mm -77.28 148.44 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.529 -0.732 . . . . 0.0 110.043 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -131.31 133.84 45.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.425 ' CG ' ' HE3' ' A' ' 126' ' ' MET . 10.4 p90 -157.5 148.92 21.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 110.415 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.3 49.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.64 -0.662 . . . . 0.0 111.158 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.01 99.04 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -129.2 47.97 2.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.41 -0.806 . . . . 0.0 111.608 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -145.09 -64.24 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.78 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -138.4 166.59 23.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.448 -0.783 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.91 102.78 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.673 -0.642 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.13 70.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.762 -0.586 . . . . 0.0 109.745 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.9 p -74.52 94.54 2.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.642 -0.661 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.98 42.11 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.425 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 1.4 ttt -72.28 140.79 48.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.973 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -136.58 159.61 41.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -135.27 97.89 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.39 133.37 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 109.728 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.412 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 28.0 tt0 -131.61 131.57 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.688 . . . . 0.0 110.29 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.5 m-70 -107.97 123.62 48.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 0.0 109.792 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.9 m -83.32 105.57 14.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.538 -0.726 . . . . 0.0 110.047 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 138' ' ' LYS . 8.6 m-85 -96.32 140.19 31.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 112.32 18.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.737 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.5 tptp 53.04 37.14 23.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.261 -0.899 . . . . 0.0 110.63 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.06 21.17 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.9 t -146.91 113.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.985 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -64.12 127.71 32.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.567 -0.708 . . . . 0.0 110.116 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.8 pt -111.35 -26.05 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.56 -0.713 . . . . 0.0 110.655 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -174.43 151.19 1.53 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.455 ' CD ' ' CE1' ' A' ' 131' ' ' HIS . 15.7 pttm -147.72 149.69 32.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -143.32 155.03 44.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.343 -0.848 . . . . 0.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -100.74 113.8 27.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.18 100.33 12.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.451 -0.781 . . . . 0.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.9 ptp -61.63 116.19 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.757 . . . . 0.0 109.693 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 158' ' ' PHE . 47.4 t -80.18 -51.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 0.0 110.286 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.89 178.33 18.68 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 77.6 p -93.37 152.35 19.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.525 -0.985 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -147.65 132.42 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 110.3 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.45 156.39 26.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.52 -171.5 1.13 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.411 1.216 . . . . 0.0 110.537 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 51.42 62.38 2.74 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.62 -0.675 . . . . 0.0 111.156 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -153.25 -94.5 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 110.273 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.34 -154.79 0.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.885 -1.135 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.49 93.41 7.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.411 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 66.1 m-85 -59.92 177.54 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.731 -0.606 . . . . 0.0 110.298 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -146.75 110.15 4.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 146' ' ' VAL . 42.3 t80 -76.85 163.27 26.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.731 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.58 116.99 15.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.517 -0.739 . . . . 0.0 110.687 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.2 p -100.51 145.99 31.26 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.12 171.6 8.71 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.755 1.397 . . . . 0.0 111.361 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -59.73 118.37 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.821 -0.549 . . . . 0.0 111.073 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 1.0 OUTLIER -105.88 124.48 49.64 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.53 136.39 35.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.509 -0.744 . . . . 0.0 110.601 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.06 171.15 9.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.737 -0.602 . . . . 0.0 110.416 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.92 129.31 14.14 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.369 1.194 . . . . 0.0 110.171 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 -178.09 3.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.601 -0.687 . . . . 0.0 110.75 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.68 138.01 8.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.2 ttm -58.98 -30.7 68.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.397 -1.061 . . . . 0.0 110.066 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 170' ' ' LEU . 4.4 mm? -69.37 -35.21 75.6 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.04 -26.92 22.32 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -50.34 155.21 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.14 -156.5 22.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 p -104.51 132.45 50.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -1.001 . . . . 0.0 110.732 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -113.77 103.03 10.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.645 -0.659 . . . . 0.0 110.732 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -66.95 142.11 57.38 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 14.5 mt -132.94 154.99 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 103.19 8.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 0.0 109.845 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.423 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.4 m -97.18 118.13 32.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.49 -0.756 . . . . 0.0 110.437 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.12 109.81 19.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -86.54 154.45 21.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.696 -0.627 . . . . 0.0 110.623 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.4 t -167.76 -156.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.982 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.732 -179.914 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.032 0.444 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -105.56 101.06 10.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.502 -0.749 . . . . 0.0 110.215 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.425 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 7.9 m170 -60.35 -56.64 19.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.763 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 17.7 tp -171.43 114.52 0.38 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.704 -0.622 . . . . 0.0 109.837 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -116.59 136.18 53.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.7 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.43 ' HB2' ' CE2' ' A' ' 97' ' ' PHE . 27.1 p90 -134.28 -159.03 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.638 . . . . 0.0 110.083 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -158.88 129.46 6.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 110.641 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 19.1 p-90 -143.55 147.95 35.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -99.09 146.07 26.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.566 -0.709 . . . . 0.0 110.939 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 43.0 tp -109.08 107.37 17.67 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -82.93 106.95 15.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 110.769 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.05 143.5 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 109.393 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -137.3 -160.25 1.04 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 110.027 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -19.48 8.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 111.055 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -152.54 60.87 0.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 110.952 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.462 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -62.43 -15.3 48.61 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.269 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.76 37.7 3.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.273 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.066 0.46 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 61.1 t -121.97 128.46 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.7 t -148.96 139.62 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 t -64.08 103.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.9 p -69.95 -50.06 45.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.504 -0.748 . . . . 0.0 110.568 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.67 174.64 14.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 110.814 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 6.8 tt -140.65 123.77 16.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.722 -0.611 . . . . 0.0 109.643 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.8 m -109.71 162.89 14.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.517 -0.739 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.85 118.31 8.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 110.534 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.39 153.06 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.6 t -147.16 25.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 81' ' ' THR . 1.4 p 67.03 -61.19 0.34 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.533 -0.729 . . . . 0.0 110.977 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.4 ' N ' ' OG ' ' A' ' 80' ' ' SER . 20.1 p -98.97 30.97 3.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.159 -0.963 . . . . 0.0 109.964 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.421 ' HB3' ' CH2' ' A' ' 202' ' ' TRP . . . -90.19 165.98 21.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.691 -0.63 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.74 -26.4 19.36 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.439 1.231 . . . . 0.0 110.221 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.11 165.86 25.22 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.01 97.42 0.83 Allowed 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.466 1.245 . . . . 0.0 110.29 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 102' ' ' PHE . 20.3 mt -64.63 114.57 4.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.688 -0.632 . . . . 0.0 109.632 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -100.95 122.46 43.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.633 -0.667 . . . . 0.0 110.602 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 9.6 mt -97.6 166.17 11.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.702 -0.624 . . . . 0.0 109.88 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.96 126.58 54.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.527 -0.733 . . . . 0.0 110.478 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.436 ' CD2' ' CD2' ' A' ' 192' ' ' TRP . 1.7 mt -128.13 49.31 2.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.581 -0.699 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 p -133.67 51.69 2.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.32 -65.16 0.26 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.1 71.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.96 . . . . 0.0 110.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 72.9 mt -90.08 -26.85 20.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.565 -0.709 . . . . 0.0 110.347 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.19 -22.05 15.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.25 -0.906 . . . . 0.0 111.074 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 p -58.23 -20.62 43.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 0.0 110.983 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 18.1 m-85 -58.37 -65.28 0.68 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.315 -0.866 . . . . 0.0 110.608 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -56.23 -20.73 19.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.525 -0.734 . . . . 0.0 111.207 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -86.93 11.65 12.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 111.323 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.76 143.13 2.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -133.16 137.07 46.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.66 . . . . 0.0 109.721 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.426 ' CD1' HD23 ' A' ' 86' ' ' LEU . 22.5 m-85 -79.22 118.6 21.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -0.79 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.97 155.53 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.25 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 2.1 mt -153.07 -171.38 3.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.756 . . . . 0.0 110.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.423 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 24.1 tttm -130.65 161.41 31.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.671 0.748 . . . . 0.0 109.857 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.81 106.37 0.06 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 37.28 69.42 0.3 Allowed Glycine 0 N--CA 1.503 3.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.698 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 35.8 m -86.65 149.85 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.266 -1.137 . . . . 0.0 109.692 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -79.94 90.58 5.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 37.4 p90 -109.34 141.58 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.562 -0.711 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.49 163.49 13.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.638 -0.664 . . . . 0.0 109.344 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.0 mm -117.75 135.1 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.371 -0.831 . . . . 0.0 110.071 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -119.64 115.11 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.28 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 128' ' ' TYR . 43.3 mm -100.72 150.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 111.156 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.5 m -131.21 122.09 25.95 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 31.1 p90 -137.83 135.15 35.95 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.785 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.09 140.07 32.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 111.046 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.47 95.93 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.724 -0.61 . . . . 0.0 109.367 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -129.2 48.69 2.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 111.427 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.93 -68.7 0.18 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.25 -0.906 . . . . 0.0 110.849 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -136.82 174.7 10.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.82 . . . . 0.0 110.519 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.3 mp -80.41 121.62 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.738 -0.601 . . . . 0.0 110.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.8 77.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.692 -0.63 . . . . 0.0 109.531 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.4 p -81.47 84.95 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.59 -0.694 . . . . 0.0 110.666 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.68 44.55 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.0 mmm -73.76 148.56 42.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.446 -1.032 . . . . 0.0 109.627 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.24 136.16 36.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.447 -0.783 . . . . 0.0 110.941 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.421 ' CZ ' HD13 ' A' ' 114' ' ' ILE . 48.2 t80 -122.2 106.18 10.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.772 -0.58 . . . . 0.0 109.484 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.5 mt -102.08 166.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -155.11 138.69 16.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.643 -0.661 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.437 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.1 m-70 -109.34 140.82 42.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.742 . . . . 0.0 109.645 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 m -103.43 78.83 1.64 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.454 -0.779 . . . . 0.0 110.062 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 131' ' ' HIS . 21.1 m-85 -90.57 120.13 31.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.43 142.42 35.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.518 -0.739 . . . . 0.0 110.491 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.67 33.79 17.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.97 27.07 66.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.03 112.55 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.435 -1.038 . . . . 0.0 109.846 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 113.65 5.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.575 -0.703 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.21 -66.12 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.629 -0.669 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.54 171.94 8.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.553 -0.717 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -126.86 168.4 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.596 -0.69 . . . . 0.0 109.557 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.4 m -131.4 117.38 18.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.498 -0.752 . . . . 0.0 110.522 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.24 116.25 28.62 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 0.0 109.821 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -114.27 142.1 46.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 ttp -98.05 123.8 42.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.75 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.419 HG23 ' CZ ' ' A' ' 181' ' ' PHE . 45.7 t -80.0 -53.71 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.518 -0.739 . . . . 0.0 110.188 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.61 -173.36 21.22 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.9 p -93.35 145.9 24.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.946 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -147.48 125.91 12.38 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.0 110.185 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.61 163.99 25.18 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 83.83 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.415 1.218 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.02 -66.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.618 -0.676 . . . . 0.0 110.17 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.87 132.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.489 -0.757 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 53.05 -157.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.403 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.22 171.06 7.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.58 -0.7 . . . . 0.0 111.031 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.3 m-85 -109.71 176.92 4.89 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -131.71 108.95 9.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.813 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 160' ' ' THR . 11.4 t80 -82.77 168.05 17.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 109.591 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.86 90.12 1.44 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.466 -0.771 . . . . 0.0 110.693 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 158' ' ' PHE . 37.6 p -76.76 158.11 81.09 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.59 158.42 50.05 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.699 1.368 . . . . 0.0 111.109 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -56.61 137.7 53.44 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.299 0.571 . . . . 0.0 111.156 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 3.1 tp10 -120.51 119.6 33.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.817 -0.552 . . . . 0.0 109.557 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.69 133.48 49.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.74 179.62 1.49 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.21 123.75 9.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.192 1.101 . . . . 0.0 110.35 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -115.11 -175.2 2.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.557 -0.714 . . . . 0.0 110.462 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.31 18.83 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -59.5 -27.44 66.15 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.51 29.51 3.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.33 18.94 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.531 -0.731 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -100.13 132.89 45.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.392 -0.817 . . . . 0.0 110.0 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.7 177.88 23.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -84.95 126.23 33.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.724 -0.868 . . . . 0.0 110.747 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -107.33 115.87 30.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 0.0 109.883 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -75.08 122.86 24.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.593 -0.692 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 20.4 mt -116.31 152.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.762 . . . . 0.0 110.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.44 117.92 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.641 -0.662 . . . . 0.0 110.356 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.421 ' HB3' ' CZ2' ' A' ' 192' ' ' TRP . 17.5 t -114.23 163.15 15.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.343 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.15 108.13 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.776 -0.577 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -80.77 116.37 20.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.998 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 82.2 p -125.03 173.53 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.679 . . . . 0.0 109.861 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.678 . . . . 0.0 110.22 179.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.216 0.532 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.32 117.32 13.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.599 -0.688 . . . . 0.0 109.796 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m-70 -59.6 -44.62 93.34 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 110.531 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 15.8 tp -162.61 156.24 20.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.461 -0.774 . . . . 0.0 110.399 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.6 p -145.16 150.72 37.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.641 -0.662 . . . . 0.0 109.946 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.436 ' CD2' ' CD2' ' A' ' 90' ' ' LEU . 14.8 p90 -147.19 -153.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.574 -0.704 . . . . 0.0 110.391 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -169.09 140.26 2.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.528 -0.733 . . . . 0.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 49.7 p-90 -145.4 147.23 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.541 -0.724 . . . . 0.0 110.384 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -87.65 165.11 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.711 -0.618 . . . . 0.0 110.949 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 24.8 tp -143.51 105.39 4.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.81 -0.557 . . . . 0.0 109.582 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.3 m -79.33 127.08 31.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.272 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -99.78 159.48 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -150.59 -153.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.518 -0.739 . . . . 0.0 110.201 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -16.36 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -0.806 . . . . 0.0 111.445 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -160.07 61.62 0.35 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.123 -0.985 . . . . 0.0 111.291 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -66.27 -11.63 51.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.385 -0.822 . . . . 0.0 111.712 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 29.57 6.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.443 179.456 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -135.72 133.71 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.628 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.3 t -137.31 155.42 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 46.2 t -66.55 100.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.217 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.2 p -70.81 -55.8 7.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.747 -0.596 . . . . 0.0 110.396 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -153.69 157.01 38.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.511 -0.743 . . . . 0.0 110.264 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' A' ' 76' ' ' THR . 9.6 tt -125.31 161.28 27.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.606 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 13.3 m -146.85 164.93 31.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.555 -0.715 . . . . 0.0 110.579 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -140.32 100.75 3.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.502 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.95 144.24 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.72 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 m -150.03 -167.38 2.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -76.21 0.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -0.775 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -94.99 36.82 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.397 -0.814 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.37 172.83 6.39 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.29 -27.46 19.6 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.218 1.115 . . . . 0.0 109.87 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.58 -174.46 38.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.89 92.94 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.575 1.303 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 22.3 mt -64.32 104.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 1.3 pt-20 -104.56 159.68 15.56 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.118 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.45 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -131.11 136.47 48.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.967 -0.458 . . . . 0.0 109.967 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.416 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 12.0 t70 -82.97 131.73 35.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -129.05 53.63 1.86 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 109.837 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 p -122.87 -58.37 1.66 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.517 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.67 -63.37 0.1 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.83 78.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.986 . . . . 0.0 110.292 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -28.17 15.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 110.285 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.7 -31.14 69.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.571 -0.705 . . . . 0.0 110.932 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -57.9 -19.95 33.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.391 -0.818 . . . . 0.0 110.956 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.45 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 6.0 m-85 -62.71 -65.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.393 -0.817 . . . . 0.0 110.467 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -57.9 -20.15 34.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.0 110.942 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -22.41 26.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.409 -0.807 . . . . 0.0 110.748 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -129.91 132.44 46.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.277 -0.889 . . . . 0.0 110.569 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -115.24 148.05 39.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 109.841 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 5.6 m-85 -74.38 154.76 38.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.79 113.02 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 0.0 110.358 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 10.1 mt -113.7 -172.83 2.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.602 -0.686 . . . . 0.0 109.553 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 37.7 tttm -121.85 167.27 13.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.791 . . . . 0.0 109.756 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -42.01 108.93 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.24 69.24 0.43 Allowed Glycine 0 N--CA 1.502 3.068 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.259 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.4 m -93.77 142.83 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -1.142 . . . . 0.0 110.086 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.73 107.19 10.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.401 -0.812 . . . . 0.0 109.192 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 163' ' ' GLU . 30.0 p90 -123.61 146.77 47.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.683 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -106.62 162.2 13.96 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -122.84 163.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.849 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -150.08 108.99 3.87 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.9 mm -98.02 146.73 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.54 -0.725 . . . . 0.0 110.807 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.36 145.51 51.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.639 -0.663 . . . . 0.0 109.639 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.42 ' CE1' ' HE3' ' A' ' 126' ' ' MET . 21.5 p90 -154.88 150.33 27.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 111.129 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.85 151.85 22.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.792 -0.568 . . . . 0.0 111.113 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.91 99.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.674 -0.641 . . . . 0.0 109.554 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.71 48.75 2.34 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -148.29 -77.78 0.16 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.185 -0.947 . . . . 0.0 110.841 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.83 -177.85 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.353 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 122' ' ' ILE . 77.3 mt -74.15 106.05 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.084 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.22 76.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.662 -0.648 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.2 98.59 7.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.449 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 128.48 40.83 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.42 ' HE3' ' CE1' ' A' ' 116' ' ' PHE . 0.9 OUTLIER -78.27 124.44 28.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -1.054 . . . . 0.0 109.503 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -123.33 142.65 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.997 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -117.48 86.99 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 0.0 109.413 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -79.06 140.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 110.044 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.7 137.6 29.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -107.05 154.96 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.74 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.1 m -116.4 64.47 0.71 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.398 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -75.25 139.48 42.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.382 -0.824 . . . . 0.0 109.828 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -120.68 -152.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.485 -0.76 . . . . 0.0 110.277 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.66 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.411 -0.806 . . . . 0.0 111.783 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.58 13.34 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.514 -0.741 . . . . 0.0 111.584 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -134.29 116.1 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 119.62 19.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.702 -0.624 . . . . 0.0 110.152 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 58.6 mt -89.62 -72.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.645 -0.659 . . . . 0.0 109.85 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.32 166.49 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.472 -0.767 . . . . 0.0 110.393 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 157.74 42.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.271 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.2 m -125.24 143.69 50.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.562 -0.711 . . . . 0.0 110.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.57 75.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.631 -0.668 . . . . 0.0 109.892 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -64.72 146.43 54.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.455 -0.778 . . . . 0.0 110.685 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -106.74 123.67 48.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.641 -0.662 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.411 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 61.6 t -79.8 -55.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.544 -0.722 . . . . 0.0 110.015 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.92 176.6 14.48 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.9 p -86.72 151.06 23.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.626 -0.926 . . . . 0.0 110.091 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -148.35 130.57 15.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.551 -0.718 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.54 157.16 32.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.01 94.76 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.389 1.205 . . . . 0.0 110.418 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -91.81 -78.23 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.559 -0.713 . . . . 0.0 109.91 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -172.6 -38.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -107.94 -161.8 0.79 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.0 110.672 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 168.81 9.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 30.0 m-85 -108.57 -178.47 3.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.773 -0.579 . . . . 0.0 109.649 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -138.86 99.51 3.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.931 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 34.5 t80 -84.16 171.46 12.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.259 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.66 131.74 4.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 111.172 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.5 p -97.31 151.73 37.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.84 -170.16 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.714 1.376 . . . . 0.0 111.203 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.2 ptm -54.43 145.25 18.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 111.266 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 4.6 tt0 -144.5 84.21 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.68 -0.638 . . . . 0.0 109.636 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.67 135.46 55.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 110.692 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.83 179.99 1.45 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.611 -0.681 . . . . 0.0 109.816 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.63 135.91 22.63 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.273 1.143 . . . . 0.0 110.211 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -110.99 -179.33 3.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.713 . . . . 0.0 110.435 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.08 156.35 18.94 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.1 ttp -61.44 -26.97 68.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.155 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.61 -24.76 33.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.568 -0.708 . . . . 0.0 110.499 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.07 -25.42 63.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.431 -0.793 . . . . 0.0 110.52 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -60.5 123.85 18.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.426 -0.796 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 159.53 -179.84 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -95.1 135.63 36.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.66 -0.906 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.05 108.56 14.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 109.921 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -71.28 122.37 20.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.636 -0.665 . . . . 0.0 110.113 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.3 mt -113.32 127.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -99.35 112.11 24.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.695 . . . . 0.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 4.0 m -105.65 130.06 53.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.634 -0.667 . . . . 0.0 110.217 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 99.68 6.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.685 . . . . 0.0 110.183 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.453 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 2.0 t80 -75.57 121.38 22.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 0.0 109.835 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.4 p -152.63 162.27 41.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 110.478 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.492 1.671 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.597 179.363 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.118 0.485 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.41 115.24 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.626 . . . . 0.0 109.607 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.49 -59.94 3.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.5 tp -167.61 170.55 11.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.449 -0.782 . . . . 0.0 110.484 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.7 t -163.85 125.29 2.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.725 -0.609 . . . . 0.0 109.872 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.425 ' CD2' HD22 ' A' ' 90' ' ' LEU . 20.5 p90 -140.16 -153.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.704 . . . . 0.0 110.304 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.11 134.25 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 110.649 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.36 146.95 42.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.674 -0.641 . . . . 0.0 109.893 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.66 141.3 29.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.628 -0.67 . . . . 0.0 111.181 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.84 108.83 19.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -88.47 122.08 31.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.771 . . . . 0.0 110.656 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.9 mm -94.32 156.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 109.486 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -138.23 -162.33 1.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.748 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 -24.43 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 110.682 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -160.01 77.36 0.65 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.387 -0.821 . . . . 0.0 110.994 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.463 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -70.51 -7.03 40.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.452 -0.78 . . . . 0.0 111.693 179.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -155.28 51.45 0.59 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.107 -0.995 . . . . 0.0 110.288 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.122 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' CB ' ' CB ' ' A' ' 120' ' ' ARG . 7.4 p-10 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.6 31.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 110.817 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.58 141.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.676 -0.64 . . . . 0.0 110.055 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 58.5 t -63.73 125.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.637 -0.664 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -82.03 -58.92 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.903 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.58 155.42 26.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.97 133.84 53.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.606 -0.684 . . . . 0.0 109.784 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -109.64 155.66 21.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.542 -0.724 . . . . 0.0 110.924 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -141.57 107.96 5.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.614 -0.679 . . . . 0.0 110.058 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.79 160.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.972 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.8 t -147.27 -80.73 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -170.81 -45.49 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.346 -0.846 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 p -123.86 34.76 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 110.118 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -87.59 173.06 6.93 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.29 -28.6 15.05 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.474 1.25 . . . . 0.0 110.077 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.35 170.97 30.01 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.1 102.83 1.4 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.526 1.277 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 8.2 mt -64.73 121.23 14.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 109.68 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.84 103.41 15.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.668 -0.645 . . . . 0.0 110.247 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.466 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 2.9 tt -80.2 119.82 23.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 110.176 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.47 129.42 37.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.422 ' CD2' ' CE2' ' A' ' 192' ' ' TRP . 6.0 mt -133.71 53.6 2.0 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.561 -0.712 . . . . 0.0 110.039 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.3 p -140.31 -43.53 0.41 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.656 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.11 -117.85 4.25 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 114.83 3.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.627 -0.925 . . . . 0.0 110.334 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 24.3 mt -92.27 -30.46 15.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -66.13 -12.69 57.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.804 . . . . 0.0 111.096 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -56.45 -20.27 19.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.111 -0.993 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.466 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 3.1 m-85 -67.99 -31.68 71.56 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.312 -0.868 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -61.49 -35.29 77.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 110.723 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -87.1 -25.2 24.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.61 126.26 46.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.468 -0.77 . . . . 0.0 110.477 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -115.38 159.77 20.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 88' ' ' LEU . 11.3 m-85 -83.27 114.64 21.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.93 118.28 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.693 -0.63 . . . . 0.0 110.51 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 82.1 mt -129.89 159.15 37.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.575 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 18.9 tttt -85.9 169.02 13.67 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -39.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 41.58 72.84 0.24 Allowed Glycine 0 N--CA 1.501 2.985 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.898 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 33.1 m -86.5 125.77 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -1.037 . . . . 0.0 110.077 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.05 90.77 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.199 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.43 ' CD1' HD21 ' A' ' 77' ' ' LEU . 11.9 p90 -109.63 150.37 28.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.156 -0.965 . . . . 0.0 111.573 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -98.04 147.07 24.9 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.1 mt -111.04 132.56 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.326 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -115.38 98.63 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.782 -0.574 . . . . 0.0 109.559 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -78.08 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.695 -0.628 . . . . 0.0 110.432 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.5 m -114.81 141.44 47.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 116' ' ' PHE . 12.9 p90 -153.87 144.65 22.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.415 -0.803 . . . . 0.0 110.968 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -87.17 132.53 33.84 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.246 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.94 95.12 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -128.15 40.12 3.72 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.596 -0.841 . . . . 0.0 112.692 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.406 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -161.31 -67.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.08 -1.013 . . . . 0.0 110.919 179.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -124.38 166.07 16.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 110.911 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 165.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.263 0.554 . . . . 0.0 110.031 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.39 54.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.699 -0.625 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.92 104.95 2.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.661 -0.649 . . . . 0.0 110.35 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.14 46.27 0.95 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.458 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -87.6 132.27 34.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.599 -0.942 . . . . 0.0 109.486 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.22 164.55 17.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.478 -0.764 . . . . 0.0 111.019 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -136.43 102.06 4.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.861 -0.524 . . . . 0.0 109.748 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -82.27 164.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 0.0 109.994 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -167.96 117.71 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.307 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 10.7 m170 -101.7 159.31 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.718 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 m -117.55 69.85 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.458 -0.777 . . . . 0.0 109.959 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 19.7 m-85 -66.2 123.72 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.417 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -126.09 134.13 51.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 110.395 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm 52.69 28.15 5.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.21 -16.61 55.36 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.6 m -106.02 156.24 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.118 -1.225 . . . . 0.0 110.576 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -86.37 134.34 33.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.676 . . . . 0.0 109.887 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.02 -25.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 110.956 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -175.79 144.45 0.63 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.225 -0.922 . . . . 0.0 110.537 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.64 152.44 50.43 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.7 m -136.27 153.45 51.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 111.374 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.69 116.37 26.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.43 114.69 29.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.981 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.4 ttt -74.64 120.07 19.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 158' ' ' PHE . 51.3 t -79.64 -68.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.403 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.57 -163.23 29.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.2 p -104.77 148.04 27.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.906 . . . . 0.0 110.256 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.74 125.84 12.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.501 -0.75 . . . . 0.0 110.154 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.65 156.61 23.26 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.36 94.13 0.67 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.406 1.214 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -86.31 -67.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.681 . . . . 0.0 110.11 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.79 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.68 -152.29 0.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 110.634 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -99.97 168.05 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -111.46 -170.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.65 -0.656 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.54 114.12 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.693 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 146' ' ' VAL . 37.7 t80 -89.64 164.73 14.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 109.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -135.75 117.41 14.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.531 -0.73 . . . . 0.0 110.656 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.6 p -102.23 147.77 34.44 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.611 -0.68 . . . . 0.0 109.297 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.21 -173.44 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.821 1.432 . . . . 0.0 111.735 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -52.67 140.67 22.82 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.472 0.653 . . . . 0.0 111.773 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 3.5 tp10 -138.42 82.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.61 137.18 58.0 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.541 0.686 . . . . 0.0 110.8 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.42 -178.7 1.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.09 124.94 10.44 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.187 1.098 . . . . 0.0 110.198 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -115.26 178.96 4.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.571 -0.706 . . . . 0.0 110.662 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.44 150.83 10.66 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 5.8 ttt -59.59 -28.83 67.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.418 -1.049 . . . . 0.0 110.025 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.2 23.96 8.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.784 . . . . 0.0 110.325 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.41 24.61 7.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -98.59 131.45 44.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 110.009 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.33 -174.26 27.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.5 p -87.6 122.84 31.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.943 . . . . 0.0 110.659 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 19.4 m-85 -103.67 107.33 18.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -66.0 133.33 50.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.596 -0.69 . . . . 0.0 110.093 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.7 mt -124.87 141.58 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.493 -0.755 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -114.12 115.06 26.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.637 -0.664 . . . . 0.0 110.211 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.5 m -113.8 157.63 22.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 110.15 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.31 101.52 4.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.452 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 2.2 t80 -75.56 92.46 2.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.644 . . . . 0.0 110.096 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.7 t -127.28 179.75 5.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.274 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.54 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.84 116.52 28.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.715 -0.616 . . . . 0.0 109.413 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -57.65 -49.52 76.2 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.433 -0.792 . . . . 0.0 110.703 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.8 tp -168.35 158.91 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.5 -0.75 . . . . 0.0 110.463 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 140.28 22.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.92 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' A' ' 90' ' ' LEU . 15.3 p90 -146.52 -155.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.581 -0.699 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -161.68 130.23 4.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.688 -0.633 . . . . 0.0 110.169 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.468 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 11.0 p-90 -137.49 145.96 43.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.498 -0.751 . . . . 0.0 110.066 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -90.13 155.88 18.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.511 0.672 . . . . 0.0 111.122 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.3 tp -121.18 95.42 4.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.777 -0.577 . . . . 0.0 109.614 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -68.91 122.6 18.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.672 . . . . 0.0 110.304 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -101.39 153.51 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 109.796 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -148.55 -157.09 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.615 -0.678 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -18.42 7.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.786 . . . . 0.0 111.355 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.8 73.73 1.08 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.0 111.079 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.59 -4.19 32.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.727 . . . . 0.0 111.569 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 37.51 4.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 110.25 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.334 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.999 0.428 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 90.6 t -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -147.54 147.41 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.765 -0.584 . . . . 0.0 109.827 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 43.2 t -68.13 113.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.627 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.8 p -77.29 -33.44 55.77 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.118 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -168.63 160.27 10.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.708 . . . . 0.0 110.324 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 tt -128.29 134.75 48.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.655 -0.653 . . . . 0.0 109.886 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -109.6 162.29 14.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.541 -0.724 . . . . 0.0 110.146 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.84 95.69 2.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.771 . . . . 0.0 110.195 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.6 t -105.19 167.32 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.857 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.8 t -159.55 -82.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.651 -0.656 . . . . 0.0 110.134 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -71.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.865 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 p -98.59 31.5 2.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -85.13 169.95 14.78 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.706 . . . . 0.0 110.088 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.6 -27.44 18.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.393 1.207 . . . . 0.0 110.24 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.56 170.57 26.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.84 104.37 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.497 1.262 . . . . 0.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.91 128.48 35.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 109.817 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -103.55 113.17 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.681 -0.637 . . . . 0.0 110.323 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' CZ ' ' A' ' 97' ' ' PHE . 1.2 tt -100.01 105.71 17.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 110.154 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -65.69 137.71 57.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.689 -0.632 . . . . 0.0 109.729 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.0 mt -135.6 56.8 1.82 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.753 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.0 p -115.75 -68.53 0.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.768 -0.582 . . . . 0.0 110.493 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 -58.18 0.18 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.45 74.81 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.969 . . . . 0.0 110.323 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.2 mt -95.46 -22.38 17.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 0.0 110.805 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.43 -1.13 28.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.345 -0.847 . . . . 0.0 111.561 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -90.06 0.37 57.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.175 -0.953 . . . . 0.0 111.288 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CZ ' HD21 ' A' ' 88' ' ' LEU . 51.8 m-85 -94.09 -32.22 13.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.114 -0.991 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -59.1 -19.72 47.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -88.07 -24.75 23.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 110.535 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.68 -179.88 3.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.429 -0.794 . . . . 0.0 110.54 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -167.31 142.88 4.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.536 -0.727 . . . . 0.0 110.146 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.09 121.72 25.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.859 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.84 123.47 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 110.341 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.42 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 55.0 mt -124.19 178.74 5.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 19.7 tttm -104.2 150.97 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.815 0.817 . . . . 0.0 109.514 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.6 pt-20 -50.63 124.5 11.0 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.56 48.99 72.77 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.626 -0.671 . . . . 0.0 113.343 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 28.0 m -97.01 133.21 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.975 1.388 . . . . 0.0 109.678 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.44 94.77 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 40.8 p90 -118.32 142.03 47.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 0.0 111.361 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.19 163.37 12.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.612 -0.68 . . . . 0.0 109.176 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.42 151.59 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.015 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -128.91 117.9 21.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.14 144.98 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.758 . . . . 0.0 110.662 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -123.72 147.54 47.38 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.454 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 34.1 p90 -168.37 161.29 11.89 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -113.0 144.59 42.31 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.843 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.79 98.89 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -128.7 49.01 2.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 0.0 111.046 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -75.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -138.28 160.22 40.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.5 mt -63.57 104.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.74 -0.6 . . . . 0.0 109.921 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.33 76.35 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.612 -0.68 . . . . 0.0 109.636 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.0 p -77.68 85.48 4.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.37 48.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -85.12 131.05 34.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.558 -0.966 . . . . 0.0 109.481 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.5 162.34 25.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.63 -0.669 . . . . 0.0 111.051 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -136.38 108.28 7.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 129' ' ' ILE . 77.2 mt -102.76 161.94 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 0.0 110.063 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -159.3 134.88 8.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.594 -0.691 . . . . 0.0 110.28 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.4 m-70 -111.23 130.68 55.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 84.3 m -84.33 72.59 10.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.849 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.403 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 4.4 m-85 -64.11 137.35 57.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 110.495 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.424 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 14.8 ttm180 -120.91 107.76 13.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.634 . . . . 0.0 109.925 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 53.27 37.09 24.39 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.399 -0.813 . . . . 0.0 110.584 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.47 19.87 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.7 t -147.24 111.41 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 126.47 28.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.73 -22.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.558 -0.714 . . . . 0.0 110.798 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -167.91 132.48 1.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.595 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.43 ' CE ' ' CE1' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -139.98 144.51 37.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.2 m -132.42 164.72 25.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 110.744 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.53 115.39 23.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.748 -0.595 . . . . 0.0 109.877 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.17 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 ttm -98.27 117.99 33.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.542 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.414 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 47.4 t -79.7 -63.21 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.786 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 143.77 178.43 19.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.2 p -87.77 149.13 24.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.909 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 76.3 m-85 -147.82 132.57 17.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.333 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.95 159.5 24.57 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.13 94.22 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.399 1.21 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -116.51 23.35 12.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 110.6 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 52.49 23.64 2.64 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.339 -0.851 . . . . 0.0 111.213 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -126.97 169.15 13.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.573 -0.704 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -100.19 163.33 12.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.604 . . . . 0.0 110.398 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.474 ' CD2' ' CD1' ' A' ' 149' ' ' TYR . 64.2 m-85 -122.88 170.57 9.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.644 -0.66 . . . . 0.0 109.954 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -136.23 103.36 5.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 160' ' ' THR . 24.4 t80 -88.18 148.34 24.45 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -133.53 111.3 10.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 110.641 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 158' ' ' PHE . 77.6 p -85.83 151.67 55.43 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.56 -0.712 . . . . 0.0 109.62 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.78 165.62 22.82 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.441 1.232 . . . . 0.0 111.093 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 mtm -54.64 168.63 0.26 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.714 -0.616 . . . . 0.0 110.755 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -155.55 140.2 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.741 -0.599 . . . . 0.0 109.775 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 129.9 42.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.591 -0.693 . . . . 0.0 110.974 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.93 178.56 2.09 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.612 -0.68 . . . . 0.0 110.25 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.39 -173.12 1.2 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.448 1.236 . . . . 0.0 110.606 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 13.8 mmtt -78.39 -176.53 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.51 -0.744 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.402 ' N ' ' CB ' ' A' ' 106' ' ' GLU . . . -95.18 -60.88 1.04 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 12.2 mmt -60.9 141.7 56.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.962 . . . . 0.0 109.44 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt 66.15 -64.27 0.22 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.673 -0.642 . . . . 0.0 110.393 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.5 -17.83 35.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 111.177 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.15 27.78 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.082 -1.011 . . . . 0.0 110.285 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.63 177.88 15.13 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.7 p -88.19 134.21 33.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.544 -0.974 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 15.9 m-85 -116.94 116.81 28.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.544 -0.722 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -61.66 145.82 51.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.427 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -125.18 108.23 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.502 -0.749 . . . . 0.0 110.361 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 1.6 ttpt -88.2 95.61 10.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.493 -0.754 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 125.29 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.48 -0.762 . . . . 0.0 110.114 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -116.01 107.8 15.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.45 -0.782 . . . . 0.0 110.35 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 2.2 t80 -83.82 136.68 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.714 -0.616 . . . . 0.0 109.741 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.0 t -172.77 -173.58 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.557 -0.714 . . . . 0.0 110.42 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 179.433 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 121.139 0.495 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -115.25 118.87 34.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.579 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.421 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 14.4 m-70 -73.23 -65.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 110.699 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.0 tp -168.42 151.49 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.797 . . . . 0.0 110.5 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.6 m -149.0 146.5 27.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.015 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -140.05 -162.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -154.44 121.89 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.401 -0.812 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.427 ' CZ2' HG22 ' A' ' 177' ' ' ILE . 30.5 p-90 -132.23 148.35 52.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.692 -0.63 . . . . 0.0 109.553 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.49 148.56 23.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.483 -0.76 . . . . 0.0 111.489 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.52 102.1 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -75.2 132.07 40.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 0.0 110.724 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.95 147.75 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.76 -159.08 0.96 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.694 -0.629 . . . . 0.0 110.129 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.58 -8.43 4.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.96 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -155.19 63.13 0.63 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.947 -1.095 . . . . 0.0 111.516 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' TRP . . . . . 0.446 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -72.17 -6.77 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.263 -0.898 . . . . 0.0 111.241 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -162.21 47.92 0.17 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.134 -179.884 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 p -139.65 138.19 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.603 -0.686 . . . . 0.0 110.098 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 t 53.04 -159.28 0.13 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.381 -0.825 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.21 166.33 13.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.533 -0.729 . . . . 0.0 110.223 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -77.18 149.9 79.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.204 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.69 -88.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.479 1.252 . . . . 0.0 110.601 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.9 m120 52.82 29.51 7.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.945 -1.097 . . . . 0.0 110.815 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.7 t -152.73 146.08 17.86 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.777 -0.577 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.35 162.36 40.86 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.282 1.148 . . . . 0.0 109.97 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' CB ' ' CB ' ' A' ' 120' ' ' ARG . 17.0 p-10 -104.14 -25.74 12.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.523 -0.736 . . . . 0.0 110.949 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 86.0 t -125.51 119.15 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.9 t -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.35 110.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.726 . . . . 0.0 109.142 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.8 p -76.2 -41.27 50.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -167.38 163.76 15.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.287 -0.883 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -121.44 125.93 48.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 85' ' ' PRO . 12.8 m -109.97 154.78 22.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 111.032 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -138.71 92.02 2.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.35 130.8 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.713 -0.617 . . . . 0.0 110.654 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.7 m -128.05 -3.13 5.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.713 -0.617 . . . . 0.0 111.145 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.83 18.7 3.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.951 -1.093 . . . . 0.0 111.29 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.5 p -142.26 -45.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.757 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.467 ' CB ' ' CZ2' ' A' ' 202' ' ' TRP . . . -57.77 -179.18 0.11 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.749 -0.594 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -73.85 -17.31 22.81 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.531 1.279 . . . . 0.0 110.238 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.7 171.61 35.45 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.924 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' ' CG2' ' A' ' 76' ' ' THR . 46.8 Cg_endo -72.56 122.26 8.11 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.778 1.409 . . . . 0.0 110.728 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.66 117.66 10.67 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.149 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.99 112.8 25.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.633 -0.667 . . . . 0.0 110.64 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 1.3 tt -101.07 101.66 12.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.554 -0.716 . . . . 0.0 109.988 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.6 t0 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.553 -0.717 . . . . 0.0 110.33 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 192' ' ' TRP . 96.0 mt -135.87 54.77 1.89 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 110.062 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 p -135.87 -42.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.783 -0.573 . . . . 0.0 110.422 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.33 -103.61 2.45 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.22 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.632 -0.923 . . . . 0.0 110.687 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.55 -26.74 15.67 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.638 -0.663 . . . . 0.0 110.395 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.94 0.2 36.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.495 -0.753 . . . . 0.0 111.523 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 t -85.9 0.25 53.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.099 -1.0 . . . . 0.0 111.208 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.439 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 34.3 m-85 -93.14 -29.42 15.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.165 -0.959 . . . . 0.0 110.045 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -12.57 60.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -86.47 -26.62 24.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.253 -0.904 . . . . 0.0 110.33 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -132.62 -172.11 2.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.5 -0.75 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.4 p -152.59 169.64 22.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.549 -0.719 . . . . 0.0 110.102 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -96.7 119.85 35.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.58 -0.7 . . . . 0.0 109.997 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.51 116.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 109.62 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 166.38 11.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.463 ' HE3' ' CG ' ' A' ' 202' ' ' TRP . 0.2 OUTLIER -96.14 148.02 23.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.593 -0.692 . . . . 0.0 111.542 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -23.46 -46.81 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.04 36.4 0.12 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.818 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 105' ' ' LYS . 27.0 m -60.41 148.31 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.235 -1.156 . . . . 0.0 110.309 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.09 93.96 5.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 163' ' ' GLU . 32.5 p90 -109.7 151.35 27.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.469 -0.77 . . . . 0.0 111.562 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.3 156.44 18.14 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.98 135.93 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.314 -0.866 . . . . 0.0 110.42 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -122.51 120.45 33.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.587 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.1 mm -97.65 134.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.701 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 p -108.67 150.12 27.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.134 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.445 ' CG ' ' HE3' ' A' ' 126' ' ' MET . 3.1 p90 -162.51 139.13 7.74 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 135.06 35.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.625 . . . . 0.0 111.126 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.26 102.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -128.63 43.89 3.06 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.781 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -155.96 -65.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.0 166.06 23.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.375 -0.828 . . . . 0.0 111.413 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.7 mt -80.25 145.97 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.3 t -114.8 74.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.673 -0.642 . . . . 0.0 109.428 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 85.4 p -64.82 85.04 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 110.474 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.18 51.76 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.445 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -75.26 131.92 40.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -1.007 . . . . 0.0 109.312 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -130.7 159.57 36.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 111.085 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -138.08 126.52 23.32 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.06 166.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -168.58 111.45 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.4 m-70 -98.39 109.26 22.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.56 -0.713 . . . . 0.0 109.979 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.5 m -68.62 79.07 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.8 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.45 ' CZ ' ' CG ' ' A' ' 138' ' ' LYS . 2.8 m-85 -69.28 124.62 24.33 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.611 -0.681 . . . . 0.0 110.021 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -127.03 130.46 50.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.552 -0.717 . . . . 0.0 110.243 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 52.74 28.56 6.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.464 -0.772 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.48 -18.78 47.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.18 152.89 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -1.198 . . . . 0.0 110.328 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -85.24 134.52 34.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 110.268 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.6 -19.61 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.2 115.76 0.96 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 110.69 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 3.3 pttm -143.49 121.15 11.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.601 -0.687 . . . . 0.0 109.891 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.5 m -143.63 169.29 18.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.452 -0.78 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.42 157.56 16.83 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.722 -0.611 . . . . 0.0 109.92 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -122.92 103.23 8.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 110.427 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ttt -65.6 120.32 12.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.515 -0.741 . . . . 0.0 109.584 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 158' ' ' PHE . 50.6 t -96.9 -69.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.47 -0.769 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.87 -162.4 31.65 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -93.89 126.04 38.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.622 -0.928 . . . . 0.0 110.27 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.425 ' CE1' HG13 ' A' ' 146' ' ' VAL . 9.9 m-85 -113.45 137.74 51.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.695 . . . . 0.0 110.487 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.89 150.61 17.58 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.48 114.41 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.419 1.221 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -106.6 -58.18 1.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.572 -0.705 . . . . 0.0 110.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -170.55 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.523 -0.736 . . . . 0.0 110.744 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.88 -154.38 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.414 -0.804 . . . . 0.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -101.56 166.33 10.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.849 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.43 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 92.8 m-85 -115.74 -166.06 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.744 -0.598 . . . . 0.0 109.388 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -148.54 110.91 4.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.666 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 146' ' ' VAL . 39.8 t80 -70.81 165.76 22.46 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.08 109.12 4.61 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.814 . . . . 0.0 110.792 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 158' ' ' PHE . 72.2 p -87.58 145.91 38.25 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.57 -171.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.658 1.346 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -54.03 158.1 2.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 5.7 tt0 -159.95 93.44 1.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.74 -0.6 . . . . 0.0 109.77 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.13 133.14 49.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.628 -0.67 . . . . 0.0 110.519 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.88 166.78 36.95 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.84 117.47 5.16 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.377 1.198 . . . . 0.0 110.118 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -108.03 172.36 6.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.514 -0.741 . . . . 0.0 110.709 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.81 155.29 8.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.1 ttm -59.28 -27.73 66.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.582 -0.952 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 170' ' ' LEU . 4.2 mm? -93.48 -28.79 15.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.655 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.58 -22.01 54.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.936 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -62.36 138.56 58.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.339 -0.85 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.35 177.3 19.11 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 p -88.62 131.59 34.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.939 . . . . 0.0 110.354 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -112.68 108.49 17.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.511 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -66.6 137.91 57.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 0.0 109.403 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.413 HD13 ' CH2' ' A' ' 194' ' ' TRP . 16.4 mt -128.69 135.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.358 -0.839 . . . . 0.0 110.828 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -108.42 105.04 14.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.738 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.414 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 2.5 p -106.45 129.28 54.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.532 -0.73 . . . . 0.0 110.593 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -126.5 91.61 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.673 -0.642 . . . . 0.0 109.886 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.82 103.66 5.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 109.7 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 69.6 p -122.37 165.81 15.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.707 . . . . 0.0 110.201 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.404 ' HB3' ' CD2' ' A' ' 189' ' ' HIS . 46.7 p-10 -115.64 164.55 14.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.624 -0.673 . . . . 0.0 109.39 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.13 55.81 3.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -117.19 -75.14 0.58 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.752 -0.593 . . . . 0.0 109.661 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.38 23.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.741 -0.599 . . . . 0.0 112.18 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t -173.09 -172.6 0.84 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.687 -1.258 . . . . 0.0 111.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.46 118.8 34.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.419 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 36.3 m-70 -56.93 -49.98 73.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 110.791 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.1 tp -168.25 153.74 6.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -154.28 140.96 19.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.419 ' CE2' HD12 ' A' ' 90' ' ' LEU . 16.0 p90 -145.57 -154.63 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.787 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.7 129.5 6.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.362 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 14.3 p-90 -137.82 146.9 44.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.574 -0.704 . . . . 0.0 109.901 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -96.79 158.08 15.6 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 21.1 tp -127.0 111.55 14.21 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.7 m -91.53 117.66 29.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.53 -0.731 . . . . 0.0 110.774 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 198' ' ' ILE . 48.5 mm -90.03 139.86 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -134.55 -155.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.467 -0.771 . . . . 0.0 110.494 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -93.83 -63.05 1.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -153.15 113.86 4.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.52 -0.737 . . . . 0.0 111.496 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.467 ' CZ2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -80.05 7.13 9.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.618 -0.676 . . . . 0.0 111.901 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -169.03 38.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.349 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.194 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.059 0.457 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 p -112.57 -25.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.636 -0.665 . . . . 0.0 110.333 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -79.68 177.16 9.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 110.196 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.74 96.27 4.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.656 -0.653 . . . . 0.0 110.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.9 175.42 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.558 -0.714 . . . . 0.0 110.641 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.81 -49.9 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.376 1.198 . . . . 0.0 110.322 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.09 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.413 -0.804 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -163.07 85.09 1.4 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.567 -0.708 . . . . 0.0 110.26 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.29 163.53 38.36 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.283 1.149 . . . . 0.0 110.328 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -98.61 -71.79 0.68 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.558 -0.714 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 57.2 t -122.48 33.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.712 0.767 . . . . 0.0 109.684 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.24 153.38 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.291 0.567 . . . . 0.0 109.986 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 57.8 t -69.03 136.84 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.669 -0.645 . . . . 0.0 109.487 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.1 p -95.44 -41.85 8.77 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -164.19 169.01 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 110.253 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.64 134.9 43.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 62.6 m -122.03 158.35 29.36 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.578 -0.702 . . . . 0.0 110.44 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.81 93.73 3.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.75 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -81.69 140.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.746 -0.596 . . . . 0.0 110.161 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.2 m -142.41 -162.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.642 -0.661 . . . . 0.0 110.063 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.7 p -111.34 -72.55 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 110.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 p -96.63 32.54 2.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.447 ' HB3' ' CZ3' ' A' ' 202' ' ' TRP . . . -90.56 -174.62 0.45 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.652 -0.655 . . . . 0.0 110.237 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 48.2 Cg_endo -79.93 -28.87 2.99 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 123.203 1.107 . . . . 0.0 110.156 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.55 -179.22 33.45 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.44 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.87 108.35 2.42 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.587 1.309 . . . . 0.0 110.511 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 37.7 mt -71.72 107.39 4.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.829 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.15 146.29 27.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.656 . . . . 0.0 110.247 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -130.91 140.82 50.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.698 . . . . 0.0 110.095 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.25 130.08 39.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.506 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mt -137.73 56.14 1.77 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -149.37 -45.64 0.14 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -0.758 . . . . 0.0 110.797 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.14 -89.02 1.13 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.75 124.14 49.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.916 . . . . 0.0 110.282 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 97' ' ' PHE . 89.4 mt -92.84 -24.16 18.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.581 -0.699 . . . . 0.0 110.392 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -23.1 6.31 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.218 -0.926 . . . . 0.0 111.295 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -57.78 -19.72 30.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 111.081 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.1 m-30 -62.56 -55.24 29.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.163 -0.961 . . . . 0.0 110.47 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -20.03 39.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.498 -0.751 . . . . 0.0 110.835 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -96.26 26.86 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -168.95 163.33 11.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.389 -0.82 . . . . 0.0 110.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 p -163.29 131.14 3.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.615 -0.678 . . . . 0.0 110.032 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 26.9 m-85 -73.79 126.6 30.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.614 -0.679 . . . . 0.0 110.094 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.1 t -87.35 122.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.71 . . . . 0.0 110.128 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.445 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 41.1 mt -114.89 -169.67 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 110.151 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 16.3 tttm -126.4 157.5 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.716 0.769 . . . . 0.0 109.868 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -41.19 117.35 0.86 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 43.44 66.2 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.127 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 35.0 m -98.44 152.21 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -1.111 . . . . 0.0 110.244 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -95.48 117.11 29.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 109.486 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 110' ' ' TYR . 33.0 p90 -142.58 149.27 38.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.387 -0.821 . . . . 0.0 111.277 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.62 166.01 11.52 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 112' ' ' ILE . 70.0 mt -126.15 148.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.022 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -123.25 92.09 3.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 109.547 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.419 HD13 ' CZ ' ' A' ' 128' ' ' TYR . 46.9 mm -73.32 135.71 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 110.322 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.1 m -117.94 136.99 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.467 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 37.9 p90 -156.71 148.9 23.11 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.413 -0.804 . . . . 0.0 110.695 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.88 138.01 35.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.716 -0.615 . . . . 0.0 110.509 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 84.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.643 . . . . 0.0 109.482 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.17 48.59 2.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.567 -0.708 . . . . 0.0 111.25 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -70.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.376 -0.827 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.22 156.81 36.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.555 -0.716 . . . . 0.0 110.416 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 122' ' ' ILE . 84.3 mt -80.17 103.4 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 110.292 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.56 99.48 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.632 -0.667 . . . . 0.0 109.497 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.431 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 83.6 p -89.39 117.72 28.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.512 -0.742 . . . . 0.0 110.758 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.92 48.94 1.12 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.467 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 1.3 ttt -73.09 125.09 26.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 109.906 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -119.69 143.71 47.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.167 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CZ ' HD13 ' A' ' 114' ' ' ILE . 30.9 t80 -120.54 106.57 11.91 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.15 163.2 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.569 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -153.25 139.56 18.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.738 -0.601 . . . . 0.0 109.944 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -117.93 132.65 56.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 m -87.55 71.1 9.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 109.543 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 7.3 m-85 -74.08 151.46 40.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.714 -0.616 . . . . 0.0 110.822 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.454 ' NE ' ' CE2' ' A' ' 175' ' ' TYR . 2.8 tpt180 -120.17 -150.96 0.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.836 -0.54 . . . . 0.0 109.735 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 66.43 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 110.848 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.3 34.66 35.97 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.9 t -144.84 95.09 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.655 -0.909 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -59.55 115.6 3.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.508 -0.745 . . . . 0.0 110.197 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 139' ' ' ILE . 95.2 mt -89.8 -58.7 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.474 -0.766 . . . . 0.0 110.115 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.29 -171.8 1.36 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.51 -0.744 . . . . 0.0 110.944 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.85 167.6 22.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.777 -0.577 . . . . 0.0 110.269 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.1 m -137.11 147.81 46.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.356 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.28 127.8 54.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.662 -0.648 . . . . 0.0 110.012 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -117.32 139.05 51.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.495 -0.753 . . . . 0.0 110.614 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.348 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 58.4 t -79.57 -69.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 0.0 110.411 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.79 171.84 20.61 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.431 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 38.7 m -94.71 150.8 19.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.609 -0.936 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 156' ' ' TYR . 63.6 m-85 -149.35 129.01 13.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.55 -0.719 . . . . 0.0 110.388 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.01 169.95 34.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.24 -165.94 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.339 1.179 . . . . 0.0 110.354 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 37.7 34.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.153 0.501 . . . . 0.0 112.234 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.29 26.9 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.711 -0.618 . . . . 0.0 110.49 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.9 -159.56 0.21 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.581 -0.7 . . . . 0.0 110.386 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -100.18 150.96 21.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.39 -0.819 . . . . 0.0 110.8 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 149' ' ' TYR . 84.7 m-85 -105.69 -165.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.726 -0.609 . . . . 0.0 109.543 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.14 123.03 1.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.422 -0.799 . . . . 0.0 110.548 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 146' ' ' VAL . 33.3 t80 -87.48 167.88 13.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.77 88.29 1.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.417 HG21 ' CE2' ' A' ' 158' ' ' PHE . 82.1 p -62.87 146.79 94.82 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 149.56 77.33 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.408 1.215 . . . . 0.0 110.621 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.73 106.28 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.558 -0.714 . . . . 0.0 110.787 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.66 159.53 14.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -91.0 148.0 22.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.0 110.547 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.19 178.95 1.84 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.659 -0.651 . . . . 0.0 110.021 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.85 132.23 18.18 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.222 1.117 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -113.28 165.32 12.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.76 161.22 17.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.3 ttp -60.85 -39.48 89.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.669 -0.9 . . . . 0.0 110.141 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -72.3 -5.47 36.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.604 -0.685 . . . . 0.0 111.687 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.3 -29.51 57.38 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -65.08 127.51 31.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.59 -179.24 21.94 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 p -88.09 134.96 33.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.994 . . . . 0.0 110.3 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CE2' ' NE ' ' A' ' 134' ' ' ARG . 24.8 m-85 -122.57 111.54 16.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.691 -0.631 . . . . 0.0 110.001 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.22 130.64 47.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.531 -0.731 . . . . 0.0 110.334 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.456 ' CG2' ' CZ2' ' A' ' 194' ' ' TRP . 49.9 mm -114.26 98.55 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.646 -0.659 . . . . 0.0 110.029 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 119.04 31.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.111 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 36.8 t -118.44 143.41 46.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.735 -0.603 . . . . 0.0 110.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -84.48 130.6 34.74 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.2 t -171.62 -171.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.536 -0.727 . . . . 0.0 110.201 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -111.09 -154.73 0.55 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.642 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.79 -59.18 5.61 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.421 -0.799 . . . . 0.0 110.098 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.7 27.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.873 -0.517 . . . . 0.0 110.677 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -80.81 -35.99 32.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.28 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t -176.99 -162.67 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.65 -0.656 . . . . 0.0 110.137 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 119.69 37.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.707 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.408 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 10.1 m-70 -75.7 -60.31 2.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 110.789 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -169.82 152.06 4.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 t -149.42 135.56 19.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.533 -0.729 . . . . 0.0 110.362 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.83 -155.69 0.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.685 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -167.87 128.07 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.981 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.456 ' CZ2' ' CG2' ' A' ' 177' ' ' ILE . 24.7 p-90 -132.74 150.6 52.14 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.0 109.719 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.52 151.58 23.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.493 -0.755 . . . . 0.0 111.137 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.53 105.09 8.78 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -81.77 138.33 35.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.604 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 198' ' ' ILE . 49.3 mm -114.57 164.04 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 109.461 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -153.94 -159.23 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -122.32 -10.65 8.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.651 -0.655 . . . . 0.0 111.346 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.06 69.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.136 -0.978 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.02 -4.56 33.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.555 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -154.44 46.17 0.56 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.126 -0.984 . . . . 0.0 110.136 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.249 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.155 0.503 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -145.24 50.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.588 -0.695 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -81.33 178.74 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.588 -0.695 . . . . 0.0 110.157 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.54 -175.03 2.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 110.216 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.64 147.97 53.64 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -176.11 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.37 1.195 . . . . 0.0 110.447 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -96.78 -176.77 3.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.613 -0.68 . . . . 0.0 110.307 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.8 p -144.87 59.46 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.714 . . . . 0.0 110.144 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.53 168.97 22.94 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.351 1.185 . . . . 0.0 110.395 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.72 -65.41 1.01 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.188 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 189' ' ' HIS . 85.0 t -141.1 119.39 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.2 t -142.85 139.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.487 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 59.4 t -64.29 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.4 p -74.8 -66.96 0.69 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.873 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -131.35 170.82 14.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.529 -0.732 . . . . 0.0 110.73 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -142.7 136.88 29.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.659 -0.651 . . . . 0.0 109.889 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -109.42 163.99 12.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 0.0 110.076 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -145.98 110.19 4.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.13 114.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 110.042 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.3 m -115.62 78.55 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 110.1 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.3 p 45.94 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.905 -0.497 . . . . 0.0 112.061 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 73.4 p -84.11 56.75 3.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 110.219 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.432 ' HA ' ' CZ2' ' A' ' 202' ' ' TRP . . . -90.72 151.89 44.26 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 110.695 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.2 -18.49 23.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.514 1.271 . . . . 0.0 110.228 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.98 152.77 7.37 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.01 98.55 0.91 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.436 1.229 . . . . 0.0 110.369 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 6.0 mt -64.72 131.46 46.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 109.879 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -103.87 113.02 26.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.542 -0.723 . . . . 0.0 110.31 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 1.2 tt -89.13 131.36 35.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.567 -0.708 . . . . 0.0 110.03 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.13 126.45 34.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.681 -0.637 . . . . 0.0 110.052 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD22 ' CE2' ' A' ' 192' ' ' TRP . 1.1 mp -130.28 52.99 1.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -129.39 -48.4 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.703 -0.623 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.4 -116.25 4.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.88 114.61 3.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.567 -0.96 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 65.4 mt -93.87 -39.12 10.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.638 -0.664 . . . . 0.0 110.058 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.86 -18.62 34.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.2 t -55.09 -20.65 10.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.24 -0.913 . . . . 0.0 111.335 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.449 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 4.6 m-30 -59.99 -31.57 70.04 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -63.3 -16.27 59.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 111.207 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -86.73 -25.48 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.906 . . . . 0.0 110.601 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.54 137.66 47.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -121.26 149.82 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 29.4 m-85 -85.46 123.04 30.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.504 -0.747 . . . . 0.0 110.105 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.71 152.61 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 109.988 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.43 HD22 ' CH2' ' A' ' 202' ' ' TRP . 1.6 mt -153.63 172.66 16.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.672 -0.643 . . . . 0.0 110.052 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -93.85 153.87 18.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.509 -0.744 . . . . 0.0 109.843 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -20.52 -55.57 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.88 69.72 0.24 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.577 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 ' CG1' ' CB ' ' A' ' 105' ' ' LYS . 20.9 m -82.63 -161.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.489 -1.006 . . . . 0.0 109.869 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.58 145.77 26.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.416 ' CZ ' ' CD1' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -109.29 111.08 22.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 112.213 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.46 98.63 6.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.64 144.88 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.464 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -120.15 107.25 12.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.428 HG22 ' CE1' ' A' ' 181' ' ' PHE . 48.2 mm -83.24 148.16 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.422 -0.798 . . . . 0.0 110.608 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -130.14 137.21 50.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 25.5 p90 -157.7 159.32 36.79 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.874 -0.731 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -98.54 138.68 35.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.382 0.611 . . . . 0.0 111.054 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 91.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -129.13 48.11 2.4 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.91 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -69.62 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.226 -0.921 . . . . 0.0 110.582 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -139.02 165.83 26.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.775 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.86 105.33 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.654 -0.653 . . . . 0.0 109.708 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.49 80.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 110.094 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.95 116.86 22.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.604 -0.685 . . . . 0.0 110.144 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.55 27.54 3.28 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -64.24 135.65 56.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.508 -0.996 . . . . 0.0 109.589 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -126.31 167.37 15.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -138.02 78.16 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.22 157.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.54 -0.725 . . . . 0.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -162.16 126.52 3.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.709 -0.619 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 15.1 m-70 -109.82 119.43 39.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.512 -0.742 . . . . 0.0 110.288 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.4 m -72.14 68.66 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.656 . . . . 0.0 109.411 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 5.5 m-85 -61.63 144.91 53.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 110.765 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -126.99 100.68 6.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.59 37.28 28.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.561 -0.712 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.65 -15.35 61.06 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.081 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.46 167.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.179 -1.189 . . . . 0.0 110.203 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 1.8 mppt? -113.66 130.9 56.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.76 -23.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.735 . . . . 0.0 111.035 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -165.39 119.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.159 -0.963 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -144.41 132.62 21.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -0.75 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.2 m -146.32 165.78 28.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.665 -0.647 . . . . 0.0 110.499 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -100.06 136.31 40.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.669 . . . . 0.0 110.038 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -111.54 154.45 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.558 -0.713 . . . . 0.0 110.454 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 12.3 ttm -101.73 112.16 24.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.606 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 57.8 t -79.49 -48.76 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.529 -0.732 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.46 165.6 10.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 65.4 p -85.77 143.75 28.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.68 -0.894 . . . . 0.0 109.403 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 148' ' ' SER . 50.2 m-85 -140.68 125.93 18.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.543 -0.723 . . . . 0.0 110.384 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.58 154.37 32.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.54 85.51 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.476 1.25 . . . . 0.0 110.378 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -85.45 -89.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.63 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.927 -1.108 . . . . 0.0 110.998 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -162.5 -163.43 0.9 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.82 . . . . 0.0 110.935 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -100.28 167.54 10.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.606 . . . . 0.0 110.092 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.439 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 27.7 m-85 -113.79 171.51 7.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.663 . . . . 0.0 109.787 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -138.36 95.33 2.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.523 -0.735 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 49.0 t80 -81.36 169.83 16.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.82 111.37 5.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.745 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 64.0 p -77.67 140.01 63.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.75 . . . . 0.0 109.064 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.11 163.28 29.43 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.75 1.395 . . . . 0.0 111.401 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.176 0.512 . . . . 0.0 111.478 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -79.39 -171.5 2.77 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.54 155.92 39.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 110.649 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.62 160.61 26.4 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.702 -0.624 . . . . 0.0 109.8 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.45 117.02 4.9 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.411 1.216 . . . . 0.0 110.777 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -113.97 -170.38 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.09 28.27 3.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 65.81 -68.51 0.12 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.452 -1.028 . . . . 0.0 110.75 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -29.22 61.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.61 -21.79 41.43 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.642 -0.661 . . . . 0.0 110.671 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -60.69 136.86 58.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 142.02 -173.52 23.64 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 p -91.6 137.99 31.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.623 -0.927 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -128.23 115.07 17.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 110.271 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.45 151.85 27.19 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.509 -0.744 . . . . 0.0 110.09 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.419 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 49.4 mm -131.51 97.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.463 -0.773 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 133' ' ' TYR . 4.3 ttpt -82.4 102.44 11.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 109.733 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.41 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.4 p -109.34 137.1 47.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.725 . . . . 0.0 110.482 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.41 99.51 5.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.781 -0.575 . . . . 0.0 110.007 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.449 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -78.77 120.42 23.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.688 -0.633 . . . . 0.0 109.75 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.0 t -142.95 -164.77 1.92 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.53 -0.731 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 13.0 p-10 -157.83 160.84 38.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.906 -0.496 . . . . 0.0 109.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.44 56.47 3.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.763 . . . . 0.0 109.964 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -131.09 -41.99 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 110.648 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -145.01 -77.65 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.931 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.6 t -150.76 -159.76 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.368 -0.832 . . . . 0.0 110.644 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.67 126.22 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.538 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 17.0 m-70 -73.48 -47.86 37.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 110.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -168.39 152.21 5.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 110.232 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.3 t -148.43 152.15 36.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.692 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CE2' HD22 ' A' ' 90' ' ' LEU . 15.4 p90 -142.97 -161.24 1.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.0 109.947 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.09 122.86 3.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.446 -0.784 . . . . 0.0 110.759 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.419 ' CZ2' HG22 ' A' ' 177' ' ' ILE . 37.6 p-90 -132.28 149.31 52.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.601 -0.687 . . . . 0.0 109.713 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.21 152.3 22.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.549 -0.719 . . . . 0.0 111.303 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 25.7 tp -122.04 108.84 13.84 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.9 m -85.74 140.31 30.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.528 -0.733 . . . . 0.0 110.581 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.6 mm -119.72 160.51 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.752 -0.592 . . . . 0.0 109.651 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.13 -153.23 0.33 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.212 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -3.65 6.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.448 -0.783 . . . . 0.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -160.05 43.96 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -54.04 -23.11 12.44 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.239 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.04 47.2 0.91 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.589 -0.695 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.265 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.194 0.521 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -140.54 154.79 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 t -88.69 148.61 23.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.59 103.45 14.28 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.434 -0.791 . . . . 0.0 110.302 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -133.12 82.08 55.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 0.0 110.144 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.95 -51.16 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.364 1.192 . . . . 0.0 110.535 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 52.2 -167.62 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.292 -0.88 . . . . 0.0 110.825 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 35.1 m -144.52 52.82 1.9 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.567 -0.708 . . . . 0.0 110.415 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 48.5 Cg_endo -74.18 106.62 2.26 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.292 1.154 . . . . 0.0 110.388 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 -62.13 1.77 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.611 -0.681 . . . . 0.0 110.062 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 189' ' ' HIS . 96.1 t -126.91 128.74 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.95 142.03 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.792 -0.567 . . . . 0.0 109.804 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.85 112.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.0 p -78.23 -35.53 48.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.0 111.062 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -159.31 176.89 11.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.367 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -145.82 113.67 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.798 -0.564 . . . . 0.0 109.665 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -109.8 164.55 12.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.445 -0.785 . . . . 0.0 110.571 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -139.23 101.67 4.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.0 167.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.717 -0.614 . . . . 0.0 110.127 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.36 -162.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.759 . . . . 0.0 110.098 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -108.84 -40.65 4.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -122.62 35.12 4.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' HB3' ' CH2' ' A' ' 202' ' ' TRP . . . -90.09 165.02 25.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.547 -0.721 . . . . 0.0 110.263 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.23 -26.8 25.01 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.385 1.203 . . . . 0.0 110.256 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.26 174.03 32.66 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.96 96.08 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.55 1.289 . . . . 0.0 110.293 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 23.6 mt -64.8 106.24 1.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.629 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.24 135.08 41.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.586 -0.696 . . . . 0.0 110.652 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.18 168.02 10.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.608 -0.682 . . . . 0.0 109.866 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.73 128.87 54.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.715 . . . . 0.0 110.111 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -128.07 50.24 2.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 110.078 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.7 p -141.0 -43.79 0.38 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.155 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.14 -92.01 2.03 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.68 98.79 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -1.021 . . . . 0.0 110.557 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -95.45 -36.92 11.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 0.0 110.089 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.36 -13.0 57.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 0.0 111.273 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 p -55.1 -28.01 49.31 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 28.7 m-85 -61.96 -39.47 92.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.46 -0.775 . . . . 0.0 109.985 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -57.92 -24.37 57.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.685 . . . . 0.0 110.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -118.67 45.41 2.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.561 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -168.35 136.13 2.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.791 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.2 p -143.41 127.88 17.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.657 . . . . 0.0 109.544 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 11.9 m-85 -76.42 115.37 16.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.369 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.77 121.14 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 109.179 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.451 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 1.0 OUTLIER -113.76 -159.31 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.618 -0.676 . . . . 0.0 110.3 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 47.0 tttm -140.94 158.79 43.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.572 -0.705 . . . . 0.0 110.555 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' CG ' ' NH1' ' A' ' 172' ' ' ARG . 22.3 mt-10 -38.36 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 33.32 70.34 0.13 Allowed Glycine 0 N--CA 1.505 3.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.863 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 33.0 m -90.83 147.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -1.14 . . . . 0.0 109.749 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.26 93.39 4.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 108.814 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 163' ' ' GLU . 31.8 p90 -113.45 146.31 39.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 111.894 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -108.38 157.49 18.35 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.66 164.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.855 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' CG ' ' CD1' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -142.67 87.15 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.87 -0.519 . . . . 0.0 109.612 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.55 150.92 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.411 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -127.02 153.02 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.705 -0.622 . . . . 0.0 109.739 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.495 ' CD2' ' CZ ' ' A' ' 181' ' ' PHE . 1.0 OUTLIER -172.09 159.32 4.9 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.576 -0.703 . . . . 0.0 110.576 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -113.94 154.54 27.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.11 97.83 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -128.98 48.93 2.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.513 -0.742 . . . . 0.0 111.291 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -70.6 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.27 -0.894 . . . . 0.0 110.777 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -135.56 172.61 12.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.671 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 122' ' ' ILE . 82.1 mt -80.35 108.76 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.726 -0.609 . . . . 0.0 110.419 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.61 86.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -78.13 59.29 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.677 -0.639 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.48 60.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.704 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.4 OUTLIER -70.25 128.67 37.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -1.058 . . . . 0.0 108.566 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -125.99 145.42 50.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.248 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.14 96.04 3.12 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.15 162.46 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.087 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -151.46 135.33 16.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.598 -0.688 . . . . 0.0 110.185 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.6 m-70 -109.55 149.1 30.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.715 . . . . 0.0 109.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.13 80.84 1.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.6 -0.687 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 11.6 m-85 -86.05 140.37 30.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 111.071 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -119.83 79.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.685 . . . . 0.0 110.399 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt 52.09 55.61 8.98 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.406 -0.809 . . . . 0.0 111.339 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.84 -19.33 52.3 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.1 t -98.73 89.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.181 -1.188 . . . . 0.0 109.829 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 5.1 pttm -66.92 122.73 18.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.575 -0.703 . . . . 0.0 110.562 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 mt -89.74 -54.03 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.15 -167.97 0.37 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.505 -0.747 . . . . 0.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -157.93 153.46 26.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.632 -0.668 . . . . 0.0 109.92 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.5 m -118.29 146.1 44.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -125.19 118.4 25.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -111.56 147.09 36.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.404 -0.81 . . . . 0.0 110.855 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.0 ttp -104.12 118.19 36.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.753 -0.592 . . . . 0.0 109.463 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 158' ' ' PHE . 49.1 t -79.87 -66.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.59 -0.694 . . . . 0.0 110.263 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.23 -148.87 20.17 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 92.5 p -108.59 136.64 47.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.543 -0.975 . . . . 0.0 110.427 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.42 ' CE1' HG13 ' A' ' 146' ' ' VAL . 23.3 m-85 -122.82 147.01 47.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 110.396 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.14 152.29 18.03 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -75.5 -174.25 1.93 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.362 1.19 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 52.01 70.11 0.59 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.5 -0.75 . . . . 0.0 111.079 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.1 -94.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.484 -0.76 . . . . 0.0 110.364 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.54 -155.17 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.838 -1.164 . . . . 0.0 109.897 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 88.73 6.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.91 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -59.75 -168.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.506 -0.746 . . . . 0.0 109.94 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.61 134.83 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.475 -0.766 . . . . 0.0 110.726 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 146' ' ' VAL . 29.9 t80 -107.09 156.86 18.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.401 ' CD1' ' CG ' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -137.93 114.0 10.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.446 -0.784 . . . . 0.0 110.595 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -78.61 154.53 78.69 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.21 154.96 72.11 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.628 1.331 . . . . 0.0 110.806 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 ttm -59.83 124.17 19.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.699 -0.626 . . . . 0.0 110.438 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.5 pt-20 -124.49 141.59 51.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.633 -0.667 . . . . 0.0 109.921 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.19 140.31 31.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.586 -0.696 . . . . 0.0 110.417 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.62 -179.27 1.34 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.637 . . . . 0.0 110.098 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.41 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 47.7 Cg_endo -75.29 125.47 9.15 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.237 1.125 . . . . 0.0 110.297 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -115.26 -176.68 2.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.656 -0.653 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.93 153.98 19.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 9.2 ttm -60.19 -28.12 67.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.644 -0.915 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 26.2 4.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 110.116 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.31 22.46 8.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.529 -0.732 . . . . 0.0 110.387 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -100.03 147.9 25.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.835 . . . . 0.0 109.94 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.83 179.97 16.77 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.6 p -81.14 140.76 34.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.67 -0.9 . . . . 0.0 110.761 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 13.4 m-85 -118.35 106.19 12.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.787 -0.571 . . . . 0.0 109.919 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -71.08 121.45 18.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.584 -0.697 . . . . 0.0 110.055 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.84 145.42 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -114.02 114.43 26.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.976 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.421 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.0 m -106.23 151.36 24.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.65 -0.656 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -149.12 93.73 2.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 116' ' ' PHE . 18.1 t80 -75.33 107.55 7.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.591 -0.693 . . . . 0.0 109.628 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.8 p -121.71 168.49 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.524 -0.735 . . . . 0.0 110.38 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 189' ' ' HIS . 7.0 p-10 -121.2 152.88 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.783 -0.573 . . . . 0.0 109.802 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.37 58.53 3.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 110.107 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -161.29 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.544 -0.722 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -112.04 -80.66 0.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.647 -0.658 . . . . 0.0 110.887 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t -169.27 -154.16 0.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.282 -0.886 . . . . 0.0 110.297 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.32 108.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.378 -0.826 . . . . 0.0 110.088 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 183' ' ' ASP . 25.8 m-70 -59.57 -55.12 38.45 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.471 -0.768 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 tp -168.56 153.87 6.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.5 t -148.26 155.73 41.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 110.142 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.421 ' CD2' HD22 ' A' ' 90' ' ' LEU . 23.1 p90 -148.6 -152.99 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -164.08 139.91 6.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 14.1 p-90 -147.89 147.82 30.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.213 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -92.73 148.88 21.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.503 -0.748 . . . . 0.0 111.224 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.05 115.72 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.0 m -87.41 152.49 22.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.477 -0.764 . . . . 0.0 110.947 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.8 mm -130.28 159.21 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -160.32 -158.51 0.63 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.284 -0.885 . . . . 0.0 111.243 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -64.31 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.61 -0.681 . . . . 0.0 111.096 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.59 103.67 3.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.0 110.93 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -72.95 -3.13 23.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.556 -0.715 . . . . 0.0 111.644 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -136.49 57.61 1.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.059 -1.026 . . . . 0.0 110.133 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.228 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 61' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.8 0.333 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 60' ' ' ALA . 19.7 m 38.4 -158.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 CA-C-O 121.022 0.439 . . . . 0.0 112.118 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.1 p 50.56 -166.84 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.353 -0.842 . . . . 0.0 111.002 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.13 -28.28 9.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -118.79 85.11 27.1 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.281 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 173.12 14.34 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.398 1.209 . . . . 0.0 110.27 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -72.05 161.09 31.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.568 -0.708 . . . . 0.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.89 147.54 37.94 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.94 -174.49 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.398 1.21 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.77 -63.75 1.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.95 122.07 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.0 t -148.89 137.15 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.302 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 58.4 t -66.12 108.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.0 p -70.62 -62.63 1.32 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.607 -0.683 . . . . 0.0 110.543 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -145.07 167.9 21.6 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.774 . . . . 0.0 110.802 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.61 136.28 53.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.717 -0.615 . . . . 0.0 109.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.4 m -125.82 149.17 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 110.638 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -133.9 103.66 5.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 109.947 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.14 166.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.616 -0.677 . . . . 0.0 110.178 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.25 -164.3 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 110.009 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -44.77 4.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 p -108.98 27.19 9.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.453 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.84 162.37 33.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.594 -0.691 . . . . 0.0 110.609 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 45.7 Cg_endo -71.78 -25.49 20.23 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.524 1.276 . . . . 0.0 110.078 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.03 176.22 33.89 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.63 104.45 1.6 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.567 1.298 . . . . 0.0 110.444 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 23.5 mt -64.88 108.75 1.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.655 -0.653 . . . . 0.0 109.634 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -86.77 139.66 30.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -120.06 149.42 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 110.085 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -103.19 118.4 36.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.715 . . . . 0.0 110.222 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 2.8 mt -128.98 50.04 2.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -96.93 -73.52 0.6 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.599 -0.688 . . . . 0.0 110.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -52.37 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.78 88.09 4.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.917 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 96.1 mt -87.82 -25.23 23.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.724 . . . . 0.0 110.405 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.85 -21.75 12.36 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.245 -0.909 . . . . 0.0 111.093 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.2 t -54.43 -22.6 13.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.347 -0.846 . . . . 0.0 111.127 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.4 m-30 -61.95 -48.03 82.2 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.802 . . . . 0.0 109.943 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -59.51 -24.8 63.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.62 -0.675 . . . . 0.0 110.659 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -86.85 -26.42 24.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 0.0 110.509 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -132.76 129.86 39.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.643 -0.661 . . . . 0.0 110.379 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -106.99 -175.03 2.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.645 -0.659 . . . . 0.0 110.093 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.434 ' CE1' ' HG ' ' A' ' 88' ' ' LEU . 2.6 m-85 -113.58 96.03 5.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.596 -0.69 . . . . 0.0 110.174 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.18 142.88 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 109.837 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.439 HD22 ' CH2' ' A' ' 202' ' ' TRP . 1.2 mt -157.32 172.51 18.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.06 157.57 17.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -20.04 -50.86 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.54 63.54 0.15 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.392 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -75.37 137.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -1.025 . . . . 0.0 110.322 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.81 105.32 8.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.67 -0.644 . . . . 0.0 109.431 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.426 ' CD1' HD21 ' A' ' 77' ' ' LEU . 18.1 p90 -121.56 171.07 9.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.317 -0.864 . . . . 0.0 111.512 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -117.18 145.61 43.75 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.61 139.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.417 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 90.59 3.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.695 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.42 147.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.569 -0.707 . . . . 0.0 110.368 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 m -130.49 134.72 47.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.461 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 25.6 p90 -154.61 160.67 41.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.441 -0.787 . . . . 0.0 111.093 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -108.29 131.44 54.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.327 0.584 . . . . 0.0 110.716 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -120.23 93.1 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -129.35 50.23 2.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.348 -0.845 . . . . 0.0 111.569 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.12 -65.26 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 110.421 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.82 169.54 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.58 101.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.717 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.9 75.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.65 -0.656 . . . . 0.0 109.743 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -83.14 110.95 18.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.718 . . . . 0.0 110.387 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.47 30.16 2.51 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.7 OUTLIER -62.24 112.11 2.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.434 -1.039 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 163.71 12.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.594 -0.692 . . . . 0.0 110.936 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -138.13 112.08 8.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.73 -0.606 . . . . 0.0 109.64 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.41 161.29 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 0.0 110.034 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -167.42 117.98 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.546 -0.721 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -110.4 131.02 55.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.597 -0.689 . . . . 0.0 110.242 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 m -86.16 93.04 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.718 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.19 127.44 32.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.718 . . . . 0.0 110.471 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 11.2 ttp180 -125.74 130.95 52.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.37 28.69 7.7 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.27 47.13 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.56 146.33 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.214 . . . . 0.0 110.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.61 138.76 40.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.597 -0.689 . . . . 0.0 110.126 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.85 -24.22 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -173.28 134.96 0.55 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.028 . . . . 0.0 110.829 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 175.57 7.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.627 -0.671 . . . . 0.0 109.438 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.3 m -154.26 144.7 22.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 111.1 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -115.15 122.51 46.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.93 130.59 56.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.442 -0.787 . . . . 0.0 111.23 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.48 119.01 17.11 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.425 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 6.4 t -79.7 -58.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.505 -0.747 . . . . 0.0 110.293 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.11 165.07 11.0 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.935 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 59.2 p -92.91 151.76 19.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.614 -0.933 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 148' ' ' SER . 12.7 m-85 -139.15 169.49 17.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.469 -0.769 . . . . 0.0 110.573 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.05 141.96 17.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.51 178.36 5.72 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.214 1.113 . . . . 0.0 110.777 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.06 71.32 0.5 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.54 -0.725 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -166.55 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.458 -0.776 . . . . 0.0 110.408 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.74 -153.94 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.028 -1.045 . . . . 0.0 110.026 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.28 168.85 10.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.427 -0.796 . . . . 0.0 110.02 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 32.2 m-85 -127.17 -176.58 3.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -150.68 113.32 4.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.493 -0.754 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 35.2 t80 -87.24 168.51 13.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.529 -0.732 . . . . 0.0 110.022 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.07 109.8 4.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 0.0 110.738 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.8 p -83.33 151.13 62.07 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.392 -0.817 . . . . 0.0 109.121 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.72 -175.13 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.524 1.276 . . . . 0.0 110.892 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.0 ptm -56.64 145.1 29.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.653 -0.655 . . . . 0.0 110.915 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.04 93.92 2.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.718 -0.614 . . . . 0.0 109.731 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -63.91 121.83 15.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.43 175.12 0.27 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.724 -0.61 . . . . 0.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 112.51 3.52 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.248 1.131 . . . . 0.0 110.85 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -172.82 2.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.886 -0.509 . . . . 0.0 110.544 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.34 31.67 1.8 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.5 mtp 63.71 -70.75 0.07 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.62 -0.929 . . . . 0.0 111.213 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 170' ' ' LEU . 1.1 pt? -69.81 -7.03 36.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.179 -0.951 . . . . 0.0 111.71 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.54 -5.13 41.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.293 -0.879 . . . . 0.0 110.94 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -67.86 140.68 56.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.86 -174.65 24.16 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.6 p -91.49 124.46 35.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.605 -0.938 . . . . 0.0 110.211 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 24.0 m-85 -112.11 112.87 24.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.358 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -62.59 143.32 57.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.592 -0.693 . . . . 0.0 109.801 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.426 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 50.5 mm -119.33 94.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.533 -0.729 . . . . 0.0 110.41 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.23 107.96 10.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.512 -0.743 . . . . 0.0 109.47 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 5.2 p -113.45 160.4 18.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -147.89 83.79 1.52 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.682 -0.636 . . . . 0.0 109.82 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.447 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -69.68 110.85 5.09 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -141.33 -168.21 2.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.521 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -99.94 -163.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.8 -53.24 60.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.28 -0.887 . . . . 0.0 110.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.23 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.829 . . . . 0.0 111.445 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -78.34 -43.81 26.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.7 t 178.35 166.18 0.8 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.951 -0.468 . . . . 0.0 110.01 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.36 125.24 37.86 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 18.9 p80 -91.56 -17.69 25.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.474 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 43.5 tp -171.39 155.05 4.07 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.034 -1.041 . . . . 0.0 111.018 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -164.96 140.27 5.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.72 -0.613 . . . . 0.0 109.677 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 90' ' ' LEU . 14.7 p90 -146.95 -153.53 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.412 -0.805 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -167.16 127.33 1.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.701 -0.625 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.426 ' CZ2' HG22 ' A' ' 177' ' ' ILE . 20.0 p-90 -130.63 145.94 52.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.25 152.1 23.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.681 -0.637 . . . . 0.0 110.989 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 13.1 tp -123.75 92.06 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.734 -0.604 . . . . 0.0 109.544 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.8 m -67.73 129.5 40.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.571 -0.705 . . . . 0.0 110.186 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.1 mm -109.73 150.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.807 -0.558 . . . . 0.0 109.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.73 -153.01 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.665 -0.647 . . . . 0.0 109.949 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 -4.87 6.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.655 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -159.98 46.7 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.982 -1.074 . . . . 0.0 110.986 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -56.06 -22.16 26.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.344 -0.848 . . . . 0.0 111.131 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.64 51.54 1.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -0.815 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.194 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.081 0.467 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.89 153.69 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.633 -0.667 . . . . 0.0 110.24 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.3 p -88.54 164.59 15.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 110.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.53 168.04 9.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.591 -0.693 . . . . 0.0 110.225 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -95.22 105.39 19.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.21 83.69 0.95 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.225 1.118 . . . . 0.0 110.463 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -121.59 52.22 1.26 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.14 156.14 38.05 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.333 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.9 -166.23 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.45 1.237 . . . . 0.0 110.513 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -98.09 -68.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 110.043 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -115.82 134.52 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.582 -0.699 . . . . 0.0 110.15 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.0 t -148.34 152.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.608 -0.683 . . . . 0.0 109.92 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.458 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 60.3 t -71.61 112.33 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -70.81 -51.3 27.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.306 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -151.3 179.77 8.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 tt -146.39 121.24 9.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.629 -0.669 . . . . 0.0 110.075 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -109.75 163.42 13.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.416 HD12 ' CD2' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -148.61 113.89 5.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.468 -0.77 . . . . 0.0 110.531 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.87 167.23 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.654 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 52.5 t -153.05 -71.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.554 -0.717 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.0 p -171.89 -71.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 p -103.99 33.59 3.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.609 -0.682 . . . . 0.0 109.928 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -79.65 172.78 8.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 110.32 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.22 -27.73 16.28 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.455 1.24 . . . . 0.0 110.046 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.57 170.44 25.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.04 97.76 0.86 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.544 1.286 . . . . 0.0 110.292 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 1.5 mp -64.67 122.68 17.42 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.523 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.22 112.93 26.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 110.678 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.449 ' CD1' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt -95.26 131.23 41.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 5.4 t70 -75.64 135.25 40.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.704 . . . . 0.0 110.614 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.61 54.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.619 -0.675 . . . . 0.0 109.71 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.7 p -130.21 49.84 2.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 110.7 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.52 -55.62 0.74 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.26 64.32 0.56 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.592 -0.946 . . . . 0.0 110.073 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 97' ' ' PHE . 29.4 mt -95.14 -0.09 53.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 111.207 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.18 -24.37 58.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.106 -0.996 . . . . 0.0 110.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.77 -6.55 45.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.42 -0.8 . . . . 0.0 111.227 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 13.9 m-85 -81.28 -38.71 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -69.95 -20.2 63.34 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.511 -0.743 . . . . 0.0 110.858 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.37 38.25 3.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -168.96 151.62 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.447 -0.783 . . . . 0.0 110.55 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -128.76 -169.53 2.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.555 -0.716 . . . . 0.0 109.989 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CE1' ' CD1' ' A' ' 88' ' ' LEU . 1.1 m-85 -125.17 111.57 15.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 109.93 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.22 147.47 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.547 -0.72 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.424 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 0.9 OUTLIER -167.38 145.05 4.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.788 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -78.59 155.6 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.454 -0.779 . . . . 0.0 109.75 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -17.24 -87.59 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.81 67.29 0.55 Allowed Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.163 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 8.6 m -75.96 157.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.467 -1.02 . . . . 0.0 110.156 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -85.5 89.53 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 46.2 p90 -109.27 138.86 44.99 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.662 0.744 . . . . 0.0 112.095 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 164.98 11.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.35 150.01 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.218 -0.926 . . . . 0.0 111.216 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -125.42 108.01 11.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.7 153.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 0.0 110.522 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.3 m -131.02 140.95 50.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.806 -0.559 . . . . 0.0 109.582 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.45 ' CD1' ' CE ' ' A' ' 126' ' ' MET . 27.8 p90 -164.47 147.58 9.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.469 -0.77 . . . . 0.0 110.505 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 161.56 17.91 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.439 -0.788 . . . . 0.0 111.195 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.1 t -133.08 117.23 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.779 -0.575 . . . . 0.0 109.593 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -128.66 46.73 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.995 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 -67.89 0.25 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -143.69 179.07 7.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.819 . . . . 0.0 110.562 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.19 109.34 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.666 -0.646 . . . . 0.0 109.981 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.5 t -91.46 83.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.9 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.5 p -85.07 107.78 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.621 -0.675 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.41 39.98 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.45 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -81.46 137.89 35.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -1.043 . . . . 0.0 109.957 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -139.39 171.87 13.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -129.52 117.84 21.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 109.73 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.32 165.74 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.736 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -168.29 124.05 1.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.284 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -113.95 117.82 32.44 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.731 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.6 m -71.89 84.58 0.95 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.717 -0.615 . . . . 0.0 109.921 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 138' ' ' LYS . 2.7 m-85 -87.41 136.39 32.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.497 -0.752 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.401 ' HD2' ' CE2' ' A' ' 175' ' ' TYR . 3.3 ttp180 -120.42 110.58 16.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 110.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 29.63 43.47 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 34.18 6.99 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.6 t -149.21 82.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.959 . . . . 0.0 110.071 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 133' ' ' TYR . 2.4 ttpm? -62.29 121.87 14.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -104.32 -31.52 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.534 -0.729 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -174.23 149.71 1.43 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.14 -0.975 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 150.71 51.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.64 . . . . 0.0 109.505 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.4 HG23 ' CE1' ' A' ' 144' ' ' TYR . 11.9 m -132.84 159.81 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 110.729 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.98 138.83 53.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.631 -0.668 . . . . 0.0 110.122 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.4 ' CE1' HG23 ' A' ' 142' ' ' THR . 24.8 m-85 -122.63 113.15 18.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.9 ttt -68.72 137.87 54.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.523 -0.736 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.426 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 60.6 t -98.11 -68.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.552 -0.717 . . . . 0.0 110.151 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.28 176.02 26.14 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.4 p -87.4 152.47 22.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.693 -0.887 . . . . 0.0 109.963 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 81.3 m-85 -148.18 144.39 27.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 110.415 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.5 154.01 19.68 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.23 65.35 5.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.377 1.199 . . . . 0.0 110.474 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -170.93 37.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 110.337 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -144.31 15.02 1.65 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.522 -0.736 . . . . 0.0 111.06 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 54.66 -148.1 0.49 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.173 -0.954 . . . . 0.0 110.734 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.95 157.06 38.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.373 -0.829 . . . . 0.0 110.84 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 153' ' ' ALA . 57.4 m-85 -115.87 177.45 4.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.737 -0.602 . . . . 0.0 109.669 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.95 92.84 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.51 -0.744 . . . . 0.0 110.355 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 28.5 t80 -80.81 168.23 19.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.009 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.4 100.63 2.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 81.0 p -76.02 155.87 84.39 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 109.252 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.76 153.02 76.91 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.615 1.324 . . . . 0.0 110.978 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.0 ptm -58.0 113.47 1.91 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.679 -0.638 . . . . 0.0 110.49 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.25 161.42 13.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.094 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -104.84 141.44 36.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.484 -0.76 . . . . 0.0 110.512 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.426 ' CB ' ' HD2' ' A' ' 166' ' ' PRO . . . -96.15 179.66 1.1 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.629 -0.67 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 165' ' ' ALA . 41.8 Cg_endo -66.44 -153.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.201 1.106 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -107.0 -162.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.061 -1.024 . . . . 0.0 110.689 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -98.86 -66.79 0.87 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.6 mtt -60.79 145.94 47.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.959 . . . . 0.0 109.233 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.93 -61.32 0.33 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.639 -0.663 . . . . 0.0 110.535 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.85 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.4 -0.812 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 150.36 48.93 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.918 -1.114 . . . . 0.0 110.136 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.56 -177.82 17.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.7 p -91.99 129.78 37.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.696 -0.885 . . . . 0.0 110.219 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.401 ' CE2' ' HD2' ' A' ' 134' ' ' ARG . 12.3 m-85 -108.01 101.12 10.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.594 -0.691 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.96 125.06 23.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.96 132.14 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -0.851 . . . . 0.0 110.506 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.8 106.51 17.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.4 m -99.09 140.6 33.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.646 -0.659 . . . . 0.0 109.728 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.44 90.07 2.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.595 -0.691 . . . . 0.0 110.393 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.458 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 3.7 t80 -64.38 131.66 47.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 109.648 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.411 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.9 t -171.0 -169.06 0.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -113.7 -164.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -57.5 11.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.293 -0.879 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.29 28.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.873 -0.517 . . . . 0.0 110.379 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -37.67 27.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 0.0 109.914 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.7 t -177.81 -167.43 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.675 -0.641 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -115.35 118.02 32.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.782 -0.574 . . . . 0.0 109.503 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.411 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.2 m-70 -75.07 -67.44 0.65 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.457 -0.777 . . . . 0.0 110.666 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.0 tp -165.74 160.29 17.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.461 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.8 p -155.94 144.91 20.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.586 -0.696 . . . . 0.0 110.403 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -138.7 -155.76 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.606 -0.684 . . . . 0.0 109.734 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.46 129.31 7.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.323 -0.86 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.5 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 4.4 p-90 -140.01 147.9 41.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -99.31 154.97 17.76 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.756 0.789 . . . . 0.0 112.452 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.454 ' CD2' ' CZ3' ' A' ' 194' ' ' TRP . 0.9 OUTLIER -111.74 103.47 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -80.21 101.12 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.753 . . . . 0.0 110.434 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 198' ' ' ILE . 49.3 mm -78.93 145.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 109.689 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -142.6 -154.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.647 -0.658 . . . . 0.0 110.401 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -108.71 -32.46 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.758 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.11 93.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.448 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -77.21 -0.2 24.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.571 -0.706 . . . . 0.0 111.307 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -127.79 43.2 3.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.066 0.46 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.16 33.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.291 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.97 -66.61 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.543 -0.723 . . . . 0.0 110.265 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -164.16 -159.3 0.48 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 110.35 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -149.46 89.99 4.68 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.37 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.27 -30.46 15.72 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.181 1.095 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.03 128.41 35.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.52 -0.738 . . . . 0.0 110.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.31 145.26 35.6 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.556 -0.715 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.92 -167.79 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.381 1.201 . . . . 0.0 110.635 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.93 -66.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.712 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 92.8 t -130.68 125.24 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.778 -0.577 . . . . 0.0 110.132 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -148.59 138.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.775 -0.578 . . . . 0.0 109.962 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 58.2 t -64.51 104.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.4 p -70.8 -63.3 1.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.668 -0.645 . . . . 0.0 110.41 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -138.61 173.21 11.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 tt -142.85 124.92 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.648 -0.658 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.0 m -114.91 157.37 23.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.442 -0.786 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -137.46 106.39 5.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.74 166.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 110.42 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.33 -154.49 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.1 p -115.03 -26.42 7.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.436 -0.79 . . . . 0.0 110.397 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.7 p -140.12 34.67 1.92 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.21 173.41 5.76 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.352 -0.843 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.36 -26.52 17.17 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.286 1.15 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.72 177.31 34.68 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.45 102.76 1.32 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.487 1.256 . . . . 0.0 110.317 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 102' ' ' PHE . 37.5 mt -64.85 112.74 3.4 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.503 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -99.67 113.67 26.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 5.6 mt -98.75 137.45 37.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.604 -0.685 . . . . 0.0 109.739 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 14.6 t0 -86.57 128.61 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.506 -0.746 . . . . 0.0 110.679 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 HD22 ' CE2' ' A' ' 192' ' ' TRP . 1.0 OUTLIER -128.52 51.44 2.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.466 -0.771 . . . . 0.0 109.982 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.6 p -115.16 -58.73 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 110.346 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.67 -57.25 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 75.64 0.96 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.548 -0.972 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.413 HD22 ' CE1' ' A' ' 97' ' ' PHE . 6.5 mt -95.01 0.03 54.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 111.213 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -70.51 -33.14 70.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.037 -1.039 . . . . 0.0 110.659 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 m -57.47 -20.82 33.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.456 -0.777 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 3.7 m-85 -55.33 -42.2 73.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.246 -0.909 . . . . 0.0 110.388 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -63.59 -26.27 68.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 0.0 109.944 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 52.5 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.015 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -158.26 30.16 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.392 -0.817 . . . . 0.0 110.657 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -55.9 121.58 9.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.77 -0.581 . . . . 0.0 110.557 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 86' ' ' LEU . 23.6 m-85 -85.21 122.73 29.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.544 -0.722 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.03 152.84 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.436 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 0.7 OUTLIER -154.54 128.04 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.424 -0.798 . . . . 0.0 110.75 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 24.3 tttm -60.57 146.34 45.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.105 0.955 . . . . 0.0 110.431 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -61.15 128.57 37.07 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.63 40.54 97.61 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.862 -0.524 . . . . 0.0 112.862 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 31.9 m -83.38 178.09 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 118.861 1.33 . . . . 0.0 110.044 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -120.27 96.38 5.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -118.93 157.54 27.49 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.887 0.851 . . . . 0.0 112.407 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -116.67 157.3 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 112' ' ' ILE . 71.8 mt -116.46 154.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -137.87 122.17 18.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.809 -0.557 . . . . 0.0 109.507 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 mm -106.54 147.09 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 110.648 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 m -127.42 134.83 49.86 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.463 ' CZ ' ' CB ' ' A' ' 156' ' ' TYR . 41.1 p90 -152.18 140.78 20.77 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.0 111.203 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 142.33 27.81 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.436 0.636 . . . . 0.0 110.946 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.96 95.49 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -129.41 48.27 2.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.0 111.687 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 -67.08 0.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.294 -0.879 . . . . 0.0 110.764 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -143.1 178.07 7.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.3 mp -80.15 107.83 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 109.735 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.9 82.02 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 p -84.64 113.4 21.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.667 -0.646 . . . . 0.0 110.438 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.68 37.07 0.8 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -79.51 145.32 33.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.498 -1.001 . . . . 0.0 109.797 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -143.82 141.23 30.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 110.958 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -109.0 109.05 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.4 mt -96.66 161.46 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 110.117 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -159.34 118.9 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.69 -0.631 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 17.8 m-70 -106.41 134.7 49.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.726 . . . . 0.0 109.899 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.8 m -90.11 113.42 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.646 -0.659 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 2.3 m-85 -111.38 119.32 38.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.679 . . . . 0.0 109.947 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -120.88 129.14 53.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.656 -0.652 . . . . 0.0 110.348 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt 52.68 39.25 28.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.35 -0.844 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.88 30.43 72.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.5 t -143.11 119.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.997 . . . . 0.0 109.881 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -77.22 138.88 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.137 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -26.87 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.492 -0.755 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -169.67 144.97 3.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HD3' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -142.42 139.88 31.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.5 m -120.51 160.8 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.824 . . . . 0.0 111.061 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -126.21 73.81 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.088 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.89 141.67 58.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.708 . . . . 0.0 110.613 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 ttt -94.37 124.27 38.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.427 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 26.3 t -79.75 -58.86 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.26 175.75 14.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.1 p -86.29 147.88 25.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.922 . . . . 0.0 109.853 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.419 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 67.3 m-85 -146.31 135.73 22.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.44 161.03 30.92 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.66 62.58 5.57 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.41 1.216 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -170.52 54.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.469 -0.77 . . . . 0.0 110.418 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.455 ' CB ' ' CZ ' ' A' ' 156' ' ' TYR . . . -155.99 23.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.499 -0.751 . . . . 0.0 111.244 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 40.46 -150.16 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.862 -0.524 . . . . 0.0 112.269 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.41 114.42 6.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.28 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 116' ' ' PHE . 3.9 m-85 -73.37 -173.34 1.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.606 -0.684 . . . . 0.0 109.755 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.96 82.53 1.44 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.571 -0.706 . . . . 0.0 110.727 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 42.7 t80 -80.97 161.99 24.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.392 -0.817 . . . . 0.0 109.384 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.51 117.54 5.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.952 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.413 HG21 ' CE2' ' A' ' 158' ' ' PHE . 24.5 p -81.05 156.7 71.9 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.434 -0.791 . . . . 0.0 108.877 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 166.3 20.03 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.711 1.374 . . . . 0.0 110.979 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 135.62 56.31 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.417 0.627 . . . . 0.0 110.948 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.64 127.49 42.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.412 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -79.2 139.65 37.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.48 -0.762 . . . . 0.0 110.883 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.33 170.52 11.19 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.733 -0.605 . . . . 0.0 110.41 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.37 132.76 21.35 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 O-C-N 123.434 1.228 . . . . 0.0 110.405 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 -171.83 2.08 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.653 -0.655 . . . . 0.0 110.571 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.55 -157.15 15.19 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.45 -38.91 6.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.626 -0.926 . . . . 0.0 109.573 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tt -86.68 -22.68 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.761 -0.587 . . . . 0.0 110.235 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.21 20.02 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -0.848 . . . . 0.0 110.778 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -62.22 147.6 47.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 110.171 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 138.17 -171.95 23.15 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.6 p -96.26 137.06 35.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.6 -0.941 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.32 108.76 14.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.629 -0.669 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.76 131.71 42.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.442 -0.786 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.2 mt -121.27 147.99 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.32 -0.863 . . . . 0.0 110.725 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -112.23 111.01 21.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 3.1 m -103.39 125.0 49.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 110.135 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -113.92 114.55 26.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 110.315 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.442 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -96.11 130.54 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 109.938 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 t -156.2 -163.45 1.47 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.528 -0.733 . . . . 0.0 110.473 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 8.6 p-10 -164.47 -149.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.651 -0.655 . . . . 0.0 109.932 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -82.17 56.34 3.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 186' ' ' ARG . 54.6 p-10 -161.6 48.41 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.512 -0.743 . . . . 0.0 109.921 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 185' ' ' ASP . 1.8 mpt_? 3.9 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -144.62 -176.84 5.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.922 -0.486 . . . . 0.0 109.913 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.28 96.46 5.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.422 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 1.6 m-70 -60.14 -47.33 86.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 109.805 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 23.3 tp -170.89 107.81 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.709 -0.619 . . . . 0.0 109.963 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -113.31 131.0 56.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.629 -0.67 . . . . 0.0 110.124 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.426 ' CE2' HD22 ' A' ' 90' ' ' LEU . 25.1 p90 -133.92 -154.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.761 . . . . 0.0 109.938 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -167.91 130.74 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 16.6 p-90 -133.14 146.23 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.681 . . . . 0.0 109.829 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.75 149.25 21.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.695 -0.628 . . . . 0.0 110.627 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.3 tp -121.33 108.76 14.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.689 -0.632 . . . . 0.0 109.391 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.5 m -78.22 136.8 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.6 mm -111.1 151.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.712 -0.618 . . . . 0.0 109.87 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.35 -160.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.659 -0.65 . . . . 0.0 109.721 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -119.62 -30.79 4.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -135.73 59.9 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 111.493 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -66.09 -11.3 47.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.305 -0.872 . . . . 0.0 111.338 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -157.02 51.22 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.02 . . . . 0.0 110.205 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.069 0.461 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.55 -83.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.585 -0.697 . . . . 0.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m 52.69 49.92 19.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.909 -1.12 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.66 171.13 14.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.508 -0.745 . . . . 0.0 110.205 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.23 81.82 1.79 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.597 -0.689 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 -35.44 5.94 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.306 1.161 . . . . 0.0 110.432 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -168.07 107.78 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.1 92.3 7.63 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.544 -0.723 . . . . 0.0 109.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.92 179.99 4.81 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.456 1.24 . . . . 0.0 110.747 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.95 -64.94 0.56 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.651 -0.656 . . . . 0.0 109.758 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' CG ' ' A' ' 189' ' ' HIS . 46.5 t -140.37 30.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.612 0.72 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 138.04 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.203 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.5 t -63.07 124.39 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.4 p -87.03 -63.5 1.3 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.258 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -135.99 172.16 13.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.357 -0.84 . . . . 0.0 111.119 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.08 124.51 14.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.712 -0.618 . . . . 0.0 109.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m -109.89 158.47 18.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.787 . . . . 0.0 110.455 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 102' ' ' PHE . 1.7 mt -142.3 103.22 4.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.53 166.95 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.497 -0.752 . . . . 0.0 110.34 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.45 -157.92 0.58 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.961 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -101.97 -29.41 11.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 0.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.4 p -138.17 41.78 2.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.675 -0.641 . . . . 0.0 110.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.449 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.39 163.43 31.06 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.592 -0.692 . . . . 0.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.27 -25.2 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.491 1.258 . . . . 0.0 110.244 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.04 167.57 25.84 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.44 100.07 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.515 1.271 . . . . 0.0 110.243 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.55 115.51 5.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.665 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -97.82 101.23 12.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.447 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.457 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -82.63 125.49 31.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.534 -0.729 . . . . 0.0 109.913 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.0 134.36 35.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.652 -0.655 . . . . 0.0 110.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.406 HD22 ' CD1' ' A' ' 192' ' ' TRP . 6.4 mt -135.27 55.15 1.9 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.66 -0.65 . . . . 0.0 109.923 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -106.34 -72.98 0.7 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.692 . . . . 0.0 110.524 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.4 -77.99 0.78 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.05 92.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.451 -1.029 . . . . 0.0 110.41 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 44.2 mt -92.34 -37.69 12.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.663 -0.648 . . . . 0.0 110.046 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -18.84 36.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.511 -0.743 . . . . 0.0 110.879 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.1 p -53.89 -22.51 10.15 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.299 -0.876 . . . . 0.0 111.153 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.457 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 7.0 m-30 -60.84 -30.24 69.98 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 109.87 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -60.78 -26.7 67.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.672 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.49 22.7 5.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.596 -0.69 . . . . 0.0 110.707 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -171.19 128.64 0.71 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 p -113.21 179.58 3.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.665 -0.647 . . . . 0.0 110.185 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.421 ' CD2' HD11 ' A' ' 77' ' ' LEU . 7.1 m-85 -111.59 104.96 13.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.7 139.74 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.48 -0.762 . . . . 0.0 110.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 0.8 OUTLIER -154.33 161.45 41.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.706 -0.621 . . . . 0.0 110.263 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.4 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 1.1 mtpm? -76.47 152.16 36.22 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.523 -0.735 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -20.61 -74.31 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.61 69.56 0.46 Allowed Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.415 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' A' ' 105' ' ' LYS . 33.9 m -80.27 -176.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.524 -0.986 . . . . 0.0 110.071 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.25 96.93 6.04 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 163' ' ' GLU . 44.6 p90 -113.26 149.23 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.505 -0.747 . . . . 0.0 111.987 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -107.32 155.48 19.93 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -121.43 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.008 -1.058 . . . . 0.0 111.197 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -120.83 107.29 12.54 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.28 151.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.44 -0.787 . . . . 0.0 111.073 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -131.32 152.1 50.89 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.496 ' CD2' ' CE2' ' A' ' 181' ' ' PHE . 2.1 p90 -167.84 159.05 11.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 111.15 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 155' ' ' GLU . 3.0 mmm180 -93.06 135.92 33.8 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.202 0.525 . . . . 0.0 111.377 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.06 85.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.21 48.38 2.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.535 -0.728 . . . . 0.0 111.998 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -68.51 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 171.51 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 0.0 110.586 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 122' ' ' ILE . 77.1 mt -70.96 108.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.666 -0.646 . . . . 0.0 110.264 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.99 75.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.646 -0.658 . . . . 0.0 109.501 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.436 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 69.8 p -64.68 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.657 -0.652 . . . . 0.0 110.358 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.92 49.38 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.448 ' HE3' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -79.78 120.7 24.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.257 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -132.88 148.2 52.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 111.1 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -125.38 113.37 17.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.47 146.71 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.625 -0.672 . . . . 0.0 110.511 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.67 141.83 43.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.556 -0.715 . . . . 0.0 110.08 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.8 m-70 -101.07 164.72 11.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.684 . . . . 0.0 109.634 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.6 m -119.7 61.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.951 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.88 118.75 7.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.741 . . . . 0.0 110.417 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.92 138.26 54.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.619 -0.675 . . . . 0.0 110.017 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? 53.35 28.74 7.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.412 -0.805 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.37 -11.46 63.34 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.196 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.55 148.02 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.024 -1.28 . . . . 0.0 110.765 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 135.92 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.284 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.68 -26.26 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.752 . . . . 0.0 111.049 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -176.3 146.02 0.62 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -133.67 143.13 48.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.535 -0.728 . . . . 0.0 109.76 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.2 m -109.9 151.83 26.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.604 -0.685 . . . . 0.0 111.043 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -126.05 136.39 52.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.63 -0.669 . . . . 0.0 109.836 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -123.41 129.02 50.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.451 -0.781 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.7 ttm -91.75 107.97 19.58 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.455 ' CG1' ' CE1' ' A' ' 149' ' ' TYR . 61.8 t -79.68 -44.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.309 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.68 -173.82 19.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.436 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 31.9 m -84.84 126.32 33.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.604 -0.939 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.455 ' CE1' ' CG1' ' A' ' 146' ' ' VAL . 8.8 m-85 -113.51 131.46 56.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.725 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -118.19 145.09 18.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.81 142.77 35.97 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.382 1.201 . . . . 0.0 110.186 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.61 -39.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.566 -0.709 . . . . 0.0 110.774 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.6 -81.85 0.46 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 111.416 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.28 -136.31 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 110.424 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -79.78 166.01 22.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.887 -1.133 . . . . 0.0 110.819 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 33.5 m-85 -121.31 -175.99 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -133.78 114.96 13.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.447 -0.783 . . . . 0.0 111.019 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.423 ' CD1' HG12 ' A' ' 146' ' ' VAL . 34.4 t80 -100.41 159.97 14.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.725 . . . . 0.0 109.202 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.81 118.79 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.459 -0.776 . . . . 0.0 110.946 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.42 HG21 ' CE2' ' A' ' 158' ' ' PHE . 30.6 p -89.78 156.41 47.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.094 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.53 169.53 12.58 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.652 1.343 . . . . 0.0 110.83 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 129.47 41.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.406 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 7.2 mm-40 -116.33 127.27 54.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.626 -0.671 . . . . 0.0 109.631 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -83.2 133.61 35.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.79 165.15 43.32 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.765 -0.585 . . . . 0.0 110.188 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.2 123.69 8.97 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.401 1.211 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 169.2 8.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.654 -0.653 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.01 160.82 10.76 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.78 -43.54 97.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.969 . . . . 0.0 110.151 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.67 -27.35 40.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.647 -0.658 . . . . 0.0 110.216 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.97 -22.18 59.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.499 -0.751 . . . . 0.0 110.645 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -68.23 131.17 44.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.478 -0.764 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 151.71 179.4 27.34 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.2 p -87.44 130.16 34.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.524 -0.986 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.03 113.88 26.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 110.641 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.86 125.33 29.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.458 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.7 mt -117.61 137.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.379 -0.825 . . . . 0.0 110.959 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -103.31 96.86 7.04 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.412 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 1.4 p -94.25 125.39 38.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.683 . . . . 0.0 110.671 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -127.6 96.83 4.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.681 . . . . 0.0 109.997 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -83.14 91.27 7.2 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.586 -0.696 . . . . 0.0 110.087 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.9 t -116.98 -171.77 2.09 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -94.19 -163.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.364 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.97 -53.29 59.05 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.0 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.252 -0.905 . . . . 0.0 110.747 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -35.69 32.32 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.902 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.9 t -178.41 -162.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.621 -0.674 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.07 120.01 38.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 16.3 m-70 -82.75 -73.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.779 . . . . 0.0 110.864 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.1 tp -156.05 151.19 26.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.669 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 t -153.86 139.69 18.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.663 . . . . 0.0 109.786 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.412 ' CE2' ' OG ' ' A' ' 179' ' ' SER . 21.9 p90 -135.19 -153.57 0.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.99 132.01 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.452 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 17.0 p-90 -139.33 147.1 41.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.678 -0.639 . . . . 0.0 109.614 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.78 152.05 20.95 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.518 0.675 . . . . 0.0 111.26 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -126.16 91.54 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -67.9 137.2 55.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.608 -0.682 . . . . 0.0 110.436 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -114.53 145.3 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 109.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -144.16 -153.07 0.45 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 109.84 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -132.06 1.41 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.399 -0.813 . . . . 0.0 111.661 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -160.23 46.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.942 -1.099 . . . . 0.0 111.122 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.449 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -59.15 -18.63 37.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 111.197 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -152.47 48.24 0.75 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.219 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.113 0.482 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t -141.01 -51.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.568 -0.707 . . . . 0.0 109.975 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.9 m -82.53 164.49 20.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.256 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.35 -28.75 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 0.0 110.3 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -127.93 139.46 35.42 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.155 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.93 -51.86 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.23 1.121 . . . . 0.0 110.441 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -142.18 179.37 6.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.538 -0.726 . . . . 0.0 110.329 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.68 140.34 21.73 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 109.98 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.12 -165.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.256 1.135 . . . . 0.0 110.556 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -98.15 -65.85 0.94 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.643 -0.66 . . . . 0.0 109.797 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' CG1' ' CE ' ' A' ' 126' ' ' MET . 93.3 t -141.92 117.76 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.507 0.67 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.0 t -139.66 144.05 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.899 -0.501 . . . . 0.0 109.775 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.408 HG23 ' CD2' ' A' ' 181' ' ' PHE . 60.0 t -64.27 99.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.1 p -70.83 -44.63 66.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.715 -0.616 . . . . 0.0 111.228 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -154.97 158.0 38.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.32 152.57 36.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.724 -0.61 . . . . 0.0 109.757 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.5 m -139.77 152.64 46.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -0.765 . . . . 0.0 110.631 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -136.67 83.52 2.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.574 -0.704 . . . . 0.0 109.973 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.85 149.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.634 . . . . 0.0 110.14 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.8 m -146.07 -164.96 2.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.693 -0.629 . . . . 0.0 110.037 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.6 p -103.53 -76.9 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.775 . . . . 0.0 110.758 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 p -96.26 32.59 1.93 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.826 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' CZ3' ' A' ' 202' ' ' TRP . . . -90.28 178.99 1.63 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.652 -0.655 . . . . 0.0 110.087 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.25 -26.85 12.1 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.342 1.18 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 156.63 -179.42 32.48 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.72 111.4 3.13 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.488 1.257 . . . . 0.0 110.416 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' CD2' ' CD1' ' A' ' 102' ' ' PHE . 13.8 mt -65.76 115.66 6.14 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.99 137.78 34.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 3.9 mt -132.71 119.67 20.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 0.0 109.717 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.49 141.95 50.17 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -138.51 56.3 1.72 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.753 . . . . 0.0 110.059 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -105.99 -66.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.265 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.57 -46.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.91 65.15 1.94 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.574 -0.956 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.418 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 13.4 mt -84.19 0.1 50.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.575 -0.703 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.61 -27.29 64.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.029 . . . . 0.0 110.787 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.8 m -65.42 -13.77 59.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.463 -0.773 . . . . 0.0 111.065 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 10.7 m-85 -72.19 -52.51 16.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.286 -0.883 . . . . 0.0 110.711 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -57.68 -20.24 32.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.521 -0.737 . . . . 0.0 111.007 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -115.0 44.96 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.4 -0.812 . . . . 0.0 110.393 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -168.66 146.55 4.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 p -150.98 131.39 13.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 109.82 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 86' ' ' LEU . 15.1 m-85 -77.12 122.99 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 110.189 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.65 113.17 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 109.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HG ' ' CZ3' ' A' ' 202' ' ' TRP . 4.1 tt -113.62 156.81 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.421 ' HB2' ' CG ' ' A' ' 202' ' ' TRP . 31.8 tttt -80.9 161.8 24.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -40.82 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.73 66.77 0.11 Allowed Glycine 0 N--CA 1.507 3.372 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.777 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 30.5 m -79.01 -160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.224 -1.162 . . . . 0.0 109.201 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.09 117.11 27.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.464 -0.773 . . . . 0.0 109.54 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.441 ' CD1' HD21 ' A' ' 77' ' ' LEU . 10.8 p90 -137.67 152.13 48.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.306 -0.872 . . . . 0.0 111.916 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -109.67 150.27 28.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.39 151.56 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.133 -0.979 . . . . 0.0 111.703 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 93.28 3.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.456 ' CG2' ' CE2' ' A' ' 181' ' ' PHE . 47.8 mm -81.18 142.6 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.743 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.8 m -122.08 135.94 54.86 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 116' ' ' PHE . 15.5 p90 -153.06 145.34 23.95 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.333 -0.854 . . . . 0.0 111.158 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -88.52 128.25 35.55 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.39 84.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.75 48.88 2.32 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 111.86 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -145.42 -66.32 0.31 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.237 -0.914 . . . . 0.0 110.904 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.74 168.92 17.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.339 -0.851 . . . . 0.0 110.412 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.29 108.37 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.99 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.4 86.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 109.798 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.3 p -88.11 88.48 7.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.616 -0.677 . . . . 0.0 110.384 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 137.94 44.64 0.08 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.446 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -80.99 121.07 25.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 109.793 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -129.5 137.42 50.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.728 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.502 ' CD1' ' CD2' ' A' ' 181' ' ' PHE . 14.0 t80 -111.62 139.02 47.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.723 . . . . 0.0 109.678 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.0 mt -136.79 144.45 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.541 -0.725 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.52 144.28 37.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 110.057 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 14.9 m-70 -117.23 116.92 28.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.596 -0.69 . . . . 0.0 110.156 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 29.3 m -68.04 77.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 0.0 110.202 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 4.2 m-85 -76.39 125.99 30.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.403 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 7.9 tpt180 -120.75 120.89 36.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt 52.89 38.59 27.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.488 -0.757 . . . . 0.0 110.754 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.8 35.56 58.47 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.5 t -147.1 109.14 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.955 . . . . 0.0 109.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 4.9 pttm -63.02 128.9 37.99 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.637 -0.664 . . . . 0.0 110.232 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.53 -23.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.635 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.43 132.18 0.29 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.89 149.99 49.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.683 . . . . 0.0 109.634 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -127.56 154.89 44.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.514 -0.741 . . . . 0.0 110.838 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -126.01 121.44 33.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.63 -0.669 . . . . 0.0 110.052 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -110.99 145.7 37.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.703 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -92.08 119.33 31.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.228 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.431 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 58.9 t -79.58 -52.43 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 110.304 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.7 175.81 14.2 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 30.8 t -99.02 139.37 34.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.927 . . . . 0.0 110.063 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.492 ' CD1' ' CE2' ' A' ' 156' ' ' TYR . 47.0 m-85 -142.04 126.89 18.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.694 . . . . 0.0 110.308 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.25 164.78 28.56 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.08 92.97 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.447 1.235 . . . . 0.0 110.342 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -169.49 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 0.0 110.447 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 156' ' ' TYR . . . -92.43 19.33 7.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.542 -0.724 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 38.1 mt-10 56.2 -143.88 0.7 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 152.35 45.5 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.05 -1.031 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 149' ' ' TYR . 42.0 m-85 -116.13 -176.31 2.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 109.546 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -147.49 104.31 3.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.509 -0.744 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 146' ' ' VAL . 34.9 t80 -77.85 165.81 23.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.87 97.57 2.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.396 -0.815 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.43 HG21 ' CE2' ' A' ' 158' ' ' PHE . 75.0 p -72.79 149.17 90.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.46 157.55 54.28 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.415 1.218 . . . . 0.0 110.702 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.71 93.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.606 -0.684 . . . . 0.0 110.976 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -79.87 167.71 20.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.416 -0.803 . . . . 0.0 109.862 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.69 123.32 48.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.504 -0.747 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.45 177.03 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.45 127.73 12.09 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.298 1.157 . . . . 0.0 111.112 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -115.63 174.97 5.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 110.121 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.65 156.5 10.66 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 15.2 ttt -62.33 -46.61 87.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.734 -0.862 . . . . 0.0 109.998 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.89 -26.42 60.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.645 . . . . 0.0 110.182 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.93 -20.7 39.44 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.421 -0.799 . . . . 0.0 110.719 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.7 mtp-105 -58.5 125.22 22.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.304 -0.872 . . . . 0.0 110.411 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.75 175.4 27.65 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.4 p -84.86 134.7 34.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.594 -0.945 . . . . 0.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.403 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 32.3 m-85 -115.59 101.41 8.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.607 -0.683 . . . . 0.0 110.693 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.18 121.37 17.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.714 . . . . 0.0 109.112 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.42 HD13 ' CZ2' ' A' ' 194' ' ' TRP . 42.6 mt -110.09 126.61 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.53 -0.732 . . . . 0.0 110.99 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -87.4 92.52 9.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.685 -0.634 . . . . 0.0 109.879 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.0 p -84.98 140.94 30.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.658 -0.651 . . . . 0.0 110.674 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.82 83.62 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.892 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.502 ' CD2' ' CD1' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -78.26 128.66 34.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.668 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -162.72 -169.88 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.672 . . . . 0.0 110.52 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -104.03 -164.34 1.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.878 -0.514 . . . . 0.0 109.762 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -57.63 11.76 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.832 . . . . 0.0 110.228 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.36 27.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.76 -0.588 . . . . 0.0 110.467 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -36.31 26.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.755 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.55 -163.21 0.08 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.805 -0.559 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.35 110.99 20.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.48 -55.04 13.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.464 -0.773 . . . . 0.0 110.665 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -166.54 164.19 17.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 190' ' ' LEU . 17.6 p -168.23 134.73 1.99 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.853 -0.529 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.422 ' CG ' HD22 ' A' ' 90' ' ' LEU . 14.5 p90 -147.0 -155.21 0.6 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 110.442 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -157.81 127.68 6.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 12.3 p-90 -134.79 146.21 49.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.697 -0.627 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.91 136.11 40.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.656 -0.653 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.7 tp -110.36 98.55 7.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.6 m -73.14 121.07 19.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.651 -0.656 . . . . 0.0 110.515 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.7 mm -90.24 149.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.592 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 -155.82 0.64 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 110.456 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -120.22 -21.3 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.504 -0.747 . . . . 0.0 111.268 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -155.04 81.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.441 ' CZ3' ' HB3' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -79.74 3.21 20.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.478 -0.764 . . . . 0.0 111.501 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 44.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.086 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.104 0.478 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.36 166.92 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.487 -0.758 . . . . 0.0 109.909 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.52 34.84 2.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 110.247 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.12 5.94 5.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.79 63.07 9.85 Favored Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.977 -1.077 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.52 -84.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.203 1.107 . . . . 0.0 110.619 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 m120 51.95 -177.72 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.877 -1.139 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.84 70.56 80.92 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.95 172.61 14.27 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.379 1.2 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -97.99 -60.62 1.52 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.667 . . . . 0.0 109.898 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.7 t -110.15 140.09 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.662 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.3 t -149.43 144.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.731 -0.606 . . . . 0.0 109.616 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.4 100.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.0 p -70.23 -44.46 68.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -159.29 173.92 15.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tt -144.3 164.41 30.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.688 -0.632 . . . . 0.0 109.544 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.4 m -151.55 163.01 39.98 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.432 -0.792 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -143.36 84.19 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.604 -0.685 . . . . 0.0 109.895 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.98 143.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.731 -0.606 . . . . 0.0 110.106 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.67 -163.13 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.592 -0.693 . . . . 0.0 110.077 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.9 p -110.53 -72.68 0.71 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.466 -0.772 . . . . 0.0 110.677 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -95.75 27.66 3.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.565 -0.709 . . . . 0.0 110.639 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.27 -176.52 0.65 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.28 -25.04 10.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.311 1.163 . . . . 0.0 110.016 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.07 -177.08 30.91 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.484 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 91.55 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.556 1.292 . . . . 0.0 110.558 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.445 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.83 111.41 2.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.696 . . . . 0.0 109.386 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.86 159.83 14.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.0 110.872 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.426 HD23 ' CE2' ' A' ' 97' ' ' PHE . 4.4 mt -132.18 128.16 37.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.722 -0.611 . . . . 0.0 109.912 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 133.46 40.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 192' ' ' TRP . 0.9 OUTLIER -132.09 51.79 2.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.3 p -123.82 -65.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.391 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.92 -53.18 0.21 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.99 71.97 0.4 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.541 -0.976 . . . . 0.0 110.158 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -33.84 13.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.009 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.29 -26.99 65.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.591 -0.693 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.4 t -60.34 -23.68 64.44 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 110.472 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.426 ' CE2' HD23 ' A' ' 88' ' ' LEU . 5.3 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -73.63 -26.96 61.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.64 -0.663 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -105.08 28.91 6.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.453 -0.779 . . . . 0.0 110.284 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -158.46 139.82 13.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.716 . . . . 0.0 110.127 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -126.24 -175.8 3.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 110.4 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.445 ' CE2' ' CB ' ' A' ' 86' ' ' LEU . 1.7 m-85 -116.65 109.31 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.673 -0.642 . . . . 0.0 109.99 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.11 105.73 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -0.779 . . . . 0.0 109.793 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.441 ' HG ' ' CZ3' ' A' ' 202' ' ' TRP . 3.8 tt -122.43 158.62 29.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.627 -0.67 . . . . 0.0 110.077 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 106' ' ' GLU . 2.2 tttt -87.22 161.56 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.472 -0.767 . . . . 0.0 110.385 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 105' ' ' LYS . 33.9 mt-10 -18.58 -71.63 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.27 63.26 0.4 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.699 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.5 m -73.29 127.41 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.442 -1.034 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -71.71 94.77 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' CD1' HD21 ' A' ' 77' ' ' LEU . 14.6 p90 -109.49 154.87 22.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 111.838 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.3 131.1 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.04 142.28 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.261 -0.9 . . . . 0.0 110.533 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -117.85 102.69 9.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.412 HG22 ' CE1' ' A' ' 181' ' ' PHE . 47.7 mm -88.11 127.92 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.755 . . . . 0.0 110.685 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -113.06 137.89 50.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 116' ' ' PHE . 19.5 p90 -151.05 174.84 12.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 110.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -127.64 150.83 49.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 111.322 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.67 111.32 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -128.66 48.39 2.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.472 -0.767 . . . . 0.0 111.472 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -69.71 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.0 110.646 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -137.93 171.98 13.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.431 -0.793 . . . . 0.0 110.472 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.9 mt -80.0 109.84 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.615 . . . . 0.0 109.966 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.9 t -84.65 82.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.848 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 p -81.21 77.58 8.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.637 -0.664 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.97 46.08 0.04 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 1.3 tpp -79.54 137.68 37.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.546 -0.973 . . . . 0.0 109.489 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -126.11 158.15 36.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -134.31 109.9 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.74 166.22 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.496 -0.753 . . . . 0.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -154.96 127.89 8.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.665 -0.647 . . . . 0.0 109.602 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 12.9 m-70 -110.32 117.19 32.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.3 m -68.51 78.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 0.0 109.902 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 2.7 m-85 -78.25 105.1 9.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.191 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HD3' ' CD2' ' A' ' 175' ' ' TYR . 11.0 tpt180 -120.76 153.76 36.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.683 -0.636 . . . . 0.0 109.686 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 52.91 36.22 21.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.33 -0.857 . . . . 0.0 110.786 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.32 23.91 66.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.3 149.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.306 -1.114 . . . . 0.0 110.181 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 21.8 ttmt -80.1 136.31 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.0 110.247 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -118.5 -25.19 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.456 -0.778 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -174.69 143.29 0.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.104 -0.998 . . . . 0.0 110.248 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 2.9 pttt -137.76 166.45 23.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.234 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.1 m -145.0 156.56 44.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.586 -0.696 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.91 132.65 52.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 110.335 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -123.08 121.92 37.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.709 . . . . 0.0 110.576 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.406 ' O ' ' CZ ' ' A' ' 158' ' ' PHE . 23.6 mtp -65.15 122.08 16.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -0.786 . . . . 0.0 109.29 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 158' ' ' PHE . 48.8 t -79.27 -56.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 110.298 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 137.41 174.04 13.17 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 p -84.99 150.31 24.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.701 -0.882 . . . . 0.0 109.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 147' ' ' GLY . 69.8 m-85 -146.7 161.32 40.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.357 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -110.07 154.55 16.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 50.5 Cg_endo -72.64 -156.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.713 1.375 . . . . 0.0 110.321 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 25.4 mtp-105 73.09 51.23 0.14 Allowed 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 50.64 23.69 1.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.428 -0.795 . . . . 0.0 111.852 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 tt0 -79.38 103.43 9.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.56 112.91 24.8 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.615 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 78.5 m-85 -96.75 -175.3 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.738 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -141.02 112.51 7.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 160' ' ' THR . 30.8 t80 -83.82 160.46 21.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.226 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.05 100.82 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 111.459 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.431 HG21 ' CE2' ' A' ' 158' ' ' PHE . 52.4 p -69.56 149.35 97.01 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.35 -179.45 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.591 1.311 . . . . 0.0 111.077 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptm -53.73 144.88 16.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.685 -0.634 . . . . 0.0 111.232 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.407 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 12.3 mt-10 -140.54 96.35 3.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.73 -0.606 . . . . 0.0 109.673 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.76 121.76 17.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.625 -0.672 . . . . 0.0 110.595 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 104' ' ' LEU . . . -55.0 176.49 0.15 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.723 -0.611 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.08 118.38 5.66 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.367 1.193 . . . . 0.0 110.299 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.75 165.85 13.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.605 -0.684 . . . . 0.0 110.712 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.82 143.64 14.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.438 ' HA ' ' CD ' ' A' ' 172' ' ' ARG . 30.6 mtp -60.26 -42.24 94.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.521 -0.988 . . . . 0.0 109.511 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.55 -22.23 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.869 -0.519 . . . . 0.0 109.938 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.72 23.06 4.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.438 ' CD ' ' HA ' ' A' ' 169' ' ' MET . 45.9 mtm180 -100.37 176.85 5.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.257 -0.902 . . . . 0.0 110.029 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 105.63 -173.99 20.64 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.9 p -86.04 131.05 34.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.924 . . . . 0.0 110.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.406 ' CD2' ' HD3' ' A' ' 134' ' ' ARG . 24.7 m-85 -116.67 108.5 15.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.688 -0.633 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -73.85 121.2 20.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.533 -0.73 . . . . 0.0 109.128 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.3 mt -110.09 129.61 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.4 -0.812 . . . . 0.0 111.061 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 108.54 20.41 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.698 -0.626 . . . . 0.0 109.729 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.3 p -113.16 135.15 54.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.8 118.43 23.71 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.604 0.716 . . . . 0.0 110.361 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -91.41 94.64 9.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.535 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -116.82 -172.5 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 111.092 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -133.53 -172.0 2.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.88 -0.512 . . . . 0.0 109.904 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -96.52 26.11 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.499 -0.751 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 -76.34 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.523 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.71 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.482 -0.761 . . . . 0.0 111.573 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t -174.48 169.48 3.7 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.037 . . . . 0.0 110.423 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.89 118.62 34.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.728 -0.607 . . . . 0.0 109.757 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -57.87 -50.79 72.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.483 -0.761 . . . . 0.0 110.697 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.0 tp -169.4 151.12 4.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.498 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 65.3 p -147.74 161.29 41.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.431 ' CD2' ' CD2' ' A' ' 90' ' ' LEU . 16.9 p90 -146.58 -156.23 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.766 . . . . 0.0 110.232 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.94 131.45 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.621 -0.674 . . . . 0.0 110.562 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.466 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.86 146.31 41.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.652 -0.655 . . . . 0.0 109.799 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.69 146.59 24.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.699 . . . . 0.0 111.079 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 53.2 tp -116.23 97.43 6.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.4 m -72.11 111.9 7.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 0.0 110.081 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.5 mm -90.41 146.94 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.625 -0.672 . . . . 0.0 109.811 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -138.25 -156.91 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.684 -0.635 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -115.85 -24.31 8.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 110.72 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.79 94.89 1.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.611 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.443 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -84.95 12.19 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.606 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -153.65 40.1 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 110.18 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.116 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.16 0.505 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.33 -26.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.712 . . . . 0.0 110.41 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p 50.19 -155.03 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.488 -0.758 . . . . 0.0 111.004 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.9 51.38 0.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.46 -0.775 . . . . 0.0 110.106 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.43 82.52 0.98 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.477 -0.764 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.26 76.49 2.65 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.367 1.193 . . . . 0.0 110.353 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.27 48.21 22.57 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.421 -0.799 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.37 99.91 23.53 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 0.0 109.878 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.25 170.89 18.05 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.302 1.159 . . . . 0.0 110.379 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -97.66 -65.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG13 ' CE1' ' A' ' 189' ' ' HIS . 95.7 t -119.96 126.51 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.792 -0.567 . . . . 0.0 110.164 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -149.02 132.55 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.832 -0.542 . . . . 0.0 109.879 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.18 108.64 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.7 p -71.2 -62.05 1.54 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.66 . . . . 0.0 110.728 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -141.03 169.01 18.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.944 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -130.64 124.49 31.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.648 -0.657 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 m -109.9 159.71 17.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -0.782 . . . . 0.0 110.486 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mt -139.76 84.15 1.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.539 -0.726 . . . . 0.0 109.978 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.21 166.68 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.685 -0.634 . . . . 0.0 110.344 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.24 -152.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.607 -0.683 . . . . 0.0 109.847 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.04 -36.24 2.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 111.068 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -126.7 26.25 6.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.348 -0.845 . . . . 0.0 110.8 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.455 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.36 -175.51 0.54 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.403 -0.811 . . . . 0.0 110.235 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 48.7 Cg_endo -80.14 -30.97 1.91 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.313 1.165 . . . . 0.0 109.97 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.61 175.54 36.24 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.521 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.4 104.67 1.73 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.521 1.274 . . . . 0.0 110.506 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 102' ' ' PHE . 2.4 mp -69.41 112.42 5.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 109.493 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.72 146.53 23.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.629 -0.67 . . . . 0.0 110.749 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -132.42 153.88 50.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 109.81 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.86 133.76 47.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.478 -0.764 . . . . 0.0 110.508 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.407 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -132.02 51.93 2.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.501 -0.75 . . . . 0.0 110.103 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.9 p -113.52 -69.57 0.85 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.94 -47.3 0.15 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -72.48 64.9 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.639 -0.919 . . . . 0.0 109.987 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.424 HD22 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -90.24 -23.16 21.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.397 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.37 -30.67 62.98 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.29 -0.881 . . . . 0.0 110.767 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -58.08 -20.23 38.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.486 -0.759 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 6.0 m-85 -60.02 -30.39 69.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.92 -22.7 66.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.743 -0.598 . . . . 0.0 110.931 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -121.92 60.11 0.98 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.697 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.61 125.03 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.374 -0.829 . . . . 0.0 110.363 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.4 p -135.04 127.18 29.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 86' ' ' LEU . 22.8 m-85 -73.98 139.05 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.537 -0.727 . . . . 0.0 109.881 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.16 108.27 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.485 -0.76 . . . . 0.0 110.449 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 58.0 mt -113.87 165.73 12.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.55 -0.718 . . . . 0.0 109.69 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.437 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 15.1 tttm -94.46 160.93 14.43 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -18.28 -108.86 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.99 75.4 0.39 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.33 -1.481 . . . . 0.0 110.144 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.3 m -85.26 143.76 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.536 -0.979 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -88.92 89.25 7.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -110.0 131.09 55.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 111.917 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.02 159.64 14.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.2 145.3 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.053 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -118.06 102.35 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.1 mm -85.2 127.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.522 -0.736 . . . . 0.0 110.851 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.18 145.98 31.92 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.467 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 27.8 p90 -162.43 149.16 13.25 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.363 -0.835 . . . . 0.0 111.009 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -101.57 133.16 46.68 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.361 0.601 . . . . 0.0 111.282 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.06 96.43 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.52 48.64 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.344 -0.847 . . . . 0.0 111.742 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -146.76 -69.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.224 -0.923 . . . . 0.0 110.794 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.9 158.16 40.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.19 102.9 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.565 -0.709 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.72 94.99 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.616 -0.677 . . . . 0.0 109.826 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.13 97.83 8.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.617 -0.677 . . . . 0.0 110.294 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.17 41.03 0.38 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.467 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -78.86 126.19 30.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.942 . . . . 0.0 109.78 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -137.2 146.87 45.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.13 137.84 48.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 129' ' ' ILE . 81.0 mt -123.19 156.45 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.516 -0.74 . . . . 0.0 110.231 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -154.64 131.88 11.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.793 -0.567 . . . . 0.0 109.74 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.403 ' ND1' ' CB ' ' A' ' 141' ' ' LYS . 23.8 m-70 -110.64 131.56 54.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.547 -0.721 . . . . 0.0 110.098 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 31.3 m -81.87 67.3 7.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.615 -0.678 . . . . 0.0 109.837 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 6.4 m-85 -61.57 136.92 58.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.498 -0.751 . . . . 0.0 110.104 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -120.84 110.53 16.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.75 35.91 22.56 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.471 -0.768 . . . . 0.0 110.588 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.31 14.96 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.13 113.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -1.041 . . . . 0.0 110.143 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -67.64 123.92 21.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.649 -0.657 . . . . 0.0 110.189 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.65 -22.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.486 -0.759 . . . . 0.0 110.8 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -169.36 123.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.403 ' CB ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -130.86 154.15 48.36 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.697 . . . . 0.0 109.468 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.5 m -142.45 146.03 34.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -109.33 120.51 42.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.695 -0.628 . . . . 0.0 109.462 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -104.37 117.68 34.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.443 -0.786 . . . . 0.0 110.946 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 124.9 23.92 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.423 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 21.7 t -90.53 -56.5 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 110.25 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.33 166.68 10.76 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 79.5 p -81.0 140.63 35.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.637 -0.92 . . . . 0.0 109.558 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.408 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 43.9 m-85 -139.45 130.04 25.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.425 -0.797 . . . . 0.0 110.36 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.23 166.84 14.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.24 68.89 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.486 1.256 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.96 27.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.459 ' CB ' ' CZ ' ' A' ' 156' ' ' TYR . . . -147.3 12.54 1.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 111.676 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 52.21 -145.08 0.57 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.956 -1.09 . . . . 0.0 111.09 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.1 122.4 20.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.39 -0.819 . . . . 0.0 110.948 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 116' ' ' PHE . 6.5 m-85 -84.17 -173.51 4.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.724 . . . . 0.0 109.911 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -153.9 104.45 2.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 22.3 t80 -85.18 162.61 19.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -140.44 87.1 2.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.403 -0.811 . . . . 0.0 111.305 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 158' ' ' PHE . 65.5 p -67.19 148.27 98.83 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.37 -0.831 . . . . 0.0 108.965 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.26 157.73 60.57 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.392 1.206 . . . . 0.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.2 ptt? -54.61 108.67 0.41 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.574 -0.704 . . . . 0.0 110.659 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -88.55 155.97 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.38 -0.825 . . . . 0.0 110.296 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.73 137.7 44.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.284 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -94.16 172.15 6.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.323 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.18 179.77 5.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.382 1.201 . . . . 0.0 110.529 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -170.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.439 -0.788 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.06 -44.14 0.09 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.7 mtt -56.2 -75.27 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -1.102 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -2.55 36.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.982 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.26 28.75 6.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -0.946 . . . . 0.0 110.082 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 163.98 27.22 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.517 -0.739 . . . . 0.0 109.985 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.18 -167.78 14.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.1 p -107.23 130.46 54.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.663 -0.904 . . . . 0.0 110.661 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.61 129.72 50.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.671 -0.643 . . . . 0.0 109.954 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.27 143.04 47.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.745 . . . . 0.0 109.851 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.413 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -121.43 130.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.51 -0.744 . . . . 0.0 110.199 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -110.92 98.89 7.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.534 -0.729 . . . . 0.0 109.307 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.43 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 10.0 m -100.82 133.66 44.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.648 -0.658 . . . . 0.0 110.422 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -139.54 90.51 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.706 -0.621 . . . . 0.0 109.39 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 189' ' ' HIS . 0.3 OUTLIER -75.77 116.47 16.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.837 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 t -129.1 -175.38 3.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.755 -0.59 . . . . 0.0 109.803 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -100.82 -152.52 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.01 -58.69 6.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.264 -0.898 . . . . 0.0 109.671 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.5 22.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.015 -0.428 . . . . 0.0 111.094 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 187' ' ' THR . 2.6 mtt180 -82.26 -43.59 17.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.861 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 186' ' ' ARG . 5.2 t 176.97 173.49 0.44 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.201 0.524 . . . . 0.0 110.197 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.59 115.75 30.12 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 31.8 p80 -74.36 -15.21 60.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 0.0 111.31 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.1 tp -168.83 156.22 7.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.124 -0.985 . . . . 0.0 110.853 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.0 p -168.38 143.79 3.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.739 -0.6 . . . . 0.0 109.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 179' ' ' SER . 40.4 p90 -151.19 -156.15 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 110.095 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.6 132.88 3.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 111.085 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 8.9 p-90 -139.33 165.44 27.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.79 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -102.19 159.68 15.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 111.291 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.48 109.75 11.31 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.1 m -85.28 130.11 34.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.696 . . . . 0.0 110.85 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.98 152.14 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.63 -0.669 . . . . 0.0 109.402 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -145.13 -151.83 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 110.605 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -107.43 -39.49 5.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 111.302 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -144.6 98.08 3.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.21 -0.931 . . . . 0.0 111.207 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.455 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -89.09 35.1 0.79 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.191 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -169.71 34.13 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.27 -0.894 . . . . 0.0 110.136 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.904 -1.045 . . . . 0.0 110.173 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.017 0.437 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.98 -50.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.607 -0.683 . . . . 0.0 109.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 p 48.9 58.14 5.65 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.644 -0.66 . . . . 0.0 111.337 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.55 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 55.38 76.9 0.46 Allowed Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.094 -1.003 . . . . 0.0 110.412 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.48 162.99 39.88 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.411 1.216 . . . . 0.0 110.536 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -167.69 38.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 109.973 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.18 116.5 19.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.388 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.39 -165.05 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.103 1.054 . . . . 0.0 110.233 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -82.17 -70.66 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.261 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -130.06 112.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.623 . . . . 0.0 110.461 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -138.64 149.5 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.926 -0.484 . . . . 0.0 109.885 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.423 HG23 ' CD2' ' A' ' 181' ' ' PHE . 59.7 t -65.68 103.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -72.02 -35.94 69.55 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.146 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -167.31 173.09 9.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 110.4 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tt -142.68 124.59 15.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.577 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.5 m -109.7 167.19 10.33 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.56 -0.713 . . . . 0.0 110.843 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.03 80.98 1.54 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.62 -0.675 . . . . 0.0 109.39 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.0 t -77.49 166.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 110.157 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.17 -166.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.691 -0.63 . . . . 0.0 110.192 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.8 p -116.55 -33.13 4.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -124.17 20.21 9.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.708 . . . . 0.0 110.856 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.453 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.62 -174.83 0.47 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 47.5 Cg_endo -81.02 -30.87 1.51 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.27 1.142 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.19 173.17 34.36 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.89 -1.147 . . . . 0.0 110.55 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.56 96.32 0.74 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.665 1.35 . . . . 0.0 110.372 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 3.6 mt -64.81 123.87 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.652 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -103.52 122.76 45.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.501 -0.749 . . . . 0.0 110.802 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -102.6 119.17 38.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -67.58 141.0 56.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.587 -0.695 . . . . 0.0 110.688 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.416 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -140.35 56.83 1.6 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.471 -0.768 . . . . 0.0 110.073 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.8 p -128.53 -56.22 1.23 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.684 -0.635 . . . . 0.0 110.3 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.89 -51.9 0.04 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.39 69.94 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.597 -0.943 . . . . 0.0 110.147 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -94.23 -22.69 18.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.51 -0.744 . . . . 0.0 110.579 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -22.17 12.88 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.373 -0.83 . . . . 0.0 111.08 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.26 63.38 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 0.0 110.548 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 5.5 m-85 -58.97 -60.34 4.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.362 -0.836 . . . . 0.0 110.667 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -13.45 47.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.482 -0.761 . . . . 0.0 111.231 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -86.36 -15.99 38.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.16 -0.962 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.68 162.23 34.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -132.4 167.74 19.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 86' ' ' LEU . 3.9 m-85 -103.18 113.13 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.636 -0.665 . . . . 0.0 109.874 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.89 117.27 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 110.787 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.452 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 37.0 mt -127.6 145.02 51.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 26.9 tttm -65.21 142.08 58.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.213 -0.93 . . . . 0.0 108.848 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.0 pt-20 -57.13 110.64 0.87 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.404 -0.81 . . . . 0.0 111.523 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.2 39.73 3.68 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.762 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 27.6 m -99.12 133.08 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.128 -1.219 . . . . 0.0 110.653 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.27 98.11 11.15 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.05 144.74 40.91 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.616 0.722 . . . . 0.0 111.611 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -106.55 150.87 25.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.8 mt -119.86 148.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -130.08 93.2 3.44 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.88 150.37 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.567 0.699 . . . . 0.0 110.652 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -124.82 145.22 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 116' ' ' PHE . 31.2 p90 -166.28 136.68 3.39 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.523 -0.735 . . . . 0.0 110.501 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -87.26 144.16 26.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.776 -0.578 . . . . 0.0 111.158 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -131.03 83.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.577 -0.702 . . . . 0.0 109.415 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.34 48.7 2.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.515 -0.741 . . . . 0.0 111.738 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -147.79 -66.39 0.25 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.287 -0.883 . . . . 0.0 111.126 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.08 169.9 16.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.935 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 91.5 mt -78.4 124.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.63 . . . . 0.0 110.115 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.11 80.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.2 p -79.77 112.11 16.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.749 -0.595 . . . . 0.0 110.705 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.75 45.35 0.51 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 1.8 mmt -61.98 132.56 53.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -1.097 . . . . 0.0 109.098 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.16 148.76 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.923 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.96 87.4 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 109.533 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 129' ' ' ILE . 85.5 mt -81.46 169.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.648 . . . . 0.0 110.072 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.18 120.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.445 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.2 m-70 -103.4 124.88 49.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.0 110.083 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.7 m -85.25 68.32 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.373 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -65.96 154.31 39.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.425 -0.797 . . . . 0.0 110.201 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -130.72 86.29 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.598 -0.689 . . . . 0.0 110.602 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 53.63 61.96 2.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.381 -0.825 . . . . 0.0 110.857 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.76 36.58 57.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.01 146.95 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.991 . . . . 0.0 109.793 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.11 121.0 43.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.44 -26.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.759 . . . . 0.0 111.145 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -161.82 153.08 18.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.888 -1.133 . . . . 0.0 111.201 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.423 ' HE3' ' CE1' ' A' ' 131' ' ' HIS . 5.9 ptmt -175.79 135.91 0.31 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.708 . . . . 0.0 109.229 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.8 m -146.23 168.82 20.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 111.231 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -108.39 151.0 26.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.723 -0.611 . . . . 0.0 110.005 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -119.86 128.42 53.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.509 -0.744 . . . . 0.0 110.676 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 ttp -87.77 109.0 19.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.451 -0.781 . . . . 0.0 109.382 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.43 HG12 ' CG ' ' A' ' 158' ' ' PHE . 80.2 t -86.43 -71.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 110.709 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.59 -165.57 38.0 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.7 p -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.676 -0.896 . . . . 0.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' A' ' 126' ' ' MET . 11.8 m-85 -126.22 -173.95 2.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.837 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.69 162.94 26.23 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.83 66.25 2.41 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.314 1.165 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.13 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.555 -0.716 . . . . 0.0 109.895 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -178.35 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.005 -1.06 . . . . 0.0 110.709 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -94.02 -171.09 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.444 -0.785 . . . . 0.0 111.563 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.4 144.31 30.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.367 0.604 . . . . 0.0 110.601 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 60.4 m-85 -107.96 154.64 21.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -128.84 135.28 48.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.331 -0.856 . . . . 0.0 111.371 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.43 ' CG ' HG12 ' A' ' 146' ' ' VAL . 28.0 t80 -103.44 136.18 43.67 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.77 116.45 25.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 110.778 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.42 HG21 ' CE2' ' A' ' 158' ' ' PHE . 43.1 p -86.54 153.05 55.55 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 162.56 37.54 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.628 1.331 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.41 123.36 15.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.567 -0.708 . . . . 0.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.45 114.15 27.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.687 -0.633 . . . . 0.0 109.999 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -69.85 127.08 31.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.646 -0.658 . . . . 0.0 110.288 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.71 172.75 4.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.8 -0.562 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.82 147.54 56.28 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 O-C-N 123.427 1.225 . . . . 0.0 110.131 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 35.7 mtmt -115.92 175.57 5.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.514 -0.741 . . . . 0.0 110.461 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.57 147.17 17.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -52.74 43.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.541 -0.976 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.2 tt -57.48 -27.93 62.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.463 -0.773 . . . . 0.0 110.34 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.29 38.25 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 mtp-105 -67.71 126.98 31.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.511 -0.743 . . . . 0.0 109.9 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.32 177.88 28.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 p -91.8 135.81 33.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.918 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -128.56 114.68 17.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 110.054 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.98 148.4 47.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.768 . . . . 0.0 110.132 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.421 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 46.2 mm -124.09 101.67 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 0.0 110.172 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -91.67 104.0 16.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 14.9 m -113.88 142.94 45.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.516 -0.74 . . . . 0.0 110.939 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -123.49 95.28 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.777 -0.577 . . . . 0.0 109.455 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 6.6 t80 -80.61 73.56 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.711 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.1 t -116.56 -168.84 1.52 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.665 . . . . 0.0 109.319 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.16 -158.08 0.62 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.541 -0.725 . . . . 0.0 109.814 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.16 -60.15 3.79 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.38 -0.825 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.02 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.822 -0.549 . . . . 0.0 110.593 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -78.0 -35.29 50.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.297 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t -176.35 -161.24 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.168 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -115.18 109.61 18.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.63 -0.669 . . . . 0.0 109.807 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -77.9 -67.76 0.7 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.451 -0.781 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -143.9 164.61 30.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 110.123 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.433 ' N ' ' CD1' ' A' ' 190' ' ' LEU . 7.4 t -168.82 135.38 1.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 16.4 p90 -145.23 -172.83 3.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.65 125.88 7.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.513 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.0 p-90 -134.48 145.25 48.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.688 -0.633 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.62 146.79 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.2 tp -120.28 94.37 4.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.731 -0.606 . . . . 0.0 109.793 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.6 m -73.23 148.58 43.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.56 -0.712 . . . . 0.0 110.017 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.9 mm -124.27 135.95 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.604 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -128.76 -156.09 0.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.569 -0.707 . . . . 0.0 110.491 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -30.45 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 111.103 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -138.22 56.7 1.72 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.368 -0.832 . . . . 0.0 111.122 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -60.87 -16.04 37.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.0 111.327 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 35.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 110.455 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.186 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.28 126.57 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.542 -0.724 . . . . 0.0 110.181 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.1 p -149.22 30.04 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.644 -0.66 . . . . 0.0 110.276 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 56.36 -86.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.705 -0.622 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.95 96.25 3.79 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 110.259 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.5 102.97 1.46 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.478 1.252 . . . . 0.0 110.375 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 m120 52.86 -167.33 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.445 -0.784 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.3 t -146.95 59.9 5.37 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 110.052 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.96 171.21 17.97 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.314 1.165 . . . . 0.0 110.422 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -166.94 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.787 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.04 111.45 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.628 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -142.03 152.78 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.2 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.454 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 58.0 t -68.81 102.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 -53.57 11.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.597 -0.69 . . . . 0.0 110.065 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -150.02 165.68 31.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.74 -0.6 . . . . 0.0 110.001 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.06 165.21 19.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.728 -0.608 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -155.04 156.13 35.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.59 -0.694 . . . . 0.0 110.81 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -136.17 96.91 3.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.0 109.737 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.26 167.88 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.852 -0.53 . . . . 0.0 110.188 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -171.7 -28.03 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.483 -0.761 . . . . 0.0 111.672 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 p 62.58 17.43 9.64 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -140.63 -46.55 0.41 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.507 -0.746 . . . . 0.0 109.224 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.463 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -59.34 -174.84 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.765 -0.584 . . . . 0.0 110.025 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 82' ' ' ALA . 43.8 Cg_endo -73.11 -23.59 18.0 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.167 1.088 . . . . 0.0 110.345 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.66 176.73 40.21 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.83 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.15 102.87 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.639 1.336 . . . . 0.0 110.452 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 30.5 mt -65.38 102.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -98.29 161.44 13.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.639 -0.663 . . . . 0.0 111.234 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.448 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 4.3 mt -130.94 167.53 18.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.822 -0.548 . . . . 0.0 109.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.419 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 11.0 t70 -111.05 131.22 55.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.578 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.415 HD22 ' CD2' ' A' ' 192' ' ' TRP . 1.5 mp -136.95 55.39 1.83 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 109.899 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -135.94 36.0 2.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.609 -0.682 . . . . 0.0 110.66 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.11 -86.65 0.22 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.97 81.18 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.694 -0.886 . . . . 0.0 110.197 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -95.12 -26.36 16.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.63 -0.669 . . . . 0.0 110.379 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -57.86 -26.64 62.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.443 -0.786 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -22.44 30.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.423 -0.798 . . . . 0.0 110.389 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.448 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 3.2 m-85 -56.47 -22.06 29.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.434 -0.791 . . . . 0.0 110.526 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -81.86 -20.18 39.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -0.783 . . . . 0.0 110.523 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -86.55 -22.15 26.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.935 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -132.4 134.81 45.59 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 110.689 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -105.83 -168.53 1.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.655 -0.653 . . . . 0.0 109.921 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CE1' ' HG ' ' A' ' 88' ' ' LEU . 1.6 m-85 -116.98 96.62 5.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.42 108.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.715 -0.616 . . . . 0.0 109.854 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.458 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 5.1 mt -113.87 -170.85 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.6 -0.687 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.432 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 31.1 tttm -134.64 157.23 47.15 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.994 0.902 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -47.54 124.46 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 45.51 60.18 4.35 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.905 -0.497 . . . . 0.0 113.097 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.7 m -96.15 119.83 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.239 -1.153 . . . . 0.0 110.596 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.43 96.0 2.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.42 ' CD1' HD21 ' A' ' 77' ' ' LEU . 14.3 p90 -115.44 148.79 38.98 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.573 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -102.0 138.14 39.36 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.73 161.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.247 -0.908 . . . . 0.0 110.521 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.59 82.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mm -75.15 143.78 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.708 -0.62 . . . . 0.0 110.49 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.07 132.21 54.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.458 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 48.6 p90 -154.2 144.71 22.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.779 . . . . 0.0 111.082 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -97.17 138.27 34.92 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.261 0.553 . . . . 0.0 110.858 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.89 87.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.633 -0.667 . . . . 0.0 109.324 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.25 47.17 2.52 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.426 -0.796 . . . . 0.0 112.164 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -139.08 -64.09 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.34 160.95 37.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.479 -0.763 . . . . 0.0 110.277 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.79 112.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.58 120.74 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.583 -0.698 . . . . 0.0 109.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.6 p -116.84 114.87 24.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.455 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.99 30.77 2.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.2 ttt -63.45 120.06 10.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.402 -1.057 . . . . 0.0 109.625 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.22 156.22 25.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.411 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 35.0 t80 -132.16 101.06 5.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.8 mt -94.27 165.67 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.295 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -158.84 134.66 8.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 0.0 110.023 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -113.96 118.23 33.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.681 -0.637 . . . . 0.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 m -75.42 74.59 2.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.533 -0.73 . . . . 0.0 109.781 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -62.27 154.64 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.518 -0.739 . . . . 0.0 110.515 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -120.22 39.26 3.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.703 -0.623 . . . . 0.0 110.27 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.46 61.34 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.253 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 149.45 -37.06 0.99 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.88 127.18 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.968 . . . . 0.0 110.297 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.38 131.34 50.68 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 139' ' ' ILE . 20.2 mt -89.79 -52.73 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.679 -0.638 . . . . 0.0 109.312 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -169.17 165.09 11.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 174.68 10.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.618 -0.676 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 m -154.65 146.25 23.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -102.38 137.46 40.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.578 -0.701 . . . . 0.0 110.109 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -120.97 129.94 53.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.431 -0.793 . . . . 0.0 110.537 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -80.44 112.5 17.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 109.389 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.425 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 49.4 t -79.72 -67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.55 171.64 19.64 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.7 p -95.4 154.93 16.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.972 . . . . 0.0 110.02 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -147.92 128.04 13.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.366 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.55 153.21 28.49 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.24 76.84 2.97 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.454 1.239 . . . . 0.0 110.435 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -169.0 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 110.34 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -142.44 -111.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 110.162 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -171.95 -148.65 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.593 -1.317 . . . . 0.0 109.739 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 91.13 1.03 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.427 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 22.7 m-85 -59.87 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.415 -0.803 . . . . 0.0 110.008 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.09 114.77 3.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 110.987 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 39.0 t80 -95.34 169.46 10.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.1 124.9 7.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.858 . . . . 0.0 111.145 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.0 p -93.75 159.92 33.72 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.31 152.77 80.04 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.63 1.332 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -57.28 116.33 3.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.746 -0.596 . . . . 0.0 111.121 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -113.11 149.35 33.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.71 -0.619 . . . . 0.0 109.617 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.44 127.35 44.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.539 -0.726 . . . . 0.0 110.934 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.421 ' CB ' ' HD2' ' A' ' 166' ' ' PRO . . . -62.72 -176.06 0.14 Allowed Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 165' ' ' ALA . 44.8 Cg_endo -73.6 127.7 11.95 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 O-C-N 123.066 1.035 . . . . 0.0 110.204 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -116.17 159.02 22.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 110.868 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.65 162.18 30.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -60.06 173.07 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -1.044 . . . . 0.0 109.556 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 tt 67.9 -60.65 0.4 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.372 -0.83 . . . . 0.0 110.625 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 175' ' ' TYR . . . -52.08 -23.25 5.03 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.15 155.57 38.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.344 -0.847 . . . . 0.0 110.101 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.23 -175.3 19.92 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -91.89 118.17 30.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.94 . . . . 0.0 110.363 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' A' ' 171' ' ' ALA . 55.3 m-85 -112.48 124.39 52.4 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 140.06 47.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.646 -0.659 . . . . 0.0 110.637 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.418 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 46.9 mm -113.53 94.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.647 -0.658 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 109.22 18.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.23 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.411 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 28.6 t -113.64 144.38 43.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.393 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.02 105.97 10.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.682 -0.637 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.7 t80 -81.62 132.63 35.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.72 -0.613 . . . . 0.0 109.852 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -171.03 -172.7 1.17 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.649 -0.657 . . . . 0.0 110.222 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -112.12 -154.37 0.54 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.738 -0.601 . . . . 0.0 109.524 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -59.32 5.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.92 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.753 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -81.64 -34.93 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.21 -166.91 0.15 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.686 -0.634 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.23 117.1 29.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.658 . . . . 0.0 109.666 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.1 m-70 -68.9 -62.5 1.35 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.508 -0.745 . . . . 0.0 110.68 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.7 tp -168.43 159.53 10.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.382 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.2 t -153.71 138.53 17.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.53 -0.732 . . . . 0.0 110.196 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.415 ' CD2' HD22 ' A' ' 90' ' ' LEU . 19.0 p90 -142.02 -155.43 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 110.083 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -169.01 128.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.377 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 8.9 p-90 -130.45 145.0 51.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.613 -0.68 . . . . 0.0 109.982 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.44 158.83 28.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.474 0.654 . . . . 0.0 110.941 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 21.9 tp -133.38 95.41 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.1 m -80.63 104.34 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.626 -0.672 . . . . 0.0 110.78 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.76 147.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -138.29 -158.83 0.89 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.424 -0.797 . . . . 0.0 110.809 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -53.13 4.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.691 -0.631 . . . . 0.0 110.928 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -147.1 94.06 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.0 110.818 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.463 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -74.97 -0.78 19.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.644 -0.66 . . . . 0.0 111.336 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.69 34.92 2.79 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 110.249 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.189 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.067 0.46 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.96 171.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.571 -0.706 . . . . 0.0 110.209 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.19 70.25 10.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.39 31.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.519 -0.738 . . . . 0.0 110.195 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.61 149.71 90.89 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.541 -0.725 . . . . 0.0 110.252 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.34 -175.54 1.82 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.353 1.186 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.99 126.45 34.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.584 -0.697 . . . . 0.0 110.151 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.32 143.63 29.68 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.122 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.91 177.39 8.2 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.298 1.157 . . . . 0.0 110.639 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -104.82 -56.85 2.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.698 -0.626 . . . . 0.0 109.862 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.9 t -114.05 130.76 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 0.0 110.078 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.2 t -148.1 137.75 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.786 -0.572 . . . . 0.0 110.284 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 57.5 t -69.44 106.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 p -73.35 -58.37 3.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.728 -0.608 . . . . 0.0 110.498 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.23 164.28 30.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.49 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 tt -132.13 124.19 28.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.673 -0.642 . . . . 0.0 109.695 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -109.87 152.04 26.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.754 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.61 114.19 9.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.612 -0.68 . . . . 0.0 110.149 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.44 165.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.712 . . . . 0.0 110.26 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.97 -156.64 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 109.956 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.1 p -97.38 -35.88 10.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 p -138.79 47.53 1.94 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.617 -0.677 . . . . 0.0 110.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.452 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.23 172.01 7.66 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.664 -0.647 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -29.12 14.11 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.442 1.233 . . . . 0.0 109.855 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.38 175.12 33.07 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.9 100.63 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.393 1.207 . . . . 0.0 110.204 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 102' ' ' PHE . 53.1 mt -65.03 113.31 3.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.631 -0.668 . . . . 0.0 109.932 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.11 116.2 29.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.758 -0.589 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -101.87 128.03 48.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.587 -0.696 . . . . 0.0 109.983 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.05 126.85 31.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.546 -0.721 . . . . 0.0 110.007 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 52.21 2.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.672 . . . . 0.0 110.062 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -101.37 -73.75 0.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.4 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.09 -42.66 0.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.33 77.66 8.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.689 -0.889 . . . . 0.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 86.9 mt -87.33 -20.87 26.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -13.71 36.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.0 111.477 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -6.2 39.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.06 -1.025 . . . . 0.0 111.567 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' CE1' HD21 ' A' ' 88' ' ' LEU . 12.4 m-30 -75.27 -55.53 5.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -58.21 -17.55 19.79 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.489 -0.757 . . . . 0.0 111.407 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -86.0 -19.85 29.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.265 -0.897 . . . . 0.0 110.89 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.62 147.08 37.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.216 -0.928 . . . . 0.0 110.582 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 160.9 37.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.449 -0.782 . . . . 0.0 109.931 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 86' ' ' LEU . 29.3 m-85 -90.98 166.08 13.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.99 128.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 88.2 mt -129.5 164.62 23.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.63 -0.669 . . . . 0.0 109.686 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 2.5 ttpt -77.2 166.54 23.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -29.24 -66.77 0.08 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.82 72.98 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.44 ' CG1' ' CB ' ' A' ' 105' ' ' LYS . 32.7 m -88.0 139.12 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.412 -1.052 . . . . 0.0 110.661 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -85.32 95.98 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 48.5 p90 -109.68 135.93 49.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.533 -0.729 . . . . 0.0 111.745 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -89.2 157.39 18.28 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.89 132.56 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.422 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -115.36 121.48 42.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.88 146.82 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.506 0.669 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -129.37 133.29 47.32 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.453 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 33.4 p90 -154.73 157.98 38.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.383 -0.823 . . . . 0.0 110.847 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.76 129.46 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.51 110.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 109.351 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -128.53 48.23 2.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 111.382 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 -67.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.295 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.66 165.67 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.509 -0.745 . . . . 0.0 110.474 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 122' ' ' ILE . 84.8 mt -69.12 106.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.691 -0.63 . . . . 0.0 109.974 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.83 95.02 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.653 -0.655 . . . . 0.0 109.966 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.1 p -88.87 74.97 8.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.322 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 153.63 53.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -82.69 151.38 26.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.988 . . . . 0.0 109.605 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -146.69 151.63 37.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.873 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -128.15 97.49 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.758 -0.588 . . . . 0.0 109.499 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.23 134.6 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 110.055 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.405 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 18.5 tt0 -129.06 138.07 51.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -113.6 138.39 50.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.444 -0.785 . . . . 0.0 110.089 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.7 m -96.6 85.92 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.707 -0.621 . . . . 0.0 109.824 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 138' ' ' LYS . 5.4 m-85 -89.84 129.26 36.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 110.398 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 3.5 tmm_? -145.52 151.43 38.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 51.49 31.23 7.2 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.452 -0.78 . . . . 0.0 111.166 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.41 60.33 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.314 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.36 149.67 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.322 . . . . 0.0 110.398 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 16.7 tttp -85.66 119.76 26.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.8 -67.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.56 -0.713 . . . . 0.0 109.914 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.73 157.45 6.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.506 -0.746 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 165.72 19.0 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.4 m -128.74 137.31 51.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.562 -0.711 . . . . 0.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -101.7 105.24 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.712 . . . . 0.0 110.077 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -96.2 148.07 23.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.75 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.05 117.2 33.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 158' ' ' PHE . 48.1 t -80.86 -55.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.48 -0.762 . . . . 0.0 110.196 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.75 -179.69 17.68 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 22.3 m -89.65 151.29 21.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.66 -0.906 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.3 129.55 14.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 0.0 110.369 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.03 152.08 30.95 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.71 90.24 0.95 Allowed 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.425 1.224 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 26.42 7.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.584 -0.698 . . . . 0.0 110.226 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 53.42 22.81 3.02 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.376 -0.827 . . . . 0.0 111.268 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -133.04 178.22 7.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.17 157.93 16.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.705 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.16 177.56 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.539 -0.726 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -148.81 91.67 1.9 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 146' ' ' VAL . 40.1 t80 -79.56 163.94 24.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.0 110.002 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -139.72 119.28 13.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.565 -0.709 . . . . 0.0 110.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 158' ' ' PHE . 66.8 p -102.26 157.09 34.37 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.522 -0.736 . . . . 0.0 109.714 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.68 159.83 46.41 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.707 1.372 . . . . 0.0 110.997 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 149.87 27.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.408 0.623 . . . . 0.0 110.872 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.409 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 16.6 tt0 -129.24 106.44 8.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.712 -0.617 . . . . 0.0 109.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.09 126.0 26.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.31 173.09 7.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.793 -0.567 . . . . 0.0 110.003 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.96 123.92 9.25 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.338 1.178 . . . . 0.0 110.362 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -118.12 -160.93 0.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 110.572 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.71 47.9 13.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 54.79 175.65 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.567 -0.961 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -61.38 0.32 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.285 -0.885 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -49.43 -24.66 2.09 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.382 -0.824 . . . . 0.0 111.407 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -58.74 128.35 36.78 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.18 -178.84 25.5 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.8 p -86.79 142.75 27.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.517 -0.99 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 38.1 m-85 -131.11 105.0 7.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.671 -0.643 . . . . 0.0 110.356 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -70.35 120.14 15.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.612 -0.68 . . . . 0.0 109.349 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 44.8 mt -109.72 148.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.982 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -114.84 118.88 34.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.748 -0.595 . . . . 0.0 109.79 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.8 m -110.53 122.48 47.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.585 -0.697 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -111.01 103.62 12.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t80 -83.26 116.79 22.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.548 -0.72 . . . . 0.0 110.071 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.3 t -131.97 -155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.746 . . . . 0.0 110.166 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -161.81 -146.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.055 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.2 27.87 2.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 186' ' ' ARG . 1.4 t70 -132.35 54.59 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.489 -0.757 . . . . 0.0 109.518 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 185' ' ' ASP . 0.0 OUTLIER 4.17 65.42 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.0 t -144.63 -174.82 4.43 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.048 0.451 . . . . 0.0 109.915 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.11 88.09 2.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -60.27 -40.62 91.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.522 -0.736 . . . . 0.0 109.973 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tp -170.35 148.21 3.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 110.032 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -159.65 136.96 9.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.654 -0.654 . . . . 0.0 110.025 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.424 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 23.9 p90 -136.48 -157.39 0.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.613 -0.68 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.742 . . . . 0.0 110.55 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 18.1 p-90 -144.13 153.27 41.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.561 -0.712 . . . . 0.0 109.987 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -94.34 153.49 17.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.536 -0.727 . . . . 0.0 111.042 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.78 90.05 3.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.1 m -67.98 145.09 54.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.0 110.94 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.6 156.89 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.707 -0.621 . . . . 0.0 109.392 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -151.91 -153.27 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.493 -0.754 . . . . 0.0 110.068 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -129.88 -0.7 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 111.624 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -160.08 47.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.085 -1.01 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.463 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -57.44 -19.85 26.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.525 -0.734 . . . . 0.0 111.292 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 56.91 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.165 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.129 0.49 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.7 -26.02 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.75 . . . . 0.0 110.429 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 m 53.21 87.29 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.353 -0.842 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.21 -160.6 0.75 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.683 . . . . 0.0 110.152 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 t0 52.51 75.6 0.62 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.411 -0.806 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.364 1.191 . . . . 0.0 110.372 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.04 174.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.544 -0.722 . . . . 0.0 110.697 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.5 m -149.77 152.27 34.3 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 110.189 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.42 168.61 24.32 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.379 1.199 . . . . 0.0 110.271 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.96 -77.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.913 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.33 119.2 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.624 -0.673 . . . . 0.0 110.338 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.52 136.74 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 181' ' ' PHE . 59.3 t -61.24 103.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.518 -0.739 . . . . 0.0 109.115 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.0 p -73.45 -56.37 5.14 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.889 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -141.99 168.35 19.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.812 . . . . 0.0 110.724 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.66 124.57 31.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.65 -0.657 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -110.4 156.22 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.621 -0.674 . . . . 0.0 110.277 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.55 82.2 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.577 -0.702 . . . . 0.0 109.879 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.49 143.93 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.725 -0.609 . . . . 0.0 110.088 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.2 m -140.82 -163.54 1.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.041 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 p -115.87 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.4 p -95.87 24.9 5.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.447 ' HB3' ' CZ3' ' A' ' 202' ' ' TRP . . . -90.5 -177.38 0.77 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.509 -0.744 . . . . 0.0 110.29 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 82' ' ' ALA . 45.2 Cg_endo -73.99 -23.59 15.97 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.359 1.189 . . . . 0.0 110.131 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.68 -175.46 29.67 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.07 104.8 1.58 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.503 1.264 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.89 114.45 4.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.722 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -90.19 146.61 24.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 3.7 tt -128.08 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.52 127.35 40.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.517 -0.739 . . . . 0.0 110.161 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.26 55.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.654 -0.654 . . . . 0.0 109.878 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -104.81 -73.63 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.728 -0.607 . . . . 0.0 110.474 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.22 -74.77 0.49 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.41 94.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.683 -0.893 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 61.0 mt -92.78 -33.41 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.492 -0.755 . . . . 0.0 110.149 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -57.57 -19.31 24.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.502 -0.749 . . . . 0.0 111.065 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.56 -24.5 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.16 -0.963 . . . . 0.0 111.263 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.456 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 8.1 m-85 -62.0 -19.24 62.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.507 -0.745 . . . . 0.0 110.309 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.9 -25.98 61.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -86.94 -25.24 24.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.494 -0.754 . . . . 0.0 110.855 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.35 151.47 51.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.392 -0.818 . . . . 0.0 110.619 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -123.81 -170.27 2.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.543 -0.723 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.416 ' CZ ' HD11 ' A' ' 88' ' ' LEU . 6.5 m-85 -115.37 102.08 9.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.641 -0.662 . . . . 0.0 110.052 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.39 147.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.65 -0.656 . . . . 0.0 110.203 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.401 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 3.8 tt -159.34 148.17 18.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.664 -0.647 . . . . 0.0 109.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.425 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 63.7 tttt -83.54 158.29 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -39.96 107.5 0.07 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 32.24 68.64 0.14 Allowed Glycine 0 N--CA 1.506 3.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.736 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 21.5 m -88.78 167.55 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -1.141 . . . . 0.0 109.647 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.38 97.94 11.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.202 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -128.42 134.28 48.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.0 111.581 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -89.46 167.53 12.92 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.0 mt -125.35 137.94 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 0.0 110.358 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -115.68 109.34 17.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.645 -0.66 . . . . 0.0 109.541 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.0 mm -93.38 126.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.583 -0.698 . . . . 0.0 110.773 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.9 p -108.59 148.55 30.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 156' ' ' TYR . 2.5 p90 -164.78 146.37 8.02 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.235 -0.916 . . . . 0.0 111.884 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -81.49 125.26 30.26 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.276 0.56 . . . . 0.0 110.748 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 156' ' ' TYR . 72.4 t -126.36 82.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.54 48.73 2.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.442 -0.786 . . . . 0.0 111.93 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -138.34 -65.97 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.104 -0.997 . . . . 0.0 111.089 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -142.67 175.98 9.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.393 -0.817 . . . . 0.0 110.86 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.58 113.28 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 110.152 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -95.76 88.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.664 -0.647 . . . . 0.0 109.8 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 77.6 p -82.97 88.06 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.632 -0.668 . . . . 0.0 110.516 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.0 46.55 0.07 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.434 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 3.0 ttt -81.22 128.48 33.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.514 -0.992 . . . . 0.0 109.597 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -140.62 167.0 23.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.507 -0.745 . . . . 0.0 110.849 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -135.75 120.12 17.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.7 -0.625 . . . . 0.0 109.733 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.57 130.25 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.583 -0.698 . . . . 0.0 110.3 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -128.1 135.61 50.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.611 -0.681 . . . . 0.0 109.862 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.1 m-70 -104.2 114.64 29.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -70.68 77.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.698 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 3.4 m-85 -80.79 141.99 34.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.985 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -119.35 -155.4 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -64.66 81.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.58 -0.7 . . . . 0.0 110.608 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.9 23.73 61.75 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -148.78 89.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -1.079 . . . . 0.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 149.84 49.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.726 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 140' ' ' ASP . 44.2 pt -118.89 -37.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.406 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.6 t70 -175.86 167.2 3.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.0 -1.063 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -126.86 -168.3 1.85 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.4 m -159.74 126.96 4.61 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.47 136.84 52.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -123.17 127.44 48.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.576 -0.703 . . . . 0.0 110.845 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.7 tpp -81.18 106.01 12.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.451 ' CG1' ' CE1' ' A' ' 149' ' ' TYR . 40.8 t -79.96 -36.4 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.547 -0.721 . . . . 0.0 110.279 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.69 -176.87 16.81 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 3.1 t -82.52 135.73 35.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.599 -0.942 . . . . 0.0 110.03 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.451 ' CE1' ' CG1' ' A' ' 146' ' ' VAL . 9.3 m-85 -118.35 128.99 55.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.633 . . . . 0.0 110.939 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.79 153.05 16.91 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.79 85.14 1.36 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.369 1.194 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -62.28 1.48 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.67 127.01 0.9 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 111.17 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.03 -156.92 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.498 -0.751 . . . . 0.0 111.545 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.81 174.79 7.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.554 -0.716 . . . . 0.0 111.26 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.437 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 44.4 m-85 -119.31 -174.63 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.657 -0.652 . . . . 0.0 109.461 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.87 100.41 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 146' ' ' VAL . 54.6 t80 -81.39 170.35 16.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.124 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -155.68 109.42 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 110.513 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 54.8 p -75.6 146.88 81.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 109.168 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.43 -177.97 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.706 1.371 . . . . 0.0 111.021 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -58.37 145.17 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.482 0.658 . . . . 0.0 110.872 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.47 119.86 3.1 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.82 146.14 37.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 111.019 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.76 -178.09 0.88 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.748 -0.595 . . . . 0.0 109.723 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.9 123.61 8.56 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.104 1.055 . . . . 0.0 110.355 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 171.36 7.78 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.459 -0.776 . . . . 0.0 110.539 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.84 161.91 11.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.99 -61.0 2.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.574 -0.956 . . . . 0.0 109.291 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.63 -29.76 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.725 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.9 -23.98 61.77 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.501 -0.749 . . . . 0.0 110.538 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -64.2 129.08 38.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.788 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.4 -177.94 30.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.6 p -86.72 133.99 33.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.949 . . . . 0.0 110.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -116.81 106.74 13.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.272 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.76 121.12 19.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.599 -0.688 . . . . 0.0 109.547 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -111.81 124.33 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.451 -0.78 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.4 ' CB ' ' HB2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -86.76 96.69 10.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.0 109.451 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.412 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.3 p -90.55 134.89 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.632 -0.667 . . . . 0.0 110.802 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -133.41 82.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.66 -0.65 . . . . 0.0 109.618 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.402 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 4.0 t80 -79.1 111.84 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.617 -0.677 . . . . 0.0 110.06 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -136.19 -166.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.31 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -133.89 163.24 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.789 -0.569 . . . . 0.0 109.992 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.21 48.46 1.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.35 -54.22 0.19 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.602 -0.686 . . . . 0.0 110.722 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -94.72 -83.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.558 -0.714 . . . . 0.0 110.703 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 t -172.76 -165.02 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.211 -0.931 . . . . 0.0 110.386 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.46 108.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 110.003 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -65.92 -56.2 12.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.543 -0.723 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -168.3 142.85 3.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.584 -0.698 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 81.0 p -142.63 147.75 36.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.532 -0.73 . . . . 0.0 109.989 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.412 ' CE2' ' OG ' ' A' ' 179' ' ' SER . 16.4 p90 -144.68 -155.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 109.975 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.99 126.04 3.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 110.613 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.426 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 23.2 p-90 -133.29 147.55 51.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.589 -0.694 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.93 135.06 35.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 111.145 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.4 tp -104.96 95.46 5.87 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.9 m -72.42 117.97 14.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.555 -0.716 . . . . 0.0 110.992 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.3 mm -91.03 153.33 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -142.89 -167.63 2.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.394 -0.816 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 -46.66 6.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.704 -0.622 . . . . 0.0 110.568 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.89 106.27 4.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.33 36.56 0.88 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.607 -0.683 . . . . 0.0 111.285 179.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -169.37 37.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.316 -0.865 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.16 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.136 0.494 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.12 -25.91 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.371 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 p -155.31 42.48 0.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.461 -0.775 . . . . 0.0 110.135 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.52 96.59 0.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.591 -0.693 . . . . 0.0 110.213 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.61 149.11 42.52 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.593 -0.692 . . . . 0.0 110.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.04 -166.48 0.3 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.344 1.181 . . . . 0.0 110.357 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -90.97 -168.14 2.0 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.541 -0.724 . . . . 0.0 110.09 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.02 64.23 6.61 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.547 -0.72 . . . . 0.0 110.376 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 149.31 53.32 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.248 1.13 . . . . 0.0 110.421 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -123.47 -73.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.688 -0.633 . . . . 0.0 109.935 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 59.2 t -138.87 135.34 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.8 t -147.73 142.1 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 0.0 109.582 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 62.1 t -63.02 105.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.1 p -70.52 -52.88 18.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 110.361 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 mtm105 -158.68 151.84 22.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.556 -0.715 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 tt -110.67 126.54 54.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.721 -0.612 . . . . 0.0 109.701 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m -109.4 152.37 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -139.74 109.04 6.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.271 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.54 167.07 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.667 -0.645 . . . . 0.0 109.887 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 -158.38 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.532 -0.73 . . . . 0.0 110.017 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 p -95.07 -34.48 12.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p -140.24 48.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.462 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.51 168.01 15.2 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -26.48 14.69 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.454 1.239 . . . . 0.0 110.07 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.07 169.13 28.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.97 103.04 1.41 Allowed 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.442 1.233 . . . . 0.0 110.209 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 15.4 mt -64.7 116.16 5.98 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.756 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.83 106.04 17.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.395 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -84.98 127.97 34.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.666 -0.646 . . . . 0.0 109.938 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.28 122.6 25.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.569 -0.707 . . . . 0.0 110.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.417 HD23 ' CG ' ' A' ' 192' ' ' TRP . 3.9 mt -128.59 51.03 2.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 109.933 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -109.89 -70.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -60.88 0.15 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.93 88.66 0.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.6 -0.941 . . . . 0.0 110.316 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 92.1 mt -94.98 -25.93 16.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.378 -0.826 . . . . 0.0 110.5 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -52.35 -23.3 5.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -18.48 35.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.431 -0.793 . . . . 0.0 111.325 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.453 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 13.3 m-30 -61.96 -56.01 23.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.199 -0.938 . . . . 0.0 110.59 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.98 25.1 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 0.0 111.132 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -86.89 9.82 18.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 111.25 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -171.6 148.0 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.166 -0.959 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.2 p -125.3 159.41 31.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.781 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 86' ' ' LEU . 7.3 m-85 -82.15 117.97 22.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 110.261 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.08 154.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.623 -0.673 . . . . 0.0 109.802 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.44 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 1.7 mt -164.76 179.0 6.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.571 -0.706 . . . . 0.0 110.328 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 152.32 24.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -19.56 -69.44 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -143.26 74.21 0.33 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.922 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.47 -173.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 110.116 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -120.79 93.63 4.09 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.413 ' CE2' ' O ' ' A' ' 163' ' ' GLU . 40.5 p90 -109.81 145.72 36.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.367 -0.833 . . . . 0.0 112.329 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 mtt85 -105.33 165.19 11.29 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.2 mt -126.41 135.35 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.664 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 100.53 8.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.826 -0.546 . . . . 0.0 109.579 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 114' ' ' ILE . 46.2 mm -77.28 148.44 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.529 -0.732 . . . . 0.0 110.043 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -131.31 133.84 45.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.425 ' CG ' ' HE3' ' A' ' 126' ' ' MET . 10.4 p90 -157.5 148.92 21.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 110.415 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.3 49.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.64 -0.662 . . . . 0.0 111.158 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.01 99.04 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -129.2 47.97 2.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.41 -0.806 . . . . 0.0 111.608 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -145.09 -64.24 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.78 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -138.4 166.59 23.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.448 -0.783 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.91 102.78 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.673 -0.642 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.13 70.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.762 -0.586 . . . . 0.0 109.745 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.9 p -74.52 94.54 2.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.642 -0.661 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.98 42.11 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.425 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 1.4 ttt -72.28 140.79 48.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.973 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -136.58 159.61 41.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -135.27 97.89 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.39 133.37 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 109.728 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.412 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 28.0 tt0 -131.61 131.57 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.688 . . . . 0.0 110.29 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.5 m-70 -107.97 123.62 48.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 0.0 109.792 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.9 m -83.32 105.57 14.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.538 -0.726 . . . . 0.0 110.047 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 138' ' ' LYS . 8.6 m-85 -96.32 140.19 31.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 112.32 18.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.737 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.5 tptp 53.04 37.14 23.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.261 -0.899 . . . . 0.0 110.63 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.06 21.17 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.9 t -146.91 113.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.985 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -64.12 127.71 32.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.567 -0.708 . . . . 0.0 110.116 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.8 pt -111.35 -26.05 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.56 -0.713 . . . . 0.0 110.655 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -174.43 151.19 1.53 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.455 ' CD ' ' CE1' ' A' ' 131' ' ' HIS . 15.7 pttm -147.72 149.69 32.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -143.32 155.03 44.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.343 -0.848 . . . . 0.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -100.74 113.8 27.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.18 100.33 12.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.451 -0.781 . . . . 0.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.9 ptp -61.63 116.19 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.757 . . . . 0.0 109.693 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 158' ' ' PHE . 47.4 t -80.18 -51.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 0.0 110.286 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.89 178.33 18.68 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 77.6 p -93.37 152.35 19.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.525 -0.985 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -147.65 132.42 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 110.3 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.45 156.39 26.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.52 -171.5 1.13 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.411 1.216 . . . . 0.0 110.537 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 51.42 62.38 2.74 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.62 -0.675 . . . . 0.0 111.156 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -153.25 -94.5 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 110.273 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.34 -154.79 0.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.885 -1.135 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.49 93.41 7.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.411 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 66.1 m-85 -59.92 177.54 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.731 -0.606 . . . . 0.0 110.298 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -146.75 110.15 4.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 146' ' ' VAL . 42.3 t80 -76.85 163.27 26.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.731 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.58 116.99 15.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.517 -0.739 . . . . 0.0 110.687 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.2 p -100.51 145.99 31.26 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.12 171.6 8.71 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.755 1.397 . . . . 0.0 111.361 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -59.73 118.37 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.821 -0.549 . . . . 0.0 111.073 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 1.0 OUTLIER -105.88 124.48 49.64 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.53 136.39 35.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.509 -0.744 . . . . 0.0 110.601 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.06 171.15 9.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.737 -0.602 . . . . 0.0 110.416 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.92 129.31 14.14 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.369 1.194 . . . . 0.0 110.171 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 -178.09 3.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.601 -0.687 . . . . 0.0 110.75 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.68 138.01 8.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.2 ttm -58.98 -30.7 68.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.397 -1.061 . . . . 0.0 110.066 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 170' ' ' LEU . 4.4 mm? -69.37 -35.21 75.6 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.04 -26.92 22.32 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -50.34 155.21 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.14 -156.5 22.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 p -104.51 132.45 50.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -1.001 . . . . 0.0 110.732 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -113.77 103.03 10.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.645 -0.659 . . . . 0.0 110.732 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -66.95 142.11 57.38 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 14.5 mt -132.94 154.99 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 103.19 8.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 0.0 109.845 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.423 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.4 m -97.18 118.13 32.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.49 -0.756 . . . . 0.0 110.437 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.12 109.81 19.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -86.54 154.45 21.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.696 -0.627 . . . . 0.0 110.623 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.4 t -167.76 -156.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.982 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -164.7 -147.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -96.0 29.88 2.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 0.0 109.729 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 186' ' ' ARG . 2.6 t70 -138.93 59.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 185' ' ' ASP . 0.0 OUTLIER 4.23 67.47 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.0 t -142.94 168.99 18.4 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.892 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -105.56 101.06 10.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.502 -0.749 . . . . 0.0 110.215 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.425 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 7.9 m170 -60.35 -56.64 19.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.763 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 17.7 tp -171.43 114.52 0.38 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.704 -0.622 . . . . 0.0 109.837 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -116.59 136.18 53.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.7 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.43 ' HB2' ' CE2' ' A' ' 97' ' ' PHE . 27.1 p90 -134.28 -159.03 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.638 . . . . 0.0 110.083 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -158.88 129.46 6.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 110.641 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 19.1 p-90 -143.55 147.95 35.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -99.09 146.07 26.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.566 -0.709 . . . . 0.0 110.939 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 43.0 tp -109.08 107.37 17.67 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -82.93 106.95 15.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 110.769 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.05 143.5 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 109.393 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -137.3 -160.25 1.04 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 110.027 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -19.48 8.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 111.055 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -152.54 60.87 0.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 110.952 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.462 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -62.43 -15.3 48.61 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.269 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.76 37.7 3.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.273 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.165 0.507 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.8 t 53.51 90.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.398 -0.814 . . . . 0.0 110.662 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.6 173.54 6.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.587 -0.696 . . . . 0.0 110.144 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.66 47.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.567 -0.708 . . . . 0.0 110.196 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 37.57 53.73 3.27 Favored Pre-proline 0 N--CA 1.51 2.558 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.33 -165.37 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.449 1.236 . . . . 0.0 110.43 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.9 176.91 0.36 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.586 -0.696 . . . . 0.0 110.147 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.3 t -96.45 143.34 25.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.416 -0.802 . . . . 0.0 110.033 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.98 159.5 44.6 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.353 1.186 . . . . 0.0 110.431 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -168.04 -60.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.715 . . . . 0.0 110.278 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 61.1 t -121.97 128.46 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.7 t -148.96 139.62 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 t -64.08 103.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.9 p -69.95 -50.06 45.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.504 -0.748 . . . . 0.0 110.568 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.67 174.64 14.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 110.814 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 6.8 tt -140.65 123.77 16.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.722 -0.611 . . . . 0.0 109.643 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.8 m -109.71 162.89 14.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.517 -0.739 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.85 118.31 8.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 110.534 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.39 153.06 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.6 t -147.16 25.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 81' ' ' THR . 1.4 p 67.03 -61.19 0.34 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.533 -0.729 . . . . 0.0 110.977 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.4 ' N ' ' OG ' ' A' ' 80' ' ' SER . 20.1 p -98.97 30.97 3.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.159 -0.963 . . . . 0.0 109.964 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' HB3' ' CH2' ' A' ' 202' ' ' TRP . . . -90.19 165.98 21.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.691 -0.63 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.74 -26.4 19.36 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.439 1.231 . . . . 0.0 110.221 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.11 165.86 25.22 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.01 97.42 0.83 Allowed 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.466 1.245 . . . . 0.0 110.29 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 102' ' ' PHE . 20.3 mt -64.63 114.57 4.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.688 -0.632 . . . . 0.0 109.632 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -100.95 122.46 43.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.633 -0.667 . . . . 0.0 110.602 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 9.6 mt -97.6 166.17 11.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.702 -0.624 . . . . 0.0 109.88 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.96 126.58 54.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.527 -0.733 . . . . 0.0 110.478 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.436 ' CD2' ' CD2' ' A' ' 192' ' ' TRP . 1.7 mt -128.13 49.31 2.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.581 -0.699 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 p -133.67 51.69 2.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.32 -65.16 0.26 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.1 71.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.96 . . . . 0.0 110.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 72.9 mt -90.08 -26.85 20.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.565 -0.709 . . . . 0.0 110.347 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.19 -22.05 15.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.25 -0.906 . . . . 0.0 111.074 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 p -58.23 -20.62 43.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 0.0 110.983 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 18.1 m-85 -58.37 -65.28 0.68 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.315 -0.866 . . . . 0.0 110.608 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -56.23 -20.73 19.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.525 -0.734 . . . . 0.0 111.207 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -86.93 11.65 12.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 111.323 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.76 143.13 2.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -133.16 137.07 46.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.66 . . . . 0.0 109.721 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.426 ' CD1' HD23 ' A' ' 86' ' ' LEU . 22.5 m-85 -79.22 118.6 21.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -0.79 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.97 155.53 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.25 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 2.1 mt -153.07 -171.38 3.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.756 . . . . 0.0 110.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.423 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 24.1 tttm -130.65 161.41 31.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.671 0.748 . . . . 0.0 109.857 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.81 106.37 0.06 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 37.28 69.42 0.3 Allowed Glycine 0 N--CA 1.503 3.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.698 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 35.8 m -86.65 149.85 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.266 -1.137 . . . . 0.0 109.692 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -79.94 90.58 5.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 37.4 p90 -109.34 141.58 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.562 -0.711 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.49 163.49 13.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.638 -0.664 . . . . 0.0 109.344 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.0 mm -117.75 135.1 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.371 -0.831 . . . . 0.0 110.071 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -119.64 115.11 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.28 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 128' ' ' TYR . 43.3 mm -100.72 150.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 111.156 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.5 m -131.21 122.09 25.95 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 31.1 p90 -137.83 135.15 35.95 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.785 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.09 140.07 32.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 111.046 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.47 95.93 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.724 -0.61 . . . . 0.0 109.367 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -129.2 48.69 2.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 111.427 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.93 -68.7 0.18 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.25 -0.906 . . . . 0.0 110.849 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -136.82 174.7 10.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.82 . . . . 0.0 110.519 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.3 mp -80.41 121.62 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.738 -0.601 . . . . 0.0 110.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.8 77.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.692 -0.63 . . . . 0.0 109.531 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.4 p -81.47 84.95 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.59 -0.694 . . . . 0.0 110.666 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.68 44.55 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.0 mmm -73.76 148.56 42.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.446 -1.032 . . . . 0.0 109.627 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.24 136.16 36.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.447 -0.783 . . . . 0.0 110.941 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.421 ' CZ ' HD13 ' A' ' 114' ' ' ILE . 48.2 t80 -122.2 106.18 10.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.772 -0.58 . . . . 0.0 109.484 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.5 mt -102.08 166.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -155.11 138.69 16.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.643 -0.661 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.437 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.1 m-70 -109.34 140.82 42.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.742 . . . . 0.0 109.645 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 m -103.43 78.83 1.64 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.454 -0.779 . . . . 0.0 110.062 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 131' ' ' HIS . 21.1 m-85 -90.57 120.13 31.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.43 142.42 35.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.518 -0.739 . . . . 0.0 110.491 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.67 33.79 17.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.97 27.07 66.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.03 112.55 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.435 -1.038 . . . . 0.0 109.846 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 113.65 5.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.575 -0.703 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.21 -66.12 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.629 -0.669 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.54 171.94 8.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.553 -0.717 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -126.86 168.4 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.596 -0.69 . . . . 0.0 109.557 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.4 m -131.4 117.38 18.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.498 -0.752 . . . . 0.0 110.522 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.24 116.25 28.62 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 0.0 109.821 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -114.27 142.1 46.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 ttp -98.05 123.8 42.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.75 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.419 HG23 ' CZ ' ' A' ' 181' ' ' PHE . 45.7 t -80.0 -53.71 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.518 -0.739 . . . . 0.0 110.188 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.61 -173.36 21.22 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.9 p -93.35 145.9 24.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.946 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -147.48 125.91 12.38 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.0 110.185 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.61 163.99 25.18 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 83.83 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.415 1.218 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.02 -66.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.618 -0.676 . . . . 0.0 110.17 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.87 132.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.489 -0.757 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 53.05 -157.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.403 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.22 171.06 7.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.58 -0.7 . . . . 0.0 111.031 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.3 m-85 -109.71 176.92 4.89 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -131.71 108.95 9.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.813 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 160' ' ' THR . 11.4 t80 -82.77 168.05 17.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 109.591 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.86 90.12 1.44 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.466 -0.771 . . . . 0.0 110.693 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 158' ' ' PHE . 37.6 p -76.76 158.11 81.09 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.59 158.42 50.05 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.699 1.368 . . . . 0.0 111.109 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -56.61 137.7 53.44 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.299 0.571 . . . . 0.0 111.156 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 3.1 tp10 -120.51 119.6 33.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.817 -0.552 . . . . 0.0 109.557 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.69 133.48 49.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.74 179.62 1.49 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.21 123.75 9.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.192 1.101 . . . . 0.0 110.35 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -115.11 -175.2 2.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.557 -0.714 . . . . 0.0 110.462 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.31 18.83 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -59.5 -27.44 66.15 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.51 29.51 3.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.33 18.94 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.531 -0.731 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -100.13 132.89 45.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.392 -0.817 . . . . 0.0 110.0 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.7 177.88 23.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -84.95 126.23 33.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.724 -0.868 . . . . 0.0 110.747 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -107.33 115.87 30.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 0.0 109.883 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -75.08 122.86 24.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.593 -0.692 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 20.4 mt -116.31 152.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.762 . . . . 0.0 110.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.44 117.92 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.641 -0.662 . . . . 0.0 110.356 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.421 ' HB3' ' CZ2' ' A' ' 192' ' ' TRP . 17.5 t -114.23 163.15 15.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.343 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.15 108.13 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.776 -0.577 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -80.77 116.37 20.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.998 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 82.2 p -125.03 173.53 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.679 . . . . 0.0 109.861 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -145.33 179.4 7.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.678 . . . . 0.0 110.22 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -96.46 55.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.487 -0.758 . . . . 0.0 110.211 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -135.68 -64.37 0.63 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.553 -0.717 . . . . 0.0 110.511 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.87 -76.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.652 -0.655 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t -156.1 -160.06 0.96 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.502 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.32 117.32 13.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.599 -0.688 . . . . 0.0 109.796 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m-70 -59.6 -44.62 93.34 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 110.531 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 15.8 tp -162.61 156.24 20.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.461 -0.774 . . . . 0.0 110.399 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.6 p -145.16 150.72 37.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.641 -0.662 . . . . 0.0 109.946 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.436 ' CD2' ' CD2' ' A' ' 90' ' ' LEU . 14.8 p90 -147.19 -153.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.574 -0.704 . . . . 0.0 110.391 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -169.09 140.26 2.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.528 -0.733 . . . . 0.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 49.7 p-90 -145.4 147.23 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.541 -0.724 . . . . 0.0 110.384 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -87.65 165.11 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.711 -0.618 . . . . 0.0 110.949 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 24.8 tp -143.51 105.39 4.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.81 -0.557 . . . . 0.0 109.582 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.3 m -79.33 127.08 31.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.272 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -99.78 159.48 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -150.59 -153.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.518 -0.739 . . . . 0.0 110.201 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -16.36 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -0.806 . . . . 0.0 111.445 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -160.07 61.62 0.35 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.123 -0.985 . . . . 0.0 111.291 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -66.27 -11.63 51.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.385 -0.822 . . . . 0.0 111.712 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 29.57 6.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.443 179.456 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.039 0.447 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.32 166.36 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.621 -0.674 . . . . 0.0 110.285 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -164.04 -68.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.98 -175.15 4.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.602 -0.686 . . . . 0.0 110.237 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.13 152.13 37.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.67 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.48 -165.73 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.426 1.224 . . . . 0.0 110.485 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.14 -168.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t 53.73 69.61 2.14 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.463 -0.773 . . . . 0.0 110.474 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.69 -165.5 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.052 0 O-C-N 123.429 1.226 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -73.88 -82.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.596 -0.69 . . . . 0.0 109.967 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -135.72 133.71 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.628 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.3 t -137.31 155.42 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 46.2 t -66.55 100.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.217 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.2 p -70.81 -55.8 7.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.747 -0.596 . . . . 0.0 110.396 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -153.69 157.01 38.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.511 -0.743 . . . . 0.0 110.264 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' A' ' 76' ' ' THR . 9.6 tt -125.31 161.28 27.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.606 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 13.3 m -146.85 164.93 31.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.555 -0.715 . . . . 0.0 110.579 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -140.32 100.75 3.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.502 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.95 144.24 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.72 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 m -150.03 -167.38 2.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -76.21 0.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -0.775 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -94.99 36.82 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.397 -0.814 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.37 172.83 6.39 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.29 -27.46 19.6 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.218 1.115 . . . . 0.0 109.87 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.58 -174.46 38.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.89 92.94 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.575 1.303 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 22.3 mt -64.32 104.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 1.3 pt-20 -104.56 159.68 15.56 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.118 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.45 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -131.11 136.47 48.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.967 -0.458 . . . . 0.0 109.967 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.416 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 12.0 t70 -82.97 131.73 35.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -129.05 53.63 1.86 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 109.837 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 p -122.87 -58.37 1.66 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.517 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.67 -63.37 0.1 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.83 78.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.986 . . . . 0.0 110.292 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -28.17 15.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 110.285 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.7 -31.14 69.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.571 -0.705 . . . . 0.0 110.932 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -57.9 -19.95 33.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.391 -0.818 . . . . 0.0 110.956 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.45 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 6.0 m-85 -62.71 -65.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.393 -0.817 . . . . 0.0 110.467 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -57.9 -20.15 34.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.0 110.942 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -22.41 26.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.409 -0.807 . . . . 0.0 110.748 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -129.91 132.44 46.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.277 -0.889 . . . . 0.0 110.569 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -115.24 148.05 39.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 109.841 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 5.6 m-85 -74.38 154.76 38.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.79 113.02 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 0.0 110.358 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 202' ' ' TRP . 10.1 mt -113.7 -172.83 2.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.602 -0.686 . . . . 0.0 109.553 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 37.7 tttm -121.85 167.27 13.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.791 . . . . 0.0 109.756 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -42.01 108.93 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.24 69.24 0.43 Allowed Glycine 0 N--CA 1.502 3.068 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.259 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 34.4 m -93.77 142.83 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -1.142 . . . . 0.0 110.086 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.73 107.19 10.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.401 -0.812 . . . . 0.0 109.192 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 163' ' ' GLU . 30.0 p90 -123.61 146.77 47.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.683 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -106.62 162.2 13.96 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -122.84 163.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.849 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -150.08 108.99 3.87 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.9 mm -98.02 146.73 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.54 -0.725 . . . . 0.0 110.807 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.36 145.51 51.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.639 -0.663 . . . . 0.0 109.639 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.42 ' CE1' ' HE3' ' A' ' 126' ' ' MET . 21.5 p90 -154.88 150.33 27.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 111.129 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.85 151.85 22.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.792 -0.568 . . . . 0.0 111.113 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.91 99.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.674 -0.641 . . . . 0.0 109.554 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.71 48.75 2.34 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -148.29 -77.78 0.16 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.185 -0.947 . . . . 0.0 110.841 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.83 -177.85 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.353 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 122' ' ' ILE . 77.3 mt -74.15 106.05 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.084 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.22 76.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.662 -0.648 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.2 98.59 7.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.449 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 128.48 40.83 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.42 ' HE3' ' CE1' ' A' ' 116' ' ' PHE . 0.9 OUTLIER -78.27 124.44 28.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -1.054 . . . . 0.0 109.503 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -123.33 142.65 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.997 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -117.48 86.99 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 0.0 109.413 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -79.06 140.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 110.044 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.7 137.6 29.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -107.05 154.96 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.74 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 57.1 m -116.4 64.47 0.71 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.398 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -75.25 139.48 42.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.382 -0.824 . . . . 0.0 109.828 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -120.68 -152.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.485 -0.76 . . . . 0.0 110.277 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.66 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.411 -0.806 . . . . 0.0 111.783 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.58 13.34 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.514 -0.741 . . . . 0.0 111.584 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -134.29 116.1 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 119.62 19.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.702 -0.624 . . . . 0.0 110.152 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 58.6 mt -89.62 -72.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.645 -0.659 . . . . 0.0 109.85 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.32 166.49 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.472 -0.767 . . . . 0.0 110.393 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 157.74 42.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.271 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.2 m -125.24 143.69 50.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.562 -0.711 . . . . 0.0 110.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.57 75.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.631 -0.668 . . . . 0.0 109.892 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -64.72 146.43 54.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.455 -0.778 . . . . 0.0 110.685 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -106.74 123.67 48.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.641 -0.662 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.411 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 61.6 t -79.8 -55.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.544 -0.722 . . . . 0.0 110.015 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.92 176.6 14.48 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.9 p -86.72 151.06 23.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.626 -0.926 . . . . 0.0 110.091 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -148.35 130.57 15.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.551 -0.718 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.54 157.16 32.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.01 94.76 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.389 1.205 . . . . 0.0 110.418 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -91.81 -78.23 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.559 -0.713 . . . . 0.0 109.91 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -172.6 -38.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -107.94 -161.8 0.79 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.0 110.672 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 168.81 9.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 30.0 m-85 -108.57 -178.47 3.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.773 -0.579 . . . . 0.0 109.649 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -138.86 99.51 3.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.931 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 34.5 t80 -84.16 171.46 12.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.259 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.66 131.74 4.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 111.172 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.5 p -97.31 151.73 37.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.84 -170.16 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.714 1.376 . . . . 0.0 111.203 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.2 ptm -54.43 145.25 18.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 111.266 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 4.6 tt0 -144.5 84.21 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.68 -0.638 . . . . 0.0 109.636 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.67 135.46 55.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 110.692 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.83 179.99 1.45 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.611 -0.681 . . . . 0.0 109.816 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.63 135.91 22.63 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.273 1.143 . . . . 0.0 110.211 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -110.99 -179.33 3.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.713 . . . . 0.0 110.435 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.08 156.35 18.94 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.1 ttp -61.44 -26.97 68.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.155 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.61 -24.76 33.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.568 -0.708 . . . . 0.0 110.499 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.07 -25.42 63.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.431 -0.793 . . . . 0.0 110.52 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -60.5 123.85 18.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.426 -0.796 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 159.53 -179.84 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -95.1 135.63 36.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.66 -0.906 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.05 108.56 14.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 109.921 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -71.28 122.37 20.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.636 -0.665 . . . . 0.0 110.113 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.3 mt -113.32 127.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -99.35 112.11 24.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.695 . . . . 0.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 4.0 m -105.65 130.06 53.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.634 -0.667 . . . . 0.0 110.217 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 99.68 6.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.685 . . . . 0.0 110.183 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.453 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 2.0 t80 -75.57 121.38 22.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 0.0 109.835 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.4 p -152.63 162.27 41.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 110.478 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -98.55 -162.32 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.597 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -58.42 8.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.65 24.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.857 -0.527 . . . . 0.0 110.741 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -37.66 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 109.405 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.6 t -179.18 -166.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.118 0.485 . . . . 0.0 109.969 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.41 115.24 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.626 . . . . 0.0 109.607 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.49 -59.94 3.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.5 tp -167.61 170.55 11.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.449 -0.782 . . . . 0.0 110.484 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.7 t -163.85 125.29 2.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.725 -0.609 . . . . 0.0 109.872 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.425 ' CD2' HD22 ' A' ' 90' ' ' LEU . 20.5 p90 -140.16 -153.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.704 . . . . 0.0 110.304 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.11 134.25 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 110.649 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.36 146.95 42.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.674 -0.641 . . . . 0.0 109.893 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.66 141.3 29.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.628 -0.67 . . . . 0.0 111.181 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.84 108.83 19.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -88.47 122.08 31.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.771 . . . . 0.0 110.656 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.9 mm -94.32 156.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 109.486 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -138.23 -162.33 1.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.748 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 -24.43 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 110.682 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -160.01 77.36 0.65 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.387 -0.821 . . . . 0.0 110.994 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.463 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -70.51 -7.03 40.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.452 -0.78 . . . . 0.0 111.693 179.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -155.28 51.45 0.59 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.107 -0.995 . . . . 0.0 110.288 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.122 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.092 0.472 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.6 t 56.83 166.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.695 -0.628 . . . . 0.0 110.515 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.15 110.31 22.6 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.832 . . . . 0.0 110.289 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.97 -157.13 0.75 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.715 . . . . 0.0 110.143 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 t70 61.75 120.24 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.462 -0.774 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.01 -165.29 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 122.881 0.938 . . . . 0.0 110.487 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -59.79 125.14 22.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.37 143.69 45.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.524 -0.735 . . . . 0.0 110.18 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.09 -163.89 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.288 1.151 . . . . 0.0 110.408 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' CB ' ' CB ' ' A' ' 120' ' ' ARG . 7.4 p-10 -132.97 18.69 4.12 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.426 -0.796 . . . . 0.0 111.419 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.6 31.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 110.817 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.58 141.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.676 -0.64 . . . . 0.0 110.055 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' CG2' ' CD2' ' A' ' 181' ' ' PHE . 58.5 t -63.73 125.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.637 -0.664 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -82.03 -58.92 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.903 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.58 155.42 26.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.97 133.84 53.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.606 -0.684 . . . . 0.0 109.784 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -109.64 155.66 21.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.542 -0.724 . . . . 0.0 110.924 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -141.57 107.96 5.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.614 -0.679 . . . . 0.0 110.058 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.79 160.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.972 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.8 t -147.27 -80.73 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -170.81 -45.49 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.346 -0.846 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 p -123.86 34.76 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 110.118 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -87.59 173.06 6.93 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.29 -28.6 15.05 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.474 1.25 . . . . 0.0 110.077 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.35 170.97 30.01 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.1 102.83 1.4 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.526 1.277 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 8.2 mt -64.73 121.23 14.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 109.68 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.84 103.41 15.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.668 -0.645 . . . . 0.0 110.247 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.466 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 2.9 tt -80.2 119.82 23.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 110.176 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.47 129.42 37.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.422 ' CD2' ' CE2' ' A' ' 192' ' ' TRP . 6.0 mt -133.71 53.6 2.0 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.561 -0.712 . . . . 0.0 110.039 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.3 p -140.31 -43.53 0.41 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.656 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.11 -117.85 4.25 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 114.83 3.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.627 -0.925 . . . . 0.0 110.334 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 24.3 mt -92.27 -30.46 15.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -66.13 -12.69 57.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.804 . . . . 0.0 111.096 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -56.45 -20.27 19.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.111 -0.993 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.466 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 3.1 m-85 -67.99 -31.68 71.56 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.312 -0.868 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -61.49 -35.29 77.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 110.723 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -87.1 -25.2 24.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.61 126.26 46.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.468 -0.77 . . . . 0.0 110.477 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -115.38 159.77 20.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 88' ' ' LEU . 11.3 m-85 -83.27 114.64 21.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.93 118.28 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.693 -0.63 . . . . 0.0 110.51 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 82.1 mt -129.89 159.15 37.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.575 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 18.9 tttt -85.9 169.02 13.67 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -39.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 41.58 72.84 0.24 Allowed Glycine 0 N--CA 1.501 2.985 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.898 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 33.1 m -86.5 125.77 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -1.037 . . . . 0.0 110.077 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.05 90.77 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.199 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' CD1' HD21 ' A' ' 77' ' ' LEU . 11.9 p90 -109.63 150.37 28.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.156 -0.965 . . . . 0.0 111.573 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -98.04 147.07 24.9 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.1 mt -111.04 132.56 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.326 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -115.38 98.63 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.782 -0.574 . . . . 0.0 109.559 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -78.08 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.695 -0.628 . . . . 0.0 110.432 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.5 m -114.81 141.44 47.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 116' ' ' PHE . 12.9 p90 -153.87 144.65 22.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.415 -0.803 . . . . 0.0 110.968 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -87.17 132.53 33.84 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.246 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.94 95.12 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -128.15 40.12 3.72 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.596 -0.841 . . . . 0.0 112.692 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -161.31 -67.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.08 -1.013 . . . . 0.0 110.919 179.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -124.38 166.07 16.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 110.911 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 165.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.263 0.554 . . . . 0.0 110.031 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.39 54.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.699 -0.625 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.92 104.95 2.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.661 -0.649 . . . . 0.0 110.35 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.14 46.27 0.95 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.458 ' HE3' ' CG ' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -87.6 132.27 34.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.599 -0.942 . . . . 0.0 109.486 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.22 164.55 17.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.478 -0.764 . . . . 0.0 111.019 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -136.43 102.06 4.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.861 -0.524 . . . . 0.0 109.748 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -82.27 164.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 0.0 109.994 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -167.96 117.71 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.307 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 10.7 m170 -101.7 159.31 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.718 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 m -117.55 69.85 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.458 -0.777 . . . . 0.0 109.959 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 19.7 m-85 -66.2 123.72 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.417 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -126.09 134.13 51.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 110.395 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm 52.69 28.15 5.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.21 -16.61 55.36 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.6 m -106.02 156.24 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.118 -1.225 . . . . 0.0 110.576 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -86.37 134.34 33.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.676 . . . . 0.0 109.887 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.02 -25.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 110.956 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -175.79 144.45 0.63 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.225 -0.922 . . . . 0.0 110.537 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.64 152.44 50.43 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.7 m -136.27 153.45 51.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 111.374 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.69 116.37 26.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.43 114.69 29.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.981 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.4 ttt -74.64 120.07 19.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 158' ' ' PHE . 51.3 t -79.64 -68.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.403 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.57 -163.23 29.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.2 p -104.77 148.04 27.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.906 . . . . 0.0 110.256 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.74 125.84 12.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.501 -0.75 . . . . 0.0 110.154 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.65 156.61 23.26 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.36 94.13 0.67 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.406 1.214 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -86.31 -67.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.681 . . . . 0.0 110.11 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.79 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.68 -152.29 0.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 110.634 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -99.97 168.05 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -111.46 -170.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.65 -0.656 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.54 114.12 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.693 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 146' ' ' VAL . 37.7 t80 -89.64 164.73 14.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 109.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -135.75 117.41 14.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.531 -0.73 . . . . 0.0 110.656 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.6 p -102.23 147.77 34.44 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.611 -0.68 . . . . 0.0 109.297 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.21 -173.44 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.821 1.432 . . . . 0.0 111.735 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -52.67 140.67 22.82 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.472 0.653 . . . . 0.0 111.773 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 3.5 tp10 -138.42 82.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.61 137.18 58.0 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.541 0.686 . . . . 0.0 110.8 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.42 -178.7 1.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.09 124.94 10.44 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.187 1.098 . . . . 0.0 110.198 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -115.26 178.96 4.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.571 -0.706 . . . . 0.0 110.662 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.44 150.83 10.66 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 5.8 ttt -59.59 -28.83 67.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.418 -1.049 . . . . 0.0 110.025 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.2 23.96 8.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.784 . . . . 0.0 110.325 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.41 24.61 7.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -98.59 131.45 44.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 110.009 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.33 -174.26 27.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.5 p -87.6 122.84 31.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.943 . . . . 0.0 110.659 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 19.4 m-85 -103.67 107.33 18.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -66.0 133.33 50.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.596 -0.69 . . . . 0.0 110.093 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.7 mt -124.87 141.58 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.493 -0.755 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -114.12 115.06 26.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.637 -0.664 . . . . 0.0 110.211 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.5 m -113.8 157.63 22.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 110.15 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.31 101.52 4.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.452 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 2.2 t80 -75.56 92.46 2.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.644 . . . . 0.0 110.096 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.7 t -127.28 179.75 5.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.274 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.34 -147.17 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.54 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -71.5 -39.7 70.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.988 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.91 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.819 -0.551 . . . . 0.0 111.575 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -51.8 13.66 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.271 -0.893 . . . . 0.0 111.824 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.1 t -175.58 -175.05 0.75 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.514 -0.741 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.84 116.52 28.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.715 -0.616 . . . . 0.0 109.413 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -57.65 -49.52 76.2 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.433 -0.792 . . . . 0.0 110.703 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.8 tp -168.35 158.91 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.5 -0.75 . . . . 0.0 110.463 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 140.28 22.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.92 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.422 ' CE2' ' CD2' ' A' ' 90' ' ' LEU . 15.3 p90 -146.52 -155.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.581 -0.699 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -161.68 130.23 4.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.688 -0.633 . . . . 0.0 110.169 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.468 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 11.0 p-90 -137.49 145.96 43.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.498 -0.751 . . . . 0.0 110.066 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -90.13 155.88 18.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.511 0.672 . . . . 0.0 111.122 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.3 tp -121.18 95.42 4.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.777 -0.577 . . . . 0.0 109.614 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -68.91 122.6 18.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.672 . . . . 0.0 110.304 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -101.39 153.51 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 109.796 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -148.55 -157.09 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.615 -0.678 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -18.42 7.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.786 . . . . 0.0 111.355 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.8 73.73 1.08 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.0 111.079 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.59 -4.19 32.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.727 . . . . 0.0 111.569 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 37.51 4.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 110.25 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.334 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.137 0.494 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 36.0 m -112.86 -168.43 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.49 -0.756 . . . . 0.0 110.348 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -155.62 99.88 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 0.0 110.203 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 -58.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.561 -0.712 . . . . 0.0 110.22 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.98 161.98 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.938 -0.476 . . . . 0.0 110.689 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.84 -165.41 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.235 1.124 . . . . 0.0 110.385 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -60.47 -168.63 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.562 -0.711 . . . . 0.0 110.163 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 p -148.35 69.5 10.54 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.21 135.89 25.74 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.327 1.172 . . . . 0.0 110.342 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -77.32 -71.89 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 110.17 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 90.6 t -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -147.54 147.41 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.765 -0.584 . . . . 0.0 109.827 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 43.2 t -68.13 113.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.627 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.8 p -77.29 -33.44 55.77 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.118 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -168.63 160.27 10.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.708 . . . . 0.0 110.324 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 tt -128.29 134.75 48.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.655 -0.653 . . . . 0.0 109.886 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -109.6 162.29 14.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.541 -0.724 . . . . 0.0 110.146 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.84 95.69 2.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.771 . . . . 0.0 110.195 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.6 t -105.19 167.32 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.857 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.8 t -159.55 -82.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.651 -0.656 . . . . 0.0 110.134 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -71.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.865 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 p -98.59 31.5 2.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -85.13 169.95 14.78 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.706 . . . . 0.0 110.088 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.6 -27.44 18.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.393 1.207 . . . . 0.0 110.24 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.56 170.57 26.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.84 104.37 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.497 1.262 . . . . 0.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.91 128.48 35.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 109.817 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -103.55 113.17 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.681 -0.637 . . . . 0.0 110.323 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' CZ ' ' A' ' 97' ' ' PHE . 1.2 tt -100.01 105.71 17.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 110.154 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -65.69 137.71 57.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.689 -0.632 . . . . 0.0 109.729 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.0 mt -135.6 56.8 1.82 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.753 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.0 p -115.75 -68.53 0.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.768 -0.582 . . . . 0.0 110.493 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 -58.18 0.18 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.45 74.81 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.969 . . . . 0.0 110.323 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.2 mt -95.46 -22.38 17.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 0.0 110.805 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.43 -1.13 28.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.345 -0.847 . . . . 0.0 111.561 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -90.06 0.37 57.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.175 -0.953 . . . . 0.0 111.288 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CZ ' HD21 ' A' ' 88' ' ' LEU . 51.8 m-85 -94.09 -32.22 13.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.114 -0.991 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -59.1 -19.72 47.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -88.07 -24.75 23.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 110.535 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.68 -179.88 3.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.429 -0.794 . . . . 0.0 110.54 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -167.31 142.88 4.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.536 -0.727 . . . . 0.0 110.146 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.09 121.72 25.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.859 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.84 123.47 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 110.341 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.42 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 55.0 mt -124.19 178.74 5.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 19.7 tttm -104.2 150.97 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.815 0.817 . . . . 0.0 109.514 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.6 pt-20 -50.63 124.5 11.0 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.56 48.99 72.77 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.626 -0.671 . . . . 0.0 113.343 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 28.0 m -97.01 133.21 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.975 1.388 . . . . 0.0 109.678 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.44 94.77 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 40.8 p90 -118.32 142.03 47.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 0.0 111.361 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.19 163.37 12.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.612 -0.68 . . . . 0.0 109.176 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.42 151.59 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.015 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -128.91 117.9 21.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.14 144.98 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.758 . . . . 0.0 110.662 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -123.72 147.54 47.38 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.454 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 34.1 p90 -168.37 161.29 11.89 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -113.0 144.59 42.31 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.843 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.79 98.89 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -128.7 49.01 2.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 0.0 111.046 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -75.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -138.28 160.22 40.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.5 mt -63.57 104.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.74 -0.6 . . . . 0.0 109.921 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.33 76.35 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.612 -0.68 . . . . 0.0 109.636 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.0 p -77.68 85.48 4.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.37 48.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -85.12 131.05 34.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.558 -0.966 . . . . 0.0 109.481 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.5 162.34 25.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.63 -0.669 . . . . 0.0 111.051 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -136.38 108.28 7.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 129' ' ' ILE . 77.2 mt -102.76 161.94 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 0.0 110.063 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -159.3 134.88 8.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.594 -0.691 . . . . 0.0 110.28 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.4 m-70 -111.23 130.68 55.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 84.3 m -84.33 72.59 10.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.849 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.403 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 4.4 m-85 -64.11 137.35 57.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 110.495 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.424 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 14.8 ttm180 -120.91 107.76 13.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.634 . . . . 0.0 109.925 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 53.27 37.09 24.39 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.399 -0.813 . . . . 0.0 110.584 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.47 19.87 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.7 t -147.24 111.41 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 126.47 28.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.73 -22.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.558 -0.714 . . . . 0.0 110.798 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -167.91 132.48 1.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.595 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.43 ' CE ' ' CE1' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -139.98 144.51 37.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.2 m -132.42 164.72 25.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 110.744 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.53 115.39 23.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.748 -0.595 . . . . 0.0 109.877 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.17 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 ttm -98.27 117.99 33.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.542 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.414 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 47.4 t -79.7 -63.21 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.786 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 143.77 178.43 19.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.2 p -87.77 149.13 24.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.909 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' A' ' 156' ' ' TYR . 76.3 m-85 -147.82 132.57 17.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.333 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.95 159.5 24.57 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.13 94.22 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.399 1.21 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -116.51 23.35 12.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 110.6 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 52.49 23.64 2.64 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.339 -0.851 . . . . 0.0 111.213 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -126.97 169.15 13.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.573 -0.704 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -100.19 163.33 12.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.604 . . . . 0.0 110.398 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.474 ' CD2' ' CD1' ' A' ' 149' ' ' TYR . 64.2 m-85 -122.88 170.57 9.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.644 -0.66 . . . . 0.0 109.954 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -136.23 103.36 5.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 160' ' ' THR . 24.4 t80 -88.18 148.34 24.45 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -133.53 111.3 10.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 110.641 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 158' ' ' PHE . 77.6 p -85.83 151.67 55.43 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.56 -0.712 . . . . 0.0 109.62 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.78 165.62 22.82 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.441 1.232 . . . . 0.0 111.093 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 mtm -54.64 168.63 0.26 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.714 -0.616 . . . . 0.0 110.755 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -155.55 140.2 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.741 -0.599 . . . . 0.0 109.775 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 129.9 42.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.591 -0.693 . . . . 0.0 110.974 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.93 178.56 2.09 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.612 -0.68 . . . . 0.0 110.25 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.39 -173.12 1.2 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.448 1.236 . . . . 0.0 110.606 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 13.8 mmtt -78.39 -176.53 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.51 -0.744 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.402 ' N ' ' CB ' ' A' ' 106' ' ' GLU . . . -95.18 -60.88 1.04 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 12.2 mmt -60.9 141.7 56.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.962 . . . . 0.0 109.44 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt 66.15 -64.27 0.22 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.673 -0.642 . . . . 0.0 110.393 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.5 -17.83 35.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 111.177 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.15 27.78 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.082 -1.011 . . . . 0.0 110.285 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.63 177.88 15.13 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.7 p -88.19 134.21 33.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.544 -0.974 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 15.9 m-85 -116.94 116.81 28.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.544 -0.722 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -61.66 145.82 51.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.427 HG22 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -125.18 108.23 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.502 -0.749 . . . . 0.0 110.361 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 1.6 ttpt -88.2 95.61 10.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.493 -0.754 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 125.29 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.48 -0.762 . . . . 0.0 110.114 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -116.01 107.8 15.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.45 -0.782 . . . . 0.0 110.35 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 2.2 t80 -83.82 136.68 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.714 -0.616 . . . . 0.0 109.741 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.0 t -172.77 -173.58 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.557 -0.714 . . . . 0.0 110.42 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.49 -155.5 0.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -171.56 27.65 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.937 -0.477 . . . . 0.0 110.642 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -79.18 -37.28 38.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.768 . . . . 0.0 110.283 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.19 -161.53 0.06 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.705 -0.622 . . . . 0.0 109.971 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -115.25 118.87 34.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.579 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.421 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 14.4 m-70 -73.23 -65.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 110.699 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.0 tp -168.42 151.49 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.797 . . . . 0.0 110.5 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.6 m -149.0 146.5 27.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.015 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -140.05 -162.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -154.44 121.89 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.401 -0.812 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.427 ' CZ2' HG22 ' A' ' 177' ' ' ILE . 30.5 p-90 -132.23 148.35 52.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.692 -0.63 . . . . 0.0 109.553 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.49 148.56 23.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.483 -0.76 . . . . 0.0 111.489 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.52 102.1 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -75.2 132.07 40.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 0.0 110.724 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.95 147.75 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.76 -159.08 0.96 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.694 -0.629 . . . . 0.0 110.129 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.58 -8.43 4.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.96 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -155.19 63.13 0.63 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.947 -1.095 . . . . 0.0 111.516 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.446 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -72.17 -6.77 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.263 -0.898 . . . . 0.0 111.241 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -162.21 47.92 0.17 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.134 -179.884 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.542 ' OD1' HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 123' ' ' VAL . 86.0 t -125.51 119.15 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.9 t -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG12 HD12 ' A' ' 90' ' ' LEU . 53.4 t -61.35 110.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.726 . . . . 0.0 109.142 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.858 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.8 p -76.2 -41.27 50.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -167.38 163.76 15.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.287 -0.883 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -121.44 125.93 48.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 85' ' ' PRO . 12.8 m -109.97 154.78 22.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 111.032 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 86' ' ' LEU . 6.2 mt -138.71 92.02 2.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.35 130.8 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.713 -0.617 . . . . 0.0 110.654 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.7 m -128.05 -3.13 5.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.713 -0.617 . . . . 0.0 111.145 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.83 18.7 3.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.951 -1.093 . . . . 0.0 111.29 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.5 p -142.26 -45.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.757 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -57.77 -179.18 0.11 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.749 -0.594 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -73.85 -17.31 22.81 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.531 1.279 . . . . 0.0 110.238 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.7 171.61 35.45 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.924 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.8 Cg_endo -72.56 122.26 8.11 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.778 1.409 . . . . 0.0 110.728 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 102' ' ' PHE . 6.3 mt -68.66 117.66 10.67 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.149 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.99 112.8 25.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.633 -0.667 . . . . 0.0 110.64 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' TRP . 1.3 tt -101.07 101.66 12.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.554 -0.716 . . . . 0.0 109.988 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.6 t0 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.553 -0.717 . . . . 0.0 110.33 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.48 HD21 HD22 ' A' ' 88' ' ' LEU . 96.0 mt -135.87 54.77 1.89 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 110.062 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 p -135.87 -42.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.783 -0.573 . . . . 0.0 110.422 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.33 -103.61 2.45 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.22 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.632 -0.923 . . . . 0.0 110.687 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -95.55 -26.74 15.67 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.638 -0.663 . . . . 0.0 110.395 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.94 0.2 36.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.495 -0.753 . . . . 0.0 111.523 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 t -85.9 0.25 53.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.099 -1.0 . . . . 0.0 111.208 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 34.3 m-85 -93.14 -29.42 15.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.165 -0.959 . . . . 0.0 110.045 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -12.57 60.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -86.47 -26.62 24.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.253 -0.904 . . . . 0.0 110.33 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -132.62 -172.11 2.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.5 -0.75 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.4 p -152.59 169.64 22.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.549 -0.719 . . . . 0.0 110.102 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 86' ' ' LEU . 17.6 m-85 -96.7 119.85 35.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.58 -0.7 . . . . 0.0 109.997 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.51 116.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 109.62 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.857 ' CD2' HD11 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -113.61 166.38 11.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.049 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.507 ' CB ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -96.14 148.02 23.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.593 -0.692 . . . . 0.0 111.542 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' CG2' ' A' ' 198' ' ' ILE . 6.2 mt-10 -23.46 -46.81 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -174.04 36.4 0.12 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.818 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' CB ' ' A' ' 105' ' ' LYS . 27.0 m -60.41 148.31 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.235 -1.156 . . . . 0.0 110.309 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.09 93.96 5.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.629 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 32.5 p90 -109.7 151.35 27.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.469 -0.77 . . . . 0.0 111.562 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.3 156.44 18.14 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.524 HG12 HD23 ' A' ' 77' ' ' LEU . 67.4 mt -122.98 135.93 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.314 -0.866 . . . . 0.0 110.42 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 159' ' ' LEU . 41.0 mtmt -122.51 120.45 33.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.587 . . . . 0.0 110.08 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.743 HG21 ' CE2' ' A' ' 181' ' ' PHE . 50.1 mm -97.65 134.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.701 . . . . 0.0 109.981 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 p -108.67 150.12 27.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.134 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.858 ' HA ' HG23 ' A' ' 73' ' ' THR . 3.1 p90 -162.51 139.13 7.74 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 135.06 35.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.625 . . . . 0.0 111.126 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.801 HG22 HG22 ' A' ' 70' ' ' VAL . 63.5 t -125.26 102.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -128.63 43.89 3.06 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.781 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -155.96 -65.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.0 166.06 23.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.375 -0.828 . . . . 0.0 111.413 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 149' ' ' TYR . 50.7 mt -80.25 145.97 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 70' ' ' VAL . 66.3 t -114.8 74.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.673 -0.642 . . . . 0.0 109.428 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 85.4 p -64.82 85.04 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 110.474 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.18 51.76 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.505 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -75.26 131.92 40.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -1.007 . . . . 0.0 109.312 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -130.7 159.57 36.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 111.085 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -138.08 126.52 23.32 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 130' ' ' GLN . 76.5 mt -116.06 166.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.473 ' N ' HG22 ' A' ' 129' ' ' ILE . 35.5 tt0 -168.58 111.45 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.4 m-70 -98.39 109.26 22.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.56 -0.713 . . . . 0.0 109.979 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 139' ' ' ILE . 23.5 m -68.62 79.07 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.8 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.45 ' CZ ' ' CG ' ' A' ' 138' ' ' LYS . 2.8 m-85 -69.28 124.62 24.33 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.611 -0.681 . . . . 0.0 110.021 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.625 ' O ' HG12 ' A' ' 137' ' ' VAL . 5.5 ttt180 -127.03 130.46 50.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.552 -0.717 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 52.74 28.56 6.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.464 -0.772 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.48 -18.78 47.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 134' ' ' ARG . 8.3 p -104.18 152.89 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -1.198 . . . . 0.0 110.328 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -85.24 134.52 34.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 110.268 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 132' ' ' THR . 1.2 pt -116.6 -19.61 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.2 115.76 0.96 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 110.69 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 3.3 pttm -143.49 121.15 11.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.601 -0.687 . . . . 0.0 109.891 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 143' ' ' ASP . 14.5 m -143.63 169.29 18.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.452 -0.78 . . . . 0.0 110.936 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.437 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -102.42 157.56 16.83 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.722 -0.611 . . . . 0.0 109.92 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -122.92 103.23 8.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 110.427 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ttt -65.6 120.32 12.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.515 -0.741 . . . . 0.0 109.584 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 149' ' ' TYR . 50.6 t -96.9 -69.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.47 -0.769 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.87 -162.4 31.65 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -93.89 126.04 38.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.622 -0.928 . . . . 0.0 110.27 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 122' ' ' ILE . 9.9 m-85 -113.45 137.74 51.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.695 . . . . 0.0 110.487 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.89 150.61 17.58 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.48 114.41 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.419 1.221 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -106.6 -58.18 1.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.572 -0.705 . . . . 0.0 110.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -170.55 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.523 -0.736 . . . . 0.0 110.744 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.88 -154.38 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.414 -0.804 . . . . 0.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.433 ' OE1' HG21 ' A' ' 73' ' ' THR . 9.3 pt-20 -101.56 166.33 10.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.849 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 92.8 m-85 -115.74 -166.06 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.744 -0.598 . . . . 0.0 109.388 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -148.54 110.91 4.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.666 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.468 ' HE2' HG22 ' A' ' 160' ' ' THR . 39.8 t80 -70.81 165.76 22.46 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.407 HD21 ' HD3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -146.08 109.12 4.61 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.814 . . . . 0.0 110.792 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.468 HG22 ' HE2' ' A' ' 158' ' ' PHE . 72.2 p -87.58 145.91 38.25 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.57 -171.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.658 1.346 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -54.03 158.1 2.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 5.7 tt0 -159.95 93.44 1.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.74 -0.6 . . . . 0.0 109.77 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.13 133.14 49.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.628 -0.67 . . . . 0.0 110.519 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.669 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -80.88 166.78 36.95 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.84 117.47 5.16 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.377 1.198 . . . . 0.0 110.118 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -108.03 172.36 6.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.514 -0.741 . . . . 0.0 110.709 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.81 155.29 8.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.1 ttm -59.28 -27.73 66.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.582 -0.952 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.2 mm? -93.48 -28.79 15.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.655 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.58 -22.01 54.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.936 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -62.36 138.56 58.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.339 -0.85 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.35 177.3 19.11 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 p -88.62 131.59 34.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.939 . . . . 0.0 110.354 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -112.68 108.49 17.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.511 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -66.6 137.91 57.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 0.0 109.403 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' CH2' ' A' ' 194' ' ' TRP . 16.4 mt -128.69 135.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.358 -0.839 . . . . 0.0 110.828 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -108.42 105.04 14.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.738 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.5 p -106.45 129.28 54.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.532 -0.73 . . . . 0.0 110.593 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -126.5 91.61 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.673 -0.642 . . . . 0.0 109.886 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.743 ' CE2' HG21 ' A' ' 114' ' ' ILE . 3.4 t80 -74.82 103.66 5.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 109.7 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.459 HG22 ' CB ' ' A' ' 188' ' ' ASP . 69.6 p -122.37 165.81 15.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.707 . . . . 0.0 110.201 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.624 -0.673 . . . . 0.0 109.39 179.318 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.459 ' CB ' HG22 ' A' ' 182' ' ' THR . 2.2 m-20 -114.46 118.8 34.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 36.3 m-70 -56.93 -49.98 73.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 110.791 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.1 tp -168.25 153.74 6.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -154.28 140.96 19.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.402 ' CB ' HD21 ' A' ' 94' ' ' LEU . 16.0 p90 -145.57 -154.63 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.787 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.7 129.5 6.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.362 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.48 ' HB3' HD11 ' A' ' 88' ' ' LEU . 14.3 p-90 -137.82 146.9 44.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.574 -0.704 . . . . 0.0 109.901 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -96.79 158.08 15.6 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 104' ' ' LEU . 21.1 tp -127.0 111.55 14.21 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.7 m -91.53 117.66 29.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.53 -0.731 . . . . 0.0 110.774 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.5 mm -90.03 139.86 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -134.55 -155.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.467 -0.771 . . . . 0.0 110.494 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -93.83 -63.05 1.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -153.15 113.86 4.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.52 -0.737 . . . . 0.0 111.496 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -80.05 7.13 9.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.618 -0.676 . . . . 0.0 111.901 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -169.03 38.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.349 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.194 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' CG ' HG23 ' A' ' 70' ' ' VAL . 31.6 t30 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.941 0.4 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 123' ' ' VAL . 57.2 t -122.48 33.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.712 0.767 . . . . 0.0 109.684 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HD22 ' A' ' 190' ' ' LEU . 60.9 t -69.24 153.38 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.291 0.567 . . . . 0.0 109.986 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 90' ' ' LEU . 57.8 t -69.03 136.84 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.669 -0.645 . . . . 0.0 109.487 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 116' ' ' PHE . 62.1 p -95.44 -41.85 8.77 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.282 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -164.19 169.01 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 110.253 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 76' ' ' THR . 5.8 tt -133.64 134.9 43.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 75' ' ' LEU . 62.6 m -122.03 158.35 29.36 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.578 -0.702 . . . . 0.0 110.44 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 86' ' ' LEU . 73.3 mt -132.81 93.73 3.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.75 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -81.69 140.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.746 -0.596 . . . . 0.0 110.161 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 84.2 m -142.41 -162.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.642 -0.661 . . . . 0.0 110.063 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.7 p -111.34 -72.55 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 110.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 p -96.63 32.54 2.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.8 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.56 -174.62 0.45 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.652 -0.655 . . . . 0.0 110.237 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.8 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.2 Cg_endo -79.93 -28.87 2.99 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 123.203 1.107 . . . . 0.0 110.156 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.55 -179.22 33.45 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.44 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.3 Cg_endo -71.87 108.35 2.42 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.587 1.309 . . . . 0.0 110.511 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.792 ' HB2' HD12 ' A' ' 77' ' ' LEU . 37.7 mt -71.72 107.39 4.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.829 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.15 146.29 27.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.656 . . . . 0.0 110.247 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -130.91 140.82 50.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.698 . . . . 0.0 110.095 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.25 130.08 39.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.506 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 72' ' ' VAL . 5.8 mt -137.73 56.14 1.77 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 0.0 109.926 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 90' ' ' LEU . 27.0 p -149.37 -45.64 0.14 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -0.758 . . . . 0.0 110.797 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.14 -89.02 1.13 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.75 124.14 49.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.916 . . . . 0.0 110.282 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.417 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 89.4 mt -92.84 -24.16 18.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.581 -0.699 . . . . 0.0 110.392 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -23.1 6.31 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.218 -0.926 . . . . 0.0 111.295 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -57.78 -19.72 30.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 111.081 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.1 m-30 -62.56 -55.24 29.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.163 -0.961 . . . . 0.0 110.47 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -20.03 39.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.498 -0.751 . . . . 0.0 110.835 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -96.26 26.86 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -168.95 163.33 11.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.389 -0.82 . . . . 0.0 110.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 p -163.29 131.14 3.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.615 -0.678 . . . . 0.0 110.032 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.627 ' HB3' HD13 ' A' ' 86' ' ' LEU . 26.9 m-85 -73.79 126.6 30.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.614 -0.679 . . . . 0.0 110.094 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.1 t -87.35 122.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.71 . . . . 0.0 110.128 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' HD13 ' A' ' 198' ' ' ILE . 41.1 mt -114.89 -169.67 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 110.151 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.789 ' O ' HG13 ' A' ' 108' ' ' VAL . 16.3 tttm -126.4 157.5 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.716 0.769 . . . . 0.0 109.868 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -41.19 117.35 0.86 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 43.44 66.2 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.127 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 105' ' ' LYS . 35.0 m -98.44 152.21 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -1.111 . . . . 0.0 110.244 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.521 ' HB3' ' HE3' ' A' ' 162' ' ' MET . 15.8 tt0 -95.48 117.11 29.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 109.486 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.43 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 33.0 p90 -142.58 149.27 38.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.387 -0.821 . . . . 0.0 111.277 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.62 166.01 11.52 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 77' ' ' LEU . 70.0 mt -126.15 148.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.022 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HD2' HD21 ' A' ' 159' ' ' LEU . 5.8 mtpp -123.25 92.09 3.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 109.547 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.605 HD13 ' HG ' ' A' ' 75' ' ' LEU . 46.9 mm -73.32 135.71 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 110.322 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.1 m -117.94 136.99 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.762 ' HA ' HG23 ' A' ' 73' ' ' THR . 37.9 p90 -156.71 148.9 23.11 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.413 -0.804 . . . . 0.0 110.695 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.88 138.01 35.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.716 -0.615 . . . . 0.0 110.509 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 70' ' ' VAL . 58.9 t -129.95 84.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.643 . . . . 0.0 109.482 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 151' ' ' PRO . 2.1 t30 -129.17 48.59 2.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.567 -0.708 . . . . 0.0 111.25 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -70.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.376 -0.827 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.22 156.81 36.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.555 -0.716 . . . . 0.0 110.416 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.17 103.4 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 70' ' ' VAL . 84.3 t -93.56 99.48 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.632 -0.667 . . . . 0.0 109.497 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 83.6 p -89.39 117.72 28.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.512 -0.742 . . . . 0.0 110.758 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 103.92 48.94 1.12 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 146' ' ' VAL . 1.3 ttt -73.09 125.09 26.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 109.906 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -119.69 143.71 47.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.167 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -120.54 106.57 11.91 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 130' ' ' GLN . 84.3 mt -103.15 163.2 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.569 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.421 ' N ' HG22 ' A' ' 129' ' ' ILE . 22.9 tt0 -153.25 139.56 18.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.738 -0.601 . . . . 0.0 109.944 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 141' ' ' LYS . 30.9 m-70 -117.93 132.65 56.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 110.496 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 m -87.55 71.1 9.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 109.543 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 7.3 m-85 -74.08 151.46 40.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.714 -0.616 . . . . 0.0 110.822 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HD3' HD11 ' A' ' 139' ' ' ILE . 2.8 tpt180 -120.17 -150.96 0.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.836 -0.54 . . . . 0.0 109.735 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 66.43 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 110.848 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.3 34.66 35.97 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.9 t -144.84 95.09 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.655 -0.909 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -59.55 115.6 3.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.508 -0.745 . . . . 0.0 110.197 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.543 HD11 ' HD3' ' A' ' 134' ' ' ARG . 95.2 mt -89.8 -58.7 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.474 -0.766 . . . . 0.0 110.115 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.29 -171.8 1.36 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.51 -0.744 . . . . 0.0 110.944 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -162.85 167.6 22.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.777 -0.577 . . . . 0.0 110.269 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.1 m -137.11 147.81 46.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.356 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.28 127.8 54.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.662 -0.648 . . . . 0.0 110.012 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -117.32 139.05 51.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.495 -0.753 . . . . 0.0 110.614 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.348 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.632 HG11 ' SD ' ' A' ' 126' ' ' MET . 58.4 t -79.57 -69.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 0.0 110.411 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.79 171.84 20.61 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 38.7 m -94.71 150.8 19.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.609 -0.936 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 156' ' ' TYR . 63.6 m-85 -149.35 129.01 13.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.55 -0.719 . . . . 0.0 110.388 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.01 169.95 34.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 119' ' ' ASN . 44.6 Cg_endo -70.24 -165.94 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.339 1.179 . . . . 0.0 110.354 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 37.7 34.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.153 0.501 . . . . 0.0 112.234 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 156' ' ' TYR . . . -133.29 26.9 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.711 -0.618 . . . . 0.0 110.49 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.9 -159.56 0.21 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.581 -0.7 . . . . 0.0 110.386 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -100.18 150.96 21.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.39 -0.819 . . . . 0.0 110.8 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 153' ' ' ALA . 84.7 m-85 -105.69 -165.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.726 -0.609 . . . . 0.0 109.543 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.14 123.03 1.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.422 -0.799 . . . . 0.0 110.548 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.624 ' HB2' HG13 ' A' ' 146' ' ' VAL . 33.3 t80 -87.48 167.88 13.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -145.77 88.29 1.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.57 HG22 ' HE2' ' A' ' 158' ' ' PHE . 82.1 p -62.87 146.79 94.82 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 149.56 77.33 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.408 1.215 . . . . 0.0 110.621 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.521 ' HE3' ' HB3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -51.73 106.28 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.558 -0.714 . . . . 0.0 110.787 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.66 159.53 14.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -91.0 148.0 22.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.0 110.547 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.19 178.95 1.84 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.659 -0.651 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.804 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.85 132.23 18.18 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.222 1.117 . . . . 0.0 110.354 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -113.28 165.32 12.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.76 161.22 17.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.3 ttp -60.85 -39.48 89.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.669 -0.9 . . . . 0.0 110.141 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.1 pt? -72.3 -5.47 36.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.604 -0.685 . . . . 0.0 111.687 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.401 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -76.3 -29.51 57.38 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -65.08 127.51 31.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.59 -179.24 21.94 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 p -88.09 134.96 33.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.994 . . . . 0.0 110.3 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CE2' ' NE ' ' A' ' 134' ' ' ARG . 24.8 m-85 -122.57 111.54 16.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.691 -0.631 . . . . 0.0 110.001 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.22 130.64 47.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.531 -0.731 . . . . 0.0 110.334 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.924 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.9 mm -114.26 98.55 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.646 -0.659 . . . . 0.0 110.029 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 119.04 31.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.111 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 36.8 t -118.44 143.41 46.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.735 -0.603 . . . . 0.0 110.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -84.48 130.6 34.74 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.2 t -171.62 -171.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.536 -0.727 . . . . 0.0 110.201 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 5.6 p-10 . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.642 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.501 2.082 0 CA-C-O 121.181 0.515 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 119.69 37.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.707 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.518 ' NE2' HG11 ' A' ' 123' ' ' VAL . 10.1 m-70 -75.7 -60.31 2.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 110.789 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.643 HD22 HG13 ' A' ' 71' ' ' VAL . 6.2 tp -169.82 152.06 4.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 t -149.42 135.56 19.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.533 -0.729 . . . . 0.0 110.362 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.406 ' CD1' HD21 ' A' ' 90' ' ' LEU . 20.4 p90 -135.83 -155.69 0.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.685 . . . . 0.0 110.006 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -167.87 128.07 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.981 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.924 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 24.7 p-90 -132.74 150.6 52.14 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.0 109.719 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.52 151.58 23.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.493 -0.755 . . . . 0.0 111.137 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 104' ' ' LEU . 17.2 tp -125.53 105.09 8.78 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -81.77 138.33 35.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.604 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.665 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.3 mm -114.57 164.04 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 109.461 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.7 ttmt -153.94 -159.23 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -122.32 -10.65 8.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.651 -0.655 . . . . 0.0 111.346 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.06 69.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.136 -0.978 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.688 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.02 -4.56 33.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.555 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -154.44 46.17 0.56 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.126 -0.984 . . . . 0.0 110.136 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.249 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' VAL . 85.0 t -141.1 119.39 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 HD22 ' A' ' 190' ' ' LEU . 62.2 t -142.85 139.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.487 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.508 HG11 HD22 ' A' ' 90' ' ' LEU . 59.4 t -64.29 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 116' ' ' PHE . 77.4 p -74.8 -66.96 0.69 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.873 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -131.35 170.82 14.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.529 -0.732 . . . . 0.0 110.73 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HG ' HD13 ' A' ' 114' ' ' ILE . 6.3 tt -142.7 136.88 29.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.659 -0.651 . . . . 0.0 109.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.3 m -109.42 163.99 12.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 0.0 110.076 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -145.98 110.19 4.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.13 114.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 110.042 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.539 ' H ' ' HB2' ' A' ' 82' ' ' ALA . 74.3 m -115.62 78.55 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 110.1 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.3 p 45.94 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.905 -0.497 . . . . 0.0 112.061 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 73.4 p -84.11 56.75 3.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 110.219 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 79' ' ' CYS . . . -90.72 151.89 44.26 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 110.695 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.2 -18.49 23.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.514 1.271 . . . . 0.0 110.228 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.98 152.77 7.37 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.01 98.55 0.91 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.436 1.229 . . . . 0.0 110.369 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 102' ' ' PHE . 6.0 mt -64.72 131.46 46.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 109.879 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -103.87 113.02 26.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.542 -0.723 . . . . 0.0 110.31 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.2 tt -89.13 131.36 35.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.567 -0.708 . . . . 0.0 110.03 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.5 ' N ' HD23 ' A' ' 88' ' ' LEU . 17.5 t70 -87.13 126.45 34.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.681 -0.637 . . . . 0.0 110.052 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 192' ' ' TRP . 1.1 mp -130.28 52.99 1.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -129.39 -48.4 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.703 -0.623 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.4 -116.25 4.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.88 114.61 3.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.567 -0.96 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' HZ ' ' A' ' 97' ' ' PHE . 65.4 mt -93.87 -39.12 10.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.638 -0.664 . . . . 0.0 110.058 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.86 -18.62 34.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.2 t -55.09 -20.65 10.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.24 -0.913 . . . . 0.0 111.335 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.577 ' CD1' HD21 ' A' ' 88' ' ' LEU . 4.6 m-30 -59.99 -31.57 70.04 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -63.3 -16.27 59.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 111.207 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -86.73 -25.48 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.906 . . . . 0.0 110.601 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.54 137.66 47.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -121.26 149.82 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CD1' HD13 ' A' ' 86' ' ' LEU . 29.4 m-85 -85.46 123.04 30.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.504 -0.747 . . . . 0.0 110.105 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.71 152.61 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 109.988 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' CG2' ' A' ' 108' ' ' VAL . 1.6 mt -153.63 172.66 16.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.672 -0.643 . . . . 0.0 110.052 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -93.85 153.87 18.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.509 -0.744 . . . . 0.0 109.843 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -20.52 -55.57 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.796 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -160.88 69.72 0.24 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.577 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.545 ' CG2' HD22 ' A' ' 104' ' ' LEU . 20.9 m -82.63 -161.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.489 -1.006 . . . . 0.0 109.869 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 7.4 mm-40 -98.58 145.77 26.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.548 ' OH ' HD21 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -109.29 111.08 22.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 112.213 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.46 98.63 6.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 66.3 mt -110.64 144.88 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.464 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.555 ' NZ ' HD21 ' A' ' 159' ' ' LEU . 10.6 mttm -120.15 107.25 12.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 48.2 mm -83.24 148.16 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.422 -0.798 . . . . 0.0 110.608 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -130.14 137.21 50.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.699 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.5 p90 -157.7 159.32 36.79 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.874 -0.731 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.46 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.1 mtm180 -98.54 138.68 35.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.382 0.611 . . . . 0.0 111.054 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 91.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -129.13 48.11 2.4 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.91 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -69.62 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.226 -0.921 . . . . 0.0 110.582 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -139.02 165.83 26.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.775 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.86 105.33 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.654 -0.653 . . . . 0.0 109.708 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 70' ' ' VAL . 58.5 t -88.49 80.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 110.094 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.95 116.86 22.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.604 -0.685 . . . . 0.0 110.144 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.55 27.54 3.28 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -64.24 135.65 56.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.508 -0.996 . . . . 0.0 109.589 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -126.31 167.37 15.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -138.02 78.16 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.22 157.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.54 -0.725 . . . . 0.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -162.16 126.52 3.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.709 -0.619 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.464 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 15.1 m-70 -109.82 119.43 39.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.512 -0.742 . . . . 0.0 110.288 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 139' ' ' ILE . 61.4 m -72.14 68.66 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.656 . . . . 0.0 109.411 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 5.5 m-85 -61.63 144.91 53.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 110.765 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -126.99 100.68 6.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.59 37.28 28.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.561 -0.712 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.65 -15.35 61.06 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.081 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 138' ' ' LYS . 58.4 t -98.46 167.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.179 -1.189 . . . . 0.0 110.203 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.8 mppt? -113.66 130.9 56.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -120.76 -23.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.735 . . . . 0.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -165.39 119.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.159 -0.963 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -144.41 132.62 21.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -0.75 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 143' ' ' ASP . 58.2 m -146.32 165.78 28.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.665 -0.647 . . . . 0.0 110.499 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 142' ' ' THR . 10.5 p-10 -100.06 136.31 40.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.669 . . . . 0.0 110.038 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -111.54 154.45 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.558 -0.713 . . . . 0.0 110.454 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 12.3 ttm -101.73 112.16 24.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.606 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' A' ' 158' ' ' PHE . 57.8 t -79.49 -48.76 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.529 -0.732 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.46 165.6 10.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 65.4 p -85.77 143.75 28.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.68 -0.894 . . . . 0.0 109.403 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 148' ' ' SER . 50.2 m-85 -140.68 125.93 18.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.543 -0.723 . . . . 0.0 110.384 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.58 154.37 32.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.54 85.51 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.476 1.25 . . . . 0.0 110.378 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -85.45 -89.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.63 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.927 -1.108 . . . . 0.0 110.998 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -162.5 -163.43 0.9 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.82 . . . . 0.0 110.935 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -100.28 167.54 10.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.606 . . . . 0.0 110.092 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 27.7 m-85 -113.79 171.51 7.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.663 . . . . 0.0 109.787 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -138.36 95.33 2.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.523 -0.735 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.505 ' CG ' HG13 ' A' ' 146' ' ' VAL . 49.0 t80 -81.36 169.83 16.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 ' NZ ' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -146.82 111.37 5.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.745 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 64.0 p -77.67 140.01 63.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.75 . . . . 0.0 109.064 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.11 163.28 29.43 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.75 1.395 . . . . 0.0 111.401 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -59.38 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.176 0.512 . . . . 0.0 111.478 -179.288 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 110' ' ' TYR . 5.9 tt0 -79.39 -171.5 2.77 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.54 155.92 39.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 110.649 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.796 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -100.62 160.61 26.4 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.702 -0.624 . . . . 0.0 109.8 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.58 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 48.0 Cg_endo -73.45 117.02 4.9 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.411 1.216 . . . . 0.0 110.777 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -113.97 -170.38 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.09 28.27 3.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 65.81 -68.51 0.12 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.452 -1.028 . . . . 0.0 110.75 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -56.57 -29.22 61.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 166' ' ' PRO . . . -57.61 -21.79 41.43 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.642 -0.661 . . . . 0.0 110.671 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.405 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 44.9 mtp180 -60.69 136.86 58.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 142.02 -173.52 23.64 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 p -91.6 137.99 31.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.623 -0.927 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -128.23 115.07 17.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 110.271 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.484 ' O ' HD13 ' A' ' 177' ' ' ILE . 1.5 m120 -60.45 151.85 27.19 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.509 -0.744 . . . . 0.0 110.09 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.775 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.4 mm -131.51 97.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.463 -0.773 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 133' ' ' TYR . 4.3 ttpt -82.4 102.44 11.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 109.733 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.4 p -109.34 137.1 47.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.725 . . . . 0.0 110.482 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.41 99.51 5.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.781 -0.575 . . . . 0.0 110.007 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -78.77 120.42 23.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.688 -0.633 . . . . 0.0 109.75 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.0 t -142.95 -164.77 1.92 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.53 -0.731 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 13.0 p-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.906 -0.496 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.232 0.539 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.67 126.22 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.538 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 17.0 m-70 -73.48 -47.86 37.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 110.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.671 HD22 HG13 ' A' ' 71' ' ' VAL . 5.7 tp -168.39 152.21 5.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 110.232 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.3 t -148.43 152.15 36.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.692 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.572 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.4 p90 -142.97 -161.24 1.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.0 109.947 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.09 122.86 3.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.446 -0.784 . . . . 0.0 110.759 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.775 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 37.6 p-90 -132.28 149.31 52.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.601 -0.687 . . . . 0.0 109.713 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -87.21 152.3 22.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.549 -0.719 . . . . 0.0 111.303 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.548 HD21 ' OH ' ' A' ' 110' ' ' TYR . 25.7 tp -122.04 108.84 13.84 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.9 m -85.74 140.31 30.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.528 -0.733 . . . . 0.0 110.581 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.6 mm -119.72 160.51 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.752 -0.592 . . . . 0.0 109.651 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.13 -153.23 0.33 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.212 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -3.65 6.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.448 -0.783 . . . . 0.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -160.05 43.96 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -54.04 -23.11 12.44 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.239 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.04 47.2 0.91 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.589 -0.695 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.265 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.142 0.496 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 123' ' ' VAL . 96.1 t -126.91 128.74 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.42 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.3 t -146.95 142.03 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.792 -0.567 . . . . 0.0 109.804 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.586 ' CG1' HD13 ' A' ' 90' ' ' LEU . 61.7 t -62.85 112.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 43.0 p -78.23 -35.53 48.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.0 111.062 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -159.31 176.89 11.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.367 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.1 tt -145.82 113.67 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.798 -0.564 . . . . 0.0 109.665 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 87' ' ' GLU . 4.1 m -109.8 164.55 12.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.445 -0.785 . . . . 0.0 110.571 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -139.23 101.67 4.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 79' ' ' CYS . 65.3 t -94.0 167.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.717 -0.614 . . . . 0.0 110.127 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -168.36 -162.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.759 . . . . 0.0 110.098 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -108.84 -40.65 4.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -122.62 35.12 4.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.09 165.02 25.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.547 -0.721 . . . . 0.0 110.263 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.4 Cg_endo -70.23 -26.8 25.01 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.385 1.203 . . . . 0.0 110.256 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.26 174.03 32.66 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.96 96.08 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.55 1.289 . . . . 0.0 110.293 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' PHE . 23.6 mt -64.8 106.24 1.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.629 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 76' ' ' THR . 2.2 mt-10 -99.24 135.08 41.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.586 -0.696 . . . . 0.0 110.652 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.536 HD22 ' HE1' ' A' ' 97' ' ' PHE . 10.8 mt -116.18 168.02 10.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.608 -0.682 . . . . 0.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.73 128.87 54.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.715 . . . . 0.0 110.111 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.586 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -128.07 50.24 2.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 110.078 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.7 p -141.0 -43.79 0.38 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.155 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.14 -92.01 2.03 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.68 98.79 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -1.021 . . . . 0.0 110.557 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -95.45 -36.92 11.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 0.0 110.089 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.36 -13.0 57.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 0.0 111.273 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 p -55.1 -28.01 49.31 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.545 ' CE2' HD13 ' A' ' 94' ' ' LEU . 28.7 m-85 -61.96 -39.47 92.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.46 -0.775 . . . . 0.0 109.985 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -57.92 -24.37 57.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.685 . . . . 0.0 110.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -118.67 45.41 2.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.561 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -168.35 136.13 2.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.791 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.2 p -143.41 127.88 17.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.657 . . . . 0.0 109.544 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.714 ' CD1' HD22 ' A' ' 86' ' ' LEU . 11.9 m-85 -76.42 115.37 16.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.369 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.77 121.14 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 109.179 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 196' ' ' LEU . 1.0 OUTLIER -113.76 -159.31 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.618 -0.676 . . . . 0.0 110.3 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HB3' HG11 ' A' ' 108' ' ' VAL . 47.0 tttm -140.94 158.79 43.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.572 -0.705 . . . . 0.0 110.555 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' CG ' ' NH1' ' A' ' 172' ' ' ARG . 22.3 mt-10 -38.36 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 33.32 70.34 0.13 Allowed Glycine 0 N--CA 1.505 3.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.863 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 105' ' ' LYS . 33.0 m -90.83 147.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -1.14 . . . . 0.0 109.749 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.26 93.39 4.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 108.814 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 163' ' ' GLU . 31.8 p90 -113.45 146.31 39.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 111.894 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -108.38 157.49 18.35 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 113' ' ' LYS . 66.8 mt -116.66 164.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.855 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.633 ' CG ' HD11 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -142.67 87.15 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.87 -0.519 . . . . 0.0 109.612 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.55 150.92 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.411 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -127.02 153.02 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.705 -0.622 . . . . 0.0 109.739 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -172.09 159.32 4.9 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.576 -0.703 . . . . 0.0 110.576 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' A' ' 73' ' ' THR . 3.3 mtm180 -113.94 154.54 27.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -133.11 97.83 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -128.98 48.93 2.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.513 -0.742 . . . . 0.0 111.291 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -70.6 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.27 -0.894 . . . . 0.0 110.777 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -135.56 172.61 12.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.671 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.1 mt -80.35 108.76 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.726 -0.609 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 70' ' ' VAL . 93.7 t -83.61 86.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -78.13 59.29 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.677 -0.639 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.48 60.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.704 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.4 OUTLIER -70.25 128.67 37.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -1.058 . . . . 0.0 108.566 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -125.99 145.42 50.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.248 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.14 96.04 3.12 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -94.15 162.46 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.087 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 129' ' ' ILE . 4.3 tt0 -151.46 135.33 16.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.598 -0.688 . . . . 0.0 110.185 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 177' ' ' ILE . 13.6 m-70 -109.55 149.1 30.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.715 . . . . 0.0 109.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.483 HG22 HH22 ' A' ' 134' ' ' ARG . 0.4 OUTLIER -108.13 80.84 1.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.6 -0.687 . . . . 0.0 109.208 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 11.6 m-85 -86.05 140.37 30.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 111.071 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.699 HH11 HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -119.83 79.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.685 . . . . 0.0 110.399 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt 52.09 55.61 8.98 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.406 -0.809 . . . . 0.0 111.339 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.84 -19.33 52.3 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.1 t -98.73 89.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.181 -1.188 . . . . 0.0 109.829 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 5.1 pttm -66.92 122.73 18.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.575 -0.703 . . . . 0.0 110.562 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.699 HD12 HH11 ' A' ' 134' ' ' ARG . 1.8 mt -89.74 -54.03 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.15 -167.97 0.37 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.505 -0.747 . . . . 0.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HE2' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -157.93 153.46 26.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.632 -0.668 . . . . 0.0 109.92 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.456 HG21 ' CZ ' ' A' ' 144' ' ' TYR . 8.5 m -118.29 146.1 44.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -125.19 118.4 25.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 142' ' ' THR . 29.2 m-85 -111.56 147.09 36.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.404 -0.81 . . . . 0.0 110.855 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.0 ttp -104.12 118.19 36.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.753 -0.592 . . . . 0.0 109.463 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 149' ' ' TYR . 49.1 t -79.87 -66.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.59 -0.694 . . . . 0.0 110.263 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.23 -148.87 20.17 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 92.5 p -108.59 136.64 47.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.543 -0.975 . . . . 0.0 110.427 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.552 ' HE1' HG12 ' A' ' 146' ' ' VAL . 23.3 m-85 -122.82 147.01 47.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 110.396 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.14 152.29 18.03 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.515 ' HA ' HG12 ' A' ' 118' ' ' VAL . 51.2 Cg_endo -75.5 -174.25 1.93 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.362 1.19 . . . . 0.0 110.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 52.01 70.11 0.59 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.5 -0.75 . . . . 0.0 111.079 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.1 -94.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.484 -0.76 . . . . 0.0 110.364 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.54 -155.17 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.838 -1.164 . . . . 0.0 109.897 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 88.73 6.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.91 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -59.75 -168.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.506 -0.746 . . . . 0.0 109.94 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.414 ' OE1' HD11 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -161.61 134.83 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.475 -0.766 . . . . 0.0 110.726 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 146' ' ' VAL . 29.9 t80 -107.09 156.86 18.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.633 HD11 ' CG ' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -137.93 114.0 10.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.446 -0.784 . . . . 0.0 110.595 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -78.61 154.53 78.69 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.21 154.96 72.11 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.628 1.331 . . . . 0.0 110.806 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 ttm -59.83 124.17 19.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.699 -0.626 . . . . 0.0 110.438 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.5 pt-20 -124.49 141.59 51.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.633 -0.667 . . . . 0.0 109.921 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.19 140.31 31.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.586 -0.696 . . . . 0.0 110.417 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -86.62 -179.27 1.34 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.637 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.7 Cg_endo -75.29 125.47 9.15 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.237 1.125 . . . . 0.0 110.297 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -115.26 -176.68 2.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.656 -0.653 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.93 153.98 19.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 9.2 ttm -60.19 -28.12 67.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.644 -0.915 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 26.2 4.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 110.116 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.31 22.46 8.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.529 -0.732 . . . . 0.0 110.387 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -100.03 147.9 25.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.835 . . . . 0.0 109.94 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.83 179.97 16.77 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.6 p -81.14 140.76 34.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.67 -0.9 . . . . 0.0 110.761 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 13.4 m-85 -118.35 106.19 12.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.787 -0.571 . . . . 0.0 109.919 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -71.08 121.45 18.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.584 -0.697 . . . . 0.0 110.055 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 131' ' ' HIS . 26.6 mt -116.84 145.42 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -114.02 114.43 26.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.976 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.0 m -106.23 151.36 24.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.65 -0.656 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -149.12 93.73 2.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 116' ' ' PHE . 18.1 t80 -75.33 107.55 7.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.591 -0.693 . . . . 0.0 109.628 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 188' ' ' ASP . 75.8 p -121.71 168.49 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.524 -0.735 . . . . 0.0 110.38 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.691 ' HB2' HG13 ' A' ' 123' ' ' VAL . 7.0 p-10 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.783 -0.573 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.003 0.43 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' A' ' 182' ' ' THR . 1.1 m-20 -78.32 108.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.378 -0.826 . . . . 0.0 110.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.414 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 25.8 m-70 -59.57 -55.12 38.45 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.471 -0.768 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 tp -168.56 153.87 6.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.5 t -148.26 155.73 41.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 110.142 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.526 ' CB ' HD11 ' A' ' 94' ' ' LEU . 23.1 p90 -148.6 -152.99 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -164.08 139.91 6.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 14.1 p-90 -147.89 147.82 30.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.213 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -92.73 148.88 21.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.503 -0.748 . . . . 0.0 111.224 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.783 HD21 HD12 ' A' ' 104' ' ' LEU . 49.6 tp -124.05 115.72 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.407 ' O ' HD13 ' A' ' 198' ' ' ILE . 96.0 m -87.41 152.49 22.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.477 -0.764 . . . . 0.0 110.947 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.488 HD13 ' CB ' ' A' ' 104' ' ' LEU . 49.8 mm -130.28 159.21 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -160.32 -158.51 0.63 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.284 -0.885 . . . . 0.0 111.243 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -64.31 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.61 -0.681 . . . . 0.0 111.096 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.59 103.67 3.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.0 110.93 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.58 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -72.95 -3.13 23.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.556 -0.715 . . . . 0.0 111.644 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -136.49 57.61 1.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.059 -1.026 . . . . 0.0 110.133 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.228 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.212 0.53 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' HG21 ' A' ' 123' ' ' VAL . 93.0 t -141.95 122.07 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.79 HG13 HD22 ' A' ' 190' ' ' LEU . 59.0 t -148.89 137.15 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.302 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.747 HG22 ' CD2' ' A' ' 181' ' ' PHE . 58.4 t -66.12 108.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.876 HG23 ' HA ' ' A' ' 116' ' ' PHE . 73.0 p -70.62 -62.63 1.32 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.607 -0.683 . . . . 0.0 110.543 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -145.07 167.9 21.6 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.774 . . . . 0.0 110.802 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.559 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -125.61 136.28 53.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.717 -0.615 . . . . 0.0 109.687 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 85' ' ' PRO . 92.4 m -125.82 149.17 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 110.638 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -133.9 103.66 5.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 109.947 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -94.14 166.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.616 -0.677 . . . . 0.0 110.178 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -167.25 -164.3 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 110.009 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -44.77 4.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 p -108.98 27.19 9.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.84 162.37 33.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.594 -0.691 . . . . 0.0 110.609 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 45.7 Cg_endo -71.78 -25.49 20.23 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.524 1.276 . . . . 0.0 110.078 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.03 176.22 33.89 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.65 ' HB2' HG23 ' A' ' 76' ' ' THR . 45.8 Cg_endo -71.63 104.45 1.6 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.567 1.298 . . . . 0.0 110.444 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 23.5 mt -64.88 108.75 1.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.655 -0.653 . . . . 0.0 109.634 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -86.77 139.66 30.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -120.06 149.42 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 110.085 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.447 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.8 t0 -103.19 118.4 36.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.715 . . . . 0.0 110.222 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 192' ' ' TRP . 2.8 mt -128.98 50.04 2.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -96.93 -73.52 0.6 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.599 -0.688 . . . . 0.0 110.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -52.37 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.78 88.09 4.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.917 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 96.1 mt -87.82 -25.23 23.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.724 . . . . 0.0 110.405 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.85 -21.75 12.36 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.245 -0.909 . . . . 0.0 111.093 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.2 t -54.43 -22.6 13.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.347 -0.846 . . . . 0.0 111.127 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CE1' HD22 ' A' ' 88' ' ' LEU . 10.4 m-30 -61.95 -48.03 82.2 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.802 . . . . 0.0 109.943 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -59.51 -24.8 63.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.62 -0.675 . . . . 0.0 110.659 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -86.85 -26.42 24.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 0.0 110.509 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -132.76 129.86 39.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.643 -0.661 . . . . 0.0 110.379 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -106.99 -175.03 2.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.645 -0.659 . . . . 0.0 110.093 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 196' ' ' LEU . 2.6 m-85 -113.58 96.03 5.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.596 -0.69 . . . . 0.0 110.174 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.18 142.88 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 109.837 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 HD11 ' A' ' 196' ' ' LEU . 1.2 mt -157.32 172.51 18.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -90.06 157.57 17.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -20.04 -50.86 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.727 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -171.54 63.54 0.15 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' LYS . 23.3 m -75.37 137.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -1.025 . . . . 0.0 110.322 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.81 105.32 8.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.67 -0.644 . . . . 0.0 109.431 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 77' ' ' LEU . 18.1 p90 -121.56 171.07 9.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.317 -0.864 . . . . 0.0 111.512 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -117.18 145.61 43.75 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.61 139.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.417 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 90.59 3.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.695 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.6 mm -74.42 147.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.569 -0.707 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 m -130.49 134.72 47.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.876 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.6 p90 -154.61 160.67 41.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.441 -0.787 . . . . 0.0 111.093 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -108.29 131.44 54.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.327 0.584 . . . . 0.0 110.716 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 149' ' ' TYR . 93.5 t -120.23 93.1 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -129.35 50.23 2.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.348 -0.845 . . . . 0.0 111.569 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.12 -65.26 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 110.421 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.82 169.54 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.58 101.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.717 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 70' ' ' VAL . 60.7 t -79.9 75.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.65 -0.656 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -83.14 110.95 18.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.718 . . . . 0.0 110.387 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.47 30.16 2.51 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.7 OUTLIER -62.24 112.11 2.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.434 -1.039 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 163.71 12.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.594 -0.692 . . . . 0.0 110.936 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -138.13 112.08 8.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.73 -0.606 . . . . 0.0 109.64 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.41 161.29 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 0.0 110.034 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -167.42 117.98 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.546 -0.721 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -110.4 131.02 55.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.597 -0.689 . . . . 0.0 110.242 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 m -86.16 93.04 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.718 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 3.1 m-85 -78.19 127.44 32.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.718 . . . . 0.0 110.471 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.2 ttp180 -125.74 130.95 52.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.37 28.69 7.7 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.27 47.13 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.5 m -106.56 146.33 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.214 . . . . 0.0 110.707 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.61 138.76 40.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.597 -0.689 . . . . 0.0 110.126 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.85 -24.22 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -173.28 134.96 0.55 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.028 . . . . 0.0 110.829 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 175.57 7.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.627 -0.671 . . . . 0.0 109.438 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.3 m -154.26 144.7 22.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 111.1 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -115.15 122.51 46.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.93 130.59 56.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.442 -0.787 . . . . 0.0 111.23 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.48 119.01 17.11 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.74 HG12 ' OH ' ' A' ' 149' ' ' TYR . 6.4 t -79.7 -58.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.505 -0.747 . . . . 0.0 110.293 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.11 165.07 11.0 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.935 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 59.2 p -92.91 151.76 19.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.614 -0.933 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.74 ' OH ' HG12 ' A' ' 146' ' ' VAL . 12.7 m-85 -139.15 169.49 17.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.469 -0.769 . . . . 0.0 110.573 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.05 141.96 17.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.51 178.36 5.72 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.214 1.113 . . . . 0.0 110.777 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.06 71.32 0.5 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.54 -0.725 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -166.55 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.458 -0.776 . . . . 0.0 110.408 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.74 -153.94 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.028 -1.045 . . . . 0.0 110.026 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.28 168.85 10.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.427 -0.796 . . . . 0.0 110.02 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 32.2 m-85 -127.17 -176.58 3.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -150.68 113.32 4.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.493 -0.754 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.517 ' HB2' HG13 ' A' ' 146' ' ' VAL . 35.2 t80 -87.24 168.51 13.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.529 -0.732 . . . . 0.0 110.022 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.07 109.8 4.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 0.0 110.738 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.8 p -83.33 151.13 62.07 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.392 -0.817 . . . . 0.0 109.121 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.72 -175.13 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.524 1.276 . . . . 0.0 110.892 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.0 ptm -56.64 145.1 29.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.653 -0.655 . . . . 0.0 110.915 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.04 93.92 2.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.718 -0.614 . . . . 0.0 109.731 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -63.91 121.83 15.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.727 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -57.43 175.12 0.27 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.724 -0.61 . . . . 0.0 110.234 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.0 Cg_endo -72.83 112.51 3.52 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.248 1.131 . . . . 0.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -172.82 2.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.886 -0.509 . . . . 0.0 110.544 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.34 31.67 1.8 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.5 mtp 63.71 -70.75 0.07 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.62 -0.929 . . . . 0.0 111.213 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -69.81 -7.03 36.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.179 -0.951 . . . . 0.0 111.71 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.54 -5.13 41.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.293 -0.879 . . . . 0.0 110.94 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 30.5 mtp180 -67.86 140.68 56.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.86 -174.65 24.16 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.6 p -91.49 124.46 35.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.605 -0.938 . . . . 0.0 110.211 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -112.11 112.87 24.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.358 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.59 143.32 57.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.592 -0.693 . . . . 0.0 109.801 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.772 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.5 mm -119.33 94.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.533 -0.729 . . . . 0.0 110.41 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 tttt -77.23 107.96 10.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.512 -0.743 . . . . 0.0 109.47 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 5.2 p -113.45 160.4 18.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -147.89 83.79 1.52 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.682 -0.636 . . . . 0.0 109.82 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.747 ' CD2' HG22 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -69.68 110.85 5.09 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.6 t -141.33 -168.21 2.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.521 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 p30 . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.316 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 120.957 0.408 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.36 125.24 37.86 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 18.9 p80 -91.56 -17.69 25.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.474 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.79 HD22 HG13 ' A' ' 71' ' ' VAL . 43.5 tp -171.39 155.05 4.07 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.034 -1.041 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -164.96 140.27 5.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.72 -0.613 . . . . 0.0 109.677 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.506 ' CD1' HD21 ' A' ' 90' ' ' LEU . 14.7 p90 -146.95 -153.53 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.412 -0.805 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -167.16 127.33 1.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.701 -0.625 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 20.0 p-90 -130.63 145.94 52.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.25 152.1 23.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.681 -0.637 . . . . 0.0 110.989 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 104' ' ' LEU . 13.1 tp -123.75 92.06 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.734 -0.604 . . . . 0.0 109.544 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.8 m -67.73 129.5 40.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.571 -0.705 . . . . 0.0 110.186 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.1 mm -109.73 150.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.807 -0.558 . . . . 0.0 109.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.73 -153.01 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.665 -0.647 . . . . 0.0 109.949 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 -4.87 6.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.655 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -159.98 46.7 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.982 -1.074 . . . . 0.0 110.986 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -56.06 -22.16 26.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.344 -0.848 . . . . 0.0 111.131 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.64 51.54 1.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -0.815 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.194 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.059 0.457 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 118' ' ' VAL . 84.6 t -115.82 134.52 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.582 -0.699 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 70' ' ' VAL . 63.0 t -148.34 152.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.608 -0.683 . . . . 0.0 109.92 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.3 t -71.61 112.33 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.881 HG23 ' HA ' ' A' ' 116' ' ' PHE . 67.5 p -70.81 -51.3 27.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.306 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -151.3 179.77 8.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.2 tt -146.39 121.24 9.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.629 -0.669 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -109.75 163.42 13.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -148.61 113.89 5.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.468 -0.77 . . . . 0.0 110.531 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -125.87 167.23 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.654 . . . . 0.0 109.817 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 78' ' ' VAL . 52.5 t -153.05 -71.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.554 -0.717 . . . . 0.0 110.315 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.0 p -171.89 -71.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 p -103.99 33.59 3.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.609 -0.682 . . . . 0.0 109.928 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -79.65 172.78 8.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 110.32 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.6 Cg_endo -72.22 -27.73 16.28 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.455 1.24 . . . . 0.0 110.046 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.57 170.44 25.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.2 Cg_endo -72.04 97.76 0.86 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.544 1.286 . . . . 0.0 110.292 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 1.5 mp -64.67 122.68 17.42 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.523 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.22 112.93 26.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 110.678 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.0 mt -95.26 131.23 41.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 5.4 t70 -75.64 135.25 40.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.704 . . . . 0.0 110.614 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HA ' HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.61 54.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.619 -0.675 . . . . 0.0 109.71 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.7 p -130.21 49.84 2.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 110.7 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.52 -55.62 0.74 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.26 64.32 0.56 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.592 -0.946 . . . . 0.0 110.073 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 90' ' ' LEU . 29.4 mt -95.14 -0.09 53.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 111.207 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.18 -24.37 58.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.106 -0.996 . . . . 0.0 110.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.77 -6.55 45.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.42 -0.8 . . . . 0.0 111.227 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 13.9 m-85 -81.28 -38.71 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -69.95 -20.2 63.34 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.511 -0.743 . . . . 0.0 110.858 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.37 38.25 3.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -168.96 151.62 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.447 -0.783 . . . . 0.0 110.55 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -128.76 -169.53 2.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.555 -0.716 . . . . 0.0 109.989 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD2' HD13 ' A' ' 77' ' ' LEU . 1.1 m-85 -125.17 111.57 15.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 109.93 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.22 147.47 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.547 -0.72 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -167.38 145.05 4.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.788 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.648 ' H ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -78.59 155.6 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.454 -0.779 . . . . 0.0 109.75 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -17.24 -87.59 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.736 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -134.81 67.29 0.55 Allowed Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.163 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.617 ' CG2' HD21 ' A' ' 104' ' ' LEU . 8.6 m -75.96 157.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.467 -1.02 . . . . 0.0 110.156 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -85.5 89.53 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.632 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 46.2 p90 -109.27 138.86 44.99 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.662 0.744 . . . . 0.0 112.095 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -105.94 164.98 11.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.35 150.01 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.218 -0.926 . . . . 0.0 111.216 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -125.42 108.01 11.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.7 153.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 0.0 110.522 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.3 m -131.02 140.95 50.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.806 -0.559 . . . . 0.0 109.582 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.881 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -164.47 147.58 9.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.469 -0.77 . . . . 0.0 110.505 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 161.56 17.91 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.439 -0.788 . . . . 0.0 111.195 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 70' ' ' VAL . 63.1 t -133.08 117.23 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.779 -0.575 . . . . 0.0 109.593 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -128.66 46.73 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.995 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 -67.89 0.25 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -143.69 179.07 7.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.819 . . . . 0.0 110.562 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.0 mp -80.19 109.34 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.666 -0.646 . . . . 0.0 109.981 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 70' ' ' VAL . 57.5 t -91.46 83.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.9 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.5 p -85.07 107.78 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.621 -0.675 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.41 39.98 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -81.46 137.89 35.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -1.043 . . . . 0.0 109.957 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.631 ' HE2' HG23 ' A' ' 182' ' ' THR . 22.5 pttt -139.39 171.87 13.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -129.52 117.84 21.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 109.73 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE3' ' A' ' 127' ' ' LYS . 49.8 mm -91.32 165.74 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.736 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 129' ' ' ILE . 49.5 tt0 -168.29 124.05 1.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -113.95 117.82 32.44 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.731 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.6 m -71.89 84.58 0.95 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.717 -0.615 . . . . 0.0 109.921 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 138' ' ' LYS . 2.7 m-85 -87.41 136.39 32.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.497 -0.752 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.428 ' HD2' ' CE2' ' A' ' 175' ' ' TYR . 3.3 ttp180 -120.42 110.58 16.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 110.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 29.63 43.47 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 92.87 34.18 6.99 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 136' ' ' GLY . 62.6 t -149.21 82.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.959 . . . . 0.0 110.071 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 133' ' ' TYR . 2.4 ttpm? -62.29 121.87 14.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 140' ' ' ASP . 31.3 pt -104.32 -31.52 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.534 -0.729 . . . . 0.0 111.067 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.5 p30 -174.23 149.71 1.43 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.14 -0.975 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 150.71 51.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.64 . . . . 0.0 109.505 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.9 m -132.84 159.81 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.98 138.83 53.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.631 -0.668 . . . . 0.0 110.122 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -122.63 113.15 18.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.9 ttt -68.72 137.87 54.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.523 -0.736 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.456 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 60.6 t -98.11 -68.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.552 -0.717 . . . . 0.0 110.151 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.28 176.02 26.14 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.4 p -87.4 152.47 22.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.693 -0.887 . . . . 0.0 109.963 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.433 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 81.3 m-85 -148.18 144.39 27.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 110.415 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.5 154.01 19.68 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.23 65.35 5.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.377 1.199 . . . . 0.0 110.474 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -170.93 37.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 110.337 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.698 ' HB3' ' OH ' ' A' ' 156' ' ' TYR . . . -144.31 15.02 1.65 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.522 -0.736 . . . . 0.0 111.06 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 54.66 -148.1 0.49 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.173 -0.954 . . . . 0.0 110.734 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.95 157.06 38.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.373 -0.829 . . . . 0.0 110.84 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.698 ' OH ' ' HB3' ' A' ' 153' ' ' ALA . 57.4 m-85 -115.87 177.45 4.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.737 -0.602 . . . . 0.0 109.669 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.95 92.84 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.51 -0.744 . . . . 0.0 110.355 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 28.5 t80 -80.81 168.23 19.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.009 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 111' ' ' ARG . 0.9 OUTLIER -154.4 100.63 2.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.395 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.426 HG22 ' HE2' ' A' ' 158' ' ' PHE . 81.0 p -76.02 155.87 84.39 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 109.252 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.76 153.02 76.91 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.615 1.324 . . . . 0.0 110.978 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.0 ptm -58.0 113.47 1.91 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.679 -0.638 . . . . 0.0 110.49 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.25 161.42 13.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.094 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -104.84 141.44 36.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.484 -0.76 . . . . 0.0 110.512 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -96.15 179.66 1.1 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.629 -0.67 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 41.8 Cg_endo -66.44 -153.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.201 1.106 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -107.0 -162.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.061 -1.024 . . . . 0.0 110.689 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 106' ' ' GLU . . . -98.86 -66.79 0.87 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 171' ' ' ALA . 6.6 mtt -60.79 145.94 47.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.959 . . . . 0.0 109.233 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER 66.93 -61.32 0.33 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.639 -0.663 . . . . 0.0 110.535 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -73.06 -2.85 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.4 -0.812 . . . . 0.0 111.695 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 150.36 48.93 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.918 -1.114 . . . . 0.0 110.136 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.56 -177.82 17.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.7 p -91.99 129.78 37.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.696 -0.885 . . . . 0.0 110.219 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.428 ' CE2' ' HD2' ' A' ' 134' ' ' ARG . 12.3 m-85 -108.01 101.12 10.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.594 -0.691 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.96 125.06 23.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.616 ' CD1' HD23 ' A' ' 196' ' ' LEU . 20.5 mt -115.96 132.14 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -0.851 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.8 106.51 17.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.4 m -99.09 140.6 33.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.646 -0.659 . . . . 0.0 109.728 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.44 90.07 2.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.595 -0.691 . . . . 0.0 110.393 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.494 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.7 t80 -64.38 131.66 47.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 109.648 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.631 HG23 ' HE2' ' A' ' 127' ' ' LYS . 5.9 t -171.0 -169.06 0.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.8 p30 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.482 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 121.234 0.54 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -115.35 118.02 32.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.782 -0.574 . . . . 0.0 109.503 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.2 m-70 -75.07 -67.44 0.65 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.457 -0.777 . . . . 0.0 110.666 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.0 tp -165.74 160.29 17.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.461 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.8 p -155.94 144.91 20.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.586 -0.696 . . . . 0.0 110.403 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 30.1 p90 -138.7 -155.76 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.606 -0.684 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.46 129.31 7.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.323 -0.86 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.739 ' CZ3' HD21 ' A' ' 196' ' ' LEU . 4.4 p-90 -140.01 147.9 41.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 175' ' ' TYR . 2.9 m-80 -99.31 154.97 17.76 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.756 0.789 . . . . 0.0 112.452 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.739 HD21 ' CZ3' ' A' ' 194' ' ' TRP . 0.9 OUTLIER -111.74 103.47 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -80.21 101.12 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.753 . . . . 0.0 110.434 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.93 145.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 109.689 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -142.6 -154.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.647 -0.658 . . . . 0.0 110.401 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -108.71 -32.46 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.758 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.11 93.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.761 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -77.21 -0.2 24.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.571 -0.706 . . . . 0.0 111.307 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -127.79 43.2 3.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.2 t30 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 123' ' ' VAL . 92.8 t -130.68 125.24 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.778 -0.577 . . . . 0.0 110.132 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -148.59 138.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.775 -0.578 . . . . 0.0 109.962 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.748 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -64.51 104.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 155' ' ' GLU . 66.4 p -70.8 -63.3 1.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.668 -0.645 . . . . 0.0 110.41 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -138.61 173.21 11.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.6 tt -142.85 124.92 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.648 -0.658 . . . . 0.0 109.559 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 85' ' ' PRO . 21.0 m -114.91 157.37 23.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.442 -0.786 . . . . 0.0 111.038 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -137.46 106.39 5.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.3 t -99.74 166.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 110.42 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -163.33 -154.49 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.1 p -115.03 -26.42 7.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.436 -0.79 . . . . 0.0 110.397 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.7 p -140.12 34.67 1.92 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.653 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.21 173.41 5.76 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.352 -0.843 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.0 Cg_endo -72.36 -26.52 17.17 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.286 1.15 . . . . 0.0 110.152 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.72 177.31 34.68 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -71.45 102.76 1.32 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.487 1.256 . . . . 0.0 110.317 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.657 HD22 ' CD1' ' A' ' 102' ' ' PHE . 37.5 mt -64.85 112.74 3.4 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.503 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -99.67 113.67 26.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.82 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.6 mt -98.75 137.45 37.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.604 -0.685 . . . . 0.0 109.739 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 14.6 t0 -86.57 128.61 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.506 -0.746 . . . . 0.0 110.679 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.748 HD22 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -128.52 51.44 2.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.466 -0.771 . . . . 0.0 109.982 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.6 p -115.16 -58.73 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 110.346 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.67 -57.25 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 75.64 0.96 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.548 -0.972 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.5 mt -95.01 0.03 54.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 111.213 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -70.51 -33.14 70.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.037 -1.039 . . . . 0.0 110.659 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 m -57.47 -20.82 33.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.456 -0.777 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.82 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.7 m-85 -55.33 -42.2 73.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.246 -0.909 . . . . 0.0 110.388 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -63.59 -26.27 68.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 0.0 109.944 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 52.5 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.015 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -158.26 30.16 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.392 -0.817 . . . . 0.0 110.657 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -55.9 121.58 9.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.77 -0.581 . . . . 0.0 110.557 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.657 ' CD1' HD22 ' A' ' 86' ' ' LEU . 23.6 m-85 -85.21 122.73 29.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.544 -0.722 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.03 152.84 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.844 HD22 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -154.54 128.04 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.424 -0.798 . . . . 0.0 110.75 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 108' ' ' VAL . 24.3 tttm -60.57 146.34 45.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.105 0.955 . . . . 0.0 110.431 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.643 ' OE1' HG21 ' A' ' 198' ' ' ILE . 4.2 mm-40 -61.15 128.57 37.07 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.63 40.54 97.61 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.862 -0.524 . . . . 0.0 112.862 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.844 HG21 HD22 ' A' ' 104' ' ' LEU . 31.9 m -83.38 178.09 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 118.861 1.33 . . . . 0.0 110.044 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -120.27 96.38 5.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.455 ' HD2' HG23 ' A' ' 108' ' ' VAL . 52.7 p90 -118.93 157.54 27.49 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.887 0.851 . . . . 0.0 112.407 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -116.67 157.3 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 159' ' ' LEU . 71.8 mt -116.46 154.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -137.87 122.17 18.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.809 -0.557 . . . . 0.0 109.507 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 mm -106.54 147.09 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 110.648 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 m -127.42 134.83 49.86 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.557 ' CD2' ' HE1' ' A' ' 126' ' ' MET . 41.1 p90 -152.18 140.78 20.77 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.0 111.203 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -88.43 142.33 27.81 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.436 0.636 . . . . 0.0 110.946 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.96 95.49 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -129.41 48.27 2.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.0 111.687 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 -67.08 0.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.294 -0.879 . . . . 0.0 110.764 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -143.1 178.07 7.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.15 107.83 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 70' ' ' VAL . 59.5 t -95.9 82.02 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 p -84.64 113.4 21.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.667 -0.646 . . . . 0.0 110.438 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.68 37.07 0.8 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.557 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -79.51 145.32 33.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.498 -1.001 . . . . 0.0 109.797 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -143.82 141.23 30.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 110.958 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -109.0 109.05 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.4 mt -96.66 161.46 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 110.117 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -159.34 118.9 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.69 -0.631 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 17.8 m-70 -106.41 134.7 49.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.726 . . . . 0.0 109.899 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.654 HG22 HD11 ' A' ' 139' ' ' ILE . 3.8 m -90.11 113.42 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.646 -0.659 . . . . 0.0 109.981 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 2.3 m-85 -111.38 119.32 38.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.679 . . . . 0.0 109.947 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -120.88 129.14 53.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.656 -0.652 . . . . 0.0 110.348 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt 52.68 39.25 28.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.35 -0.844 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.88 30.43 72.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.5 t -143.11 119.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.997 . . . . 0.0 109.881 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -77.22 138.88 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.137 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.654 HD11 HG22 ' A' ' 132' ' ' THR . 0.1 OUTLIER -116.8 -26.87 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.492 -0.755 . . . . 0.0 110.555 179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -169.67 144.97 3.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -142.42 139.88 31.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.089 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.5 m -120.51 160.8 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.824 . . . . 0.0 111.061 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -126.21 73.81 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.088 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.89 141.67 58.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.708 . . . . 0.0 110.613 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 ttt -94.37 124.27 38.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 158' ' ' PHE . 26.3 t -79.75 -58.86 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.26 175.75 14.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.1 p -86.29 147.88 25.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.922 . . . . 0.0 109.853 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.432 ' OH ' HG12 ' A' ' 146' ' ' VAL . 67.3 m-85 -146.31 135.73 22.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.44 161.03 30.92 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.66 62.58 5.57 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.41 1.216 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -170.52 54.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.469 -0.77 . . . . 0.0 110.418 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.749 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -155.99 23.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.499 -0.751 . . . . 0.0 111.244 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 40.46 -150.16 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.862 -0.524 . . . . 0.0 112.269 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.699 ' HG2' HG21 ' A' ' 73' ' ' THR . 49.8 mt-10 -67.41 114.42 6.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.28 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.749 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 3.9 m-85 -73.37 -173.34 1.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.606 -0.684 . . . . 0.0 109.755 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.96 82.53 1.44 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.571 -0.706 . . . . 0.0 110.727 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.533 ' HB2' HG13 ' A' ' 146' ' ' VAL . 42.7 t80 -80.97 161.99 24.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.392 -0.817 . . . . 0.0 109.384 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER -150.51 117.54 5.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.952 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.5 p -81.05 156.7 71.9 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.434 -0.791 . . . . 0.0 108.877 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 166.3 20.03 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.711 1.374 . . . . 0.0 110.979 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 135.62 56.31 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.417 0.627 . . . . 0.0 110.948 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.64 127.49 42.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.412 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -79.2 139.65 37.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.48 -0.762 . . . . 0.0 110.883 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.33 170.52 11.19 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.733 -0.605 . . . . 0.0 110.41 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.37 132.76 21.35 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 O-C-N 123.434 1.228 . . . . 0.0 110.405 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 -171.83 2.08 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.653 -0.655 . . . . 0.0 110.571 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.55 -157.15 15.19 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.45 -38.91 6.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.626 -0.926 . . . . 0.0 109.573 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.734 ' O ' HD23 ' A' ' 170' ' ' LEU . 2.2 tt -86.68 -22.68 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.761 -0.587 . . . . 0.0 110.235 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HB3' ' OE2' ' A' ' 106' ' ' GLU . . . -55.5 -22.21 20.02 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -0.848 . . . . 0.0 110.778 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.426 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 40.2 mtp180 -62.22 147.6 47.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 110.171 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 138.17 -171.95 23.15 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.6 p -96.26 137.06 35.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.6 -0.941 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.32 108.76 14.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.629 -0.669 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.76 131.71 42.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.442 -0.786 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.2 mt -121.27 147.99 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.32 -0.863 . . . . 0.0 110.725 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -112.23 111.01 21.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.438 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 3.1 m -103.39 125.0 49.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 110.135 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -113.92 114.55 26.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 110.315 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.442 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -96.11 130.54 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 109.938 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 t -156.2 -163.45 1.47 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.528 -0.733 . . . . 0.0 110.473 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 8.6 p-10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.651 -0.655 . . . . 0.0 109.932 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.103 0.478 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.28 96.46 5.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 1.6 m-70 -60.14 -47.33 86.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 109.805 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.594 HD23 ' HB ' ' A' ' 72' ' ' VAL . 23.3 tp -170.89 107.81 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.709 -0.619 . . . . 0.0 109.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -113.31 131.0 56.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.629 -0.67 . . . . 0.0 110.124 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.585 ' CE2' HD21 ' A' ' 90' ' ' LEU . 25.1 p90 -133.92 -154.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.761 . . . . 0.0 109.938 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -167.91 130.74 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.629 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 16.6 p-90 -133.14 146.23 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.681 . . . . 0.0 109.829 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.75 149.25 21.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.695 -0.628 . . . . 0.0 110.627 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.783 HD11 HD12 ' A' ' 104' ' ' LEU . 22.3 tp -121.33 108.76 14.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.689 -0.632 . . . . 0.0 109.391 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.5 m -78.22 136.8 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.643 HG21 ' OE1' ' A' ' 106' ' ' GLU . 47.6 mm -111.1 151.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.712 -0.618 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.35 -160.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.659 -0.65 . . . . 0.0 109.721 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -119.62 -30.79 4.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -135.73 59.9 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 111.493 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -66.09 -11.3 47.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.305 -0.872 . . . . 0.0 111.338 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -157.02 51.22 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.02 . . . . 0.0 110.205 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.591 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 70' ' ' VAL . 46.5 t -140.37 30.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.612 0.72 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.887 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -68.0 138.04 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.203 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.611 HG21 ' CZ3' ' A' ' 192' ' ' TRP . 67.5 t -63.07 124.39 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 116' ' ' PHE . 36.4 p -87.03 -63.5 1.3 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.258 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -135.99 172.16 13.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.357 -0.84 . . . . 0.0 111.119 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.08 124.51 14.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.712 -0.618 . . . . 0.0 109.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m -109.89 158.47 18.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.787 . . . . 0.0 110.455 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -142.3 103.22 4.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.229 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.0 t -105.53 166.95 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.497 -0.752 . . . . 0.0 110.34 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -160.45 -157.92 0.58 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.961 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -101.97 -29.41 11.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 0.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.4 p -138.17 41.78 2.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.675 -0.641 . . . . 0.0 110.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.449 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.39 163.43 31.06 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.592 -0.692 . . . . 0.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.27 -25.2 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.491 1.258 . . . . 0.0 110.244 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.04 167.57 25.84 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.44 100.07 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.515 1.271 . . . . 0.0 110.243 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.55 115.51 5.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.665 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -97.82 101.23 12.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.447 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -82.63 125.49 31.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.534 -0.729 . . . . 0.0 109.913 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.0 134.36 35.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.652 -0.655 . . . . 0.0 110.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.513 HD13 ' CG1' ' A' ' 72' ' ' VAL . 6.4 mt -135.27 55.15 1.9 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.66 -0.65 . . . . 0.0 109.923 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -106.34 -72.98 0.7 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.692 . . . . 0.0 110.524 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.4 -77.99 0.78 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.05 92.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.451 -1.029 . . . . 0.0 110.41 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 94' ' ' LEU . 44.2 mt -92.34 -37.69 12.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.663 -0.648 . . . . 0.0 110.046 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -18.84 36.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.511 -0.743 . . . . 0.0 110.879 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.1 p -53.89 -22.51 10.15 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.299 -0.876 . . . . 0.0 111.153 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 88' ' ' LEU . 7.0 m-30 -60.84 -30.24 69.98 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 109.87 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -60.78 -26.7 67.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.672 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.49 22.7 5.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.596 -0.69 . . . . 0.0 110.707 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -171.19 128.64 0.71 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 p -113.21 179.58 3.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.665 -0.647 . . . . 0.0 110.185 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 196' ' ' LEU . 7.1 m-85 -111.59 104.96 13.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.7 139.74 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.48 -0.762 . . . . 0.0 110.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -154.33 161.45 41.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.706 -0.621 . . . . 0.0 110.263 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.423 ' HB2' HG11 ' A' ' 108' ' ' VAL . 1.1 mtpm? -76.47 152.16 36.22 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.523 -0.735 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -20.61 -74.31 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.61 69.56 0.46 Allowed Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.415 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.651 HG21 HD22 ' A' ' 104' ' ' LEU . 33.9 m -80.27 -176.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.524 -0.986 . . . . 0.0 110.071 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.25 96.93 6.04 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.441 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 44.6 p90 -113.26 149.23 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.505 -0.747 . . . . 0.0 111.987 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HD3' HD21 ' A' ' 159' ' ' LEU . 2.5 ttt180 -107.32 155.48 19.93 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -121.43 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.008 -1.058 . . . . 0.0 111.197 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -120.83 107.29 12.54 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.28 151.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.44 -0.787 . . . . 0.0 111.073 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -131.32 152.1 50.89 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.65 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.1 p90 -167.84 159.05 11.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 111.15 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -93.06 135.92 33.8 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.202 0.525 . . . . 0.0 111.377 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.06 85.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.21 48.38 2.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.535 -0.728 . . . . 0.0 111.998 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -68.51 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 171.51 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 0.0 110.586 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.96 108.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.666 -0.646 . . . . 0.0 110.264 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 70' ' ' VAL . 65.6 t -93.99 75.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.646 -0.658 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.44 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 69.8 p -64.68 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.657 -0.652 . . . . 0.0 110.358 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.92 49.38 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.45 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -79.78 120.7 24.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.257 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -132.88 148.2 52.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 111.1 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -125.38 113.37 17.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -114.47 146.71 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.625 -0.672 . . . . 0.0 110.511 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.67 141.83 43.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.556 -0.715 . . . . 0.0 110.08 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.815 ' O ' HG23 ' A' ' 177' ' ' ILE . 6.9 m80 -101.07 164.72 11.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.684 . . . . 0.0 109.634 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.426 ' CG2' HD11 ' A' ' 139' ' ' ILE . 17.6 m -119.7 61.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.951 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.88 118.75 7.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.741 . . . . 0.0 110.417 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.603 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -120.92 138.26 54.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.619 -0.675 . . . . 0.0 110.017 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? 53.35 28.74 7.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.412 -0.805 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.37 -11.46 63.34 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.196 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.8 m -111.55 148.02 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.024 -1.28 . . . . 0.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 135.92 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.284 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.426 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -120.68 -26.26 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.752 . . . . 0.0 111.049 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -176.3 146.02 0.62 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -133.67 143.13 48.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.535 -0.728 . . . . 0.0 109.76 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 129' ' ' ILE . 17.2 m -109.9 151.83 26.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.604 -0.685 . . . . 0.0 111.043 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -126.05 136.39 52.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.63 -0.669 . . . . 0.0 109.836 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -123.41 129.02 50.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.451 -0.781 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.7 ttm -91.75 107.97 19.58 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.845 HG12 ' CE1' ' A' ' 149' ' ' TYR . 61.8 t -79.68 -44.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.309 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.68 -173.82 19.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.44 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 31.9 m -84.84 126.32 33.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.604 -0.939 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.845 ' CE1' HG12 ' A' ' 146' ' ' VAL . 8.8 m-85 -113.51 131.46 56.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.725 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -118.19 145.09 18.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.81 142.77 35.97 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.382 1.201 . . . . 0.0 110.186 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.61 -39.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.566 -0.709 . . . . 0.0 110.774 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.6 -81.85 0.46 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 111.416 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.28 -136.31 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 110.424 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.78 166.01 22.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.887 -1.133 . . . . 0.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 33.5 m-85 -121.31 -175.99 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -133.78 114.96 13.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.447 -0.783 . . . . 0.0 111.019 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.615 ' CD1' HG13 ' A' ' 146' ' ' VAL . 34.4 t80 -100.41 159.97 14.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.725 . . . . 0.0 109.202 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.438 HD21 ' HD3' ' A' ' 111' ' ' ARG . 1.1 tt -149.81 118.79 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.459 -0.776 . . . . 0.0 110.946 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.6 p -89.78 156.41 47.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.094 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.53 169.53 12.58 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.652 1.343 . . . . 0.0 110.83 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 129.47 41.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.406 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 7.2 mm-40 -116.33 127.27 54.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.626 -0.671 . . . . 0.0 109.631 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -83.2 133.61 35.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.441 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -82.79 165.15 43.32 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.765 -0.585 . . . . 0.0 110.188 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.2 Cg_endo -73.2 123.69 8.97 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.401 1.211 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 169.2 8.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.654 -0.653 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.01 160.82 10.76 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.78 -43.54 97.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.969 . . . . 0.0 110.151 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -79.67 -27.35 40.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.647 -0.658 . . . . 0.0 110.216 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.97 -22.18 59.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.499 -0.751 . . . . 0.0 110.645 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -68.23 131.17 44.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.478 -0.764 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 151.71 179.4 27.34 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.2 p -87.44 130.16 34.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.524 -0.986 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.03 113.88 26.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 110.641 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.86 125.33 29.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.458 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 131' ' ' HIS . 17.7 mt -117.61 137.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.379 -0.825 . . . . 0.0 110.959 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -103.31 96.86 7.04 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.4 p -94.25 125.39 38.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.683 . . . . 0.0 110.671 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -127.6 96.83 4.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.681 . . . . 0.0 109.997 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -83.14 91.27 7.2 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.586 -0.696 . . . . 0.0 110.087 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.9 t -116.98 -171.77 2.09 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 p30 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.364 179.151 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.502 2.143 0 CA-C-O 121.242 0.544 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.07 120.01 38.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 16.3 m-70 -82.75 -73.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.779 . . . . 0.0 110.864 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.887 HD22 HG13 ' A' ' 71' ' ' VAL . 3.1 tp -156.05 151.19 26.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.669 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 t -153.86 139.69 18.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.663 . . . . 0.0 109.786 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.611 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 21.9 p90 -135.19 -153.57 0.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.99 132.01 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 17.0 p-90 -139.33 147.1 41.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.678 -0.639 . . . . 0.0 109.614 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.78 152.05 20.95 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.518 0.675 . . . . 0.0 111.26 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 102' ' ' PHE . 9.4 tp -126.16 91.54 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -67.9 137.2 55.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.608 -0.682 . . . . 0.0 110.436 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -114.53 145.3 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 109.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -144.16 -153.07 0.45 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 109.84 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -132.06 1.41 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.399 -0.813 . . . . 0.0 111.661 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -160.23 46.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.942 -1.099 . . . . 0.0 111.122 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.478 ' CH2' HD21 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -59.15 -18.63 37.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 111.197 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -152.47 48.24 0.75 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.219 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.1 t30 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 123' ' ' VAL . 93.3 t -141.92 117.76 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.507 0.67 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.0 t -139.66 144.05 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.899 -0.501 . . . . 0.0 109.775 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.0 t -64.27 99.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 116' ' ' PHE . 82.1 p -70.83 -44.63 66.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.715 -0.616 . . . . 0.0 111.228 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -154.97 158.0 38.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 76' ' ' THR . 8.2 tt -119.32 152.57 36.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.724 -0.61 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.555 ' N ' HD23 ' A' ' 75' ' ' LEU . 19.5 m -139.77 152.64 46.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -0.765 . . . . 0.0 110.631 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -136.67 83.52 2.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.574 -0.704 . . . . 0.0 109.973 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.85 149.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.634 . . . . 0.0 110.14 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 94.8 m -146.07 -164.96 2.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.693 -0.629 . . . . 0.0 110.037 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.6 p -103.53 -76.9 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.775 . . . . 0.0 110.758 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 p -96.26 32.59 1.93 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.826 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.28 178.99 1.63 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.652 -0.655 . . . . 0.0 110.087 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.771 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 46.6 Cg_endo -74.25 -26.85 12.1 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.342 1.18 . . . . 0.0 110.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 156.63 -179.42 32.48 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.0 Cg_endo -71.72 111.4 3.13 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.488 1.257 . . . . 0.0 110.416 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' CD1' ' A' ' 102' ' ' PHE . 13.8 mt -65.76 115.66 6.14 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.99 137.78 34.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.97 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 3.9 mt -132.71 119.67 20.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 0.0 109.717 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.49 141.95 50.17 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.599 HD21 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -138.51 56.3 1.72 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.753 . . . . 0.0 110.059 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -105.99 -66.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.265 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.57 -46.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.91 65.15 1.94 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.574 -0.956 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.651 HD23 ' CE1' ' A' ' 97' ' ' PHE . 13.4 mt -84.19 0.1 50.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.575 -0.703 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.61 -27.29 64.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.029 . . . . 0.0 110.787 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.8 m -65.42 -13.77 59.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.463 -0.773 . . . . 0.0 111.065 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.97 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 10.7 m-85 -72.19 -52.51 16.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.286 -0.883 . . . . 0.0 110.711 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -57.68 -20.24 32.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.521 -0.737 . . . . 0.0 111.007 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -115.0 44.96 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.4 -0.812 . . . . 0.0 110.393 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -168.66 146.55 4.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 p -150.98 131.39 13.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 109.82 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.938 ' CD1' HD22 ' A' ' 86' ' ' LEU . 15.1 m-85 -77.12 122.99 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 110.189 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.65 113.17 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 109.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.015 HD21 HG22 ' A' ' 108' ' ' VAL . 4.1 tt -113.62 156.81 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.657 ' N ' HD23 ' A' ' 104' ' ' LEU . 31.8 tttt -80.9 161.8 24.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -40.82 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 29.73 66.77 0.11 Allowed Glycine 0 N--CA 1.507 3.372 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.777 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.015 HG22 HD21 ' A' ' 104' ' ' LEU . 30.5 m -79.01 -160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.224 -1.162 . . . . 0.0 109.201 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.09 117.11 27.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.464 -0.773 . . . . 0.0 109.54 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.604 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 10.8 p90 -137.67 152.13 48.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.306 -0.872 . . . . 0.0 111.916 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -109.67 150.27 28.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.39 151.56 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.133 -0.979 . . . . 0.0 111.703 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HG3' HD23 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -126.24 93.28 3.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.989 HG21 ' CE2' ' A' ' 181' ' ' PHE . 47.8 mm -81.18 142.6 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.743 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.8 m -122.08 135.94 54.86 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.758 ' HA ' HG23 ' A' ' 73' ' ' THR . 15.5 p90 -153.06 145.34 23.95 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.333 -0.854 . . . . 0.0 111.158 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -88.52 128.25 35.55 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 70' ' ' VAL . 59.9 t -123.39 84.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.75 48.88 2.32 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 111.86 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -145.42 -66.32 0.31 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.237 -0.914 . . . . 0.0 110.904 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.74 168.92 17.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.339 -0.851 . . . . 0.0 110.412 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.29 108.37 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.99 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 70' ' ' VAL . 97.6 t -89.4 86.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 109.798 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.3 p -88.11 88.48 7.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.616 -0.677 . . . . 0.0 110.384 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 137.94 44.64 0.08 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -80.99 121.07 25.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 109.793 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -129.5 137.42 50.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.728 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.502 ' CD1' ' CD2' ' A' ' 181' ' ' PHE . 14.0 t80 -111.62 139.02 47.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.723 . . . . 0.0 109.678 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.0 mt -136.79 144.45 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.541 -0.725 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.52 144.28 37.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 110.057 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 14.9 m-70 -117.23 116.92 28.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.596 -0.69 . . . . 0.0 110.156 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 139' ' ' ILE . 29.3 m -68.04 77.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 0.0 110.202 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 4.2 m-85 -76.39 125.99 30.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 7.9 tpt180 -120.75 120.89 36.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt 52.89 38.59 27.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.488 -0.757 . . . . 0.0 110.754 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 72.8 35.56 58.47 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.5 t -147.1 109.14 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.955 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 4.9 pttm -63.02 128.9 37.99 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.637 -0.664 . . . . 0.0 110.232 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pt -115.53 -23.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.635 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.43 132.18 0.29 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.89 149.99 49.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.683 . . . . 0.0 109.634 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -127.56 154.89 44.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.514 -0.741 . . . . 0.0 110.838 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -126.01 121.44 33.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.63 -0.669 . . . . 0.0 110.052 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -110.99 145.7 37.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.703 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -92.08 119.33 31.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.228 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 58.9 t -79.58 -52.43 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 110.304 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.7 175.81 14.2 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 30.8 t -99.02 139.37 34.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.927 . . . . 0.0 110.063 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.492 ' HE2' HG12 ' A' ' 146' ' ' VAL . 47.0 m-85 -142.04 126.89 18.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.694 . . . . 0.0 110.308 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.25 164.78 28.56 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.08 92.97 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.447 1.235 . . . . 0.0 110.342 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -169.49 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 0.0 110.447 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.778 ' HB3' ' CZ ' ' A' ' 156' ' ' TYR . . . -92.43 19.33 7.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.542 -0.724 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 38.1 mt-10 56.2 -143.88 0.7 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 152.35 45.5 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.05 -1.031 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.778 ' CZ ' ' HB3' ' A' ' 153' ' ' ALA . 42.0 m-85 -116.13 -176.31 2.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 109.546 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -147.49 104.31 3.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.509 -0.744 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.531 ' HE2' HG22 ' A' ' 160' ' ' THR . 34.9 t80 -77.85 165.81 23.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -146.87 97.57 2.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.396 -0.815 . . . . 0.0 110.653 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.531 HG22 ' HE2' ' A' ' 158' ' ' PHE . 75.0 p -72.79 149.17 90.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.46 157.55 54.28 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.415 1.218 . . . . 0.0 110.702 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.71 93.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.606 -0.684 . . . . 0.0 110.976 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -79.87 167.71 20.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.416 -0.803 . . . . 0.0 109.862 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.69 123.32 48.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.504 -0.747 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -75.45 177.03 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.4 Cg_endo -73.45 127.73 12.09 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.298 1.157 . . . . 0.0 111.112 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 5.4 ptpp? -115.63 174.97 5.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 110.121 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.65 156.5 10.66 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 15.2 ttt -62.33 -46.61 87.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.734 -0.862 . . . . 0.0 109.998 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.3 tt -73.89 -26.42 60.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.645 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -57.93 -20.7 39.44 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.421 -0.799 . . . . 0.0 110.719 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 2.7 mtp-105 -58.5 125.22 22.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.304 -0.872 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.75 175.4 27.65 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.4 p -84.86 134.7 34.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.594 -0.945 . . . . 0.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 32.3 m-85 -115.59 101.41 8.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.607 -0.683 . . . . 0.0 110.693 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.18 121.37 17.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.714 . . . . 0.0 109.112 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.516 HD12 ' CZ2' ' A' ' 194' ' ' TRP . 42.6 mt -110.09 126.61 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.53 -0.732 . . . . 0.0 110.99 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -87.4 92.52 9.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.685 -0.634 . . . . 0.0 109.879 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.0 p -84.98 140.94 30.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.658 -0.651 . . . . 0.0 110.674 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.82 83.62 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.892 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -78.26 128.66 34.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.668 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -162.72 -169.88 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.672 . . . . 0.0 110.52 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.878 -0.514 . . . . 0.0 109.762 179.686 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 121.105 0.479 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.35 110.99 20.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.48 -55.04 13.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.464 -0.773 . . . . 0.0 110.665 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -166.54 164.19 17.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 190' ' ' LEU . 17.6 p -168.23 134.73 1.99 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.853 -0.529 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.599 ' CD2' HD21 ' A' ' 90' ' ' LEU . 14.5 p90 -147.0 -155.21 0.6 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 110.442 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -157.81 127.68 6.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.533 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 12.3 p-90 -134.79 146.21 49.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.697 -0.627 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.91 136.11 40.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.656 -0.653 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.748 HD21 HD13 ' A' ' 104' ' ' LEU . 6.7 tp -110.36 98.55 7.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.6 m -73.14 121.07 19.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.651 -0.656 . . . . 0.0 110.515 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 104' ' ' LEU . 47.7 mm -90.24 149.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.592 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 -155.82 0.64 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 110.456 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -120.22 -21.3 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.504 -0.747 . . . . 0.0 111.268 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -155.04 81.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -79.74 3.21 20.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.478 -0.764 . . . . 0.0 111.501 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 44.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.086 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 123' ' ' VAL . 77.7 t -110.15 140.09 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.662 . . . . 0.0 110.354 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HD22 ' A' ' 190' ' ' LEU . 72.3 t -149.43 144.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.731 -0.606 . . . . 0.0 109.616 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 HD13 ' A' ' 90' ' ' LEU . 57.4 t -68.4 100.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 117' ' ' ARG . 68.0 p -70.23 -44.46 68.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.596 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -159.29 173.92 15.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 76' ' ' THR . 9.7 tt -144.3 164.41 30.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.688 -0.632 . . . . 0.0 109.544 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.678 ' N ' HD23 ' A' ' 75' ' ' LEU . 27.4 m -151.55 163.01 39.98 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.432 -0.792 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -143.36 84.19 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.604 -0.685 . . . . 0.0 109.895 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.98 143.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.731 -0.606 . . . . 0.0 110.106 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 89.7 m -141.67 -163.13 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.592 -0.693 . . . . 0.0 110.077 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.9 p -110.53 -72.68 0.71 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.466 -0.772 . . . . 0.0 110.677 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -95.75 27.66 3.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.565 -0.709 . . . . 0.0 110.639 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.27 -176.52 0.65 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -76.28 -25.04 10.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.311 1.163 . . . . 0.0 110.016 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.07 -177.08 30.91 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.484 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 91.55 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.556 1.292 . . . . 0.0 110.558 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.83 111.41 2.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.696 . . . . 0.0 109.386 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.86 159.83 14.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.0 110.872 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.801 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.4 mt -132.18 128.16 37.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.722 -0.611 . . . . 0.0 109.912 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 133.46 40.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -132.09 51.79 2.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.3 p -123.82 -65.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.391 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.92 -53.18 0.21 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.99 71.97 0.4 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.541 -0.976 . . . . 0.0 110.158 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -93.71 -33.84 13.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.29 -26.99 65.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.591 -0.693 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.4 t -60.34 -23.68 64.44 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 110.472 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.801 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.3 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -73.63 -26.96 61.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.64 -0.663 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -105.08 28.91 6.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.453 -0.779 . . . . 0.0 110.284 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -158.46 139.82 13.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.716 . . . . 0.0 110.127 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -126.24 -175.8 3.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 110.4 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.7 m-85 -116.65 109.31 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.673 -0.642 . . . . 0.0 109.99 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.11 105.73 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -0.779 . . . . 0.0 109.793 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.071 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -122.43 158.62 29.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.627 -0.67 . . . . 0.0 110.077 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.683 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.2 tttt -87.22 161.56 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.472 -0.767 . . . . 0.0 110.385 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 105' ' ' LYS . 33.9 mt-10 -18.58 -71.63 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -150.27 63.26 0.4 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.699 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.071 HG22 HD21 ' A' ' 104' ' ' LEU . 34.5 m -73.29 127.41 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.442 -1.034 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -71.71 94.77 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.6 p90 -109.49 154.87 22.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 111.838 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.3 131.1 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 76' ' ' THR . 62.1 mt -96.04 142.28 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.261 -0.9 . . . . 0.0 110.533 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -117.85 102.69 9.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.7 mm -88.11 127.92 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.755 . . . . 0.0 110.685 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -113.06 137.89 50.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 116' ' ' PHE . 19.5 p90 -151.05 174.84 12.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 110.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.6 mmm-85 -127.64 150.83 49.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 111.322 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -132.67 111.32 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -128.66 48.39 2.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.472 -0.767 . . . . 0.0 111.472 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -69.71 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.0 110.646 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -137.93 171.98 13.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.431 -0.793 . . . . 0.0 110.472 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 149' ' ' TYR . 86.9 mt -80.0 109.84 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.615 . . . . 0.0 109.966 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 70' ' ' VAL . 66.9 t -84.65 82.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.848 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 p -81.21 77.58 8.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.637 -0.664 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.97 46.08 0.04 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.623 ' HE3' ' CE2' ' A' ' 181' ' ' PHE . 1.3 tpp -79.54 137.68 37.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.546 -0.973 . . . . 0.0 109.489 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -126.11 158.15 36.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -134.31 109.9 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.4 mp -107.74 166.22 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.496 -0.753 . . . . 0.0 110.437 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.474 ' N ' HG22 ' A' ' 129' ' ' ILE . 1.4 mt-30 -154.96 127.89 8.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.665 -0.647 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 12.9 m-70 -110.32 117.19 32.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 139' ' ' ILE . 19.3 m -68.51 78.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 0.0 109.902 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 2.7 m-85 -78.25 105.1 9.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.191 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.533 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.0 tpt180 -120.76 153.76 36.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.683 -0.636 . . . . 0.0 109.686 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 52.91 36.22 21.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.33 -0.857 . . . . 0.0 110.786 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.437 ' C ' HG13 ' A' ' 137' ' ' VAL . . . 63.32 23.91 66.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 134' ' ' ARG . 35.4 m -149.3 149.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.306 -1.114 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 21.8 ttmt -80.1 136.31 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.0 110.247 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -118.5 -25.19 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.456 -0.778 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -174.69 143.29 0.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.104 -0.998 . . . . 0.0 110.248 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 2.9 pttt -137.76 166.45 23.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.234 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.1 m -145.0 156.56 44.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.586 -0.696 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.91 132.65 52.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 110.335 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -123.08 121.92 37.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.709 . . . . 0.0 110.576 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.406 ' O ' ' CZ ' ' A' ' 158' ' ' PHE . 23.6 mtp -65.15 122.08 16.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -0.786 . . . . 0.0 109.29 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 158' ' ' PHE . 48.8 t -79.27 -56.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 110.298 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 137.41 174.04 13.17 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 p -84.99 150.31 24.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.701 -0.882 . . . . 0.0 109.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.507 ' CE2' HG12 ' A' ' 146' ' ' VAL . 69.8 m-85 -146.7 161.32 40.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.357 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -110.07 154.55 16.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -72.64 -156.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.713 1.375 . . . . 0.0 110.321 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 25.4 mtp-105 73.09 51.23 0.14 Allowed 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 50.64 23.69 1.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.428 -0.795 . . . . 0.0 111.852 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 tt0 -79.38 103.43 9.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.56 112.91 24.8 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.615 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 78.5 m-85 -96.75 -175.3 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.738 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -141.02 112.51 7.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.681 ' HB2' HG13 ' A' ' 146' ' ' VAL . 30.8 t80 -83.82 160.46 21.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.226 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.05 100.82 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 111.459 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.4 p -69.56 149.35 97.01 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.35 -179.45 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.591 1.311 . . . . 0.0 111.077 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptm -53.73 144.88 16.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.685 -0.634 . . . . 0.0 111.232 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.407 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 12.3 mt-10 -140.54 96.35 3.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.73 -0.606 . . . . 0.0 109.673 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.76 121.76 17.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.625 -0.672 . . . . 0.0 110.595 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -55.0 176.49 0.15 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.723 -0.611 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.762 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 45.6 Cg_endo -71.08 118.38 5.66 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.367 1.193 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 20.6 mttt -90.75 165.85 13.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.605 -0.684 . . . . 0.0 110.712 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.82 143.64 14.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.467 ' HA ' ' CD ' ' A' ' 172' ' ' ARG . 30.6 mtp -60.26 -42.24 94.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.521 -0.988 . . . . 0.0 109.511 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 170' ' ' LEU . 1.9 tm? -64.55 -22.23 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.869 -0.519 . . . . 0.0 109.938 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -92.72 23.06 4.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.82 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 169' ' ' MET . 45.9 mtm180 -100.37 176.85 5.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.257 -0.902 . . . . 0.0 110.029 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 105.63 -173.99 20.64 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.9 p -86.04 131.05 34.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.924 . . . . 0.0 110.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 134' ' ' ARG . 24.7 m-85 -116.67 108.5 15.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.688 -0.633 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -73.85 121.2 20.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.533 -0.73 . . . . 0.0 109.128 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.3 mt -110.09 129.61 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.4 -0.812 . . . . 0.0 111.061 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 108.54 20.41 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.698 -0.626 . . . . 0.0 109.729 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -113.16 135.15 54.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.53 ' CD ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.8 118.43 23.71 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.604 0.716 . . . . 0.0 110.361 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.623 ' CE2' ' HE3' ' A' ' 126' ' ' MET . 0.9 OUTLIER -91.41 94.64 9.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.535 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -116.82 -172.5 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 111.092 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.88 -0.512 . . . . 0.0 109.904 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 121.239 0.543 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.89 118.62 34.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.728 -0.607 . . . . 0.0 109.757 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -57.87 -50.79 72.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.483 -0.761 . . . . 0.0 110.697 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.678 HD22 HG13 ' A' ' 71' ' ' VAL . 4.0 tp -169.4 151.12 4.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 65.3 p -147.74 161.29 41.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 16.9 p90 -146.58 -156.23 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.766 . . . . 0.0 110.232 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.94 131.45 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.621 -0.674 . . . . 0.0 110.562 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.86 146.31 41.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.652 -0.655 . . . . 0.0 109.799 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.69 146.59 24.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.699 . . . . 0.0 111.079 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 102' ' ' PHE . 53.2 tp -116.23 97.43 6.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.4 m -72.11 111.9 7.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 0.0 110.081 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 48.5 mm -90.41 146.94 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.625 -0.672 . . . . 0.0 109.811 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -138.25 -156.91 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.684 -0.635 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -115.85 -24.31 8.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 110.72 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.79 94.89 1.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.611 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.821 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -84.95 12.19 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.606 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -153.65 40.1 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 110.18 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.116 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.079 0.466 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 123' ' ' VAL . 95.7 t -119.96 126.51 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.792 -0.567 . . . . 0.0 110.164 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 70' ' ' VAL . 64.5 t -149.02 132.55 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.832 -0.542 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.0 t -67.18 108.64 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.778 HG23 ' HA ' ' A' ' 116' ' ' PHE . 68.7 p -71.2 -62.05 1.54 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.66 . . . . 0.0 110.728 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -141.03 169.01 18.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.944 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.3 tt -130.64 124.49 31.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.648 -0.657 . . . . 0.0 109.744 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 112' ' ' ILE . 46.9 m -109.9 159.71 17.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -0.782 . . . . 0.0 110.486 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mt -139.76 84.15 1.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.539 -0.726 . . . . 0.0 109.978 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 59.6 t -82.21 166.68 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.685 -0.634 . . . . 0.0 110.344 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -162.24 -152.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.607 -0.683 . . . . 0.0 109.847 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.04 -36.24 2.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 111.068 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -126.7 26.25 6.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.348 -0.845 . . . . 0.0 110.8 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.36 -175.51 0.54 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.403 -0.811 . . . . 0.0 110.235 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.7 Cg_endo -80.14 -30.97 1.91 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.313 1.165 . . . . 0.0 109.97 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.61 175.54 36.24 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.521 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 47.3 Cg_endo -72.4 104.67 1.73 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.521 1.274 . . . . 0.0 110.506 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.62 HD22 ' CD1' ' A' ' 102' ' ' PHE . 2.4 mp -69.41 112.42 5.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 109.493 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.72 146.53 23.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.629 -0.67 . . . . 0.0 110.749 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.934 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -132.42 153.88 50.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 109.81 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.86 133.76 47.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.478 -0.764 . . . . 0.0 110.508 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -132.02 51.93 2.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.501 -0.75 . . . . 0.0 110.103 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.9 p -113.52 -69.57 0.85 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.94 -47.3 0.15 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -72.48 64.9 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.639 -0.919 . . . . 0.0 109.987 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -90.24 -23.16 21.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.397 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.37 -30.67 62.98 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.29 -0.881 . . . . 0.0 110.767 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -58.08 -20.23 38.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.486 -0.759 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -60.02 -30.39 69.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.92 -22.7 66.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.743 -0.598 . . . . 0.0 110.931 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -121.92 60.11 0.98 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.697 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.421 ' CG ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -170.61 125.03 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.374 -0.829 . . . . 0.0 110.363 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.4 p -135.04 127.18 29.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.62 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.8 m-85 -73.98 139.05 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.537 -0.727 . . . . 0.0 109.881 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.16 108.27 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.485 -0.76 . . . . 0.0 110.449 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 196' ' ' LEU . 58.0 mt -113.87 165.73 12.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.55 -0.718 . . . . 0.0 109.69 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 108' ' ' VAL . 15.1 tttm -94.46 160.93 14.43 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -18.28 -108.86 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.99 75.4 0.39 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.33 -1.481 . . . . 0.0 110.144 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 105' ' ' LYS . 34.3 m -85.26 143.76 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.536 -0.979 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -88.92 89.25 7.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.433 ' HE2' HD11 ' A' ' 112' ' ' ILE . 38.6 p90 -110.0 131.09 55.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 111.917 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.02 159.64 14.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 76' ' ' THR . 76.4 mt -126.2 145.3 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.053 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -118.06 102.35 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.432 HG21 ' HE2' ' A' ' 181' ' ' PHE . 48.1 mm -85.2 127.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.522 -0.736 . . . . 0.0 110.851 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.18 145.98 31.92 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.778 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -162.43 149.16 13.25 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.363 -0.835 . . . . 0.0 111.009 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.476 ' HG3' HG21 ' A' ' 73' ' ' THR . 9.0 mtm180 -101.57 133.16 46.68 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.361 0.601 . . . . 0.0 111.282 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.06 96.43 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.52 48.64 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.344 -0.847 . . . . 0.0 111.742 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -146.76 -69.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.224 -0.923 . . . . 0.0 110.794 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.9 158.16 40.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.19 102.9 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.565 -0.709 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 70' ' ' VAL . 62.8 t -85.72 94.99 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.616 -0.677 . . . . 0.0 109.826 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.13 97.83 8.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.617 -0.677 . . . . 0.0 110.294 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.17 41.03 0.38 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.628 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -78.86 126.19 30.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.942 . . . . 0.0 109.78 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 146' ' ' VAL . 1.5 ptmm? -137.2 146.87 45.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HH ' ' HZ2' ' A' ' 192' ' ' TRP . 21.6 t80 -111.13 137.84 48.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -123.19 156.45 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.516 -0.74 . . . . 0.0 110.231 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -154.64 131.88 11.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.793 -0.567 . . . . 0.0 109.74 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.403 ' ND1' ' CB ' ' A' ' 141' ' ' LYS . 23.8 m-70 -110.64 131.56 54.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.547 -0.721 . . . . 0.0 110.098 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 31.3 m -81.87 67.3 7.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.615 -0.678 . . . . 0.0 109.837 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 6.4 m-85 -61.57 136.92 58.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.498 -0.751 . . . . 0.0 110.104 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -120.84 110.53 16.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.75 35.91 22.56 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.471 -0.768 . . . . 0.0 110.588 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.413 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.28 35.31 14.96 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.1 t -147.13 113.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -1.041 . . . . 0.0 110.143 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -67.64 123.92 21.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.649 -0.657 . . . . 0.0 110.189 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.65 -22.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.486 -0.759 . . . . 0.0 110.8 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -169.36 123.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.403 ' CB ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -130.86 154.15 48.36 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.697 . . . . 0.0 109.468 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.5 m -142.45 146.03 34.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -109.33 120.51 42.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.695 -0.628 . . . . 0.0 109.462 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -104.37 117.68 34.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.443 -0.786 . . . . 0.0 110.946 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 124.9 23.92 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 21.7 t -90.53 -56.5 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 110.25 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.33 166.68 10.76 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 79.5 p -81.0 140.63 35.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.637 -0.92 . . . . 0.0 109.558 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 146' ' ' VAL . 43.9 m-85 -139.45 130.04 25.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.425 -0.797 . . . . 0.0 110.36 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.23 166.84 14.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.24 68.89 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.486 1.256 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.96 27.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.666 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -147.3 12.54 1.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 111.676 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 52.21 -145.08 0.57 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.956 -1.09 . . . . 0.0 111.09 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.1 122.4 20.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.39 -0.819 . . . . 0.0 110.948 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 6.5 m-85 -84.17 -173.51 4.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.724 . . . . 0.0 109.911 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -153.9 104.45 2.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 22.3 t80 -85.18 162.61 19.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -140.44 87.1 2.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.403 -0.811 . . . . 0.0 111.305 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.416 HG22 ' HE2' ' A' ' 158' ' ' PHE . 65.5 p -67.19 148.27 98.83 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.37 -0.831 . . . . 0.0 108.965 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.26 157.73 60.57 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.392 1.206 . . . . 0.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.2 ptt? -54.61 108.67 0.41 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.574 -0.704 . . . . 0.0 110.659 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -88.55 155.97 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.38 -0.825 . . . . 0.0 110.296 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.73 137.7 44.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.284 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.628 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -94.16 172.15 6.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.323 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.628 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.0 Cg_endo -73.18 179.77 5.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.382 1.201 . . . . 0.0 110.529 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -170.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.439 -0.788 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.06 -44.14 0.09 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.7 mtt -56.2 -75.27 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -1.102 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -77.64 -2.55 36.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.982 179.069 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.421 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -124.26 28.75 6.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -0.946 . . . . 0.0 110.082 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 163.98 27.22 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.517 -0.739 . . . . 0.0 109.985 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.18 -167.78 14.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.1 p -107.23 130.46 54.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.663 -0.904 . . . . 0.0 110.661 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.61 129.72 50.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.671 -0.643 . . . . 0.0 109.954 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.8 OUTLIER -73.27 143.04 47.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.745 . . . . 0.0 109.851 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.831 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -121.43 130.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.51 -0.744 . . . . 0.0 110.199 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -110.92 98.89 7.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.534 -0.729 . . . . 0.0 109.307 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 10.0 m -100.82 133.66 44.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.648 -0.658 . . . . 0.0 110.422 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -139.54 90.51 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.706 -0.621 . . . . 0.0 109.39 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -75.77 116.47 16.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.837 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 t -129.1 -175.38 3.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.755 -0.59 . . . . 0.0 109.803 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 4.4 p30 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 121.201 0.524 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.59 115.75 30.12 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 31.8 p80 -74.36 -15.21 60.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 0.0 111.31 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.1 tp -168.83 156.22 7.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.124 -0.985 . . . . 0.0 110.853 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.0 p -168.38 143.79 3.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.739 -0.6 . . . . 0.0 109.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CE2' HD21 ' A' ' 90' ' ' LEU . 40.4 p90 -151.19 -156.15 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 110.095 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.6 132.88 3.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 111.085 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -139.33 165.44 27.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.79 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -102.19 159.68 15.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 111.291 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 104' ' ' LEU . 17.6 tp -129.48 109.75 11.31 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.1 m -85.28 130.11 34.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.696 . . . . 0.0 110.85 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.98 152.14 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.63 -0.669 . . . . 0.0 109.402 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -145.13 -151.83 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 110.605 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -107.43 -39.49 5.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 111.302 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -144.6 98.08 3.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.21 -0.931 . . . . 0.0 111.207 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -89.09 35.1 0.79 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.191 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -169.71 34.13 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.27 -0.894 . . . . 0.0 110.136 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.904 -1.045 . . . . 0.0 110.173 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.408 ' OD1' HG23 ' A' ' 70' ' ' VAL . 42.2 t-20 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 120.84 0.352 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 123' ' ' VAL . 94.3 t -130.06 112.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.623 . . . . 0.0 110.461 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -138.64 149.5 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.926 -0.484 . . . . 0.0 109.885 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.678 HG22 ' CD2' ' A' ' 181' ' ' PHE . 59.7 t -65.68 103.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.864 HG23 ' HA ' ' A' ' 116' ' ' PHE . 71.0 p -72.02 -35.94 69.55 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.146 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -167.31 173.09 9.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 110.4 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.5 tt -142.68 124.59 15.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.577 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 77' ' ' LEU . 24.5 m -109.7 167.19 10.33 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.56 -0.713 . . . . 0.0 110.843 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -147.03 80.98 1.54 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.62 -0.675 . . . . 0.0 109.39 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 85' ' ' PRO . 67.0 t -77.49 166.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 110.157 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' N ' HG12 ' A' ' 78' ' ' VAL . 1.2 m -161.17 -166.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.691 -0.63 . . . . 0.0 110.192 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.8 p -116.55 -33.13 4.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -124.17 20.21 9.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.708 . . . . 0.0 110.856 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.62 -174.83 0.47 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.5 Cg_endo -81.02 -30.87 1.51 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.27 1.142 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.19 173.17 34.36 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.89 -1.147 . . . . 0.0 110.55 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.715 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.3 Cg_endo -71.56 96.32 0.74 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.665 1.35 . . . . 0.0 110.372 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 3.6 mt -64.81 123.87 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.652 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 53.1 mt-10 -103.52 122.76 45.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.501 -0.749 . . . . 0.0 110.802 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -102.6 119.17 38.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -67.58 141.0 56.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.587 -0.695 . . . . 0.0 110.688 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -140.35 56.83 1.6 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.471 -0.768 . . . . 0.0 110.073 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.8 p -128.53 -56.22 1.23 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.684 -0.635 . . . . 0.0 110.3 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.89 -51.9 0.04 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.39 69.94 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.597 -0.943 . . . . 0.0 110.147 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 94' ' ' LEU . 10.9 mt -94.23 -22.69 18.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.51 -0.744 . . . . 0.0 110.579 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -22.17 12.88 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.373 -0.83 . . . . 0.0 111.08 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.26 63.38 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 0.0 110.548 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.5 m-85 -58.97 -60.34 4.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.362 -0.836 . . . . 0.0 110.667 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -13.45 47.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.482 -0.761 . . . . 0.0 111.231 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -86.36 -15.99 38.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.16 -0.962 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.68 162.23 34.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -132.4 167.74 19.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.444 ' CE2' HD13 ' A' ' 77' ' ' LEU . 3.9 m-85 -103.18 113.13 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.636 -0.665 . . . . 0.0 109.874 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 104' ' ' LEU . 60.4 t -88.89 117.27 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 110.787 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.673 ' HB3' HG21 ' A' ' 108' ' ' VAL . 37.0 mt -127.6 145.02 51.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.794 ' O ' HG13 ' A' ' 108' ' ' VAL . 26.9 tttm -65.21 142.08 58.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.213 -0.93 . . . . 0.0 108.848 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.0 pt-20 -57.13 110.64 0.87 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.404 -0.81 . . . . 0.0 111.523 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.2 39.73 3.68 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.762 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 105' ' ' LYS . 27.6 m -99.12 133.08 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.128 -1.219 . . . . 0.0 110.653 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.27 98.11 11.15 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' HD2' HG23 ' A' ' 108' ' ' VAL . 38.0 p90 -112.05 144.74 40.91 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.616 0.722 . . . . 0.0 111.611 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -106.55 150.87 25.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.8 mt -119.86 148.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 159' ' ' LEU . 25.3 ttpp -130.08 93.2 3.44 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 44.4 mm -72.88 150.37 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.567 0.699 . . . . 0.0 110.652 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -124.82 145.22 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.864 ' HA ' HG23 ' A' ' 73' ' ' THR . 31.2 p90 -166.28 136.68 3.39 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.523 -0.735 . . . . 0.0 110.501 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -87.26 144.16 26.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.776 -0.578 . . . . 0.0 111.158 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 70' ' ' VAL . 61.5 t -131.03 83.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.577 -0.702 . . . . 0.0 109.415 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.34 48.7 2.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.515 -0.741 . . . . 0.0 111.738 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -147.79 -66.39 0.25 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.287 -0.883 . . . . 0.0 111.126 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.08 169.9 16.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.935 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 91.5 mt -78.4 124.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.63 . . . . 0.0 110.115 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 70' ' ' VAL . 67.9 t -114.11 80.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.2 p -79.77 112.11 16.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.749 -0.595 . . . . 0.0 110.705 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.75 45.35 0.51 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.555 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 1.8 mmt -61.98 132.56 53.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -1.097 . . . . 0.0 109.098 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.16 148.76 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.923 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.96 87.4 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 109.533 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -81.46 169.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.648 . . . . 0.0 110.072 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.49 ' N ' HG22 ' A' ' 129' ' ' ILE . 33.1 tt0 -166.18 120.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.445 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.2 m-70 -103.4 124.88 49.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.0 110.083 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.452 ' CG2' HD11 ' A' ' 139' ' ' ILE . 41.7 m -85.25 68.32 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.373 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -65.96 154.31 39.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.425 -0.797 . . . . 0.0 110.201 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -130.72 86.29 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.598 -0.689 . . . . 0.0 110.602 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 53.63 61.96 2.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.381 -0.825 . . . . 0.0 110.857 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.76 36.58 57.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.01 146.95 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.991 . . . . 0.0 109.793 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.11 121.0 43.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -123.44 -26.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.759 . . . . 0.0 111.145 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -161.82 153.08 18.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.888 -1.133 . . . . 0.0 111.201 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HE3' ' CE1' ' A' ' 131' ' ' HIS . 5.9 ptmt -175.79 135.91 0.31 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.708 . . . . 0.0 109.229 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 143' ' ' ASP . 17.8 m -146.23 168.82 20.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 111.231 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -108.39 151.0 26.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.723 -0.611 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -119.86 128.42 53.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.509 -0.744 . . . . 0.0 110.676 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 ttp -87.77 109.0 19.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.451 -0.781 . . . . 0.0 109.382 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.793 HG13 ' CD1' ' A' ' 158' ' ' PHE . 80.2 t -86.43 -71.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 110.709 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.59 -165.57 38.0 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.7 p -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.676 -0.896 . . . . 0.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.585 ' OH ' HG12 ' A' ' 146' ' ' VAL . 11.8 m-85 -126.22 -173.95 2.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.837 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.69 162.94 26.23 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.83 66.25 2.41 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.314 1.165 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 153' ' ' ALA . 0.7 OUTLIER -68.13 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.555 -0.716 . . . . 0.0 109.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 152' ' ' ARG . . . -178.35 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.005 -1.06 . . . . 0.0 110.709 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -94.02 -171.09 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.444 -0.785 . . . . 0.0 111.563 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.4 144.31 30.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.367 0.604 . . . . 0.0 110.601 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.489 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 60.4 m-85 -107.96 154.64 21.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -128.84 135.28 48.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.331 -0.856 . . . . 0.0 111.371 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.793 ' CD1' HG13 ' A' ' 146' ' ' VAL . 28.0 t80 -103.44 136.18 43.67 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -120.77 116.45 25.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 110.778 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.436 HG22 ' CE2' ' A' ' 158' ' ' PHE . 43.1 p -86.54 153.05 55.55 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 162.56 37.54 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.628 1.331 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.41 123.36 15.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.567 -0.708 . . . . 0.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.45 114.15 27.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.687 -0.633 . . . . 0.0 109.999 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -69.85 127.08 31.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.646 -0.658 . . . . 0.0 110.288 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -69.71 172.75 4.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.8 -0.562 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 44.2 Cg_endo -70.82 147.54 56.28 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 O-C-N 123.427 1.225 . . . . 0.0 110.131 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 35.7 mtmt -115.92 175.57 5.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.514 -0.741 . . . . 0.0 110.461 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 171' ' ' ALA . . . 103.57 147.17 17.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -52.74 43.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.541 -0.976 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 170' ' ' LEU . 9.2 tt -57.48 -27.93 62.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.463 -0.773 . . . . 0.0 110.34 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . -56.48 -23.29 38.25 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 mtp-105 -67.71 126.98 31.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.511 -0.743 . . . . 0.0 109.9 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.32 177.88 28.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 p -91.8 135.81 33.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.918 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -128.56 114.68 17.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 110.054 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.98 148.4 47.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.768 . . . . 0.0 110.132 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.803 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.2 mm -124.09 101.67 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 0.0 110.172 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -91.67 104.0 16.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 14.9 m -113.88 142.94 45.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.516 -0.74 . . . . 0.0 110.939 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -123.49 95.28 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.777 -0.577 . . . . 0.0 109.455 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.678 ' CD2' HG22 ' A' ' 72' ' ' VAL . 6.6 t80 -80.61 73.56 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.711 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.1 t -116.56 -168.84 1.52 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.665 . . . . 0.0 109.319 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.541 -0.725 . . . . 0.0 109.814 179.521 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -115.18 109.61 18.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.63 -0.669 . . . . 0.0 109.807 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -77.9 -67.76 0.7 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.451 -0.781 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.885 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -143.9 164.61 30.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 110.123 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.885 ' N ' HD13 ' A' ' 190' ' ' LEU . 7.4 t -168.82 135.38 1.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.448 ' CD2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -145.23 -172.83 3.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.65 125.88 7.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.513 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 10.0 p-90 -134.48 145.25 48.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.688 -0.633 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.62 146.79 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 104' ' ' LEU . 35.2 tp -120.28 94.37 4.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.731 -0.606 . . . . 0.0 109.793 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 103' ' ' VAL . 91.6 m -73.23 148.58 43.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.56 -0.712 . . . . 0.0 110.017 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 47.9 mm -124.27 135.95 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -128.76 -156.09 0.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.569 -0.707 . . . . 0.0 110.491 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -30.45 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 111.103 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -138.22 56.7 1.72 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.368 -0.832 . . . . 0.0 111.122 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.732 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -60.87 -16.04 37.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.0 111.327 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 35.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 110.455 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.186 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.182 0.515 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 123' ' ' VAL . 93.1 t -125.04 111.45 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.628 . . . . 0.0 109.77 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -142.03 152.78 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.2 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 HD22 ' A' ' 90' ' ' LEU . 58.0 t -68.81 102.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.3 p -72.75 -53.57 11.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.597 -0.69 . . . . 0.0 110.065 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -150.02 165.68 31.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.74 -0.6 . . . . 0.0 110.001 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.689 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -127.06 165.21 19.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.728 -0.608 . . . . 0.0 109.685 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.573 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.4 m -155.04 156.13 35.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.59 -0.694 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -136.17 96.91 3.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.0 109.737 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 79' ' ' CYS . 57.5 t -74.26 167.88 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.852 -0.53 . . . . 0.0 110.188 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -171.7 -28.03 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.483 -0.761 . . . . 0.0 111.672 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 p 62.58 17.43 9.64 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -140.63 -46.55 0.41 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.507 -0.746 . . . . 0.0 109.224 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -59.34 -174.84 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.765 -0.584 . . . . 0.0 110.025 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.912 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.8 Cg_endo -73.11 -23.59 18.0 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.167 1.088 . . . . 0.0 110.345 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.66 176.73 40.21 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.83 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HB2' HG23 ' A' ' 76' ' ' THR . 43.9 Cg_endo -70.15 102.87 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.639 1.336 . . . . 0.0 110.452 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 30.5 mt -65.38 102.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -98.29 161.44 13.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.639 -0.663 . . . . 0.0 111.234 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.955 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.3 mt -130.94 167.53 18.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.822 -0.548 . . . . 0.0 109.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.419 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 11.0 t70 -111.05 131.22 55.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.578 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD22 HG11 ' A' ' 72' ' ' VAL . 1.5 mp -136.95 55.39 1.83 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 109.899 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -135.94 36.0 2.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.609 -0.682 . . . . 0.0 110.66 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.11 -86.65 0.22 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.97 81.18 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.694 -0.886 . . . . 0.0 110.197 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -95.12 -26.36 16.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.63 -0.669 . . . . 0.0 110.379 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -57.86 -26.64 62.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.443 -0.786 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -22.44 30.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.423 -0.798 . . . . 0.0 110.389 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.955 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.2 m-85 -56.47 -22.06 29.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.434 -0.791 . . . . 0.0 110.526 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -81.86 -20.18 39.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -0.783 . . . . 0.0 110.523 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -86.55 -22.15 26.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.935 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -132.4 134.81 45.59 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 110.689 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -105.83 -168.53 1.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.655 -0.653 . . . . 0.0 109.921 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.528 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.6 m-85 -116.98 96.62 5.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.42 108.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.715 -0.616 . . . . 0.0 109.854 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 196' ' ' LEU . 5.1 mt -113.87 -170.85 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.6 -0.687 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 31.1 tttm -134.64 157.23 47.15 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.994 0.902 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -47.54 124.46 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 45.51 60.18 4.35 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.905 -0.497 . . . . 0.0 113.097 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 104' ' ' LEU . 34.7 m -96.15 119.83 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.239 -1.153 . . . . 0.0 110.596 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.43 96.0 2.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.629 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.3 p90 -115.44 148.79 38.98 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.573 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -102.0 138.14 39.36 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HE1' ' A' ' 110' ' ' TYR . 42.2 mm -85.73 161.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.247 -0.908 . . . . 0.0 110.521 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -148.59 82.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.689 HD13 ' HG ' ' A' ' 75' ' ' LEU . 47.9 mm -75.15 143.78 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.708 -0.62 . . . . 0.0 110.49 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.07 132.21 54.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.722 ' HA ' HG23 ' A' ' 73' ' ' THR . 48.6 p90 -154.2 144.71 22.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.779 . . . . 0.0 111.082 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG3' HG21 ' A' ' 73' ' ' THR . 5.4 mtt180 -97.17 138.27 34.92 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.261 0.553 . . . . 0.0 110.858 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 70' ' ' VAL . 59.5 t -130.89 87.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.633 -0.667 . . . . 0.0 109.324 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.25 47.17 2.52 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.426 -0.796 . . . . 0.0 112.164 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HB3' ' A' ' 151' ' ' PRO . 2.8 ttt-85 -139.08 -64.09 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.34 160.95 37.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.479 -0.763 . . . . 0.0 110.277 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.79 112.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 70' ' ' VAL . 58.0 t -101.58 120.74 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.583 -0.698 . . . . 0.0 109.599 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.6 p -116.84 114.87 24.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.455 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.99 30.77 2.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.611 ' SD ' HG11 ' A' ' 146' ' ' VAL . 3.2 ttt -63.45 120.06 10.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.402 -1.057 . . . . 0.0 109.625 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.22 156.22 25.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.409 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 35.0 t80 -132.16 101.06 5.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 130' ' ' GLN . 81.8 mt -94.27 165.67 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 129' ' ' ILE . 24.2 tt0 -158.84 134.66 8.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -113.96 118.23 33.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.681 -0.637 . . . . 0.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 m -75.42 74.59 2.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.533 -0.73 . . . . 0.0 109.781 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -62.27 154.64 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.518 -0.739 . . . . 0.0 110.515 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.486 ' CG ' HD11 ' A' ' 139' ' ' ILE . 11.9 ttp85 -120.22 39.26 3.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.703 -0.623 . . . . 0.0 110.27 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.46 61.34 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.253 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 149.45 -37.06 0.99 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 137' ' ' VAL . 9.1 p -157.88 127.18 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.968 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.38 131.34 50.68 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 134' ' ' ARG . 20.2 mt -89.79 -52.73 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.679 -0.638 . . . . 0.0 109.312 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -169.17 165.09 11.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 174.68 10.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.618 -0.676 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 m -154.65 146.25 23.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -102.38 137.46 40.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.578 -0.701 . . . . 0.0 110.109 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -120.97 129.94 53.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.431 -0.793 . . . . 0.0 110.537 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -80.44 112.5 17.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 109.389 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.611 HG11 ' SD ' ' A' ' 126' ' ' MET . 49.4 t -79.72 -67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.55 171.64 19.64 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.7 p -95.4 154.93 16.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.972 . . . . 0.0 110.02 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -147.92 128.04 13.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.366 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.55 153.21 28.49 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' A' ' 120' ' ' ARG . 49.9 Cg_endo -74.24 76.84 2.97 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.454 1.239 . . . . 0.0 110.435 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -169.0 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 110.34 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -142.44 -111.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 110.162 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -171.95 -148.65 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.593 -1.317 . . . . 0.0 109.739 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 91.13 1.03 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 22.7 m-85 -59.87 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.415 -0.803 . . . . 0.0 110.008 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.705 ' OE1' HD12 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -156.09 114.77 3.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 110.987 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.526 ' CG ' HG13 ' A' ' 146' ' ' VAL . 39.0 t80 -95.34 169.46 10.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.705 HD12 ' OE1' ' A' ' 157' ' ' GLU . 0.2 OUTLIER -154.1 124.9 7.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.858 . . . . 0.0 111.145 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.0 p -93.75 159.92 33.72 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.31 152.77 80.04 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.63 1.332 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -57.28 116.33 3.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.746 -0.596 . . . . 0.0 111.121 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -113.11 149.35 33.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.71 -0.619 . . . . 0.0 109.617 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.44 127.35 44.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.539 -0.726 . . . . 0.0 110.934 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -62.72 -176.06 0.14 Allowed Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.919 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 44.8 Cg_endo -73.6 127.7 11.95 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 O-C-N 123.066 1.035 . . . . 0.0 110.204 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -116.17 159.02 22.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 110.868 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.65 162.18 30.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -60.06 173.07 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -1.044 . . . . 0.0 109.556 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 tt 67.9 -60.65 0.4 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.372 -0.83 . . . . 0.0 110.625 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.919 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -52.08 -23.25 5.03 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.427 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 11.4 mtp180 -67.15 155.57 38.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.344 -0.847 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.23 -175.3 19.92 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -91.89 118.17 30.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.94 . . . . 0.0 110.363 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' A' ' 171' ' ' ALA . 55.3 m-85 -112.48 124.39 52.4 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 140.06 47.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.646 -0.659 . . . . 0.0 110.637 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.815 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.9 mm -113.53 94.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.647 -0.658 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 109.22 18.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.23 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.409 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 28.6 t -113.64 144.38 43.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.393 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.02 105.97 10.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.682 -0.637 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.455 ' CD2' HG23 ' A' ' 72' ' ' VAL . 1.7 t80 -81.62 132.63 35.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.72 -0.613 . . . . 0.0 109.852 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -171.03 -172.7 1.17 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.649 -0.657 . . . . 0.0 110.222 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.738 -0.601 . . . . 0.0 109.524 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 121.23 0.538 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.23 117.1 29.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.658 . . . . 0.0 109.666 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.458 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.1 m-70 -68.9 -62.5 1.35 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.508 -0.745 . . . . 0.0 110.68 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.7 tp -168.43 159.53 10.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.382 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.2 t -153.71 138.53 17.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.53 -0.732 . . . . 0.0 110.196 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.41 ' CE2' HD21 ' A' ' 90' ' ' LEU . 19.0 p90 -142.02 -155.43 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 110.083 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -169.01 128.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.377 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.815 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -130.45 145.0 51.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.613 -0.68 . . . . 0.0 109.982 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.44 158.83 28.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.474 0.654 . . . . 0.0 110.941 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 104' ' ' LEU . 21.9 tp -133.38 95.41 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.1 m -80.63 104.34 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.626 -0.672 . . . . 0.0 110.78 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.3 mm -80.76 147.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -138.29 -158.83 0.89 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.424 -0.797 . . . . 0.0 110.809 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -53.13 4.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.691 -0.631 . . . . 0.0 110.928 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -147.1 94.06 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.0 110.818 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -74.97 -0.78 19.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.644 -0.66 . . . . 0.0 111.336 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.69 34.92 2.79 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 110.249 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.189 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.237 0.541 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.616 ' CG2' HG21 ' A' ' 123' ' ' VAL . 86.9 t -114.05 130.76 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 0.0 110.078 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.759 HG13 HD13 ' A' ' 190' ' ' LEU . 62.2 t -148.1 137.75 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.786 -0.572 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.5 t -69.44 106.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 72.7 p -73.35 -58.37 3.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.728 -0.608 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.23 164.28 30.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.49 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -132.13 124.19 28.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.673 -0.642 . . . . 0.0 109.695 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.3 m -109.87 152.04 26.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.754 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.61 114.19 9.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.612 -0.68 . . . . 0.0 110.149 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.2 t -113.44 165.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.712 . . . . 0.0 110.26 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.453 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -156.97 -156.64 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 109.956 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.1 p -97.38 -35.88 10.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 p -138.79 47.53 1.94 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.617 -0.677 . . . . 0.0 110.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.23 172.01 7.66 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.664 -0.647 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.4 Cg_endo -72.4 -29.12 14.11 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.442 1.233 . . . . 0.0 109.855 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.38 175.12 33.07 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -70.9 100.63 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.393 1.207 . . . . 0.0 110.204 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.623 HD13 ' CG ' ' A' ' 102' ' ' PHE . 53.1 mt -65.03 113.31 3.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.631 -0.668 . . . . 0.0 109.932 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.11 116.2 29.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.758 -0.589 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -101.87 128.03 48.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.587 -0.696 . . . . 0.0 109.983 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.05 126.85 31.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.546 -0.721 . . . . 0.0 110.007 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.473 HD13 ' CG1' ' A' ' 72' ' ' VAL . 1.6 mt -129.76 52.21 2.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.672 . . . . 0.0 110.062 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -101.37 -73.75 0.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.4 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.09 -42.66 0.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.33 77.66 8.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.689 -0.889 . . . . 0.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 86.9 mt -87.33 -20.87 26.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -13.71 36.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.0 111.477 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -6.2 39.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.06 -1.025 . . . . 0.0 111.567 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 88' ' ' LEU . 12.4 m-30 -75.27 -55.53 5.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -58.21 -17.55 19.79 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.489 -0.757 . . . . 0.0 111.407 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -86.0 -19.85 29.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.265 -0.897 . . . . 0.0 110.89 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.62 147.08 37.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.216 -0.928 . . . . 0.0 110.582 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 195' ' ' ASN . 0.7 OUTLIER -136.28 160.9 37.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.449 -0.782 . . . . 0.0 109.931 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.623 ' CG ' HD13 ' A' ' 86' ' ' LEU . 29.3 m-85 -90.98 166.08 13.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.99 128.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 196' ' ' LEU . 88.2 mt -129.5 164.62 23.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.63 -0.669 . . . . 0.0 109.686 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 2.5 ttpt -77.2 166.54 23.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -29.24 -66.77 0.08 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.82 72.98 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 104' ' ' LEU . 32.7 m -88.0 139.12 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.412 -1.052 . . . . 0.0 110.661 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -85.32 95.98 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 48.5 p90 -109.68 135.93 49.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.533 -0.729 . . . . 0.0 111.745 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -89.2 157.39 18.28 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.89 132.56 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.422 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -115.36 121.48 42.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.88 146.82 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.506 0.669 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -129.37 133.29 47.32 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 33.4 p90 -154.73 157.98 38.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.383 -0.823 . . . . 0.0 110.847 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.76 129.46 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.51 110.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 109.351 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -128.53 48.23 2.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 111.382 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 -67.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.295 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.66 165.67 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.509 -0.745 . . . . 0.0 110.474 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.12 106.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.691 -0.63 . . . . 0.0 109.974 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.616 HG21 ' CG2' ' A' ' 70' ' ' VAL . 59.9 t -84.83 95.02 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.653 -0.655 . . . . 0.0 109.966 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.1 p -88.87 74.97 8.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.322 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 153.63 53.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -82.69 151.38 26.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.988 . . . . 0.0 109.605 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -146.69 151.63 37.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.873 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -128.15 97.49 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.758 -0.588 . . . . 0.0 109.499 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.585 HG23 ' OD1' ' A' ' 143' ' ' ASP . 78.4 mt -96.23 134.6 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 110.055 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.405 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 18.5 tt0 -129.06 138.07 51.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.6 m-70 -113.6 138.39 50.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.444 -0.785 . . . . 0.0 110.089 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.7 m -96.6 85.92 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.707 -0.621 . . . . 0.0 109.824 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 138' ' ' LYS . 5.4 m-85 -89.84 129.26 36.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 110.398 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 137' ' ' VAL . 3.5 tmm_? -145.52 151.43 38.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 51.49 31.23 7.2 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.452 -0.78 . . . . 0.0 111.166 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.41 60.33 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.314 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.7 m -120.36 149.67 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.322 . . . . 0.0 110.398 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 16.7 tttp -85.66 119.76 26.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.62 HD11 ' HB3' ' A' ' 134' ' ' ARG . 95.9 mt -89.8 -67.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.56 -0.713 . . . . 0.0 109.914 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.73 157.45 6.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.506 -0.746 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 165.72 19.0 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.4 m -128.74 137.31 51.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.562 -0.711 . . . . 0.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 129' ' ' ILE . 72.4 m-20 -101.7 105.24 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.712 . . . . 0.0 110.077 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -96.2 148.07 23.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.75 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.05 117.2 33.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.718 HG13 ' CG ' ' A' ' 158' ' ' PHE . 48.1 t -80.86 -55.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.48 -0.762 . . . . 0.0 110.196 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.75 -179.69 17.68 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 22.3 m -89.65 151.29 21.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.66 -0.906 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.52 ' CE2' HG12 ' A' ' 146' ' ' VAL . 82.8 m-85 -148.3 129.55 14.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 0.0 110.369 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.03 152.08 30.95 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.71 90.24 0.95 Allowed 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.425 1.224 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 26.42 7.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.584 -0.698 . . . . 0.0 110.226 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 53.42 22.81 3.02 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.376 -0.827 . . . . 0.0 111.268 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -133.04 178.22 7.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.17 157.93 16.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.705 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.1 m-85 -114.16 177.56 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.539 -0.726 . . . . 0.0 110.089 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -148.81 91.67 1.9 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.718 ' CG ' HG13 ' A' ' 146' ' ' VAL . 40.1 t80 -79.56 163.94 24.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.0 110.002 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -139.72 119.28 13.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.565 -0.709 . . . . 0.0 110.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.496 HG22 ' HE2' ' A' ' 158' ' ' PHE . 66.8 p -102.26 157.09 34.37 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.522 -0.736 . . . . 0.0 109.714 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.68 159.83 46.41 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.707 1.372 . . . . 0.0 110.997 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 149.87 27.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.408 0.623 . . . . 0.0 110.872 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.409 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 16.6 tt0 -129.24 106.44 8.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.712 -0.617 . . . . 0.0 109.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.09 126.0 26.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -74.31 173.09 7.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.793 -0.567 . . . . 0.0 110.003 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.5 Cg_endo -72.96 123.92 9.25 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.338 1.178 . . . . 0.0 110.362 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -118.12 -160.93 0.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 110.572 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.71 47.9 13.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 54.79 175.65 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.567 -0.961 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -61.38 0.32 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.285 -0.885 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -49.43 -24.66 2.09 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.382 -0.824 . . . . 0.0 111.407 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -58.74 128.35 36.78 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.18 -178.84 25.5 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.8 p -86.79 142.75 27.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.517 -0.99 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 38.1 m-85 -131.11 105.0 7.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.671 -0.643 . . . . 0.0 110.356 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.35 120.14 15.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.612 -0.68 . . . . 0.0 109.349 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 131' ' ' HIS . 44.8 mt -109.72 148.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.982 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -114.84 118.88 34.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.748 -0.595 . . . . 0.0 109.79 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.8 m -110.53 122.48 47.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.585 -0.697 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -111.01 103.62 12.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t80 -83.26 116.79 22.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.548 -0.72 . . . . 0.0 110.071 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.3 t -131.97 -155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.746 . . . . 0.0 110.166 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 26.6 p-10 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.055 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.048 0.451 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.11 88.09 2.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -60.27 -40.62 91.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.522 -0.736 . . . . 0.0 109.973 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.759 HD13 HG13 ' A' ' 71' ' ' VAL . 5.2 tp -170.35 148.21 3.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 110.032 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -159.65 136.96 9.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.654 -0.654 . . . . 0.0 110.025 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.443 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 23.9 p90 -136.48 -157.39 0.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.613 -0.68 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.742 . . . . 0.0 110.55 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.544 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 18.1 p-90 -144.13 153.27 41.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.561 -0.712 . . . . 0.0 109.987 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 101' ' ' SER . 5.1 m120 -94.34 153.49 17.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.536 -0.727 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.544 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 23.5 tp -126.78 90.05 3.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.1 m -67.98 145.09 54.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.0 110.94 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.6 156.89 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.707 -0.621 . . . . 0.0 109.392 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -151.91 -153.27 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.493 -0.754 . . . . 0.0 110.068 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -129.88 -0.7 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 111.624 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -160.08 47.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.085 -1.01 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.579 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -57.44 -19.85 26.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.525 -0.734 . . . . 0.0 111.292 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 56.91 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.165 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.405 ' OD1' HG23 ' A' ' 70' ' ' VAL . 23.4 t30 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 123' ' ' VAL . 96.2 t -134.33 119.2 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.624 -0.673 . . . . 0.0 110.338 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 190' ' ' LEU . 79.2 t -142.52 136.74 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG12 HD13 ' A' ' 90' ' ' LEU . 59.3 t -61.24 103.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.518 -0.739 . . . . 0.0 109.115 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.67 HG23 ' HA ' ' A' ' 116' ' ' PHE . 39.0 p -73.45 -56.37 5.14 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.889 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -141.99 168.35 19.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.812 . . . . 0.0 110.724 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.66 124.57 31.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.65 -0.657 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 85' ' ' PRO . 4.1 m -110.4 156.22 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.621 -0.674 . . . . 0.0 110.277 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.528 HD23 HG12 ' A' ' 112' ' ' ILE . 5.4 mt -139.55 82.2 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.577 -0.702 . . . . 0.0 109.879 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.49 143.93 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.725 -0.609 . . . . 0.0 110.088 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 72.2 m -140.82 -163.54 1.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.041 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 p -115.87 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.4 p -95.87 24.9 5.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.93 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -90.5 -177.38 0.77 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.509 -0.744 . . . . 0.0 110.29 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.2 Cg_endo -73.99 -23.59 15.97 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.359 1.189 . . . . 0.0 110.131 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.68 -175.46 29.67 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HB2' ' CG2' ' A' ' 76' ' ' THR . 45.0 Cg_endo -71.07 104.8 1.58 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.503 1.264 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.89 114.45 4.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.722 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -90.19 146.61 24.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.809 HD21 ' CE1' ' A' ' 97' ' ' PHE . 3.7 tt -128.08 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.575 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -94.52 127.35 40.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.517 -0.739 . . . . 0.0 110.161 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.673 HD13 HG12 ' A' ' 72' ' ' VAL . 2.9 mt -135.26 55.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.654 -0.654 . . . . 0.0 109.878 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -104.81 -73.63 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.728 -0.607 . . . . 0.0 110.474 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.22 -74.77 0.49 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.41 94.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.683 -0.893 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 61.0 mt -92.78 -33.41 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.492 -0.755 . . . . 0.0 110.149 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -57.57 -19.31 24.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.502 -0.749 . . . . 0.0 111.065 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.56 -24.5 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.16 -0.963 . . . . 0.0 111.263 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.809 ' CE1' HD21 ' A' ' 88' ' ' LEU . 8.1 m-85 -62.0 -19.24 62.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.507 -0.745 . . . . 0.0 110.309 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.9 -25.98 61.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -86.94 -25.24 24.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.494 -0.754 . . . . 0.0 110.855 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.35 151.47 51.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.392 -0.818 . . . . 0.0 110.619 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -123.81 -170.27 2.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.543 -0.723 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.765 ' CZ ' HD12 ' A' ' 88' ' ' LEU . 6.5 m-85 -115.37 102.08 9.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.641 -0.662 . . . . 0.0 110.052 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.39 147.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.65 -0.656 . . . . 0.0 110.203 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.107 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -159.34 148.17 18.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.664 -0.647 . . . . 0.0 109.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.651 ' HB3' HG11 ' A' ' 108' ' ' VAL . 63.7 tttt -83.54 158.29 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -39.96 107.5 0.07 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 32.24 68.64 0.14 Allowed Glycine 0 N--CA 1.506 3.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.736 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.107 HG22 HD21 ' A' ' 104' ' ' LEU . 21.5 m -88.78 167.55 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -1.141 . . . . 0.0 109.647 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.38 97.94 11.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.202 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.648 ' HE1' ' HB2' ' A' ' 165' ' ' ALA . 32.4 p90 -128.42 134.28 48.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.0 111.581 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -89.46 167.53 12.92 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.528 HG12 HD23 ' A' ' 77' ' ' LEU . 71.0 mt -125.35 137.94 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 0.0 110.358 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -115.68 109.34 17.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.645 -0.66 . . . . 0.0 109.541 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.801 HG21 ' CE2' ' A' ' 181' ' ' PHE . 49.0 mm -93.38 126.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.583 -0.698 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.9 p -108.59 148.55 30.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.67 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.5 p90 -164.78 146.37 8.02 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.235 -0.916 . . . . 0.0 111.884 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -81.49 125.26 30.26 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.276 0.56 . . . . 0.0 110.748 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 70' ' ' VAL . 72.4 t -126.36 82.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.54 48.73 2.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.442 -0.786 . . . . 0.0 111.93 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -138.34 -65.97 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.104 -0.997 . . . . 0.0 111.089 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -142.67 175.98 9.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.393 -0.817 . . . . 0.0 110.86 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.58 113.28 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 110.152 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 70' ' ' VAL . 74.3 t -95.76 88.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.664 -0.647 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 77.6 p -82.97 88.06 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.632 -0.668 . . . . 0.0 110.516 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.0 46.55 0.07 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.453 ' HE3' ' CE1' ' A' ' 116' ' ' PHE . 3.0 ttt -81.22 128.48 33.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.514 -0.992 . . . . 0.0 109.597 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -140.62 167.0 23.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.507 -0.745 . . . . 0.0 110.849 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -135.75 120.12 17.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.7 -0.625 . . . . 0.0 109.733 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -116.57 130.25 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.583 -0.698 . . . . 0.0 110.3 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -128.1 135.61 50.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.611 -0.681 . . . . 0.0 109.862 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.1 m-70 -104.2 114.64 29.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -70.68 77.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.698 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 3.4 m-85 -80.79 141.99 34.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.985 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -119.35 -155.4 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -64.66 81.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.58 -0.7 . . . . 0.0 110.608 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 60.9 23.73 61.75 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 136' ' ' GLY . 97.5 t -148.78 89.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -1.079 . . . . 0.0 109.982 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 149.84 49.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.726 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 140' ' ' ASP . 44.2 pt -118.89 -37.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.406 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.431 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.6 t70 -175.86 167.2 3.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.0 -1.063 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.428 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -126.86 -168.3 1.85 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.427 HG22 ' CE2' ' A' ' 144' ' ' TYR . 34.4 m -159.74 126.96 4.61 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.554 ' OD1' HG23 ' A' ' 129' ' ' ILE . 1.5 m-20 -113.47 136.84 52.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CE2' HG22 ' A' ' 142' ' ' THR . 48.5 m-85 -123.17 127.44 48.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.576 -0.703 . . . . 0.0 110.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.7 tpp -81.18 106.01 12.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.85 HG12 ' CE1' ' A' ' 149' ' ' TYR . 40.8 t -79.96 -36.4 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.547 -0.721 . . . . 0.0 110.279 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.69 -176.87 16.81 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 3.1 t -82.52 135.73 35.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.599 -0.942 . . . . 0.0 110.03 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.85 ' CE1' HG12 ' A' ' 146' ' ' VAL . 9.3 m-85 -118.35 128.99 55.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.633 . . . . 0.0 110.939 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.79 153.05 16.91 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.79 85.14 1.36 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.369 1.194 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -62.28 1.48 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.67 127.01 0.9 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 111.17 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.03 -156.92 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.498 -0.751 . . . . 0.0 111.545 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.81 174.79 7.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.554 -0.716 . . . . 0.0 111.26 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.451 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 44.4 m-85 -119.31 -174.63 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.657 -0.652 . . . . 0.0 109.461 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.87 100.41 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.642 ' CD1' HG13 ' A' ' 146' ' ' VAL . 54.6 t80 -81.39 170.35 16.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.124 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -155.68 109.42 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 110.513 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.407 HG22 ' HE2' ' A' ' 158' ' ' PHE . 54.8 p -75.6 146.88 81.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 109.168 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.43 -177.97 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.706 1.371 . . . . 0.0 111.021 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -58.37 145.17 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.482 0.658 . . . . 0.0 110.872 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.47 119.86 3.1 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.82 146.14 37.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 111.019 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -90.76 -178.09 0.88 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.748 -0.595 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.9 123.61 8.56 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.104 1.055 . . . . 0.0 110.355 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 171.36 7.78 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.459 -0.776 . . . . 0.0 110.539 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.84 161.91 11.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.99 -61.0 2.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.574 -0.956 . . . . 0.0 109.291 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -61.63 -29.76 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.725 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.9 -23.98 61.77 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.501 -0.749 . . . . 0.0 110.538 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -64.2 129.08 38.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.788 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.4 -177.94 30.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.6 p -86.72 133.99 33.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.949 . . . . 0.0 110.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -116.81 106.74 13.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.272 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.76 121.12 19.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.599 -0.688 . . . . 0.0 109.547 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 33.3 mt -111.81 124.33 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.451 -0.78 . . . . 0.0 110.89 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.406 ' CB ' ' HB2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -86.76 96.69 10.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.0 109.451 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -90.55 134.89 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.632 -0.667 . . . . 0.0 110.802 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -133.41 82.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.66 -0.65 . . . . 0.0 109.618 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 114' ' ' ILE . 4.0 t80 -79.1 111.84 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.617 -0.677 . . . . 0.0 110.06 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -136.19 -166.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.31 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.789 -0.569 . . . . 0.0 109.992 179.814 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.084 0.469 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.46 108.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 110.003 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -65.92 -56.2 12.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.543 -0.723 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 71' ' ' VAL . 6.7 tp -168.3 142.85 3.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.584 -0.698 . . . . 0.0 110.356 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 81.0 p -142.63 147.75 36.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.532 -0.73 . . . . 0.0 109.989 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.449 ' CE2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -144.68 -155.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 109.975 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.99 126.04 3.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 110.613 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.54 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 23.2 p-90 -133.29 147.55 51.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.589 -0.694 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.93 135.06 35.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 111.145 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.54 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 27.4 tp -104.96 95.46 5.87 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.9 m -72.42 117.97 14.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.555 -0.716 . . . . 0.0 110.992 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.3 mm -91.03 153.33 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -142.89 -167.63 2.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.394 -0.816 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 -46.66 6.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.704 -0.622 . . . . 0.0 110.568 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.89 106.27 4.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.93 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.33 36.56 0.88 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.607 -0.683 . . . . 0.0 111.285 179.602 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -169.37 37.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.316 -0.865 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.16 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.0 t30 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 123' ' ' VAL . 59.2 t -138.87 135.34 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.551 ' CG1' HD22 ' A' ' 190' ' ' LEU . 76.8 t -147.73 142.1 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 0.0 109.582 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.729 ' HB ' HD23 ' A' ' 190' ' ' LEU . 62.1 t -63.02 105.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.1 p -70.52 -52.88 18.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 110.361 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 mtm105 -158.68 151.84 22.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.556 -0.715 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 76' ' ' THR . 4.3 tt -110.67 126.54 54.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.721 -0.612 . . . . 0.0 109.701 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.587 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.7 m -109.4 152.37 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.338 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.671 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -139.74 109.04 6.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.271 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.7 t -108.54 167.07 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.667 -0.645 . . . . 0.0 109.887 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -157.11 -158.38 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.532 -0.73 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 p -95.07 -34.48 12.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p -140.24 48.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.51 168.01 15.2 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.3 Cg_endo -73.2 -26.48 14.69 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.454 1.239 . . . . 0.0 110.07 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.07 169.13 28.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.97 103.04 1.41 Allowed 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.442 1.233 . . . . 0.0 110.209 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 102' ' ' PHE . 15.4 mt -64.7 116.16 5.98 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.756 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.83 106.04 17.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.395 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.509 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -84.98 127.97 34.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.666 -0.646 . . . . 0.0 109.938 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.28 122.6 25.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.569 -0.707 . . . . 0.0 110.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD13 ' CG1' ' A' ' 72' ' ' VAL . 3.9 mt -128.59 51.03 2.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 109.933 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -109.89 -70.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -60.88 0.15 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.93 88.66 0.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.6 -0.941 . . . . 0.0 110.316 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 92.1 mt -94.98 -25.93 16.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.378 -0.826 . . . . 0.0 110.5 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -52.35 -23.3 5.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -18.48 35.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.431 -0.793 . . . . 0.0 111.325 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.509 ' CE1' HD22 ' A' ' 88' ' ' LEU . 13.3 m-30 -61.96 -56.01 23.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.199 -0.938 . . . . 0.0 110.59 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.98 25.1 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 0.0 111.132 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -86.89 9.82 18.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 111.25 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -171.6 148.0 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.166 -0.959 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.2 p -125.3 159.41 31.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.781 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -82.15 117.97 22.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 110.261 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 199' ' ' LYS . 57.3 t -78.08 154.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.623 -0.673 . . . . 0.0 109.802 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 196' ' ' LEU . 1.7 mt -164.76 179.0 6.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.571 -0.706 . . . . 0.0 110.328 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -107.33 152.32 24.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -19.56 -69.44 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -143.26 74.21 0.33 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.922 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.643 HG21 HD22 ' A' ' 104' ' ' LEU . 33.4 m -88.47 -173.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 110.116 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -120.79 93.63 4.09 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.581 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 40.5 p90 -109.81 145.72 36.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.367 -0.833 . . . . 0.0 112.329 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 162' ' ' MET . 38.4 mtt85 -105.33 165.19 11.29 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 75' ' ' LEU . 68.2 mt -126.41 135.35 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 100.53 8.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.826 -0.546 . . . . 0.0 109.579 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' GLU . 46.2 mm -77.28 148.44 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.529 -0.732 . . . . 0.0 110.043 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -131.31 133.84 45.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 10.4 p90 -157.5 148.92 21.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 110.415 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.3 49.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.64 -0.662 . . . . 0.0 111.158 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 70' ' ' VAL . 57.4 t -115.01 99.04 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -129.2 47.97 2.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.41 -0.806 . . . . 0.0 111.608 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -145.09 -64.24 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.78 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -138.4 166.59 23.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.448 -0.783 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.91 102.78 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.673 -0.642 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 70' ' ' VAL . 58.3 t -81.13 70.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.762 -0.586 . . . . 0.0 109.745 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.9 p -74.52 94.54 2.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.642 -0.661 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.98 42.11 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.4 ttt -72.28 140.79 48.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.973 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -136.58 159.61 41.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -135.27 97.89 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.438 HG22 ' CE1' ' A' ' 131' ' ' HIS . 76.4 mt -94.39 133.37 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 109.728 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.412 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 28.0 tt0 -131.61 131.57 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.688 . . . . 0.0 110.29 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.563 ' CD2' ' HD3' ' A' ' 141' ' ' LYS . 4.9 m80 -107.97 123.62 48.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 0.0 109.792 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.9 m -83.32 105.57 14.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.538 -0.726 . . . . 0.0 110.047 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 138' ' ' LYS . 8.6 m-85 -96.32 140.19 31.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 112.32 18.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.737 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.5 tptp 53.04 37.14 23.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.261 -0.899 . . . . 0.0 110.63 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 82.48 35.06 21.17 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.9 t -146.91 113.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.985 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -64.12 127.71 32.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.567 -0.708 . . . . 0.0 110.116 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.542 HD12 ' OD2' ' A' ' 140' ' ' ASP . 2.8 pt -111.35 -26.05 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.56 -0.713 . . . . 0.0 110.655 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.542 ' OD2' HD12 ' A' ' 139' ' ' ILE . 3.2 p30 -174.43 151.19 1.53 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.563 ' HD3' ' CD2' ' A' ' 131' ' ' HIS . 15.7 pttm -147.72 149.69 32.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -143.32 155.03 44.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.343 -0.848 . . . . 0.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -100.74 113.8 27.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.18 100.33 12.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.451 -0.781 . . . . 0.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.9 ptp -61.63 116.19 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.757 . . . . 0.0 109.693 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.777 HG13 ' CG ' ' A' ' 158' ' ' PHE . 47.4 t -80.18 -51.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 0.0 110.286 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.89 178.33 18.68 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 77.6 p -93.37 152.35 19.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.525 -0.985 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -147.65 132.42 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 110.3 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.45 156.39 26.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.52 -171.5 1.13 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.411 1.216 . . . . 0.0 110.537 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 51.42 62.38 2.74 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.62 -0.675 . . . . 0.0 111.156 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -153.25 -94.5 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 110.273 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.34 -154.79 0.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.885 -1.135 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 73' ' ' THR . 32.7 tt0 -94.49 93.41 7.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 66.1 m-85 -59.92 177.54 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.731 -0.606 . . . . 0.0 110.298 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 12.3 mt-10 -146.75 110.15 4.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 110.314 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.777 ' CG ' HG13 ' A' ' 146' ' ' VAL . 42.3 t80 -76.85 163.27 26.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.731 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.58 116.99 15.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.517 -0.739 . . . . 0.0 110.687 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.2 p -100.51 145.99 31.26 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.12 171.6 8.71 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.755 1.397 . . . . 0.0 111.361 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.41 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 8.2 ptt? -59.73 118.37 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.821 -0.549 . . . . 0.0 111.073 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 1.0 OUTLIER -105.88 124.48 49.64 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.53 136.39 35.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.509 -0.744 . . . . 0.0 110.601 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -90.06 171.15 9.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.737 -0.602 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.8 Cg_endo -72.92 129.31 14.14 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.369 1.194 . . . . 0.0 110.171 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -112.71 -178.09 3.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.601 -0.687 . . . . 0.0 110.75 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.68 138.01 8.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.2 ttm -58.98 -30.7 68.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.397 -1.061 . . . . 0.0 110.066 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.4 mm? -69.37 -35.21 75.6 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 167' ' ' LYS . . . -88.04 -26.92 22.32 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.097 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -50.34 155.21 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.14 -156.5 22.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 p -104.51 132.45 50.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -1.001 . . . . 0.0 110.732 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -113.77 103.03 10.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.645 -0.659 . . . . 0.0 110.732 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -66.95 142.11 57.38 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 14.5 mt -132.94 154.99 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 103.19 8.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 0.0 109.845 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.4 m -97.18 118.13 32.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.49 -0.756 . . . . 0.0 110.437 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.12 109.81 19.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -86.54 154.45 21.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.696 -0.627 . . . . 0.0 110.623 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.4 t -167.76 -156.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.982 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.6 p-10 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.032 0.444 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -105.56 101.06 10.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.502 -0.749 . . . . 0.0 110.215 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 7.9 m170 -60.35 -56.64 19.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.763 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 72' ' ' VAL . 17.7 tp -171.43 114.52 0.38 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.704 -0.622 . . . . 0.0 109.837 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -116.59 136.18 53.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.7 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 97' ' ' PHE . 27.1 p90 -134.28 -159.03 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.638 . . . . 0.0 110.083 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -158.88 129.46 6.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 110.641 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 19.1 p-90 -143.55 147.95 35.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -99.09 146.07 26.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.566 -0.709 . . . . 0.0 110.939 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.749 HD11 HD12 ' A' ' 104' ' ' LEU . 43.0 tp -109.08 107.37 17.67 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -82.93 106.95 15.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 110.769 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.05 143.5 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 109.393 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.467 ' HD2' HG13 ' A' ' 103' ' ' VAL . 6.4 mttt -137.3 -160.25 1.04 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 110.027 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -19.48 8.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 111.055 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -152.54 60.87 0.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 110.952 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -62.43 -15.3 48.61 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.269 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.76 37.7 3.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.273 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.066 0.46 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 123' ' ' VAL . 61.1 t -121.97 128.46 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 70' ' ' VAL . 69.7 t -148.96 139.62 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 181' ' ' PHE . 9.8 t -64.08 103.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 155' ' ' GLU . 65.9 p -69.95 -50.06 45.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.504 -0.748 . . . . 0.0 110.568 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.67 174.64 14.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 110.814 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -140.65 123.77 16.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.722 -0.611 . . . . 0.0 109.643 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 85' ' ' PRO . 89.8 m -109.71 162.89 14.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.517 -0.739 . . . . 0.0 110.288 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -145.85 118.31 8.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 110.534 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.39 153.06 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 t -147.16 25.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 81' ' ' THR . 1.4 p 67.03 -61.19 0.34 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.533 -0.729 . . . . 0.0 110.977 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.4 ' N ' ' OG ' ' A' ' 80' ' ' SER . 20.1 p -98.97 30.97 3.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.159 -0.963 . . . . 0.0 109.964 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.19 165.98 21.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.691 -0.63 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.7 Cg_endo -71.74 -26.4 19.36 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.439 1.231 . . . . 0.0 110.221 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.11 165.86 25.22 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.1 Cg_endo -72.01 97.42 0.83 Allowed 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.466 1.245 . . . . 0.0 110.29 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 102' ' ' PHE . 20.3 mt -64.63 114.57 4.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.688 -0.632 . . . . 0.0 109.632 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -100.95 122.46 43.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.633 -0.667 . . . . 0.0 110.602 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.687 HD22 ' CE1' ' A' ' 97' ' ' PHE . 9.6 mt -97.6 166.17 11.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.702 -0.624 . . . . 0.0 109.88 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.96 126.58 54.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.527 -0.733 . . . . 0.0 110.478 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.659 HD13 HG12 ' A' ' 72' ' ' VAL . 1.7 mt -128.13 49.31 2.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.581 -0.699 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 p -133.67 51.69 2.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.32 -65.16 0.26 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.1 71.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.96 . . . . 0.0 110.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 72.9 mt -90.08 -26.85 20.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.565 -0.709 . . . . 0.0 110.347 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.19 -22.05 15.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.25 -0.906 . . . . 0.0 111.074 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 p -58.23 -20.62 43.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 0.0 110.983 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' A' ' 88' ' ' LEU . 18.1 m-85 -58.37 -65.28 0.68 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.315 -0.866 . . . . 0.0 110.608 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -56.23 -20.73 19.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.525 -0.734 . . . . 0.0 111.207 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -86.93 11.65 12.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 111.323 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.76 143.13 2.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -133.16 137.07 46.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.66 . . . . 0.0 109.721 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.5 m-85 -79.22 118.6 21.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -0.79 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.97 155.53 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.25 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 196' ' ' LEU . 2.1 mt -153.07 -171.38 3.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.756 . . . . 0.0 110.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.456 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.1 tttm -130.65 161.41 31.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.671 0.748 . . . . 0.0 109.857 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.81 106.37 0.06 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 37.28 69.42 0.3 Allowed Glycine 0 N--CA 1.503 3.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.698 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 104' ' ' LEU . 35.8 m -86.65 149.85 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.266 -1.137 . . . . 0.0 109.692 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -79.94 90.58 5.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.653 ' HE1' HD11 ' A' ' 112' ' ' ILE . 37.4 p90 -109.34 141.58 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.562 -0.711 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.49 163.49 13.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.638 -0.664 . . . . 0.0 109.344 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.653 HD11 ' HE1' ' A' ' 110' ' ' TYR . 45.0 mm -117.75 135.1 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.371 -0.831 . . . . 0.0 110.071 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -119.64 115.11 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.28 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 181' ' ' PHE . 43.3 mm -100.72 150.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 111.156 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.5 m -131.21 122.09 25.95 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 31.1 p90 -137.83 135.15 35.95 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.785 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.405 ' H ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -84.09 140.07 32.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 111.046 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.47 95.93 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.724 -0.61 . . . . 0.0 109.367 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -129.2 48.69 2.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 111.427 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.93 -68.7 0.18 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.25 -0.906 . . . . 0.0 110.849 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -136.82 174.7 10.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.82 . . . . 0.0 110.519 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.41 121.62 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.738 -0.601 . . . . 0.0 110.04 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 70' ' ' VAL . 63.0 t -103.8 77.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.692 -0.63 . . . . 0.0 109.531 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.4 p -81.47 84.95 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.59 -0.694 . . . . 0.0 110.666 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.68 44.55 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.0 mmm -73.76 148.56 42.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.446 -1.032 . . . . 0.0 109.627 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.24 136.16 36.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.447 -0.783 . . . . 0.0 110.941 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.417 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 48.2 t80 -122.2 106.18 10.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.772 -0.58 . . . . 0.0 109.484 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 130' ' ' GLN . 80.5 mt -102.08 166.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 129' ' ' ILE . 2.8 tt0 -155.11 138.69 16.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.643 -0.661 . . . . 0.0 110.376 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 141' ' ' LYS . 3.9 m80 -109.34 140.82 42.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.742 . . . . 0.0 109.645 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 m -103.43 78.83 1.64 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.454 -0.779 . . . . 0.0 110.062 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 131' ' ' HIS . 21.1 m-85 -90.57 120.13 31.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.704 ' HG2' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -140.43 142.42 35.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.518 -0.739 . . . . 0.0 110.491 179.411 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.0 OUTLIER 53.67 33.79 17.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.97 27.07 66.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 135' ' ' LYS . 57.4 t -128.03 112.55 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.435 -1.038 . . . . 0.0 109.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 113.65 5.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.575 -0.703 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.704 HD12 ' HG2' ' A' ' 134' ' ' ARG . 4.6 mt -90.21 -66.12 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.629 -0.669 . . . . 0.0 109.438 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.4 p30 -168.54 171.94 8.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.553 -0.717 . . . . 0.0 110.534 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -126.86 168.4 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.596 -0.69 . . . . 0.0 109.557 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.4 m -131.4 117.38 18.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.498 -0.752 . . . . 0.0 110.522 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.24 116.25 28.62 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 0.0 109.821 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -114.27 142.1 46.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 ttp -98.05 123.8 42.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.75 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 181' ' ' PHE . 45.7 t -80.0 -53.71 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.518 -0.739 . . . . 0.0 110.188 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.61 -173.36 21.22 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.9 p -93.35 145.9 24.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.946 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.657 ' CE2' HG12 ' A' ' 146' ' ' VAL . 84.2 m-85 -147.48 125.91 12.38 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.0 110.185 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.61 163.99 25.18 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 83.83 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.415 1.218 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.02 -66.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.618 -0.676 . . . . 0.0 110.17 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.87 132.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.489 -0.757 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 53.05 -157.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.403 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -101.22 171.06 7.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.58 -0.7 . . . . 0.0 111.031 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.3 m-85 -109.71 176.92 4.89 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -131.71 108.95 9.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.813 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 160' ' ' THR . 11.4 t80 -82.77 168.05 17.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 109.591 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.86 90.12 1.44 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.466 -0.771 . . . . 0.0 110.693 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 158' ' ' PHE . 37.6 p -76.76 158.11 81.09 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.59 158.42 50.05 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.699 1.368 . . . . 0.0 111.109 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -56.61 137.7 53.44 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.299 0.571 . . . . 0.0 111.156 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 3.1 tp10 -120.51 119.6 33.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.817 -0.552 . . . . 0.0 109.557 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.69 133.48 49.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -89.74 179.62 1.49 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.3 Cg_endo -72.21 123.75 9.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.192 1.101 . . . . 0.0 110.35 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -115.11 -175.2 2.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.557 -0.714 . . . . 0.0 110.462 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.31 18.83 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -59.5 -27.44 66.15 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -98.51 29.51 3.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 110.049 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.33 18.94 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.531 -0.731 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -100.13 132.89 45.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.392 -0.817 . . . . 0.0 110.0 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.7 177.88 23.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -84.95 126.23 33.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.724 -0.868 . . . . 0.0 110.747 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -107.33 115.87 30.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 0.0 109.883 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -75.08 122.86 24.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.593 -0.692 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.508 HD12 ' CH2' ' A' ' 194' ' ' TRP . 20.4 mt -116.31 152.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.762 . . . . 0.0 110.85 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.44 117.92 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.641 -0.662 . . . . 0.0 110.356 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 192' ' ' TRP . 17.5 t -114.23 163.15 15.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.343 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.15 108.13 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.776 -0.577 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.724 ' HD2' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -80.77 116.37 20.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.998 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.685 HG22 ' CB ' ' A' ' 188' ' ' ASP . 82.2 p -125.03 173.53 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.679 . . . . 0.0 109.861 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 189' ' ' HIS . 25.3 p-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.678 . . . . 0.0 110.22 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.216 0.532 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.685 ' CB ' HG22 ' A' ' 182' ' ' THR . 5.8 p-10 -72.32 117.32 13.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.599 -0.688 . . . . 0.0 109.796 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 183' ' ' ASP . 88.9 m-70 -59.6 -44.62 93.34 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 110.531 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 15.8 tp -162.61 156.24 20.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.461 -0.774 . . . . 0.0 110.399 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.6 p -145.16 150.72 37.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.641 -0.662 . . . . 0.0 109.946 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.472 ' CE2' HD21 ' A' ' 90' ' ' LEU . 14.8 p90 -147.19 -153.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.574 -0.704 . . . . 0.0 110.391 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -169.09 140.26 2.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.528 -0.733 . . . . 0.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.653 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 49.7 p-90 -145.4 147.23 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.541 -0.724 . . . . 0.0 110.384 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -87.65 165.11 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.711 -0.618 . . . . 0.0 110.949 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 104' ' ' LEU . 24.8 tp -143.51 105.39 4.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.81 -0.557 . . . . 0.0 109.582 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.3 m -79.33 127.08 31.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.272 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -99.78 159.48 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -150.59 -153.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.518 -0.739 . . . . 0.0 110.201 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -16.36 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -0.806 . . . . 0.0 111.445 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -160.07 61.62 0.35 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.123 -0.985 . . . . 0.0 111.291 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -66.27 -11.63 51.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.385 -0.822 . . . . 0.0 111.712 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 29.57 6.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.443 179.456 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 123' ' ' VAL . 68.4 t -135.72 133.71 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.3 t -137.31 155.42 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 90' ' ' LEU . 46.2 t -66.55 100.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.217 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 116' ' ' PHE . 55.2 p -70.81 -55.8 7.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.747 -0.596 . . . . 0.0 110.396 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -153.69 157.01 38.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.511 -0.743 . . . . 0.0 110.264 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 76' ' ' THR . 9.6 tt -125.31 161.28 27.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.606 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.725 ' N ' HD23 ' A' ' 75' ' ' LEU . 13.3 m -146.85 164.93 31.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.555 -0.715 . . . . 0.0 110.579 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 86' ' ' LEU . 2.6 mt -140.32 100.75 3.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.95 144.24 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.72 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 m -150.03 -167.38 2.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -76.21 0.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -0.775 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -94.99 36.82 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.397 -0.814 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.692 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.37 172.83 6.39 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.2 Cg_endo -71.29 -27.46 19.6 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.218 1.115 . . . . 0.0 109.87 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.58 -174.46 38.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.89 92.94 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.575 1.303 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' A' ' 102' ' ' PHE . 22.3 mt -64.32 104.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.56 159.68 15.56 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.118 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.927 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -131.11 136.47 48.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.967 -0.458 . . . . 0.0 109.967 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.416 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 12.0 t70 -82.97 131.73 35.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -129.05 53.63 1.86 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 109.837 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 p -122.87 -58.37 1.66 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.517 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.67 -63.37 0.1 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.83 78.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.986 . . . . 0.0 110.292 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -95.37 -28.17 15.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 110.285 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.7 -31.14 69.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.571 -0.705 . . . . 0.0 110.932 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -57.9 -19.95 33.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.391 -0.818 . . . . 0.0 110.956 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.927 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -62.71 -65.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.393 -0.817 . . . . 0.0 110.467 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -57.9 -20.15 34.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.0 110.942 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -22.41 26.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.409 -0.807 . . . . 0.0 110.748 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -129.91 132.44 46.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.277 -0.889 . . . . 0.0 110.569 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -115.24 148.05 39.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 109.841 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 m-85 -74.38 154.76 38.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.79 113.02 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 0.0 110.358 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.932 HD22 HG21 ' A' ' 108' ' ' VAL . 10.1 mt -113.7 -172.83 2.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.602 -0.686 . . . . 0.0 109.553 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.589 ' HB3' HG11 ' A' ' 108' ' ' VAL . 37.7 tttm -121.85 167.27 13.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.791 . . . . 0.0 109.756 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -42.01 108.93 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.24 69.24 0.43 Allowed Glycine 0 N--CA 1.502 3.068 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.259 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.932 HG21 HD22 ' A' ' 104' ' ' LEU . 34.4 m -93.77 142.83 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -1.142 . . . . 0.0 110.086 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.73 107.19 10.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.401 -0.812 . . . . 0.0 109.192 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.614 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 30.0 p90 -123.61 146.77 47.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.683 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -106.62 162.2 13.96 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.449 HG22 ' N ' ' A' ' 113' ' ' LYS . 70.2 mt -122.84 163.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 112' ' ' ILE . 14.0 ttmm -150.08 108.99 3.87 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' HD12 ' A' ' 75' ' ' LEU . 49.9 mm -98.02 146.73 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.54 -0.725 . . . . 0.0 110.807 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.36 145.51 51.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.639 -0.663 . . . . 0.0 109.639 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.533 ' HA ' HG23 ' A' ' 73' ' ' THR . 21.5 p90 -154.88 150.33 27.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 111.129 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.85 151.85 22.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.792 -0.568 . . . . 0.0 111.113 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 151' ' ' PRO . 57.7 t -133.91 99.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.674 -0.641 . . . . 0.0 109.554 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.71 48.75 2.34 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -148.29 -77.78 0.16 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.185 -0.947 . . . . 0.0 110.841 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.83 -177.85 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.353 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.3 mt -74.15 106.05 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 70' ' ' VAL . 57.6 t -80.22 76.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.662 -0.648 . . . . 0.0 109.908 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.2 98.59 7.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.449 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 128.48 40.83 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.548 ' CE ' HG11 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -78.27 124.44 28.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -1.054 . . . . 0.0 109.503 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -123.33 142.65 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.997 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -117.48 86.99 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 0.0 109.413 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -79.06 140.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 110.044 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.7 137.6 29.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.5 m-70 -107.05 154.96 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.74 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.537 ' O ' HD12 ' A' ' 139' ' ' ILE . 57.1 m -116.4 64.47 0.71 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -75.25 139.48 42.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.382 -0.824 . . . . 0.0 109.828 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NH1' HG11 ' A' ' 137' ' ' VAL . 3.4 ptt180 -120.68 -152.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.485 -0.76 . . . . 0.0 110.277 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -56.66 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.411 -0.806 . . . . 0.0 111.783 -178.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.58 13.34 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.514 -0.741 . . . . 0.0 111.584 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 135' ' ' LYS . 63.0 t -134.29 116.1 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 119.62 19.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.702 -0.624 . . . . 0.0 110.152 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.556 HG22 ' OD2' ' A' ' 140' ' ' ASP . 58.6 mt -89.62 -72.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.645 -0.659 . . . . 0.0 109.85 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.3 p30 -172.32 166.49 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.472 -0.767 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 157.74 42.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.271 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.2 m -125.24 143.69 50.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.562 -0.711 . . . . 0.0 110.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.57 75.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.631 -0.668 . . . . 0.0 109.892 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -64.72 146.43 54.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.455 -0.778 . . . . 0.0 110.685 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -106.74 123.67 48.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.641 -0.662 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.61 HG12 ' CE2' ' A' ' 149' ' ' TYR . 61.6 t -79.8 -55.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.544 -0.722 . . . . 0.0 110.015 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.92 176.6 14.48 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.9 p -86.72 151.06 23.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.626 -0.926 . . . . 0.0 110.091 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' HG12 ' A' ' 146' ' ' VAL . 88.4 m-85 -148.35 130.57 15.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.551 -0.718 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.54 157.16 32.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.675 ' HA ' HG12 ' A' ' 118' ' ' VAL . 48.5 Cg_endo -74.01 94.76 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.389 1.205 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -91.81 -78.23 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.559 -0.713 . . . . 0.0 109.91 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -172.6 -38.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -107.94 -161.8 0.79 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.0 110.672 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 168.81 9.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 30.0 m-85 -108.57 -178.47 3.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.773 -0.579 . . . . 0.0 109.649 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -138.86 99.51 3.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.931 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 34.5 t80 -84.16 171.46 12.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.259 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.66 131.74 4.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 111.172 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.5 p -97.31 151.73 37.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.84 -170.16 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.714 1.376 . . . . 0.0 111.203 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.2 ptm -54.43 145.25 18.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 111.266 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 4.6 tt0 -144.5 84.21 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.68 -0.638 . . . . 0.0 109.636 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.67 135.46 55.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 110.692 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.83 179.99 1.45 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.611 -0.681 . . . . 0.0 109.816 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.63 135.91 22.63 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.273 1.143 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 7.6 ptpp? -110.99 -179.33 3.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.713 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.08 156.35 18.94 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.1 ttp -61.44 -26.97 68.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.155 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.627 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -82.61 -24.76 33.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.568 -0.708 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -59.07 -25.42 63.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.431 -0.793 . . . . 0.0 110.52 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -60.5 123.85 18.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.426 -0.796 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 159.53 -179.84 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -95.1 135.63 36.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.66 -0.906 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.05 108.56 14.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 109.921 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -71.28 122.37 20.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.636 -0.665 . . . . 0.0 110.113 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 131' ' ' HIS . 36.3 mt -113.32 127.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -99.35 112.11 24.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.695 . . . . 0.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 4.0 m -105.65 130.06 53.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.634 -0.667 . . . . 0.0 110.217 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 99.68 6.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.685 . . . . 0.0 110.183 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.46 ' C ' HG23 ' A' ' 182' ' ' THR . 2.0 t80 -75.57 121.38 22.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 0.0 109.835 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.46 HG23 ' C ' ' A' ' 181' ' ' PHE . 32.4 p -152.63 162.27 41.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.492 1.671 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.597 179.363 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.118 0.485 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.41 115.24 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.626 . . . . 0.0 109.607 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.49 -59.94 3.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.5 tp -167.61 170.55 11.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.449 -0.782 . . . . 0.0 110.484 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.7 t -163.85 125.29 2.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.725 -0.609 . . . . 0.0 109.872 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.606 ' CE2' HD21 ' A' ' 90' ' ' LEU . 20.5 p90 -140.16 -153.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.704 . . . . 0.0 110.304 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.11 134.25 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 110.649 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.36 146.95 42.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.674 -0.641 . . . . 0.0 109.893 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -95.66 141.3 29.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.628 -0.67 . . . . 0.0 111.181 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 104' ' ' LEU . 44.1 tp -108.84 108.83 19.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -88.47 122.08 31.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.771 . . . . 0.0 110.656 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.9 mm -94.32 156.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 109.486 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -138.23 -162.33 1.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.748 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 -24.43 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 110.682 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -160.01 77.36 0.65 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.387 -0.821 . . . . 0.0 110.994 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.791 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -70.51 -7.03 40.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.452 -0.78 . . . . 0.0 111.693 179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -155.28 51.45 0.59 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.107 -0.995 . . . . 0.0 110.288 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.122 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.43 ' HB3' ' CB ' ' A' ' 120' ' ' ARG . 3.9 p30 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 70' ' ' VAL . 21.4 t -143.6 31.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 110.817 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.58 141.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.676 -0.64 . . . . 0.0 110.055 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 90' ' ' LEU . 58.5 t -63.73 125.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.637 -0.664 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.5 p -82.03 -58.92 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.903 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.58 155.42 26.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.454 ' HG ' HD13 ' A' ' 114' ' ' ILE . 4.5 tt -110.97 133.84 53.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.606 -0.684 . . . . 0.0 109.784 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -109.64 155.66 21.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.542 -0.724 . . . . 0.0 110.924 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -141.57 107.96 5.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.614 -0.679 . . . . 0.0 110.058 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 85' ' ' PRO . 60.3 t -121.79 160.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.972 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.8 t -147.27 -80.73 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -170.81 -45.49 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.346 -0.846 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 p -123.86 34.76 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 110.118 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -87.59 173.06 6.93 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.9 Cg_endo -72.29 -28.6 15.05 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.474 1.25 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.35 170.97 30.01 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.0 Cg_endo -72.1 102.83 1.4 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.526 1.277 . . . . 0.0 110.188 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 8.2 mt -64.73 121.23 14.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 109.68 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.84 103.41 15.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.668 -0.645 . . . . 0.0 110.247 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.9 tt -80.2 119.82 23.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 110.176 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.47 129.42 37.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.717 HD13 HG11 ' A' ' 72' ' ' VAL . 6.0 mt -133.71 53.6 2.0 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.561 -0.712 . . . . 0.0 110.039 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.3 p -140.31 -43.53 0.41 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.656 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.11 -117.85 4.25 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 114.83 3.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.627 -0.925 . . . . 0.0 110.334 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mt -92.27 -30.46 15.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -66.13 -12.69 57.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.804 . . . . 0.0 111.096 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -56.45 -20.27 19.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.111 -0.993 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 88' ' ' LEU . 3.1 m-85 -67.99 -31.68 71.56 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.312 -0.868 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -61.49 -35.29 77.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 110.723 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -87.1 -25.2 24.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.61 126.26 46.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.468 -0.77 . . . . 0.0 110.477 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -115.38 159.77 20.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.784 ' HB2' HD12 ' A' ' 196' ' ' LEU . 11.3 m-85 -83.27 114.64 21.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.93 118.28 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.693 -0.63 . . . . 0.0 110.51 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 196' ' ' LEU . 82.1 mt -129.89 159.15 37.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.575 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 108' ' ' VAL . 18.9 tttt -85.9 169.02 13.67 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -39.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 41.58 72.84 0.24 Allowed Glycine 0 N--CA 1.501 2.985 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.898 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 105' ' ' LYS . 33.1 m -86.5 125.77 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -1.037 . . . . 0.0 110.077 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.05 90.77 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.199 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.549 ' CD1' HD23 ' A' ' 77' ' ' LEU . 11.9 p90 -109.63 150.37 28.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.156 -0.965 . . . . 0.0 111.573 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -98.04 147.07 24.9 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.412 HD11 ' HE1' ' A' ' 110' ' ' TYR . 69.1 mt -111.04 132.56 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -115.38 98.63 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.782 -0.574 . . . . 0.0 109.559 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.496 HG21 ' CE1' ' A' ' 181' ' ' PHE . 42.4 mm -78.08 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.695 -0.628 . . . . 0.0 110.432 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.5 m -114.81 141.44 47.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 12.9 p90 -153.87 144.65 22.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.415 -0.803 . . . . 0.0 110.968 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -87.17 132.53 33.84 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.246 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 151' ' ' PRO . 60.8 t -122.94 95.12 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.15 40.12 3.72 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.596 -0.841 . . . . 0.0 112.692 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -161.31 -67.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.08 -1.013 . . . . 0.0 110.919 179.077 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -124.38 166.07 16.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 110.911 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 123' ' ' VAL . 81.8 mt -72.97 165.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.263 0.554 . . . . 0.0 110.031 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 126' ' ' MET . 48.6 t -128.39 54.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.699 -0.625 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.92 104.95 2.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.661 -0.649 . . . . 0.0 110.35 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.14 46.27 0.95 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.537 ' HB2' HG12 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -87.6 132.27 34.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.599 -0.942 . . . . 0.0 109.486 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.22 164.55 17.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.478 -0.764 . . . . 0.0 111.019 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -136.43 102.06 4.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.861 -0.524 . . . . 0.0 109.748 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 130' ' ' GLN . 50.8 mm -82.27 164.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 0.0 109.994 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 129' ' ' ILE . 39.5 tt0 -167.96 117.71 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.775 ' O ' HG23 ' A' ' 177' ' ' ILE . 10.7 m170 -101.7 159.31 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.718 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.471 ' CG2' HD11 ' A' ' 139' ' ' ILE . 9.2 m -117.55 69.85 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.458 -0.777 . . . . 0.0 109.959 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 19.7 m-85 -66.2 123.72 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.09 134.13 51.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 110.395 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm 52.69 28.15 5.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.21 -16.61 55.36 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.6 m -106.02 156.24 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.118 -1.225 . . . . 0.0 110.576 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -86.37 134.34 33.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.676 . . . . 0.0 109.887 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.471 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pt -118.02 -25.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 110.956 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -175.79 144.45 0.63 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.225 -0.922 . . . . 0.0 110.537 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.64 152.44 50.43 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.7 m -136.27 153.45 51.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 111.374 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.69 116.37 26.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.43 114.69 29.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.981 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.4 ttt -74.64 120.07 19.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.702 HG13 ' CG ' ' A' ' 158' ' ' PHE . 51.3 t -79.64 -68.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.403 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.57 -163.23 29.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.2 p -104.77 148.04 27.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.906 . . . . 0.0 110.256 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.485 ' CE2' HG12 ' A' ' 146' ' ' VAL . 89.8 m-85 -147.74 125.84 12.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.501 -0.75 . . . . 0.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.65 156.61 23.26 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.715 ' HA ' HG12 ' A' ' 118' ' ' VAL . 45.9 Cg_endo -71.36 94.13 0.67 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.406 1.214 . . . . 0.0 110.49 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -86.31 -67.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.681 . . . . 0.0 110.11 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.79 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.68 -152.29 0.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 110.634 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -99.97 168.05 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 34.1 m-85 -111.46 -170.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.65 -0.656 . . . . 0.0 109.909 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.54 114.12 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.693 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.702 ' CG ' HG13 ' A' ' 146' ' ' VAL . 37.7 t80 -89.64 164.73 14.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 109.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -135.75 117.41 14.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.531 -0.73 . . . . 0.0 110.656 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 158' ' ' PHE . 71.6 p -102.23 147.77 34.44 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.611 -0.68 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.21 -173.44 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.821 1.432 . . . . 0.0 111.735 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -52.67 140.67 22.82 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.472 0.653 . . . . 0.0 111.773 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 3.5 tp10 -138.42 82.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.61 137.18 58.0 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.541 0.686 . . . . 0.0 110.8 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -82.42 -178.7 1.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.09 124.94 10.44 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.187 1.098 . . . . 0.0 110.198 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -115.26 178.96 4.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.571 -0.706 . . . . 0.0 110.662 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.44 150.83 10.66 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 5.8 ttt -59.59 -28.83 67.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.418 -1.049 . . . . 0.0 110.025 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 170' ' ' LEU . 0.2 OUTLIER -99.2 23.96 8.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.784 . . . . 0.0 110.325 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.41 24.61 7.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -98.59 131.45 44.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 110.009 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.33 -174.26 27.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.5 p -87.6 122.84 31.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.943 . . . . 0.0 110.659 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 19.4 m-85 -103.67 107.33 18.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -66.0 133.33 50.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.596 -0.69 . . . . 0.0 110.093 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 131' ' ' HIS . 15.7 mt -124.87 141.58 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.493 -0.755 . . . . 0.0 110.62 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -114.12 115.06 26.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.637 -0.664 . . . . 0.0 110.211 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.5 m -113.8 157.63 22.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 110.15 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.31 101.52 4.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.62 ' CD2' HG22 ' A' ' 72' ' ' VAL . 2.2 t80 -75.56 92.46 2.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.644 . . . . 0.0 110.096 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.7 t -127.28 179.75 5.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.274 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.54 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.84 116.52 28.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.715 -0.616 . . . . 0.0 109.413 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -57.65 -49.52 76.2 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.433 -0.792 . . . . 0.0 110.703 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.8 tp -168.35 158.91 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.5 -0.75 . . . . 0.0 110.463 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 140.28 22.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.92 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.535 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.3 p90 -146.52 -155.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.581 -0.699 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -161.68 130.23 4.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.688 -0.633 . . . . 0.0 110.169 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.519 ' CZ3' HD13 ' A' ' 196' ' ' LEU . 11.0 p-90 -137.49 145.96 43.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.498 -0.751 . . . . 0.0 110.066 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -90.13 155.88 18.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.511 0.672 . . . . 0.0 111.122 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 104' ' ' LEU . 15.3 tp -121.18 95.42 4.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.777 -0.577 . . . . 0.0 109.614 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -68.91 122.6 18.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.672 . . . . 0.0 110.304 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -101.39 153.51 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 109.796 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -148.55 -157.09 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.615 -0.678 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -18.42 7.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.786 . . . . 0.0 111.355 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.8 73.73 1.08 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.0 111.079 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.782 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.59 -4.19 32.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.727 . . . . 0.0 111.569 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 37.51 4.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 110.25 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.334 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' HG23 ' A' ' 70' ' ' VAL . 43.4 t-20 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.999 0.428 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 123' ' ' VAL . 90.6 t -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.1 t -147.54 147.41 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.765 -0.584 . . . . 0.0 109.827 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.65 HG23 ' CD2' ' A' ' 181' ' ' PHE . 43.2 t -68.13 113.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.627 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 116' ' ' PHE . 32.8 p -77.29 -33.44 55.77 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.118 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -168.63 160.27 10.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.708 . . . . 0.0 110.324 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 10.4 tt -128.29 134.75 48.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.655 -0.653 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.3 m -109.6 162.29 14.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.541 -0.724 . . . . 0.0 110.146 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.84 95.69 2.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.771 . . . . 0.0 110.195 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 85' ' ' PRO . 71.6 t -105.19 167.32 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.857 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 40.8 t -159.55 -82.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.651 -0.656 . . . . 0.0 110.134 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -71.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.865 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 p -98.59 31.5 2.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.725 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -85.13 169.95 14.78 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.706 . . . . 0.0 110.088 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.7 Cg_endo -71.6 -27.44 18.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.393 1.207 . . . . 0.0 110.24 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.56 170.57 26.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HB3' HG22 ' A' ' 78' ' ' VAL . 44.9 Cg_endo -71.84 104.37 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.497 1.262 . . . . 0.0 110.192 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 102' ' ' PHE . 9.5 mt -64.91 128.48 35.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 109.817 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -103.55 113.17 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.681 -0.637 . . . . 0.0 110.323 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 102' ' ' PHE . 1.2 tt -100.01 105.71 17.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 110.154 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -65.69 137.71 57.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.689 -0.632 . . . . 0.0 109.729 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HA ' HD21 ' A' ' 94' ' ' LEU . 95.0 mt -135.6 56.8 1.82 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.753 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.0 p -115.75 -68.53 0.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.768 -0.582 . . . . 0.0 110.493 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 -58.18 0.18 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.45 74.81 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.969 . . . . 0.0 110.323 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 90' ' ' LEU . 18.2 mt -95.46 -22.38 17.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 0.0 110.805 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.43 -1.13 28.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.345 -0.847 . . . . 0.0 111.561 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -90.06 0.37 57.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.175 -0.953 . . . . 0.0 111.288 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 51.8 m-85 -94.09 -32.22 13.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.114 -0.991 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -59.1 -19.72 47.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -88.07 -24.75 23.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 110.535 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.68 -179.88 3.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.429 -0.794 . . . . 0.0 110.54 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -167.31 142.88 4.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.536 -0.727 . . . . 0.0 110.146 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.641 ' HE2' HD12 ' A' ' 88' ' ' LEU . 29.5 m-85 -79.09 121.72 25.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.859 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.84 123.47 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 110.341 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.528 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 55.0 mt -124.19 178.74 5.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 19.7 tttm -104.2 150.97 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.815 0.817 . . . . 0.0 109.514 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.6 pt-20 -50.63 124.5 11.0 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.56 48.99 72.77 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.626 -0.671 . . . . 0.0 113.343 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 105' ' ' LYS . 28.0 m -97.01 133.21 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.975 1.388 . . . . 0.0 109.678 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.44 94.77 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.75 ' HD2' HG23 ' A' ' 108' ' ' VAL . 40.8 p90 -118.32 142.03 47.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 0.0 111.361 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.19 163.37 12.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.612 -0.68 . . . . 0.0 109.176 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 82.5 mt -126.42 151.59 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.015 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.512 ' HE2' HD23 ' A' ' 159' ' ' LEU . 39.9 ttmt -128.91 117.9 21.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.14 144.98 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.758 . . . . 0.0 110.662 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -123.72 147.54 47.38 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.779 ' HA ' HG23 ' A' ' 73' ' ' THR . 34.1 p90 -168.37 161.29 11.89 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.572 ' HG3' HG21 ' A' ' 73' ' ' THR . 7.7 mtm180 -113.0 144.59 42.31 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.843 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 70' ' ' VAL . 57.8 t -125.79 98.89 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -128.7 49.01 2.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 0.0 111.046 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -75.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 123' ' ' VAL . 3.7 tt0 -138.28 160.22 40.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.5 mt -63.57 104.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.74 -0.6 . . . . 0.0 109.921 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 70' ' ' VAL . 57.9 t -91.33 76.35 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.612 -0.68 . . . . 0.0 109.636 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.0 p -77.68 85.48 4.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.37 48.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.458 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 0.0 OUTLIER -85.12 131.05 34.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.558 -0.966 . . . . 0.0 109.481 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.5 162.34 25.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.63 -0.669 . . . . 0.0 111.051 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -136.38 108.28 7.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 77.2 mt -102.76 161.94 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -159.3 134.88 8.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.594 -0.691 . . . . 0.0 110.28 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.465 ' CD2' ' HD2' ' A' ' 141' ' ' LYS . 5.9 m80 -111.23 130.68 55.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 84.3 m -84.33 72.59 10.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.849 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.41 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 4.4 m-85 -64.11 137.35 57.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 110.495 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 14.8 ttm180 -120.91 107.76 13.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.634 . . . . 0.0 109.925 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 53.27 37.09 24.39 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.399 -0.813 . . . . 0.0 110.584 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.34 33.47 19.87 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 136' ' ' GLY . 59.7 t -147.24 111.41 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 126.47 28.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.73 -22.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.558 -0.714 . . . . 0.0 110.798 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -167.91 132.48 1.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.595 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.465 ' HD2' ' CD2' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -139.98 144.51 37.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 143' ' ' ASP . 28.2 m -132.42 164.72 25.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 110.744 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 142' ' ' THR . 1.5 m-20 -120.53 115.39 23.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.748 -0.595 . . . . 0.0 109.877 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.17 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 ttm -98.27 117.99 33.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.542 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.502 HG12 ' CE2' ' A' ' 149' ' ' TYR . 47.4 t -79.7 -63.21 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.786 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 143.77 178.43 19.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.2 p -87.77 149.13 24.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.909 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 146' ' ' VAL . 76.3 m-85 -147.82 132.57 17.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.333 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.95 159.5 24.57 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.13 94.22 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.399 1.21 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -116.51 23.35 12.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 110.6 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 52.49 23.64 2.64 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.339 -0.851 . . . . 0.0 111.213 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -126.97 169.15 13.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.573 -0.704 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -100.19 163.33 12.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.604 . . . . 0.0 110.398 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.474 ' CD2' ' CD1' ' A' ' 149' ' ' TYR . 64.2 m-85 -122.88 170.57 9.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.644 -0.66 . . . . 0.0 109.954 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -136.23 103.36 5.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.486 ' HB2' HG13 ' A' ' 146' ' ' VAL . 24.4 t80 -88.18 148.34 24.45 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 159' ' ' LEU . 3.4 tm? -133.53 111.3 10.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 110.641 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 158' ' ' PHE . 77.6 p -85.83 151.67 55.43 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.56 -0.712 . . . . 0.0 109.62 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.78 165.62 22.82 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.441 1.232 . . . . 0.0 111.093 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 mtm -54.64 168.63 0.26 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.714 -0.616 . . . . 0.0 110.755 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -155.55 140.2 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.741 -0.599 . . . . 0.0 109.775 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 129.9 42.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.591 -0.693 . . . . 0.0 110.974 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -77.93 178.56 2.09 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.612 -0.68 . . . . 0.0 110.25 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.3 Cg_endo -73.39 -173.12 1.2 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.448 1.236 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 13.8 mmtt -78.39 -176.53 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.51 -0.744 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.402 ' N ' ' CB ' ' A' ' 106' ' ' GLU . . . -95.18 -60.88 1.04 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 171' ' ' ALA . 12.2 mmt -60.9 141.7 56.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.962 . . . . 0.0 109.44 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt 66.15 -64.27 0.22 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.673 -0.642 . . . . 0.0 110.393 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -59.5 -17.83 35.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 111.177 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.15 27.78 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.082 -1.011 . . . . 0.0 110.285 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.63 177.88 15.13 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.7 p -88.19 134.21 33.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.544 -0.974 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 15.9 m-85 -116.94 116.81 28.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.544 -0.722 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -61.66 145.82 51.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.827 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -125.18 108.23 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.502 -0.749 . . . . 0.0 110.361 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 1.6 ttpt -88.2 95.61 10.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.493 -0.754 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 125.29 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.48 -0.762 . . . . 0.0 110.114 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -116.01 107.8 15.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.45 -0.782 . . . . 0.0 110.35 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.65 ' CD2' HG23 ' A' ' 72' ' ' VAL . 2.2 t80 -83.82 136.68 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.714 -0.616 . . . . 0.0 109.741 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.0 t -172.77 -173.58 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.557 -0.714 . . . . 0.0 110.42 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 6.6 p-10 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 121.139 0.495 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -115.25 118.87 34.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.579 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.23 -65.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 110.699 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.0 tp -168.42 151.49 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.797 . . . . 0.0 110.5 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.6 m -149.0 146.5 27.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.015 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -140.05 -162.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -154.44 121.89 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.401 -0.812 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.827 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 30.5 p-90 -132.23 148.35 52.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.692 -0.63 . . . . 0.0 109.553 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -89.49 148.56 23.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.483 -0.76 . . . . 0.0 111.489 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.52 102.1 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -75.2 132.07 40.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 0.0 110.724 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.95 147.75 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.76 -159.08 0.96 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.694 -0.629 . . . . 0.0 110.129 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.58 -8.43 4.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.96 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -155.19 63.13 0.63 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.947 -1.095 . . . . 0.0 111.516 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' TRP . . . . . 0.725 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -72.17 -6.77 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.263 -0.898 . . . . 0.0 111.241 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -162.21 47.92 0.17 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.134 -179.884 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 p -139.65 138.19 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.603 -0.686 . . . . 0.0 110.098 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 t 53.04 -159.28 0.13 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.381 -0.825 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.21 166.33 13.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.533 -0.729 . . . . 0.0 110.223 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -77.18 149.9 79.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.204 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.69 -88.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.479 1.252 . . . . 0.0 110.601 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.486 ' C ' HG23 ' A' ' 67' ' ' VAL . 18.9 m120 52.82 29.51 7.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.945 -1.097 . . . . 0.0 110.815 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG13 ' HD2' ' A' ' 68' ' ' PRO . 72.7 t -152.73 146.08 17.86 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.777 -0.577 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.538 ' HD2' HG13 ' A' ' 67' ' ' VAL . 42.3 Cg_endo -68.35 162.36 40.86 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.282 1.148 . . . . 0.0 109.97 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.673 ' ND2' HG23 ' A' ' 70' ' ' VAL . 17.0 p-10 -104.14 -25.74 12.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.523 -0.736 . . . . 0.0 110.949 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 123' ' ' VAL . 86.0 t -125.51 119.15 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.9 t -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG12 HD12 ' A' ' 90' ' ' LEU . 53.4 t -61.35 110.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.726 . . . . 0.0 109.142 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.858 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.8 p -76.2 -41.27 50.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -167.38 163.76 15.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.287 -0.883 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -121.44 125.93 48.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 85' ' ' PRO . 12.8 m -109.97 154.78 22.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 111.032 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 86' ' ' LEU . 6.2 mt -138.71 92.02 2.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.35 130.8 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.713 -0.617 . . . . 0.0 110.654 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.7 m -128.05 -3.13 5.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.713 -0.617 . . . . 0.0 111.145 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.83 18.7 3.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.951 -1.093 . . . . 0.0 111.29 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.5 p -142.26 -45.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.757 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -57.77 -179.18 0.11 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.749 -0.594 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -73.85 -17.31 22.81 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.531 1.279 . . . . 0.0 110.238 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.7 171.61 35.45 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.924 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.8 Cg_endo -72.56 122.26 8.11 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.778 1.409 . . . . 0.0 110.728 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 102' ' ' PHE . 6.3 mt -68.66 117.66 10.67 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.149 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.99 112.8 25.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.633 -0.667 . . . . 0.0 110.64 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' TRP . 1.3 tt -101.07 101.66 12.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.554 -0.716 . . . . 0.0 109.988 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.6 t0 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.553 -0.717 . . . . 0.0 110.33 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.48 HD21 HD22 ' A' ' 88' ' ' LEU . 96.0 mt -135.87 54.77 1.89 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 110.062 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 p -135.87 -42.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.783 -0.573 . . . . 0.0 110.422 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.33 -103.61 2.45 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.22 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.632 -0.923 . . . . 0.0 110.687 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -95.55 -26.74 15.67 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.638 -0.663 . . . . 0.0 110.395 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.94 0.2 36.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.495 -0.753 . . . . 0.0 111.523 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 t -85.9 0.25 53.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.099 -1.0 . . . . 0.0 111.208 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 34.3 m-85 -93.14 -29.42 15.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.165 -0.959 . . . . 0.0 110.045 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -12.57 60.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -86.47 -26.62 24.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.253 -0.904 . . . . 0.0 110.33 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -132.62 -172.11 2.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.5 -0.75 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.4 p -152.59 169.64 22.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.549 -0.719 . . . . 0.0 110.102 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 86' ' ' LEU . 17.6 m-85 -96.7 119.85 35.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.58 -0.7 . . . . 0.0 109.997 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.51 116.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 109.62 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.857 ' CD2' HD11 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -113.61 166.38 11.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.049 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.507 ' CB ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -96.14 148.02 23.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.593 -0.692 . . . . 0.0 111.542 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' CG2' ' A' ' 198' ' ' ILE . 6.2 mt-10 -23.46 -46.81 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -174.04 36.4 0.12 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.818 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' CB ' ' A' ' 105' ' ' LYS . 27.0 m -60.41 148.31 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.235 -1.156 . . . . 0.0 110.309 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.09 93.96 5.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.629 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 32.5 p90 -109.7 151.35 27.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.469 -0.77 . . . . 0.0 111.562 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.3 156.44 18.14 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.524 HG12 HD23 ' A' ' 77' ' ' LEU . 67.4 mt -122.98 135.93 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.314 -0.866 . . . . 0.0 110.42 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 159' ' ' LEU . 41.0 mtmt -122.51 120.45 33.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.587 . . . . 0.0 110.08 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.743 HG21 ' CE2' ' A' ' 181' ' ' PHE . 50.1 mm -97.65 134.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.701 . . . . 0.0 109.981 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 p -108.67 150.12 27.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.134 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.858 ' HA ' HG23 ' A' ' 73' ' ' THR . 3.1 p90 -162.51 139.13 7.74 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 135.06 35.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.625 . . . . 0.0 111.126 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.801 HG22 HG22 ' A' ' 70' ' ' VAL . 63.5 t -125.26 102.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -128.63 43.89 3.06 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.781 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -155.96 -65.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.0 166.06 23.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.375 -0.828 . . . . 0.0 111.413 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 149' ' ' TYR . 50.7 mt -80.25 145.97 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 70' ' ' VAL . 66.3 t -114.8 74.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.673 -0.642 . . . . 0.0 109.428 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 85.4 p -64.82 85.04 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 110.474 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.18 51.76 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.505 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -75.26 131.92 40.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -1.007 . . . . 0.0 109.312 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -130.7 159.57 36.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 111.085 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -138.08 126.52 23.32 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 130' ' ' GLN . 76.5 mt -116.06 166.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.473 ' N ' HG22 ' A' ' 129' ' ' ILE . 35.5 tt0 -168.58 111.45 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.4 m-70 -98.39 109.26 22.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.56 -0.713 . . . . 0.0 109.979 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 139' ' ' ILE . 23.5 m -68.62 79.07 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.8 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.45 ' CZ ' ' CG ' ' A' ' 138' ' ' LYS . 2.8 m-85 -69.28 124.62 24.33 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.611 -0.681 . . . . 0.0 110.021 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.625 ' O ' HG12 ' A' ' 137' ' ' VAL . 5.5 ttt180 -127.03 130.46 50.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.552 -0.717 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 52.74 28.56 6.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.464 -0.772 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.48 -18.78 47.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 134' ' ' ARG . 8.3 p -104.18 152.89 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -1.198 . . . . 0.0 110.328 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -85.24 134.52 34.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 110.268 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 132' ' ' THR . 1.2 pt -116.6 -19.61 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.2 115.76 0.96 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 110.69 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 3.3 pttm -143.49 121.15 11.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.601 -0.687 . . . . 0.0 109.891 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 143' ' ' ASP . 14.5 m -143.63 169.29 18.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.452 -0.78 . . . . 0.0 110.936 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.437 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -102.42 157.56 16.83 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.722 -0.611 . . . . 0.0 109.92 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -122.92 103.23 8.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 110.427 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ttt -65.6 120.32 12.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.515 -0.741 . . . . 0.0 109.584 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 149' ' ' TYR . 50.6 t -96.9 -69.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.47 -0.769 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.87 -162.4 31.65 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -93.89 126.04 38.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.622 -0.928 . . . . 0.0 110.27 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 122' ' ' ILE . 9.9 m-85 -113.45 137.74 51.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.695 . . . . 0.0 110.487 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.89 150.61 17.58 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.48 114.41 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.419 1.221 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -106.6 -58.18 1.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.572 -0.705 . . . . 0.0 110.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -170.55 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.523 -0.736 . . . . 0.0 110.744 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.88 -154.38 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.414 -0.804 . . . . 0.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.433 ' OE1' HG21 ' A' ' 73' ' ' THR . 9.3 pt-20 -101.56 166.33 10.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.849 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 92.8 m-85 -115.74 -166.06 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.744 -0.598 . . . . 0.0 109.388 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -148.54 110.91 4.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.666 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.468 ' HE2' HG22 ' A' ' 160' ' ' THR . 39.8 t80 -70.81 165.76 22.46 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.407 HD21 ' HD3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -146.08 109.12 4.61 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.814 . . . . 0.0 110.792 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.468 HG22 ' HE2' ' A' ' 158' ' ' PHE . 72.2 p -87.58 145.91 38.25 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.57 -171.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.658 1.346 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -54.03 158.1 2.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 5.7 tt0 -159.95 93.44 1.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.74 -0.6 . . . . 0.0 109.77 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.13 133.14 49.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.628 -0.67 . . . . 0.0 110.519 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.669 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -80.88 166.78 36.95 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.84 117.47 5.16 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.377 1.198 . . . . 0.0 110.118 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -108.03 172.36 6.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.514 -0.741 . . . . 0.0 110.709 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.81 155.29 8.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.1 ttm -59.28 -27.73 66.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.582 -0.952 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.2 mm? -93.48 -28.79 15.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.655 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.58 -22.01 54.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.936 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -62.36 138.56 58.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.339 -0.85 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.35 177.3 19.11 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 p -88.62 131.59 34.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.939 . . . . 0.0 110.354 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -112.68 108.49 17.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.511 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -66.6 137.91 57.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 0.0 109.403 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' CH2' ' A' ' 194' ' ' TRP . 16.4 mt -128.69 135.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.358 -0.839 . . . . 0.0 110.828 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -108.42 105.04 14.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.738 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.5 p -106.45 129.28 54.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.532 -0.73 . . . . 0.0 110.593 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -126.5 91.61 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.673 -0.642 . . . . 0.0 109.886 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.743 ' CE2' HG21 ' A' ' 114' ' ' ILE . 3.4 t80 -74.82 103.66 5.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 109.7 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.459 HG22 ' CB ' ' A' ' 188' ' ' ASP . 69.6 p -122.37 165.81 15.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.707 . . . . 0.0 110.201 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -115.64 164.55 14.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.624 -0.673 . . . . 0.0 109.39 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.13 55.81 3.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -117.19 -75.14 0.58 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.752 -0.593 . . . . 0.0 109.661 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.38 23.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.741 -0.599 . . . . 0.0 112.18 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t -173.09 -172.6 0.84 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.687 -1.258 . . . . 0.0 111.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.459 ' CB ' HG22 ' A' ' 182' ' ' THR . 2.2 m-20 -114.46 118.8 34.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 36.3 m-70 -56.93 -49.98 73.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 110.791 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.1 tp -168.25 153.74 6.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -154.28 140.96 19.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.402 ' CB ' HD21 ' A' ' 94' ' ' LEU . 16.0 p90 -145.57 -154.63 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.787 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.7 129.5 6.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.362 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.48 ' HB3' HD11 ' A' ' 88' ' ' LEU . 14.3 p-90 -137.82 146.9 44.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.574 -0.704 . . . . 0.0 109.901 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -96.79 158.08 15.6 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 104' ' ' LEU . 21.1 tp -127.0 111.55 14.21 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.7 m -91.53 117.66 29.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.53 -0.731 . . . . 0.0 110.774 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.5 mm -90.03 139.86 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -134.55 -155.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.467 -0.771 . . . . 0.0 110.494 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -93.83 -63.05 1.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -153.15 113.86 4.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.52 -0.737 . . . . 0.0 111.496 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -80.05 7.13 9.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.618 -0.676 . . . . 0.0 111.901 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -169.03 38.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.349 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.194 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.059 0.457 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 p -112.57 -25.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.636 -0.665 . . . . 0.0 110.333 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -79.68 177.16 9.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 110.196 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.74 96.27 4.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.656 -0.653 . . . . 0.0 110.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.9 175.42 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.558 -0.714 . . . . 0.0 110.641 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.81 -49.9 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.376 1.198 . . . . 0.0 110.322 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.09 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.413 -0.804 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 67' ' ' VAL . 7.2 p -163.07 85.09 1.4 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.567 -0.708 . . . . 0.0 110.26 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.29 163.53 38.36 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.283 1.149 . . . . 0.0 110.328 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' CG ' HG23 ' A' ' 70' ' ' VAL . 31.6 t30 -98.61 -71.79 0.68 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.558 -0.714 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 123' ' ' VAL . 57.2 t -122.48 33.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.712 0.767 . . . . 0.0 109.684 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HD22 ' A' ' 190' ' ' LEU . 60.9 t -69.24 153.38 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.291 0.567 . . . . 0.0 109.986 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 90' ' ' LEU . 57.8 t -69.03 136.84 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.669 -0.645 . . . . 0.0 109.487 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 116' ' ' PHE . 62.1 p -95.44 -41.85 8.77 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.282 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -164.19 169.01 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 110.253 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 76' ' ' THR . 5.8 tt -133.64 134.9 43.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 75' ' ' LEU . 62.6 m -122.03 158.35 29.36 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.578 -0.702 . . . . 0.0 110.44 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 86' ' ' LEU . 73.3 mt -132.81 93.73 3.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.75 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -81.69 140.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.746 -0.596 . . . . 0.0 110.161 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 84.2 m -142.41 -162.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.642 -0.661 . . . . 0.0 110.063 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.7 p -111.34 -72.55 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 110.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 p -96.63 32.54 2.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.8 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.56 -174.62 0.45 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.652 -0.655 . . . . 0.0 110.237 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.8 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.2 Cg_endo -79.93 -28.87 2.99 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 123.203 1.107 . . . . 0.0 110.156 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.55 -179.22 33.45 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.44 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.3 Cg_endo -71.87 108.35 2.42 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.587 1.309 . . . . 0.0 110.511 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.792 ' HB2' HD12 ' A' ' 77' ' ' LEU . 37.7 mt -71.72 107.39 4.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.829 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.15 146.29 27.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.656 . . . . 0.0 110.247 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -130.91 140.82 50.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.698 . . . . 0.0 110.095 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.25 130.08 39.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.506 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 72' ' ' VAL . 5.8 mt -137.73 56.14 1.77 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 0.0 109.926 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 90' ' ' LEU . 27.0 p -149.37 -45.64 0.14 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -0.758 . . . . 0.0 110.797 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.14 -89.02 1.13 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.75 124.14 49.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.916 . . . . 0.0 110.282 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 89.4 mt -92.84 -24.16 18.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.581 -0.699 . . . . 0.0 110.392 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -23.1 6.31 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.218 -0.926 . . . . 0.0 111.295 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -57.78 -19.72 30.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 111.081 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.1 m-30 -62.56 -55.24 29.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.163 -0.961 . . . . 0.0 110.47 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -20.03 39.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.498 -0.751 . . . . 0.0 110.835 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -96.26 26.86 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -168.95 163.33 11.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.389 -0.82 . . . . 0.0 110.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 p -163.29 131.14 3.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.615 -0.678 . . . . 0.0 110.032 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.627 ' HB3' HD13 ' A' ' 86' ' ' LEU . 26.9 m-85 -73.79 126.6 30.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.614 -0.679 . . . . 0.0 110.094 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.1 t -87.35 122.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.71 . . . . 0.0 110.128 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' HD13 ' A' ' 198' ' ' ILE . 41.1 mt -114.89 -169.67 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 110.151 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.789 ' O ' HG13 ' A' ' 108' ' ' VAL . 16.3 tttm -126.4 157.5 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.716 0.769 . . . . 0.0 109.868 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -41.19 117.35 0.86 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 43.44 66.2 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.127 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 105' ' ' LYS . 35.0 m -98.44 152.21 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -1.111 . . . . 0.0 110.244 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.521 ' HB3' ' HE3' ' A' ' 162' ' ' MET . 15.8 tt0 -95.48 117.11 29.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 109.486 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 33.0 p90 -142.58 149.27 38.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.387 -0.821 . . . . 0.0 111.277 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.62 166.01 11.52 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 77' ' ' LEU . 70.0 mt -126.15 148.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.022 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HD2' HD21 ' A' ' 159' ' ' LEU . 5.8 mtpp -123.25 92.09 3.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 109.547 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.605 HD13 ' HG ' ' A' ' 75' ' ' LEU . 46.9 mm -73.32 135.71 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 110.322 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.1 m -117.94 136.99 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.762 ' HA ' HG23 ' A' ' 73' ' ' THR . 37.9 p90 -156.71 148.9 23.11 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.413 -0.804 . . . . 0.0 110.695 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.88 138.01 35.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.716 -0.615 . . . . 0.0 110.509 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 70' ' ' VAL . 58.9 t -129.95 84.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.643 . . . . 0.0 109.482 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 151' ' ' PRO . 2.1 t30 -129.17 48.59 2.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.567 -0.708 . . . . 0.0 111.25 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -70.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.376 -0.827 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.22 156.81 36.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.555 -0.716 . . . . 0.0 110.416 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.17 103.4 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 70' ' ' VAL . 84.3 t -93.56 99.48 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.632 -0.667 . . . . 0.0 109.497 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 83.6 p -89.39 117.72 28.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.512 -0.742 . . . . 0.0 110.758 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 103.92 48.94 1.12 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 146' ' ' VAL . 1.3 ttt -73.09 125.09 26.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 109.906 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -119.69 143.71 47.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.167 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -120.54 106.57 11.91 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 130' ' ' GLN . 84.3 mt -103.15 163.2 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.569 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.421 ' N ' HG22 ' A' ' 129' ' ' ILE . 22.9 tt0 -153.25 139.56 18.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.738 -0.601 . . . . 0.0 109.944 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 141' ' ' LYS . 30.9 m-70 -117.93 132.65 56.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 110.496 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 m -87.55 71.1 9.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 109.543 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 7.3 m-85 -74.08 151.46 40.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.714 -0.616 . . . . 0.0 110.822 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HD3' HD11 ' A' ' 139' ' ' ILE . 2.8 tpt180 -120.17 -150.96 0.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.836 -0.54 . . . . 0.0 109.735 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 66.43 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 110.848 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.3 34.66 35.97 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.9 t -144.84 95.09 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.655 -0.909 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -59.55 115.6 3.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.508 -0.745 . . . . 0.0 110.197 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.543 HD11 ' HD3' ' A' ' 134' ' ' ARG . 95.2 mt -89.8 -58.7 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.474 -0.766 . . . . 0.0 110.115 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.29 -171.8 1.36 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.51 -0.744 . . . . 0.0 110.944 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -162.85 167.6 22.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.777 -0.577 . . . . 0.0 110.269 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.1 m -137.11 147.81 46.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.356 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.28 127.8 54.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.662 -0.648 . . . . 0.0 110.012 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -117.32 139.05 51.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.495 -0.753 . . . . 0.0 110.614 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.348 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.632 HG11 ' SD ' ' A' ' 126' ' ' MET . 58.4 t -79.57 -69.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 0.0 110.411 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.79 171.84 20.61 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 38.7 m -94.71 150.8 19.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.609 -0.936 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 156' ' ' TYR . 63.6 m-85 -149.35 129.01 13.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.55 -0.719 . . . . 0.0 110.388 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.01 169.95 34.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 119' ' ' ASN . 44.6 Cg_endo -70.24 -165.94 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.339 1.179 . . . . 0.0 110.354 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 37.7 34.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.153 0.501 . . . . 0.0 112.234 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 156' ' ' TYR . . . -133.29 26.9 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.711 -0.618 . . . . 0.0 110.49 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.9 -159.56 0.21 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.581 -0.7 . . . . 0.0 110.386 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -100.18 150.96 21.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.39 -0.819 . . . . 0.0 110.8 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 153' ' ' ALA . 84.7 m-85 -105.69 -165.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.726 -0.609 . . . . 0.0 109.543 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.14 123.03 1.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.422 -0.799 . . . . 0.0 110.548 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.624 ' HB2' HG13 ' A' ' 146' ' ' VAL . 33.3 t80 -87.48 167.88 13.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -145.77 88.29 1.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.57 HG22 ' HE2' ' A' ' 158' ' ' PHE . 82.1 p -62.87 146.79 94.82 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 149.56 77.33 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.408 1.215 . . . . 0.0 110.621 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.521 ' HE3' ' HB3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -51.73 106.28 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.558 -0.714 . . . . 0.0 110.787 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.66 159.53 14.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -91.0 148.0 22.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.0 110.547 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.19 178.95 1.84 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.659 -0.651 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.804 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.85 132.23 18.18 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.222 1.117 . . . . 0.0 110.354 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -113.28 165.32 12.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.76 161.22 17.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.3 ttp -60.85 -39.48 89.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.669 -0.9 . . . . 0.0 110.141 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.1 pt? -72.3 -5.47 36.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.604 -0.685 . . . . 0.0 111.687 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.401 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -76.3 -29.51 57.38 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -65.08 127.51 31.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.59 -179.24 21.94 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 p -88.09 134.96 33.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.994 . . . . 0.0 110.3 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CE2' ' NE ' ' A' ' 134' ' ' ARG . 24.8 m-85 -122.57 111.54 16.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.691 -0.631 . . . . 0.0 110.001 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.22 130.64 47.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.531 -0.731 . . . . 0.0 110.334 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.924 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.9 mm -114.26 98.55 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.646 -0.659 . . . . 0.0 110.029 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 119.04 31.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.111 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 36.8 t -118.44 143.41 46.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.735 -0.603 . . . . 0.0 110.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -84.48 130.6 34.74 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.2 t -171.62 -171.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.536 -0.727 . . . . 0.0 110.201 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 5.6 p-10 -111.09 -154.73 0.55 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.642 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.79 -59.18 5.61 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.421 -0.799 . . . . 0.0 110.098 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.7 27.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.873 -0.517 . . . . 0.0 110.677 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -80.81 -35.99 32.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.28 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t -176.99 -162.67 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.65 -0.656 . . . . 0.0 110.137 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 119.69 37.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.707 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.518 ' NE2' HG11 ' A' ' 123' ' ' VAL . 10.1 m-70 -75.7 -60.31 2.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 110.789 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.643 HD22 HG13 ' A' ' 71' ' ' VAL . 6.2 tp -169.82 152.06 4.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 t -149.42 135.56 19.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.533 -0.729 . . . . 0.0 110.362 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.406 ' CD1' HD21 ' A' ' 90' ' ' LEU . 20.4 p90 -135.83 -155.69 0.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.685 . . . . 0.0 110.006 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -167.87 128.07 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.981 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.924 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 24.7 p-90 -132.74 150.6 52.14 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.0 109.719 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.52 151.58 23.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.493 -0.755 . . . . 0.0 111.137 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 104' ' ' LEU . 17.2 tp -125.53 105.09 8.78 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -81.77 138.33 35.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.604 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.665 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.3 mm -114.57 164.04 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 109.461 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.7 ttmt -153.94 -159.23 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -122.32 -10.65 8.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.651 -0.655 . . . . 0.0 111.346 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.06 69.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.136 -0.978 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.688 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.02 -4.56 33.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.555 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -154.44 46.17 0.56 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.126 -0.984 . . . . 0.0 110.136 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.249 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.155 0.503 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -145.24 50.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.588 -0.695 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -81.33 178.74 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.588 -0.695 . . . . 0.0 110.157 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.54 -175.03 2.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 110.216 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.64 147.97 53.64 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -176.11 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.37 1.195 . . . . 0.0 110.447 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -96.78 -176.77 3.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.613 -0.68 . . . . 0.0 110.307 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 67' ' ' VAL . 8.8 p -144.87 59.46 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.714 . . . . 0.0 110.144 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.53 168.97 22.94 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.351 1.185 . . . . 0.0 110.395 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.72 -65.41 1.01 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.188 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' VAL . 85.0 t -141.1 119.39 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 HD22 ' A' ' 190' ' ' LEU . 62.2 t -142.85 139.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.487 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.508 HG11 HD22 ' A' ' 90' ' ' LEU . 59.4 t -64.29 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 116' ' ' PHE . 77.4 p -74.8 -66.96 0.69 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.873 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -131.35 170.82 14.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.529 -0.732 . . . . 0.0 110.73 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HG ' HD13 ' A' ' 114' ' ' ILE . 6.3 tt -142.7 136.88 29.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.659 -0.651 . . . . 0.0 109.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.3 m -109.42 163.99 12.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 0.0 110.076 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -145.98 110.19 4.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.13 114.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 110.042 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.539 ' H ' ' HB2' ' A' ' 82' ' ' ALA . 74.3 m -115.62 78.55 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 110.1 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.3 p 45.94 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.905 -0.497 . . . . 0.0 112.061 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 73.4 p -84.11 56.75 3.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 110.219 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 79' ' ' CYS . . . -90.72 151.89 44.26 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 110.695 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.2 -18.49 23.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.514 1.271 . . . . 0.0 110.228 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.98 152.77 7.37 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.01 98.55 0.91 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.436 1.229 . . . . 0.0 110.369 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 102' ' ' PHE . 6.0 mt -64.72 131.46 46.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 109.879 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -103.87 113.02 26.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.542 -0.723 . . . . 0.0 110.31 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.2 tt -89.13 131.36 35.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.567 -0.708 . . . . 0.0 110.03 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.5 ' N ' HD23 ' A' ' 88' ' ' LEU . 17.5 t70 -87.13 126.45 34.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.681 -0.637 . . . . 0.0 110.052 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 192' ' ' TRP . 1.1 mp -130.28 52.99 1.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -129.39 -48.4 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.703 -0.623 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.4 -116.25 4.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.88 114.61 3.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.567 -0.96 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' HZ ' ' A' ' 97' ' ' PHE . 65.4 mt -93.87 -39.12 10.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.638 -0.664 . . . . 0.0 110.058 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.86 -18.62 34.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.2 t -55.09 -20.65 10.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.24 -0.913 . . . . 0.0 111.335 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.577 ' CD1' HD21 ' A' ' 88' ' ' LEU . 4.6 m-30 -59.99 -31.57 70.04 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -63.3 -16.27 59.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 111.207 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -86.73 -25.48 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.906 . . . . 0.0 110.601 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.54 137.66 47.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -121.26 149.82 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CD1' HD13 ' A' ' 86' ' ' LEU . 29.4 m-85 -85.46 123.04 30.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.504 -0.747 . . . . 0.0 110.105 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.71 152.61 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 109.988 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' CG2' ' A' ' 108' ' ' VAL . 1.6 mt -153.63 172.66 16.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.672 -0.643 . . . . 0.0 110.052 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -93.85 153.87 18.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.509 -0.744 . . . . 0.0 109.843 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -20.52 -55.57 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.796 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -160.88 69.72 0.24 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.577 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.545 ' CG2' HD22 ' A' ' 104' ' ' LEU . 20.9 m -82.63 -161.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.489 -1.006 . . . . 0.0 109.869 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 7.4 mm-40 -98.58 145.77 26.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.548 ' OH ' HD21 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -109.29 111.08 22.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 112.213 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.46 98.63 6.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 66.3 mt -110.64 144.88 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.464 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.555 ' NZ ' HD21 ' A' ' 159' ' ' LEU . 10.6 mttm -120.15 107.25 12.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 48.2 mm -83.24 148.16 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.422 -0.798 . . . . 0.0 110.608 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -130.14 137.21 50.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.699 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.5 p90 -157.7 159.32 36.79 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.874 -0.731 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.46 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.1 mtm180 -98.54 138.68 35.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.382 0.611 . . . . 0.0 111.054 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 91.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -129.13 48.11 2.4 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.91 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -69.62 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.226 -0.921 . . . . 0.0 110.582 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -139.02 165.83 26.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.775 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.86 105.33 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.654 -0.653 . . . . 0.0 109.708 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 70' ' ' VAL . 58.5 t -88.49 80.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 110.094 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.95 116.86 22.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.604 -0.685 . . . . 0.0 110.144 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.55 27.54 3.28 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -64.24 135.65 56.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.508 -0.996 . . . . 0.0 109.589 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -126.31 167.37 15.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -138.02 78.16 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.22 157.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.54 -0.725 . . . . 0.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -162.16 126.52 3.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.709 -0.619 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.464 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 15.1 m-70 -109.82 119.43 39.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.512 -0.742 . . . . 0.0 110.288 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 139' ' ' ILE . 61.4 m -72.14 68.66 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.656 . . . . 0.0 109.411 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 5.5 m-85 -61.63 144.91 53.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 110.765 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -126.99 100.68 6.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.59 37.28 28.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.561 -0.712 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.65 -15.35 61.06 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.081 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 138' ' ' LYS . 58.4 t -98.46 167.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.179 -1.189 . . . . 0.0 110.203 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.8 mppt? -113.66 130.9 56.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -120.76 -23.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.735 . . . . 0.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -165.39 119.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.159 -0.963 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -144.41 132.62 21.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -0.75 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 143' ' ' ASP . 58.2 m -146.32 165.78 28.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.665 -0.647 . . . . 0.0 110.499 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 142' ' ' THR . 10.5 p-10 -100.06 136.31 40.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.669 . . . . 0.0 110.038 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -111.54 154.45 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.558 -0.713 . . . . 0.0 110.454 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 12.3 ttm -101.73 112.16 24.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.606 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' A' ' 158' ' ' PHE . 57.8 t -79.49 -48.76 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.529 -0.732 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.46 165.6 10.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 65.4 p -85.77 143.75 28.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.68 -0.894 . . . . 0.0 109.403 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 148' ' ' SER . 50.2 m-85 -140.68 125.93 18.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.543 -0.723 . . . . 0.0 110.384 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.58 154.37 32.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.54 85.51 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.476 1.25 . . . . 0.0 110.378 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -85.45 -89.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.63 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.927 -1.108 . . . . 0.0 110.998 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -162.5 -163.43 0.9 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.82 . . . . 0.0 110.935 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -100.28 167.54 10.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.606 . . . . 0.0 110.092 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 27.7 m-85 -113.79 171.51 7.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.663 . . . . 0.0 109.787 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -138.36 95.33 2.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.523 -0.735 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.505 ' CG ' HG13 ' A' ' 146' ' ' VAL . 49.0 t80 -81.36 169.83 16.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 ' NZ ' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -146.82 111.37 5.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.745 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 64.0 p -77.67 140.01 63.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.75 . . . . 0.0 109.064 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.11 163.28 29.43 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.75 1.395 . . . . 0.0 111.401 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -59.38 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.176 0.512 . . . . 0.0 111.478 -179.288 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 110' ' ' TYR . 5.9 tt0 -79.39 -171.5 2.77 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.54 155.92 39.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 110.649 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.796 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -100.62 160.61 26.4 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.702 -0.624 . . . . 0.0 109.8 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.58 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 48.0 Cg_endo -73.45 117.02 4.9 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.411 1.216 . . . . 0.0 110.777 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -113.97 -170.38 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.09 28.27 3.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 65.81 -68.51 0.12 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.452 -1.028 . . . . 0.0 110.75 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -56.57 -29.22 61.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 166' ' ' PRO . . . -57.61 -21.79 41.43 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.642 -0.661 . . . . 0.0 110.671 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.405 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 44.9 mtp180 -60.69 136.86 58.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 142.02 -173.52 23.64 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 p -91.6 137.99 31.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.623 -0.927 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -128.23 115.07 17.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 110.271 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.484 ' O ' HD13 ' A' ' 177' ' ' ILE . 1.5 m120 -60.45 151.85 27.19 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.509 -0.744 . . . . 0.0 110.09 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.775 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.4 mm -131.51 97.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.463 -0.773 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 133' ' ' TYR . 4.3 ttpt -82.4 102.44 11.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 109.733 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.4 p -109.34 137.1 47.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.725 . . . . 0.0 110.482 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.41 99.51 5.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.781 -0.575 . . . . 0.0 110.007 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -78.77 120.42 23.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.688 -0.633 . . . . 0.0 109.75 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.0 t -142.95 -164.77 1.92 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.53 -0.731 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 13.0 p-10 -157.83 160.84 38.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.906 -0.496 . . . . 0.0 109.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.44 56.47 3.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.763 . . . . 0.0 109.964 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -131.09 -41.99 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 110.648 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -145.01 -77.65 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.931 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.6 t -150.76 -159.76 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.368 -0.832 . . . . 0.0 110.644 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.67 126.22 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.538 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 17.0 m-70 -73.48 -47.86 37.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 110.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.671 HD22 HG13 ' A' ' 71' ' ' VAL . 5.7 tp -168.39 152.21 5.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 110.232 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.3 t -148.43 152.15 36.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.692 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.572 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.4 p90 -142.97 -161.24 1.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.0 109.947 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.09 122.86 3.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.446 -0.784 . . . . 0.0 110.759 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.775 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 37.6 p-90 -132.28 149.31 52.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.601 -0.687 . . . . 0.0 109.713 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -87.21 152.3 22.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.549 -0.719 . . . . 0.0 111.303 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.548 HD21 ' OH ' ' A' ' 110' ' ' TYR . 25.7 tp -122.04 108.84 13.84 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.9 m -85.74 140.31 30.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.528 -0.733 . . . . 0.0 110.581 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.6 mm -119.72 160.51 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.752 -0.592 . . . . 0.0 109.651 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.13 -153.23 0.33 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.212 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -3.65 6.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.448 -0.783 . . . . 0.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -160.05 43.96 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -54.04 -23.11 12.44 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.239 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.04 47.2 0.91 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.589 -0.695 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.265 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.194 0.521 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -140.54 154.79 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 t -88.69 148.61 23.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.59 103.45 14.28 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.434 -0.791 . . . . 0.0 110.302 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -133.12 82.08 55.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 0.0 110.144 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.95 -51.16 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.364 1.192 . . . . 0.0 110.535 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.2 m120 52.2 -167.62 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.292 -0.88 . . . . 0.0 110.825 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 35.1 m -144.52 52.82 1.9 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.567 -0.708 . . . . 0.0 110.415 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 48.5 Cg_endo -74.18 106.62 2.26 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.292 1.154 . . . . 0.0 110.388 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 -62.13 1.77 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.611 -0.681 . . . . 0.0 110.062 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 123' ' ' VAL . 96.1 t -126.91 128.74 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.3 t -146.95 142.03 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.792 -0.567 . . . . 0.0 109.804 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.586 ' CG1' HD13 ' A' ' 90' ' ' LEU . 61.7 t -62.85 112.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 43.0 p -78.23 -35.53 48.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.0 111.062 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -159.31 176.89 11.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.367 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.1 tt -145.82 113.67 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.798 -0.564 . . . . 0.0 109.665 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 87' ' ' GLU . 4.1 m -109.8 164.55 12.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.445 -0.785 . . . . 0.0 110.571 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -139.23 101.67 4.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 79' ' ' CYS . 65.3 t -94.0 167.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.717 -0.614 . . . . 0.0 110.127 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -168.36 -162.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.759 . . . . 0.0 110.098 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -108.84 -40.65 4.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -122.62 35.12 4.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.09 165.02 25.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.547 -0.721 . . . . 0.0 110.263 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.4 Cg_endo -70.23 -26.8 25.01 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.385 1.203 . . . . 0.0 110.256 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.26 174.03 32.66 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.96 96.08 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.55 1.289 . . . . 0.0 110.293 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' PHE . 23.6 mt -64.8 106.24 1.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.629 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 76' ' ' THR . 2.2 mt-10 -99.24 135.08 41.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.586 -0.696 . . . . 0.0 110.652 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.536 HD22 ' HE1' ' A' ' 97' ' ' PHE . 10.8 mt -116.18 168.02 10.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.608 -0.682 . . . . 0.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.73 128.87 54.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.715 . . . . 0.0 110.111 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.586 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -128.07 50.24 2.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 110.078 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.7 p -141.0 -43.79 0.38 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.155 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.14 -92.01 2.03 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.68 98.79 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -1.021 . . . . 0.0 110.557 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -95.45 -36.92 11.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 0.0 110.089 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.36 -13.0 57.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 0.0 111.273 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 p -55.1 -28.01 49.31 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.545 ' CE2' HD13 ' A' ' 94' ' ' LEU . 28.7 m-85 -61.96 -39.47 92.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.46 -0.775 . . . . 0.0 109.985 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -57.92 -24.37 57.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.685 . . . . 0.0 110.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -118.67 45.41 2.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.561 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -168.35 136.13 2.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.791 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.2 p -143.41 127.88 17.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.657 . . . . 0.0 109.544 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.714 ' CD1' HD22 ' A' ' 86' ' ' LEU . 11.9 m-85 -76.42 115.37 16.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.369 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.77 121.14 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 109.179 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 196' ' ' LEU . 1.0 OUTLIER -113.76 -159.31 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.618 -0.676 . . . . 0.0 110.3 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HB3' HG11 ' A' ' 108' ' ' VAL . 47.0 tttm -140.94 158.79 43.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.572 -0.705 . . . . 0.0 110.555 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' CG ' ' NH1' ' A' ' 172' ' ' ARG . 22.3 mt-10 -38.36 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 33.32 70.34 0.13 Allowed Glycine 0 N--CA 1.505 3.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.863 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 105' ' ' LYS . 33.0 m -90.83 147.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -1.14 . . . . 0.0 109.749 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.26 93.39 4.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 108.814 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 163' ' ' GLU . 31.8 p90 -113.45 146.31 39.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 111.894 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -108.38 157.49 18.35 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 113' ' ' LYS . 66.8 mt -116.66 164.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.855 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.633 ' CG ' HD11 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -142.67 87.15 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.87 -0.519 . . . . 0.0 109.612 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.55 150.92 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.411 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -127.02 153.02 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.705 -0.622 . . . . 0.0 109.739 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -172.09 159.32 4.9 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.576 -0.703 . . . . 0.0 110.576 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' A' ' 73' ' ' THR . 3.3 mtm180 -113.94 154.54 27.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -133.11 97.83 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -128.98 48.93 2.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.513 -0.742 . . . . 0.0 111.291 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -70.6 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.27 -0.894 . . . . 0.0 110.777 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -135.56 172.61 12.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.671 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.1 mt -80.35 108.76 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.726 -0.609 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 70' ' ' VAL . 93.7 t -83.61 86.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -78.13 59.29 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.677 -0.639 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.48 60.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.704 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.4 OUTLIER -70.25 128.67 37.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -1.058 . . . . 0.0 108.566 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -125.99 145.42 50.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.248 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.14 96.04 3.12 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -94.15 162.46 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.087 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 129' ' ' ILE . 4.3 tt0 -151.46 135.33 16.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.598 -0.688 . . . . 0.0 110.185 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 177' ' ' ILE . 13.6 m-70 -109.55 149.1 30.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.715 . . . . 0.0 109.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.483 HG22 HH22 ' A' ' 134' ' ' ARG . 0.4 OUTLIER -108.13 80.84 1.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.6 -0.687 . . . . 0.0 109.208 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 11.6 m-85 -86.05 140.37 30.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 111.071 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.699 HH11 HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -119.83 79.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.685 . . . . 0.0 110.399 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt 52.09 55.61 8.98 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.406 -0.809 . . . . 0.0 111.339 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.84 -19.33 52.3 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.1 t -98.73 89.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.181 -1.188 . . . . 0.0 109.829 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 5.1 pttm -66.92 122.73 18.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.575 -0.703 . . . . 0.0 110.562 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.699 HD12 HH11 ' A' ' 134' ' ' ARG . 1.8 mt -89.74 -54.03 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.15 -167.97 0.37 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.505 -0.747 . . . . 0.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HE2' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -157.93 153.46 26.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.632 -0.668 . . . . 0.0 109.92 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.456 HG21 ' CZ ' ' A' ' 144' ' ' TYR . 8.5 m -118.29 146.1 44.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -125.19 118.4 25.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 142' ' ' THR . 29.2 m-85 -111.56 147.09 36.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.404 -0.81 . . . . 0.0 110.855 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.0 ttp -104.12 118.19 36.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.753 -0.592 . . . . 0.0 109.463 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 149' ' ' TYR . 49.1 t -79.87 -66.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.59 -0.694 . . . . 0.0 110.263 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.23 -148.87 20.17 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 92.5 p -108.59 136.64 47.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.543 -0.975 . . . . 0.0 110.427 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.552 ' HE1' HG12 ' A' ' 146' ' ' VAL . 23.3 m-85 -122.82 147.01 47.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 110.396 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.14 152.29 18.03 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.515 ' HA ' HG12 ' A' ' 118' ' ' VAL . 51.2 Cg_endo -75.5 -174.25 1.93 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.362 1.19 . . . . 0.0 110.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 52.01 70.11 0.59 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.5 -0.75 . . . . 0.0 111.079 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.1 -94.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.484 -0.76 . . . . 0.0 110.364 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.54 -155.17 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.838 -1.164 . . . . 0.0 109.897 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 88.73 6.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.91 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -59.75 -168.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.506 -0.746 . . . . 0.0 109.94 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.414 ' OE1' HD11 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -161.61 134.83 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.475 -0.766 . . . . 0.0 110.726 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 146' ' ' VAL . 29.9 t80 -107.09 156.86 18.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.633 HD11 ' CG ' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -137.93 114.0 10.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.446 -0.784 . . . . 0.0 110.595 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -78.61 154.53 78.69 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.21 154.96 72.11 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.628 1.331 . . . . 0.0 110.806 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 ttm -59.83 124.17 19.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.699 -0.626 . . . . 0.0 110.438 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.5 pt-20 -124.49 141.59 51.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.633 -0.667 . . . . 0.0 109.921 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.19 140.31 31.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.586 -0.696 . . . . 0.0 110.417 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -86.62 -179.27 1.34 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.637 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.7 Cg_endo -75.29 125.47 9.15 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.237 1.125 . . . . 0.0 110.297 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -115.26 -176.68 2.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.656 -0.653 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.93 153.98 19.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 9.2 ttm -60.19 -28.12 67.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.644 -0.915 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 26.2 4.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 110.116 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.31 22.46 8.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.529 -0.732 . . . . 0.0 110.387 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -100.03 147.9 25.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.835 . . . . 0.0 109.94 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.83 179.97 16.77 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.6 p -81.14 140.76 34.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.67 -0.9 . . . . 0.0 110.761 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 13.4 m-85 -118.35 106.19 12.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.787 -0.571 . . . . 0.0 109.919 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -71.08 121.45 18.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.584 -0.697 . . . . 0.0 110.055 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 131' ' ' HIS . 26.6 mt -116.84 145.42 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -114.02 114.43 26.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.976 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.0 m -106.23 151.36 24.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.65 -0.656 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -149.12 93.73 2.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 116' ' ' PHE . 18.1 t80 -75.33 107.55 7.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.591 -0.693 . . . . 0.0 109.628 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 188' ' ' ASP . 75.8 p -121.71 168.49 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.524 -0.735 . . . . 0.0 110.38 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.691 ' HB2' HG13 ' A' ' 123' ' ' VAL . 7.0 p-10 -121.2 152.88 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.783 -0.573 . . . . 0.0 109.802 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.37 58.53 3.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 110.107 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -161.29 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.544 -0.722 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -112.04 -80.66 0.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.647 -0.658 . . . . 0.0 110.887 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t -169.27 -154.16 0.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.282 -0.886 . . . . 0.0 110.297 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' A' ' 182' ' ' THR . 1.1 m-20 -78.32 108.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.378 -0.826 . . . . 0.0 110.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.414 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 25.8 m-70 -59.57 -55.12 38.45 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.471 -0.768 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 tp -168.56 153.87 6.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.5 t -148.26 155.73 41.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 110.142 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.526 ' CB ' HD11 ' A' ' 94' ' ' LEU . 23.1 p90 -148.6 -152.99 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -164.08 139.91 6.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 14.1 p-90 -147.89 147.82 30.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.213 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -92.73 148.88 21.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.503 -0.748 . . . . 0.0 111.224 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.783 HD21 HD12 ' A' ' 104' ' ' LEU . 49.6 tp -124.05 115.72 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.407 ' O ' HD13 ' A' ' 198' ' ' ILE . 96.0 m -87.41 152.49 22.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.477 -0.764 . . . . 0.0 110.947 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.488 HD13 ' CB ' ' A' ' 104' ' ' LEU . 49.8 mm -130.28 159.21 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -160.32 -158.51 0.63 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.284 -0.885 . . . . 0.0 111.243 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -64.31 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.61 -0.681 . . . . 0.0 111.096 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.59 103.67 3.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.0 110.93 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.58 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -72.95 -3.13 23.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.556 -0.715 . . . . 0.0 111.644 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -136.49 57.61 1.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.059 -1.026 . . . . 0.0 110.133 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.228 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.478 ' C ' HG22 ' A' ' 61' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.8 0.333 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG22 ' C ' ' A' ' 60' ' ' ALA . 19.7 m 38.4 -158.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 CA-C-O 121.022 0.439 . . . . 0.0 112.118 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.1 p 50.56 -166.84 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.353 -0.842 . . . . 0.0 111.002 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.13 -28.28 9.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -118.79 85.11 27.1 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.281 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 173.12 14.34 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.398 1.209 . . . . 0.0 110.27 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -72.05 161.09 31.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.568 -0.708 . . . . 0.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.89 147.54 37.94 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.94 -174.49 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.398 1.21 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.77 -63.75 1.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' HG21 ' A' ' 123' ' ' VAL . 93.0 t -141.95 122.07 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.79 HG13 HD22 ' A' ' 190' ' ' LEU . 59.0 t -148.89 137.15 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.302 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.747 HG22 ' CD2' ' A' ' 181' ' ' PHE . 58.4 t -66.12 108.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.876 HG23 ' HA ' ' A' ' 116' ' ' PHE . 73.0 p -70.62 -62.63 1.32 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.607 -0.683 . . . . 0.0 110.543 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -145.07 167.9 21.6 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.774 . . . . 0.0 110.802 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.559 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -125.61 136.28 53.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.717 -0.615 . . . . 0.0 109.687 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 85' ' ' PRO . 92.4 m -125.82 149.17 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 110.638 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -133.9 103.66 5.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 109.947 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -94.14 166.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.616 -0.677 . . . . 0.0 110.178 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -167.25 -164.3 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 110.009 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -44.77 4.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 p -108.98 27.19 9.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.84 162.37 33.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.594 -0.691 . . . . 0.0 110.609 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 45.7 Cg_endo -71.78 -25.49 20.23 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.524 1.276 . . . . 0.0 110.078 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.03 176.22 33.89 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.65 ' HB2' HG23 ' A' ' 76' ' ' THR . 45.8 Cg_endo -71.63 104.45 1.6 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.567 1.298 . . . . 0.0 110.444 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 23.5 mt -64.88 108.75 1.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.655 -0.653 . . . . 0.0 109.634 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -86.77 139.66 30.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -120.06 149.42 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 110.085 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.447 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.8 t0 -103.19 118.4 36.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.715 . . . . 0.0 110.222 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 192' ' ' TRP . 2.8 mt -128.98 50.04 2.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -96.93 -73.52 0.6 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.599 -0.688 . . . . 0.0 110.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -52.37 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.78 88.09 4.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.917 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 96.1 mt -87.82 -25.23 23.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.724 . . . . 0.0 110.405 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.85 -21.75 12.36 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.245 -0.909 . . . . 0.0 111.093 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.2 t -54.43 -22.6 13.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.347 -0.846 . . . . 0.0 111.127 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CE1' HD22 ' A' ' 88' ' ' LEU . 10.4 m-30 -61.95 -48.03 82.2 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.802 . . . . 0.0 109.943 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -59.51 -24.8 63.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.62 -0.675 . . . . 0.0 110.659 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -86.85 -26.42 24.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 0.0 110.509 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -132.76 129.86 39.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.643 -0.661 . . . . 0.0 110.379 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -106.99 -175.03 2.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.645 -0.659 . . . . 0.0 110.093 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 196' ' ' LEU . 2.6 m-85 -113.58 96.03 5.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.596 -0.69 . . . . 0.0 110.174 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.18 142.88 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 109.837 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 HD11 ' A' ' 196' ' ' LEU . 1.2 mt -157.32 172.51 18.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -90.06 157.57 17.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -20.04 -50.86 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.727 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -171.54 63.54 0.15 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' LYS . 23.3 m -75.37 137.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -1.025 . . . . 0.0 110.322 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.81 105.32 8.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.67 -0.644 . . . . 0.0 109.431 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 77' ' ' LEU . 18.1 p90 -121.56 171.07 9.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.317 -0.864 . . . . 0.0 111.512 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -117.18 145.61 43.75 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.61 139.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.417 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 90.59 3.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.695 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.6 mm -74.42 147.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.569 -0.707 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 m -130.49 134.72 47.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.876 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.6 p90 -154.61 160.67 41.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.441 -0.787 . . . . 0.0 111.093 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -108.29 131.44 54.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.327 0.584 . . . . 0.0 110.716 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 149' ' ' TYR . 93.5 t -120.23 93.1 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -129.35 50.23 2.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.348 -0.845 . . . . 0.0 111.569 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.12 -65.26 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 110.421 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.82 169.54 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.58 101.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.717 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 70' ' ' VAL . 60.7 t -79.9 75.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.65 -0.656 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -83.14 110.95 18.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.718 . . . . 0.0 110.387 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.47 30.16 2.51 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.7 OUTLIER -62.24 112.11 2.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.434 -1.039 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 163.71 12.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.594 -0.692 . . . . 0.0 110.936 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -138.13 112.08 8.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.73 -0.606 . . . . 0.0 109.64 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.41 161.29 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 0.0 110.034 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -167.42 117.98 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.546 -0.721 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -110.4 131.02 55.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.597 -0.689 . . . . 0.0 110.242 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 m -86.16 93.04 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.718 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 3.1 m-85 -78.19 127.44 32.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.718 . . . . 0.0 110.471 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.2 ttp180 -125.74 130.95 52.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.37 28.69 7.7 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.27 47.13 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.5 m -106.56 146.33 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.214 . . . . 0.0 110.707 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.61 138.76 40.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.597 -0.689 . . . . 0.0 110.126 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.85 -24.22 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -173.28 134.96 0.55 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.028 . . . . 0.0 110.829 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 175.57 7.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.627 -0.671 . . . . 0.0 109.438 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.3 m -154.26 144.7 22.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 111.1 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -115.15 122.51 46.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.93 130.59 56.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.442 -0.787 . . . . 0.0 111.23 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.48 119.01 17.11 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.74 HG12 ' OH ' ' A' ' 149' ' ' TYR . 6.4 t -79.7 -58.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.505 -0.747 . . . . 0.0 110.293 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.11 165.07 11.0 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.935 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 59.2 p -92.91 151.76 19.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.614 -0.933 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.74 ' OH ' HG12 ' A' ' 146' ' ' VAL . 12.7 m-85 -139.15 169.49 17.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.469 -0.769 . . . . 0.0 110.573 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.05 141.96 17.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.51 178.36 5.72 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.214 1.113 . . . . 0.0 110.777 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.06 71.32 0.5 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.54 -0.725 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -166.55 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.458 -0.776 . . . . 0.0 110.408 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.74 -153.94 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.028 -1.045 . . . . 0.0 110.026 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.28 168.85 10.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.427 -0.796 . . . . 0.0 110.02 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 32.2 m-85 -127.17 -176.58 3.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -150.68 113.32 4.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.493 -0.754 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.517 ' HB2' HG13 ' A' ' 146' ' ' VAL . 35.2 t80 -87.24 168.51 13.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.529 -0.732 . . . . 0.0 110.022 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.07 109.8 4.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 0.0 110.738 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.8 p -83.33 151.13 62.07 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.392 -0.817 . . . . 0.0 109.121 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.72 -175.13 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.524 1.276 . . . . 0.0 110.892 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.0 ptm -56.64 145.1 29.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.653 -0.655 . . . . 0.0 110.915 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.04 93.92 2.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.718 -0.614 . . . . 0.0 109.731 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -63.91 121.83 15.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.727 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -57.43 175.12 0.27 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.724 -0.61 . . . . 0.0 110.234 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.0 Cg_endo -72.83 112.51 3.52 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.248 1.131 . . . . 0.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -172.82 2.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.886 -0.509 . . . . 0.0 110.544 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.34 31.67 1.8 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.5 mtp 63.71 -70.75 0.07 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.62 -0.929 . . . . 0.0 111.213 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -69.81 -7.03 36.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.179 -0.951 . . . . 0.0 111.71 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.54 -5.13 41.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.293 -0.879 . . . . 0.0 110.94 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 30.5 mtp180 -67.86 140.68 56.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.86 -174.65 24.16 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.6 p -91.49 124.46 35.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.605 -0.938 . . . . 0.0 110.211 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -112.11 112.87 24.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.358 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.59 143.32 57.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.592 -0.693 . . . . 0.0 109.801 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.772 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.5 mm -119.33 94.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.533 -0.729 . . . . 0.0 110.41 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 tttt -77.23 107.96 10.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.512 -0.743 . . . . 0.0 109.47 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 5.2 p -113.45 160.4 18.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -147.89 83.79 1.52 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.682 -0.636 . . . . 0.0 109.82 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.747 ' CD2' HG22 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -69.68 110.85 5.09 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.6 t -141.33 -168.21 2.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.521 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -99.94 -163.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.8 -53.24 60.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.28 -0.887 . . . . 0.0 110.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.23 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.829 . . . . 0.0 111.445 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.417 ' O ' ' HB ' ' A' ' 187' ' ' THR . 5.7 mmt180 -78.34 -43.81 26.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 186' ' ' ARG . 9.7 t 178.35 166.18 0.8 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.951 -0.468 . . . . 0.0 110.01 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.36 125.24 37.86 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 18.9 p80 -91.56 -17.69 25.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.474 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.79 HD22 HG13 ' A' ' 71' ' ' VAL . 43.5 tp -171.39 155.05 4.07 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.034 -1.041 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -164.96 140.27 5.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.72 -0.613 . . . . 0.0 109.677 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.506 ' CD1' HD21 ' A' ' 90' ' ' LEU . 14.7 p90 -146.95 -153.53 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.412 -0.805 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -167.16 127.33 1.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.701 -0.625 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 20.0 p-90 -130.63 145.94 52.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.25 152.1 23.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.681 -0.637 . . . . 0.0 110.989 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 104' ' ' LEU . 13.1 tp -123.75 92.06 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.734 -0.604 . . . . 0.0 109.544 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.8 m -67.73 129.5 40.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.571 -0.705 . . . . 0.0 110.186 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.1 mm -109.73 150.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.807 -0.558 . . . . 0.0 109.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.73 -153.01 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.665 -0.647 . . . . 0.0 109.949 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 -4.87 6.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.655 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -159.98 46.7 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.982 -1.074 . . . . 0.0 110.986 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -56.06 -22.16 26.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.344 -0.848 . . . . 0.0 111.131 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.64 51.54 1.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -0.815 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.194 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.081 0.467 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.89 153.69 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.633 -0.667 . . . . 0.0 110.24 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.3 p -88.54 164.59 15.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 110.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.53 168.04 9.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.591 -0.693 . . . . 0.0 110.225 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -95.22 105.39 19.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.21 83.69 0.95 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.225 1.118 . . . . 0.0 110.463 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -121.59 52.22 1.26 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.14 156.14 38.05 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.333 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HG2' HG21 ' A' ' 71' ' ' VAL . 47.0 Cg_endo -72.9 -166.23 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.45 1.237 . . . . 0.0 110.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -98.09 -68.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 110.043 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 118' ' ' VAL . 84.6 t -115.82 134.52 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.582 -0.699 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG21 ' HG2' ' A' ' 68' ' ' PRO . 63.0 t -148.34 152.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.608 -0.683 . . . . 0.0 109.92 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.3 t -71.61 112.33 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.881 HG23 ' HA ' ' A' ' 116' ' ' PHE . 67.5 p -70.81 -51.3 27.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.306 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -151.3 179.77 8.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.2 tt -146.39 121.24 9.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.629 -0.669 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -109.75 163.42 13.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -148.61 113.89 5.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.468 -0.77 . . . . 0.0 110.531 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -125.87 167.23 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.654 . . . . 0.0 109.817 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 78' ' ' VAL . 52.5 t -153.05 -71.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.554 -0.717 . . . . 0.0 110.315 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.0 p -171.89 -71.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 p -103.99 33.59 3.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.609 -0.682 . . . . 0.0 109.928 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -79.65 172.78 8.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 110.32 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.6 Cg_endo -72.22 -27.73 16.28 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.455 1.24 . . . . 0.0 110.046 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.57 170.44 25.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.2 Cg_endo -72.04 97.76 0.86 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.544 1.286 . . . . 0.0 110.292 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 1.5 mp -64.67 122.68 17.42 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.523 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.22 112.93 26.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 110.678 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.0 mt -95.26 131.23 41.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 5.4 t70 -75.64 135.25 40.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.704 . . . . 0.0 110.614 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HA ' HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.61 54.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.619 -0.675 . . . . 0.0 109.71 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.7 p -130.21 49.84 2.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 110.7 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.52 -55.62 0.74 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.26 64.32 0.56 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.592 -0.946 . . . . 0.0 110.073 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 90' ' ' LEU . 29.4 mt -95.14 -0.09 53.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 111.207 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.18 -24.37 58.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.106 -0.996 . . . . 0.0 110.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.77 -6.55 45.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.42 -0.8 . . . . 0.0 111.227 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 13.9 m-85 -81.28 -38.71 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -69.95 -20.2 63.34 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.511 -0.743 . . . . 0.0 110.858 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.37 38.25 3.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -168.96 151.62 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.447 -0.783 . . . . 0.0 110.55 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -128.76 -169.53 2.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.555 -0.716 . . . . 0.0 109.989 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD2' HD13 ' A' ' 77' ' ' LEU . 1.1 m-85 -125.17 111.57 15.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 109.93 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.22 147.47 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.547 -0.72 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -167.38 145.05 4.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.788 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.648 ' H ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -78.59 155.6 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.454 -0.779 . . . . 0.0 109.75 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -17.24 -87.59 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.736 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -134.81 67.29 0.55 Allowed Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.163 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.617 ' CG2' HD21 ' A' ' 104' ' ' LEU . 8.6 m -75.96 157.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.467 -1.02 . . . . 0.0 110.156 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -85.5 89.53 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.632 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 46.2 p90 -109.27 138.86 44.99 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.662 0.744 . . . . 0.0 112.095 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -105.94 164.98 11.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.35 150.01 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.218 -0.926 . . . . 0.0 111.216 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -125.42 108.01 11.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.7 153.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 0.0 110.522 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.3 m -131.02 140.95 50.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.806 -0.559 . . . . 0.0 109.582 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.881 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -164.47 147.58 9.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.469 -0.77 . . . . 0.0 110.505 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 161.56 17.91 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.439 -0.788 . . . . 0.0 111.195 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 70' ' ' VAL . 63.1 t -133.08 117.23 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.779 -0.575 . . . . 0.0 109.593 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -128.66 46.73 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.995 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 -67.89 0.25 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -143.69 179.07 7.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.819 . . . . 0.0 110.562 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.0 mp -80.19 109.34 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.666 -0.646 . . . . 0.0 109.981 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 70' ' ' VAL . 57.5 t -91.46 83.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.9 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.5 p -85.07 107.78 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.621 -0.675 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.41 39.98 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -81.46 137.89 35.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -1.043 . . . . 0.0 109.957 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.631 ' HE2' HG23 ' A' ' 182' ' ' THR . 22.5 pttt -139.39 171.87 13.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -129.52 117.84 21.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 109.73 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE3' ' A' ' 127' ' ' LYS . 49.8 mm -91.32 165.74 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.736 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 129' ' ' ILE . 49.5 tt0 -168.29 124.05 1.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -113.95 117.82 32.44 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.731 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.6 m -71.89 84.58 0.95 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.717 -0.615 . . . . 0.0 109.921 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 138' ' ' LYS . 2.7 m-85 -87.41 136.39 32.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.497 -0.752 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.428 ' HD2' ' CE2' ' A' ' 175' ' ' TYR . 3.3 ttp180 -120.42 110.58 16.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 110.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 29.63 43.47 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 92.87 34.18 6.99 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 136' ' ' GLY . 62.6 t -149.21 82.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.959 . . . . 0.0 110.071 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 133' ' ' TYR . 2.4 ttpm? -62.29 121.87 14.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 140' ' ' ASP . 31.3 pt -104.32 -31.52 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.534 -0.729 . . . . 0.0 111.067 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.5 p30 -174.23 149.71 1.43 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.14 -0.975 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 150.71 51.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.64 . . . . 0.0 109.505 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.9 m -132.84 159.81 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.98 138.83 53.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.631 -0.668 . . . . 0.0 110.122 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -122.63 113.15 18.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.9 ttt -68.72 137.87 54.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.523 -0.736 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.456 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 60.6 t -98.11 -68.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.552 -0.717 . . . . 0.0 110.151 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.28 176.02 26.14 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.4 p -87.4 152.47 22.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.693 -0.887 . . . . 0.0 109.963 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.433 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 81.3 m-85 -148.18 144.39 27.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 110.415 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.5 154.01 19.68 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.23 65.35 5.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.377 1.199 . . . . 0.0 110.474 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -170.93 37.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 110.337 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.698 ' HB3' ' OH ' ' A' ' 156' ' ' TYR . . . -144.31 15.02 1.65 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.522 -0.736 . . . . 0.0 111.06 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 54.66 -148.1 0.49 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.173 -0.954 . . . . 0.0 110.734 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.95 157.06 38.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.373 -0.829 . . . . 0.0 110.84 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.698 ' OH ' ' HB3' ' A' ' 153' ' ' ALA . 57.4 m-85 -115.87 177.45 4.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.737 -0.602 . . . . 0.0 109.669 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.95 92.84 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.51 -0.744 . . . . 0.0 110.355 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 28.5 t80 -80.81 168.23 19.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.009 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 111' ' ' ARG . 0.9 OUTLIER -154.4 100.63 2.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.395 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.426 HG22 ' HE2' ' A' ' 158' ' ' PHE . 81.0 p -76.02 155.87 84.39 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 109.252 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.76 153.02 76.91 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.615 1.324 . . . . 0.0 110.978 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.0 ptm -58.0 113.47 1.91 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.679 -0.638 . . . . 0.0 110.49 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.25 161.42 13.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.094 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -104.84 141.44 36.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.484 -0.76 . . . . 0.0 110.512 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -96.15 179.66 1.1 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.629 -0.67 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 41.8 Cg_endo -66.44 -153.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.201 1.106 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -107.0 -162.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.061 -1.024 . . . . 0.0 110.689 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 106' ' ' GLU . . . -98.86 -66.79 0.87 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 171' ' ' ALA . 6.6 mtt -60.79 145.94 47.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.959 . . . . 0.0 109.233 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER 66.93 -61.32 0.33 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.639 -0.663 . . . . 0.0 110.535 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -73.06 -2.85 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.4 -0.812 . . . . 0.0 111.695 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 150.36 48.93 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.918 -1.114 . . . . 0.0 110.136 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.56 -177.82 17.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.7 p -91.99 129.78 37.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.696 -0.885 . . . . 0.0 110.219 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.428 ' CE2' ' HD2' ' A' ' 134' ' ' ARG . 12.3 m-85 -108.01 101.12 10.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.594 -0.691 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.96 125.06 23.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.616 ' CD1' HD23 ' A' ' 196' ' ' LEU . 20.5 mt -115.96 132.14 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -0.851 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.8 106.51 17.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.4 m -99.09 140.6 33.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.646 -0.659 . . . . 0.0 109.728 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.44 90.07 2.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.595 -0.691 . . . . 0.0 110.393 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.494 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.7 t80 -64.38 131.66 47.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 109.648 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.631 HG23 ' HE2' ' A' ' 127' ' ' LYS . 5.9 t -171.0 -169.06 0.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -113.7 -164.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -57.5 11.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.293 -0.879 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.29 28.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.873 -0.517 . . . . 0.0 110.379 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -37.67 27.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 0.0 109.914 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.7 t -177.81 -167.43 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.675 -0.641 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -115.35 118.02 32.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.782 -0.574 . . . . 0.0 109.503 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.2 m-70 -75.07 -67.44 0.65 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.457 -0.777 . . . . 0.0 110.666 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.0 tp -165.74 160.29 17.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.461 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.8 p -155.94 144.91 20.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.586 -0.696 . . . . 0.0 110.403 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 30.1 p90 -138.7 -155.76 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.606 -0.684 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.46 129.31 7.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.323 -0.86 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.739 ' CZ3' HD21 ' A' ' 196' ' ' LEU . 4.4 p-90 -140.01 147.9 41.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 175' ' ' TYR . 2.9 m-80 -99.31 154.97 17.76 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.756 0.789 . . . . 0.0 112.452 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.739 HD21 ' CZ3' ' A' ' 194' ' ' TRP . 0.9 OUTLIER -111.74 103.47 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -80.21 101.12 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.753 . . . . 0.0 110.434 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.93 145.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 109.689 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -142.6 -154.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.647 -0.658 . . . . 0.0 110.401 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -108.71 -32.46 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.758 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.11 93.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.761 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -77.21 -0.2 24.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.571 -0.706 . . . . 0.0 111.307 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -127.79 43.2 3.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.066 0.46 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.16 33.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.291 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.97 -66.61 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.543 -0.723 . . . . 0.0 110.265 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -164.16 -159.3 0.48 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 110.35 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -149.46 89.99 4.68 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.37 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.27 -30.46 15.72 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.181 1.095 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.03 128.41 35.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.52 -0.738 . . . . 0.0 110.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.31 145.26 35.6 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.556 -0.715 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.92 -167.79 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.381 1.201 . . . . 0.0 110.635 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -92.93 -66.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.712 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 123' ' ' VAL . 92.8 t -130.68 125.24 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.778 -0.577 . . . . 0.0 110.132 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -148.59 138.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.775 -0.578 . . . . 0.0 109.962 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.748 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -64.51 104.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 155' ' ' GLU . 66.4 p -70.8 -63.3 1.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.668 -0.645 . . . . 0.0 110.41 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -138.61 173.21 11.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.6 tt -142.85 124.92 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.648 -0.658 . . . . 0.0 109.559 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 85' ' ' PRO . 21.0 m -114.91 157.37 23.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.442 -0.786 . . . . 0.0 111.038 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -137.46 106.39 5.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.3 t -99.74 166.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 110.42 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -163.33 -154.49 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.1 p -115.03 -26.42 7.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.436 -0.79 . . . . 0.0 110.397 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.7 p -140.12 34.67 1.92 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.653 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.21 173.41 5.76 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.352 -0.843 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.0 Cg_endo -72.36 -26.52 17.17 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.286 1.15 . . . . 0.0 110.152 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.72 177.31 34.68 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -71.45 102.76 1.32 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.487 1.256 . . . . 0.0 110.317 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.657 HD22 ' CD1' ' A' ' 102' ' ' PHE . 37.5 mt -64.85 112.74 3.4 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.503 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -99.67 113.67 26.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.82 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.6 mt -98.75 137.45 37.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.604 -0.685 . . . . 0.0 109.739 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 14.6 t0 -86.57 128.61 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.506 -0.746 . . . . 0.0 110.679 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.748 HD22 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -128.52 51.44 2.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.466 -0.771 . . . . 0.0 109.982 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.6 p -115.16 -58.73 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 110.346 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.67 -57.25 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 75.64 0.96 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.548 -0.972 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.5 mt -95.01 0.03 54.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 111.213 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -70.51 -33.14 70.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.037 -1.039 . . . . 0.0 110.659 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 m -57.47 -20.82 33.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.456 -0.777 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.82 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.7 m-85 -55.33 -42.2 73.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.246 -0.909 . . . . 0.0 110.388 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -63.59 -26.27 68.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 0.0 109.944 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 52.5 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.015 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -158.26 30.16 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.392 -0.817 . . . . 0.0 110.657 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -55.9 121.58 9.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.77 -0.581 . . . . 0.0 110.557 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.657 ' CD1' HD22 ' A' ' 86' ' ' LEU . 23.6 m-85 -85.21 122.73 29.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.544 -0.722 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.03 152.84 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.844 HD22 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -154.54 128.04 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.424 -0.798 . . . . 0.0 110.75 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 108' ' ' VAL . 24.3 tttm -60.57 146.34 45.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.105 0.955 . . . . 0.0 110.431 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.643 ' OE1' HG21 ' A' ' 198' ' ' ILE . 4.2 mm-40 -61.15 128.57 37.07 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.63 40.54 97.61 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.862 -0.524 . . . . 0.0 112.862 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.844 HG21 HD22 ' A' ' 104' ' ' LEU . 31.9 m -83.38 178.09 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 118.861 1.33 . . . . 0.0 110.044 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -120.27 96.38 5.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.455 ' HD2' HG23 ' A' ' 108' ' ' VAL . 52.7 p90 -118.93 157.54 27.49 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.887 0.851 . . . . 0.0 112.407 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -116.67 157.3 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 159' ' ' LEU . 71.8 mt -116.46 154.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -137.87 122.17 18.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.809 -0.557 . . . . 0.0 109.507 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 mm -106.54 147.09 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 110.648 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 m -127.42 134.83 49.86 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.557 ' CD2' ' HE1' ' A' ' 126' ' ' MET . 41.1 p90 -152.18 140.78 20.77 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.0 111.203 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -88.43 142.33 27.81 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.436 0.636 . . . . 0.0 110.946 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.96 95.49 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -129.41 48.27 2.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.0 111.687 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 -67.08 0.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.294 -0.879 . . . . 0.0 110.764 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -143.1 178.07 7.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.15 107.83 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 70' ' ' VAL . 59.5 t -95.9 82.02 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 p -84.64 113.4 21.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.667 -0.646 . . . . 0.0 110.438 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.68 37.07 0.8 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.557 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -79.51 145.32 33.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.498 -1.001 . . . . 0.0 109.797 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -143.82 141.23 30.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 110.958 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -109.0 109.05 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.4 mt -96.66 161.46 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 110.117 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -159.34 118.9 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.69 -0.631 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 17.8 m-70 -106.41 134.7 49.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.726 . . . . 0.0 109.899 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.654 HG22 HD11 ' A' ' 139' ' ' ILE . 3.8 m -90.11 113.42 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.646 -0.659 . . . . 0.0 109.981 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 2.3 m-85 -111.38 119.32 38.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.679 . . . . 0.0 109.947 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -120.88 129.14 53.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.656 -0.652 . . . . 0.0 110.348 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt 52.68 39.25 28.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.35 -0.844 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.88 30.43 72.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.5 t -143.11 119.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.997 . . . . 0.0 109.881 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -77.22 138.88 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.137 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.654 HD11 HG22 ' A' ' 132' ' ' THR . 0.1 OUTLIER -116.8 -26.87 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.492 -0.755 . . . . 0.0 110.555 179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -169.67 144.97 3.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -142.42 139.88 31.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.089 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.5 m -120.51 160.8 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.824 . . . . 0.0 111.061 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -126.21 73.81 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.088 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.89 141.67 58.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.708 . . . . 0.0 110.613 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 ttt -94.37 124.27 38.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 158' ' ' PHE . 26.3 t -79.75 -58.86 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.26 175.75 14.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.1 p -86.29 147.88 25.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.922 . . . . 0.0 109.853 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.432 ' OH ' HG12 ' A' ' 146' ' ' VAL . 67.3 m-85 -146.31 135.73 22.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.44 161.03 30.92 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.66 62.58 5.57 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.41 1.216 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -170.52 54.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.469 -0.77 . . . . 0.0 110.418 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.749 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -155.99 23.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.499 -0.751 . . . . 0.0 111.244 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 40.46 -150.16 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.862 -0.524 . . . . 0.0 112.269 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.699 ' HG2' HG21 ' A' ' 73' ' ' THR . 49.8 mt-10 -67.41 114.42 6.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.28 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.749 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 3.9 m-85 -73.37 -173.34 1.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.606 -0.684 . . . . 0.0 109.755 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.96 82.53 1.44 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.571 -0.706 . . . . 0.0 110.727 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.533 ' HB2' HG13 ' A' ' 146' ' ' VAL . 42.7 t80 -80.97 161.99 24.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.392 -0.817 . . . . 0.0 109.384 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER -150.51 117.54 5.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.952 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.5 p -81.05 156.7 71.9 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.434 -0.791 . . . . 0.0 108.877 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 166.3 20.03 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.711 1.374 . . . . 0.0 110.979 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 135.62 56.31 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.417 0.627 . . . . 0.0 110.948 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.64 127.49 42.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.412 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -79.2 139.65 37.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.48 -0.762 . . . . 0.0 110.883 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.33 170.52 11.19 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.733 -0.605 . . . . 0.0 110.41 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.37 132.76 21.35 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 O-C-N 123.434 1.228 . . . . 0.0 110.405 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 -171.83 2.08 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.653 -0.655 . . . . 0.0 110.571 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.55 -157.15 15.19 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.45 -38.91 6.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.626 -0.926 . . . . 0.0 109.573 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.734 ' O ' HD23 ' A' ' 170' ' ' LEU . 2.2 tt -86.68 -22.68 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.761 -0.587 . . . . 0.0 110.235 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HB3' ' OE2' ' A' ' 106' ' ' GLU . . . -55.5 -22.21 20.02 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -0.848 . . . . 0.0 110.778 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.426 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 40.2 mtp180 -62.22 147.6 47.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 110.171 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 138.17 -171.95 23.15 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.6 p -96.26 137.06 35.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.6 -0.941 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.32 108.76 14.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.629 -0.669 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.76 131.71 42.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.442 -0.786 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.2 mt -121.27 147.99 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.32 -0.863 . . . . 0.0 110.725 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -112.23 111.01 21.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.438 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 3.1 m -103.39 125.0 49.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 110.135 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -113.92 114.55 26.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 110.315 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.442 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -96.11 130.54 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 109.938 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 t -156.2 -163.45 1.47 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.528 -0.733 . . . . 0.0 110.473 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 8.6 p-10 -164.47 -149.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.651 -0.655 . . . . 0.0 109.932 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -82.17 56.34 3.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.554 ' OD1' HG22 ' A' ' 187' ' ' THR . 54.6 p-10 -161.6 48.41 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.512 -0.743 . . . . 0.0 109.921 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 185' ' ' ASP . 1.8 mpt_? 3.9 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.554 HG22 ' OD1' ' A' ' 185' ' ' ASP . 8.8 t -144.62 -176.84 5.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.922 -0.486 . . . . 0.0 109.913 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.28 96.46 5.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 1.6 m-70 -60.14 -47.33 86.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 109.805 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.594 HD23 ' HB ' ' A' ' 72' ' ' VAL . 23.3 tp -170.89 107.81 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.709 -0.619 . . . . 0.0 109.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -113.31 131.0 56.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.629 -0.67 . . . . 0.0 110.124 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.585 ' CE2' HD21 ' A' ' 90' ' ' LEU . 25.1 p90 -133.92 -154.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.761 . . . . 0.0 109.938 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -167.91 130.74 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.629 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 16.6 p-90 -133.14 146.23 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.681 . . . . 0.0 109.829 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.75 149.25 21.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.695 -0.628 . . . . 0.0 110.627 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.783 HD11 HD12 ' A' ' 104' ' ' LEU . 22.3 tp -121.33 108.76 14.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.689 -0.632 . . . . 0.0 109.391 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.5 m -78.22 136.8 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.643 HG21 ' OE1' ' A' ' 106' ' ' GLU . 47.6 mm -111.1 151.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.712 -0.618 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.35 -160.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.659 -0.65 . . . . 0.0 109.721 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -119.62 -30.79 4.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -135.73 59.9 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 111.493 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -66.09 -11.3 47.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.305 -0.872 . . . . 0.0 111.338 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -157.02 51.22 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.02 . . . . 0.0 110.205 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.069 0.461 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -140.55 -83.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.585 -0.697 . . . . 0.0 110.387 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.472 ' H ' HG23 ' A' ' 61' ' ' VAL . 2.6 m 52.69 49.92 19.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.909 -1.12 . . . . 0.0 110.746 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.66 171.13 14.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.508 -0.745 . . . . 0.0 110.205 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.23 81.82 1.79 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.597 -0.689 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 -35.44 5.94 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.306 1.161 . . . . 0.0 110.432 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -168.07 107.78 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.1 92.3 7.63 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.544 -0.723 . . . . 0.0 109.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.92 179.99 4.81 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.456 1.24 . . . . 0.0 110.747 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.591 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -136.95 -64.94 0.56 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.651 -0.656 . . . . 0.0 109.758 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 70' ' ' VAL . 46.5 t -140.37 30.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.612 0.72 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.887 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -68.0 138.04 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.203 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.611 HG21 ' CZ3' ' A' ' 192' ' ' TRP . 67.5 t -63.07 124.39 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 116' ' ' PHE . 36.4 p -87.03 -63.5 1.3 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.258 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -135.99 172.16 13.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.357 -0.84 . . . . 0.0 111.119 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.08 124.51 14.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.712 -0.618 . . . . 0.0 109.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m -109.89 158.47 18.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.787 . . . . 0.0 110.455 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -142.3 103.22 4.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.229 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.0 t -105.53 166.95 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.497 -0.752 . . . . 0.0 110.34 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -160.45 -157.92 0.58 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.961 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -101.97 -29.41 11.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 0.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.4 p -138.17 41.78 2.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.675 -0.641 . . . . 0.0 110.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.449 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.39 163.43 31.06 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.592 -0.692 . . . . 0.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.27 -25.2 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.491 1.258 . . . . 0.0 110.244 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.04 167.57 25.84 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.44 100.07 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.515 1.271 . . . . 0.0 110.243 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.55 115.51 5.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.665 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -97.82 101.23 12.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.447 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -82.63 125.49 31.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.534 -0.729 . . . . 0.0 109.913 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.0 134.36 35.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.652 -0.655 . . . . 0.0 110.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.513 HD13 ' CG1' ' A' ' 72' ' ' VAL . 6.4 mt -135.27 55.15 1.9 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.66 -0.65 . . . . 0.0 109.923 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -106.34 -72.98 0.7 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.692 . . . . 0.0 110.524 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.4 -77.99 0.78 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.05 92.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.451 -1.029 . . . . 0.0 110.41 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 94' ' ' LEU . 44.2 mt -92.34 -37.69 12.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.663 -0.648 . . . . 0.0 110.046 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -18.84 36.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.511 -0.743 . . . . 0.0 110.879 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.1 p -53.89 -22.51 10.15 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.299 -0.876 . . . . 0.0 111.153 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 88' ' ' LEU . 7.0 m-30 -60.84 -30.24 69.98 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 109.87 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -60.78 -26.7 67.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.672 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.49 22.7 5.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.596 -0.69 . . . . 0.0 110.707 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -171.19 128.64 0.71 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 p -113.21 179.58 3.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.665 -0.647 . . . . 0.0 110.185 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 196' ' ' LEU . 7.1 m-85 -111.59 104.96 13.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.7 139.74 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.48 -0.762 . . . . 0.0 110.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -154.33 161.45 41.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.706 -0.621 . . . . 0.0 110.263 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.423 ' HB2' HG11 ' A' ' 108' ' ' VAL . 1.1 mtpm? -76.47 152.16 36.22 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.523 -0.735 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -20.61 -74.31 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.61 69.56 0.46 Allowed Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.415 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.651 HG21 HD22 ' A' ' 104' ' ' LEU . 33.9 m -80.27 -176.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.524 -0.986 . . . . 0.0 110.071 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.25 96.93 6.04 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.441 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 44.6 p90 -113.26 149.23 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.505 -0.747 . . . . 0.0 111.987 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HD3' HD21 ' A' ' 159' ' ' LEU . 2.5 ttt180 -107.32 155.48 19.93 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -121.43 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.008 -1.058 . . . . 0.0 111.197 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -120.83 107.29 12.54 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.28 151.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.44 -0.787 . . . . 0.0 111.073 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -131.32 152.1 50.89 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.65 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.1 p90 -167.84 159.05 11.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 111.15 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -93.06 135.92 33.8 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.202 0.525 . . . . 0.0 111.377 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.06 85.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -130.21 48.38 2.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.535 -0.728 . . . . 0.0 111.998 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -68.51 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 171.51 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 0.0 110.586 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.96 108.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.666 -0.646 . . . . 0.0 110.264 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 70' ' ' VAL . 65.6 t -93.99 75.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.646 -0.658 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.44 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 69.8 p -64.68 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.657 -0.652 . . . . 0.0 110.358 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.92 49.38 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.45 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -79.78 120.7 24.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.257 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -132.88 148.2 52.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 111.1 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -125.38 113.37 17.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -114.47 146.71 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.625 -0.672 . . . . 0.0 110.511 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.67 141.83 43.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.556 -0.715 . . . . 0.0 110.08 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.815 ' O ' HG23 ' A' ' 177' ' ' ILE . 6.9 m80 -101.07 164.72 11.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.684 . . . . 0.0 109.634 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.426 ' CG2' HD11 ' A' ' 139' ' ' ILE . 17.6 m -119.7 61.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.951 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.88 118.75 7.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.741 . . . . 0.0 110.417 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.603 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -120.92 138.26 54.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.619 -0.675 . . . . 0.0 110.017 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? 53.35 28.74 7.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.412 -0.805 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.37 -11.46 63.34 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.196 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.8 m -111.55 148.02 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.024 -1.28 . . . . 0.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 135.92 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.284 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.426 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -120.68 -26.26 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.752 . . . . 0.0 111.049 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -176.3 146.02 0.62 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -133.67 143.13 48.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.535 -0.728 . . . . 0.0 109.76 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 129' ' ' ILE . 17.2 m -109.9 151.83 26.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.604 -0.685 . . . . 0.0 111.043 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -126.05 136.39 52.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.63 -0.669 . . . . 0.0 109.836 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -123.41 129.02 50.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.451 -0.781 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.7 ttm -91.75 107.97 19.58 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.845 HG12 ' CE1' ' A' ' 149' ' ' TYR . 61.8 t -79.68 -44.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.309 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.68 -173.82 19.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.44 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 31.9 m -84.84 126.32 33.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.604 -0.939 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.845 ' CE1' HG12 ' A' ' 146' ' ' VAL . 8.8 m-85 -113.51 131.46 56.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.725 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -118.19 145.09 18.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.81 142.77 35.97 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.382 1.201 . . . . 0.0 110.186 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.61 -39.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.566 -0.709 . . . . 0.0 110.774 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.6 -81.85 0.46 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 111.416 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.28 -136.31 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 110.424 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.78 166.01 22.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.887 -1.133 . . . . 0.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 33.5 m-85 -121.31 -175.99 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -133.78 114.96 13.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.447 -0.783 . . . . 0.0 111.019 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.615 ' CD1' HG13 ' A' ' 146' ' ' VAL . 34.4 t80 -100.41 159.97 14.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.725 . . . . 0.0 109.202 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.438 HD21 ' HD3' ' A' ' 111' ' ' ARG . 1.1 tt -149.81 118.79 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.459 -0.776 . . . . 0.0 110.946 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.6 p -89.78 156.41 47.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.094 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.53 169.53 12.58 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.652 1.343 . . . . 0.0 110.83 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 129.47 41.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.406 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 7.2 mm-40 -116.33 127.27 54.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.626 -0.671 . . . . 0.0 109.631 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -83.2 133.61 35.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.441 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -82.79 165.15 43.32 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.765 -0.585 . . . . 0.0 110.188 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.2 Cg_endo -73.2 123.69 8.97 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.401 1.211 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 169.2 8.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.654 -0.653 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.01 160.82 10.76 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.78 -43.54 97.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.969 . . . . 0.0 110.151 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -79.67 -27.35 40.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.647 -0.658 . . . . 0.0 110.216 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.97 -22.18 59.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.499 -0.751 . . . . 0.0 110.645 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -68.23 131.17 44.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.478 -0.764 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 151.71 179.4 27.34 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.2 p -87.44 130.16 34.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.524 -0.986 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.03 113.88 26.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 110.641 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.86 125.33 29.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.458 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 131' ' ' HIS . 17.7 mt -117.61 137.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.379 -0.825 . . . . 0.0 110.959 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -103.31 96.86 7.04 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.4 p -94.25 125.39 38.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.683 . . . . 0.0 110.671 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -127.6 96.83 4.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.681 . . . . 0.0 109.997 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -83.14 91.27 7.2 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.586 -0.696 . . . . 0.0 110.087 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.9 t -116.98 -171.77 2.09 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -94.19 -163.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.364 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.97 -53.29 59.05 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.0 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.252 -0.905 . . . . 0.0 110.747 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -35.69 32.32 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.902 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.9 t -178.41 -162.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.621 -0.674 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.07 120.01 38.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 16.3 m-70 -82.75 -73.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.779 . . . . 0.0 110.864 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.887 HD22 HG13 ' A' ' 71' ' ' VAL . 3.1 tp -156.05 151.19 26.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.669 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 t -153.86 139.69 18.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.663 . . . . 0.0 109.786 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.611 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 21.9 p90 -135.19 -153.57 0.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.99 132.01 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 17.0 p-90 -139.33 147.1 41.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.678 -0.639 . . . . 0.0 109.614 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.78 152.05 20.95 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.518 0.675 . . . . 0.0 111.26 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 102' ' ' PHE . 9.4 tp -126.16 91.54 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -67.9 137.2 55.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.608 -0.682 . . . . 0.0 110.436 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -114.53 145.3 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 109.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -144.16 -153.07 0.45 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 109.84 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -132.06 1.41 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.399 -0.813 . . . . 0.0 111.661 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -160.23 46.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.942 -1.099 . . . . 0.0 111.122 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.478 ' CH2' HD21 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -59.15 -18.63 37.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 111.197 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -152.47 48.24 0.75 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.219 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.113 0.482 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t -141.01 -51.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.568 -0.707 . . . . 0.0 109.975 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.9 m -82.53 164.49 20.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.256 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.35 -28.75 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 0.0 110.3 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -127.93 139.46 35.42 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.155 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.93 -51.86 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.23 1.121 . . . . 0.0 110.441 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -142.18 179.37 6.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.538 -0.726 . . . . 0.0 110.329 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.68 140.34 21.73 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 109.98 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.12 -165.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.256 1.135 . . . . 0.0 110.556 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -98.15 -65.85 0.94 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.643 -0.66 . . . . 0.0 109.797 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 123' ' ' VAL . 93.3 t -141.92 117.76 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.507 0.67 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.0 t -139.66 144.05 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.899 -0.501 . . . . 0.0 109.775 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.0 t -64.27 99.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 116' ' ' PHE . 82.1 p -70.83 -44.63 66.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.715 -0.616 . . . . 0.0 111.228 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -154.97 158.0 38.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 76' ' ' THR . 8.2 tt -119.32 152.57 36.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.724 -0.61 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.555 ' N ' HD23 ' A' ' 75' ' ' LEU . 19.5 m -139.77 152.64 46.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -0.765 . . . . 0.0 110.631 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -136.67 83.52 2.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.574 -0.704 . . . . 0.0 109.973 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.85 149.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.634 . . . . 0.0 110.14 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 94.8 m -146.07 -164.96 2.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.693 -0.629 . . . . 0.0 110.037 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.6 p -103.53 -76.9 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.775 . . . . 0.0 110.758 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 p -96.26 32.59 1.93 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.826 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.28 178.99 1.63 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.652 -0.655 . . . . 0.0 110.087 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.771 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 46.6 Cg_endo -74.25 -26.85 12.1 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.342 1.18 . . . . 0.0 110.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 156.63 -179.42 32.48 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.0 Cg_endo -71.72 111.4 3.13 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.488 1.257 . . . . 0.0 110.416 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' CD1' ' A' ' 102' ' ' PHE . 13.8 mt -65.76 115.66 6.14 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.99 137.78 34.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.97 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 3.9 mt -132.71 119.67 20.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 0.0 109.717 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.49 141.95 50.17 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.599 HD21 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -138.51 56.3 1.72 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.753 . . . . 0.0 110.059 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -105.99 -66.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.265 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.57 -46.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.91 65.15 1.94 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.574 -0.956 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.651 HD23 ' CE1' ' A' ' 97' ' ' PHE . 13.4 mt -84.19 0.1 50.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.575 -0.703 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.61 -27.29 64.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.029 . . . . 0.0 110.787 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.8 m -65.42 -13.77 59.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.463 -0.773 . . . . 0.0 111.065 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.97 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 10.7 m-85 -72.19 -52.51 16.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.286 -0.883 . . . . 0.0 110.711 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -57.68 -20.24 32.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.521 -0.737 . . . . 0.0 111.007 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -115.0 44.96 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.4 -0.812 . . . . 0.0 110.393 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -168.66 146.55 4.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 p -150.98 131.39 13.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 109.82 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.938 ' CD1' HD22 ' A' ' 86' ' ' LEU . 15.1 m-85 -77.12 122.99 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 110.189 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.65 113.17 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 109.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.015 HD21 HG22 ' A' ' 108' ' ' VAL . 4.1 tt -113.62 156.81 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.657 ' N ' HD23 ' A' ' 104' ' ' LEU . 31.8 tttt -80.9 161.8 24.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -40.82 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 29.73 66.77 0.11 Allowed Glycine 0 N--CA 1.507 3.372 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.777 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.015 HG22 HD21 ' A' ' 104' ' ' LEU . 30.5 m -79.01 -160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.224 -1.162 . . . . 0.0 109.201 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.09 117.11 27.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.464 -0.773 . . . . 0.0 109.54 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.604 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 10.8 p90 -137.67 152.13 48.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.306 -0.872 . . . . 0.0 111.916 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -109.67 150.27 28.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.39 151.56 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.133 -0.979 . . . . 0.0 111.703 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HG3' HD23 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -126.24 93.28 3.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.989 HG21 ' CE2' ' A' ' 181' ' ' PHE . 47.8 mm -81.18 142.6 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.743 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.8 m -122.08 135.94 54.86 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.758 ' HA ' HG23 ' A' ' 73' ' ' THR . 15.5 p90 -153.06 145.34 23.95 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.333 -0.854 . . . . 0.0 111.158 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -88.52 128.25 35.55 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 70' ' ' VAL . 59.9 t -123.39 84.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.75 48.88 2.32 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 111.86 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -145.42 -66.32 0.31 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.237 -0.914 . . . . 0.0 110.904 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.74 168.92 17.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.339 -0.851 . . . . 0.0 110.412 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.29 108.37 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.99 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 70' ' ' VAL . 97.6 t -89.4 86.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 109.798 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.3 p -88.11 88.48 7.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.616 -0.677 . . . . 0.0 110.384 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 137.94 44.64 0.08 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -80.99 121.07 25.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 109.793 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -129.5 137.42 50.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.728 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.502 ' CD1' ' CD2' ' A' ' 181' ' ' PHE . 14.0 t80 -111.62 139.02 47.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.723 . . . . 0.0 109.678 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.0 mt -136.79 144.45 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.541 -0.725 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.52 144.28 37.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 110.057 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 14.9 m-70 -117.23 116.92 28.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.596 -0.69 . . . . 0.0 110.156 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 139' ' ' ILE . 29.3 m -68.04 77.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 0.0 110.202 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 4.2 m-85 -76.39 125.99 30.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 7.9 tpt180 -120.75 120.89 36.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt 52.89 38.59 27.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.488 -0.757 . . . . 0.0 110.754 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 72.8 35.56 58.47 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.5 t -147.1 109.14 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.955 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 4.9 pttm -63.02 128.9 37.99 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.637 -0.664 . . . . 0.0 110.232 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pt -115.53 -23.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.635 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.43 132.18 0.29 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.89 149.99 49.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.683 . . . . 0.0 109.634 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -127.56 154.89 44.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.514 -0.741 . . . . 0.0 110.838 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -126.01 121.44 33.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.63 -0.669 . . . . 0.0 110.052 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -110.99 145.7 37.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.703 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -92.08 119.33 31.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.228 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 58.9 t -79.58 -52.43 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 110.304 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.7 175.81 14.2 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 30.8 t -99.02 139.37 34.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.927 . . . . 0.0 110.063 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.492 ' HE2' HG12 ' A' ' 146' ' ' VAL . 47.0 m-85 -142.04 126.89 18.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.694 . . . . 0.0 110.308 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.25 164.78 28.56 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.08 92.97 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.447 1.235 . . . . 0.0 110.342 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -169.49 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 0.0 110.447 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.778 ' HB3' ' CZ ' ' A' ' 156' ' ' TYR . . . -92.43 19.33 7.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.542 -0.724 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 38.1 mt-10 56.2 -143.88 0.7 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 152.35 45.5 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.05 -1.031 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.778 ' CZ ' ' HB3' ' A' ' 153' ' ' ALA . 42.0 m-85 -116.13 -176.31 2.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 109.546 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -147.49 104.31 3.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.509 -0.744 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.531 ' HE2' HG22 ' A' ' 160' ' ' THR . 34.9 t80 -77.85 165.81 23.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -146.87 97.57 2.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.396 -0.815 . . . . 0.0 110.653 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.531 HG22 ' HE2' ' A' ' 158' ' ' PHE . 75.0 p -72.79 149.17 90.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.46 157.55 54.28 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.415 1.218 . . . . 0.0 110.702 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.71 93.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.606 -0.684 . . . . 0.0 110.976 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -79.87 167.71 20.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.416 -0.803 . . . . 0.0 109.862 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.69 123.32 48.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.504 -0.747 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -75.45 177.03 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.4 Cg_endo -73.45 127.73 12.09 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.298 1.157 . . . . 0.0 111.112 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 5.4 ptpp? -115.63 174.97 5.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 110.121 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.65 156.5 10.66 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 15.2 ttt -62.33 -46.61 87.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.734 -0.862 . . . . 0.0 109.998 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.3 tt -73.89 -26.42 60.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.645 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -57.93 -20.7 39.44 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.421 -0.799 . . . . 0.0 110.719 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 2.7 mtp-105 -58.5 125.22 22.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.304 -0.872 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.75 175.4 27.65 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.4 p -84.86 134.7 34.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.594 -0.945 . . . . 0.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 32.3 m-85 -115.59 101.41 8.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.607 -0.683 . . . . 0.0 110.693 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.18 121.37 17.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.714 . . . . 0.0 109.112 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.516 HD12 ' CZ2' ' A' ' 194' ' ' TRP . 42.6 mt -110.09 126.61 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.53 -0.732 . . . . 0.0 110.99 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -87.4 92.52 9.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.685 -0.634 . . . . 0.0 109.879 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.0 p -84.98 140.94 30.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.658 -0.651 . . . . 0.0 110.674 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.82 83.62 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.892 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -78.26 128.66 34.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.668 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -162.72 -169.88 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.672 . . . . 0.0 110.52 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -104.03 -164.34 1.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.878 -0.514 . . . . 0.0 109.762 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -57.63 11.76 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.832 . . . . 0.0 110.228 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.36 27.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.76 -0.588 . . . . 0.0 110.467 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -36.31 26.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.755 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.55 -163.21 0.08 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.805 -0.559 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.35 110.99 20.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.48 -55.04 13.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.464 -0.773 . . . . 0.0 110.665 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -166.54 164.19 17.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 190' ' ' LEU . 17.6 p -168.23 134.73 1.99 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.853 -0.529 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.599 ' CD2' HD21 ' A' ' 90' ' ' LEU . 14.5 p90 -147.0 -155.21 0.6 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 110.442 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -157.81 127.68 6.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.533 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 12.3 p-90 -134.79 146.21 49.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.697 -0.627 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.91 136.11 40.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.656 -0.653 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.748 HD21 HD13 ' A' ' 104' ' ' LEU . 6.7 tp -110.36 98.55 7.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.6 m -73.14 121.07 19.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.651 -0.656 . . . . 0.0 110.515 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 104' ' ' LEU . 47.7 mm -90.24 149.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.592 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 -155.82 0.64 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 110.456 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -120.22 -21.3 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.504 -0.747 . . . . 0.0 111.268 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -155.04 81.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -79.74 3.21 20.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.478 -0.764 . . . . 0.0 111.501 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 44.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.086 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.104 0.478 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 62' ' ' SER . 57.4 t -81.36 166.92 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.487 -0.758 . . . . 0.0 109.909 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -104.52 34.84 2.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 110.247 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.12 5.94 5.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.79 63.07 9.85 Favored Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.977 -1.077 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.52 -84.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.203 1.107 . . . . 0.0 110.619 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 m120 51.95 -177.72 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.877 -1.139 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' VAL . 7.6 p -131.84 70.56 80.92 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.95 172.61 14.27 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.379 1.2 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -97.99 -60.62 1.52 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.667 . . . . 0.0 109.898 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 123' ' ' VAL . 77.7 t -110.15 140.09 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.662 . . . . 0.0 110.354 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HD22 ' A' ' 190' ' ' LEU . 72.3 t -149.43 144.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.731 -0.606 . . . . 0.0 109.616 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 HD13 ' A' ' 90' ' ' LEU . 57.4 t -68.4 100.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 117' ' ' ARG . 68.0 p -70.23 -44.46 68.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.596 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -159.29 173.92 15.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 76' ' ' THR . 9.7 tt -144.3 164.41 30.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.688 -0.632 . . . . 0.0 109.544 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.678 ' N ' HD23 ' A' ' 75' ' ' LEU . 27.4 m -151.55 163.01 39.98 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.432 -0.792 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -143.36 84.19 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.604 -0.685 . . . . 0.0 109.895 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.98 143.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.731 -0.606 . . . . 0.0 110.106 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 89.7 m -141.67 -163.13 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.592 -0.693 . . . . 0.0 110.077 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.9 p -110.53 -72.68 0.71 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.466 -0.772 . . . . 0.0 110.677 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -95.75 27.66 3.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.565 -0.709 . . . . 0.0 110.639 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.27 -176.52 0.65 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -76.28 -25.04 10.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.311 1.163 . . . . 0.0 110.016 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.07 -177.08 30.91 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.484 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 91.55 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.556 1.292 . . . . 0.0 110.558 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.445 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.83 111.41 2.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.696 . . . . 0.0 109.386 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.86 159.83 14.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.0 110.872 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.801 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.4 mt -132.18 128.16 37.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.722 -0.611 . . . . 0.0 109.912 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 133.46 40.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -132.09 51.79 2.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.3 p -123.82 -65.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.391 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.92 -53.18 0.21 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.99 71.97 0.4 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.541 -0.976 . . . . 0.0 110.158 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -93.71 -33.84 13.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.29 -26.99 65.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.591 -0.693 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.4 t -60.34 -23.68 64.44 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 110.472 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.801 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.3 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -73.63 -26.96 61.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.64 -0.663 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -105.08 28.91 6.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.453 -0.779 . . . . 0.0 110.284 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -158.46 139.82 13.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.716 . . . . 0.0 110.127 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -126.24 -175.8 3.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 110.4 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.7 m-85 -116.65 109.31 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.673 -0.642 . . . . 0.0 109.99 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.11 105.73 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -0.779 . . . . 0.0 109.793 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.071 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -122.43 158.62 29.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.627 -0.67 . . . . 0.0 110.077 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.683 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.2 tttt -87.22 161.56 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.472 -0.767 . . . . 0.0 110.385 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 105' ' ' LYS . 33.9 mt-10 -18.58 -71.63 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -150.27 63.26 0.4 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.699 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.071 HG22 HD21 ' A' ' 104' ' ' LEU . 34.5 m -73.29 127.41 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.442 -1.034 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -71.71 94.77 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.6 p90 -109.49 154.87 22.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 111.838 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.3 131.1 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 76' ' ' THR . 62.1 mt -96.04 142.28 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.261 -0.9 . . . . 0.0 110.533 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -117.85 102.69 9.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.7 mm -88.11 127.92 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.755 . . . . 0.0 110.685 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -113.06 137.89 50.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 116' ' ' PHE . 19.5 p90 -151.05 174.84 12.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 110.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.6 mmm-85 -127.64 150.83 49.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 111.322 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -132.67 111.32 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -128.66 48.39 2.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.472 -0.767 . . . . 0.0 111.472 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -69.71 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.0 110.646 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -137.93 171.98 13.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.431 -0.793 . . . . 0.0 110.472 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 149' ' ' TYR . 86.9 mt -80.0 109.84 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.615 . . . . 0.0 109.966 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 70' ' ' VAL . 66.9 t -84.65 82.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.848 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 p -81.21 77.58 8.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.637 -0.664 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.97 46.08 0.04 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.623 ' HE3' ' CE2' ' A' ' 181' ' ' PHE . 1.3 tpp -79.54 137.68 37.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.546 -0.973 . . . . 0.0 109.489 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -126.11 158.15 36.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -134.31 109.9 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.4 mp -107.74 166.22 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.496 -0.753 . . . . 0.0 110.437 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.474 ' N ' HG22 ' A' ' 129' ' ' ILE . 1.4 mt-30 -154.96 127.89 8.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.665 -0.647 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 12.9 m-70 -110.32 117.19 32.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 139' ' ' ILE . 19.3 m -68.51 78.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 0.0 109.902 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 2.7 m-85 -78.25 105.1 9.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.191 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.533 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.0 tpt180 -120.76 153.76 36.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.683 -0.636 . . . . 0.0 109.686 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 52.91 36.22 21.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.33 -0.857 . . . . 0.0 110.786 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.437 ' C ' HG13 ' A' ' 137' ' ' VAL . . . 63.32 23.91 66.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 134' ' ' ARG . 35.4 m -149.3 149.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.306 -1.114 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 21.8 ttmt -80.1 136.31 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.0 110.247 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -118.5 -25.19 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.456 -0.778 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -174.69 143.29 0.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.104 -0.998 . . . . 0.0 110.248 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 2.9 pttt -137.76 166.45 23.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.234 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.1 m -145.0 156.56 44.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.586 -0.696 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.91 132.65 52.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 110.335 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -123.08 121.92 37.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.709 . . . . 0.0 110.576 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.406 ' O ' ' CZ ' ' A' ' 158' ' ' PHE . 23.6 mtp -65.15 122.08 16.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -0.786 . . . . 0.0 109.29 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 158' ' ' PHE . 48.8 t -79.27 -56.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 110.298 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 137.41 174.04 13.17 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 p -84.99 150.31 24.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.701 -0.882 . . . . 0.0 109.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.507 ' CE2' HG12 ' A' ' 146' ' ' VAL . 69.8 m-85 -146.7 161.32 40.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.357 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -110.07 154.55 16.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -72.64 -156.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.713 1.375 . . . . 0.0 110.321 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 25.4 mtp-105 73.09 51.23 0.14 Allowed 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 50.64 23.69 1.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.428 -0.795 . . . . 0.0 111.852 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 tt0 -79.38 103.43 9.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.56 112.91 24.8 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.615 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 78.5 m-85 -96.75 -175.3 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.738 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -141.02 112.51 7.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.681 ' HB2' HG13 ' A' ' 146' ' ' VAL . 30.8 t80 -83.82 160.46 21.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.226 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.05 100.82 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 111.459 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.4 p -69.56 149.35 97.01 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.35 -179.45 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.591 1.311 . . . . 0.0 111.077 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptm -53.73 144.88 16.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.685 -0.634 . . . . 0.0 111.232 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.407 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 12.3 mt-10 -140.54 96.35 3.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.73 -0.606 . . . . 0.0 109.673 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.76 121.76 17.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.625 -0.672 . . . . 0.0 110.595 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -55.0 176.49 0.15 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.723 -0.611 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.762 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 45.6 Cg_endo -71.08 118.38 5.66 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.367 1.193 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 20.6 mttt -90.75 165.85 13.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.605 -0.684 . . . . 0.0 110.712 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.82 143.64 14.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.467 ' HA ' ' CD ' ' A' ' 172' ' ' ARG . 30.6 mtp -60.26 -42.24 94.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.521 -0.988 . . . . 0.0 109.511 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 170' ' ' LEU . 1.9 tm? -64.55 -22.23 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.869 -0.519 . . . . 0.0 109.938 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -92.72 23.06 4.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.82 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 169' ' ' MET . 45.9 mtm180 -100.37 176.85 5.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.257 -0.902 . . . . 0.0 110.029 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 105.63 -173.99 20.64 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.9 p -86.04 131.05 34.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.924 . . . . 0.0 110.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 134' ' ' ARG . 24.7 m-85 -116.67 108.5 15.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.688 -0.633 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -73.85 121.2 20.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.533 -0.73 . . . . 0.0 109.128 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.3 mt -110.09 129.61 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.4 -0.812 . . . . 0.0 111.061 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 108.54 20.41 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.698 -0.626 . . . . 0.0 109.729 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -113.16 135.15 54.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.53 ' CD ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.8 118.43 23.71 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.604 0.716 . . . . 0.0 110.361 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.623 ' CE2' ' HE3' ' A' ' 126' ' ' MET . 0.9 OUTLIER -91.41 94.64 9.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.535 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -116.82 -172.5 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 111.092 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -133.53 -172.0 2.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.88 -0.512 . . . . 0.0 109.904 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -96.52 26.11 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.499 -0.751 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 -76.34 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.523 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.622 ' HD2' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER 179.71 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.482 -0.761 . . . . 0.0 111.573 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.622 HG22 ' HD2' ' A' ' 186' ' ' ARG . 8.5 t -174.48 169.48 3.7 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.037 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.89 118.62 34.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.728 -0.607 . . . . 0.0 109.757 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -57.87 -50.79 72.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.483 -0.761 . . . . 0.0 110.697 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.678 HD22 HG13 ' A' ' 71' ' ' VAL . 4.0 tp -169.4 151.12 4.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 65.3 p -147.74 161.29 41.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 16.9 p90 -146.58 -156.23 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.766 . . . . 0.0 110.232 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.94 131.45 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.621 -0.674 . . . . 0.0 110.562 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.86 146.31 41.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.652 -0.655 . . . . 0.0 109.799 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.69 146.59 24.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.699 . . . . 0.0 111.079 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 102' ' ' PHE . 53.2 tp -116.23 97.43 6.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.4 m -72.11 111.9 7.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 0.0 110.081 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 48.5 mm -90.41 146.94 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.625 -0.672 . . . . 0.0 109.811 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -138.25 -156.91 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.684 -0.635 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -115.85 -24.31 8.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 110.72 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.79 94.89 1.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.611 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.821 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -84.95 12.19 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.606 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -153.65 40.1 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 110.18 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.116 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.16 0.505 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.33 -26.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.712 . . . . 0.0 110.41 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p 50.19 -155.03 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.488 -0.758 . . . . 0.0 111.004 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.9 51.38 0.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.46 -0.775 . . . . 0.0 110.106 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.43 82.52 0.98 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.477 -0.764 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 46.6 Cg_endo -73.26 76.49 2.65 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.367 1.193 . . . . 0.0 110.353 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.27 48.21 22.57 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.421 -0.799 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 65' ' ' PRO . 61.5 t -128.37 99.91 23.53 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.25 170.89 18.05 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.302 1.159 . . . . 0.0 110.379 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -97.66 -65.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 123' ' ' VAL . 95.7 t -119.96 126.51 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.792 -0.567 . . . . 0.0 110.164 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 70' ' ' VAL . 64.5 t -149.02 132.55 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.832 -0.542 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.0 t -67.18 108.64 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.778 HG23 ' HA ' ' A' ' 116' ' ' PHE . 68.7 p -71.2 -62.05 1.54 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.66 . . . . 0.0 110.728 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -141.03 169.01 18.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.944 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.3 tt -130.64 124.49 31.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.648 -0.657 . . . . 0.0 109.744 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 112' ' ' ILE . 46.9 m -109.9 159.71 17.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -0.782 . . . . 0.0 110.486 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mt -139.76 84.15 1.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.539 -0.726 . . . . 0.0 109.978 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 59.6 t -82.21 166.68 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.685 -0.634 . . . . 0.0 110.344 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -162.24 -152.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.607 -0.683 . . . . 0.0 109.847 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.04 -36.24 2.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 111.068 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -126.7 26.25 6.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.348 -0.845 . . . . 0.0 110.8 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.36 -175.51 0.54 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.403 -0.811 . . . . 0.0 110.235 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.7 Cg_endo -80.14 -30.97 1.91 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.313 1.165 . . . . 0.0 109.97 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.61 175.54 36.24 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.521 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 47.3 Cg_endo -72.4 104.67 1.73 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.521 1.274 . . . . 0.0 110.506 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.62 HD22 ' CD1' ' A' ' 102' ' ' PHE . 2.4 mp -69.41 112.42 5.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 109.493 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.72 146.53 23.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.629 -0.67 . . . . 0.0 110.749 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.934 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -132.42 153.88 50.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 109.81 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.86 133.76 47.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.478 -0.764 . . . . 0.0 110.508 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -132.02 51.93 2.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.501 -0.75 . . . . 0.0 110.103 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.9 p -113.52 -69.57 0.85 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.94 -47.3 0.15 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -72.48 64.9 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.639 -0.919 . . . . 0.0 109.987 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -90.24 -23.16 21.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.397 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.37 -30.67 62.98 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.29 -0.881 . . . . 0.0 110.767 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -58.08 -20.23 38.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.486 -0.759 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -60.02 -30.39 69.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.92 -22.7 66.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.743 -0.598 . . . . 0.0 110.931 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -121.92 60.11 0.98 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.697 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.421 ' CG ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -170.61 125.03 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.374 -0.829 . . . . 0.0 110.363 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.4 p -135.04 127.18 29.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.62 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.8 m-85 -73.98 139.05 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.537 -0.727 . . . . 0.0 109.881 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.16 108.27 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.485 -0.76 . . . . 0.0 110.449 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 196' ' ' LEU . 58.0 mt -113.87 165.73 12.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.55 -0.718 . . . . 0.0 109.69 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 108' ' ' VAL . 15.1 tttm -94.46 160.93 14.43 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -18.28 -108.86 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.99 75.4 0.39 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.33 -1.481 . . . . 0.0 110.144 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 105' ' ' LYS . 34.3 m -85.26 143.76 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.536 -0.979 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -88.92 89.25 7.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' HE2' HD11 ' A' ' 112' ' ' ILE . 38.6 p90 -110.0 131.09 55.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 111.917 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.02 159.64 14.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 76' ' ' THR . 76.4 mt -126.2 145.3 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.053 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -118.06 102.35 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.432 HG21 ' HE2' ' A' ' 181' ' ' PHE . 48.1 mm -85.2 127.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.522 -0.736 . . . . 0.0 110.851 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.18 145.98 31.92 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.778 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -162.43 149.16 13.25 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.363 -0.835 . . . . 0.0 111.009 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.476 ' HG3' HG21 ' A' ' 73' ' ' THR . 9.0 mtm180 -101.57 133.16 46.68 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.361 0.601 . . . . 0.0 111.282 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.06 96.43 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.52 48.64 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.344 -0.847 . . . . 0.0 111.742 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -146.76 -69.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.224 -0.923 . . . . 0.0 110.794 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.9 158.16 40.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.19 102.9 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.565 -0.709 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 70' ' ' VAL . 62.8 t -85.72 94.99 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.616 -0.677 . . . . 0.0 109.826 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.13 97.83 8.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.617 -0.677 . . . . 0.0 110.294 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.17 41.03 0.38 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.628 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -78.86 126.19 30.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.942 . . . . 0.0 109.78 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 146' ' ' VAL . 1.5 ptmm? -137.2 146.87 45.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HH ' ' HZ2' ' A' ' 192' ' ' TRP . 21.6 t80 -111.13 137.84 48.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -123.19 156.45 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.516 -0.74 . . . . 0.0 110.231 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -154.64 131.88 11.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.793 -0.567 . . . . 0.0 109.74 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.403 ' ND1' ' CB ' ' A' ' 141' ' ' LYS . 23.8 m-70 -110.64 131.56 54.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.547 -0.721 . . . . 0.0 110.098 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 31.3 m -81.87 67.3 7.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.615 -0.678 . . . . 0.0 109.837 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 6.4 m-85 -61.57 136.92 58.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.498 -0.751 . . . . 0.0 110.104 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -120.84 110.53 16.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.75 35.91 22.56 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.471 -0.768 . . . . 0.0 110.588 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.413 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.28 35.31 14.96 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.1 t -147.13 113.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -1.041 . . . . 0.0 110.143 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -67.64 123.92 21.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.649 -0.657 . . . . 0.0 110.189 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.65 -22.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.486 -0.759 . . . . 0.0 110.8 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -169.36 123.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.403 ' CB ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -130.86 154.15 48.36 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.697 . . . . 0.0 109.468 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.5 m -142.45 146.03 34.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -109.33 120.51 42.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.695 -0.628 . . . . 0.0 109.462 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -104.37 117.68 34.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.443 -0.786 . . . . 0.0 110.946 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 124.9 23.92 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 21.7 t -90.53 -56.5 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 110.25 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.33 166.68 10.76 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 79.5 p -81.0 140.63 35.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.637 -0.92 . . . . 0.0 109.558 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 146' ' ' VAL . 43.9 m-85 -139.45 130.04 25.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.425 -0.797 . . . . 0.0 110.36 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.23 166.84 14.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.24 68.89 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.486 1.256 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.96 27.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.666 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -147.3 12.54 1.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 111.676 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 52.21 -145.08 0.57 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.956 -1.09 . . . . 0.0 111.09 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.1 122.4 20.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.39 -0.819 . . . . 0.0 110.948 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 6.5 m-85 -84.17 -173.51 4.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.724 . . . . 0.0 109.911 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -153.9 104.45 2.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 22.3 t80 -85.18 162.61 19.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -140.44 87.1 2.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.403 -0.811 . . . . 0.0 111.305 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.416 HG22 ' HE2' ' A' ' 158' ' ' PHE . 65.5 p -67.19 148.27 98.83 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.37 -0.831 . . . . 0.0 108.965 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.26 157.73 60.57 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.392 1.206 . . . . 0.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.2 ptt? -54.61 108.67 0.41 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.574 -0.704 . . . . 0.0 110.659 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -88.55 155.97 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.38 -0.825 . . . . 0.0 110.296 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.73 137.7 44.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.284 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.628 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -94.16 172.15 6.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.323 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.628 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.0 Cg_endo -73.18 179.77 5.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.382 1.201 . . . . 0.0 110.529 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -170.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.439 -0.788 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.06 -44.14 0.09 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.7 mtt -56.2 -75.27 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -1.102 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -77.64 -2.55 36.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.982 179.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.421 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -124.26 28.75 6.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -0.946 . . . . 0.0 110.082 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 163.98 27.22 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.517 -0.739 . . . . 0.0 109.985 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.18 -167.78 14.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.1 p -107.23 130.46 54.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.663 -0.904 . . . . 0.0 110.661 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.61 129.72 50.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.671 -0.643 . . . . 0.0 109.954 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.8 OUTLIER -73.27 143.04 47.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.745 . . . . 0.0 109.851 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.831 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -121.43 130.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.51 -0.744 . . . . 0.0 110.199 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -110.92 98.89 7.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.534 -0.729 . . . . 0.0 109.307 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 10.0 m -100.82 133.66 44.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.648 -0.658 . . . . 0.0 110.422 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -139.54 90.51 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.706 -0.621 . . . . 0.0 109.39 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -75.77 116.47 16.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.837 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 t -129.1 -175.38 3.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.755 -0.59 . . . . 0.0 109.803 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 4.4 p30 -100.82 -152.52 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.01 -58.69 6.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.264 -0.898 . . . . 0.0 109.671 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.5 22.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.015 -0.428 . . . . 0.0 111.094 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' O ' ' HB ' ' A' ' 187' ' ' THR . 2.6 mtt180 -82.26 -43.59 17.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.861 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 186' ' ' ARG . 5.2 t 176.97 173.49 0.44 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.201 0.524 . . . . 0.0 110.197 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.59 115.75 30.12 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 31.8 p80 -74.36 -15.21 60.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 0.0 111.31 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.1 tp -168.83 156.22 7.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.124 -0.985 . . . . 0.0 110.853 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.0 p -168.38 143.79 3.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.739 -0.6 . . . . 0.0 109.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CE2' HD21 ' A' ' 90' ' ' LEU . 40.4 p90 -151.19 -156.15 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 110.095 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.6 132.88 3.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 111.085 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -139.33 165.44 27.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.79 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -102.19 159.68 15.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 111.291 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 104' ' ' LEU . 17.6 tp -129.48 109.75 11.31 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.1 m -85.28 130.11 34.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.696 . . . . 0.0 110.85 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.98 152.14 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.63 -0.669 . . . . 0.0 109.402 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -145.13 -151.83 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 110.605 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -107.43 -39.49 5.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 111.302 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -144.6 98.08 3.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.21 -0.931 . . . . 0.0 111.207 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -89.09 35.1 0.79 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.191 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -169.71 34.13 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.27 -0.894 . . . . 0.0 110.136 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.904 -1.045 . . . . 0.0 110.173 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.017 0.437 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.98 -50.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.607 -0.683 . . . . 0.0 109.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 18.8 p 48.9 58.14 5.65 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.644 -0.66 . . . . 0.0 111.337 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 62' ' ' SER . . . 60.55 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 55.38 76.9 0.46 Allowed Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.094 -1.003 . . . . 0.0 110.412 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.48 162.99 39.88 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.411 1.216 . . . . 0.0 110.536 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -167.69 38.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 109.973 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 67' ' ' VAL . 34.7 m -61.18 116.5 19.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.388 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.577 ' CG ' HG21 ' A' ' 71' ' ' VAL . 46.1 Cg_endo -71.39 -165.05 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.103 1.054 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.408 ' OD1' HG23 ' A' ' 70' ' ' VAL . 42.2 t-20 -82.17 -70.66 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 123' ' ' VAL . 94.3 t -130.06 112.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.623 . . . . 0.0 110.461 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG21 ' CG ' ' A' ' 68' ' ' PRO . 87.5 t -138.64 149.5 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.926 -0.484 . . . . 0.0 109.885 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.678 HG22 ' CD2' ' A' ' 181' ' ' PHE . 59.7 t -65.68 103.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.864 HG23 ' HA ' ' A' ' 116' ' ' PHE . 71.0 p -72.02 -35.94 69.55 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.146 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -167.31 173.09 9.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 110.4 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.5 tt -142.68 124.59 15.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.577 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 77' ' ' LEU . 24.5 m -109.7 167.19 10.33 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.56 -0.713 . . . . 0.0 110.843 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -147.03 80.98 1.54 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.62 -0.675 . . . . 0.0 109.39 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 85' ' ' PRO . 67.0 t -77.49 166.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 110.157 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.469 ' N ' HG12 ' A' ' 78' ' ' VAL . 1.2 m -161.17 -166.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.691 -0.63 . . . . 0.0 110.192 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.8 p -116.55 -33.13 4.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -124.17 20.21 9.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.708 . . . . 0.0 110.856 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.62 -174.83 0.47 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.5 Cg_endo -81.02 -30.87 1.51 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.27 1.142 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.19 173.17 34.36 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.89 -1.147 . . . . 0.0 110.55 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.715 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.3 Cg_endo -71.56 96.32 0.74 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.665 1.35 . . . . 0.0 110.372 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 3.6 mt -64.81 123.87 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.652 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 53.1 mt-10 -103.52 122.76 45.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.501 -0.749 . . . . 0.0 110.802 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -102.6 119.17 38.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -67.58 141.0 56.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.587 -0.695 . . . . 0.0 110.688 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -140.35 56.83 1.6 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.471 -0.768 . . . . 0.0 110.073 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.8 p -128.53 -56.22 1.23 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.684 -0.635 . . . . 0.0 110.3 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.89 -51.9 0.04 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.39 69.94 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.597 -0.943 . . . . 0.0 110.147 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 94' ' ' LEU . 10.9 mt -94.23 -22.69 18.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.51 -0.744 . . . . 0.0 110.579 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -22.17 12.88 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.373 -0.83 . . . . 0.0 111.08 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.26 63.38 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 0.0 110.548 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.5 m-85 -58.97 -60.34 4.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.362 -0.836 . . . . 0.0 110.667 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -13.45 47.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.482 -0.761 . . . . 0.0 111.231 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -86.36 -15.99 38.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.16 -0.962 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.68 162.23 34.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -132.4 167.74 19.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.444 ' CE2' HD13 ' A' ' 77' ' ' LEU . 3.9 m-85 -103.18 113.13 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.636 -0.665 . . . . 0.0 109.874 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 104' ' ' LEU . 60.4 t -88.89 117.27 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 110.787 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.673 ' HB3' HG21 ' A' ' 108' ' ' VAL . 37.0 mt -127.6 145.02 51.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.794 ' O ' HG13 ' A' ' 108' ' ' VAL . 26.9 tttm -65.21 142.08 58.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.213 -0.93 . . . . 0.0 108.848 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.0 pt-20 -57.13 110.64 0.87 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.404 -0.81 . . . . 0.0 111.523 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.2 39.73 3.68 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.762 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 105' ' ' LYS . 27.6 m -99.12 133.08 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.128 -1.219 . . . . 0.0 110.653 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.27 98.11 11.15 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' HD2' HG23 ' A' ' 108' ' ' VAL . 38.0 p90 -112.05 144.74 40.91 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.616 0.722 . . . . 0.0 111.611 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -106.55 150.87 25.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.8 mt -119.86 148.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 159' ' ' LEU . 25.3 ttpp -130.08 93.2 3.44 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 44.4 mm -72.88 150.37 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.567 0.699 . . . . 0.0 110.652 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -124.82 145.22 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.864 ' HA ' HG23 ' A' ' 73' ' ' THR . 31.2 p90 -166.28 136.68 3.39 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.523 -0.735 . . . . 0.0 110.501 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -87.26 144.16 26.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.776 -0.578 . . . . 0.0 111.158 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 70' ' ' VAL . 61.5 t -131.03 83.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.577 -0.702 . . . . 0.0 109.415 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.34 48.7 2.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.515 -0.741 . . . . 0.0 111.738 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -147.79 -66.39 0.25 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.287 -0.883 . . . . 0.0 111.126 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.08 169.9 16.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.935 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 91.5 mt -78.4 124.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.63 . . . . 0.0 110.115 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 70' ' ' VAL . 67.9 t -114.11 80.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.2 p -79.77 112.11 16.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.749 -0.595 . . . . 0.0 110.705 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.75 45.35 0.51 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.555 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 1.8 mmt -61.98 132.56 53.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -1.097 . . . . 0.0 109.098 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.16 148.76 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.923 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.96 87.4 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 109.533 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -81.46 169.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.648 . . . . 0.0 110.072 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.49 ' N ' HG22 ' A' ' 129' ' ' ILE . 33.1 tt0 -166.18 120.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.445 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.2 m-70 -103.4 124.88 49.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.0 110.083 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.452 ' CG2' HD11 ' A' ' 139' ' ' ILE . 41.7 m -85.25 68.32 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.373 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -65.96 154.31 39.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.425 -0.797 . . . . 0.0 110.201 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -130.72 86.29 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.598 -0.689 . . . . 0.0 110.602 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 53.63 61.96 2.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.381 -0.825 . . . . 0.0 110.857 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.76 36.58 57.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.01 146.95 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.991 . . . . 0.0 109.793 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.11 121.0 43.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -123.44 -26.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.759 . . . . 0.0 111.145 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -161.82 153.08 18.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.888 -1.133 . . . . 0.0 111.201 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HE3' ' CE1' ' A' ' 131' ' ' HIS . 5.9 ptmt -175.79 135.91 0.31 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.708 . . . . 0.0 109.229 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 143' ' ' ASP . 17.8 m -146.23 168.82 20.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 111.231 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -108.39 151.0 26.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.723 -0.611 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -119.86 128.42 53.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.509 -0.744 . . . . 0.0 110.676 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 ttp -87.77 109.0 19.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.451 -0.781 . . . . 0.0 109.382 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.793 HG13 ' CD1' ' A' ' 158' ' ' PHE . 80.2 t -86.43 -71.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 110.709 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.59 -165.57 38.0 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.7 p -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.676 -0.896 . . . . 0.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.585 ' OH ' HG12 ' A' ' 146' ' ' VAL . 11.8 m-85 -126.22 -173.95 2.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.837 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.69 162.94 26.23 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.83 66.25 2.41 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.314 1.165 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 153' ' ' ALA . 0.7 OUTLIER -68.13 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.555 -0.716 . . . . 0.0 109.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 152' ' ' ARG . . . -178.35 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.005 -1.06 . . . . 0.0 110.709 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -94.02 -171.09 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.444 -0.785 . . . . 0.0 111.563 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.4 144.31 30.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.367 0.604 . . . . 0.0 110.601 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.489 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 60.4 m-85 -107.96 154.64 21.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -128.84 135.28 48.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.331 -0.856 . . . . 0.0 111.371 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.793 ' CD1' HG13 ' A' ' 146' ' ' VAL . 28.0 t80 -103.44 136.18 43.67 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -120.77 116.45 25.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 110.778 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.436 HG22 ' CE2' ' A' ' 158' ' ' PHE . 43.1 p -86.54 153.05 55.55 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 162.56 37.54 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.628 1.331 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.41 123.36 15.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.567 -0.708 . . . . 0.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.45 114.15 27.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.687 -0.633 . . . . 0.0 109.999 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -69.85 127.08 31.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.646 -0.658 . . . . 0.0 110.288 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -69.71 172.75 4.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.8 -0.562 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 44.2 Cg_endo -70.82 147.54 56.28 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 O-C-N 123.427 1.225 . . . . 0.0 110.131 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 35.7 mtmt -115.92 175.57 5.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.514 -0.741 . . . . 0.0 110.461 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 171' ' ' ALA . . . 103.57 147.17 17.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -52.74 43.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.541 -0.976 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 170' ' ' LEU . 9.2 tt -57.48 -27.93 62.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.463 -0.773 . . . . 0.0 110.34 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . -56.48 -23.29 38.25 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 mtp-105 -67.71 126.98 31.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.511 -0.743 . . . . 0.0 109.9 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.32 177.88 28.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 p -91.8 135.81 33.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.918 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -128.56 114.68 17.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 110.054 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.98 148.4 47.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.768 . . . . 0.0 110.132 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.803 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.2 mm -124.09 101.67 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 0.0 110.172 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -91.67 104.0 16.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 14.9 m -113.88 142.94 45.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.516 -0.74 . . . . 0.0 110.939 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -123.49 95.28 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.777 -0.577 . . . . 0.0 109.455 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.678 ' CD2' HG22 ' A' ' 72' ' ' VAL . 6.6 t80 -80.61 73.56 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.711 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.1 t -116.56 -168.84 1.52 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.665 . . . . 0.0 109.319 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.16 -158.08 0.62 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.541 -0.725 . . . . 0.0 109.814 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.16 -60.15 3.79 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.38 -0.825 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.02 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.822 -0.549 . . . . 0.0 110.593 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -78.0 -35.29 50.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.297 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t -176.35 -161.24 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.168 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -115.18 109.61 18.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.63 -0.669 . . . . 0.0 109.807 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -77.9 -67.76 0.7 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.451 -0.781 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.885 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -143.9 164.61 30.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 110.123 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.885 ' N ' HD13 ' A' ' 190' ' ' LEU . 7.4 t -168.82 135.38 1.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.448 ' CD2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -145.23 -172.83 3.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.65 125.88 7.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.513 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 10.0 p-90 -134.48 145.25 48.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.688 -0.633 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.62 146.79 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 104' ' ' LEU . 35.2 tp -120.28 94.37 4.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.731 -0.606 . . . . 0.0 109.793 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 103' ' ' VAL . 91.6 m -73.23 148.58 43.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.56 -0.712 . . . . 0.0 110.017 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 47.9 mm -124.27 135.95 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -128.76 -156.09 0.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.569 -0.707 . . . . 0.0 110.491 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -30.45 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 111.103 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -138.22 56.7 1.72 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.368 -0.832 . . . . 0.0 111.122 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.732 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -60.87 -16.04 37.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.0 111.327 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 35.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 110.455 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.186 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 61' ' ' VAL . 34.5 m -62.28 126.57 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.542 -0.724 . . . . 0.0 110.181 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.1 p -149.22 30.04 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.644 -0.66 . . . . 0.0 110.276 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 56.36 -86.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.705 -0.622 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.95 96.25 3.79 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 110.259 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.5 102.97 1.46 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.478 1.252 . . . . 0.0 110.375 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' C ' HG23 ' A' ' 67' ' ' VAL . 2.9 m120 52.86 -167.33 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.445 -0.784 . . . . 0.0 110.833 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 67' ' ' VAL . 63.3 t -146.95 59.9 5.37 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 110.052 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.96 171.21 17.97 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.314 1.165 . . . . 0.0 110.422 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -166.94 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.787 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 123' ' ' VAL . 93.1 t -125.04 111.45 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.628 . . . . 0.0 109.77 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -142.03 152.78 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.2 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 HD22 ' A' ' 90' ' ' LEU . 58.0 t -68.81 102.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.3 p -72.75 -53.57 11.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.597 -0.69 . . . . 0.0 110.065 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -150.02 165.68 31.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.74 -0.6 . . . . 0.0 110.001 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.689 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -127.06 165.21 19.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.728 -0.608 . . . . 0.0 109.685 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.573 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.4 m -155.04 156.13 35.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.59 -0.694 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -136.17 96.91 3.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.0 109.737 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 79' ' ' CYS . 57.5 t -74.26 167.88 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.852 -0.53 . . . . 0.0 110.188 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -171.7 -28.03 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.483 -0.761 . . . . 0.0 111.672 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 p 62.58 17.43 9.64 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -140.63 -46.55 0.41 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.507 -0.746 . . . . 0.0 109.224 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -59.34 -174.84 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.765 -0.584 . . . . 0.0 110.025 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.912 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.8 Cg_endo -73.11 -23.59 18.0 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.167 1.088 . . . . 0.0 110.345 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.66 176.73 40.21 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.83 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HB2' HG23 ' A' ' 76' ' ' THR . 43.9 Cg_endo -70.15 102.87 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.639 1.336 . . . . 0.0 110.452 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 30.5 mt -65.38 102.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -98.29 161.44 13.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.639 -0.663 . . . . 0.0 111.234 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.955 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.3 mt -130.94 167.53 18.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.822 -0.548 . . . . 0.0 109.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.419 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 11.0 t70 -111.05 131.22 55.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.578 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD22 HG11 ' A' ' 72' ' ' VAL . 1.5 mp -136.95 55.39 1.83 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 109.899 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -135.94 36.0 2.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.609 -0.682 . . . . 0.0 110.66 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.11 -86.65 0.22 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.97 81.18 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.694 -0.886 . . . . 0.0 110.197 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -95.12 -26.36 16.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.63 -0.669 . . . . 0.0 110.379 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -57.86 -26.64 62.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.443 -0.786 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -22.44 30.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.423 -0.798 . . . . 0.0 110.389 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.955 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.2 m-85 -56.47 -22.06 29.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.434 -0.791 . . . . 0.0 110.526 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -81.86 -20.18 39.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -0.783 . . . . 0.0 110.523 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -86.55 -22.15 26.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.935 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -132.4 134.81 45.59 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 110.689 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -105.83 -168.53 1.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.655 -0.653 . . . . 0.0 109.921 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.528 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.6 m-85 -116.98 96.62 5.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.42 108.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.715 -0.616 . . . . 0.0 109.854 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 196' ' ' LEU . 5.1 mt -113.87 -170.85 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.6 -0.687 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 31.1 tttm -134.64 157.23 47.15 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.994 0.902 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -47.54 124.46 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 45.51 60.18 4.35 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.905 -0.497 . . . . 0.0 113.097 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 104' ' ' LEU . 34.7 m -96.15 119.83 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.239 -1.153 . . . . 0.0 110.596 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.43 96.0 2.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.629 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.3 p90 -115.44 148.79 38.98 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.573 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -102.0 138.14 39.36 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HE1' ' A' ' 110' ' ' TYR . 42.2 mm -85.73 161.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.247 -0.908 . . . . 0.0 110.521 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -148.59 82.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.689 HD13 ' HG ' ' A' ' 75' ' ' LEU . 47.9 mm -75.15 143.78 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.708 -0.62 . . . . 0.0 110.49 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.07 132.21 54.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.722 ' HA ' HG23 ' A' ' 73' ' ' THR . 48.6 p90 -154.2 144.71 22.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.779 . . . . 0.0 111.082 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG3' HG21 ' A' ' 73' ' ' THR . 5.4 mtt180 -97.17 138.27 34.92 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.261 0.553 . . . . 0.0 110.858 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 70' ' ' VAL . 59.5 t -130.89 87.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.633 -0.667 . . . . 0.0 109.324 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.25 47.17 2.52 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.426 -0.796 . . . . 0.0 112.164 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HB3' ' A' ' 151' ' ' PRO . 2.8 ttt-85 -139.08 -64.09 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.34 160.95 37.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.479 -0.763 . . . . 0.0 110.277 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.79 112.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 70' ' ' VAL . 58.0 t -101.58 120.74 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.583 -0.698 . . . . 0.0 109.599 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.6 p -116.84 114.87 24.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.455 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.99 30.77 2.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.611 ' SD ' HG11 ' A' ' 146' ' ' VAL . 3.2 ttt -63.45 120.06 10.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.402 -1.057 . . . . 0.0 109.625 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.22 156.22 25.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.409 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 35.0 t80 -132.16 101.06 5.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 130' ' ' GLN . 81.8 mt -94.27 165.67 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 129' ' ' ILE . 24.2 tt0 -158.84 134.66 8.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -113.96 118.23 33.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.681 -0.637 . . . . 0.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 m -75.42 74.59 2.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.533 -0.73 . . . . 0.0 109.781 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -62.27 154.64 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.518 -0.739 . . . . 0.0 110.515 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.486 ' CG ' HD11 ' A' ' 139' ' ' ILE . 11.9 ttp85 -120.22 39.26 3.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.703 -0.623 . . . . 0.0 110.27 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.46 61.34 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.253 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 149.45 -37.06 0.99 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 137' ' ' VAL . 9.1 p -157.88 127.18 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.968 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.38 131.34 50.68 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 134' ' ' ARG . 20.2 mt -89.79 -52.73 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.679 -0.638 . . . . 0.0 109.312 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -169.17 165.09 11.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 174.68 10.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.618 -0.676 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 m -154.65 146.25 23.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -102.38 137.46 40.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.578 -0.701 . . . . 0.0 110.109 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -120.97 129.94 53.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.431 -0.793 . . . . 0.0 110.537 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -80.44 112.5 17.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 109.389 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.611 HG11 ' SD ' ' A' ' 126' ' ' MET . 49.4 t -79.72 -67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.55 171.64 19.64 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.7 p -95.4 154.93 16.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.972 . . . . 0.0 110.02 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -147.92 128.04 13.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.366 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.55 153.21 28.49 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' A' ' 120' ' ' ARG . 49.9 Cg_endo -74.24 76.84 2.97 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.454 1.239 . . . . 0.0 110.435 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -169.0 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 110.34 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -142.44 -111.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 110.162 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -171.95 -148.65 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.593 -1.317 . . . . 0.0 109.739 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 91.13 1.03 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 22.7 m-85 -59.87 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.415 -0.803 . . . . 0.0 110.008 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.705 ' OE1' HD12 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -156.09 114.77 3.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 110.987 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.526 ' CG ' HG13 ' A' ' 146' ' ' VAL . 39.0 t80 -95.34 169.46 10.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.705 HD12 ' OE1' ' A' ' 157' ' ' GLU . 0.2 OUTLIER -154.1 124.9 7.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.858 . . . . 0.0 111.145 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.0 p -93.75 159.92 33.72 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.31 152.77 80.04 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.63 1.332 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -57.28 116.33 3.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.746 -0.596 . . . . 0.0 111.121 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -113.11 149.35 33.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.71 -0.619 . . . . 0.0 109.617 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.44 127.35 44.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.539 -0.726 . . . . 0.0 110.934 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -62.72 -176.06 0.14 Allowed Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.919 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 44.8 Cg_endo -73.6 127.7 11.95 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 O-C-N 123.066 1.035 . . . . 0.0 110.204 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -116.17 159.02 22.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 110.868 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.65 162.18 30.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -60.06 173.07 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -1.044 . . . . 0.0 109.556 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 tt 67.9 -60.65 0.4 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.372 -0.83 . . . . 0.0 110.625 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.919 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -52.08 -23.25 5.03 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.427 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 11.4 mtp180 -67.15 155.57 38.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.344 -0.847 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.23 -175.3 19.92 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -91.89 118.17 30.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.94 . . . . 0.0 110.363 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' A' ' 171' ' ' ALA . 55.3 m-85 -112.48 124.39 52.4 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 140.06 47.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.646 -0.659 . . . . 0.0 110.637 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.815 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.9 mm -113.53 94.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.647 -0.658 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 109.22 18.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.23 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.409 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 28.6 t -113.64 144.38 43.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.393 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.02 105.97 10.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.682 -0.637 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.455 ' CD2' HG23 ' A' ' 72' ' ' VAL . 1.7 t80 -81.62 132.63 35.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.72 -0.613 . . . . 0.0 109.852 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -171.03 -172.7 1.17 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.649 -0.657 . . . . 0.0 110.222 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -112.12 -154.37 0.54 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.738 -0.601 . . . . 0.0 109.524 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -59.32 5.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.92 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.753 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -81.64 -34.93 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.21 -166.91 0.15 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.686 -0.634 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.23 117.1 29.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.658 . . . . 0.0 109.666 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.458 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.1 m-70 -68.9 -62.5 1.35 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.508 -0.745 . . . . 0.0 110.68 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.7 tp -168.43 159.53 10.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.382 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.2 t -153.71 138.53 17.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.53 -0.732 . . . . 0.0 110.196 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.41 ' CE2' HD21 ' A' ' 90' ' ' LEU . 19.0 p90 -142.02 -155.43 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 110.083 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -169.01 128.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.377 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.815 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -130.45 145.0 51.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.613 -0.68 . . . . 0.0 109.982 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.44 158.83 28.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.474 0.654 . . . . 0.0 110.941 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 104' ' ' LEU . 21.9 tp -133.38 95.41 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.1 m -80.63 104.34 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.626 -0.672 . . . . 0.0 110.78 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.3 mm -80.76 147.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -138.29 -158.83 0.89 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.424 -0.797 . . . . 0.0 110.809 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -53.13 4.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.691 -0.631 . . . . 0.0 110.928 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -147.1 94.06 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.0 110.818 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -74.97 -0.78 19.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.644 -0.66 . . . . 0.0 111.336 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.69 34.92 2.79 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 110.249 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.189 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.067 0.46 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.96 171.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.571 -0.706 . . . . 0.0 110.209 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.19 70.25 10.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.39 31.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.519 -0.738 . . . . 0.0 110.195 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.61 149.71 90.89 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.541 -0.725 . . . . 0.0 110.252 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.34 -175.54 1.82 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.353 1.186 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.99 126.45 34.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.584 -0.697 . . . . 0.0 110.151 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' HD2' ' A' ' 68' ' ' PRO . 8.6 p -113.32 143.63 29.68 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 67' ' ' VAL . 48.1 Cg_endo -73.91 177.39 8.2 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.298 1.157 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -104.82 -56.85 2.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.698 -0.626 . . . . 0.0 109.862 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.616 ' CG2' HG21 ' A' ' 123' ' ' VAL . 86.9 t -114.05 130.76 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 0.0 110.078 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.759 HG13 HD13 ' A' ' 190' ' ' LEU . 62.2 t -148.1 137.75 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.786 -0.572 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.5 t -69.44 106.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 72.7 p -73.35 -58.37 3.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.728 -0.608 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.23 164.28 30.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.49 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -132.13 124.19 28.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.673 -0.642 . . . . 0.0 109.695 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.3 m -109.87 152.04 26.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.754 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.61 114.19 9.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.612 -0.68 . . . . 0.0 110.149 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.2 t -113.44 165.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.712 . . . . 0.0 110.26 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.453 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -156.97 -156.64 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 109.956 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.1 p -97.38 -35.88 10.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 p -138.79 47.53 1.94 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.617 -0.677 . . . . 0.0 110.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.23 172.01 7.66 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.664 -0.647 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.4 Cg_endo -72.4 -29.12 14.11 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.442 1.233 . . . . 0.0 109.855 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.38 175.12 33.07 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -70.9 100.63 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.393 1.207 . . . . 0.0 110.204 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD13 ' CG ' ' A' ' 102' ' ' PHE . 53.1 mt -65.03 113.31 3.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.631 -0.668 . . . . 0.0 109.932 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.11 116.2 29.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.758 -0.589 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -101.87 128.03 48.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.587 -0.696 . . . . 0.0 109.983 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.05 126.85 31.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.546 -0.721 . . . . 0.0 110.007 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.473 HD13 ' CG1' ' A' ' 72' ' ' VAL . 1.6 mt -129.76 52.21 2.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.672 . . . . 0.0 110.062 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -101.37 -73.75 0.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.4 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.09 -42.66 0.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.33 77.66 8.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.689 -0.889 . . . . 0.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 86.9 mt -87.33 -20.87 26.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -13.71 36.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.0 111.477 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -6.2 39.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.06 -1.025 . . . . 0.0 111.567 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 88' ' ' LEU . 12.4 m-30 -75.27 -55.53 5.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -58.21 -17.55 19.79 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.489 -0.757 . . . . 0.0 111.407 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -86.0 -19.85 29.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.265 -0.897 . . . . 0.0 110.89 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.62 147.08 37.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.216 -0.928 . . . . 0.0 110.582 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 195' ' ' ASN . 0.7 OUTLIER -136.28 160.9 37.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.449 -0.782 . . . . 0.0 109.931 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.623 ' CG ' HD13 ' A' ' 86' ' ' LEU . 29.3 m-85 -90.98 166.08 13.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.99 128.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 196' ' ' LEU . 88.2 mt -129.5 164.62 23.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.63 -0.669 . . . . 0.0 109.686 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 2.5 ttpt -77.2 166.54 23.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -29.24 -66.77 0.08 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.82 72.98 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 104' ' ' LEU . 32.7 m -88.0 139.12 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.412 -1.052 . . . . 0.0 110.661 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -85.32 95.98 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 48.5 p90 -109.68 135.93 49.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.533 -0.729 . . . . 0.0 111.745 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -89.2 157.39 18.28 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.89 132.56 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.422 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -115.36 121.48 42.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.88 146.82 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.506 0.669 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -129.37 133.29 47.32 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 33.4 p90 -154.73 157.98 38.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.383 -0.823 . . . . 0.0 110.847 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.76 129.46 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.51 110.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 109.351 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -128.53 48.23 2.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 111.382 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 -67.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.295 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.66 165.67 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.509 -0.745 . . . . 0.0 110.474 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.12 106.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.691 -0.63 . . . . 0.0 109.974 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.616 HG21 ' CG2' ' A' ' 70' ' ' VAL . 59.9 t -84.83 95.02 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.653 -0.655 . . . . 0.0 109.966 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.1 p -88.87 74.97 8.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.322 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 153.63 53.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -82.69 151.38 26.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.988 . . . . 0.0 109.605 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -146.69 151.63 37.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.873 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -128.15 97.49 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.758 -0.588 . . . . 0.0 109.499 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.585 HG23 ' OD1' ' A' ' 143' ' ' ASP . 78.4 mt -96.23 134.6 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 110.055 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.405 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 18.5 tt0 -129.06 138.07 51.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.6 m-70 -113.6 138.39 50.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.444 -0.785 . . . . 0.0 110.089 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.7 m -96.6 85.92 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.707 -0.621 . . . . 0.0 109.824 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 138' ' ' LYS . 5.4 m-85 -89.84 129.26 36.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 110.398 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 137' ' ' VAL . 3.5 tmm_? -145.52 151.43 38.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 51.49 31.23 7.2 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.452 -0.78 . . . . 0.0 111.166 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.41 60.33 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.314 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.7 m -120.36 149.67 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.322 . . . . 0.0 110.398 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 16.7 tttp -85.66 119.76 26.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.62 HD11 ' HB3' ' A' ' 134' ' ' ARG . 95.9 mt -89.8 -67.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.56 -0.713 . . . . 0.0 109.914 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.73 157.45 6.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.506 -0.746 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 165.72 19.0 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.4 m -128.74 137.31 51.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.562 -0.711 . . . . 0.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 129' ' ' ILE . 72.4 m-20 -101.7 105.24 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.712 . . . . 0.0 110.077 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -96.2 148.07 23.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.75 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.05 117.2 33.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.718 HG13 ' CG ' ' A' ' 158' ' ' PHE . 48.1 t -80.86 -55.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.48 -0.762 . . . . 0.0 110.196 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.75 -179.69 17.68 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 22.3 m -89.65 151.29 21.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.66 -0.906 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.52 ' CE2' HG12 ' A' ' 146' ' ' VAL . 82.8 m-85 -148.3 129.55 14.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 0.0 110.369 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.03 152.08 30.95 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.71 90.24 0.95 Allowed 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.425 1.224 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 26.42 7.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.584 -0.698 . . . . 0.0 110.226 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 53.42 22.81 3.02 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.376 -0.827 . . . . 0.0 111.268 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -133.04 178.22 7.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.17 157.93 16.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.705 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.1 m-85 -114.16 177.56 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.539 -0.726 . . . . 0.0 110.089 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -148.81 91.67 1.9 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.718 ' CG ' HG13 ' A' ' 146' ' ' VAL . 40.1 t80 -79.56 163.94 24.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.0 110.002 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -139.72 119.28 13.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.565 -0.709 . . . . 0.0 110.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.496 HG22 ' HE2' ' A' ' 158' ' ' PHE . 66.8 p -102.26 157.09 34.37 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.522 -0.736 . . . . 0.0 109.714 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.68 159.83 46.41 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.707 1.372 . . . . 0.0 110.997 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 149.87 27.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.408 0.623 . . . . 0.0 110.872 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.409 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 16.6 tt0 -129.24 106.44 8.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.712 -0.617 . . . . 0.0 109.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.09 126.0 26.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -74.31 173.09 7.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.793 -0.567 . . . . 0.0 110.003 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.5 Cg_endo -72.96 123.92 9.25 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.338 1.178 . . . . 0.0 110.362 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -118.12 -160.93 0.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 110.572 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.71 47.9 13.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 54.79 175.65 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.567 -0.961 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -61.38 0.32 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.285 -0.885 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -49.43 -24.66 2.09 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.382 -0.824 . . . . 0.0 111.407 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -58.74 128.35 36.78 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.18 -178.84 25.5 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.8 p -86.79 142.75 27.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.517 -0.99 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 38.1 m-85 -131.11 105.0 7.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.671 -0.643 . . . . 0.0 110.356 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.35 120.14 15.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.612 -0.68 . . . . 0.0 109.349 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 131' ' ' HIS . 44.8 mt -109.72 148.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.982 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -114.84 118.88 34.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.748 -0.595 . . . . 0.0 109.79 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.8 m -110.53 122.48 47.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.585 -0.697 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -111.01 103.62 12.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t80 -83.26 116.79 22.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.548 -0.72 . . . . 0.0 110.071 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.3 t -131.97 -155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.746 . . . . 0.0 110.166 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 26.6 p-10 -161.81 -146.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.055 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.2 27.87 2.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 187' ' ' THR . 1.4 t70 -132.35 54.59 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.489 -0.757 . . . . 0.0 109.518 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 185' ' ' ASP . 0.0 OUTLIER 4.17 65.42 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 185' ' ' ASP . 8.0 t -144.63 -174.82 4.43 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.048 0.451 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.11 88.09 2.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -60.27 -40.62 91.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.522 -0.736 . . . . 0.0 109.973 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.759 HD13 HG13 ' A' ' 71' ' ' VAL . 5.2 tp -170.35 148.21 3.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 110.032 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -159.65 136.96 9.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.654 -0.654 . . . . 0.0 110.025 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.443 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 23.9 p90 -136.48 -157.39 0.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.613 -0.68 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.742 . . . . 0.0 110.55 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.544 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 18.1 p-90 -144.13 153.27 41.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.561 -0.712 . . . . 0.0 109.987 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 101' ' ' SER . 5.1 m120 -94.34 153.49 17.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.536 -0.727 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.544 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 23.5 tp -126.78 90.05 3.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.1 m -67.98 145.09 54.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.0 110.94 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.6 156.89 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.707 -0.621 . . . . 0.0 109.392 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -151.91 -153.27 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.493 -0.754 . . . . 0.0 110.068 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -129.88 -0.7 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 111.624 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -160.08 47.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.085 -1.01 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.579 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -57.44 -19.85 26.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.525 -0.734 . . . . 0.0 111.292 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 56.91 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.165 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.129 0.49 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.7 -26.02 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.75 . . . . 0.0 110.429 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 m 53.21 87.29 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.353 -0.842 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.21 -160.6 0.75 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.683 . . . . 0.0 110.152 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 t0 52.51 75.6 0.62 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.411 -0.806 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.364 1.191 . . . . 0.0 110.372 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.458 ' C ' HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER 55.04 174.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.544 -0.722 . . . . 0.0 110.697 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 66' ' ' ASN . 31.5 m -149.77 152.27 34.3 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 110.189 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.42 168.61 24.32 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.379 1.199 . . . . 0.0 110.271 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.405 ' OD1' HG23 ' A' ' 70' ' ' VAL . 23.4 t30 -83.96 -77.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 123' ' ' VAL . 96.2 t -134.33 119.2 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.624 -0.673 . . . . 0.0 110.338 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 190' ' ' LEU . 79.2 t -142.52 136.74 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG12 HD13 ' A' ' 90' ' ' LEU . 59.3 t -61.24 103.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.518 -0.739 . . . . 0.0 109.115 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.67 HG23 ' HA ' ' A' ' 116' ' ' PHE . 39.0 p -73.45 -56.37 5.14 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.889 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -141.99 168.35 19.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.812 . . . . 0.0 110.724 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.66 124.57 31.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.65 -0.657 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 85' ' ' PRO . 4.1 m -110.4 156.22 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.621 -0.674 . . . . 0.0 110.277 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.528 HD23 HG12 ' A' ' 112' ' ' ILE . 5.4 mt -139.55 82.2 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.577 -0.702 . . . . 0.0 109.879 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.49 143.93 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.725 -0.609 . . . . 0.0 110.088 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 72.2 m -140.82 -163.54 1.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.041 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 p -115.87 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.4 p -95.87 24.9 5.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.93 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -90.5 -177.38 0.77 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.509 -0.744 . . . . 0.0 110.29 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.2 Cg_endo -73.99 -23.59 15.97 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.359 1.189 . . . . 0.0 110.131 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.68 -175.46 29.67 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HB2' ' CG2' ' A' ' 76' ' ' THR . 45.0 Cg_endo -71.07 104.8 1.58 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.503 1.264 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.89 114.45 4.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.722 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -90.19 146.61 24.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.809 HD21 ' CE1' ' A' ' 97' ' ' PHE . 3.7 tt -128.08 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.575 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -94.52 127.35 40.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.517 -0.739 . . . . 0.0 110.161 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.673 HD13 HG12 ' A' ' 72' ' ' VAL . 2.9 mt -135.26 55.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.654 -0.654 . . . . 0.0 109.878 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -104.81 -73.63 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.728 -0.607 . . . . 0.0 110.474 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.22 -74.77 0.49 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.41 94.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.683 -0.893 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 61.0 mt -92.78 -33.41 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.492 -0.755 . . . . 0.0 110.149 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -57.57 -19.31 24.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.502 -0.749 . . . . 0.0 111.065 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.56 -24.5 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.16 -0.963 . . . . 0.0 111.263 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.809 ' CE1' HD21 ' A' ' 88' ' ' LEU . 8.1 m-85 -62.0 -19.24 62.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.507 -0.745 . . . . 0.0 110.309 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.9 -25.98 61.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -86.94 -25.24 24.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.494 -0.754 . . . . 0.0 110.855 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.35 151.47 51.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.392 -0.818 . . . . 0.0 110.619 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -123.81 -170.27 2.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.543 -0.723 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.765 ' CZ ' HD12 ' A' ' 88' ' ' LEU . 6.5 m-85 -115.37 102.08 9.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.641 -0.662 . . . . 0.0 110.052 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.39 147.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.65 -0.656 . . . . 0.0 110.203 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.107 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -159.34 148.17 18.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.664 -0.647 . . . . 0.0 109.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.651 ' HB3' HG11 ' A' ' 108' ' ' VAL . 63.7 tttt -83.54 158.29 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -39.96 107.5 0.07 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 32.24 68.64 0.14 Allowed Glycine 0 N--CA 1.506 3.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.736 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.107 HG22 HD21 ' A' ' 104' ' ' LEU . 21.5 m -88.78 167.55 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -1.141 . . . . 0.0 109.647 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.38 97.94 11.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.202 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.648 ' HE1' ' HB2' ' A' ' 165' ' ' ALA . 32.4 p90 -128.42 134.28 48.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.0 111.581 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -89.46 167.53 12.92 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.528 HG12 HD23 ' A' ' 77' ' ' LEU . 71.0 mt -125.35 137.94 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 0.0 110.358 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -115.68 109.34 17.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.645 -0.66 . . . . 0.0 109.541 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.801 HG21 ' CE2' ' A' ' 181' ' ' PHE . 49.0 mm -93.38 126.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.583 -0.698 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.9 p -108.59 148.55 30.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.67 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.5 p90 -164.78 146.37 8.02 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.235 -0.916 . . . . 0.0 111.884 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -81.49 125.26 30.26 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.276 0.56 . . . . 0.0 110.748 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 70' ' ' VAL . 72.4 t -126.36 82.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.54 48.73 2.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.442 -0.786 . . . . 0.0 111.93 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -138.34 -65.97 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.104 -0.997 . . . . 0.0 111.089 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -142.67 175.98 9.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.393 -0.817 . . . . 0.0 110.86 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.58 113.28 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 110.152 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 70' ' ' VAL . 74.3 t -95.76 88.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.664 -0.647 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 77.6 p -82.97 88.06 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.632 -0.668 . . . . 0.0 110.516 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.0 46.55 0.07 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.453 ' HE3' ' CE1' ' A' ' 116' ' ' PHE . 3.0 ttt -81.22 128.48 33.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.514 -0.992 . . . . 0.0 109.597 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -140.62 167.0 23.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.507 -0.745 . . . . 0.0 110.849 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -135.75 120.12 17.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.7 -0.625 . . . . 0.0 109.733 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -116.57 130.25 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.583 -0.698 . . . . 0.0 110.3 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -128.1 135.61 50.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.611 -0.681 . . . . 0.0 109.862 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.1 m-70 -104.2 114.64 29.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -70.68 77.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.698 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 3.4 m-85 -80.79 141.99 34.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.985 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -119.35 -155.4 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -64.66 81.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.58 -0.7 . . . . 0.0 110.608 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 60.9 23.73 61.75 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 136' ' ' GLY . 97.5 t -148.78 89.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -1.079 . . . . 0.0 109.982 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 149.84 49.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.726 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 140' ' ' ASP . 44.2 pt -118.89 -37.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.406 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.431 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.6 t70 -175.86 167.2 3.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.0 -1.063 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.428 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -126.86 -168.3 1.85 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.427 HG22 ' CE2' ' A' ' 144' ' ' TYR . 34.4 m -159.74 126.96 4.61 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.554 ' OD1' HG23 ' A' ' 129' ' ' ILE . 1.5 m-20 -113.47 136.84 52.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CE2' HG22 ' A' ' 142' ' ' THR . 48.5 m-85 -123.17 127.44 48.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.576 -0.703 . . . . 0.0 110.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.7 tpp -81.18 106.01 12.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.85 HG12 ' CE1' ' A' ' 149' ' ' TYR . 40.8 t -79.96 -36.4 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.547 -0.721 . . . . 0.0 110.279 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.69 -176.87 16.81 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 3.1 t -82.52 135.73 35.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.599 -0.942 . . . . 0.0 110.03 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.85 ' CE1' HG12 ' A' ' 146' ' ' VAL . 9.3 m-85 -118.35 128.99 55.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.633 . . . . 0.0 110.939 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.79 153.05 16.91 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.79 85.14 1.36 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.369 1.194 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -62.28 1.48 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.67 127.01 0.9 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 111.17 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.03 -156.92 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.498 -0.751 . . . . 0.0 111.545 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.81 174.79 7.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.554 -0.716 . . . . 0.0 111.26 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.451 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 44.4 m-85 -119.31 -174.63 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.657 -0.652 . . . . 0.0 109.461 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.87 100.41 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.642 ' CD1' HG13 ' A' ' 146' ' ' VAL . 54.6 t80 -81.39 170.35 16.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.124 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -155.68 109.42 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 110.513 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.407 HG22 ' HE2' ' A' ' 158' ' ' PHE . 54.8 p -75.6 146.88 81.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 109.168 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.43 -177.97 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.706 1.371 . . . . 0.0 111.021 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -58.37 145.17 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.482 0.658 . . . . 0.0 110.872 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.47 119.86 3.1 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.82 146.14 37.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 111.019 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -90.76 -178.09 0.88 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.748 -0.595 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.9 123.61 8.56 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.104 1.055 . . . . 0.0 110.355 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 171.36 7.78 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.459 -0.776 . . . . 0.0 110.539 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.84 161.91 11.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.99 -61.0 2.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.574 -0.956 . . . . 0.0 109.291 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -61.63 -29.76 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.725 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.9 -23.98 61.77 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.501 -0.749 . . . . 0.0 110.538 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -64.2 129.08 38.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.788 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.4 -177.94 30.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.6 p -86.72 133.99 33.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.949 . . . . 0.0 110.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -116.81 106.74 13.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.272 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.76 121.12 19.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.599 -0.688 . . . . 0.0 109.547 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 33.3 mt -111.81 124.33 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.451 -0.78 . . . . 0.0 110.89 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.406 ' CB ' ' HB2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -86.76 96.69 10.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.0 109.451 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -90.55 134.89 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.632 -0.667 . . . . 0.0 110.802 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -133.41 82.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.66 -0.65 . . . . 0.0 109.618 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 114' ' ' ILE . 4.0 t80 -79.1 111.84 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.617 -0.677 . . . . 0.0 110.06 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -136.19 -166.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.31 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -133.89 163.24 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.789 -0.569 . . . . 0.0 109.992 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.21 48.46 1.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.35 -54.22 0.19 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.602 -0.686 . . . . 0.0 110.722 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -94.72 -83.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.558 -0.714 . . . . 0.0 110.703 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 t -172.76 -165.02 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.211 -0.931 . . . . 0.0 110.386 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.46 108.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 110.003 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -65.92 -56.2 12.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.543 -0.723 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 71' ' ' VAL . 6.7 tp -168.3 142.85 3.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.584 -0.698 . . . . 0.0 110.356 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 81.0 p -142.63 147.75 36.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.532 -0.73 . . . . 0.0 109.989 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.449 ' CE2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -144.68 -155.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 109.975 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.99 126.04 3.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 110.613 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.54 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 23.2 p-90 -133.29 147.55 51.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.589 -0.694 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.93 135.06 35.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 111.145 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.54 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 27.4 tp -104.96 95.46 5.87 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.9 m -72.42 117.97 14.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.555 -0.716 . . . . 0.0 110.992 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.3 mm -91.03 153.33 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -142.89 -167.63 2.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.394 -0.816 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 -46.66 6.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.704 -0.622 . . . . 0.0 110.568 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.89 106.27 4.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.93 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.33 36.56 0.88 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.607 -0.683 . . . . 0.0 111.285 179.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -169.37 37.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.316 -0.865 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.16 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.136 0.494 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.12 -25.91 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.371 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 p -155.31 42.48 0.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.461 -0.775 . . . . 0.0 110.135 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.52 96.59 0.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.591 -0.693 . . . . 0.0 110.213 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.61 149.11 42.52 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.593 -0.692 . . . . 0.0 110.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.04 -166.48 0.3 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.344 1.181 . . . . 0.0 110.357 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -90.97 -168.14 2.0 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.541 -0.724 . . . . 0.0 110.09 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 67' ' ' VAL . 35.6 m -119.02 64.23 6.61 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.547 -0.72 . . . . 0.0 110.376 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 149.31 53.32 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.248 1.13 . . . . 0.0 110.421 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -123.47 -73.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.688 -0.633 . . . . 0.0 109.935 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 123' ' ' VAL . 59.2 t -138.87 135.34 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.551 ' CG1' HD22 ' A' ' 190' ' ' LEU . 76.8 t -147.73 142.1 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 0.0 109.582 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.729 ' HB ' HD23 ' A' ' 190' ' ' LEU . 62.1 t -63.02 105.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.1 p -70.52 -52.88 18.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 110.361 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 mtm105 -158.68 151.84 22.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.556 -0.715 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 76' ' ' THR . 4.3 tt -110.67 126.54 54.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.721 -0.612 . . . . 0.0 109.701 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.587 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.7 m -109.4 152.37 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.338 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.671 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -139.74 109.04 6.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.271 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.7 t -108.54 167.07 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.667 -0.645 . . . . 0.0 109.887 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -157.11 -158.38 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.532 -0.73 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 p -95.07 -34.48 12.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p -140.24 48.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.51 168.01 15.2 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.3 Cg_endo -73.2 -26.48 14.69 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.454 1.239 . . . . 0.0 110.07 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.07 169.13 28.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.97 103.04 1.41 Allowed 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.442 1.233 . . . . 0.0 110.209 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 102' ' ' PHE . 15.4 mt -64.7 116.16 5.98 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.756 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.83 106.04 17.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.395 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.509 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -84.98 127.97 34.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.666 -0.646 . . . . 0.0 109.938 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.28 122.6 25.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.569 -0.707 . . . . 0.0 110.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD13 ' CG1' ' A' ' 72' ' ' VAL . 3.9 mt -128.59 51.03 2.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 109.933 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -109.89 -70.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -60.88 0.15 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.93 88.66 0.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.6 -0.941 . . . . 0.0 110.316 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 92.1 mt -94.98 -25.93 16.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.378 -0.826 . . . . 0.0 110.5 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -52.35 -23.3 5.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -18.48 35.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.431 -0.793 . . . . 0.0 111.325 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.509 ' CE1' HD22 ' A' ' 88' ' ' LEU . 13.3 m-30 -61.96 -56.01 23.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.199 -0.938 . . . . 0.0 110.59 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.98 25.1 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 0.0 111.132 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -86.89 9.82 18.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 111.25 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -171.6 148.0 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.166 -0.959 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.2 p -125.3 159.41 31.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.781 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -82.15 117.97 22.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 110.261 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 199' ' ' LYS . 57.3 t -78.08 154.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.623 -0.673 . . . . 0.0 109.802 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 196' ' ' LEU . 1.7 mt -164.76 179.0 6.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.571 -0.706 . . . . 0.0 110.328 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -107.33 152.32 24.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -19.56 -69.44 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -143.26 74.21 0.33 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.922 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.643 HG21 HD22 ' A' ' 104' ' ' LEU . 33.4 m -88.47 -173.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 110.116 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -120.79 93.63 4.09 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.581 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 40.5 p90 -109.81 145.72 36.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.367 -0.833 . . . . 0.0 112.329 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 162' ' ' MET . 38.4 mtt85 -105.33 165.19 11.29 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 75' ' ' LEU . 68.2 mt -126.41 135.35 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 100.53 8.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.826 -0.546 . . . . 0.0 109.579 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' GLU . 46.2 mm -77.28 148.44 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.529 -0.732 . . . . 0.0 110.043 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -131.31 133.84 45.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 10.4 p90 -157.5 148.92 21.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 110.415 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.3 49.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.64 -0.662 . . . . 0.0 111.158 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 70' ' ' VAL . 57.4 t -115.01 99.04 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -129.2 47.97 2.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.41 -0.806 . . . . 0.0 111.608 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -145.09 -64.24 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.78 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -138.4 166.59 23.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.448 -0.783 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.91 102.78 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.673 -0.642 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 70' ' ' VAL . 58.3 t -81.13 70.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.762 -0.586 . . . . 0.0 109.745 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.9 p -74.52 94.54 2.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.642 -0.661 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.98 42.11 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.4 ttt -72.28 140.79 48.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.973 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -136.58 159.61 41.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -135.27 97.89 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.438 HG22 ' CE1' ' A' ' 131' ' ' HIS . 76.4 mt -94.39 133.37 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 109.728 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.412 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 28.0 tt0 -131.61 131.57 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.688 . . . . 0.0 110.29 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.563 ' CD2' ' HD3' ' A' ' 141' ' ' LYS . 4.9 m80 -107.97 123.62 48.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 0.0 109.792 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.9 m -83.32 105.57 14.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.538 -0.726 . . . . 0.0 110.047 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 138' ' ' LYS . 8.6 m-85 -96.32 140.19 31.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 112.32 18.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.737 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.5 tptp 53.04 37.14 23.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.261 -0.899 . . . . 0.0 110.63 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 82.48 35.06 21.17 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.9 t -146.91 113.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.985 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -64.12 127.71 32.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.567 -0.708 . . . . 0.0 110.116 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.542 HD12 ' OD2' ' A' ' 140' ' ' ASP . 2.8 pt -111.35 -26.05 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.56 -0.713 . . . . 0.0 110.655 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.542 ' OD2' HD12 ' A' ' 139' ' ' ILE . 3.2 p30 -174.43 151.19 1.53 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.563 ' HD3' ' CD2' ' A' ' 131' ' ' HIS . 15.7 pttm -147.72 149.69 32.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -143.32 155.03 44.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.343 -0.848 . . . . 0.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -100.74 113.8 27.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.18 100.33 12.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.451 -0.781 . . . . 0.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.9 ptp -61.63 116.19 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.757 . . . . 0.0 109.693 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.777 HG13 ' CG ' ' A' ' 158' ' ' PHE . 47.4 t -80.18 -51.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 0.0 110.286 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.89 178.33 18.68 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 77.6 p -93.37 152.35 19.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.525 -0.985 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -147.65 132.42 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 110.3 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.45 156.39 26.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.52 -171.5 1.13 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.411 1.216 . . . . 0.0 110.537 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 51.42 62.38 2.74 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.62 -0.675 . . . . 0.0 111.156 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -153.25 -94.5 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 110.273 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.34 -154.79 0.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.885 -1.135 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 73' ' ' THR . 32.7 tt0 -94.49 93.41 7.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 66.1 m-85 -59.92 177.54 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.731 -0.606 . . . . 0.0 110.298 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 12.3 mt-10 -146.75 110.15 4.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 110.314 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.777 ' CG ' HG13 ' A' ' 146' ' ' VAL . 42.3 t80 -76.85 163.27 26.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.731 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.58 116.99 15.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.517 -0.739 . . . . 0.0 110.687 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.2 p -100.51 145.99 31.26 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.12 171.6 8.71 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.755 1.397 . . . . 0.0 111.361 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.41 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 8.2 ptt? -59.73 118.37 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.821 -0.549 . . . . 0.0 111.073 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 1.0 OUTLIER -105.88 124.48 49.64 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.53 136.39 35.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.509 -0.744 . . . . 0.0 110.601 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -90.06 171.15 9.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.737 -0.602 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.8 Cg_endo -72.92 129.31 14.14 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.369 1.194 . . . . 0.0 110.171 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -112.71 -178.09 3.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.601 -0.687 . . . . 0.0 110.75 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.68 138.01 8.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.2 ttm -58.98 -30.7 68.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.397 -1.061 . . . . 0.0 110.066 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.4 mm? -69.37 -35.21 75.6 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 167' ' ' LYS . . . -88.04 -26.92 22.32 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.097 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -50.34 155.21 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.14 -156.5 22.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 p -104.51 132.45 50.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -1.001 . . . . 0.0 110.732 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -113.77 103.03 10.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.645 -0.659 . . . . 0.0 110.732 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -66.95 142.11 57.38 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 14.5 mt -132.94 154.99 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 103.19 8.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 0.0 109.845 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.4 m -97.18 118.13 32.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.49 -0.756 . . . . 0.0 110.437 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.12 109.81 19.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -86.54 154.45 21.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.696 -0.627 . . . . 0.0 110.623 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.4 t -167.76 -156.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.982 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.6 p-10 -164.7 -147.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.732 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -96.0 29.88 2.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 0.0 109.729 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 186' ' ' ARG . 2.6 t70 -138.93 59.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 185' ' ' ASP . 0.0 OUTLIER 4.23 67.47 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.0 t -142.94 168.99 18.4 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.892 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -105.56 101.06 10.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.502 -0.749 . . . . 0.0 110.215 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 7.9 m170 -60.35 -56.64 19.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.763 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 72' ' ' VAL . 17.7 tp -171.43 114.52 0.38 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.704 -0.622 . . . . 0.0 109.837 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -116.59 136.18 53.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.7 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 97' ' ' PHE . 27.1 p90 -134.28 -159.03 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.638 . . . . 0.0 110.083 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -158.88 129.46 6.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 110.641 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 19.1 p-90 -143.55 147.95 35.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -99.09 146.07 26.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.566 -0.709 . . . . 0.0 110.939 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.749 HD11 HD12 ' A' ' 104' ' ' LEU . 43.0 tp -109.08 107.37 17.67 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -82.93 106.95 15.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 110.769 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.05 143.5 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 109.393 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.467 ' HD2' HG13 ' A' ' 103' ' ' VAL . 6.4 mttt -137.3 -160.25 1.04 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 110.027 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -19.48 8.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 111.055 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -152.54 60.87 0.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 110.952 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -62.43 -15.3 48.61 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.269 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.76 37.7 3.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.273 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.165 0.507 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.8 t 53.51 90.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.398 -0.814 . . . . 0.0 110.662 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.6 173.54 6.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.587 -0.696 . . . . 0.0 110.144 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.66 47.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.567 -0.708 . . . . 0.0 110.196 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 37.57 53.73 3.27 Favored Pre-proline 0 N--CA 1.51 2.558 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.33 -165.37 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.449 1.236 . . . . 0.0 110.43 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.9 176.91 0.36 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.586 -0.696 . . . . 0.0 110.147 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 68' ' ' PRO . 62.3 t -96.45 143.34 25.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.416 -0.802 . . . . 0.0 110.033 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 67' ' ' VAL . 49.2 Cg_endo -73.98 159.5 44.6 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.353 1.186 . . . . 0.0 110.431 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -168.04 -60.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.715 . . . . 0.0 110.278 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 123' ' ' VAL . 61.1 t -121.97 128.46 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 70' ' ' VAL . 69.7 t -148.96 139.62 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 181' ' ' PHE . 9.8 t -64.08 103.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 155' ' ' GLU . 65.9 p -69.95 -50.06 45.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.504 -0.748 . . . . 0.0 110.568 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.67 174.64 14.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 110.814 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -140.65 123.77 16.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.722 -0.611 . . . . 0.0 109.643 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 85' ' ' PRO . 89.8 m -109.71 162.89 14.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.517 -0.739 . . . . 0.0 110.288 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -145.85 118.31 8.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 110.534 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.39 153.06 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 t -147.16 25.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 81' ' ' THR . 1.4 p 67.03 -61.19 0.34 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.533 -0.729 . . . . 0.0 110.977 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.4 ' N ' ' OG ' ' A' ' 80' ' ' SER . 20.1 p -98.97 30.97 3.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.159 -0.963 . . . . 0.0 109.964 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.19 165.98 21.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.691 -0.63 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.7 Cg_endo -71.74 -26.4 19.36 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.439 1.231 . . . . 0.0 110.221 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.11 165.86 25.22 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.1 Cg_endo -72.01 97.42 0.83 Allowed 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.466 1.245 . . . . 0.0 110.29 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 102' ' ' PHE . 20.3 mt -64.63 114.57 4.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.688 -0.632 . . . . 0.0 109.632 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -100.95 122.46 43.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.633 -0.667 . . . . 0.0 110.602 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.687 HD22 ' CE1' ' A' ' 97' ' ' PHE . 9.6 mt -97.6 166.17 11.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.702 -0.624 . . . . 0.0 109.88 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.96 126.58 54.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.527 -0.733 . . . . 0.0 110.478 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.659 HD13 HG12 ' A' ' 72' ' ' VAL . 1.7 mt -128.13 49.31 2.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.581 -0.699 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 p -133.67 51.69 2.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.32 -65.16 0.26 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.1 71.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.96 . . . . 0.0 110.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 72.9 mt -90.08 -26.85 20.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.565 -0.709 . . . . 0.0 110.347 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.19 -22.05 15.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.25 -0.906 . . . . 0.0 111.074 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 p -58.23 -20.62 43.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 0.0 110.983 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' A' ' 88' ' ' LEU . 18.1 m-85 -58.37 -65.28 0.68 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.315 -0.866 . . . . 0.0 110.608 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -56.23 -20.73 19.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.525 -0.734 . . . . 0.0 111.207 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -86.93 11.65 12.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 111.323 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.76 143.13 2.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -133.16 137.07 46.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.66 . . . . 0.0 109.721 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.5 m-85 -79.22 118.6 21.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -0.79 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.97 155.53 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.25 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 196' ' ' LEU . 2.1 mt -153.07 -171.38 3.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.756 . . . . 0.0 110.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.456 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.1 tttm -130.65 161.41 31.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.671 0.748 . . . . 0.0 109.857 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.81 106.37 0.06 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 37.28 69.42 0.3 Allowed Glycine 0 N--CA 1.503 3.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.698 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 104' ' ' LEU . 35.8 m -86.65 149.85 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.266 -1.137 . . . . 0.0 109.692 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -79.94 90.58 5.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.653 ' HE1' HD11 ' A' ' 112' ' ' ILE . 37.4 p90 -109.34 141.58 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.562 -0.711 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.49 163.49 13.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.638 -0.664 . . . . 0.0 109.344 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.653 HD11 ' HE1' ' A' ' 110' ' ' TYR . 45.0 mm -117.75 135.1 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.371 -0.831 . . . . 0.0 110.071 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -119.64 115.11 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.28 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 181' ' ' PHE . 43.3 mm -100.72 150.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 111.156 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.5 m -131.21 122.09 25.95 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 31.1 p90 -137.83 135.15 35.95 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.785 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.405 ' H ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -84.09 140.07 32.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 111.046 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.47 95.93 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.724 -0.61 . . . . 0.0 109.367 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -129.2 48.69 2.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 111.427 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.93 -68.7 0.18 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.25 -0.906 . . . . 0.0 110.849 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -136.82 174.7 10.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.82 . . . . 0.0 110.519 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.41 121.62 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.738 -0.601 . . . . 0.0 110.04 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 70' ' ' VAL . 63.0 t -103.8 77.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.692 -0.63 . . . . 0.0 109.531 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.4 p -81.47 84.95 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.59 -0.694 . . . . 0.0 110.666 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.68 44.55 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.0 mmm -73.76 148.56 42.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.446 -1.032 . . . . 0.0 109.627 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.24 136.16 36.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.447 -0.783 . . . . 0.0 110.941 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.417 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 48.2 t80 -122.2 106.18 10.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.772 -0.58 . . . . 0.0 109.484 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 130' ' ' GLN . 80.5 mt -102.08 166.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 129' ' ' ILE . 2.8 tt0 -155.11 138.69 16.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.643 -0.661 . . . . 0.0 110.376 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 141' ' ' LYS . 3.9 m80 -109.34 140.82 42.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.742 . . . . 0.0 109.645 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 m -103.43 78.83 1.64 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.454 -0.779 . . . . 0.0 110.062 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 131' ' ' HIS . 21.1 m-85 -90.57 120.13 31.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.704 ' HG2' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -140.43 142.42 35.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.518 -0.739 . . . . 0.0 110.491 179.411 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.0 OUTLIER 53.67 33.79 17.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.97 27.07 66.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 135' ' ' LYS . 57.4 t -128.03 112.55 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.435 -1.038 . . . . 0.0 109.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 113.65 5.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.575 -0.703 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.704 HD12 ' HG2' ' A' ' 134' ' ' ARG . 4.6 mt -90.21 -66.12 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.629 -0.669 . . . . 0.0 109.438 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.4 p30 -168.54 171.94 8.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.553 -0.717 . . . . 0.0 110.534 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -126.86 168.4 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.596 -0.69 . . . . 0.0 109.557 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.4 m -131.4 117.38 18.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.498 -0.752 . . . . 0.0 110.522 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.24 116.25 28.62 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 0.0 109.821 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -114.27 142.1 46.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 ttp -98.05 123.8 42.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.75 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 181' ' ' PHE . 45.7 t -80.0 -53.71 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.518 -0.739 . . . . 0.0 110.188 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.61 -173.36 21.22 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.9 p -93.35 145.9 24.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.946 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.657 ' CE2' HG12 ' A' ' 146' ' ' VAL . 84.2 m-85 -147.48 125.91 12.38 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.0 110.185 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.61 163.99 25.18 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 83.83 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.415 1.218 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.02 -66.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.618 -0.676 . . . . 0.0 110.17 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.87 132.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.489 -0.757 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 53.05 -157.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.403 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -101.22 171.06 7.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.58 -0.7 . . . . 0.0 111.031 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.3 m-85 -109.71 176.92 4.89 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -131.71 108.95 9.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.813 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 160' ' ' THR . 11.4 t80 -82.77 168.05 17.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 109.591 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.86 90.12 1.44 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.466 -0.771 . . . . 0.0 110.693 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 158' ' ' PHE . 37.6 p -76.76 158.11 81.09 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.59 158.42 50.05 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.699 1.368 . . . . 0.0 111.109 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -56.61 137.7 53.44 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.299 0.571 . . . . 0.0 111.156 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 3.1 tp10 -120.51 119.6 33.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.817 -0.552 . . . . 0.0 109.557 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.69 133.48 49.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -89.74 179.62 1.49 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.3 Cg_endo -72.21 123.75 9.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.192 1.101 . . . . 0.0 110.35 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -115.11 -175.2 2.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.557 -0.714 . . . . 0.0 110.462 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.31 18.83 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -59.5 -27.44 66.15 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -98.51 29.51 3.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 110.049 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.33 18.94 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.531 -0.731 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -100.13 132.89 45.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.392 -0.817 . . . . 0.0 110.0 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.7 177.88 23.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -84.95 126.23 33.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.724 -0.868 . . . . 0.0 110.747 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -107.33 115.87 30.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 0.0 109.883 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -75.08 122.86 24.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.593 -0.692 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.508 HD12 ' CH2' ' A' ' 194' ' ' TRP . 20.4 mt -116.31 152.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.762 . . . . 0.0 110.85 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.44 117.92 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.641 -0.662 . . . . 0.0 110.356 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 192' ' ' TRP . 17.5 t -114.23 163.15 15.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.343 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.15 108.13 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.776 -0.577 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.724 ' HD2' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -80.77 116.37 20.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.998 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.685 HG22 ' CB ' ' A' ' 188' ' ' ASP . 82.2 p -125.03 173.53 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.679 . . . . 0.0 109.861 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 189' ' ' HIS . 25.3 p-10 -145.33 179.4 7.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.678 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -96.46 55.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.487 -0.758 . . . . 0.0 110.211 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -135.68 -64.37 0.63 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.553 -0.717 . . . . 0.0 110.511 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.87 -76.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.652 -0.655 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t -156.1 -160.06 0.96 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.502 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.685 ' CB ' HG22 ' A' ' 182' ' ' THR . 5.8 p-10 -72.32 117.32 13.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.599 -0.688 . . . . 0.0 109.796 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 183' ' ' ASP . 88.9 m-70 -59.6 -44.62 93.34 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 110.531 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 15.8 tp -162.61 156.24 20.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.461 -0.774 . . . . 0.0 110.399 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.6 p -145.16 150.72 37.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.641 -0.662 . . . . 0.0 109.946 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.472 ' CE2' HD21 ' A' ' 90' ' ' LEU . 14.8 p90 -147.19 -153.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.574 -0.704 . . . . 0.0 110.391 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -169.09 140.26 2.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.528 -0.733 . . . . 0.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.653 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 49.7 p-90 -145.4 147.23 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.541 -0.724 . . . . 0.0 110.384 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -87.65 165.11 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.711 -0.618 . . . . 0.0 110.949 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 104' ' ' LEU . 24.8 tp -143.51 105.39 4.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.81 -0.557 . . . . 0.0 109.582 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.3 m -79.33 127.08 31.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.272 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -99.78 159.48 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -150.59 -153.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.518 -0.739 . . . . 0.0 110.201 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -16.36 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -0.806 . . . . 0.0 111.445 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -160.07 61.62 0.35 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.123 -0.985 . . . . 0.0 111.291 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -66.27 -11.63 51.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.385 -0.822 . . . . 0.0 111.712 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 29.57 6.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.443 179.456 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.039 0.447 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.32 166.36 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.621 -0.674 . . . . 0.0 110.285 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -164.04 -68.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.98 -175.15 4.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.602 -0.686 . . . . 0.0 110.237 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.13 152.13 37.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.67 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.48 -165.73 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.426 1.224 . . . . 0.0 110.485 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.14 -168.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 67' ' ' VAL . 60.1 t 53.73 69.61 2.14 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.463 -0.773 . . . . 0.0 110.474 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.69 -165.5 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.052 0 O-C-N 123.429 1.226 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -73.88 -82.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.596 -0.69 . . . . 0.0 109.967 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 123' ' ' VAL . 68.4 t -135.72 133.71 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.3 t -137.31 155.42 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 90' ' ' LEU . 46.2 t -66.55 100.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.217 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 116' ' ' PHE . 55.2 p -70.81 -55.8 7.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.747 -0.596 . . . . 0.0 110.396 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -153.69 157.01 38.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.511 -0.743 . . . . 0.0 110.264 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 76' ' ' THR . 9.6 tt -125.31 161.28 27.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.606 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.725 ' N ' HD23 ' A' ' 75' ' ' LEU . 13.3 m -146.85 164.93 31.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.555 -0.715 . . . . 0.0 110.579 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 86' ' ' LEU . 2.6 mt -140.32 100.75 3.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.95 144.24 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.72 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 m -150.03 -167.38 2.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -76.21 0.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -0.775 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -94.99 36.82 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.397 -0.814 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.692 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.37 172.83 6.39 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.2 Cg_endo -71.29 -27.46 19.6 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.218 1.115 . . . . 0.0 109.87 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.58 -174.46 38.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.89 92.94 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.575 1.303 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' A' ' 102' ' ' PHE . 22.3 mt -64.32 104.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.56 159.68 15.56 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.118 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.927 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -131.11 136.47 48.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.967 -0.458 . . . . 0.0 109.967 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.416 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 12.0 t70 -82.97 131.73 35.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -129.05 53.63 1.86 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 109.837 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 p -122.87 -58.37 1.66 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.517 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.67 -63.37 0.1 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.83 78.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.986 . . . . 0.0 110.292 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -95.37 -28.17 15.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 110.285 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.7 -31.14 69.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.571 -0.705 . . . . 0.0 110.932 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -57.9 -19.95 33.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.391 -0.818 . . . . 0.0 110.956 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.927 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -62.71 -65.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.393 -0.817 . . . . 0.0 110.467 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -57.9 -20.15 34.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.0 110.942 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -22.41 26.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.409 -0.807 . . . . 0.0 110.748 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -129.91 132.44 46.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.277 -0.889 . . . . 0.0 110.569 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -115.24 148.05 39.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 109.841 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 m-85 -74.38 154.76 38.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.79 113.02 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 0.0 110.358 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.932 HD22 HG21 ' A' ' 108' ' ' VAL . 10.1 mt -113.7 -172.83 2.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.602 -0.686 . . . . 0.0 109.553 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.589 ' HB3' HG11 ' A' ' 108' ' ' VAL . 37.7 tttm -121.85 167.27 13.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.791 . . . . 0.0 109.756 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -42.01 108.93 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.24 69.24 0.43 Allowed Glycine 0 N--CA 1.502 3.068 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.259 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.932 HG21 HD22 ' A' ' 104' ' ' LEU . 34.4 m -93.77 142.83 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -1.142 . . . . 0.0 110.086 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.73 107.19 10.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.401 -0.812 . . . . 0.0 109.192 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.614 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 30.0 p90 -123.61 146.77 47.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.683 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -106.62 162.2 13.96 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.449 HG22 ' N ' ' A' ' 113' ' ' LYS . 70.2 mt -122.84 163.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 112' ' ' ILE . 14.0 ttmm -150.08 108.99 3.87 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' HD12 ' A' ' 75' ' ' LEU . 49.9 mm -98.02 146.73 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.54 -0.725 . . . . 0.0 110.807 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.36 145.51 51.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.639 -0.663 . . . . 0.0 109.639 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.533 ' HA ' HG23 ' A' ' 73' ' ' THR . 21.5 p90 -154.88 150.33 27.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 111.129 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.85 151.85 22.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.792 -0.568 . . . . 0.0 111.113 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 151' ' ' PRO . 57.7 t -133.91 99.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.674 -0.641 . . . . 0.0 109.554 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.71 48.75 2.34 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -148.29 -77.78 0.16 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.185 -0.947 . . . . 0.0 110.841 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.83 -177.85 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.353 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.3 mt -74.15 106.05 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 70' ' ' VAL . 57.6 t -80.22 76.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.662 -0.648 . . . . 0.0 109.908 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.2 98.59 7.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.449 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 128.48 40.83 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.548 ' CE ' HG11 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -78.27 124.44 28.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -1.054 . . . . 0.0 109.503 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -123.33 142.65 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.997 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -117.48 86.99 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 0.0 109.413 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -79.06 140.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 110.044 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.7 137.6 29.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.5 m-70 -107.05 154.96 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.74 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.537 ' O ' HD12 ' A' ' 139' ' ' ILE . 57.1 m -116.4 64.47 0.71 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -75.25 139.48 42.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.382 -0.824 . . . . 0.0 109.828 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NH1' HG11 ' A' ' 137' ' ' VAL . 3.4 ptt180 -120.68 -152.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.485 -0.76 . . . . 0.0 110.277 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -56.66 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.411 -0.806 . . . . 0.0 111.783 -178.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.58 13.34 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.514 -0.741 . . . . 0.0 111.584 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 135' ' ' LYS . 63.0 t -134.29 116.1 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 119.62 19.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.702 -0.624 . . . . 0.0 110.152 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.556 HG22 ' OD2' ' A' ' 140' ' ' ASP . 58.6 mt -89.62 -72.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.645 -0.659 . . . . 0.0 109.85 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.3 p30 -172.32 166.49 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.472 -0.767 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 157.74 42.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.271 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.2 m -125.24 143.69 50.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.562 -0.711 . . . . 0.0 110.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.57 75.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.631 -0.668 . . . . 0.0 109.892 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -64.72 146.43 54.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.455 -0.778 . . . . 0.0 110.685 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -106.74 123.67 48.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.641 -0.662 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.61 HG12 ' CE2' ' A' ' 149' ' ' TYR . 61.6 t -79.8 -55.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.544 -0.722 . . . . 0.0 110.015 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.92 176.6 14.48 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.9 p -86.72 151.06 23.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.626 -0.926 . . . . 0.0 110.091 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' HG12 ' A' ' 146' ' ' VAL . 88.4 m-85 -148.35 130.57 15.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.551 -0.718 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.54 157.16 32.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.675 ' HA ' HG12 ' A' ' 118' ' ' VAL . 48.5 Cg_endo -74.01 94.76 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.389 1.205 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -91.81 -78.23 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.559 -0.713 . . . . 0.0 109.91 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -172.6 -38.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -107.94 -161.8 0.79 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.0 110.672 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 168.81 9.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 30.0 m-85 -108.57 -178.47 3.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.773 -0.579 . . . . 0.0 109.649 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -138.86 99.51 3.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.931 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 34.5 t80 -84.16 171.46 12.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.259 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.66 131.74 4.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 111.172 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.5 p -97.31 151.73 37.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.84 -170.16 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.714 1.376 . . . . 0.0 111.203 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.2 ptm -54.43 145.25 18.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 111.266 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 4.6 tt0 -144.5 84.21 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.68 -0.638 . . . . 0.0 109.636 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.67 135.46 55.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 110.692 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.83 179.99 1.45 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.611 -0.681 . . . . 0.0 109.816 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.63 135.91 22.63 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.273 1.143 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 7.6 ptpp? -110.99 -179.33 3.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.713 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.08 156.35 18.94 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.1 ttp -61.44 -26.97 68.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.155 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.627 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -82.61 -24.76 33.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.568 -0.708 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -59.07 -25.42 63.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.431 -0.793 . . . . 0.0 110.52 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -60.5 123.85 18.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.426 -0.796 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 159.53 -179.84 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -95.1 135.63 36.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.66 -0.906 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.05 108.56 14.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 109.921 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -71.28 122.37 20.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.636 -0.665 . . . . 0.0 110.113 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 131' ' ' HIS . 36.3 mt -113.32 127.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -99.35 112.11 24.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.695 . . . . 0.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 4.0 m -105.65 130.06 53.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.634 -0.667 . . . . 0.0 110.217 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 99.68 6.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.685 . . . . 0.0 110.183 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.46 ' C ' HG23 ' A' ' 182' ' ' THR . 2.0 t80 -75.57 121.38 22.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 0.0 109.835 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.46 HG23 ' C ' ' A' ' 181' ' ' PHE . 32.4 p -152.63 162.27 41.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -98.55 -162.32 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.597 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -58.42 8.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.65 24.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.857 -0.527 . . . . 0.0 110.741 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -37.66 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 109.405 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.6 t -179.18 -166.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.118 0.485 . . . . 0.0 109.969 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.41 115.24 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.626 . . . . 0.0 109.607 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.49 -59.94 3.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.5 tp -167.61 170.55 11.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.449 -0.782 . . . . 0.0 110.484 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.7 t -163.85 125.29 2.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.725 -0.609 . . . . 0.0 109.872 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.606 ' CE2' HD21 ' A' ' 90' ' ' LEU . 20.5 p90 -140.16 -153.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.704 . . . . 0.0 110.304 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.11 134.25 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 110.649 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.36 146.95 42.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.674 -0.641 . . . . 0.0 109.893 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -95.66 141.3 29.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.628 -0.67 . . . . 0.0 111.181 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 104' ' ' LEU . 44.1 tp -108.84 108.83 19.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -88.47 122.08 31.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.771 . . . . 0.0 110.656 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.9 mm -94.32 156.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 109.486 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -138.23 -162.33 1.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.748 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 -24.43 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 110.682 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -160.01 77.36 0.65 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.387 -0.821 . . . . 0.0 110.994 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.791 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -70.51 -7.03 40.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.452 -0.78 . . . . 0.0 111.693 179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -155.28 51.45 0.59 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.107 -0.995 . . . . 0.0 110.288 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.122 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.092 0.472 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 62' ' ' SER . 50.6 t 56.83 166.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.695 -0.628 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 61' ' ' VAL . 0.4 OUTLIER -96.15 110.31 22.6 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.832 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.97 -157.13 0.75 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.715 . . . . 0.0 110.143 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 t70 61.75 120.24 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.462 -0.774 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.01 -165.29 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 122.881 0.938 . . . . 0.0 110.487 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -59.79 125.14 22.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 68' ' ' PRO . 8.1 p -125.37 143.69 45.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.524 -0.735 . . . . 0.0 110.18 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -71.09 -163.89 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.288 1.151 . . . . 0.0 110.408 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.43 ' HB3' ' CB ' ' A' ' 120' ' ' ARG . 3.9 p30 -132.97 18.69 4.12 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.426 -0.796 . . . . 0.0 111.419 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 70' ' ' VAL . 21.4 t -143.6 31.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 110.817 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.58 141.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.676 -0.64 . . . . 0.0 110.055 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 90' ' ' LEU . 58.5 t -63.73 125.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.637 -0.664 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.5 p -82.03 -58.92 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.903 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.58 155.42 26.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.454 ' HG ' HD13 ' A' ' 114' ' ' ILE . 4.5 tt -110.97 133.84 53.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.606 -0.684 . . . . 0.0 109.784 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -109.64 155.66 21.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.542 -0.724 . . . . 0.0 110.924 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -141.57 107.96 5.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.614 -0.679 . . . . 0.0 110.058 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 85' ' ' PRO . 60.3 t -121.79 160.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.972 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.8 t -147.27 -80.73 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -170.81 -45.49 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.346 -0.846 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 p -123.86 34.76 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 110.118 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -87.59 173.06 6.93 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.9 Cg_endo -72.29 -28.6 15.05 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.474 1.25 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.35 170.97 30.01 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.0 Cg_endo -72.1 102.83 1.4 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.526 1.277 . . . . 0.0 110.188 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 8.2 mt -64.73 121.23 14.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 109.68 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.84 103.41 15.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.668 -0.645 . . . . 0.0 110.247 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.9 tt -80.2 119.82 23.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 110.176 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.47 129.42 37.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.717 HD13 HG11 ' A' ' 72' ' ' VAL . 6.0 mt -133.71 53.6 2.0 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.561 -0.712 . . . . 0.0 110.039 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.3 p -140.31 -43.53 0.41 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.656 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.11 -117.85 4.25 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 114.83 3.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.627 -0.925 . . . . 0.0 110.334 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mt -92.27 -30.46 15.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -66.13 -12.69 57.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.804 . . . . 0.0 111.096 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -56.45 -20.27 19.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.111 -0.993 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 88' ' ' LEU . 3.1 m-85 -67.99 -31.68 71.56 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.312 -0.868 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -61.49 -35.29 77.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 110.723 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -87.1 -25.2 24.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.61 126.26 46.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.468 -0.77 . . . . 0.0 110.477 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -115.38 159.77 20.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.784 ' HB2' HD12 ' A' ' 196' ' ' LEU . 11.3 m-85 -83.27 114.64 21.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.93 118.28 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.693 -0.63 . . . . 0.0 110.51 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 196' ' ' LEU . 82.1 mt -129.89 159.15 37.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.575 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 108' ' ' VAL . 18.9 tttt -85.9 169.02 13.67 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -39.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 41.58 72.84 0.24 Allowed Glycine 0 N--CA 1.501 2.985 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.898 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 105' ' ' LYS . 33.1 m -86.5 125.77 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -1.037 . . . . 0.0 110.077 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.05 90.77 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.199 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.549 ' CD1' HD23 ' A' ' 77' ' ' LEU . 11.9 p90 -109.63 150.37 28.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.156 -0.965 . . . . 0.0 111.573 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -98.04 147.07 24.9 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.412 HD11 ' HE1' ' A' ' 110' ' ' TYR . 69.1 mt -111.04 132.56 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -115.38 98.63 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.782 -0.574 . . . . 0.0 109.559 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.496 HG21 ' CE1' ' A' ' 181' ' ' PHE . 42.4 mm -78.08 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.695 -0.628 . . . . 0.0 110.432 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.5 m -114.81 141.44 47.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 12.9 p90 -153.87 144.65 22.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.415 -0.803 . . . . 0.0 110.968 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -87.17 132.53 33.84 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.246 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 151' ' ' PRO . 60.8 t -122.94 95.12 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.15 40.12 3.72 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.596 -0.841 . . . . 0.0 112.692 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -161.31 -67.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.08 -1.013 . . . . 0.0 110.919 179.077 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -124.38 166.07 16.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 110.911 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 123' ' ' VAL . 81.8 mt -72.97 165.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.263 0.554 . . . . 0.0 110.031 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 126' ' ' MET . 48.6 t -128.39 54.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.699 -0.625 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.92 104.95 2.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.661 -0.649 . . . . 0.0 110.35 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.14 46.27 0.95 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.537 ' HB2' HG12 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -87.6 132.27 34.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.599 -0.942 . . . . 0.0 109.486 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.22 164.55 17.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.478 -0.764 . . . . 0.0 111.019 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -136.43 102.06 4.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.861 -0.524 . . . . 0.0 109.748 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 130' ' ' GLN . 50.8 mm -82.27 164.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 0.0 109.994 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 129' ' ' ILE . 39.5 tt0 -167.96 117.71 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.775 ' O ' HG23 ' A' ' 177' ' ' ILE . 10.7 m170 -101.7 159.31 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.718 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.471 ' CG2' HD11 ' A' ' 139' ' ' ILE . 9.2 m -117.55 69.85 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.458 -0.777 . . . . 0.0 109.959 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 19.7 m-85 -66.2 123.72 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.09 134.13 51.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 110.395 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm 52.69 28.15 5.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.21 -16.61 55.36 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.6 m -106.02 156.24 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.118 -1.225 . . . . 0.0 110.576 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -86.37 134.34 33.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.676 . . . . 0.0 109.887 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.471 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pt -118.02 -25.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 110.956 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -175.79 144.45 0.63 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.225 -0.922 . . . . 0.0 110.537 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.64 152.44 50.43 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.7 m -136.27 153.45 51.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 111.374 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.69 116.37 26.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.43 114.69 29.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.981 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.4 ttt -74.64 120.07 19.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.702 HG13 ' CG ' ' A' ' 158' ' ' PHE . 51.3 t -79.64 -68.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.403 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.57 -163.23 29.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.2 p -104.77 148.04 27.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.906 . . . . 0.0 110.256 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.485 ' CE2' HG12 ' A' ' 146' ' ' VAL . 89.8 m-85 -147.74 125.84 12.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.501 -0.75 . . . . 0.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.65 156.61 23.26 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.715 ' HA ' HG12 ' A' ' 118' ' ' VAL . 45.9 Cg_endo -71.36 94.13 0.67 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.406 1.214 . . . . 0.0 110.49 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -86.31 -67.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.681 . . . . 0.0 110.11 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.79 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.68 -152.29 0.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 110.634 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -99.97 168.05 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 34.1 m-85 -111.46 -170.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.65 -0.656 . . . . 0.0 109.909 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.54 114.12 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.693 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.702 ' CG ' HG13 ' A' ' 146' ' ' VAL . 37.7 t80 -89.64 164.73 14.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 109.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -135.75 117.41 14.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.531 -0.73 . . . . 0.0 110.656 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 158' ' ' PHE . 71.6 p -102.23 147.77 34.44 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.611 -0.68 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.21 -173.44 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.821 1.432 . . . . 0.0 111.735 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -52.67 140.67 22.82 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.472 0.653 . . . . 0.0 111.773 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 3.5 tp10 -138.42 82.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.61 137.18 58.0 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.541 0.686 . . . . 0.0 110.8 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -82.42 -178.7 1.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.09 124.94 10.44 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.187 1.098 . . . . 0.0 110.198 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -115.26 178.96 4.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.571 -0.706 . . . . 0.0 110.662 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.44 150.83 10.66 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 5.8 ttt -59.59 -28.83 67.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.418 -1.049 . . . . 0.0 110.025 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 170' ' ' LEU . 0.2 OUTLIER -99.2 23.96 8.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.784 . . . . 0.0 110.325 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.41 24.61 7.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -98.59 131.45 44.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 110.009 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.33 -174.26 27.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.5 p -87.6 122.84 31.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.943 . . . . 0.0 110.659 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 19.4 m-85 -103.67 107.33 18.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -66.0 133.33 50.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.596 -0.69 . . . . 0.0 110.093 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 131' ' ' HIS . 15.7 mt -124.87 141.58 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.493 -0.755 . . . . 0.0 110.62 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -114.12 115.06 26.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.637 -0.664 . . . . 0.0 110.211 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.5 m -113.8 157.63 22.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 110.15 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.31 101.52 4.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.62 ' CD2' HG22 ' A' ' 72' ' ' VAL . 2.2 t80 -75.56 92.46 2.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.644 . . . . 0.0 110.096 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.7 t -127.28 179.75 5.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.274 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.34 -147.17 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.54 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -71.5 -39.7 70.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.988 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.91 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.819 -0.551 . . . . 0.0 111.575 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -51.8 13.66 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.271 -0.893 . . . . 0.0 111.824 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.1 t -175.58 -175.05 0.75 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.514 -0.741 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.84 116.52 28.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.715 -0.616 . . . . 0.0 109.413 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -57.65 -49.52 76.2 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.433 -0.792 . . . . 0.0 110.703 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.8 tp -168.35 158.91 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.5 -0.75 . . . . 0.0 110.463 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 140.28 22.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.92 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.535 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.3 p90 -146.52 -155.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.581 -0.699 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -161.68 130.23 4.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.688 -0.633 . . . . 0.0 110.169 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.519 ' CZ3' HD13 ' A' ' 196' ' ' LEU . 11.0 p-90 -137.49 145.96 43.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.498 -0.751 . . . . 0.0 110.066 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -90.13 155.88 18.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.511 0.672 . . . . 0.0 111.122 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 104' ' ' LEU . 15.3 tp -121.18 95.42 4.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.777 -0.577 . . . . 0.0 109.614 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -68.91 122.6 18.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.672 . . . . 0.0 110.304 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -101.39 153.51 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 109.796 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -148.55 -157.09 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.615 -0.678 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -18.42 7.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.786 . . . . 0.0 111.355 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.8 73.73 1.08 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.0 111.079 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.782 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.59 -4.19 32.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.727 . . . . 0.0 111.569 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 37.51 4.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 110.25 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.334 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.137 0.494 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 36.0 m -112.86 -168.43 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.49 -0.756 . . . . 0.0 110.348 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -155.62 99.88 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 0.0 110.203 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 -58.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.561 -0.712 . . . . 0.0 110.22 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.98 161.98 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.938 -0.476 . . . . 0.0 110.689 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.84 -165.41 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.235 1.124 . . . . 0.0 110.385 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -60.47 -168.63 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.562 -0.711 . . . . 0.0 110.163 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 67' ' ' VAL . 9.1 p -148.35 69.5 10.54 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.21 135.89 25.74 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.327 1.172 . . . . 0.0 110.342 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' HG23 ' A' ' 70' ' ' VAL . 43.4 t-20 -77.32 -71.89 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 123' ' ' VAL . 90.6 t -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.1 t -147.54 147.41 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.765 -0.584 . . . . 0.0 109.827 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG23 ' CD2' ' A' ' 181' ' ' PHE . 43.2 t -68.13 113.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.627 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 116' ' ' PHE . 32.8 p -77.29 -33.44 55.77 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.118 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -168.63 160.27 10.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.708 . . . . 0.0 110.324 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 10.4 tt -128.29 134.75 48.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.655 -0.653 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.3 m -109.6 162.29 14.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.541 -0.724 . . . . 0.0 110.146 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.84 95.69 2.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.771 . . . . 0.0 110.195 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 85' ' ' PRO . 71.6 t -105.19 167.32 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.857 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 40.8 t -159.55 -82.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.651 -0.656 . . . . 0.0 110.134 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -71.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.865 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 p -98.59 31.5 2.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.725 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -85.13 169.95 14.78 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.706 . . . . 0.0 110.088 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.7 Cg_endo -71.6 -27.44 18.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.393 1.207 . . . . 0.0 110.24 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.56 170.57 26.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HB3' HG22 ' A' ' 78' ' ' VAL . 44.9 Cg_endo -71.84 104.37 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.497 1.262 . . . . 0.0 110.192 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 102' ' ' PHE . 9.5 mt -64.91 128.48 35.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 109.817 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -103.55 113.17 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.681 -0.637 . . . . 0.0 110.323 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 102' ' ' PHE . 1.2 tt -100.01 105.71 17.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 110.154 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -65.69 137.71 57.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.689 -0.632 . . . . 0.0 109.729 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HA ' HD21 ' A' ' 94' ' ' LEU . 95.0 mt -135.6 56.8 1.82 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.753 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.0 p -115.75 -68.53 0.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.768 -0.582 . . . . 0.0 110.493 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 -58.18 0.18 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.45 74.81 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.969 . . . . 0.0 110.323 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 90' ' ' LEU . 18.2 mt -95.46 -22.38 17.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 0.0 110.805 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.43 -1.13 28.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.345 -0.847 . . . . 0.0 111.561 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -90.06 0.37 57.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.175 -0.953 . . . . 0.0 111.288 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 51.8 m-85 -94.09 -32.22 13.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.114 -0.991 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -59.1 -19.72 47.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -88.07 -24.75 23.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 110.535 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.68 -179.88 3.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.429 -0.794 . . . . 0.0 110.54 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -167.31 142.88 4.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.536 -0.727 . . . . 0.0 110.146 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.641 ' HE2' HD12 ' A' ' 88' ' ' LEU . 29.5 m-85 -79.09 121.72 25.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.859 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.84 123.47 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 110.341 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.528 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 55.0 mt -124.19 178.74 5.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 19.7 tttm -104.2 150.97 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.815 0.817 . . . . 0.0 109.514 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.6 pt-20 -50.63 124.5 11.0 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.56 48.99 72.77 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.626 -0.671 . . . . 0.0 113.343 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 105' ' ' LYS . 28.0 m -97.01 133.21 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.975 1.388 . . . . 0.0 109.678 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.44 94.77 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.75 ' HD2' HG23 ' A' ' 108' ' ' VAL . 40.8 p90 -118.32 142.03 47.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 0.0 111.361 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.19 163.37 12.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.612 -0.68 . . . . 0.0 109.176 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 82.5 mt -126.42 151.59 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.015 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.512 ' HE2' HD23 ' A' ' 159' ' ' LEU . 39.9 ttmt -128.91 117.9 21.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.14 144.98 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.758 . . . . 0.0 110.662 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -123.72 147.54 47.38 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.779 ' HA ' HG23 ' A' ' 73' ' ' THR . 34.1 p90 -168.37 161.29 11.89 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.572 ' HG3' HG21 ' A' ' 73' ' ' THR . 7.7 mtm180 -113.0 144.59 42.31 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.843 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 70' ' ' VAL . 57.8 t -125.79 98.89 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -128.7 49.01 2.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 0.0 111.046 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -75.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 123' ' ' VAL . 3.7 tt0 -138.28 160.22 40.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.5 mt -63.57 104.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.74 -0.6 . . . . 0.0 109.921 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 70' ' ' VAL . 57.9 t -91.33 76.35 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.612 -0.68 . . . . 0.0 109.636 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.0 p -77.68 85.48 4.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.37 48.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.458 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 0.0 OUTLIER -85.12 131.05 34.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.558 -0.966 . . . . 0.0 109.481 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.5 162.34 25.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.63 -0.669 . . . . 0.0 111.051 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -136.38 108.28 7.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 77.2 mt -102.76 161.94 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -159.3 134.88 8.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.594 -0.691 . . . . 0.0 110.28 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.465 ' CD2' ' HD2' ' A' ' 141' ' ' LYS . 5.9 m80 -111.23 130.68 55.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 84.3 m -84.33 72.59 10.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.849 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.41 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 4.4 m-85 -64.11 137.35 57.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 110.495 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 14.8 ttm180 -120.91 107.76 13.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.634 . . . . 0.0 109.925 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 53.27 37.09 24.39 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.399 -0.813 . . . . 0.0 110.584 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.34 33.47 19.87 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 136' ' ' GLY . 59.7 t -147.24 111.41 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 126.47 28.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.73 -22.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.558 -0.714 . . . . 0.0 110.798 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -167.91 132.48 1.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.595 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.465 ' HD2' ' CD2' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -139.98 144.51 37.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 143' ' ' ASP . 28.2 m -132.42 164.72 25.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 110.744 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 142' ' ' THR . 1.5 m-20 -120.53 115.39 23.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.748 -0.595 . . . . 0.0 109.877 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.17 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 ttm -98.27 117.99 33.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.542 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.502 HG12 ' CE2' ' A' ' 149' ' ' TYR . 47.4 t -79.7 -63.21 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.786 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 143.77 178.43 19.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.2 p -87.77 149.13 24.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.909 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 146' ' ' VAL . 76.3 m-85 -147.82 132.57 17.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.333 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.95 159.5 24.57 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.13 94.22 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.399 1.21 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -116.51 23.35 12.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 110.6 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 52.49 23.64 2.64 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.339 -0.851 . . . . 0.0 111.213 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -126.97 169.15 13.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.573 -0.704 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -100.19 163.33 12.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.604 . . . . 0.0 110.398 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.474 ' CD2' ' CD1' ' A' ' 149' ' ' TYR . 64.2 m-85 -122.88 170.57 9.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.644 -0.66 . . . . 0.0 109.954 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -136.23 103.36 5.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.486 ' HB2' HG13 ' A' ' 146' ' ' VAL . 24.4 t80 -88.18 148.34 24.45 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 159' ' ' LEU . 3.4 tm? -133.53 111.3 10.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 110.641 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 158' ' ' PHE . 77.6 p -85.83 151.67 55.43 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.56 -0.712 . . . . 0.0 109.62 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.78 165.62 22.82 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.441 1.232 . . . . 0.0 111.093 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 mtm -54.64 168.63 0.26 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.714 -0.616 . . . . 0.0 110.755 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -155.55 140.2 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.741 -0.599 . . . . 0.0 109.775 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 129.9 42.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.591 -0.693 . . . . 0.0 110.974 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -77.93 178.56 2.09 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.612 -0.68 . . . . 0.0 110.25 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.3 Cg_endo -73.39 -173.12 1.2 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.448 1.236 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 13.8 mmtt -78.39 -176.53 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.51 -0.744 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.402 ' N ' ' CB ' ' A' ' 106' ' ' GLU . . . -95.18 -60.88 1.04 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 171' ' ' ALA . 12.2 mmt -60.9 141.7 56.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.962 . . . . 0.0 109.44 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt 66.15 -64.27 0.22 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.673 -0.642 . . . . 0.0 110.393 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -59.5 -17.83 35.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 111.177 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.15 27.78 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.082 -1.011 . . . . 0.0 110.285 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.63 177.88 15.13 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.7 p -88.19 134.21 33.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.544 -0.974 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 15.9 m-85 -116.94 116.81 28.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.544 -0.722 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -61.66 145.82 51.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.827 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -125.18 108.23 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.502 -0.749 . . . . 0.0 110.361 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 1.6 ttpt -88.2 95.61 10.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.493 -0.754 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 125.29 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.48 -0.762 . . . . 0.0 110.114 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -116.01 107.8 15.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.45 -0.782 . . . . 0.0 110.35 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.65 ' CD2' HG23 ' A' ' 72' ' ' VAL . 2.2 t80 -83.82 136.68 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.714 -0.616 . . . . 0.0 109.741 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.0 t -172.77 -173.58 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.557 -0.714 . . . . 0.0 110.42 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 6.6 p-10 -108.49 -155.5 0.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -171.56 27.65 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.937 -0.477 . . . . 0.0 110.642 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -79.18 -37.28 38.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.768 . . . . 0.0 110.283 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.19 -161.53 0.06 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.705 -0.622 . . . . 0.0 109.971 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -115.25 118.87 34.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.579 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.23 -65.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 110.699 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.0 tp -168.42 151.49 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.797 . . . . 0.0 110.5 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.6 m -149.0 146.5 27.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.015 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -140.05 -162.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -154.44 121.89 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.401 -0.812 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.827 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 30.5 p-90 -132.23 148.35 52.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.692 -0.63 . . . . 0.0 109.553 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -89.49 148.56 23.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.483 -0.76 . . . . 0.0 111.489 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.52 102.1 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -75.2 132.07 40.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 0.0 110.724 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.95 147.75 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.76 -159.08 0.96 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.694 -0.629 . . . . 0.0 110.129 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.58 -8.43 4.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.96 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -155.19 63.13 0.63 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.947 -1.095 . . . . 0.0 111.516 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.725 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -72.17 -6.77 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.263 -0.898 . . . . 0.0 111.241 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -162.21 47.92 0.17 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.134 -179.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.673 ' ND2' HG23 ' A' ' 70' ' ' VAL . 17.0 p-10 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 123' ' ' VAL . 86.0 t -125.51 119.15 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.9 t -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG12 HD12 ' A' ' 90' ' ' LEU . 53.4 t -61.35 110.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.726 . . . . 0.0 109.142 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.858 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.8 p -76.2 -41.27 50.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -167.38 163.76 15.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.287 -0.883 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -121.44 125.93 48.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 85' ' ' PRO . 12.8 m -109.97 154.78 22.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 111.032 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 86' ' ' LEU . 6.2 mt -138.71 92.02 2.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.35 130.8 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.713 -0.617 . . . . 0.0 110.654 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.7 m -128.05 -3.13 5.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.713 -0.617 . . . . 0.0 111.145 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.83 18.7 3.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.951 -1.093 . . . . 0.0 111.29 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.5 p -142.26 -45.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.757 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -57.77 -179.18 0.11 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.749 -0.594 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -73.85 -17.31 22.81 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.531 1.279 . . . . 0.0 110.238 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.7 171.61 35.45 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.924 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.8 Cg_endo -72.56 122.26 8.11 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.778 1.409 . . . . 0.0 110.728 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 102' ' ' PHE . 6.3 mt -68.66 117.66 10.67 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.149 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.99 112.8 25.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.633 -0.667 . . . . 0.0 110.64 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' TRP . 1.3 tt -101.07 101.66 12.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.554 -0.716 . . . . 0.0 109.988 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.6 t0 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.553 -0.717 . . . . 0.0 110.33 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.48 HD21 HD22 ' A' ' 88' ' ' LEU . 96.0 mt -135.87 54.77 1.89 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 110.062 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 p -135.87 -42.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.783 -0.573 . . . . 0.0 110.422 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.33 -103.61 2.45 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.22 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.632 -0.923 . . . . 0.0 110.687 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -95.55 -26.74 15.67 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.638 -0.663 . . . . 0.0 110.395 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.94 0.2 36.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.495 -0.753 . . . . 0.0 111.523 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 t -85.9 0.25 53.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.099 -1.0 . . . . 0.0 111.208 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 34.3 m-85 -93.14 -29.42 15.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.165 -0.959 . . . . 0.0 110.045 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -12.57 60.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -86.47 -26.62 24.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.253 -0.904 . . . . 0.0 110.33 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -132.62 -172.11 2.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.5 -0.75 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.4 p -152.59 169.64 22.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.549 -0.719 . . . . 0.0 110.102 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 86' ' ' LEU . 17.6 m-85 -96.7 119.85 35.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.58 -0.7 . . . . 0.0 109.997 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.51 116.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 109.62 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.857 ' CD2' HD11 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -113.61 166.38 11.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.049 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.507 ' CB ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -96.14 148.02 23.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.593 -0.692 . . . . 0.0 111.542 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' CG2' ' A' ' 198' ' ' ILE . 6.2 mt-10 -23.46 -46.81 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -174.04 36.4 0.12 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.818 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' CB ' ' A' ' 105' ' ' LYS . 27.0 m -60.41 148.31 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.235 -1.156 . . . . 0.0 110.309 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.09 93.96 5.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.629 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 32.5 p90 -109.7 151.35 27.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.469 -0.77 . . . . 0.0 111.562 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.3 156.44 18.14 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.524 HG12 HD23 ' A' ' 77' ' ' LEU . 67.4 mt -122.98 135.93 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.314 -0.866 . . . . 0.0 110.42 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 159' ' ' LEU . 41.0 mtmt -122.51 120.45 33.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.587 . . . . 0.0 110.08 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.743 HG21 ' CE2' ' A' ' 181' ' ' PHE . 50.1 mm -97.65 134.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.701 . . . . 0.0 109.981 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 p -108.67 150.12 27.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.134 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.858 ' HA ' HG23 ' A' ' 73' ' ' THR . 3.1 p90 -162.51 139.13 7.74 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 135.06 35.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.625 . . . . 0.0 111.126 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.801 HG22 HG22 ' A' ' 70' ' ' VAL . 63.5 t -125.26 102.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -128.63 43.89 3.06 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.781 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -155.96 -65.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.0 166.06 23.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.375 -0.828 . . . . 0.0 111.413 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 149' ' ' TYR . 50.7 mt -80.25 145.97 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 70' ' ' VAL . 66.3 t -114.8 74.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.673 -0.642 . . . . 0.0 109.428 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 85.4 p -64.82 85.04 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 110.474 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.18 51.76 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.505 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -75.26 131.92 40.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -1.007 . . . . 0.0 109.312 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -130.7 159.57 36.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 111.085 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -138.08 126.52 23.32 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 130' ' ' GLN . 76.5 mt -116.06 166.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.473 ' N ' HG22 ' A' ' 129' ' ' ILE . 35.5 tt0 -168.58 111.45 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.4 m-70 -98.39 109.26 22.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.56 -0.713 . . . . 0.0 109.979 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 139' ' ' ILE . 23.5 m -68.62 79.07 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.8 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.45 ' CZ ' ' CG ' ' A' ' 138' ' ' LYS . 2.8 m-85 -69.28 124.62 24.33 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.611 -0.681 . . . . 0.0 110.021 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.625 ' O ' HG12 ' A' ' 137' ' ' VAL . 5.5 ttt180 -127.03 130.46 50.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.552 -0.717 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 52.74 28.56 6.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.464 -0.772 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.48 -18.78 47.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 134' ' ' ARG . 8.3 p -104.18 152.89 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -1.198 . . . . 0.0 110.328 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -85.24 134.52 34.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 110.268 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 132' ' ' THR . 1.2 pt -116.6 -19.61 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.2 115.76 0.96 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 110.69 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 3.3 pttm -143.49 121.15 11.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.601 -0.687 . . . . 0.0 109.891 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 143' ' ' ASP . 14.5 m -143.63 169.29 18.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.452 -0.78 . . . . 0.0 110.936 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.437 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -102.42 157.56 16.83 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.722 -0.611 . . . . 0.0 109.92 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -122.92 103.23 8.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 110.427 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ttt -65.6 120.32 12.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.515 -0.741 . . . . 0.0 109.584 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 149' ' ' TYR . 50.6 t -96.9 -69.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.47 -0.769 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.87 -162.4 31.65 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -93.89 126.04 38.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.622 -0.928 . . . . 0.0 110.27 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 122' ' ' ILE . 9.9 m-85 -113.45 137.74 51.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.695 . . . . 0.0 110.487 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.89 150.61 17.58 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.48 114.41 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.419 1.221 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -106.6 -58.18 1.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.572 -0.705 . . . . 0.0 110.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -170.55 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.523 -0.736 . . . . 0.0 110.744 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.88 -154.38 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.414 -0.804 . . . . 0.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.433 ' OE1' HG21 ' A' ' 73' ' ' THR . 9.3 pt-20 -101.56 166.33 10.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.849 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 92.8 m-85 -115.74 -166.06 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.744 -0.598 . . . . 0.0 109.388 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -148.54 110.91 4.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.666 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.468 ' HE2' HG22 ' A' ' 160' ' ' THR . 39.8 t80 -70.81 165.76 22.46 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.407 HD21 ' HD3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -146.08 109.12 4.61 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.814 . . . . 0.0 110.792 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.468 HG22 ' HE2' ' A' ' 158' ' ' PHE . 72.2 p -87.58 145.91 38.25 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.57 -171.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.658 1.346 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -54.03 158.1 2.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 5.7 tt0 -159.95 93.44 1.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.74 -0.6 . . . . 0.0 109.77 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.13 133.14 49.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.628 -0.67 . . . . 0.0 110.519 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.669 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -80.88 166.78 36.95 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.84 117.47 5.16 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.377 1.198 . . . . 0.0 110.118 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -108.03 172.36 6.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.514 -0.741 . . . . 0.0 110.709 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.81 155.29 8.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.1 ttm -59.28 -27.73 66.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.582 -0.952 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.2 mm? -93.48 -28.79 15.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.655 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.58 -22.01 54.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.936 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -62.36 138.56 58.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.339 -0.85 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.35 177.3 19.11 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 p -88.62 131.59 34.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.939 . . . . 0.0 110.354 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -112.68 108.49 17.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.511 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -66.6 137.91 57.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 0.0 109.403 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' CH2' ' A' ' 194' ' ' TRP . 16.4 mt -128.69 135.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.358 -0.839 . . . . 0.0 110.828 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -108.42 105.04 14.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.738 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.5 p -106.45 129.28 54.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.532 -0.73 . . . . 0.0 110.593 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -126.5 91.61 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.673 -0.642 . . . . 0.0 109.886 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.743 ' CE2' HG21 ' A' ' 114' ' ' ILE . 3.4 t80 -74.82 103.66 5.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 109.7 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.459 HG22 ' CB ' ' A' ' 188' ' ' ASP . 69.6 p -122.37 165.81 15.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.707 . . . . 0.0 110.201 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.624 -0.673 . . . . 0.0 109.39 179.318 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.459 ' CB ' HG22 ' A' ' 182' ' ' THR . 2.2 m-20 -114.46 118.8 34.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 36.3 m-70 -56.93 -49.98 73.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 110.791 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.1 tp -168.25 153.74 6.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -154.28 140.96 19.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.402 ' CB ' HD21 ' A' ' 94' ' ' LEU . 16.0 p90 -145.57 -154.63 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.787 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.7 129.5 6.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.362 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.48 ' HB3' HD11 ' A' ' 88' ' ' LEU . 14.3 p-90 -137.82 146.9 44.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.574 -0.704 . . . . 0.0 109.901 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -96.79 158.08 15.6 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 104' ' ' LEU . 21.1 tp -127.0 111.55 14.21 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.7 m -91.53 117.66 29.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.53 -0.731 . . . . 0.0 110.774 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.5 mm -90.03 139.86 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -134.55 -155.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.467 -0.771 . . . . 0.0 110.494 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -93.83 -63.05 1.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -153.15 113.86 4.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.52 -0.737 . . . . 0.0 111.496 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -80.05 7.13 9.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.618 -0.676 . . . . 0.0 111.901 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -169.03 38.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.349 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.194 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' CG ' HG23 ' A' ' 70' ' ' VAL . 31.6 t30 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.941 0.4 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 123' ' ' VAL . 57.2 t -122.48 33.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.712 0.767 . . . . 0.0 109.684 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HD22 ' A' ' 190' ' ' LEU . 60.9 t -69.24 153.38 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.291 0.567 . . . . 0.0 109.986 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 90' ' ' LEU . 57.8 t -69.03 136.84 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.669 -0.645 . . . . 0.0 109.487 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 116' ' ' PHE . 62.1 p -95.44 -41.85 8.77 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.282 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -164.19 169.01 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 110.253 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 76' ' ' THR . 5.8 tt -133.64 134.9 43.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 75' ' ' LEU . 62.6 m -122.03 158.35 29.36 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.578 -0.702 . . . . 0.0 110.44 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 86' ' ' LEU . 73.3 mt -132.81 93.73 3.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.75 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -81.69 140.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.746 -0.596 . . . . 0.0 110.161 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 84.2 m -142.41 -162.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.642 -0.661 . . . . 0.0 110.063 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.7 p -111.34 -72.55 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 110.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 p -96.63 32.54 2.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.8 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.56 -174.62 0.45 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.652 -0.655 . . . . 0.0 110.237 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.8 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.2 Cg_endo -79.93 -28.87 2.99 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 123.203 1.107 . . . . 0.0 110.156 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.55 -179.22 33.45 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.44 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.3 Cg_endo -71.87 108.35 2.42 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.587 1.309 . . . . 0.0 110.511 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.792 ' HB2' HD12 ' A' ' 77' ' ' LEU . 37.7 mt -71.72 107.39 4.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.829 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.15 146.29 27.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.656 . . . . 0.0 110.247 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -130.91 140.82 50.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.698 . . . . 0.0 110.095 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.25 130.08 39.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.506 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 72' ' ' VAL . 5.8 mt -137.73 56.14 1.77 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 0.0 109.926 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 90' ' ' LEU . 27.0 p -149.37 -45.64 0.14 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -0.758 . . . . 0.0 110.797 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.14 -89.02 1.13 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.75 124.14 49.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.916 . . . . 0.0 110.282 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.417 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 89.4 mt -92.84 -24.16 18.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.581 -0.699 . . . . 0.0 110.392 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -23.1 6.31 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.218 -0.926 . . . . 0.0 111.295 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -57.78 -19.72 30.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 111.081 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.1 m-30 -62.56 -55.24 29.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.163 -0.961 . . . . 0.0 110.47 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -20.03 39.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.498 -0.751 . . . . 0.0 110.835 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -96.26 26.86 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -168.95 163.33 11.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.389 -0.82 . . . . 0.0 110.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 p -163.29 131.14 3.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.615 -0.678 . . . . 0.0 110.032 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.627 ' HB3' HD13 ' A' ' 86' ' ' LEU . 26.9 m-85 -73.79 126.6 30.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.614 -0.679 . . . . 0.0 110.094 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.1 t -87.35 122.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.71 . . . . 0.0 110.128 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' HD13 ' A' ' 198' ' ' ILE . 41.1 mt -114.89 -169.67 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 110.151 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.789 ' O ' HG13 ' A' ' 108' ' ' VAL . 16.3 tttm -126.4 157.5 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.716 0.769 . . . . 0.0 109.868 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -41.19 117.35 0.86 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 43.44 66.2 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.127 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 105' ' ' LYS . 35.0 m -98.44 152.21 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -1.111 . . . . 0.0 110.244 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.521 ' HB3' ' HE3' ' A' ' 162' ' ' MET . 15.8 tt0 -95.48 117.11 29.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 109.486 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.43 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 33.0 p90 -142.58 149.27 38.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.387 -0.821 . . . . 0.0 111.277 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.62 166.01 11.52 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 77' ' ' LEU . 70.0 mt -126.15 148.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.022 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HD2' HD21 ' A' ' 159' ' ' LEU . 5.8 mtpp -123.25 92.09 3.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 109.547 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.605 HD13 ' HG ' ' A' ' 75' ' ' LEU . 46.9 mm -73.32 135.71 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 110.322 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.1 m -117.94 136.99 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.762 ' HA ' HG23 ' A' ' 73' ' ' THR . 37.9 p90 -156.71 148.9 23.11 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.413 -0.804 . . . . 0.0 110.695 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.88 138.01 35.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.716 -0.615 . . . . 0.0 110.509 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 70' ' ' VAL . 58.9 t -129.95 84.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.643 . . . . 0.0 109.482 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 151' ' ' PRO . 2.1 t30 -129.17 48.59 2.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.567 -0.708 . . . . 0.0 111.25 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -70.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.376 -0.827 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.22 156.81 36.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.555 -0.716 . . . . 0.0 110.416 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.17 103.4 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 70' ' ' VAL . 84.3 t -93.56 99.48 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.632 -0.667 . . . . 0.0 109.497 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 83.6 p -89.39 117.72 28.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.512 -0.742 . . . . 0.0 110.758 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 103.92 48.94 1.12 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 146' ' ' VAL . 1.3 ttt -73.09 125.09 26.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 109.906 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -119.69 143.71 47.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.167 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -120.54 106.57 11.91 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 130' ' ' GLN . 84.3 mt -103.15 163.2 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.569 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.421 ' N ' HG22 ' A' ' 129' ' ' ILE . 22.9 tt0 -153.25 139.56 18.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.738 -0.601 . . . . 0.0 109.944 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 141' ' ' LYS . 30.9 m-70 -117.93 132.65 56.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 110.496 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 m -87.55 71.1 9.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 109.543 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 7.3 m-85 -74.08 151.46 40.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.714 -0.616 . . . . 0.0 110.822 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HD3' HD11 ' A' ' 139' ' ' ILE . 2.8 tpt180 -120.17 -150.96 0.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.836 -0.54 . . . . 0.0 109.735 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 66.43 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 110.848 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.3 34.66 35.97 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.9 t -144.84 95.09 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.655 -0.909 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -59.55 115.6 3.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.508 -0.745 . . . . 0.0 110.197 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.543 HD11 ' HD3' ' A' ' 134' ' ' ARG . 95.2 mt -89.8 -58.7 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.474 -0.766 . . . . 0.0 110.115 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.29 -171.8 1.36 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.51 -0.744 . . . . 0.0 110.944 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -162.85 167.6 22.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.777 -0.577 . . . . 0.0 110.269 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.1 m -137.11 147.81 46.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.356 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.28 127.8 54.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.662 -0.648 . . . . 0.0 110.012 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -117.32 139.05 51.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.495 -0.753 . . . . 0.0 110.614 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.348 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.632 HG11 ' SD ' ' A' ' 126' ' ' MET . 58.4 t -79.57 -69.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 0.0 110.411 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.79 171.84 20.61 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 38.7 m -94.71 150.8 19.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.609 -0.936 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 156' ' ' TYR . 63.6 m-85 -149.35 129.01 13.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.55 -0.719 . . . . 0.0 110.388 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.01 169.95 34.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 119' ' ' ASN . 44.6 Cg_endo -70.24 -165.94 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.339 1.179 . . . . 0.0 110.354 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 37.7 34.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.153 0.501 . . . . 0.0 112.234 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 156' ' ' TYR . . . -133.29 26.9 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.711 -0.618 . . . . 0.0 110.49 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.9 -159.56 0.21 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.581 -0.7 . . . . 0.0 110.386 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -100.18 150.96 21.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.39 -0.819 . . . . 0.0 110.8 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 153' ' ' ALA . 84.7 m-85 -105.69 -165.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.726 -0.609 . . . . 0.0 109.543 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.14 123.03 1.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.422 -0.799 . . . . 0.0 110.548 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.624 ' HB2' HG13 ' A' ' 146' ' ' VAL . 33.3 t80 -87.48 167.88 13.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -145.77 88.29 1.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.57 HG22 ' HE2' ' A' ' 158' ' ' PHE . 82.1 p -62.87 146.79 94.82 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 149.56 77.33 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.408 1.215 . . . . 0.0 110.621 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.521 ' HE3' ' HB3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -51.73 106.28 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.558 -0.714 . . . . 0.0 110.787 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.66 159.53 14.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -91.0 148.0 22.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.0 110.547 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.19 178.95 1.84 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.659 -0.651 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.804 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.85 132.23 18.18 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.222 1.117 . . . . 0.0 110.354 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -113.28 165.32 12.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.76 161.22 17.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.3 ttp -60.85 -39.48 89.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.669 -0.9 . . . . 0.0 110.141 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.1 pt? -72.3 -5.47 36.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.604 -0.685 . . . . 0.0 111.687 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.401 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -76.3 -29.51 57.38 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -65.08 127.51 31.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.59 -179.24 21.94 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 p -88.09 134.96 33.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.994 . . . . 0.0 110.3 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CE2' ' NE ' ' A' ' 134' ' ' ARG . 24.8 m-85 -122.57 111.54 16.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.691 -0.631 . . . . 0.0 110.001 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.22 130.64 47.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.531 -0.731 . . . . 0.0 110.334 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.924 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.9 mm -114.26 98.55 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.646 -0.659 . . . . 0.0 110.029 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 119.04 31.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.111 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 36.8 t -118.44 143.41 46.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.735 -0.603 . . . . 0.0 110.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -84.48 130.6 34.74 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.2 t -171.62 -171.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.536 -0.727 . . . . 0.0 110.201 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 5.6 p-10 . . . . . 0 N--CA 1.488 1.465 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.642 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.501 2.082 0 CA-C-O 121.181 0.515 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 119.69 37.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.707 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.518 ' NE2' HG11 ' A' ' 123' ' ' VAL . 10.1 m-70 -75.7 -60.31 2.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 110.789 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.643 HD22 HG13 ' A' ' 71' ' ' VAL . 6.2 tp -169.82 152.06 4.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 t -149.42 135.56 19.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.533 -0.729 . . . . 0.0 110.362 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.406 ' CD1' HD21 ' A' ' 90' ' ' LEU . 20.4 p90 -135.83 -155.69 0.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.685 . . . . 0.0 110.006 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -167.87 128.07 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.981 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.924 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 24.7 p-90 -132.74 150.6 52.14 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.0 109.719 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.52 151.58 23.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.493 -0.755 . . . . 0.0 111.137 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 104' ' ' LEU . 17.2 tp -125.53 105.09 8.78 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -81.77 138.33 35.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.604 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.665 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.3 mm -114.57 164.04 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 109.461 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.7 ttmt -153.94 -159.23 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -122.32 -10.65 8.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.651 -0.655 . . . . 0.0 111.346 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.06 69.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.136 -0.978 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.688 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.02 -4.56 33.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.555 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -154.44 46.17 0.56 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.126 -0.984 . . . . 0.0 110.136 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.249 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.526 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.188 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' VAL . 85.0 t -141.1 119.39 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 HD22 ' A' ' 190' ' ' LEU . 62.2 t -142.85 139.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.487 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.508 HG11 HD22 ' A' ' 90' ' ' LEU . 59.4 t -64.29 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 116' ' ' PHE . 77.4 p -74.8 -66.96 0.69 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.873 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -131.35 170.82 14.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.529 -0.732 . . . . 0.0 110.73 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HG ' HD13 ' A' ' 114' ' ' ILE . 6.3 tt -142.7 136.88 29.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.659 -0.651 . . . . 0.0 109.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.3 m -109.42 163.99 12.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 0.0 110.076 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -145.98 110.19 4.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.13 114.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 110.042 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.539 ' H ' ' HB2' ' A' ' 82' ' ' ALA . 74.3 m -115.62 78.55 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 110.1 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.3 p 45.94 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.905 -0.497 . . . . 0.0 112.061 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 73.4 p -84.11 56.75 3.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 110.219 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 79' ' ' CYS . . . -90.72 151.89 44.26 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 110.695 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.2 -18.49 23.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.514 1.271 . . . . 0.0 110.228 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.98 152.77 7.37 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.01 98.55 0.91 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.436 1.229 . . . . 0.0 110.369 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 102' ' ' PHE . 6.0 mt -64.72 131.46 46.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 109.879 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -103.87 113.02 26.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.542 -0.723 . . . . 0.0 110.31 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.2 tt -89.13 131.36 35.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.567 -0.708 . . . . 0.0 110.03 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.5 ' N ' HD23 ' A' ' 88' ' ' LEU . 17.5 t70 -87.13 126.45 34.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.681 -0.637 . . . . 0.0 110.052 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 192' ' ' TRP . 1.1 mp -130.28 52.99 1.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -129.39 -48.4 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.703 -0.623 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.4 -116.25 4.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.88 114.61 3.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.567 -0.96 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' HZ ' ' A' ' 97' ' ' PHE . 65.4 mt -93.87 -39.12 10.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.638 -0.664 . . . . 0.0 110.058 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.86 -18.62 34.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.2 t -55.09 -20.65 10.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.24 -0.913 . . . . 0.0 111.335 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.577 ' CD1' HD21 ' A' ' 88' ' ' LEU . 4.6 m-30 -59.99 -31.57 70.04 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -63.3 -16.27 59.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 111.207 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -86.73 -25.48 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.906 . . . . 0.0 110.601 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.54 137.66 47.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -121.26 149.82 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CD1' HD13 ' A' ' 86' ' ' LEU . 29.4 m-85 -85.46 123.04 30.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.504 -0.747 . . . . 0.0 110.105 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.71 152.61 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 109.988 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' CG2' ' A' ' 108' ' ' VAL . 1.6 mt -153.63 172.66 16.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.672 -0.643 . . . . 0.0 110.052 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -93.85 153.87 18.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.509 -0.744 . . . . 0.0 109.843 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -20.52 -55.57 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.796 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -160.88 69.72 0.24 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.577 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.545 ' CG2' HD22 ' A' ' 104' ' ' LEU . 20.9 m -82.63 -161.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.489 -1.006 . . . . 0.0 109.869 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 7.4 mm-40 -98.58 145.77 26.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.548 ' OH ' HD21 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -109.29 111.08 22.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 112.213 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.46 98.63 6.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 66.3 mt -110.64 144.88 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.464 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.555 ' NZ ' HD21 ' A' ' 159' ' ' LEU . 10.6 mttm -120.15 107.25 12.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 48.2 mm -83.24 148.16 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.422 -0.798 . . . . 0.0 110.608 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -130.14 137.21 50.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.699 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.5 p90 -157.7 159.32 36.79 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.874 -0.731 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.46 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.1 mtm180 -98.54 138.68 35.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.382 0.611 . . . . 0.0 111.054 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 91.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -129.13 48.11 2.4 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.91 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HB3' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -140.19 -69.62 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.226 -0.921 . . . . 0.0 110.582 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -139.02 165.83 26.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.775 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.86 105.33 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.654 -0.653 . . . . 0.0 109.708 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 70' ' ' VAL . 58.5 t -88.49 80.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 110.094 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.95 116.86 22.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.604 -0.685 . . . . 0.0 110.144 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.55 27.54 3.28 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -64.24 135.65 56.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.508 -0.996 . . . . 0.0 109.589 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -126.31 167.37 15.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -138.02 78.16 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.22 157.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.54 -0.725 . . . . 0.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -162.16 126.52 3.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.709 -0.619 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.464 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 15.1 m-70 -109.82 119.43 39.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.512 -0.742 . . . . 0.0 110.288 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 139' ' ' ILE . 61.4 m -72.14 68.66 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.656 . . . . 0.0 109.411 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 5.5 m-85 -61.63 144.91 53.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 110.765 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -126.99 100.68 6.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.59 37.28 28.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.561 -0.712 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.65 -15.35 61.06 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.081 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 138' ' ' LYS . 58.4 t -98.46 167.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.179 -1.189 . . . . 0.0 110.203 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.8 mppt? -113.66 130.9 56.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -120.76 -23.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.735 . . . . 0.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -165.39 119.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.159 -0.963 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -144.41 132.62 21.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -0.75 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 143' ' ' ASP . 58.2 m -146.32 165.78 28.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.665 -0.647 . . . . 0.0 110.499 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 142' ' ' THR . 10.5 p-10 -100.06 136.31 40.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.669 . . . . 0.0 110.038 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -111.54 154.45 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.558 -0.713 . . . . 0.0 110.454 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 12.3 ttm -101.73 112.16 24.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.606 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' A' ' 158' ' ' PHE . 57.8 t -79.49 -48.76 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.529 -0.732 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.46 165.6 10.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 65.4 p -85.77 143.75 28.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.68 -0.894 . . . . 0.0 109.403 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 148' ' ' SER . 50.2 m-85 -140.68 125.93 18.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.543 -0.723 . . . . 0.0 110.384 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.58 154.37 32.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.54 85.51 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.476 1.25 . . . . 0.0 110.378 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -85.45 -89.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.63 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.927 -1.108 . . . . 0.0 110.998 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -162.5 -163.43 0.9 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.82 . . . . 0.0 110.935 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -100.28 167.54 10.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.606 . . . . 0.0 110.092 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 27.7 m-85 -113.79 171.51 7.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.663 . . . . 0.0 109.787 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -138.36 95.33 2.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.523 -0.735 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.505 ' CG ' HG13 ' A' ' 146' ' ' VAL . 49.0 t80 -81.36 169.83 16.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 ' NZ ' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -146.82 111.37 5.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.745 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 64.0 p -77.67 140.01 63.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.75 . . . . 0.0 109.064 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.11 163.28 29.43 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.75 1.395 . . . . 0.0 111.401 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -59.38 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.176 0.512 . . . . 0.0 111.478 -179.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 110' ' ' TYR . 5.9 tt0 -79.39 -171.5 2.77 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.54 155.92 39.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 110.649 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.796 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -100.62 160.61 26.4 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.702 -0.624 . . . . 0.0 109.8 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.58 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 48.0 Cg_endo -73.45 117.02 4.9 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.411 1.216 . . . . 0.0 110.777 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -113.97 -170.38 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.09 28.27 3.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 65.81 -68.51 0.12 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.452 -1.028 . . . . 0.0 110.75 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -56.57 -29.22 61.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 166' ' ' PRO . . . -57.61 -21.79 41.43 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.642 -0.661 . . . . 0.0 110.671 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.405 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 44.9 mtp180 -60.69 136.86 58.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 142.02 -173.52 23.64 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 p -91.6 137.99 31.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.623 -0.927 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -128.23 115.07 17.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 110.271 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.484 ' O ' HD13 ' A' ' 177' ' ' ILE . 1.5 m120 -60.45 151.85 27.19 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.509 -0.744 . . . . 0.0 110.09 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.775 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.4 mm -131.51 97.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.463 -0.773 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 133' ' ' TYR . 4.3 ttpt -82.4 102.44 11.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 109.733 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.4 p -109.34 137.1 47.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.725 . . . . 0.0 110.482 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.41 99.51 5.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.781 -0.575 . . . . 0.0 110.007 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -78.77 120.42 23.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.688 -0.633 . . . . 0.0 109.75 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.0 t -142.95 -164.77 1.92 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.53 -0.731 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 13.0 p-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.906 -0.496 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.232 0.539 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.67 126.22 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.538 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 17.0 m-70 -73.48 -47.86 37.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 110.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.671 HD22 HG13 ' A' ' 71' ' ' VAL . 5.7 tp -168.39 152.21 5.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 110.232 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.3 t -148.43 152.15 36.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.692 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.572 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.4 p90 -142.97 -161.24 1.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.0 109.947 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.09 122.86 3.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.446 -0.784 . . . . 0.0 110.759 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.775 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 37.6 p-90 -132.28 149.31 52.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.601 -0.687 . . . . 0.0 109.713 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.21 152.3 22.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.549 -0.719 . . . . 0.0 111.303 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.548 HD21 ' OH ' ' A' ' 110' ' ' TYR . 25.7 tp -122.04 108.84 13.84 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.9 m -85.74 140.31 30.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.528 -0.733 . . . . 0.0 110.581 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.6 mm -119.72 160.51 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.752 -0.592 . . . . 0.0 109.651 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.13 -153.23 0.33 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.212 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -3.65 6.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.448 -0.783 . . . . 0.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -160.05 43.96 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -54.04 -23.11 12.44 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.239 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.04 47.2 0.91 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.589 -0.695 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.265 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.142 0.496 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 123' ' ' VAL . 96.1 t -126.91 128.74 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.42 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.3 t -146.95 142.03 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.792 -0.567 . . . . 0.0 109.804 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.586 ' CG1' HD13 ' A' ' 90' ' ' LEU . 61.7 t -62.85 112.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 43.0 p -78.23 -35.53 48.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.0 111.062 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -159.31 176.89 11.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.367 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.1 tt -145.82 113.67 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.798 -0.564 . . . . 0.0 109.665 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 87' ' ' GLU . 4.1 m -109.8 164.55 12.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.445 -0.785 . . . . 0.0 110.571 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -139.23 101.67 4.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 79' ' ' CYS . 65.3 t -94.0 167.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.717 -0.614 . . . . 0.0 110.127 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -168.36 -162.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.759 . . . . 0.0 110.098 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -108.84 -40.65 4.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -122.62 35.12 4.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.09 165.02 25.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.547 -0.721 . . . . 0.0 110.263 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.4 Cg_endo -70.23 -26.8 25.01 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.385 1.203 . . . . 0.0 110.256 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.26 174.03 32.66 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.96 96.08 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.55 1.289 . . . . 0.0 110.293 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' PHE . 23.6 mt -64.8 106.24 1.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.629 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 76' ' ' THR . 2.2 mt-10 -99.24 135.08 41.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.586 -0.696 . . . . 0.0 110.652 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.536 HD22 ' HE1' ' A' ' 97' ' ' PHE . 10.8 mt -116.18 168.02 10.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.608 -0.682 . . . . 0.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.73 128.87 54.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.715 . . . . 0.0 110.111 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.586 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -128.07 50.24 2.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 110.078 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.7 p -141.0 -43.79 0.38 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.155 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.14 -92.01 2.03 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.68 98.79 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -1.021 . . . . 0.0 110.557 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -95.45 -36.92 11.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 0.0 110.089 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.36 -13.0 57.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 0.0 111.273 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 p -55.1 -28.01 49.31 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.545 ' CE2' HD13 ' A' ' 94' ' ' LEU . 28.7 m-85 -61.96 -39.47 92.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.46 -0.775 . . . . 0.0 109.985 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -57.92 -24.37 57.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.685 . . . . 0.0 110.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -118.67 45.41 2.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.561 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -168.35 136.13 2.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.791 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.2 p -143.41 127.88 17.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.657 . . . . 0.0 109.544 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.714 ' CD1' HD22 ' A' ' 86' ' ' LEU . 11.9 m-85 -76.42 115.37 16.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.369 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.77 121.14 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 109.179 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 196' ' ' LEU . 1.0 OUTLIER -113.76 -159.31 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.618 -0.676 . . . . 0.0 110.3 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HB3' HG11 ' A' ' 108' ' ' VAL . 47.0 tttm -140.94 158.79 43.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.572 -0.705 . . . . 0.0 110.555 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' CG ' ' NH1' ' A' ' 172' ' ' ARG . 22.3 mt-10 -38.36 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 33.32 70.34 0.13 Allowed Glycine 0 N--CA 1.505 3.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.863 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 105' ' ' LYS . 33.0 m -90.83 147.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -1.14 . . . . 0.0 109.749 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.26 93.39 4.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 108.814 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 163' ' ' GLU . 31.8 p90 -113.45 146.31 39.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 111.894 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -108.38 157.49 18.35 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 113' ' ' LYS . 66.8 mt -116.66 164.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.855 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.633 ' CG ' HD11 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -142.67 87.15 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.87 -0.519 . . . . 0.0 109.612 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.55 150.92 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.411 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -127.02 153.02 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.705 -0.622 . . . . 0.0 109.739 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -172.09 159.32 4.9 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.576 -0.703 . . . . 0.0 110.576 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' A' ' 73' ' ' THR . 3.3 mtm180 -113.94 154.54 27.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -133.11 97.83 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -128.98 48.93 2.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.513 -0.742 . . . . 0.0 111.291 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -70.6 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.27 -0.894 . . . . 0.0 110.777 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -135.56 172.61 12.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.671 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.1 mt -80.35 108.76 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.726 -0.609 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 70' ' ' VAL . 93.7 t -83.61 86.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -78.13 59.29 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.677 -0.639 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.48 60.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.704 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.4 OUTLIER -70.25 128.67 37.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -1.058 . . . . 0.0 108.566 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -125.99 145.42 50.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.248 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.14 96.04 3.12 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -94.15 162.46 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.087 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 129' ' ' ILE . 4.3 tt0 -151.46 135.33 16.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.598 -0.688 . . . . 0.0 110.185 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 177' ' ' ILE . 13.6 m-70 -109.55 149.1 30.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.715 . . . . 0.0 109.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.483 HG22 HH22 ' A' ' 134' ' ' ARG . 0.4 OUTLIER -108.13 80.84 1.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.6 -0.687 . . . . 0.0 109.208 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 11.6 m-85 -86.05 140.37 30.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 111.071 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.699 HH11 HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -119.83 79.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.685 . . . . 0.0 110.399 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt 52.09 55.61 8.98 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.406 -0.809 . . . . 0.0 111.339 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.84 -19.33 52.3 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.1 t -98.73 89.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.181 -1.188 . . . . 0.0 109.829 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 5.1 pttm -66.92 122.73 18.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.575 -0.703 . . . . 0.0 110.562 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.699 HD12 HH11 ' A' ' 134' ' ' ARG . 1.8 mt -89.74 -54.03 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.15 -167.97 0.37 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.505 -0.747 . . . . 0.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HE2' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -157.93 153.46 26.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.632 -0.668 . . . . 0.0 109.92 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.456 HG21 ' CZ ' ' A' ' 144' ' ' TYR . 8.5 m -118.29 146.1 44.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -125.19 118.4 25.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 142' ' ' THR . 29.2 m-85 -111.56 147.09 36.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.404 -0.81 . . . . 0.0 110.855 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.0 ttp -104.12 118.19 36.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.753 -0.592 . . . . 0.0 109.463 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 149' ' ' TYR . 49.1 t -79.87 -66.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.59 -0.694 . . . . 0.0 110.263 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.23 -148.87 20.17 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 92.5 p -108.59 136.64 47.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.543 -0.975 . . . . 0.0 110.427 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.552 ' HE1' HG12 ' A' ' 146' ' ' VAL . 23.3 m-85 -122.82 147.01 47.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 110.396 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.14 152.29 18.03 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.515 ' HA ' HG12 ' A' ' 118' ' ' VAL . 51.2 Cg_endo -75.5 -174.25 1.93 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.362 1.19 . . . . 0.0 110.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 52.01 70.11 0.59 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.5 -0.75 . . . . 0.0 111.079 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.1 -94.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.484 -0.76 . . . . 0.0 110.364 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.54 -155.17 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.838 -1.164 . . . . 0.0 109.897 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 88.73 6.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.91 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -59.75 -168.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.506 -0.746 . . . . 0.0 109.94 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.414 ' OE1' HD11 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -161.61 134.83 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.475 -0.766 . . . . 0.0 110.726 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 146' ' ' VAL . 29.9 t80 -107.09 156.86 18.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.633 HD11 ' CG ' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -137.93 114.0 10.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.446 -0.784 . . . . 0.0 110.595 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -78.61 154.53 78.69 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.21 154.96 72.11 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.628 1.331 . . . . 0.0 110.806 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 ttm -59.83 124.17 19.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.699 -0.626 . . . . 0.0 110.438 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.5 pt-20 -124.49 141.59 51.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.633 -0.667 . . . . 0.0 109.921 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.19 140.31 31.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.586 -0.696 . . . . 0.0 110.417 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -86.62 -179.27 1.34 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.637 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.7 Cg_endo -75.29 125.47 9.15 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.237 1.125 . . . . 0.0 110.297 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -115.26 -176.68 2.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.656 -0.653 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.93 153.98 19.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 9.2 ttm -60.19 -28.12 67.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.644 -0.915 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 26.2 4.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 110.116 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.31 22.46 8.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.529 -0.732 . . . . 0.0 110.387 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -100.03 147.9 25.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.835 . . . . 0.0 109.94 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.83 179.97 16.77 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.6 p -81.14 140.76 34.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.67 -0.9 . . . . 0.0 110.761 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 13.4 m-85 -118.35 106.19 12.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.787 -0.571 . . . . 0.0 109.919 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -71.08 121.45 18.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.584 -0.697 . . . . 0.0 110.055 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 131' ' ' HIS . 26.6 mt -116.84 145.42 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -114.02 114.43 26.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.976 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.0 m -106.23 151.36 24.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.65 -0.656 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -149.12 93.73 2.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 116' ' ' PHE . 18.1 t80 -75.33 107.55 7.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.591 -0.693 . . . . 0.0 109.628 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 188' ' ' ASP . 75.8 p -121.71 168.49 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.524 -0.735 . . . . 0.0 110.38 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.691 ' HB2' HG13 ' A' ' 123' ' ' VAL . 7.0 p-10 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.783 -0.573 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.003 0.43 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' A' ' 182' ' ' THR . 1.1 m-20 -78.32 108.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.378 -0.826 . . . . 0.0 110.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.414 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 25.8 m-70 -59.57 -55.12 38.45 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.471 -0.768 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 tp -168.56 153.87 6.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.5 t -148.26 155.73 41.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 110.142 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.526 ' CB ' HD11 ' A' ' 94' ' ' LEU . 23.1 p90 -148.6 -152.99 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -164.08 139.91 6.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 14.1 p-90 -147.89 147.82 30.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.213 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -92.73 148.88 21.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.503 -0.748 . . . . 0.0 111.224 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.783 HD21 HD12 ' A' ' 104' ' ' LEU . 49.6 tp -124.05 115.72 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.407 ' O ' HD13 ' A' ' 198' ' ' ILE . 96.0 m -87.41 152.49 22.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.477 -0.764 . . . . 0.0 110.947 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.488 HD13 ' CB ' ' A' ' 104' ' ' LEU . 49.8 mm -130.28 159.21 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -160.32 -158.51 0.63 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.284 -0.885 . . . . 0.0 111.243 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -64.31 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.61 -0.681 . . . . 0.0 111.096 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.59 103.67 3.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.0 110.93 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.58 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -72.95 -3.13 23.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.556 -0.715 . . . . 0.0 111.644 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -136.49 57.61 1.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.059 -1.026 . . . . 0.0 110.133 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.228 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.487 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.212 0.53 . . . . 0.0 110.034 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.487 HG23 HD22 ' A' ' 69' ' ' ASN . 93.0 t -141.95 122.07 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.79 HG13 HD22 ' A' ' 190' ' ' LEU . 59.0 t -148.89 137.15 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.302 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.747 HG22 ' CD2' ' A' ' 181' ' ' PHE . 58.4 t -66.12 108.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.876 HG23 ' HA ' ' A' ' 116' ' ' PHE . 73.0 p -70.62 -62.63 1.32 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.607 -0.683 . . . . 0.0 110.543 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -145.07 167.9 21.6 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.774 . . . . 0.0 110.802 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.559 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -125.61 136.28 53.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.717 -0.615 . . . . 0.0 109.687 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 85' ' ' PRO . 92.4 m -125.82 149.17 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 110.638 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -133.9 103.66 5.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 109.947 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -94.14 166.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.616 -0.677 . . . . 0.0 110.178 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -167.25 -164.3 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 110.009 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -44.77 4.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 p -108.98 27.19 9.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.84 162.37 33.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.594 -0.691 . . . . 0.0 110.609 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 45.7 Cg_endo -71.78 -25.49 20.23 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.524 1.276 . . . . 0.0 110.078 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.03 176.22 33.89 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.65 ' HB2' HG23 ' A' ' 76' ' ' THR . 45.8 Cg_endo -71.63 104.45 1.6 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.567 1.298 . . . . 0.0 110.444 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 23.5 mt -64.88 108.75 1.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.655 -0.653 . . . . 0.0 109.634 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -86.77 139.66 30.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -120.06 149.42 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 110.085 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.447 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.8 t0 -103.19 118.4 36.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.715 . . . . 0.0 110.222 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 192' ' ' TRP . 2.8 mt -128.98 50.04 2.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -96.93 -73.52 0.6 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.599 -0.688 . . . . 0.0 110.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -52.37 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.78 88.09 4.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.917 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 96.1 mt -87.82 -25.23 23.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.724 . . . . 0.0 110.405 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.85 -21.75 12.36 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.245 -0.909 . . . . 0.0 111.093 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.2 t -54.43 -22.6 13.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.347 -0.846 . . . . 0.0 111.127 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CE1' HD22 ' A' ' 88' ' ' LEU . 10.4 m-30 -61.95 -48.03 82.2 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.802 . . . . 0.0 109.943 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -59.51 -24.8 63.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.62 -0.675 . . . . 0.0 110.659 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -86.85 -26.42 24.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 0.0 110.509 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -132.76 129.86 39.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.643 -0.661 . . . . 0.0 110.379 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -106.99 -175.03 2.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.645 -0.659 . . . . 0.0 110.093 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 196' ' ' LEU . 2.6 m-85 -113.58 96.03 5.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.596 -0.69 . . . . 0.0 110.174 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.18 142.88 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 109.837 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 HD11 ' A' ' 196' ' ' LEU . 1.2 mt -157.32 172.51 18.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -90.06 157.57 17.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -20.04 -50.86 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.727 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -171.54 63.54 0.15 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' LYS . 23.3 m -75.37 137.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -1.025 . . . . 0.0 110.322 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.81 105.32 8.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.67 -0.644 . . . . 0.0 109.431 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 77' ' ' LEU . 18.1 p90 -121.56 171.07 9.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.317 -0.864 . . . . 0.0 111.512 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -117.18 145.61 43.75 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.61 139.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.417 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 90.59 3.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.695 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.6 mm -74.42 147.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.569 -0.707 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 m -130.49 134.72 47.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.876 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.6 p90 -154.61 160.67 41.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.441 -0.787 . . . . 0.0 111.093 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -108.29 131.44 54.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.327 0.584 . . . . 0.0 110.716 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 149' ' ' TYR . 93.5 t -120.23 93.1 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -129.35 50.23 2.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.348 -0.845 . . . . 0.0 111.569 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.12 -65.26 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 110.421 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.82 169.54 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.58 101.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.717 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 70' ' ' VAL . 60.7 t -79.9 75.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.65 -0.656 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -83.14 110.95 18.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.718 . . . . 0.0 110.387 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.47 30.16 2.51 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.7 OUTLIER -62.24 112.11 2.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.434 -1.039 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 163.71 12.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.594 -0.692 . . . . 0.0 110.936 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -138.13 112.08 8.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.73 -0.606 . . . . 0.0 109.64 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.41 161.29 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 0.0 110.034 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -167.42 117.98 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.546 -0.721 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -110.4 131.02 55.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.597 -0.689 . . . . 0.0 110.242 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 m -86.16 93.04 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.718 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 3.1 m-85 -78.19 127.44 32.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.718 . . . . 0.0 110.471 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.2 ttp180 -125.74 130.95 52.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.37 28.69 7.7 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.27 47.13 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.5 m -106.56 146.33 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.214 . . . . 0.0 110.707 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.61 138.76 40.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.597 -0.689 . . . . 0.0 110.126 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.85 -24.22 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -173.28 134.96 0.55 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.028 . . . . 0.0 110.829 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 175.57 7.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.627 -0.671 . . . . 0.0 109.438 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.3 m -154.26 144.7 22.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 111.1 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -115.15 122.51 46.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.93 130.59 56.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.442 -0.787 . . . . 0.0 111.23 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.48 119.01 17.11 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.74 HG12 ' OH ' ' A' ' 149' ' ' TYR . 6.4 t -79.7 -58.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.505 -0.747 . . . . 0.0 110.293 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.11 165.07 11.0 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.935 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 59.2 p -92.91 151.76 19.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.614 -0.933 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.74 ' OH ' HG12 ' A' ' 146' ' ' VAL . 12.7 m-85 -139.15 169.49 17.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.469 -0.769 . . . . 0.0 110.573 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.05 141.96 17.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.51 178.36 5.72 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.214 1.113 . . . . 0.0 110.777 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.06 71.32 0.5 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.54 -0.725 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -166.55 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.458 -0.776 . . . . 0.0 110.408 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.74 -153.94 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.028 -1.045 . . . . 0.0 110.026 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.28 168.85 10.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.427 -0.796 . . . . 0.0 110.02 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 32.2 m-85 -127.17 -176.58 3.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -150.68 113.32 4.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.493 -0.754 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.517 ' HB2' HG13 ' A' ' 146' ' ' VAL . 35.2 t80 -87.24 168.51 13.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.529 -0.732 . . . . 0.0 110.022 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.07 109.8 4.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 0.0 110.738 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.8 p -83.33 151.13 62.07 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.392 -0.817 . . . . 0.0 109.121 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.72 -175.13 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.524 1.276 . . . . 0.0 110.892 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.0 ptm -56.64 145.1 29.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.653 -0.655 . . . . 0.0 110.915 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.04 93.92 2.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.718 -0.614 . . . . 0.0 109.731 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -63.91 121.83 15.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.727 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -57.43 175.12 0.27 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.724 -0.61 . . . . 0.0 110.234 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.0 Cg_endo -72.83 112.51 3.52 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.248 1.131 . . . . 0.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -172.82 2.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.886 -0.509 . . . . 0.0 110.544 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.34 31.67 1.8 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.5 mtp 63.71 -70.75 0.07 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.62 -0.929 . . . . 0.0 111.213 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -69.81 -7.03 36.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.179 -0.951 . . . . 0.0 111.71 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.54 -5.13 41.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.293 -0.879 . . . . 0.0 110.94 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 30.5 mtp180 -67.86 140.68 56.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.86 -174.65 24.16 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.6 p -91.49 124.46 35.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.605 -0.938 . . . . 0.0 110.211 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -112.11 112.87 24.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.358 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -62.59 143.32 57.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.592 -0.693 . . . . 0.0 109.801 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.772 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.5 mm -119.33 94.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.533 -0.729 . . . . 0.0 110.41 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 tttt -77.23 107.96 10.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.512 -0.743 . . . . 0.0 109.47 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 5.2 p -113.45 160.4 18.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -147.89 83.79 1.52 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.682 -0.636 . . . . 0.0 109.82 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.747 ' CD2' HG22 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -69.68 110.85 5.09 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.6 t -141.33 -168.21 2.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.521 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 p30 . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.316 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 120.957 0.408 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.36 125.24 37.86 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 18.9 p80 -91.56 -17.69 25.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.474 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.79 HD22 HG13 ' A' ' 71' ' ' VAL . 43.5 tp -171.39 155.05 4.07 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.034 -1.041 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -164.96 140.27 5.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.72 -0.613 . . . . 0.0 109.677 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.506 ' CD1' HD21 ' A' ' 90' ' ' LEU . 14.7 p90 -146.95 -153.53 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.412 -0.805 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -167.16 127.33 1.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.701 -0.625 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 20.0 p-90 -130.63 145.94 52.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.25 152.1 23.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.681 -0.637 . . . . 0.0 110.989 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 104' ' ' LEU . 13.1 tp -123.75 92.06 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.734 -0.604 . . . . 0.0 109.544 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.8 m -67.73 129.5 40.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.571 -0.705 . . . . 0.0 110.186 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.1 mm -109.73 150.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.807 -0.558 . . . . 0.0 109.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.73 -153.01 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.665 -0.647 . . . . 0.0 109.949 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 -4.87 6.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.655 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -159.98 46.7 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.982 -1.074 . . . . 0.0 110.986 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -56.06 -22.16 26.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.344 -0.848 . . . . 0.0 111.131 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.64 51.54 1.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -0.815 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.194 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.059 0.457 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 118' ' ' VAL . 84.6 t -115.82 134.52 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.582 -0.699 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 70' ' ' VAL . 63.0 t -148.34 152.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.608 -0.683 . . . . 0.0 109.92 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.3 t -71.61 112.33 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.881 HG23 ' HA ' ' A' ' 116' ' ' PHE . 67.5 p -70.81 -51.3 27.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.306 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -151.3 179.77 8.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.2 tt -146.39 121.24 9.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.629 -0.669 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -109.75 163.42 13.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -148.61 113.89 5.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.468 -0.77 . . . . 0.0 110.531 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -125.87 167.23 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.654 . . . . 0.0 109.817 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 78' ' ' VAL . 52.5 t -153.05 -71.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.554 -0.717 . . . . 0.0 110.315 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.0 p -171.89 -71.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 p -103.99 33.59 3.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.609 -0.682 . . . . 0.0 109.928 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -79.65 172.78 8.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 110.32 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.6 Cg_endo -72.22 -27.73 16.28 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.455 1.24 . . . . 0.0 110.046 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.57 170.44 25.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.2 Cg_endo -72.04 97.76 0.86 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.544 1.286 . . . . 0.0 110.292 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 1.5 mp -64.67 122.68 17.42 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.523 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.22 112.93 26.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 110.678 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.0 mt -95.26 131.23 41.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 5.4 t70 -75.64 135.25 40.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.704 . . . . 0.0 110.614 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HA ' HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.61 54.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.619 -0.675 . . . . 0.0 109.71 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.7 p -130.21 49.84 2.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 110.7 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.52 -55.62 0.74 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.26 64.32 0.56 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.592 -0.946 . . . . 0.0 110.073 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 90' ' ' LEU . 29.4 mt -95.14 -0.09 53.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 111.207 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.18 -24.37 58.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.106 -0.996 . . . . 0.0 110.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.77 -6.55 45.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.42 -0.8 . . . . 0.0 111.227 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 13.9 m-85 -81.28 -38.71 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -69.95 -20.2 63.34 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.511 -0.743 . . . . 0.0 110.858 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.37 38.25 3.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -168.96 151.62 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.447 -0.783 . . . . 0.0 110.55 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -128.76 -169.53 2.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.555 -0.716 . . . . 0.0 109.989 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD2' HD13 ' A' ' 77' ' ' LEU . 1.1 m-85 -125.17 111.57 15.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 109.93 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.22 147.47 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.547 -0.72 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -167.38 145.05 4.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.788 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.648 ' H ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -78.59 155.6 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.454 -0.779 . . . . 0.0 109.75 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -17.24 -87.59 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.736 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -134.81 67.29 0.55 Allowed Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.163 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.617 ' CG2' HD21 ' A' ' 104' ' ' LEU . 8.6 m -75.96 157.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.467 -1.02 . . . . 0.0 110.156 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -85.5 89.53 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.632 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 46.2 p90 -109.27 138.86 44.99 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.662 0.744 . . . . 0.0 112.095 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -105.94 164.98 11.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.35 150.01 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.218 -0.926 . . . . 0.0 111.216 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -125.42 108.01 11.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.7 153.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 0.0 110.522 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.3 m -131.02 140.95 50.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.806 -0.559 . . . . 0.0 109.582 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.881 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -164.47 147.58 9.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.469 -0.77 . . . . 0.0 110.505 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 161.56 17.91 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.439 -0.788 . . . . 0.0 111.195 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 70' ' ' VAL . 63.1 t -133.08 117.23 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.779 -0.575 . . . . 0.0 109.593 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -128.66 46.73 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.995 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 -67.89 0.25 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -143.69 179.07 7.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.819 . . . . 0.0 110.562 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.0 mp -80.19 109.34 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.666 -0.646 . . . . 0.0 109.981 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 70' ' ' VAL . 57.5 t -91.46 83.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.9 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.5 p -85.07 107.78 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.621 -0.675 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.41 39.98 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -81.46 137.89 35.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -1.043 . . . . 0.0 109.957 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.631 ' HE2' HG23 ' A' ' 182' ' ' THR . 22.5 pttt -139.39 171.87 13.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -129.52 117.84 21.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 109.73 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE3' ' A' ' 127' ' ' LYS . 49.8 mm -91.32 165.74 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.736 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 129' ' ' ILE . 49.5 tt0 -168.29 124.05 1.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -113.95 117.82 32.44 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.731 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.6 m -71.89 84.58 0.95 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.717 -0.615 . . . . 0.0 109.921 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 138' ' ' LYS . 2.7 m-85 -87.41 136.39 32.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.497 -0.752 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.428 ' HD2' ' CE2' ' A' ' 175' ' ' TYR . 3.3 ttp180 -120.42 110.58 16.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 110.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 29.63 43.47 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 92.87 34.18 6.99 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 136' ' ' GLY . 62.6 t -149.21 82.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.959 . . . . 0.0 110.071 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 133' ' ' TYR . 2.4 ttpm? -62.29 121.87 14.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 140' ' ' ASP . 31.3 pt -104.32 -31.52 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.534 -0.729 . . . . 0.0 111.067 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.5 p30 -174.23 149.71 1.43 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.14 -0.975 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 150.71 51.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.64 . . . . 0.0 109.505 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.9 m -132.84 159.81 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.98 138.83 53.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.631 -0.668 . . . . 0.0 110.122 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -122.63 113.15 18.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.9 ttt -68.72 137.87 54.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.523 -0.736 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.456 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 60.6 t -98.11 -68.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.552 -0.717 . . . . 0.0 110.151 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.28 176.02 26.14 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.4 p -87.4 152.47 22.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.693 -0.887 . . . . 0.0 109.963 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.433 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 81.3 m-85 -148.18 144.39 27.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 110.415 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.5 154.01 19.68 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.23 65.35 5.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.377 1.199 . . . . 0.0 110.474 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -170.93 37.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 110.337 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.698 ' HB3' ' OH ' ' A' ' 156' ' ' TYR . . . -144.31 15.02 1.65 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.522 -0.736 . . . . 0.0 111.06 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 54.66 -148.1 0.49 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.173 -0.954 . . . . 0.0 110.734 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.95 157.06 38.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.373 -0.829 . . . . 0.0 110.84 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.698 ' OH ' ' HB3' ' A' ' 153' ' ' ALA . 57.4 m-85 -115.87 177.45 4.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.737 -0.602 . . . . 0.0 109.669 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.95 92.84 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.51 -0.744 . . . . 0.0 110.355 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 28.5 t80 -80.81 168.23 19.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.009 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 111' ' ' ARG . 0.9 OUTLIER -154.4 100.63 2.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.395 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.426 HG22 ' HE2' ' A' ' 158' ' ' PHE . 81.0 p -76.02 155.87 84.39 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 109.252 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.76 153.02 76.91 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.615 1.324 . . . . 0.0 110.978 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.0 ptm -58.0 113.47 1.91 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.679 -0.638 . . . . 0.0 110.49 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.25 161.42 13.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.094 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -104.84 141.44 36.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.484 -0.76 . . . . 0.0 110.512 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -96.15 179.66 1.1 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.629 -0.67 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 41.8 Cg_endo -66.44 -153.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.201 1.106 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -107.0 -162.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.061 -1.024 . . . . 0.0 110.689 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 106' ' ' GLU . . . -98.86 -66.79 0.87 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 171' ' ' ALA . 6.6 mtt -60.79 145.94 47.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.959 . . . . 0.0 109.233 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER 66.93 -61.32 0.33 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.639 -0.663 . . . . 0.0 110.535 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -73.06 -2.85 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.4 -0.812 . . . . 0.0 111.695 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 150.36 48.93 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.918 -1.114 . . . . 0.0 110.136 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.56 -177.82 17.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.7 p -91.99 129.78 37.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.696 -0.885 . . . . 0.0 110.219 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.428 ' CE2' ' HD2' ' A' ' 134' ' ' ARG . 12.3 m-85 -108.01 101.12 10.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.594 -0.691 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.96 125.06 23.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.616 ' CD1' HD23 ' A' ' 196' ' ' LEU . 20.5 mt -115.96 132.14 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -0.851 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.8 106.51 17.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.4 m -99.09 140.6 33.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.646 -0.659 . . . . 0.0 109.728 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.44 90.07 2.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.595 -0.691 . . . . 0.0 110.393 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.494 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.7 t80 -64.38 131.66 47.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 109.648 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.631 HG23 ' HE2' ' A' ' 127' ' ' LYS . 5.9 t -171.0 -169.06 0.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.8 p30 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.482 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 121.234 0.54 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -115.35 118.02 32.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.782 -0.574 . . . . 0.0 109.503 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.2 m-70 -75.07 -67.44 0.65 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.457 -0.777 . . . . 0.0 110.666 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.0 tp -165.74 160.29 17.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.461 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.8 p -155.94 144.91 20.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.586 -0.696 . . . . 0.0 110.403 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 30.1 p90 -138.7 -155.76 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.606 -0.684 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.46 129.31 7.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.323 -0.86 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.739 ' CZ3' HD21 ' A' ' 196' ' ' LEU . 4.4 p-90 -140.01 147.9 41.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 175' ' ' TYR . 4.9 m120 -99.31 154.97 17.76 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.756 0.789 . . . . 0.0 112.452 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.739 HD21 ' CZ3' ' A' ' 194' ' ' TRP . 0.9 OUTLIER -111.74 103.47 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -80.21 101.12 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.753 . . . . 0.0 110.434 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.93 145.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 109.689 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -142.6 -154.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.647 -0.658 . . . . 0.0 110.401 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -108.71 -32.46 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.758 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.11 93.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.761 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -77.21 -0.2 24.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.571 -0.706 . . . . 0.0 111.307 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -127.79 43.2 3.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' A' ' 70' ' ' VAL . 1.3 t-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 123' ' ' VAL . 92.8 t -130.68 125.24 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.778 -0.577 . . . . 0.0 110.132 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -148.59 138.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.775 -0.578 . . . . 0.0 109.962 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.748 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -64.51 104.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 155' ' ' GLU . 66.4 p -70.8 -63.3 1.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.668 -0.645 . . . . 0.0 110.41 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -138.61 173.21 11.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.6 tt -142.85 124.92 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.648 -0.658 . . . . 0.0 109.559 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 85' ' ' PRO . 21.0 m -114.91 157.37 23.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.442 -0.786 . . . . 0.0 111.038 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -137.46 106.39 5.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.3 t -99.74 166.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 110.42 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -163.33 -154.49 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.1 p -115.03 -26.42 7.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.436 -0.79 . . . . 0.0 110.397 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.7 p -140.12 34.67 1.92 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.653 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.21 173.41 5.76 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.352 -0.843 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.0 Cg_endo -72.36 -26.52 17.17 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.286 1.15 . . . . 0.0 110.152 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.72 177.31 34.68 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -71.45 102.76 1.32 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.487 1.256 . . . . 0.0 110.317 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.657 HD22 ' CD1' ' A' ' 102' ' ' PHE . 37.5 mt -64.85 112.74 3.4 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.503 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -99.67 113.67 26.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.82 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.6 mt -98.75 137.45 37.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.604 -0.685 . . . . 0.0 109.739 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 14.6 t0 -86.57 128.61 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.506 -0.746 . . . . 0.0 110.679 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.748 HD22 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -128.52 51.44 2.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.466 -0.771 . . . . 0.0 109.982 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.6 p -115.16 -58.73 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 110.346 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.67 -57.25 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 75.64 0.96 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.548 -0.972 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.5 mt -95.01 0.03 54.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 111.213 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -70.51 -33.14 70.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.037 -1.039 . . . . 0.0 110.659 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 m -57.47 -20.82 33.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.456 -0.777 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.82 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.7 m-85 -55.33 -42.2 73.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.246 -0.909 . . . . 0.0 110.388 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -63.59 -26.27 68.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 0.0 109.944 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 52.5 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.015 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -158.26 30.16 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.392 -0.817 . . . . 0.0 110.657 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -55.9 121.58 9.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.77 -0.581 . . . . 0.0 110.557 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.657 ' CD1' HD22 ' A' ' 86' ' ' LEU . 23.6 m-85 -85.21 122.73 29.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.544 -0.722 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.03 152.84 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.844 HD22 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -154.54 128.04 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.424 -0.798 . . . . 0.0 110.75 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 108' ' ' VAL . 24.3 tttm -60.57 146.34 45.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.105 0.955 . . . . 0.0 110.431 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.643 ' OE1' HG21 ' A' ' 198' ' ' ILE . 4.2 mm-40 -61.15 128.57 37.07 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.63 40.54 97.61 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.862 -0.524 . . . . 0.0 112.862 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.844 HG21 HD22 ' A' ' 104' ' ' LEU . 31.9 m -83.38 178.09 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 118.861 1.33 . . . . 0.0 110.044 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -120.27 96.38 5.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.455 ' HD2' HG23 ' A' ' 108' ' ' VAL . 52.7 p90 -118.93 157.54 27.49 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.887 0.851 . . . . 0.0 112.407 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -116.67 157.3 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 159' ' ' LEU . 71.8 mt -116.46 154.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -137.87 122.17 18.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.809 -0.557 . . . . 0.0 109.507 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 mm -106.54 147.09 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 110.648 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 m -127.42 134.83 49.86 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.557 ' CD2' ' HE1' ' A' ' 126' ' ' MET . 41.1 p90 -152.18 140.78 20.77 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.0 111.203 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -88.43 142.33 27.81 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.436 0.636 . . . . 0.0 110.946 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.96 95.49 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -129.41 48.27 2.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.0 111.687 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 -67.08 0.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.294 -0.879 . . . . 0.0 110.764 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -143.1 178.07 7.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.15 107.83 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 70' ' ' VAL . 59.5 t -95.9 82.02 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 p -84.64 113.4 21.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.667 -0.646 . . . . 0.0 110.438 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.68 37.07 0.8 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.557 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -79.51 145.32 33.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.498 -1.001 . . . . 0.0 109.797 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -143.82 141.23 30.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 110.958 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -109.0 109.05 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.4 mt -96.66 161.46 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 110.117 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -159.34 118.9 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.69 -0.631 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 17.8 m-70 -106.41 134.7 49.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.726 . . . . 0.0 109.899 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.654 HG22 HD11 ' A' ' 139' ' ' ILE . 3.8 m -90.11 113.42 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.646 -0.659 . . . . 0.0 109.981 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 2.3 m-85 -111.38 119.32 38.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.679 . . . . 0.0 109.947 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -120.88 129.14 53.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.656 -0.652 . . . . 0.0 110.348 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt 52.68 39.25 28.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.35 -0.844 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.88 30.43 72.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.5 t -143.11 119.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.997 . . . . 0.0 109.881 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -77.22 138.88 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.137 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.654 HD11 HG22 ' A' ' 132' ' ' THR . 0.1 OUTLIER -116.8 -26.87 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.492 -0.755 . . . . 0.0 110.555 179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -169.67 144.97 3.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -142.42 139.88 31.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.5 m -120.51 160.8 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.824 . . . . 0.0 111.061 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -126.21 73.81 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.088 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.89 141.67 58.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.708 . . . . 0.0 110.613 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 ttt -94.37 124.27 38.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 158' ' ' PHE . 26.3 t -79.75 -58.86 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.26 175.75 14.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.1 p -86.29 147.88 25.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.922 . . . . 0.0 109.853 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.432 ' OH ' HG12 ' A' ' 146' ' ' VAL . 67.3 m-85 -146.31 135.73 22.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.44 161.03 30.92 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.66 62.58 5.57 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.41 1.216 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -170.52 54.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.469 -0.77 . . . . 0.0 110.418 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.749 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -155.99 23.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.499 -0.751 . . . . 0.0 111.244 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 40.46 -150.16 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.862 -0.524 . . . . 0.0 112.269 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.699 ' HG2' HG21 ' A' ' 73' ' ' THR . 49.8 mt-10 -67.41 114.42 6.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.28 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.749 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 3.9 m-85 -73.37 -173.34 1.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.606 -0.684 . . . . 0.0 109.755 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.96 82.53 1.44 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.571 -0.706 . . . . 0.0 110.727 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.533 ' HB2' HG13 ' A' ' 146' ' ' VAL . 42.7 t80 -80.97 161.99 24.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.392 -0.817 . . . . 0.0 109.384 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER -150.51 117.54 5.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.952 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.5 p -81.05 156.7 71.9 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.434 -0.791 . . . . 0.0 108.877 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 166.3 20.03 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.711 1.374 . . . . 0.0 110.979 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 135.62 56.31 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.417 0.627 . . . . 0.0 110.948 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.64 127.49 42.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.412 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -79.2 139.65 37.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.48 -0.762 . . . . 0.0 110.883 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.33 170.52 11.19 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.733 -0.605 . . . . 0.0 110.41 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.37 132.76 21.35 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 O-C-N 123.434 1.228 . . . . 0.0 110.405 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 -171.83 2.08 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.653 -0.655 . . . . 0.0 110.571 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.55 -157.15 15.19 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.45 -38.91 6.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.626 -0.926 . . . . 0.0 109.573 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.734 ' O ' HD23 ' A' ' 170' ' ' LEU . 2.2 tt -86.68 -22.68 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.761 -0.587 . . . . 0.0 110.235 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HB3' ' OE2' ' A' ' 106' ' ' GLU . . . -55.5 -22.21 20.02 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -0.848 . . . . 0.0 110.778 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.426 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 40.2 mtp180 -62.22 147.6 47.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 110.171 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 138.17 -171.95 23.15 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.6 p -96.26 137.06 35.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.6 -0.941 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.32 108.76 14.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.629 -0.669 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.76 131.71 42.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.442 -0.786 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.2 mt -121.27 147.99 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.32 -0.863 . . . . 0.0 110.725 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -112.23 111.01 21.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.438 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 3.1 m -103.39 125.0 49.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 110.135 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -113.92 114.55 26.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 110.315 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.442 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -96.11 130.54 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 109.938 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 t -156.2 -163.45 1.47 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.528 -0.733 . . . . 0.0 110.473 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 8.6 p-10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.651 -0.655 . . . . 0.0 109.932 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.103 0.478 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.28 96.46 5.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 1.6 m-70 -60.14 -47.33 86.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 109.805 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.594 HD23 ' HB ' ' A' ' 72' ' ' VAL . 23.3 tp -170.89 107.81 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.709 -0.619 . . . . 0.0 109.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -113.31 131.0 56.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.629 -0.67 . . . . 0.0 110.124 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.585 ' CE2' HD21 ' A' ' 90' ' ' LEU . 25.1 p90 -133.92 -154.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.761 . . . . 0.0 109.938 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -167.91 130.74 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.629 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 16.6 p-90 -133.14 146.23 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.681 . . . . 0.0 109.829 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.75 149.25 21.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.695 -0.628 . . . . 0.0 110.627 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.783 HD11 HD12 ' A' ' 104' ' ' LEU . 22.3 tp -121.33 108.76 14.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.689 -0.632 . . . . 0.0 109.391 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.5 m -78.22 136.8 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.643 HG21 ' OE1' ' A' ' 106' ' ' GLU . 47.6 mm -111.1 151.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.712 -0.618 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.35 -160.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.659 -0.65 . . . . 0.0 109.721 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -119.62 -30.79 4.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -135.73 59.9 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 111.493 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -66.09 -11.3 47.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.305 -0.872 . . . . 0.0 111.338 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -157.02 51.22 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.02 . . . . 0.0 110.205 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.591 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 70' ' ' VAL . 46.5 t -140.37 30.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.612 0.72 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.887 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -68.0 138.04 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.203 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.611 HG21 ' CZ3' ' A' ' 192' ' ' TRP . 67.5 t -63.07 124.39 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 116' ' ' PHE . 36.4 p -87.03 -63.5 1.3 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.258 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -135.99 172.16 13.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.357 -0.84 . . . . 0.0 111.119 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.08 124.51 14.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.712 -0.618 . . . . 0.0 109.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m -109.89 158.47 18.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.787 . . . . 0.0 110.455 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -142.3 103.22 4.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.229 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.0 t -105.53 166.95 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.497 -0.752 . . . . 0.0 110.34 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -160.45 -157.92 0.58 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.961 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -101.97 -29.41 11.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 0.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.4 p -138.17 41.78 2.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.675 -0.641 . . . . 0.0 110.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.449 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.39 163.43 31.06 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.592 -0.692 . . . . 0.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.27 -25.2 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.491 1.258 . . . . 0.0 110.244 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.04 167.57 25.84 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.44 100.07 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.515 1.271 . . . . 0.0 110.243 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.55 115.51 5.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.665 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -97.82 101.23 12.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.447 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -82.63 125.49 31.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.534 -0.729 . . . . 0.0 109.913 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.0 134.36 35.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.652 -0.655 . . . . 0.0 110.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.513 HD13 ' CG1' ' A' ' 72' ' ' VAL . 6.4 mt -135.27 55.15 1.9 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.66 -0.65 . . . . 0.0 109.923 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -106.34 -72.98 0.7 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.692 . . . . 0.0 110.524 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.4 -77.99 0.78 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.05 92.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.451 -1.029 . . . . 0.0 110.41 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 94' ' ' LEU . 44.2 mt -92.34 -37.69 12.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.663 -0.648 . . . . 0.0 110.046 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -18.84 36.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.511 -0.743 . . . . 0.0 110.879 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.1 p -53.89 -22.51 10.15 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.299 -0.876 . . . . 0.0 111.153 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 88' ' ' LEU . 7.0 m-30 -60.84 -30.24 69.98 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 109.87 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -60.78 -26.7 67.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.672 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.49 22.7 5.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.596 -0.69 . . . . 0.0 110.707 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -171.19 128.64 0.71 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 p -113.21 179.58 3.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.665 -0.647 . . . . 0.0 110.185 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 196' ' ' LEU . 7.1 m-85 -111.59 104.96 13.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.7 139.74 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.48 -0.762 . . . . 0.0 110.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -154.33 161.45 41.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.706 -0.621 . . . . 0.0 110.263 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.423 ' HB2' HG11 ' A' ' 108' ' ' VAL . 1.1 mtpm? -76.47 152.16 36.22 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.523 -0.735 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -20.61 -74.31 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.61 69.56 0.46 Allowed Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.415 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.651 HG21 HD22 ' A' ' 104' ' ' LEU . 33.9 m -80.27 -176.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.524 -0.986 . . . . 0.0 110.071 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.25 96.93 6.04 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.441 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 44.6 p90 -113.26 149.23 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.505 -0.747 . . . . 0.0 111.987 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HD3' HD21 ' A' ' 159' ' ' LEU . 2.5 ttt180 -107.32 155.48 19.93 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -121.43 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.008 -1.058 . . . . 0.0 111.197 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -120.83 107.29 12.54 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.28 151.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.44 -0.787 . . . . 0.0 111.073 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -131.32 152.1 50.89 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.65 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.1 p90 -167.84 159.05 11.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 111.15 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -93.06 135.92 33.8 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.202 0.525 . . . . 0.0 111.377 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.06 85.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.21 48.38 2.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.535 -0.728 . . . . 0.0 111.998 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -68.51 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 171.51 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 0.0 110.586 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.96 108.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.666 -0.646 . . . . 0.0 110.264 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 70' ' ' VAL . 65.6 t -93.99 75.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.646 -0.658 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.44 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 69.8 p -64.68 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.657 -0.652 . . . . 0.0 110.358 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.92 49.38 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.45 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -79.78 120.7 24.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.257 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -132.88 148.2 52.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 111.1 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -125.38 113.37 17.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -114.47 146.71 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.625 -0.672 . . . . 0.0 110.511 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.67 141.83 43.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.556 -0.715 . . . . 0.0 110.08 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.815 ' O ' HG23 ' A' ' 177' ' ' ILE . 13.8 m-70 -101.07 164.72 11.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.684 . . . . 0.0 109.634 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.426 ' CG2' HD11 ' A' ' 139' ' ' ILE . 17.6 m -119.7 61.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.951 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.88 118.75 7.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.741 . . . . 0.0 110.417 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.603 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -120.92 138.26 54.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.619 -0.675 . . . . 0.0 110.017 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? 53.35 28.74 7.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.412 -0.805 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.37 -11.46 63.34 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.196 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.8 m -111.55 148.02 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.024 -1.28 . . . . 0.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 135.92 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.284 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.426 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -120.68 -26.26 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.752 . . . . 0.0 111.049 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -176.3 146.02 0.62 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -133.67 143.13 48.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.535 -0.728 . . . . 0.0 109.76 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 129' ' ' ILE . 17.2 m -109.9 151.83 26.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.604 -0.685 . . . . 0.0 111.043 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -126.05 136.39 52.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.63 -0.669 . . . . 0.0 109.836 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -123.41 129.02 50.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.451 -0.781 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.7 ttm -91.75 107.97 19.58 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.845 HG12 ' CE1' ' A' ' 149' ' ' TYR . 61.8 t -79.68 -44.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.309 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.68 -173.82 19.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.44 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 31.9 m -84.84 126.32 33.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.604 -0.939 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.845 ' CE1' HG12 ' A' ' 146' ' ' VAL . 8.8 m-85 -113.51 131.46 56.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.725 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -118.19 145.09 18.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.81 142.77 35.97 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.382 1.201 . . . . 0.0 110.186 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.61 -39.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.566 -0.709 . . . . 0.0 110.774 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.6 -81.85 0.46 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 111.416 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.28 -136.31 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 110.424 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.78 166.01 22.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.887 -1.133 . . . . 0.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 33.5 m-85 -121.31 -175.99 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -133.78 114.96 13.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.447 -0.783 . . . . 0.0 111.019 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.615 ' CD1' HG13 ' A' ' 146' ' ' VAL . 34.4 t80 -100.41 159.97 14.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.725 . . . . 0.0 109.202 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.438 HD21 ' HD3' ' A' ' 111' ' ' ARG . 1.1 tt -149.81 118.79 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.459 -0.776 . . . . 0.0 110.946 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.6 p -89.78 156.41 47.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.094 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.53 169.53 12.58 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.652 1.343 . . . . 0.0 110.83 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 129.47 41.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.406 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 7.2 mm-40 -116.33 127.27 54.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.626 -0.671 . . . . 0.0 109.631 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -83.2 133.61 35.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.441 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -82.79 165.15 43.32 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.765 -0.585 . . . . 0.0 110.188 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.2 Cg_endo -73.2 123.69 8.97 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.401 1.211 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 169.2 8.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.654 -0.653 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.01 160.82 10.76 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.78 -43.54 97.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.969 . . . . 0.0 110.151 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -79.67 -27.35 40.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.647 -0.658 . . . . 0.0 110.216 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.97 -22.18 59.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.499 -0.751 . . . . 0.0 110.645 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -68.23 131.17 44.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.478 -0.764 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 151.71 179.4 27.34 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.2 p -87.44 130.16 34.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.524 -0.986 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.03 113.88 26.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 110.641 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.86 125.33 29.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.458 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 131' ' ' HIS . 17.7 mt -117.61 137.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.379 -0.825 . . . . 0.0 110.959 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -103.31 96.86 7.04 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.4 p -94.25 125.39 38.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.683 . . . . 0.0 110.671 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -127.6 96.83 4.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.681 . . . . 0.0 109.997 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -83.14 91.27 7.2 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.586 -0.696 . . . . 0.0 110.087 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.9 t -116.98 -171.77 2.09 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 p30 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.364 179.151 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.502 2.143 0 CA-C-O 121.242 0.544 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.07 120.01 38.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 16.3 m-70 -82.75 -73.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.779 . . . . 0.0 110.864 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.887 HD22 HG13 ' A' ' 71' ' ' VAL . 3.1 tp -156.05 151.19 26.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.669 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 t -153.86 139.69 18.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.663 . . . . 0.0 109.786 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.611 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 21.9 p90 -135.19 -153.57 0.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.99 132.01 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 17.0 p-90 -139.33 147.1 41.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.678 -0.639 . . . . 0.0 109.614 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.78 152.05 20.95 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.518 0.675 . . . . 0.0 111.26 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 102' ' ' PHE . 9.4 tp -126.16 91.54 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -67.9 137.2 55.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.608 -0.682 . . . . 0.0 110.436 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -114.53 145.3 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 109.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -144.16 -153.07 0.45 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 109.84 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -132.06 1.41 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.399 -0.813 . . . . 0.0 111.661 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -160.23 46.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.942 -1.099 . . . . 0.0 111.122 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.478 ' CH2' HD21 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -59.15 -18.63 37.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 111.197 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -152.47 48.24 0.75 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.219 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.499 ' ND2' HG23 ' A' ' 70' ' ' VAL . 1.8 t-20 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 123' ' ' VAL . 93.3 t -141.92 117.76 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.507 0.67 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.0 t -139.66 144.05 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.899 -0.501 . . . . 0.0 109.775 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.0 t -64.27 99.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 116' ' ' PHE . 82.1 p -70.83 -44.63 66.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.715 -0.616 . . . . 0.0 111.228 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -154.97 158.0 38.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 76' ' ' THR . 8.2 tt -119.32 152.57 36.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.724 -0.61 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.555 ' N ' HD23 ' A' ' 75' ' ' LEU . 19.5 m -139.77 152.64 46.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -0.765 . . . . 0.0 110.631 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -136.67 83.52 2.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.574 -0.704 . . . . 0.0 109.973 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.85 149.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.634 . . . . 0.0 110.14 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 94.8 m -146.07 -164.96 2.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.693 -0.629 . . . . 0.0 110.037 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.6 p -103.53 -76.9 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.775 . . . . 0.0 110.758 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 p -96.26 32.59 1.93 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.826 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.28 178.99 1.63 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.652 -0.655 . . . . 0.0 110.087 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.771 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 46.6 Cg_endo -74.25 -26.85 12.1 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.342 1.18 . . . . 0.0 110.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 156.63 -179.42 32.48 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.0 Cg_endo -71.72 111.4 3.13 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.488 1.257 . . . . 0.0 110.416 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' CD1' ' A' ' 102' ' ' PHE . 13.8 mt -65.76 115.66 6.14 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.99 137.78 34.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.97 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 3.9 mt -132.71 119.67 20.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 0.0 109.717 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.49 141.95 50.17 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.599 HD21 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -138.51 56.3 1.72 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.753 . . . . 0.0 110.059 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -105.99 -66.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.265 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.57 -46.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.91 65.15 1.94 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.574 -0.956 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.651 HD23 ' CE1' ' A' ' 97' ' ' PHE . 13.4 mt -84.19 0.1 50.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.575 -0.703 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.61 -27.29 64.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.029 . . . . 0.0 110.787 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.8 m -65.42 -13.77 59.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.463 -0.773 . . . . 0.0 111.065 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.97 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 10.7 m-85 -72.19 -52.51 16.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.286 -0.883 . . . . 0.0 110.711 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -57.68 -20.24 32.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.521 -0.737 . . . . 0.0 111.007 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -115.0 44.96 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.4 -0.812 . . . . 0.0 110.393 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -168.66 146.55 4.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 p -150.98 131.39 13.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 109.82 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.938 ' CD1' HD22 ' A' ' 86' ' ' LEU . 15.1 m-85 -77.12 122.99 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 110.189 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.65 113.17 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 109.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.015 HD21 HG22 ' A' ' 108' ' ' VAL . 4.1 tt -113.62 156.81 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.657 ' N ' HD23 ' A' ' 104' ' ' LEU . 31.8 tttt -80.9 161.8 24.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -40.82 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 29.73 66.77 0.11 Allowed Glycine 0 N--CA 1.507 3.372 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.777 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.015 HG22 HD21 ' A' ' 104' ' ' LEU . 30.5 m -79.01 -160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.224 -1.162 . . . . 0.0 109.201 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.09 117.11 27.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.464 -0.773 . . . . 0.0 109.54 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.604 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 10.8 p90 -137.67 152.13 48.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.306 -0.872 . . . . 0.0 111.916 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -109.67 150.27 28.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.39 151.56 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.133 -0.979 . . . . 0.0 111.703 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HG3' HD23 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -126.24 93.28 3.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.989 HG21 ' CE2' ' A' ' 181' ' ' PHE . 47.8 mm -81.18 142.6 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.743 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.8 m -122.08 135.94 54.86 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.758 ' HA ' HG23 ' A' ' 73' ' ' THR . 15.5 p90 -153.06 145.34 23.95 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.333 -0.854 . . . . 0.0 111.158 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -88.52 128.25 35.55 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 70' ' ' VAL . 59.9 t -123.39 84.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.75 48.88 2.32 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 111.86 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -145.42 -66.32 0.31 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.237 -0.914 . . . . 0.0 110.904 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.74 168.92 17.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.339 -0.851 . . . . 0.0 110.412 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.29 108.37 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.99 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 70' ' ' VAL . 97.6 t -89.4 86.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 109.798 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.3 p -88.11 88.48 7.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.616 -0.677 . . . . 0.0 110.384 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 137.94 44.64 0.08 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -80.99 121.07 25.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 109.793 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -129.5 137.42 50.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.728 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.502 ' CD1' ' CD2' ' A' ' 181' ' ' PHE . 14.0 t80 -111.62 139.02 47.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.723 . . . . 0.0 109.678 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.0 mt -136.79 144.45 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.541 -0.725 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.52 144.28 37.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 110.057 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 14.9 m-70 -117.23 116.92 28.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.596 -0.69 . . . . 0.0 110.156 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 139' ' ' ILE . 29.3 m -68.04 77.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 0.0 110.202 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 4.2 m-85 -76.39 125.99 30.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 7.9 tpt180 -120.75 120.89 36.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt 52.89 38.59 27.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.488 -0.757 . . . . 0.0 110.754 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 72.8 35.56 58.47 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.5 t -147.1 109.14 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.955 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 4.9 pttm -63.02 128.9 37.99 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.637 -0.664 . . . . 0.0 110.232 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pt -115.53 -23.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.635 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.43 132.18 0.29 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.89 149.99 49.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.683 . . . . 0.0 109.634 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -127.56 154.89 44.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.514 -0.741 . . . . 0.0 110.838 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -126.01 121.44 33.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.63 -0.669 . . . . 0.0 110.052 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -110.99 145.7 37.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.703 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -92.08 119.33 31.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.228 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 58.9 t -79.58 -52.43 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 110.304 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.7 175.81 14.2 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 30.8 t -99.02 139.37 34.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.927 . . . . 0.0 110.063 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.492 ' HE2' HG12 ' A' ' 146' ' ' VAL . 47.0 m-85 -142.04 126.89 18.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.694 . . . . 0.0 110.308 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.25 164.78 28.56 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.08 92.97 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.447 1.235 . . . . 0.0 110.342 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -169.49 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 0.0 110.447 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.778 ' HB3' ' CZ ' ' A' ' 156' ' ' TYR . . . -92.43 19.33 7.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.542 -0.724 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 38.1 mt-10 56.2 -143.88 0.7 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 152.35 45.5 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.05 -1.031 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.778 ' CZ ' ' HB3' ' A' ' 153' ' ' ALA . 42.0 m-85 -116.13 -176.31 2.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 109.546 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -147.49 104.31 3.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.509 -0.744 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.531 ' HE2' HG22 ' A' ' 160' ' ' THR . 34.9 t80 -77.85 165.81 23.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -146.87 97.57 2.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.396 -0.815 . . . . 0.0 110.653 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.531 HG22 ' HE2' ' A' ' 158' ' ' PHE . 75.0 p -72.79 149.17 90.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.46 157.55 54.28 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.415 1.218 . . . . 0.0 110.702 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.71 93.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.606 -0.684 . . . . 0.0 110.976 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -79.87 167.71 20.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.416 -0.803 . . . . 0.0 109.862 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.69 123.32 48.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.504 -0.747 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -75.45 177.03 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.4 Cg_endo -73.45 127.73 12.09 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.298 1.157 . . . . 0.0 111.112 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 5.4 ptpp? -115.63 174.97 5.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 110.121 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.65 156.5 10.66 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 15.2 ttt -62.33 -46.61 87.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.734 -0.862 . . . . 0.0 109.998 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.3 tt -73.89 -26.42 60.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.645 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -57.93 -20.7 39.44 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.421 -0.799 . . . . 0.0 110.719 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 2.7 mtp-105 -58.5 125.22 22.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.304 -0.872 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.75 175.4 27.65 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.4 p -84.86 134.7 34.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.594 -0.945 . . . . 0.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 32.3 m-85 -115.59 101.41 8.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.607 -0.683 . . . . 0.0 110.693 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.18 121.37 17.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.714 . . . . 0.0 109.112 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.516 HD12 ' CZ2' ' A' ' 194' ' ' TRP . 42.6 mt -110.09 126.61 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.53 -0.732 . . . . 0.0 110.99 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -87.4 92.52 9.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.685 -0.634 . . . . 0.0 109.879 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.0 p -84.98 140.94 30.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.658 -0.651 . . . . 0.0 110.674 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.82 83.62 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.892 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -78.26 128.66 34.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.668 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -162.72 -169.88 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.672 . . . . 0.0 110.52 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.878 -0.514 . . . . 0.0 109.762 179.686 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 121.105 0.479 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.35 110.99 20.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.48 -55.04 13.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.464 -0.773 . . . . 0.0 110.665 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -166.54 164.19 17.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 190' ' ' LEU . 17.6 p -168.23 134.73 1.99 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.853 -0.529 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.599 ' CD2' HD21 ' A' ' 90' ' ' LEU . 14.5 p90 -147.0 -155.21 0.6 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 110.442 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -157.81 127.68 6.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.533 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 12.3 p-90 -134.79 146.21 49.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.697 -0.627 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.91 136.11 40.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.656 -0.653 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.748 HD21 HD13 ' A' ' 104' ' ' LEU . 6.7 tp -110.36 98.55 7.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.6 m -73.14 121.07 19.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.651 -0.656 . . . . 0.0 110.515 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 104' ' ' LEU . 47.7 mm -90.24 149.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.592 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 -155.82 0.64 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 110.456 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -120.22 -21.3 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.504 -0.747 . . . . 0.0 111.268 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -155.04 81.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -79.74 3.21 20.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.478 -0.764 . . . . 0.0 111.501 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 44.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.086 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 123' ' ' VAL . 77.7 t -110.15 140.09 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.662 . . . . 0.0 110.354 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HD22 ' A' ' 190' ' ' LEU . 72.3 t -149.43 144.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.731 -0.606 . . . . 0.0 109.616 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 HD13 ' A' ' 90' ' ' LEU . 57.4 t -68.4 100.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 117' ' ' ARG . 68.0 p -70.23 -44.46 68.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.596 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -159.29 173.92 15.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 76' ' ' THR . 9.7 tt -144.3 164.41 30.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.688 -0.632 . . . . 0.0 109.544 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.678 ' N ' HD23 ' A' ' 75' ' ' LEU . 27.4 m -151.55 163.01 39.98 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.432 -0.792 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -143.36 84.19 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.604 -0.685 . . . . 0.0 109.895 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.98 143.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.731 -0.606 . . . . 0.0 110.106 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 89.7 m -141.67 -163.13 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.592 -0.693 . . . . 0.0 110.077 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.9 p -110.53 -72.68 0.71 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.466 -0.772 . . . . 0.0 110.677 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -95.75 27.66 3.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.565 -0.709 . . . . 0.0 110.639 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.27 -176.52 0.65 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -76.28 -25.04 10.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.311 1.163 . . . . 0.0 110.016 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.07 -177.08 30.91 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.484 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 91.55 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.556 1.292 . . . . 0.0 110.558 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.83 111.41 2.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.696 . . . . 0.0 109.386 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.86 159.83 14.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.0 110.872 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.801 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.4 mt -132.18 128.16 37.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.722 -0.611 . . . . 0.0 109.912 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 133.46 40.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -132.09 51.79 2.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.3 p -123.82 -65.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.391 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.92 -53.18 0.21 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.99 71.97 0.4 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.541 -0.976 . . . . 0.0 110.158 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -93.71 -33.84 13.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.29 -26.99 65.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.591 -0.693 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.4 t -60.34 -23.68 64.44 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 110.472 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.801 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.3 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -73.63 -26.96 61.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.64 -0.663 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -105.08 28.91 6.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.453 -0.779 . . . . 0.0 110.284 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -158.46 139.82 13.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.716 . . . . 0.0 110.127 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -126.24 -175.8 3.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 110.4 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.7 m-85 -116.65 109.31 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.673 -0.642 . . . . 0.0 109.99 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.11 105.73 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -0.779 . . . . 0.0 109.793 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.071 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -122.43 158.62 29.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.627 -0.67 . . . . 0.0 110.077 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.683 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.2 tttt -87.22 161.56 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.472 -0.767 . . . . 0.0 110.385 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 105' ' ' LYS . 33.9 mt-10 -18.58 -71.63 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -150.27 63.26 0.4 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.699 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.071 HG22 HD21 ' A' ' 104' ' ' LEU . 34.5 m -73.29 127.41 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.442 -1.034 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -71.71 94.77 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.6 p90 -109.49 154.87 22.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 111.838 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.3 131.1 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 76' ' ' THR . 62.1 mt -96.04 142.28 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.261 -0.9 . . . . 0.0 110.533 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -117.85 102.69 9.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.7 mm -88.11 127.92 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.755 . . . . 0.0 110.685 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -113.06 137.89 50.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 116' ' ' PHE . 19.5 p90 -151.05 174.84 12.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 110.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.6 mmm-85 -127.64 150.83 49.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 111.322 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -132.67 111.32 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -128.66 48.39 2.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.472 -0.767 . . . . 0.0 111.472 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -69.71 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.0 110.646 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -137.93 171.98 13.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.431 -0.793 . . . . 0.0 110.472 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 149' ' ' TYR . 86.9 mt -80.0 109.84 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.615 . . . . 0.0 109.966 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 70' ' ' VAL . 66.9 t -84.65 82.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.848 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 p -81.21 77.58 8.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.637 -0.664 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.97 46.08 0.04 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.623 ' HE3' ' CE2' ' A' ' 181' ' ' PHE . 1.3 tpp -79.54 137.68 37.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.546 -0.973 . . . . 0.0 109.489 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -126.11 158.15 36.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -134.31 109.9 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.4 mp -107.74 166.22 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.496 -0.753 . . . . 0.0 110.437 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.474 ' N ' HG22 ' A' ' 129' ' ' ILE . 7.8 mt-30 -154.96 127.89 8.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.665 -0.647 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 12.9 m-70 -110.32 117.19 32.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 139' ' ' ILE . 19.3 m -68.51 78.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 0.0 109.902 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 2.7 m-85 -78.25 105.1 9.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.191 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.533 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.0 tpt180 -120.76 153.76 36.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.683 -0.636 . . . . 0.0 109.686 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 52.91 36.22 21.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.33 -0.857 . . . . 0.0 110.786 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.437 ' C ' HG13 ' A' ' 137' ' ' VAL . . . 63.32 23.91 66.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 134' ' ' ARG . 35.4 m -149.3 149.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.306 -1.114 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 21.8 ttmt -80.1 136.31 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.0 110.247 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -118.5 -25.19 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.456 -0.778 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -174.69 143.29 0.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.104 -0.998 . . . . 0.0 110.248 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 2.9 pttt -137.76 166.45 23.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.234 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.1 m -145.0 156.56 44.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.586 -0.696 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.91 132.65 52.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 110.335 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -123.08 121.92 37.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.709 . . . . 0.0 110.576 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.406 ' O ' ' CZ ' ' A' ' 158' ' ' PHE . 23.6 mtp -65.15 122.08 16.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -0.786 . . . . 0.0 109.29 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 158' ' ' PHE . 48.8 t -79.27 -56.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 110.298 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 137.41 174.04 13.17 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 p -84.99 150.31 24.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.701 -0.882 . . . . 0.0 109.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.507 ' CE2' HG12 ' A' ' 146' ' ' VAL . 69.8 m-85 -146.7 161.32 40.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.357 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -110.07 154.55 16.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -72.64 -156.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.713 1.375 . . . . 0.0 110.321 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 25.4 mtp-105 73.09 51.23 0.14 Allowed 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 50.64 23.69 1.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.428 -0.795 . . . . 0.0 111.852 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 tt0 -79.38 103.43 9.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.56 112.91 24.8 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.615 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 78.5 m-85 -96.75 -175.3 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.738 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -141.02 112.51 7.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.681 ' HB2' HG13 ' A' ' 146' ' ' VAL . 30.8 t80 -83.82 160.46 21.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.226 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.05 100.82 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 111.459 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.4 p -69.56 149.35 97.01 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.35 -179.45 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.591 1.311 . . . . 0.0 111.077 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptm -53.73 144.88 16.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.685 -0.634 . . . . 0.0 111.232 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.407 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 12.3 mt-10 -140.54 96.35 3.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.73 -0.606 . . . . 0.0 109.673 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.76 121.76 17.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.625 -0.672 . . . . 0.0 110.595 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -55.0 176.49 0.15 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.723 -0.611 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.762 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 45.6 Cg_endo -71.08 118.38 5.66 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.367 1.193 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 20.6 mttt -90.75 165.85 13.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.605 -0.684 . . . . 0.0 110.712 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.82 143.64 14.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.467 ' HA ' ' CD ' ' A' ' 172' ' ' ARG . 30.6 mtp -60.26 -42.24 94.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.521 -0.988 . . . . 0.0 109.511 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 170' ' ' LEU . 1.9 tm? -64.55 -22.23 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.869 -0.519 . . . . 0.0 109.938 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -92.72 23.06 4.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.82 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 169' ' ' MET . 45.9 mtm180 -100.37 176.85 5.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.257 -0.902 . . . . 0.0 110.029 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 105.63 -173.99 20.64 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.9 p -86.04 131.05 34.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.924 . . . . 0.0 110.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 134' ' ' ARG . 24.7 m-85 -116.67 108.5 15.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.688 -0.633 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -73.85 121.2 20.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.533 -0.73 . . . . 0.0 109.128 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.3 mt -110.09 129.61 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.4 -0.812 . . . . 0.0 111.061 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 108.54 20.41 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.698 -0.626 . . . . 0.0 109.729 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -113.16 135.15 54.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.53 ' CD ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.8 118.43 23.71 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.604 0.716 . . . . 0.0 110.361 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.623 ' CE2' ' HE3' ' A' ' 126' ' ' MET . 0.9 OUTLIER -91.41 94.64 9.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.535 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -116.82 -172.5 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 111.092 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.88 -0.512 . . . . 0.0 109.904 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 121.239 0.543 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.89 118.62 34.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.728 -0.607 . . . . 0.0 109.757 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -57.87 -50.79 72.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.483 -0.761 . . . . 0.0 110.697 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.678 HD22 HG13 ' A' ' 71' ' ' VAL . 4.0 tp -169.4 151.12 4.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 65.3 p -147.74 161.29 41.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 16.9 p90 -146.58 -156.23 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.766 . . . . 0.0 110.232 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.94 131.45 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.621 -0.674 . . . . 0.0 110.562 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.86 146.31 41.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.652 -0.655 . . . . 0.0 109.799 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.69 146.59 24.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.699 . . . . 0.0 111.079 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 102' ' ' PHE . 53.2 tp -116.23 97.43 6.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.4 m -72.11 111.9 7.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 0.0 110.081 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 48.5 mm -90.41 146.94 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.625 -0.672 . . . . 0.0 109.811 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -138.25 -156.91 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.684 -0.635 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -115.85 -24.31 8.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 110.72 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.79 94.89 1.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.611 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.821 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -84.95 12.19 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.606 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -153.65 40.1 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 110.18 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.116 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.079 0.466 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 123' ' ' VAL . 95.7 t -119.96 126.51 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.792 -0.567 . . . . 0.0 110.164 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 70' ' ' VAL . 64.5 t -149.02 132.55 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.832 -0.542 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.0 t -67.18 108.64 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.778 HG23 ' HA ' ' A' ' 116' ' ' PHE . 68.7 p -71.2 -62.05 1.54 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.66 . . . . 0.0 110.728 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -141.03 169.01 18.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.944 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.3 tt -130.64 124.49 31.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.648 -0.657 . . . . 0.0 109.744 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 112' ' ' ILE . 46.9 m -109.9 159.71 17.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -0.782 . . . . 0.0 110.486 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mt -139.76 84.15 1.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.539 -0.726 . . . . 0.0 109.978 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 59.6 t -82.21 166.68 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.685 -0.634 . . . . 0.0 110.344 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -162.24 -152.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.607 -0.683 . . . . 0.0 109.847 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.04 -36.24 2.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 111.068 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -126.7 26.25 6.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.348 -0.845 . . . . 0.0 110.8 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.36 -175.51 0.54 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.403 -0.811 . . . . 0.0 110.235 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.7 Cg_endo -80.14 -30.97 1.91 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.313 1.165 . . . . 0.0 109.97 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.61 175.54 36.24 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.521 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 47.3 Cg_endo -72.4 104.67 1.73 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.521 1.274 . . . . 0.0 110.506 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.62 HD22 ' CD1' ' A' ' 102' ' ' PHE . 2.4 mp -69.41 112.42 5.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 109.493 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.72 146.53 23.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.629 -0.67 . . . . 0.0 110.749 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.934 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -132.42 153.88 50.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 109.81 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.86 133.76 47.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.478 -0.764 . . . . 0.0 110.508 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -132.02 51.93 2.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.501 -0.75 . . . . 0.0 110.103 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.9 p -113.52 -69.57 0.85 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.94 -47.3 0.15 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -72.48 64.9 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.639 -0.919 . . . . 0.0 109.987 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -90.24 -23.16 21.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.397 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.37 -30.67 62.98 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.29 -0.881 . . . . 0.0 110.767 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -58.08 -20.23 38.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.486 -0.759 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -60.02 -30.39 69.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.92 -22.7 66.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.743 -0.598 . . . . 0.0 110.931 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -121.92 60.11 0.98 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.697 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.421 ' CG ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -170.61 125.03 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.374 -0.829 . . . . 0.0 110.363 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.4 p -135.04 127.18 29.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.62 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.8 m-85 -73.98 139.05 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.537 -0.727 . . . . 0.0 109.881 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.16 108.27 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.485 -0.76 . . . . 0.0 110.449 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 196' ' ' LEU . 58.0 mt -113.87 165.73 12.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.55 -0.718 . . . . 0.0 109.69 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 108' ' ' VAL . 15.1 tttm -94.46 160.93 14.43 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -18.28 -108.86 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.99 75.4 0.39 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.33 -1.481 . . . . 0.0 110.144 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 105' ' ' LYS . 34.3 m -85.26 143.76 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.536 -0.979 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -88.92 89.25 7.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.433 ' HE2' HD11 ' A' ' 112' ' ' ILE . 38.6 p90 -110.0 131.09 55.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 111.917 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.02 159.64 14.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 76' ' ' THR . 76.4 mt -126.2 145.3 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.053 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -118.06 102.35 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.432 HG21 ' HE2' ' A' ' 181' ' ' PHE . 48.1 mm -85.2 127.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.522 -0.736 . . . . 0.0 110.851 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.18 145.98 31.92 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.778 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -162.43 149.16 13.25 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.363 -0.835 . . . . 0.0 111.009 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.476 ' HG3' HG21 ' A' ' 73' ' ' THR . 9.0 mtm180 -101.57 133.16 46.68 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.361 0.601 . . . . 0.0 111.282 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.06 96.43 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.52 48.64 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.344 -0.847 . . . . 0.0 111.742 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -146.76 -69.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.224 -0.923 . . . . 0.0 110.794 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.9 158.16 40.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.19 102.9 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.565 -0.709 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 70' ' ' VAL . 62.8 t -85.72 94.99 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.616 -0.677 . . . . 0.0 109.826 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.13 97.83 8.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.617 -0.677 . . . . 0.0 110.294 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.17 41.03 0.38 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.628 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -78.86 126.19 30.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.942 . . . . 0.0 109.78 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 146' ' ' VAL . 1.5 ptmm? -137.2 146.87 45.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HH ' ' HZ2' ' A' ' 192' ' ' TRP . 21.6 t80 -111.13 137.84 48.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -123.19 156.45 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.516 -0.74 . . . . 0.0 110.231 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -154.64 131.88 11.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.793 -0.567 . . . . 0.0 109.74 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.403 ' ND1' ' CB ' ' A' ' 141' ' ' LYS . 23.8 m-70 -110.64 131.56 54.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.547 -0.721 . . . . 0.0 110.098 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 31.3 m -81.87 67.3 7.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.615 -0.678 . . . . 0.0 109.837 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 6.4 m-85 -61.57 136.92 58.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.498 -0.751 . . . . 0.0 110.104 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -120.84 110.53 16.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.75 35.91 22.56 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.471 -0.768 . . . . 0.0 110.588 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.413 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.28 35.31 14.96 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.1 t -147.13 113.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -1.041 . . . . 0.0 110.143 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -67.64 123.92 21.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.649 -0.657 . . . . 0.0 110.189 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.65 -22.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.486 -0.759 . . . . 0.0 110.8 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -169.36 123.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.403 ' CB ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -130.86 154.15 48.36 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.697 . . . . 0.0 109.468 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.5 m -142.45 146.03 34.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -109.33 120.51 42.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.695 -0.628 . . . . 0.0 109.462 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -104.37 117.68 34.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.443 -0.786 . . . . 0.0 110.946 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 124.9 23.92 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 21.7 t -90.53 -56.5 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 110.25 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.33 166.68 10.76 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 79.5 p -81.0 140.63 35.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.637 -0.92 . . . . 0.0 109.558 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 146' ' ' VAL . 43.9 m-85 -139.45 130.04 25.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.425 -0.797 . . . . 0.0 110.36 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.23 166.84 14.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.24 68.89 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.486 1.256 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.96 27.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.666 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -147.3 12.54 1.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 111.676 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 52.21 -145.08 0.57 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.956 -1.09 . . . . 0.0 111.09 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.1 122.4 20.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.39 -0.819 . . . . 0.0 110.948 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 6.5 m-85 -84.17 -173.51 4.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.724 . . . . 0.0 109.911 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -153.9 104.45 2.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 22.3 t80 -85.18 162.61 19.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -140.44 87.1 2.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.403 -0.811 . . . . 0.0 111.305 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.416 HG22 ' HE2' ' A' ' 158' ' ' PHE . 65.5 p -67.19 148.27 98.83 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.37 -0.831 . . . . 0.0 108.965 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.26 157.73 60.57 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.392 1.206 . . . . 0.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.2 ptt? -54.61 108.67 0.41 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.574 -0.704 . . . . 0.0 110.659 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -88.55 155.97 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.38 -0.825 . . . . 0.0 110.296 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.73 137.7 44.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.284 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.628 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -94.16 172.15 6.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.323 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.628 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.0 Cg_endo -73.18 179.77 5.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.382 1.201 . . . . 0.0 110.529 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -170.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.439 -0.788 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.06 -44.14 0.09 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.7 mtt -56.2 -75.27 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -1.102 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -77.64 -2.55 36.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.982 179.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.421 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -124.26 28.75 6.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -0.946 . . . . 0.0 110.082 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 163.98 27.22 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.517 -0.739 . . . . 0.0 109.985 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.18 -167.78 14.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.1 p -107.23 130.46 54.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.663 -0.904 . . . . 0.0 110.661 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.61 129.72 50.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.671 -0.643 . . . . 0.0 109.954 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.8 OUTLIER -73.27 143.04 47.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.745 . . . . 0.0 109.851 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.831 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -121.43 130.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.51 -0.744 . . . . 0.0 110.199 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -110.92 98.89 7.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.534 -0.729 . . . . 0.0 109.307 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 10.0 m -100.82 133.66 44.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.648 -0.658 . . . . 0.0 110.422 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -139.54 90.51 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.706 -0.621 . . . . 0.0 109.39 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -75.77 116.47 16.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.837 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 t -129.1 -175.38 3.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.755 -0.59 . . . . 0.0 109.803 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 4.4 p30 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 121.201 0.524 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.59 115.75 30.12 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 31.8 p80 -74.36 -15.21 60.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 0.0 111.31 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.1 tp -168.83 156.22 7.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.124 -0.985 . . . . 0.0 110.853 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.0 p -168.38 143.79 3.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.739 -0.6 . . . . 0.0 109.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CE2' HD21 ' A' ' 90' ' ' LEU . 40.4 p90 -151.19 -156.15 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 110.095 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.6 132.88 3.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 111.085 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -139.33 165.44 27.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.79 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -102.19 159.68 15.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 111.291 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 104' ' ' LEU . 17.6 tp -129.48 109.75 11.31 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.1 m -85.28 130.11 34.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.696 . . . . 0.0 110.85 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.98 152.14 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.63 -0.669 . . . . 0.0 109.402 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -145.13 -151.83 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 110.605 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -107.43 -39.49 5.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 111.302 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -144.6 98.08 3.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.21 -0.931 . . . . 0.0 111.207 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -89.09 35.1 0.79 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.191 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -169.71 34.13 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.27 -0.894 . . . . 0.0 110.136 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.904 -1.045 . . . . 0.0 110.173 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.408 ' OD1' HG23 ' A' ' 70' ' ' VAL . 42.2 t-20 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 120.84 0.352 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 123' ' ' VAL . 94.3 t -130.06 112.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.623 . . . . 0.0 110.461 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -138.64 149.5 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.926 -0.484 . . . . 0.0 109.885 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.678 HG22 ' CD2' ' A' ' 181' ' ' PHE . 59.7 t -65.68 103.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.864 HG23 ' HA ' ' A' ' 116' ' ' PHE . 71.0 p -72.02 -35.94 69.55 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.146 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -167.31 173.09 9.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 110.4 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.5 tt -142.68 124.59 15.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.577 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 77' ' ' LEU . 24.5 m -109.7 167.19 10.33 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.56 -0.713 . . . . 0.0 110.843 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -147.03 80.98 1.54 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.62 -0.675 . . . . 0.0 109.39 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 85' ' ' PRO . 67.0 t -77.49 166.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 110.157 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' N ' HG12 ' A' ' 78' ' ' VAL . 1.2 m -161.17 -166.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.691 -0.63 . . . . 0.0 110.192 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.8 p -116.55 -33.13 4.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -124.17 20.21 9.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.708 . . . . 0.0 110.856 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.62 -174.83 0.47 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.5 Cg_endo -81.02 -30.87 1.51 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.27 1.142 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.19 173.17 34.36 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.89 -1.147 . . . . 0.0 110.55 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.715 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.3 Cg_endo -71.56 96.32 0.74 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.665 1.35 . . . . 0.0 110.372 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 3.6 mt -64.81 123.87 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.652 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 53.1 mt-10 -103.52 122.76 45.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.501 -0.749 . . . . 0.0 110.802 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -102.6 119.17 38.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -67.58 141.0 56.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.587 -0.695 . . . . 0.0 110.688 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -140.35 56.83 1.6 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.471 -0.768 . . . . 0.0 110.073 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.8 p -128.53 -56.22 1.23 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.684 -0.635 . . . . 0.0 110.3 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.89 -51.9 0.04 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.39 69.94 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.597 -0.943 . . . . 0.0 110.147 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 94' ' ' LEU . 10.9 mt -94.23 -22.69 18.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.51 -0.744 . . . . 0.0 110.579 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -22.17 12.88 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.373 -0.83 . . . . 0.0 111.08 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.26 63.38 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 0.0 110.548 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.5 m-85 -58.97 -60.34 4.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.362 -0.836 . . . . 0.0 110.667 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -13.45 47.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.482 -0.761 . . . . 0.0 111.231 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -86.36 -15.99 38.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.16 -0.962 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.68 162.23 34.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -132.4 167.74 19.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.444 ' CE2' HD13 ' A' ' 77' ' ' LEU . 3.9 m-85 -103.18 113.13 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.636 -0.665 . . . . 0.0 109.874 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 104' ' ' LEU . 60.4 t -88.89 117.27 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 110.787 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.673 ' HB3' HG21 ' A' ' 108' ' ' VAL . 37.0 mt -127.6 145.02 51.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.794 ' O ' HG13 ' A' ' 108' ' ' VAL . 26.9 tttm -65.21 142.08 58.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.213 -0.93 . . . . 0.0 108.848 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.0 pt-20 -57.13 110.64 0.87 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.404 -0.81 . . . . 0.0 111.523 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.2 39.73 3.68 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.762 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 105' ' ' LYS . 27.6 m -99.12 133.08 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.128 -1.219 . . . . 0.0 110.653 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.27 98.11 11.15 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' HD2' HG23 ' A' ' 108' ' ' VAL . 38.0 p90 -112.05 144.74 40.91 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.616 0.722 . . . . 0.0 111.611 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -106.55 150.87 25.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.8 mt -119.86 148.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 159' ' ' LEU . 25.3 ttpp -130.08 93.2 3.44 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 44.4 mm -72.88 150.37 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.567 0.699 . . . . 0.0 110.652 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -124.82 145.22 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.864 ' HA ' HG23 ' A' ' 73' ' ' THR . 31.2 p90 -166.28 136.68 3.39 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.523 -0.735 . . . . 0.0 110.501 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -87.26 144.16 26.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.776 -0.578 . . . . 0.0 111.158 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 70' ' ' VAL . 61.5 t -131.03 83.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.577 -0.702 . . . . 0.0 109.415 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.34 48.7 2.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.515 -0.741 . . . . 0.0 111.738 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -147.79 -66.39 0.25 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.287 -0.883 . . . . 0.0 111.126 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.08 169.9 16.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.935 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 91.5 mt -78.4 124.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.63 . . . . 0.0 110.115 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 70' ' ' VAL . 67.9 t -114.11 80.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.2 p -79.77 112.11 16.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.749 -0.595 . . . . 0.0 110.705 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.75 45.35 0.51 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.555 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 1.8 mmt -61.98 132.56 53.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -1.097 . . . . 0.0 109.098 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.16 148.76 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.923 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.96 87.4 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 109.533 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -81.46 169.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.648 . . . . 0.0 110.072 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.49 ' N ' HG22 ' A' ' 129' ' ' ILE . 33.1 tt0 -166.18 120.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.445 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.2 m-70 -103.4 124.88 49.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.0 110.083 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.452 ' CG2' HD11 ' A' ' 139' ' ' ILE . 41.7 m -85.25 68.32 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.373 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -65.96 154.31 39.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.425 -0.797 . . . . 0.0 110.201 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -130.72 86.29 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.598 -0.689 . . . . 0.0 110.602 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 53.63 61.96 2.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.381 -0.825 . . . . 0.0 110.857 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.76 36.58 57.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.01 146.95 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.991 . . . . 0.0 109.793 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.11 121.0 43.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -123.44 -26.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.759 . . . . 0.0 111.145 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -161.82 153.08 18.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.888 -1.133 . . . . 0.0 111.201 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HE3' ' CE1' ' A' ' 131' ' ' HIS . 5.9 ptmt -175.79 135.91 0.31 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.708 . . . . 0.0 109.229 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 143' ' ' ASP . 17.8 m -146.23 168.82 20.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 111.231 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -108.39 151.0 26.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.723 -0.611 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -119.86 128.42 53.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.509 -0.744 . . . . 0.0 110.676 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 ttp -87.77 109.0 19.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.451 -0.781 . . . . 0.0 109.382 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.793 HG13 ' CD1' ' A' ' 158' ' ' PHE . 80.2 t -86.43 -71.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 110.709 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.59 -165.57 38.0 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.7 p -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.676 -0.896 . . . . 0.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.585 ' OH ' HG12 ' A' ' 146' ' ' VAL . 11.8 m-85 -126.22 -173.95 2.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.837 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.69 162.94 26.23 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.83 66.25 2.41 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.314 1.165 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 153' ' ' ALA . 0.7 OUTLIER -68.13 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.555 -0.716 . . . . 0.0 109.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 152' ' ' ARG . . . -178.35 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.005 -1.06 . . . . 0.0 110.709 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -94.02 -171.09 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.444 -0.785 . . . . 0.0 111.563 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.4 144.31 30.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.367 0.604 . . . . 0.0 110.601 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.489 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 60.4 m-85 -107.96 154.64 21.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -128.84 135.28 48.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.331 -0.856 . . . . 0.0 111.371 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.793 ' CD1' HG13 ' A' ' 146' ' ' VAL . 28.0 t80 -103.44 136.18 43.67 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -120.77 116.45 25.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 110.778 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.436 HG22 ' CE2' ' A' ' 158' ' ' PHE . 43.1 p -86.54 153.05 55.55 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 162.56 37.54 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.628 1.331 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.41 123.36 15.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.567 -0.708 . . . . 0.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.45 114.15 27.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.687 -0.633 . . . . 0.0 109.999 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -69.85 127.08 31.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.646 -0.658 . . . . 0.0 110.288 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -69.71 172.75 4.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.8 -0.562 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 44.2 Cg_endo -70.82 147.54 56.28 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 O-C-N 123.427 1.225 . . . . 0.0 110.131 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 35.7 mtmt -115.92 175.57 5.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.514 -0.741 . . . . 0.0 110.461 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 171' ' ' ALA . . . 103.57 147.17 17.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -52.74 43.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.541 -0.976 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 170' ' ' LEU . 9.2 tt -57.48 -27.93 62.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.463 -0.773 . . . . 0.0 110.34 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . -56.48 -23.29 38.25 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 mtp-105 -67.71 126.98 31.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.511 -0.743 . . . . 0.0 109.9 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.32 177.88 28.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 p -91.8 135.81 33.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.918 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -128.56 114.68 17.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 110.054 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.98 148.4 47.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.768 . . . . 0.0 110.132 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.803 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.2 mm -124.09 101.67 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 0.0 110.172 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -91.67 104.0 16.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 14.9 m -113.88 142.94 45.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.516 -0.74 . . . . 0.0 110.939 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -123.49 95.28 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.777 -0.577 . . . . 0.0 109.455 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.678 ' CD2' HG22 ' A' ' 72' ' ' VAL . 6.6 t80 -80.61 73.56 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.711 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.1 t -116.56 -168.84 1.52 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.665 . . . . 0.0 109.319 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.541 -0.725 . . . . 0.0 109.814 179.521 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -115.18 109.61 18.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.63 -0.669 . . . . 0.0 109.807 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -77.9 -67.76 0.7 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.451 -0.781 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.885 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -143.9 164.61 30.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 110.123 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.885 ' N ' HD13 ' A' ' 190' ' ' LEU . 7.4 t -168.82 135.38 1.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.448 ' CD2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -145.23 -172.83 3.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.65 125.88 7.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.513 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 10.0 p-90 -134.48 145.25 48.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.688 -0.633 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.62 146.79 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 104' ' ' LEU . 35.2 tp -120.28 94.37 4.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.731 -0.606 . . . . 0.0 109.793 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 103' ' ' VAL . 91.6 m -73.23 148.58 43.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.56 -0.712 . . . . 0.0 110.017 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 47.9 mm -124.27 135.95 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -128.76 -156.09 0.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.569 -0.707 . . . . 0.0 110.491 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -30.45 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 111.103 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -138.22 56.7 1.72 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.368 -0.832 . . . . 0.0 111.122 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.732 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -60.87 -16.04 37.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.0 111.327 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 35.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 110.455 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.186 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.182 0.515 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 123' ' ' VAL . 93.1 t -125.04 111.45 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.628 . . . . 0.0 109.77 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -142.03 152.78 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.2 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 HD22 ' A' ' 90' ' ' LEU . 58.0 t -68.81 102.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.3 p -72.75 -53.57 11.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.597 -0.69 . . . . 0.0 110.065 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -150.02 165.68 31.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.74 -0.6 . . . . 0.0 110.001 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.689 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -127.06 165.21 19.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.728 -0.608 . . . . 0.0 109.685 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.573 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.4 m -155.04 156.13 35.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.59 -0.694 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -136.17 96.91 3.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.0 109.737 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 79' ' ' CYS . 57.5 t -74.26 167.88 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.852 -0.53 . . . . 0.0 110.188 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -171.7 -28.03 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.483 -0.761 . . . . 0.0 111.672 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 p 62.58 17.43 9.64 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -140.63 -46.55 0.41 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.507 -0.746 . . . . 0.0 109.224 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -59.34 -174.84 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.765 -0.584 . . . . 0.0 110.025 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.912 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.8 Cg_endo -73.11 -23.59 18.0 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.167 1.088 . . . . 0.0 110.345 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.66 176.73 40.21 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.83 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HB2' HG23 ' A' ' 76' ' ' THR . 43.9 Cg_endo -70.15 102.87 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.639 1.336 . . . . 0.0 110.452 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 30.5 mt -65.38 102.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -98.29 161.44 13.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.639 -0.663 . . . . 0.0 111.234 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.955 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.3 mt -130.94 167.53 18.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.822 -0.548 . . . . 0.0 109.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.419 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 11.0 t70 -111.05 131.22 55.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.578 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD22 HG11 ' A' ' 72' ' ' VAL . 1.5 mp -136.95 55.39 1.83 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 109.899 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -135.94 36.0 2.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.609 -0.682 . . . . 0.0 110.66 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.11 -86.65 0.22 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.97 81.18 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.694 -0.886 . . . . 0.0 110.197 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -95.12 -26.36 16.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.63 -0.669 . . . . 0.0 110.379 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -57.86 -26.64 62.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.443 -0.786 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -22.44 30.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.423 -0.798 . . . . 0.0 110.389 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.955 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.2 m-85 -56.47 -22.06 29.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.434 -0.791 . . . . 0.0 110.526 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -81.86 -20.18 39.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -0.783 . . . . 0.0 110.523 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -86.55 -22.15 26.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.935 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -132.4 134.81 45.59 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 110.689 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -105.83 -168.53 1.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.655 -0.653 . . . . 0.0 109.921 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.528 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.6 m-85 -116.98 96.62 5.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.42 108.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.715 -0.616 . . . . 0.0 109.854 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 196' ' ' LEU . 5.1 mt -113.87 -170.85 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.6 -0.687 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 31.1 tttm -134.64 157.23 47.15 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.994 0.902 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -47.54 124.46 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 45.51 60.18 4.35 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.905 -0.497 . . . . 0.0 113.097 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 104' ' ' LEU . 34.7 m -96.15 119.83 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.239 -1.153 . . . . 0.0 110.596 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.43 96.0 2.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.629 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.3 p90 -115.44 148.79 38.98 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.573 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -102.0 138.14 39.36 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HE1' ' A' ' 110' ' ' TYR . 42.2 mm -85.73 161.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.247 -0.908 . . . . 0.0 110.521 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -148.59 82.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.689 HD13 ' HG ' ' A' ' 75' ' ' LEU . 47.9 mm -75.15 143.78 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.708 -0.62 . . . . 0.0 110.49 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.07 132.21 54.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.722 ' HA ' HG23 ' A' ' 73' ' ' THR . 48.6 p90 -154.2 144.71 22.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.779 . . . . 0.0 111.082 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG3' HG21 ' A' ' 73' ' ' THR . 5.4 mtt180 -97.17 138.27 34.92 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.261 0.553 . . . . 0.0 110.858 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 70' ' ' VAL . 59.5 t -130.89 87.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.633 -0.667 . . . . 0.0 109.324 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.25 47.17 2.52 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.426 -0.796 . . . . 0.0 112.164 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HB3' ' A' ' 151' ' ' PRO . 2.8 ttt-85 -139.08 -64.09 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.34 160.95 37.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.479 -0.763 . . . . 0.0 110.277 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.79 112.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 70' ' ' VAL . 58.0 t -101.58 120.74 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.583 -0.698 . . . . 0.0 109.599 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.6 p -116.84 114.87 24.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.455 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.99 30.77 2.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.611 ' SD ' HG11 ' A' ' 146' ' ' VAL . 3.2 ttt -63.45 120.06 10.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.402 -1.057 . . . . 0.0 109.625 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.22 156.22 25.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.409 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 35.0 t80 -132.16 101.06 5.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 130' ' ' GLN . 81.8 mt -94.27 165.67 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 129' ' ' ILE . 24.2 tt0 -158.84 134.66 8.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -113.96 118.23 33.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.681 -0.637 . . . . 0.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 m -75.42 74.59 2.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.533 -0.73 . . . . 0.0 109.781 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -62.27 154.64 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.518 -0.739 . . . . 0.0 110.515 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.486 ' CG ' HD11 ' A' ' 139' ' ' ILE . 11.9 ttp85 -120.22 39.26 3.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.703 -0.623 . . . . 0.0 110.27 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.46 61.34 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.253 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 149.45 -37.06 0.99 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 137' ' ' VAL . 9.1 p -157.88 127.18 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.968 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.38 131.34 50.68 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 134' ' ' ARG . 20.2 mt -89.79 -52.73 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.679 -0.638 . . . . 0.0 109.312 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -169.17 165.09 11.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 174.68 10.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.618 -0.676 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 m -154.65 146.25 23.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -102.38 137.46 40.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.578 -0.701 . . . . 0.0 110.109 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -120.97 129.94 53.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.431 -0.793 . . . . 0.0 110.537 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -80.44 112.5 17.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 109.389 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.611 HG11 ' SD ' ' A' ' 126' ' ' MET . 49.4 t -79.72 -67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.55 171.64 19.64 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.7 p -95.4 154.93 16.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.972 . . . . 0.0 110.02 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -147.92 128.04 13.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.366 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.55 153.21 28.49 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' A' ' 120' ' ' ARG . 49.9 Cg_endo -74.24 76.84 2.97 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.454 1.239 . . . . 0.0 110.435 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -169.0 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 110.34 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -142.44 -111.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 110.162 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -171.95 -148.65 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.593 -1.317 . . . . 0.0 109.739 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 91.13 1.03 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 22.7 m-85 -59.87 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.415 -0.803 . . . . 0.0 110.008 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.705 ' OE1' HD12 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -156.09 114.77 3.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 110.987 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.526 ' CG ' HG13 ' A' ' 146' ' ' VAL . 39.0 t80 -95.34 169.46 10.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.705 HD12 ' OE1' ' A' ' 157' ' ' GLU . 0.2 OUTLIER -154.1 124.9 7.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.858 . . . . 0.0 111.145 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.0 p -93.75 159.92 33.72 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.31 152.77 80.04 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.63 1.332 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -57.28 116.33 3.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.746 -0.596 . . . . 0.0 111.121 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -113.11 149.35 33.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.71 -0.619 . . . . 0.0 109.617 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.44 127.35 44.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.539 -0.726 . . . . 0.0 110.934 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -62.72 -176.06 0.14 Allowed Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.919 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 44.8 Cg_endo -73.6 127.7 11.95 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 O-C-N 123.066 1.035 . . . . 0.0 110.204 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -116.17 159.02 22.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 110.868 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.65 162.18 30.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -60.06 173.07 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -1.044 . . . . 0.0 109.556 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 tt 67.9 -60.65 0.4 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.372 -0.83 . . . . 0.0 110.625 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.919 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -52.08 -23.25 5.03 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.427 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 11.4 mtp180 -67.15 155.57 38.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.344 -0.847 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.23 -175.3 19.92 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -91.89 118.17 30.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.94 . . . . 0.0 110.363 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' A' ' 171' ' ' ALA . 55.3 m-85 -112.48 124.39 52.4 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 140.06 47.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.646 -0.659 . . . . 0.0 110.637 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.815 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.9 mm -113.53 94.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.647 -0.658 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 109.22 18.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.23 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.409 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 28.6 t -113.64 144.38 43.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.393 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.02 105.97 10.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.682 -0.637 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.455 ' CD2' HG23 ' A' ' 72' ' ' VAL . 1.7 t80 -81.62 132.63 35.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.72 -0.613 . . . . 0.0 109.852 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -171.03 -172.7 1.17 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.649 -0.657 . . . . 0.0 110.222 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.738 -0.601 . . . . 0.0 109.524 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 121.23 0.538 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.23 117.1 29.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.658 . . . . 0.0 109.666 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.458 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.1 m-70 -68.9 -62.5 1.35 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.508 -0.745 . . . . 0.0 110.68 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.7 tp -168.43 159.53 10.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.382 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.2 t -153.71 138.53 17.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.53 -0.732 . . . . 0.0 110.196 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.41 ' CE2' HD21 ' A' ' 90' ' ' LEU . 19.0 p90 -142.02 -155.43 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 110.083 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -169.01 128.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.377 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.815 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -130.45 145.0 51.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.613 -0.68 . . . . 0.0 109.982 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.44 158.83 28.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.474 0.654 . . . . 0.0 110.941 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 104' ' ' LEU . 21.9 tp -133.38 95.41 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.1 m -80.63 104.34 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.626 -0.672 . . . . 0.0 110.78 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.3 mm -80.76 147.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -138.29 -158.83 0.89 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.424 -0.797 . . . . 0.0 110.809 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -53.13 4.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.691 -0.631 . . . . 0.0 110.928 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -147.1 94.06 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.0 110.818 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -74.97 -0.78 19.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.644 -0.66 . . . . 0.0 111.336 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.69 34.92 2.79 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 110.249 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.189 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.237 0.541 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.616 ' CG2' HG21 ' A' ' 123' ' ' VAL . 86.9 t -114.05 130.76 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 0.0 110.078 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.759 HG13 HD13 ' A' ' 190' ' ' LEU . 62.2 t -148.1 137.75 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.786 -0.572 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.5 t -69.44 106.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 72.7 p -73.35 -58.37 3.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.728 -0.608 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.23 164.28 30.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.49 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -132.13 124.19 28.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.673 -0.642 . . . . 0.0 109.695 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.3 m -109.87 152.04 26.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.754 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.61 114.19 9.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.612 -0.68 . . . . 0.0 110.149 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.2 t -113.44 165.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.712 . . . . 0.0 110.26 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.453 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -156.97 -156.64 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 109.956 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.1 p -97.38 -35.88 10.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 p -138.79 47.53 1.94 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.617 -0.677 . . . . 0.0 110.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.23 172.01 7.66 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.664 -0.647 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.4 Cg_endo -72.4 -29.12 14.11 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.442 1.233 . . . . 0.0 109.855 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.38 175.12 33.07 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -70.9 100.63 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.393 1.207 . . . . 0.0 110.204 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.623 HD13 ' CG ' ' A' ' 102' ' ' PHE . 53.1 mt -65.03 113.31 3.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.631 -0.668 . . . . 0.0 109.932 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.11 116.2 29.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.758 -0.589 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -101.87 128.03 48.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.587 -0.696 . . . . 0.0 109.983 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.05 126.85 31.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.546 -0.721 . . . . 0.0 110.007 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.473 HD13 ' CG1' ' A' ' 72' ' ' VAL . 1.6 mt -129.76 52.21 2.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.672 . . . . 0.0 110.062 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -101.37 -73.75 0.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.4 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.09 -42.66 0.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.33 77.66 8.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.689 -0.889 . . . . 0.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 86.9 mt -87.33 -20.87 26.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -13.71 36.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.0 111.477 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -6.2 39.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.06 -1.025 . . . . 0.0 111.567 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 88' ' ' LEU . 12.4 m-30 -75.27 -55.53 5.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -58.21 -17.55 19.79 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.489 -0.757 . . . . 0.0 111.407 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -86.0 -19.85 29.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.265 -0.897 . . . . 0.0 110.89 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.62 147.08 37.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.216 -0.928 . . . . 0.0 110.582 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 195' ' ' ASN . 0.7 OUTLIER -136.28 160.9 37.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.449 -0.782 . . . . 0.0 109.931 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.623 ' CG ' HD13 ' A' ' 86' ' ' LEU . 29.3 m-85 -90.98 166.08 13.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.99 128.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 196' ' ' LEU . 88.2 mt -129.5 164.62 23.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.63 -0.669 . . . . 0.0 109.686 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 2.5 ttpt -77.2 166.54 23.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -29.24 -66.77 0.08 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.82 72.98 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 104' ' ' LEU . 32.7 m -88.0 139.12 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.412 -1.052 . . . . 0.0 110.661 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -85.32 95.98 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 48.5 p90 -109.68 135.93 49.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.533 -0.729 . . . . 0.0 111.745 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -89.2 157.39 18.28 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.89 132.56 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.422 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -115.36 121.48 42.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.88 146.82 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.506 0.669 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -129.37 133.29 47.32 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 33.4 p90 -154.73 157.98 38.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.383 -0.823 . . . . 0.0 110.847 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.76 129.46 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.51 110.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 109.351 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -128.53 48.23 2.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 111.382 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 -67.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.295 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.66 165.67 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.509 -0.745 . . . . 0.0 110.474 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.12 106.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.691 -0.63 . . . . 0.0 109.974 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.616 HG21 ' CG2' ' A' ' 70' ' ' VAL . 59.9 t -84.83 95.02 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.653 -0.655 . . . . 0.0 109.966 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.1 p -88.87 74.97 8.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.322 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 153.63 53.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -82.69 151.38 26.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.988 . . . . 0.0 109.605 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -146.69 151.63 37.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.873 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -128.15 97.49 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.758 -0.588 . . . . 0.0 109.499 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.585 HG23 ' OD1' ' A' ' 143' ' ' ASP . 78.4 mt -96.23 134.6 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 110.055 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.405 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 18.5 tt0 -129.06 138.07 51.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.6 m-70 -113.6 138.39 50.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.444 -0.785 . . . . 0.0 110.089 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.7 m -96.6 85.92 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.707 -0.621 . . . . 0.0 109.824 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 138' ' ' LYS . 5.4 m-85 -89.84 129.26 36.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 110.398 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 137' ' ' VAL . 3.5 tmm_? -145.52 151.43 38.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 51.49 31.23 7.2 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.452 -0.78 . . . . 0.0 111.166 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.41 60.33 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.314 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.7 m -120.36 149.67 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.322 . . . . 0.0 110.398 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 16.7 tttp -85.66 119.76 26.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.62 HD11 ' HB3' ' A' ' 134' ' ' ARG . 95.9 mt -89.8 -67.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.56 -0.713 . . . . 0.0 109.914 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.73 157.45 6.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.506 -0.746 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 165.72 19.0 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.4 m -128.74 137.31 51.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.562 -0.711 . . . . 0.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 129' ' ' ILE . 72.4 m-20 -101.7 105.24 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.712 . . . . 0.0 110.077 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -96.2 148.07 23.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.75 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.05 117.2 33.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.718 HG13 ' CG ' ' A' ' 158' ' ' PHE . 48.1 t -80.86 -55.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.48 -0.762 . . . . 0.0 110.196 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.75 -179.69 17.68 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 22.3 m -89.65 151.29 21.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.66 -0.906 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.52 ' CE2' HG12 ' A' ' 146' ' ' VAL . 82.8 m-85 -148.3 129.55 14.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 0.0 110.369 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.03 152.08 30.95 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.71 90.24 0.95 Allowed 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.425 1.224 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 26.42 7.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.584 -0.698 . . . . 0.0 110.226 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 53.42 22.81 3.02 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.376 -0.827 . . . . 0.0 111.268 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -133.04 178.22 7.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.17 157.93 16.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.705 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.1 m-85 -114.16 177.56 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.539 -0.726 . . . . 0.0 110.089 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -148.81 91.67 1.9 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.718 ' CG ' HG13 ' A' ' 146' ' ' VAL . 40.1 t80 -79.56 163.94 24.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.0 110.002 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -139.72 119.28 13.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.565 -0.709 . . . . 0.0 110.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.496 HG22 ' HE2' ' A' ' 158' ' ' PHE . 66.8 p -102.26 157.09 34.37 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.522 -0.736 . . . . 0.0 109.714 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.68 159.83 46.41 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.707 1.372 . . . . 0.0 110.997 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 149.87 27.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.408 0.623 . . . . 0.0 110.872 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.409 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 16.6 tt0 -129.24 106.44 8.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.712 -0.617 . . . . 0.0 109.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.09 126.0 26.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -74.31 173.09 7.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.793 -0.567 . . . . 0.0 110.003 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.5 Cg_endo -72.96 123.92 9.25 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.338 1.178 . . . . 0.0 110.362 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -118.12 -160.93 0.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 110.572 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.71 47.9 13.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 54.79 175.65 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.567 -0.961 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -61.38 0.32 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.285 -0.885 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -49.43 -24.66 2.09 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.382 -0.824 . . . . 0.0 111.407 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -58.74 128.35 36.78 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.18 -178.84 25.5 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.8 p -86.79 142.75 27.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.517 -0.99 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 38.1 m-85 -131.11 105.0 7.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.671 -0.643 . . . . 0.0 110.356 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -70.35 120.14 15.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.612 -0.68 . . . . 0.0 109.349 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 131' ' ' HIS . 44.8 mt -109.72 148.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.982 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -114.84 118.88 34.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.748 -0.595 . . . . 0.0 109.79 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.8 m -110.53 122.48 47.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.585 -0.697 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -111.01 103.62 12.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t80 -83.26 116.79 22.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.548 -0.72 . . . . 0.0 110.071 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.3 t -131.97 -155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.746 . . . . 0.0 110.166 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 26.6 p-10 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.055 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.048 0.451 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.11 88.09 2.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -60.27 -40.62 91.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.522 -0.736 . . . . 0.0 109.973 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.759 HD13 HG13 ' A' ' 71' ' ' VAL . 5.2 tp -170.35 148.21 3.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 110.032 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -159.65 136.96 9.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.654 -0.654 . . . . 0.0 110.025 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.443 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 23.9 p90 -136.48 -157.39 0.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.613 -0.68 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.742 . . . . 0.0 110.55 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.544 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 18.1 p-90 -144.13 153.27 41.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.561 -0.712 . . . . 0.0 109.987 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 101' ' ' SER . 4.3 m-80 -94.34 153.49 17.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.536 -0.727 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.544 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 23.5 tp -126.78 90.05 3.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.1 m -67.98 145.09 54.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.0 110.94 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.6 156.89 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.707 -0.621 . . . . 0.0 109.392 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -151.91 -153.27 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.493 -0.754 . . . . 0.0 110.068 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -129.88 -0.7 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 111.624 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -160.08 47.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.085 -1.01 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.579 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -57.44 -19.85 26.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.525 -0.734 . . . . 0.0 111.292 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 56.91 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.165 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.548 ' ND2' HG23 ' A' ' 70' ' ' VAL . 1.9 t-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 123' ' ' VAL . 96.2 t -134.33 119.2 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.624 -0.673 . . . . 0.0 110.338 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 190' ' ' LEU . 79.2 t -142.52 136.74 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG12 HD13 ' A' ' 90' ' ' LEU . 59.3 t -61.24 103.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.518 -0.739 . . . . 0.0 109.115 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.67 HG23 ' HA ' ' A' ' 116' ' ' PHE . 39.0 p -73.45 -56.37 5.14 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.889 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -141.99 168.35 19.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.812 . . . . 0.0 110.724 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.66 124.57 31.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.65 -0.657 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 85' ' ' PRO . 4.1 m -110.4 156.22 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.621 -0.674 . . . . 0.0 110.277 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.528 HD23 HG12 ' A' ' 112' ' ' ILE . 5.4 mt -139.55 82.2 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.577 -0.702 . . . . 0.0 109.879 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.49 143.93 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.725 -0.609 . . . . 0.0 110.088 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 72.2 m -140.82 -163.54 1.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.041 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 p -115.87 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.4 p -95.87 24.9 5.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.93 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -90.5 -177.38 0.77 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.509 -0.744 . . . . 0.0 110.29 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.2 Cg_endo -73.99 -23.59 15.97 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.359 1.189 . . . . 0.0 110.131 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.68 -175.46 29.67 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HB2' ' CG2' ' A' ' 76' ' ' THR . 45.0 Cg_endo -71.07 104.8 1.58 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.503 1.264 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.89 114.45 4.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.722 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -90.19 146.61 24.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.809 HD21 ' CE1' ' A' ' 97' ' ' PHE . 3.7 tt -128.08 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.575 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -94.52 127.35 40.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.517 -0.739 . . . . 0.0 110.161 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.673 HD13 HG12 ' A' ' 72' ' ' VAL . 2.9 mt -135.26 55.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.654 -0.654 . . . . 0.0 109.878 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -104.81 -73.63 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.728 -0.607 . . . . 0.0 110.474 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.22 -74.77 0.49 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.41 94.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.683 -0.893 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 61.0 mt -92.78 -33.41 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.492 -0.755 . . . . 0.0 110.149 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -57.57 -19.31 24.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.502 -0.749 . . . . 0.0 111.065 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.56 -24.5 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.16 -0.963 . . . . 0.0 111.263 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.809 ' CE1' HD21 ' A' ' 88' ' ' LEU . 8.1 m-85 -62.0 -19.24 62.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.507 -0.745 . . . . 0.0 110.309 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.9 -25.98 61.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -86.94 -25.24 24.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.494 -0.754 . . . . 0.0 110.855 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.35 151.47 51.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.392 -0.818 . . . . 0.0 110.619 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -123.81 -170.27 2.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.543 -0.723 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.765 ' CZ ' HD12 ' A' ' 88' ' ' LEU . 6.5 m-85 -115.37 102.08 9.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.641 -0.662 . . . . 0.0 110.052 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.39 147.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.65 -0.656 . . . . 0.0 110.203 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.107 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -159.34 148.17 18.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.664 -0.647 . . . . 0.0 109.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.651 ' HB3' HG11 ' A' ' 108' ' ' VAL . 63.7 tttt -83.54 158.29 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -39.96 107.5 0.07 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 32.24 68.64 0.14 Allowed Glycine 0 N--CA 1.506 3.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.736 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.107 HG22 HD21 ' A' ' 104' ' ' LEU . 21.5 m -88.78 167.55 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -1.141 . . . . 0.0 109.647 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.38 97.94 11.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.202 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.648 ' HE1' ' HB2' ' A' ' 165' ' ' ALA . 32.4 p90 -128.42 134.28 48.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.0 111.581 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -89.46 167.53 12.92 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.528 HG12 HD23 ' A' ' 77' ' ' LEU . 71.0 mt -125.35 137.94 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 0.0 110.358 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -115.68 109.34 17.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.645 -0.66 . . . . 0.0 109.541 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.801 HG21 ' CE2' ' A' ' 181' ' ' PHE . 49.0 mm -93.38 126.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.583 -0.698 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.9 p -108.59 148.55 30.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.67 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.5 p90 -164.78 146.37 8.02 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.235 -0.916 . . . . 0.0 111.884 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -81.49 125.26 30.26 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.276 0.56 . . . . 0.0 110.748 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 70' ' ' VAL . 72.4 t -126.36 82.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.54 48.73 2.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.442 -0.786 . . . . 0.0 111.93 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -138.34 -65.97 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.104 -0.997 . . . . 0.0 111.089 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -142.67 175.98 9.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.393 -0.817 . . . . 0.0 110.86 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.58 113.28 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 110.152 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 70' ' ' VAL . 74.3 t -95.76 88.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.664 -0.647 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 77.6 p -82.97 88.06 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.632 -0.668 . . . . 0.0 110.516 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.0 46.55 0.07 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.453 ' HE3' ' CE1' ' A' ' 116' ' ' PHE . 3.0 ttt -81.22 128.48 33.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.514 -0.992 . . . . 0.0 109.597 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -140.62 167.0 23.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.507 -0.745 . . . . 0.0 110.849 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -135.75 120.12 17.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.7 -0.625 . . . . 0.0 109.733 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -116.57 130.25 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.583 -0.698 . . . . 0.0 110.3 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -128.1 135.61 50.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.611 -0.681 . . . . 0.0 109.862 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.1 m-70 -104.2 114.64 29.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -70.68 77.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.698 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 3.4 m-85 -80.79 141.99 34.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.985 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -119.35 -155.4 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -64.66 81.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.58 -0.7 . . . . 0.0 110.608 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 60.9 23.73 61.75 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 136' ' ' GLY . 97.5 t -148.78 89.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -1.079 . . . . 0.0 109.982 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 149.84 49.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.726 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 140' ' ' ASP . 44.2 pt -118.89 -37.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.406 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.431 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.6 t70 -175.86 167.2 3.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.0 -1.063 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.428 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -126.86 -168.3 1.85 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.427 HG22 ' CE2' ' A' ' 144' ' ' TYR . 34.4 m -159.74 126.96 4.61 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.554 ' OD1' HG23 ' A' ' 129' ' ' ILE . 1.5 m-20 -113.47 136.84 52.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CE2' HG22 ' A' ' 142' ' ' THR . 48.5 m-85 -123.17 127.44 48.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.576 -0.703 . . . . 0.0 110.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.7 tpp -81.18 106.01 12.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.85 HG12 ' CE1' ' A' ' 149' ' ' TYR . 40.8 t -79.96 -36.4 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.547 -0.721 . . . . 0.0 110.279 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.69 -176.87 16.81 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 3.1 t -82.52 135.73 35.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.599 -0.942 . . . . 0.0 110.03 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.85 ' CE1' HG12 ' A' ' 146' ' ' VAL . 9.3 m-85 -118.35 128.99 55.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.633 . . . . 0.0 110.939 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.79 153.05 16.91 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.79 85.14 1.36 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.369 1.194 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -62.28 1.48 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.67 127.01 0.9 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 111.17 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.03 -156.92 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.498 -0.751 . . . . 0.0 111.545 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.81 174.79 7.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.554 -0.716 . . . . 0.0 111.26 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.451 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 44.4 m-85 -119.31 -174.63 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.657 -0.652 . . . . 0.0 109.461 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.87 100.41 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.642 ' CD1' HG13 ' A' ' 146' ' ' VAL . 54.6 t80 -81.39 170.35 16.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.124 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -155.68 109.42 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 110.513 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.407 HG22 ' HE2' ' A' ' 158' ' ' PHE . 54.8 p -75.6 146.88 81.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 109.168 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.43 -177.97 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.706 1.371 . . . . 0.0 111.021 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -58.37 145.17 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.482 0.658 . . . . 0.0 110.872 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.47 119.86 3.1 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.82 146.14 37.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 111.019 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -90.76 -178.09 0.88 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.748 -0.595 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.9 123.61 8.56 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.104 1.055 . . . . 0.0 110.355 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 171.36 7.78 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.459 -0.776 . . . . 0.0 110.539 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.84 161.91 11.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.99 -61.0 2.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.574 -0.956 . . . . 0.0 109.291 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -61.63 -29.76 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.725 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.9 -23.98 61.77 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.501 -0.749 . . . . 0.0 110.538 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -64.2 129.08 38.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.788 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.4 -177.94 30.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.6 p -86.72 133.99 33.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.949 . . . . 0.0 110.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -116.81 106.74 13.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.272 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.76 121.12 19.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.599 -0.688 . . . . 0.0 109.547 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 33.3 mt -111.81 124.33 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.451 -0.78 . . . . 0.0 110.89 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.406 ' CB ' ' HB2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -86.76 96.69 10.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.0 109.451 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -90.55 134.89 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.632 -0.667 . . . . 0.0 110.802 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -133.41 82.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.66 -0.65 . . . . 0.0 109.618 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 114' ' ' ILE . 4.0 t80 -79.1 111.84 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.617 -0.677 . . . . 0.0 110.06 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -136.19 -166.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.31 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.789 -0.569 . . . . 0.0 109.992 179.814 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.084 0.469 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.46 108.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 110.003 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -65.92 -56.2 12.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.543 -0.723 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 71' ' ' VAL . 6.7 tp -168.3 142.85 3.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.584 -0.698 . . . . 0.0 110.356 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 81.0 p -142.63 147.75 36.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.532 -0.73 . . . . 0.0 109.989 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.449 ' CE2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -144.68 -155.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 109.975 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.99 126.04 3.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 110.613 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.54 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 23.2 p-90 -133.29 147.55 51.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.589 -0.694 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.93 135.06 35.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 111.145 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.54 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 27.4 tp -104.96 95.46 5.87 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.9 m -72.42 117.97 14.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.555 -0.716 . . . . 0.0 110.992 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.3 mm -91.03 153.33 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -142.89 -167.63 2.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.394 -0.816 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 -46.66 6.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.704 -0.622 . . . . 0.0 110.568 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.89 106.27 4.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.93 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.33 36.56 0.88 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.607 -0.683 . . . . 0.0 111.285 179.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -169.37 37.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.316 -0.865 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.16 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.494 ' ND2' HG23 ' A' ' 70' ' ' VAL . 2.2 t-20 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 123' ' ' VAL . 59.2 t -138.87 135.34 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.551 ' CG1' HD22 ' A' ' 190' ' ' LEU . 76.8 t -147.73 142.1 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 0.0 109.582 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.729 ' HB ' HD23 ' A' ' 190' ' ' LEU . 62.1 t -63.02 105.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.1 p -70.52 -52.88 18.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 110.361 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 mtm105 -158.68 151.84 22.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.556 -0.715 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 76' ' ' THR . 4.3 tt -110.67 126.54 54.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.721 -0.612 . . . . 0.0 109.701 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.587 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.7 m -109.4 152.37 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.338 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.671 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -139.74 109.04 6.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.271 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.7 t -108.54 167.07 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.667 -0.645 . . . . 0.0 109.887 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -157.11 -158.38 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.532 -0.73 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 p -95.07 -34.48 12.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p -140.24 48.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.51 168.01 15.2 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.3 Cg_endo -73.2 -26.48 14.69 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.454 1.239 . . . . 0.0 110.07 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.07 169.13 28.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.97 103.04 1.41 Allowed 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.442 1.233 . . . . 0.0 110.209 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 102' ' ' PHE . 15.4 mt -64.7 116.16 5.98 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.756 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.83 106.04 17.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.395 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.509 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -84.98 127.97 34.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.666 -0.646 . . . . 0.0 109.938 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.28 122.6 25.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.569 -0.707 . . . . 0.0 110.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD13 ' CG1' ' A' ' 72' ' ' VAL . 3.9 mt -128.59 51.03 2.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 109.933 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -109.89 -70.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -60.88 0.15 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.93 88.66 0.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.6 -0.941 . . . . 0.0 110.316 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 92.1 mt -94.98 -25.93 16.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.378 -0.826 . . . . 0.0 110.5 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -52.35 -23.3 5.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -18.48 35.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.431 -0.793 . . . . 0.0 111.325 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.509 ' CE1' HD22 ' A' ' 88' ' ' LEU . 13.3 m-30 -61.96 -56.01 23.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.199 -0.938 . . . . 0.0 110.59 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.98 25.1 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 0.0 111.132 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -86.89 9.82 18.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 111.25 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -171.6 148.0 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.166 -0.959 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.2 p -125.3 159.41 31.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.781 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -82.15 117.97 22.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 110.261 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 199' ' ' LYS . 57.3 t -78.08 154.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.623 -0.673 . . . . 0.0 109.802 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 196' ' ' LEU . 1.7 mt -164.76 179.0 6.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.571 -0.706 . . . . 0.0 110.328 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -107.33 152.32 24.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -19.56 -69.44 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -143.26 74.21 0.33 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.922 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.643 HG21 HD22 ' A' ' 104' ' ' LEU . 33.4 m -88.47 -173.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 110.116 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -120.79 93.63 4.09 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.581 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 40.5 p90 -109.81 145.72 36.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.367 -0.833 . . . . 0.0 112.329 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 162' ' ' MET . 38.4 mtt85 -105.33 165.19 11.29 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 75' ' ' LEU . 68.2 mt -126.41 135.35 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 100.53 8.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.826 -0.546 . . . . 0.0 109.579 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' GLU . 46.2 mm -77.28 148.44 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.529 -0.732 . . . . 0.0 110.043 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -131.31 133.84 45.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 10.4 p90 -157.5 148.92 21.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 110.415 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.3 49.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.64 -0.662 . . . . 0.0 111.158 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 70' ' ' VAL . 57.4 t -115.01 99.04 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -129.2 47.97 2.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.41 -0.806 . . . . 0.0 111.608 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -145.09 -64.24 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.78 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -138.4 166.59 23.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.448 -0.783 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.91 102.78 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.673 -0.642 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 70' ' ' VAL . 58.3 t -81.13 70.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.762 -0.586 . . . . 0.0 109.745 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.9 p -74.52 94.54 2.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.642 -0.661 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.98 42.11 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.4 ttt -72.28 140.79 48.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.973 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -136.58 159.61 41.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -135.27 97.89 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.39 133.37 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 109.728 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.412 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 28.0 tt0 -131.61 131.57 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.688 . . . . 0.0 110.29 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.5 m-70 -107.97 123.62 48.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 0.0 109.792 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.9 m -83.32 105.57 14.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.538 -0.726 . . . . 0.0 110.047 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 138' ' ' LYS . 8.6 m-85 -96.32 140.19 31.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 112.32 18.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.737 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.5 tptp 53.04 37.14 23.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.261 -0.899 . . . . 0.0 110.63 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 82.48 35.06 21.17 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.9 t -146.91 113.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.985 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -64.12 127.71 32.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.567 -0.708 . . . . 0.0 110.116 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.542 HD12 ' OD2' ' A' ' 140' ' ' ASP . 2.8 pt -111.35 -26.05 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.56 -0.713 . . . . 0.0 110.655 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.542 ' OD2' HD12 ' A' ' 139' ' ' ILE . 3.2 p30 -174.43 151.19 1.53 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.455 ' CD ' ' CE1' ' A' ' 131' ' ' HIS . 15.7 pttm -147.72 149.69 32.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -143.32 155.03 44.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.343 -0.848 . . . . 0.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -100.74 113.8 27.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.18 100.33 12.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.451 -0.781 . . . . 0.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.9 ptp -61.63 116.19 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.757 . . . . 0.0 109.693 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.777 HG13 ' CG ' ' A' ' 158' ' ' PHE . 47.4 t -80.18 -51.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 0.0 110.286 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.89 178.33 18.68 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 77.6 p -93.37 152.35 19.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.525 -0.985 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -147.65 132.42 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 110.3 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.45 156.39 26.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.52 -171.5 1.13 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.411 1.216 . . . . 0.0 110.537 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 51.42 62.38 2.74 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.62 -0.675 . . . . 0.0 111.156 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -153.25 -94.5 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 110.273 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.34 -154.79 0.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.885 -1.135 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 73' ' ' THR . 32.7 tt0 -94.49 93.41 7.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 66.1 m-85 -59.92 177.54 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.731 -0.606 . . . . 0.0 110.298 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 12.3 mt-10 -146.75 110.15 4.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 110.314 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.777 ' CG ' HG13 ' A' ' 146' ' ' VAL . 42.3 t80 -76.85 163.27 26.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.731 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.58 116.99 15.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.517 -0.739 . . . . 0.0 110.687 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.2 p -100.51 145.99 31.26 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.12 171.6 8.71 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.755 1.397 . . . . 0.0 111.361 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.41 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 8.2 ptt? -59.73 118.37 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.821 -0.549 . . . . 0.0 111.073 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 1.0 OUTLIER -105.88 124.48 49.64 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.53 136.39 35.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.509 -0.744 . . . . 0.0 110.601 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -90.06 171.15 9.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.737 -0.602 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.8 Cg_endo -72.92 129.31 14.14 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.369 1.194 . . . . 0.0 110.171 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -112.71 -178.09 3.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.601 -0.687 . . . . 0.0 110.75 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.68 138.01 8.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.2 ttm -58.98 -30.7 68.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.397 -1.061 . . . . 0.0 110.066 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.4 mm? -69.37 -35.21 75.6 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 167' ' ' LYS . . . -88.04 -26.92 22.32 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.097 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -50.34 155.21 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.14 -156.5 22.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 p -104.51 132.45 50.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -1.001 . . . . 0.0 110.732 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -113.77 103.03 10.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.645 -0.659 . . . . 0.0 110.732 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -66.95 142.11 57.38 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 14.5 mt -132.94 154.99 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 103.19 8.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 0.0 109.845 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.4 m -97.18 118.13 32.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.49 -0.756 . . . . 0.0 110.437 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.12 109.81 19.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -86.54 154.45 21.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.696 -0.627 . . . . 0.0 110.623 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.4 t -167.76 -156.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.982 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.6 p-10 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.032 0.444 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -105.56 101.06 10.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.502 -0.749 . . . . 0.0 110.215 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 7.9 m170 -60.35 -56.64 19.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.763 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 72' ' ' VAL . 17.7 tp -171.43 114.52 0.38 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.704 -0.622 . . . . 0.0 109.837 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -116.59 136.18 53.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.7 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 97' ' ' PHE . 27.1 p90 -134.28 -159.03 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.638 . . . . 0.0 110.083 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -158.88 129.46 6.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 110.641 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 19.1 p-90 -143.55 147.95 35.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -99.09 146.07 26.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.566 -0.709 . . . . 0.0 110.939 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.749 HD11 HD12 ' A' ' 104' ' ' LEU . 43.0 tp -109.08 107.37 17.67 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -82.93 106.95 15.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 110.769 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.05 143.5 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 109.393 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.467 ' HD2' HG13 ' A' ' 103' ' ' VAL . 6.4 mttt -137.3 -160.25 1.04 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 110.027 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -19.48 8.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 111.055 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -152.54 60.87 0.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 110.952 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -62.43 -15.3 48.61 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.269 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.76 37.7 3.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.273 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.066 0.46 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 123' ' ' VAL . 61.1 t -121.97 128.46 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 70' ' ' VAL . 69.7 t -148.96 139.62 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 181' ' ' PHE . 9.8 t -64.08 103.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 155' ' ' GLU . 65.9 p -69.95 -50.06 45.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.504 -0.748 . . . . 0.0 110.568 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.67 174.64 14.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 110.814 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -140.65 123.77 16.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.722 -0.611 . . . . 0.0 109.643 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 85' ' ' PRO . 89.8 m -109.71 162.89 14.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.517 -0.739 . . . . 0.0 110.288 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -145.85 118.31 8.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 110.534 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.39 153.06 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 t -147.16 25.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 81' ' ' THR . 1.4 p 67.03 -61.19 0.34 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.533 -0.729 . . . . 0.0 110.977 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.4 ' N ' ' OG ' ' A' ' 80' ' ' SER . 20.1 p -98.97 30.97 3.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.159 -0.963 . . . . 0.0 109.964 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.19 165.98 21.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.691 -0.63 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.7 Cg_endo -71.74 -26.4 19.36 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.439 1.231 . . . . 0.0 110.221 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.11 165.86 25.22 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.1 Cg_endo -72.01 97.42 0.83 Allowed 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.466 1.245 . . . . 0.0 110.29 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 102' ' ' PHE . 20.3 mt -64.63 114.57 4.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.688 -0.632 . . . . 0.0 109.632 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -100.95 122.46 43.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.633 -0.667 . . . . 0.0 110.602 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.687 HD22 ' CE1' ' A' ' 97' ' ' PHE . 9.6 mt -97.6 166.17 11.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.702 -0.624 . . . . 0.0 109.88 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.96 126.58 54.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.527 -0.733 . . . . 0.0 110.478 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.659 HD13 HG12 ' A' ' 72' ' ' VAL . 1.7 mt -128.13 49.31 2.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.581 -0.699 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 p -133.67 51.69 2.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.32 -65.16 0.26 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.1 71.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.96 . . . . 0.0 110.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 72.9 mt -90.08 -26.85 20.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.565 -0.709 . . . . 0.0 110.347 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.19 -22.05 15.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.25 -0.906 . . . . 0.0 111.074 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 p -58.23 -20.62 43.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 0.0 110.983 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' A' ' 88' ' ' LEU . 18.1 m-85 -58.37 -65.28 0.68 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.315 -0.866 . . . . 0.0 110.608 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -56.23 -20.73 19.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.525 -0.734 . . . . 0.0 111.207 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -86.93 11.65 12.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 111.323 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.76 143.13 2.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -133.16 137.07 46.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.66 . . . . 0.0 109.721 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.5 m-85 -79.22 118.6 21.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -0.79 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.97 155.53 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.25 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 196' ' ' LEU . 2.1 mt -153.07 -171.38 3.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.756 . . . . 0.0 110.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.456 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.1 tttm -130.65 161.41 31.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.671 0.748 . . . . 0.0 109.857 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.81 106.37 0.06 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 37.28 69.42 0.3 Allowed Glycine 0 N--CA 1.503 3.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.698 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 104' ' ' LEU . 35.8 m -86.65 149.85 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.266 -1.137 . . . . 0.0 109.692 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -79.94 90.58 5.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.653 ' HE1' HD11 ' A' ' 112' ' ' ILE . 37.4 p90 -109.34 141.58 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.562 -0.711 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.49 163.49 13.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.638 -0.664 . . . . 0.0 109.344 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.653 HD11 ' HE1' ' A' ' 110' ' ' TYR . 45.0 mm -117.75 135.1 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.371 -0.831 . . . . 0.0 110.071 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -119.64 115.11 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.28 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 181' ' ' PHE . 43.3 mm -100.72 150.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 111.156 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.5 m -131.21 122.09 25.95 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 31.1 p90 -137.83 135.15 35.95 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.785 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.405 ' H ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -84.09 140.07 32.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 111.046 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.47 95.93 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.724 -0.61 . . . . 0.0 109.367 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -129.2 48.69 2.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 111.427 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.93 -68.7 0.18 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.25 -0.906 . . . . 0.0 110.849 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -136.82 174.7 10.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.82 . . . . 0.0 110.519 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.41 121.62 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.738 -0.601 . . . . 0.0 110.04 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 70' ' ' VAL . 63.0 t -103.8 77.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.692 -0.63 . . . . 0.0 109.531 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.4 p -81.47 84.95 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.59 -0.694 . . . . 0.0 110.666 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.68 44.55 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.0 mmm -73.76 148.56 42.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.446 -1.032 . . . . 0.0 109.627 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.24 136.16 36.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.447 -0.783 . . . . 0.0 110.941 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.417 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 48.2 t80 -122.2 106.18 10.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.772 -0.58 . . . . 0.0 109.484 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 130' ' ' GLN . 80.5 mt -102.08 166.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 129' ' ' ILE . 2.8 tt0 -155.11 138.69 16.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.643 -0.661 . . . . 0.0 110.376 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 177' ' ' ILE . 11.1 m-70 -109.34 140.82 42.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.742 . . . . 0.0 109.645 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 m -103.43 78.83 1.64 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.454 -0.779 . . . . 0.0 110.062 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 131' ' ' HIS . 21.1 m-85 -90.57 120.13 31.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.704 ' HG2' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -140.43 142.42 35.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.518 -0.739 . . . . 0.0 110.491 179.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.0 OUTLIER 53.67 33.79 17.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.97 27.07 66.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 135' ' ' LYS . 57.4 t -128.03 112.55 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.435 -1.038 . . . . 0.0 109.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 113.65 5.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.575 -0.703 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.704 HD12 ' HG2' ' A' ' 134' ' ' ARG . 4.6 mt -90.21 -66.12 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.629 -0.669 . . . . 0.0 109.438 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.4 p30 -168.54 171.94 8.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.553 -0.717 . . . . 0.0 110.534 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -126.86 168.4 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.596 -0.69 . . . . 0.0 109.557 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.4 m -131.4 117.38 18.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.498 -0.752 . . . . 0.0 110.522 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.24 116.25 28.62 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 0.0 109.821 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -114.27 142.1 46.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 ttp -98.05 123.8 42.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.75 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 181' ' ' PHE . 45.7 t -80.0 -53.71 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.518 -0.739 . . . . 0.0 110.188 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.61 -173.36 21.22 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.9 p -93.35 145.9 24.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.946 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.657 ' CE2' HG12 ' A' ' 146' ' ' VAL . 84.2 m-85 -147.48 125.91 12.38 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.0 110.185 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.61 163.99 25.18 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 83.83 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.415 1.218 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.02 -66.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.618 -0.676 . . . . 0.0 110.17 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.87 132.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.489 -0.757 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 53.05 -157.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.403 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -101.22 171.06 7.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.58 -0.7 . . . . 0.0 111.031 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.3 m-85 -109.71 176.92 4.89 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -131.71 108.95 9.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.813 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 160' ' ' THR . 11.4 t80 -82.77 168.05 17.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 109.591 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.86 90.12 1.44 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.466 -0.771 . . . . 0.0 110.693 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 158' ' ' PHE . 37.6 p -76.76 158.11 81.09 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.59 158.42 50.05 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.699 1.368 . . . . 0.0 111.109 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -56.61 137.7 53.44 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.299 0.571 . . . . 0.0 111.156 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 3.1 tp10 -120.51 119.6 33.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.817 -0.552 . . . . 0.0 109.557 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.69 133.48 49.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -89.74 179.62 1.49 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.3 Cg_endo -72.21 123.75 9.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.192 1.101 . . . . 0.0 110.35 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -115.11 -175.2 2.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.557 -0.714 . . . . 0.0 110.462 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.31 18.83 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -59.5 -27.44 66.15 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -98.51 29.51 3.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 110.049 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.33 18.94 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.531 -0.731 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -100.13 132.89 45.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.392 -0.817 . . . . 0.0 110.0 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.7 177.88 23.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -84.95 126.23 33.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.724 -0.868 . . . . 0.0 110.747 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -107.33 115.87 30.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 0.0 109.883 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -75.08 122.86 24.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.593 -0.692 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.508 HD12 ' CH2' ' A' ' 194' ' ' TRP . 20.4 mt -116.31 152.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.762 . . . . 0.0 110.85 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.44 117.92 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.641 -0.662 . . . . 0.0 110.356 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 192' ' ' TRP . 17.5 t -114.23 163.15 15.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.343 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.15 108.13 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.776 -0.577 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.724 ' HD2' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -80.77 116.37 20.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.998 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.685 HG22 ' CB ' ' A' ' 188' ' ' ASP . 82.2 p -125.03 173.53 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.679 . . . . 0.0 109.861 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 189' ' ' HIS . 25.3 p-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.678 . . . . 0.0 110.22 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.216 0.532 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.685 ' CB ' HG22 ' A' ' 182' ' ' THR . 5.8 p-10 -72.32 117.32 13.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.599 -0.688 . . . . 0.0 109.796 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 183' ' ' ASP . 88.9 m-70 -59.6 -44.62 93.34 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 110.531 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 15.8 tp -162.61 156.24 20.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.461 -0.774 . . . . 0.0 110.399 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.6 p -145.16 150.72 37.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.641 -0.662 . . . . 0.0 109.946 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.472 ' CE2' HD21 ' A' ' 90' ' ' LEU . 14.8 p90 -147.19 -153.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.574 -0.704 . . . . 0.0 110.391 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -169.09 140.26 2.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.528 -0.733 . . . . 0.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.653 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 49.7 p-90 -145.4 147.23 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.541 -0.724 . . . . 0.0 110.384 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -87.65 165.11 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.711 -0.618 . . . . 0.0 110.949 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 104' ' ' LEU . 24.8 tp -143.51 105.39 4.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.81 -0.557 . . . . 0.0 109.582 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.3 m -79.33 127.08 31.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.272 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -99.78 159.48 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -150.59 -153.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.518 -0.739 . . . . 0.0 110.201 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -16.36 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -0.806 . . . . 0.0 111.445 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -160.07 61.62 0.35 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.123 -0.985 . . . . 0.0 111.291 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -66.27 -11.63 51.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.385 -0.822 . . . . 0.0 111.712 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 29.57 6.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.443 179.456 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 123' ' ' VAL . 68.4 t -135.72 133.71 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.3 t -137.31 155.42 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 90' ' ' LEU . 46.2 t -66.55 100.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.217 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 116' ' ' PHE . 55.2 p -70.81 -55.8 7.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.747 -0.596 . . . . 0.0 110.396 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -153.69 157.01 38.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.511 -0.743 . . . . 0.0 110.264 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 76' ' ' THR . 9.6 tt -125.31 161.28 27.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.606 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.725 ' N ' HD23 ' A' ' 75' ' ' LEU . 13.3 m -146.85 164.93 31.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.555 -0.715 . . . . 0.0 110.579 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 86' ' ' LEU . 2.6 mt -140.32 100.75 3.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.95 144.24 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.72 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 m -150.03 -167.38 2.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -76.21 0.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -0.775 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -94.99 36.82 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.397 -0.814 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.692 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.37 172.83 6.39 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.2 Cg_endo -71.29 -27.46 19.6 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.218 1.115 . . . . 0.0 109.87 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.58 -174.46 38.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.89 92.94 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.575 1.303 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' A' ' 102' ' ' PHE . 22.3 mt -64.32 104.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.56 159.68 15.56 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.118 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.927 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -131.11 136.47 48.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.967 -0.458 . . . . 0.0 109.967 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.416 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 12.0 t70 -82.97 131.73 35.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -129.05 53.63 1.86 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 109.837 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 p -122.87 -58.37 1.66 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.517 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.67 -63.37 0.1 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.83 78.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.986 . . . . 0.0 110.292 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -95.37 -28.17 15.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 110.285 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.7 -31.14 69.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.571 -0.705 . . . . 0.0 110.932 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -57.9 -19.95 33.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.391 -0.818 . . . . 0.0 110.956 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.927 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -62.71 -65.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.393 -0.817 . . . . 0.0 110.467 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -57.9 -20.15 34.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.0 110.942 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -22.41 26.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.409 -0.807 . . . . 0.0 110.748 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -129.91 132.44 46.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.277 -0.889 . . . . 0.0 110.569 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -115.24 148.05 39.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 109.841 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 m-85 -74.38 154.76 38.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.79 113.02 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 0.0 110.358 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.932 HD22 HG21 ' A' ' 108' ' ' VAL . 10.1 mt -113.7 -172.83 2.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.602 -0.686 . . . . 0.0 109.553 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.589 ' HB3' HG11 ' A' ' 108' ' ' VAL . 37.7 tttm -121.85 167.27 13.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.791 . . . . 0.0 109.756 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -42.01 108.93 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.24 69.24 0.43 Allowed Glycine 0 N--CA 1.502 3.068 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.259 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.932 HG21 HD22 ' A' ' 104' ' ' LEU . 34.4 m -93.77 142.83 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -1.142 . . . . 0.0 110.086 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.73 107.19 10.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.401 -0.812 . . . . 0.0 109.192 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.614 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 30.0 p90 -123.61 146.77 47.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.683 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -106.62 162.2 13.96 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.449 HG22 ' N ' ' A' ' 113' ' ' LYS . 70.2 mt -122.84 163.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 112' ' ' ILE . 14.0 ttmm -150.08 108.99 3.87 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' HD12 ' A' ' 75' ' ' LEU . 49.9 mm -98.02 146.73 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.54 -0.725 . . . . 0.0 110.807 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.36 145.51 51.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.639 -0.663 . . . . 0.0 109.639 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.533 ' HA ' HG23 ' A' ' 73' ' ' THR . 21.5 p90 -154.88 150.33 27.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 111.129 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.85 151.85 22.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.792 -0.568 . . . . 0.0 111.113 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 151' ' ' PRO . 57.7 t -133.91 99.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.674 -0.641 . . . . 0.0 109.554 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.71 48.75 2.34 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -148.29 -77.78 0.16 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.185 -0.947 . . . . 0.0 110.841 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.83 -177.85 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.353 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.3 mt -74.15 106.05 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 70' ' ' VAL . 57.6 t -80.22 76.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.662 -0.648 . . . . 0.0 109.908 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.2 98.59 7.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.449 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 128.48 40.83 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.548 ' CE ' HG11 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -78.27 124.44 28.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -1.054 . . . . 0.0 109.503 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -123.33 142.65 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.997 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -117.48 86.99 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 0.0 109.413 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -79.06 140.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 110.044 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.7 137.6 29.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.5 m-70 -107.05 154.96 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.74 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.537 ' O ' HD12 ' A' ' 139' ' ' ILE . 57.1 m -116.4 64.47 0.71 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -75.25 139.48 42.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.382 -0.824 . . . . 0.0 109.828 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NH1' HG11 ' A' ' 137' ' ' VAL . 3.4 ptt180 -120.68 -152.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.485 -0.76 . . . . 0.0 110.277 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -56.66 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.411 -0.806 . . . . 0.0 111.783 -178.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.58 13.34 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.514 -0.741 . . . . 0.0 111.584 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 135' ' ' LYS . 63.0 t -134.29 116.1 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 119.62 19.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.702 -0.624 . . . . 0.0 110.152 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.556 HG22 ' OD2' ' A' ' 140' ' ' ASP . 58.6 mt -89.62 -72.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.645 -0.659 . . . . 0.0 109.85 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.3 p30 -172.32 166.49 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.472 -0.767 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 157.74 42.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.271 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.2 m -125.24 143.69 50.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.562 -0.711 . . . . 0.0 110.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.57 75.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.631 -0.668 . . . . 0.0 109.892 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -64.72 146.43 54.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.455 -0.778 . . . . 0.0 110.685 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -106.74 123.67 48.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.641 -0.662 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.61 HG12 ' CE2' ' A' ' 149' ' ' TYR . 61.6 t -79.8 -55.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.544 -0.722 . . . . 0.0 110.015 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.92 176.6 14.48 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.9 p -86.72 151.06 23.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.626 -0.926 . . . . 0.0 110.091 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' HG12 ' A' ' 146' ' ' VAL . 88.4 m-85 -148.35 130.57 15.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.551 -0.718 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.54 157.16 32.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.675 ' HA ' HG12 ' A' ' 118' ' ' VAL . 48.5 Cg_endo -74.01 94.76 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.389 1.205 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -91.81 -78.23 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.559 -0.713 . . . . 0.0 109.91 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -172.6 -38.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -107.94 -161.8 0.79 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.0 110.672 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 168.81 9.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 30.0 m-85 -108.57 -178.47 3.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.773 -0.579 . . . . 0.0 109.649 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -138.86 99.51 3.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.931 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 34.5 t80 -84.16 171.46 12.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.259 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.66 131.74 4.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 111.172 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.5 p -97.31 151.73 37.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.84 -170.16 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.714 1.376 . . . . 0.0 111.203 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.2 ptm -54.43 145.25 18.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 111.266 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 4.6 tt0 -144.5 84.21 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.68 -0.638 . . . . 0.0 109.636 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.67 135.46 55.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 110.692 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.83 179.99 1.45 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.611 -0.681 . . . . 0.0 109.816 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.63 135.91 22.63 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.273 1.143 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 7.6 ptpp? -110.99 -179.33 3.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.713 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.08 156.35 18.94 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.1 ttp -61.44 -26.97 68.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.155 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.627 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -82.61 -24.76 33.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.568 -0.708 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -59.07 -25.42 63.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.431 -0.793 . . . . 0.0 110.52 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -60.5 123.85 18.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.426 -0.796 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 159.53 -179.84 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -95.1 135.63 36.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.66 -0.906 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.05 108.56 14.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 109.921 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -71.28 122.37 20.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.636 -0.665 . . . . 0.0 110.113 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 131' ' ' HIS . 36.3 mt -113.32 127.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -99.35 112.11 24.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.695 . . . . 0.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 4.0 m -105.65 130.06 53.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.634 -0.667 . . . . 0.0 110.217 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 99.68 6.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.685 . . . . 0.0 110.183 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.46 ' C ' HG23 ' A' ' 182' ' ' THR . 2.0 t80 -75.57 121.38 22.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 0.0 109.835 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.46 HG23 ' C ' ' A' ' 181' ' ' PHE . 32.4 p -152.63 162.27 41.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.492 1.671 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.597 179.363 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.118 0.485 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.41 115.24 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.626 . . . . 0.0 109.607 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.49 -59.94 3.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.5 tp -167.61 170.55 11.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.449 -0.782 . . . . 0.0 110.484 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.7 t -163.85 125.29 2.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.725 -0.609 . . . . 0.0 109.872 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.606 ' CE2' HD21 ' A' ' 90' ' ' LEU . 20.5 p90 -140.16 -153.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.704 . . . . 0.0 110.304 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.11 134.25 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 110.649 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.36 146.95 42.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.674 -0.641 . . . . 0.0 109.893 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.66 141.3 29.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.628 -0.67 . . . . 0.0 111.181 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 104' ' ' LEU . 44.1 tp -108.84 108.83 19.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -88.47 122.08 31.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.771 . . . . 0.0 110.656 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.9 mm -94.32 156.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 109.486 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -138.23 -162.33 1.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.748 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 -24.43 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 110.682 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -160.01 77.36 0.65 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.387 -0.821 . . . . 0.0 110.994 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.791 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -70.51 -7.03 40.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.452 -0.78 . . . . 0.0 111.693 179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -155.28 51.45 0.59 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.107 -0.995 . . . . 0.0 110.288 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.122 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.43 ' HB3' ' CB ' ' A' ' 120' ' ' ARG . 7.4 p-10 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 70' ' ' VAL . 21.4 t -143.6 31.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 110.817 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.58 141.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.676 -0.64 . . . . 0.0 110.055 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 90' ' ' LEU . 58.5 t -63.73 125.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.637 -0.664 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.5 p -82.03 -58.92 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.903 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.58 155.42 26.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.454 ' HG ' HD13 ' A' ' 114' ' ' ILE . 4.5 tt -110.97 133.84 53.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.606 -0.684 . . . . 0.0 109.784 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -109.64 155.66 21.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.542 -0.724 . . . . 0.0 110.924 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -141.57 107.96 5.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.614 -0.679 . . . . 0.0 110.058 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 85' ' ' PRO . 60.3 t -121.79 160.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.972 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.8 t -147.27 -80.73 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -170.81 -45.49 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.346 -0.846 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 p -123.86 34.76 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 110.118 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -87.59 173.06 6.93 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.9 Cg_endo -72.29 -28.6 15.05 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.474 1.25 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.35 170.97 30.01 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.0 Cg_endo -72.1 102.83 1.4 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.526 1.277 . . . . 0.0 110.188 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 8.2 mt -64.73 121.23 14.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 109.68 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.84 103.41 15.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.668 -0.645 . . . . 0.0 110.247 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.9 tt -80.2 119.82 23.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 110.176 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.47 129.42 37.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.717 HD13 HG11 ' A' ' 72' ' ' VAL . 6.0 mt -133.71 53.6 2.0 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.561 -0.712 . . . . 0.0 110.039 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.3 p -140.31 -43.53 0.41 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.656 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.11 -117.85 4.25 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 114.83 3.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.627 -0.925 . . . . 0.0 110.334 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mt -92.27 -30.46 15.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -66.13 -12.69 57.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.804 . . . . 0.0 111.096 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -56.45 -20.27 19.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.111 -0.993 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 88' ' ' LEU . 3.1 m-85 -67.99 -31.68 71.56 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.312 -0.868 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -61.49 -35.29 77.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 110.723 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -87.1 -25.2 24.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.61 126.26 46.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.468 -0.77 . . . . 0.0 110.477 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -115.38 159.77 20.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.784 ' HB2' HD12 ' A' ' 196' ' ' LEU . 11.3 m-85 -83.27 114.64 21.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.93 118.28 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.693 -0.63 . . . . 0.0 110.51 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 196' ' ' LEU . 82.1 mt -129.89 159.15 37.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.575 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 108' ' ' VAL . 18.9 tttt -85.9 169.02 13.67 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -39.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 41.58 72.84 0.24 Allowed Glycine 0 N--CA 1.501 2.985 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.898 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 105' ' ' LYS . 33.1 m -86.5 125.77 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -1.037 . . . . 0.0 110.077 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.05 90.77 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.199 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.549 ' CD1' HD23 ' A' ' 77' ' ' LEU . 11.9 p90 -109.63 150.37 28.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.156 -0.965 . . . . 0.0 111.573 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -98.04 147.07 24.9 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.412 HD11 ' HE1' ' A' ' 110' ' ' TYR . 69.1 mt -111.04 132.56 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -115.38 98.63 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.782 -0.574 . . . . 0.0 109.559 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.496 HG21 ' CE1' ' A' ' 181' ' ' PHE . 42.4 mm -78.08 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.695 -0.628 . . . . 0.0 110.432 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.5 m -114.81 141.44 47.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 12.9 p90 -153.87 144.65 22.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.415 -0.803 . . . . 0.0 110.968 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -87.17 132.53 33.84 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.246 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 151' ' ' PRO . 60.8 t -122.94 95.12 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -128.15 40.12 3.72 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.596 -0.841 . . . . 0.0 112.692 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -161.31 -67.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.08 -1.013 . . . . 0.0 110.919 179.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -124.38 166.07 16.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 110.911 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 123' ' ' VAL . 81.8 mt -72.97 165.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.263 0.554 . . . . 0.0 110.031 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 126' ' ' MET . 48.6 t -128.39 54.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.699 -0.625 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.92 104.95 2.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.661 -0.649 . . . . 0.0 110.35 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.14 46.27 0.95 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.537 ' HB2' HG12 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -87.6 132.27 34.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.599 -0.942 . . . . 0.0 109.486 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.22 164.55 17.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.478 -0.764 . . . . 0.0 111.019 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -136.43 102.06 4.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.861 -0.524 . . . . 0.0 109.748 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 130' ' ' GLN . 50.8 mm -82.27 164.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 0.0 109.994 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 129' ' ' ILE . 39.5 tt0 -167.96 117.71 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.775 ' O ' HG23 ' A' ' 177' ' ' ILE . 10.7 m170 -101.7 159.31 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.718 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.471 ' CG2' HD11 ' A' ' 139' ' ' ILE . 9.2 m -117.55 69.85 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.458 -0.777 . . . . 0.0 109.959 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 19.7 m-85 -66.2 123.72 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.09 134.13 51.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 110.395 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm 52.69 28.15 5.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.21 -16.61 55.36 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.6 m -106.02 156.24 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.118 -1.225 . . . . 0.0 110.576 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -86.37 134.34 33.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.676 . . . . 0.0 109.887 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.471 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pt -118.02 -25.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 110.956 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -175.79 144.45 0.63 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.225 -0.922 . . . . 0.0 110.537 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.64 152.44 50.43 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.7 m -136.27 153.45 51.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 111.374 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.69 116.37 26.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.43 114.69 29.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.981 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.4 ttt -74.64 120.07 19.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.702 HG13 ' CG ' ' A' ' 158' ' ' PHE . 51.3 t -79.64 -68.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.403 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.57 -163.23 29.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.2 p -104.77 148.04 27.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.906 . . . . 0.0 110.256 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.485 ' CE2' HG12 ' A' ' 146' ' ' VAL . 89.8 m-85 -147.74 125.84 12.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.501 -0.75 . . . . 0.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.65 156.61 23.26 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.715 ' HA ' HG12 ' A' ' 118' ' ' VAL . 45.9 Cg_endo -71.36 94.13 0.67 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.406 1.214 . . . . 0.0 110.49 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -86.31 -67.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.681 . . . . 0.0 110.11 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.79 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.68 -152.29 0.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 110.634 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -99.97 168.05 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 34.1 m-85 -111.46 -170.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.65 -0.656 . . . . 0.0 109.909 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.54 114.12 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.693 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.702 ' CG ' HG13 ' A' ' 146' ' ' VAL . 37.7 t80 -89.64 164.73 14.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 109.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -135.75 117.41 14.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.531 -0.73 . . . . 0.0 110.656 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 158' ' ' PHE . 71.6 p -102.23 147.77 34.44 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.611 -0.68 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.21 -173.44 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.821 1.432 . . . . 0.0 111.735 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -52.67 140.67 22.82 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.472 0.653 . . . . 0.0 111.773 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 3.5 tp10 -138.42 82.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.61 137.18 58.0 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.541 0.686 . . . . 0.0 110.8 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -82.42 -178.7 1.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.09 124.94 10.44 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.187 1.098 . . . . 0.0 110.198 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -115.26 178.96 4.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.571 -0.706 . . . . 0.0 110.662 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.44 150.83 10.66 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 5.8 ttt -59.59 -28.83 67.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.418 -1.049 . . . . 0.0 110.025 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 170' ' ' LEU . 0.2 OUTLIER -99.2 23.96 8.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.784 . . . . 0.0 110.325 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.41 24.61 7.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -98.59 131.45 44.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 110.009 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.33 -174.26 27.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.5 p -87.6 122.84 31.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.943 . . . . 0.0 110.659 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 19.4 m-85 -103.67 107.33 18.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -66.0 133.33 50.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.596 -0.69 . . . . 0.0 110.093 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 131' ' ' HIS . 15.7 mt -124.87 141.58 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.493 -0.755 . . . . 0.0 110.62 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -114.12 115.06 26.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.637 -0.664 . . . . 0.0 110.211 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.5 m -113.8 157.63 22.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 110.15 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.31 101.52 4.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.62 ' CD2' HG22 ' A' ' 72' ' ' VAL . 2.2 t80 -75.56 92.46 2.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.644 . . . . 0.0 110.096 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.7 t -127.28 179.75 5.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.274 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.54 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.84 116.52 28.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.715 -0.616 . . . . 0.0 109.413 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -57.65 -49.52 76.2 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.433 -0.792 . . . . 0.0 110.703 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.8 tp -168.35 158.91 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.5 -0.75 . . . . 0.0 110.463 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 140.28 22.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.92 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.535 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.3 p90 -146.52 -155.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.581 -0.699 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -161.68 130.23 4.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.688 -0.633 . . . . 0.0 110.169 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.519 ' CZ3' HD13 ' A' ' 196' ' ' LEU . 11.0 p-90 -137.49 145.96 43.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.498 -0.751 . . . . 0.0 110.066 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -90.13 155.88 18.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.511 0.672 . . . . 0.0 111.122 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 104' ' ' LEU . 15.3 tp -121.18 95.42 4.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.777 -0.577 . . . . 0.0 109.614 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -68.91 122.6 18.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.672 . . . . 0.0 110.304 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -101.39 153.51 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 109.796 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -148.55 -157.09 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.615 -0.678 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -18.42 7.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.786 . . . . 0.0 111.355 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.8 73.73 1.08 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.0 111.079 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.782 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.59 -4.19 32.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.727 . . . . 0.0 111.569 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 37.51 4.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 110.25 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.334 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' HG23 ' A' ' 70' ' ' VAL . 43.4 t-20 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.999 0.428 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 123' ' ' VAL . 90.6 t -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.1 t -147.54 147.41 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.765 -0.584 . . . . 0.0 109.827 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.65 HG23 ' CD2' ' A' ' 181' ' ' PHE . 43.2 t -68.13 113.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.627 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 116' ' ' PHE . 32.8 p -77.29 -33.44 55.77 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.118 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -168.63 160.27 10.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.708 . . . . 0.0 110.324 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 10.4 tt -128.29 134.75 48.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.655 -0.653 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.3 m -109.6 162.29 14.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.541 -0.724 . . . . 0.0 110.146 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.84 95.69 2.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.771 . . . . 0.0 110.195 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 85' ' ' PRO . 71.6 t -105.19 167.32 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.857 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 40.8 t -159.55 -82.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.651 -0.656 . . . . 0.0 110.134 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -71.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.865 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 p -98.59 31.5 2.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.725 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -85.13 169.95 14.78 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.706 . . . . 0.0 110.088 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.7 Cg_endo -71.6 -27.44 18.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.393 1.207 . . . . 0.0 110.24 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.56 170.57 26.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HB3' HG22 ' A' ' 78' ' ' VAL . 44.9 Cg_endo -71.84 104.37 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.497 1.262 . . . . 0.0 110.192 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 102' ' ' PHE . 9.5 mt -64.91 128.48 35.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 109.817 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -103.55 113.17 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.681 -0.637 . . . . 0.0 110.323 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 102' ' ' PHE . 1.2 tt -100.01 105.71 17.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 110.154 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -65.69 137.71 57.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.689 -0.632 . . . . 0.0 109.729 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HA ' HD21 ' A' ' 94' ' ' LEU . 95.0 mt -135.6 56.8 1.82 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.753 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.0 p -115.75 -68.53 0.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.768 -0.582 . . . . 0.0 110.493 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 -58.18 0.18 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.45 74.81 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.969 . . . . 0.0 110.323 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 90' ' ' LEU . 18.2 mt -95.46 -22.38 17.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 0.0 110.805 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.43 -1.13 28.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.345 -0.847 . . . . 0.0 111.561 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -90.06 0.37 57.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.175 -0.953 . . . . 0.0 111.288 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 51.8 m-85 -94.09 -32.22 13.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.114 -0.991 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -59.1 -19.72 47.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -88.07 -24.75 23.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 110.535 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.68 -179.88 3.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.429 -0.794 . . . . 0.0 110.54 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -167.31 142.88 4.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.536 -0.727 . . . . 0.0 110.146 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.641 ' HE2' HD12 ' A' ' 88' ' ' LEU . 29.5 m-85 -79.09 121.72 25.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.859 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.84 123.47 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 110.341 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.528 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 55.0 mt -124.19 178.74 5.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 19.7 tttm -104.2 150.97 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.815 0.817 . . . . 0.0 109.514 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.6 pt-20 -50.63 124.5 11.0 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.56 48.99 72.77 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.626 -0.671 . . . . 0.0 113.343 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 105' ' ' LYS . 28.0 m -97.01 133.21 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.975 1.388 . . . . 0.0 109.678 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.44 94.77 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.75 ' HD2' HG23 ' A' ' 108' ' ' VAL . 40.8 p90 -118.32 142.03 47.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 0.0 111.361 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.19 163.37 12.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.612 -0.68 . . . . 0.0 109.176 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 82.5 mt -126.42 151.59 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.015 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.512 ' HE2' HD23 ' A' ' 159' ' ' LEU . 39.9 ttmt -128.91 117.9 21.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.14 144.98 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.758 . . . . 0.0 110.662 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -123.72 147.54 47.38 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.779 ' HA ' HG23 ' A' ' 73' ' ' THR . 34.1 p90 -168.37 161.29 11.89 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.572 ' HG3' HG21 ' A' ' 73' ' ' THR . 7.7 mtm180 -113.0 144.59 42.31 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.843 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 70' ' ' VAL . 57.8 t -125.79 98.89 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -128.7 49.01 2.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 0.0 111.046 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -75.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 123' ' ' VAL . 3.7 tt0 -138.28 160.22 40.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.5 mt -63.57 104.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.74 -0.6 . . . . 0.0 109.921 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 70' ' ' VAL . 57.9 t -91.33 76.35 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.612 -0.68 . . . . 0.0 109.636 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.0 p -77.68 85.48 4.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.37 48.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.458 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 0.0 OUTLIER -85.12 131.05 34.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.558 -0.966 . . . . 0.0 109.481 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.5 162.34 25.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.63 -0.669 . . . . 0.0 111.051 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -136.38 108.28 7.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 77.2 mt -102.76 161.94 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -159.3 134.88 8.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.594 -0.691 . . . . 0.0 110.28 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.4 m-70 -111.23 130.68 55.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 84.3 m -84.33 72.59 10.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.849 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.41 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 4.4 m-85 -64.11 137.35 57.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 110.495 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 14.8 ttm180 -120.91 107.76 13.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.634 . . . . 0.0 109.925 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 53.27 37.09 24.39 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.399 -0.813 . . . . 0.0 110.584 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.34 33.47 19.87 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 136' ' ' GLY . 59.7 t -147.24 111.41 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 126.47 28.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.73 -22.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.558 -0.714 . . . . 0.0 110.798 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -167.91 132.48 1.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.595 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.43 ' CE ' ' CE1' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -139.98 144.51 37.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 143' ' ' ASP . 28.2 m -132.42 164.72 25.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 110.744 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 142' ' ' THR . 1.5 m-20 -120.53 115.39 23.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.748 -0.595 . . . . 0.0 109.877 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.17 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 ttm -98.27 117.99 33.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.542 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.502 HG12 ' CE2' ' A' ' 149' ' ' TYR . 47.4 t -79.7 -63.21 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.786 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 143.77 178.43 19.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.2 p -87.77 149.13 24.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.909 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 146' ' ' VAL . 76.3 m-85 -147.82 132.57 17.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.333 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.95 159.5 24.57 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.13 94.22 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.399 1.21 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -116.51 23.35 12.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 110.6 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 52.49 23.64 2.64 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.339 -0.851 . . . . 0.0 111.213 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -126.97 169.15 13.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.573 -0.704 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -100.19 163.33 12.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.604 . . . . 0.0 110.398 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.474 ' CD2' ' CD1' ' A' ' 149' ' ' TYR . 64.2 m-85 -122.88 170.57 9.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.644 -0.66 . . . . 0.0 109.954 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -136.23 103.36 5.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.486 ' HB2' HG13 ' A' ' 146' ' ' VAL . 24.4 t80 -88.18 148.34 24.45 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 159' ' ' LEU . 3.4 tm? -133.53 111.3 10.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 110.641 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 158' ' ' PHE . 77.6 p -85.83 151.67 55.43 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.56 -0.712 . . . . 0.0 109.62 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.78 165.62 22.82 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.441 1.232 . . . . 0.0 111.093 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 mtm -54.64 168.63 0.26 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.714 -0.616 . . . . 0.0 110.755 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -155.55 140.2 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.741 -0.599 . . . . 0.0 109.775 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 129.9 42.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.591 -0.693 . . . . 0.0 110.974 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -77.93 178.56 2.09 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.612 -0.68 . . . . 0.0 110.25 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.3 Cg_endo -73.39 -173.12 1.2 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.448 1.236 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 13.8 mmtt -78.39 -176.53 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.51 -0.744 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.402 ' N ' ' CB ' ' A' ' 106' ' ' GLU . . . -95.18 -60.88 1.04 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 171' ' ' ALA . 12.2 mmt -60.9 141.7 56.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.962 . . . . 0.0 109.44 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt 66.15 -64.27 0.22 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.673 -0.642 . . . . 0.0 110.393 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -59.5 -17.83 35.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 111.177 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.15 27.78 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.082 -1.011 . . . . 0.0 110.285 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.63 177.88 15.13 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.7 p -88.19 134.21 33.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.544 -0.974 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 15.9 m-85 -116.94 116.81 28.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.544 -0.722 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -61.66 145.82 51.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.827 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -125.18 108.23 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.502 -0.749 . . . . 0.0 110.361 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 1.6 ttpt -88.2 95.61 10.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.493 -0.754 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 125.29 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.48 -0.762 . . . . 0.0 110.114 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -116.01 107.8 15.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.45 -0.782 . . . . 0.0 110.35 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.65 ' CD2' HG23 ' A' ' 72' ' ' VAL . 2.2 t80 -83.82 136.68 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.714 -0.616 . . . . 0.0 109.741 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.434 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -172.77 -173.58 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.557 -0.714 . . . . 0.0 110.42 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 6.6 p-10 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 121.139 0.495 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -115.25 118.87 34.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.579 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 14.4 m-70 -73.23 -65.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 110.699 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.0 tp -168.42 151.49 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.797 . . . . 0.0 110.5 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.6 m -149.0 146.5 27.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.015 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -140.05 -162.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -154.44 121.89 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.401 -0.812 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.827 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 30.5 p-90 -132.23 148.35 52.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.692 -0.63 . . . . 0.0 109.553 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.49 148.56 23.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.483 -0.76 . . . . 0.0 111.489 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.52 102.1 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -75.2 132.07 40.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 0.0 110.724 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.95 147.75 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.76 -159.08 0.96 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.694 -0.629 . . . . 0.0 110.129 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.58 -8.43 4.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.96 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -155.19 63.13 0.63 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.947 -1.095 . . . . 0.0 111.516 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' TRP . . . . . 0.725 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -72.17 -6.77 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.263 -0.898 . . . . 0.0 111.241 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -162.21 47.92 0.17 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.134 -179.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 p -139.65 138.19 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.603 -0.686 . . . . 0.0 110.098 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 t 53.04 -159.28 0.13 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.381 -0.825 . . . . 0.0 110.719 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.21 166.33 13.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.533 -0.729 . . . . 0.0 110.223 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -77.18 149.9 79.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.204 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.69 -88.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.479 1.252 . . . . 0.0 110.601 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.486 ' C ' HG23 ' A' ' 67' ' ' VAL . 18.9 m120 52.82 29.51 7.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.945 -1.097 . . . . 0.0 110.815 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG13 ' HD2' ' A' ' 68' ' ' PRO . 72.7 t -152.73 146.08 17.86 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.777 -0.577 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.538 ' HD2' HG13 ' A' ' 67' ' ' VAL . 42.3 Cg_endo -68.35 162.36 40.86 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.282 1.148 . . . . 0.0 109.97 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.673 ' ND2' HG23 ' A' ' 70' ' ' VAL . 17.0 p-10 -104.14 -25.74 12.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.523 -0.736 . . . . 0.0 110.949 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 123' ' ' VAL . 86.0 t -125.51 119.15 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.9 t -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG12 HD12 ' A' ' 90' ' ' LEU . 53.4 t -61.35 110.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.726 . . . . 0.0 109.142 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.858 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.8 p -76.2 -41.27 50.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -167.38 163.76 15.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.287 -0.883 . . . . 0.0 111.428 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -121.44 125.93 48.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 85' ' ' PRO . 12.8 m -109.97 154.78 22.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 111.032 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 86' ' ' LEU . 6.2 mt -138.71 92.02 2.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.35 130.8 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.713 -0.617 . . . . 0.0 110.654 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.7 m -128.05 -3.13 5.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.713 -0.617 . . . . 0.0 111.145 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.83 18.7 3.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.951 -1.093 . . . . 0.0 111.29 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.5 p -142.26 -45.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 109.757 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -57.77 -179.18 0.11 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.749 -0.594 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -73.85 -17.31 22.81 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.531 1.279 . . . . 0.0 110.238 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.7 171.61 35.45 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.924 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.8 Cg_endo -72.56 122.26 8.11 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.778 1.409 . . . . 0.0 110.728 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 102' ' ' PHE . 6.3 mt -68.66 117.66 10.67 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.149 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.99 112.8 25.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.633 -0.667 . . . . 0.0 110.64 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' TRP . 1.3 tt -101.07 101.66 12.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.554 -0.716 . . . . 0.0 109.988 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.6 t0 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.553 -0.717 . . . . 0.0 110.33 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.48 HD21 HD22 ' A' ' 88' ' ' LEU . 96.0 mt -135.87 54.77 1.89 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 110.062 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 p -135.87 -42.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.783 -0.573 . . . . 0.0 110.422 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.33 -103.61 2.45 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.22 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.632 -0.923 . . . . 0.0 110.687 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -95.55 -26.74 15.67 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.638 -0.663 . . . . 0.0 110.395 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.94 0.2 36.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.495 -0.753 . . . . 0.0 111.523 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 t -85.9 0.25 53.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.099 -1.0 . . . . 0.0 111.208 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 34.3 m-85 -93.14 -29.42 15.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.165 -0.959 . . . . 0.0 110.045 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -12.57 60.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -86.47 -26.62 24.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.253 -0.904 . . . . 0.0 110.33 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -132.62 -172.11 2.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.5 -0.75 . . . . 0.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.4 p -152.59 169.64 22.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.549 -0.719 . . . . 0.0 110.102 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 86' ' ' LEU . 17.6 m-85 -96.7 119.85 35.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.58 -0.7 . . . . 0.0 109.997 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.51 116.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 109.62 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.857 ' CD2' HD11 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -113.61 166.38 11.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.049 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.507 ' CB ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -96.14 148.02 23.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.593 -0.692 . . . . 0.0 111.542 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' CG2' ' A' ' 198' ' ' ILE . 6.2 mt-10 -23.46 -46.81 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -174.04 36.4 0.12 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.818 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.507 HG13 ' CB ' ' A' ' 105' ' ' LYS . 27.0 m -60.41 148.31 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.235 -1.156 . . . . 0.0 110.309 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.09 93.96 5.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.629 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 32.5 p90 -109.7 151.35 27.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.469 -0.77 . . . . 0.0 111.562 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.3 156.44 18.14 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.524 HG12 HD23 ' A' ' 77' ' ' LEU . 67.4 mt -122.98 135.93 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.314 -0.866 . . . . 0.0 110.42 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 159' ' ' LEU . 41.0 mtmt -122.51 120.45 33.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.587 . . . . 0.0 110.08 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.743 HG21 ' CE2' ' A' ' 181' ' ' PHE . 50.1 mm -97.65 134.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.701 . . . . 0.0 109.981 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 p -108.67 150.12 27.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.134 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.858 ' HA ' HG23 ' A' ' 73' ' ' THR . 3.1 p90 -162.51 139.13 7.74 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 135.06 35.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.625 . . . . 0.0 111.126 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.801 HG22 HG22 ' A' ' 70' ' ' VAL . 63.5 t -125.26 102.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -128.63 43.89 3.06 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.781 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -155.96 -65.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.0 166.06 23.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.375 -0.828 . . . . 0.0 111.413 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 149' ' ' TYR . 50.7 mt -80.25 145.97 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.99 HG21 HG21 ' A' ' 70' ' ' VAL . 66.3 t -114.8 74.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.673 -0.642 . . . . 0.0 109.428 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 85.4 p -64.82 85.04 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 110.474 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.18 51.76 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.505 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -75.26 131.92 40.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -1.007 . . . . 0.0 109.312 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -130.7 159.57 36.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 111.085 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -138.08 126.52 23.32 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 130' ' ' GLN . 76.5 mt -116.06 166.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.473 ' N ' HG22 ' A' ' 129' ' ' ILE . 35.5 tt0 -168.58 111.45 0.56 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.4 m-70 -98.39 109.26 22.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.56 -0.713 . . . . 0.0 109.979 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 139' ' ' ILE . 23.5 m -68.62 79.07 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.8 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.45 ' CZ ' ' CG ' ' A' ' 138' ' ' LYS . 2.8 m-85 -69.28 124.62 24.33 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.611 -0.681 . . . . 0.0 110.021 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.625 ' O ' HG12 ' A' ' 137' ' ' VAL . 5.5 ttt180 -127.03 130.46 50.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.552 -0.717 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 52.74 28.56 6.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.464 -0.772 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.48 -18.78 47.76 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 134' ' ' ARG . 8.3 p -104.18 152.89 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -1.198 . . . . 0.0 110.328 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -85.24 134.52 34.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 110.268 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 132' ' ' THR . 1.2 pt -116.6 -19.61 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.2 115.76 0.96 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 110.69 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 3.3 pttm -143.49 121.15 11.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.601 -0.687 . . . . 0.0 109.891 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 143' ' ' ASP . 14.5 m -143.63 169.29 18.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.452 -0.78 . . . . 0.0 110.936 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.437 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -102.42 157.56 16.83 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.722 -0.611 . . . . 0.0 109.92 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -122.92 103.23 8.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 110.427 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ttt -65.6 120.32 12.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.515 -0.741 . . . . 0.0 109.584 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 149' ' ' TYR . 50.6 t -96.9 -69.59 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.47 -0.769 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.87 -162.4 31.65 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -93.89 126.04 38.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.622 -0.928 . . . . 0.0 110.27 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 122' ' ' ILE . 9.9 m-85 -113.45 137.74 51.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.695 . . . . 0.0 110.487 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.89 150.61 17.58 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.48 114.41 4.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.419 1.221 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -106.6 -58.18 1.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.572 -0.705 . . . . 0.0 110.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -170.55 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.523 -0.736 . . . . 0.0 110.744 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.88 -154.38 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.414 -0.804 . . . . 0.0 111.031 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.433 ' OE1' HG21 ' A' ' 73' ' ' THR . 9.3 pt-20 -101.56 166.33 10.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.732 . . . . 0.0 110.849 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 92.8 m-85 -115.74 -166.06 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.744 -0.598 . . . . 0.0 109.388 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -148.54 110.91 4.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 110.666 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.468 ' HE2' HG22 ' A' ' 160' ' ' THR . 39.8 t80 -70.81 165.76 22.46 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.407 HD21 ' HD3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -146.08 109.12 4.61 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.814 . . . . 0.0 110.792 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.468 HG22 ' HE2' ' A' ' 158' ' ' PHE . 72.2 p -87.58 145.91 38.25 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.57 -171.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.658 1.346 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -54.03 158.1 2.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.674 -0.641 . . . . 0.0 111.22 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 5.7 tt0 -159.95 93.44 1.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.74 -0.6 . . . . 0.0 109.77 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.13 133.14 49.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.628 -0.67 . . . . 0.0 110.519 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.669 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -80.88 166.78 36.95 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.84 117.47 5.16 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.377 1.198 . . . . 0.0 110.118 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -108.03 172.36 6.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.514 -0.741 . . . . 0.0 110.709 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.81 155.29 8.83 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.1 ttm -59.28 -27.73 66.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.582 -0.952 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.2 mm? -93.48 -28.79 15.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.655 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.58 -22.01 54.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.936 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -62.36 138.56 58.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.339 -0.85 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.35 177.3 19.11 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 p -88.62 131.59 34.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.603 -0.939 . . . . 0.0 110.354 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -112.68 108.49 17.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.511 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -66.6 137.91 57.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 0.0 109.403 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' CH2' ' A' ' 194' ' ' TRP . 16.4 mt -128.69 135.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.358 -0.839 . . . . 0.0 110.828 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -108.42 105.04 14.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.738 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.5 p -106.45 129.28 54.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.532 -0.73 . . . . 0.0 110.593 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -126.5 91.61 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.673 -0.642 . . . . 0.0 109.886 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.743 ' CE2' HG21 ' A' ' 114' ' ' ILE . 3.4 t80 -74.82 103.66 5.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 109.7 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.459 HG22 ' CB ' ' A' ' 188' ' ' ASP . 69.6 p -122.37 165.81 15.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.568 -0.707 . . . . 0.0 110.201 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -115.64 164.55 14.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.624 -0.673 . . . . 0.0 109.39 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.13 55.81 3.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -117.19 -75.14 0.58 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.752 -0.593 . . . . 0.0 109.661 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.38 23.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.741 -0.599 . . . . 0.0 112.18 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t -173.09 -172.6 0.84 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.687 -1.258 . . . . 0.0 111.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.459 ' CB ' HG22 ' A' ' 182' ' ' THR . 2.2 m-20 -114.46 118.8 34.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 36.3 m-70 -56.93 -49.98 73.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 110.791 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.1 tp -168.25 153.74 6.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.439 -0.788 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -154.28 140.96 19.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.659 -0.651 . . . . 0.0 109.678 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.402 ' CB ' HD21 ' A' ' 94' ' ' LEU . 16.0 p90 -145.57 -154.63 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.787 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.7 129.5 6.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.362 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.48 ' HB3' HD11 ' A' ' 88' ' ' LEU . 14.3 p-90 -137.82 146.9 44.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.574 -0.704 . . . . 0.0 109.901 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -96.79 158.08 15.6 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 104' ' ' LEU . 21.1 tp -127.0 111.55 14.21 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.7 m -91.53 117.66 29.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.53 -0.731 . . . . 0.0 110.774 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.5 mm -90.03 139.86 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -134.55 -155.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.467 -0.771 . . . . 0.0 110.494 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -93.83 -63.05 1.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -153.15 113.86 4.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.52 -0.737 . . . . 0.0 111.496 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -80.05 7.13 9.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.618 -0.676 . . . . 0.0 111.901 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -169.03 38.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.349 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.194 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.059 0.457 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 p -112.57 -25.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.636 -0.665 . . . . 0.0 110.333 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -79.68 177.16 9.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 110.196 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.74 96.27 4.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.656 -0.653 . . . . 0.0 110.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.9 175.42 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.558 -0.714 . . . . 0.0 110.641 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.81 -49.9 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.376 1.198 . . . . 0.0 110.322 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.09 97.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.413 -0.804 . . . . 0.0 110.805 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 67' ' ' VAL . 7.2 p -163.07 85.09 1.4 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.567 -0.708 . . . . 0.0 110.26 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.29 163.53 38.36 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.283 1.149 . . . . 0.0 110.328 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' CG ' HG23 ' A' ' 70' ' ' VAL . 31.6 t30 -98.61 -71.79 0.68 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.558 -0.714 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 123' ' ' VAL . 57.2 t -122.48 33.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.712 0.767 . . . . 0.0 109.684 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HD22 ' A' ' 190' ' ' LEU . 60.9 t -69.24 153.38 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.291 0.567 . . . . 0.0 109.986 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 90' ' ' LEU . 57.8 t -69.03 136.84 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.669 -0.645 . . . . 0.0 109.487 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 116' ' ' PHE . 62.1 p -95.44 -41.85 8.77 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.282 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -164.19 169.01 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 110.253 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 76' ' ' THR . 5.8 tt -133.64 134.9 43.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.68 ' N ' HD23 ' A' ' 75' ' ' LEU . 62.6 m -122.03 158.35 29.36 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.578 -0.702 . . . . 0.0 110.44 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 86' ' ' LEU . 73.3 mt -132.81 93.73 3.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.75 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -81.69 140.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.746 -0.596 . . . . 0.0 110.161 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 84.2 m -142.41 -162.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.642 -0.661 . . . . 0.0 110.063 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.7 p -111.34 -72.55 0.71 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 110.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 p -96.63 32.54 2.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.451 -0.78 . . . . 0.0 110.452 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.8 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.56 -174.62 0.45 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.652 -0.655 . . . . 0.0 110.237 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.8 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.2 Cg_endo -79.93 -28.87 2.99 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 123.203 1.107 . . . . 0.0 110.156 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.55 -179.22 33.45 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.44 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.3 Cg_endo -71.87 108.35 2.42 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.587 1.309 . . . . 0.0 110.511 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.792 ' HB2' HD12 ' A' ' 77' ' ' LEU . 37.7 mt -71.72 107.39 4.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.829 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.15 146.29 27.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.65 -0.656 . . . . 0.0 110.247 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -130.91 140.82 50.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.582 -0.698 . . . . 0.0 110.095 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.25 130.08 39.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.506 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 72' ' ' VAL . 5.8 mt -137.73 56.14 1.77 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 0.0 109.926 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 90' ' ' LEU . 27.0 p -149.37 -45.64 0.14 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.487 -0.758 . . . . 0.0 110.797 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.14 -89.02 1.13 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.75 124.14 49.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.916 . . . . 0.0 110.282 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 89.4 mt -92.84 -24.16 18.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.581 -0.699 . . . . 0.0 110.392 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -23.1 6.31 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.218 -0.926 . . . . 0.0 111.295 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -57.78 -19.72 30.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 111.081 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CE1' ' CD2' ' A' ' 88' ' ' LEU . 10.1 m-30 -62.56 -55.24 29.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.163 -0.961 . . . . 0.0 110.47 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -20.03 39.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.498 -0.751 . . . . 0.0 110.835 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -96.26 26.86 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -168.95 163.33 11.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.389 -0.82 . . . . 0.0 110.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 p -163.29 131.14 3.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.615 -0.678 . . . . 0.0 110.032 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.627 ' HB3' HD13 ' A' ' 86' ' ' LEU . 26.9 m-85 -73.79 126.6 30.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.614 -0.679 . . . . 0.0 110.094 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.1 t -87.35 122.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.71 . . . . 0.0 110.128 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' HD13 ' A' ' 198' ' ' ILE . 41.1 mt -114.89 -169.67 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.632 -0.667 . . . . 0.0 110.151 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.789 ' O ' HG13 ' A' ' 108' ' ' VAL . 16.3 tttm -126.4 157.5 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.716 0.769 . . . . 0.0 109.868 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -41.19 117.35 0.86 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 43.44 66.2 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.127 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 105' ' ' LYS . 35.0 m -98.44 152.21 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -1.111 . . . . 0.0 110.244 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.521 ' HB3' ' HE3' ' A' ' 162' ' ' MET . 15.8 tt0 -95.48 117.11 29.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 109.486 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 33.0 p90 -142.58 149.27 38.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.387 -0.821 . . . . 0.0 111.277 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.62 166.01 11.52 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 77' ' ' LEU . 70.0 mt -126.15 148.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.022 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HD2' HD21 ' A' ' 159' ' ' LEU . 5.8 mtpp -123.25 92.09 3.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 109.547 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.605 HD13 ' HG ' ' A' ' 75' ' ' LEU . 46.9 mm -73.32 135.71 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 110.322 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.1 m -117.94 136.99 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.762 ' HA ' HG23 ' A' ' 73' ' ' THR . 37.9 p90 -156.71 148.9 23.11 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.413 -0.804 . . . . 0.0 110.695 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.88 138.01 35.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.716 -0.615 . . . . 0.0 110.509 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 70' ' ' VAL . 58.9 t -129.95 84.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.643 . . . . 0.0 109.482 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 151' ' ' PRO . 2.1 t30 -129.17 48.59 2.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.567 -0.708 . . . . 0.0 111.25 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -70.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.376 -0.827 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.22 156.81 36.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.555 -0.716 . . . . 0.0 110.416 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.17 103.4 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 110.292 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 70' ' ' VAL . 84.3 t -93.56 99.48 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.632 -0.667 . . . . 0.0 109.497 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 83.6 p -89.39 117.72 28.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.512 -0.742 . . . . 0.0 110.758 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 103.92 48.94 1.12 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 146' ' ' VAL . 1.3 ttt -73.09 125.09 26.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 109.906 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -119.69 143.71 47.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.167 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -120.54 106.57 11.91 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 130' ' ' GLN . 84.3 mt -103.15 163.2 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.569 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.421 ' N ' HG22 ' A' ' 129' ' ' ILE . 22.9 tt0 -153.25 139.56 18.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.738 -0.601 . . . . 0.0 109.944 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 141' ' ' LYS . 30.9 m-70 -117.93 132.65 56.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 110.496 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 m -87.55 71.1 9.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 109.543 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 7.3 m-85 -74.08 151.46 40.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.714 -0.616 . . . . 0.0 110.822 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HD3' HD11 ' A' ' 139' ' ' ILE . 2.8 tpt180 -120.17 -150.96 0.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.836 -0.54 . . . . 0.0 109.735 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 66.43 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 110.848 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.3 34.66 35.97 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.9 t -144.84 95.09 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.655 -0.909 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -59.55 115.6 3.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.508 -0.745 . . . . 0.0 110.197 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.543 HD11 ' HD3' ' A' ' 134' ' ' ARG . 95.2 mt -89.8 -58.7 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.474 -0.766 . . . . 0.0 110.115 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.29 -171.8 1.36 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.51 -0.744 . . . . 0.0 110.944 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -162.85 167.6 22.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.777 -0.577 . . . . 0.0 110.269 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.1 m -137.11 147.81 46.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.356 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.28 127.8 54.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.662 -0.648 . . . . 0.0 110.012 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -117.32 139.05 51.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.495 -0.753 . . . . 0.0 110.614 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.348 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.632 HG11 ' SD ' ' A' ' 126' ' ' MET . 58.4 t -79.57 -69.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 0.0 110.411 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.79 171.84 20.61 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 38.7 m -94.71 150.8 19.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.609 -0.936 . . . . 0.0 110.3 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.486 ' CD1' ' CD1' ' A' ' 156' ' ' TYR . 63.6 m-85 -149.35 129.01 13.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.55 -0.719 . . . . 0.0 110.388 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.01 169.95 34.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 119' ' ' ASN . 44.6 Cg_endo -70.24 -165.94 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.339 1.179 . . . . 0.0 110.354 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 37.7 34.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.153 0.501 . . . . 0.0 112.234 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 156' ' ' TYR . . . -133.29 26.9 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.711 -0.618 . . . . 0.0 110.49 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.9 -159.56 0.21 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.581 -0.7 . . . . 0.0 110.386 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -100.18 150.96 21.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.39 -0.819 . . . . 0.0 110.8 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 153' ' ' ALA . 84.7 m-85 -105.69 -165.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.726 -0.609 . . . . 0.0 109.543 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.14 123.03 1.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.422 -0.799 . . . . 0.0 110.548 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.624 ' HB2' HG13 ' A' ' 146' ' ' VAL . 33.3 t80 -87.48 167.88 13.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -145.77 88.29 1.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.57 HG22 ' HE2' ' A' ' 158' ' ' PHE . 82.1 p -62.87 146.79 94.82 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 149.56 77.33 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.408 1.215 . . . . 0.0 110.621 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.521 ' HE3' ' HB3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -51.73 106.28 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.558 -0.714 . . . . 0.0 110.787 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.66 159.53 14.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -91.0 148.0 22.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.516 -0.74 . . . . 0.0 110.547 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.19 178.95 1.84 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.659 -0.651 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.804 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.85 132.23 18.18 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.222 1.117 . . . . 0.0 110.354 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -113.28 165.32 12.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.76 161.22 17.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.3 ttp -60.85 -39.48 89.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.669 -0.9 . . . . 0.0 110.141 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.1 pt? -72.3 -5.47 36.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.604 -0.685 . . . . 0.0 111.687 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.401 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -76.3 -29.51 57.38 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -65.08 127.51 31.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.59 -179.24 21.94 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.2 p -88.09 134.96 33.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.994 . . . . 0.0 110.3 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.454 ' CE2' ' NE ' ' A' ' 134' ' ' ARG . 24.8 m-85 -122.57 111.54 16.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.691 -0.631 . . . . 0.0 110.001 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.22 130.64 47.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.531 -0.731 . . . . 0.0 110.334 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.924 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.9 mm -114.26 98.55 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.646 -0.659 . . . . 0.0 110.029 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 119.04 31.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.111 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 36.8 t -118.44 143.41 46.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.735 -0.603 . . . . 0.0 110.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -84.48 130.6 34.74 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.2 t -171.62 -171.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.536 -0.727 . . . . 0.0 110.201 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 5.6 p-10 -111.09 -154.73 0.55 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.642 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.79 -59.18 5.61 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.421 -0.799 . . . . 0.0 110.098 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.7 27.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.873 -0.517 . . . . 0.0 110.677 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -80.81 -35.99 32.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.28 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t -176.99 -162.67 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.65 -0.656 . . . . 0.0 110.137 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 119.69 37.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.57 -0.707 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.518 ' NE2' HG11 ' A' ' 123' ' ' VAL . 10.1 m-70 -75.7 -60.31 2.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 110.789 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.643 HD22 HG13 ' A' ' 71' ' ' VAL . 6.2 tp -169.82 152.06 4.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 t -149.42 135.56 19.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.533 -0.729 . . . . 0.0 110.362 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.406 ' CD1' HD21 ' A' ' 90' ' ' LEU . 20.4 p90 -135.83 -155.69 0.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.685 . . . . 0.0 110.006 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -167.87 128.07 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.981 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.924 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 24.7 p-90 -132.74 150.6 52.14 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.0 109.719 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.52 151.58 23.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.493 -0.755 . . . . 0.0 111.137 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 104' ' ' LEU . 17.2 tp -125.53 105.09 8.78 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -81.77 138.33 35.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.604 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.665 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.3 mm -114.57 164.04 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 109.461 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.7 ttmt -153.94 -159.23 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -122.32 -10.65 8.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.651 -0.655 . . . . 0.0 111.346 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.06 69.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.136 -0.978 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.688 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.02 -4.56 33.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.555 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -154.44 46.17 0.56 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.126 -0.984 . . . . 0.0 110.136 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.249 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.155 0.503 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -145.24 50.08 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.588 -0.695 . . . . 0.0 110.276 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -81.33 178.74 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.588 -0.695 . . . . 0.0 110.157 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.54 -175.03 2.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 110.216 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.64 147.97 53.64 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -176.11 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.37 1.195 . . . . 0.0 110.447 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -96.78 -176.77 3.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.613 -0.68 . . . . 0.0 110.307 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 67' ' ' VAL . 8.8 p -144.87 59.46 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.714 . . . . 0.0 110.144 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.53 168.97 22.94 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.351 1.185 . . . . 0.0 110.395 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.526 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -82.72 -65.41 1.01 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.188 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' VAL . 85.0 t -141.1 119.39 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 HD22 ' A' ' 190' ' ' LEU . 62.2 t -142.85 139.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.487 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.508 HG11 HD22 ' A' ' 90' ' ' LEU . 59.4 t -64.29 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 116' ' ' PHE . 77.4 p -74.8 -66.96 0.69 Allowed 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.873 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -131.35 170.82 14.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.529 -0.732 . . . . 0.0 110.73 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HG ' HD13 ' A' ' 114' ' ' ILE . 6.3 tt -142.7 136.88 29.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.659 -0.651 . . . . 0.0 109.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.3 m -109.42 163.99 12.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 0.0 110.076 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -145.98 110.19 4.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.13 114.94 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 110.042 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.539 ' H ' ' HB2' ' A' ' 82' ' ' ALA . 74.3 m -115.62 78.55 1.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 110.1 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.3 p 45.94 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.905 -0.497 . . . . 0.0 112.061 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 73.4 p -84.11 56.75 3.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 110.219 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 79' ' ' CYS . . . -90.72 151.89 44.26 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 110.695 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.2 -18.49 23.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.514 1.271 . . . . 0.0 110.228 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.98 152.77 7.37 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.01 98.55 0.91 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.436 1.229 . . . . 0.0 110.369 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 102' ' ' PHE . 6.0 mt -64.72 131.46 46.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 109.879 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -103.87 113.02 26.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.542 -0.723 . . . . 0.0 110.31 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.2 tt -89.13 131.36 35.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.567 -0.708 . . . . 0.0 110.03 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.5 ' N ' HD23 ' A' ' 88' ' ' LEU . 17.5 t70 -87.13 126.45 34.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.681 -0.637 . . . . 0.0 110.052 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 192' ' ' TRP . 1.1 mp -130.28 52.99 1.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -129.39 -48.4 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.703 -0.623 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.4 -116.25 4.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.88 114.61 3.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.567 -0.96 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' HZ ' ' A' ' 97' ' ' PHE . 65.4 mt -93.87 -39.12 10.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.638 -0.664 . . . . 0.0 110.058 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.86 -18.62 34.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.2 t -55.09 -20.65 10.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.24 -0.913 . . . . 0.0 111.335 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.577 ' CD1' HD21 ' A' ' 88' ' ' LEU . 4.6 m-30 -59.99 -31.57 70.04 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.216 -0.928 . . . . 0.0 109.844 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -63.3 -16.27 59.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 111.207 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -86.73 -25.48 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.906 . . . . 0.0 110.601 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.54 137.66 47.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.468 -0.77 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -121.26 149.82 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CD1' HD13 ' A' ' 86' ' ' LEU . 29.4 m-85 -85.46 123.04 30.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.504 -0.747 . . . . 0.0 110.105 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.71 152.61 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.0 109.988 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' CG2' ' A' ' 108' ' ' VAL . 1.6 mt -153.63 172.66 16.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.672 -0.643 . . . . 0.0 110.052 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -93.85 153.87 18.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.509 -0.744 . . . . 0.0 109.843 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -20.52 -55.57 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.796 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -160.88 69.72 0.24 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.577 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.545 ' CG2' HD22 ' A' ' 104' ' ' LEU . 20.9 m -82.63 -161.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.489 -1.006 . . . . 0.0 109.869 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 7.4 mm-40 -98.58 145.77 26.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.548 ' OH ' HD21 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -109.29 111.08 22.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 112.213 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.46 98.63 6.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 66.3 mt -110.64 144.88 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.464 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.555 ' NZ ' HD21 ' A' ' 159' ' ' LEU . 10.6 mttm -120.15 107.25 12.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 48.2 mm -83.24 148.16 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.422 -0.798 . . . . 0.0 110.608 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -130.14 137.21 50.01 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.699 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.5 p90 -157.7 159.32 36.79 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.874 -0.731 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.46 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.1 mtm180 -98.54 138.68 35.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.382 0.611 . . . . 0.0 111.054 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 91.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -129.13 48.11 2.4 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.91 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HB3' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -140.19 -69.62 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.226 -0.921 . . . . 0.0 110.582 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -139.02 165.83 26.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.775 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.86 105.33 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.654 -0.653 . . . . 0.0 109.708 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 70' ' ' VAL . 58.5 t -88.49 80.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.657 . . . . 0.0 110.094 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.95 116.86 22.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.604 -0.685 . . . . 0.0 110.144 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.55 27.54 3.28 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -64.24 135.65 56.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.508 -0.996 . . . . 0.0 109.589 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -126.31 167.37 15.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 110.944 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -138.02 78.16 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.22 157.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.54 -0.725 . . . . 0.0 110.049 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -162.16 126.52 3.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.709 -0.619 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.464 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 15.1 m-70 -109.82 119.43 39.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.512 -0.742 . . . . 0.0 110.288 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 139' ' ' ILE . 61.4 m -72.14 68.66 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.65 -0.656 . . . . 0.0 109.411 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 5.5 m-85 -61.63 144.91 53.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 110.765 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -126.99 100.68 6.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.59 37.28 28.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.561 -0.712 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.65 -15.35 61.06 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.081 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 138' ' ' LYS . 58.4 t -98.46 167.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.179 -1.189 . . . . 0.0 110.203 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.8 mppt? -113.66 130.9 56.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -120.76 -23.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.735 . . . . 0.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -165.39 119.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.159 -0.963 . . . . 0.0 110.85 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -144.41 132.62 21.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -0.75 . . . . 0.0 110.08 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 143' ' ' ASP . 58.2 m -146.32 165.78 28.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.665 -0.647 . . . . 0.0 110.499 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 142' ' ' THR . 10.5 p-10 -100.06 136.31 40.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.669 . . . . 0.0 110.038 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -111.54 154.45 24.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.558 -0.713 . . . . 0.0 110.454 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 12.3 ttm -101.73 112.16 24.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.0 109.606 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' A' ' 158' ' ' PHE . 57.8 t -79.49 -48.76 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.529 -0.732 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.46 165.6 10.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 65.4 p -85.77 143.75 28.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.68 -0.894 . . . . 0.0 109.403 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 148' ' ' SER . 50.2 m-85 -140.68 125.93 18.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.543 -0.723 . . . . 0.0 110.384 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.58 154.37 32.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.54 85.51 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.476 1.25 . . . . 0.0 110.378 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -85.45 -89.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.63 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.927 -1.108 . . . . 0.0 110.998 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -162.5 -163.43 0.9 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.82 . . . . 0.0 110.935 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -100.28 167.54 10.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.606 . . . . 0.0 110.092 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.46 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 27.7 m-85 -113.79 171.51 7.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.663 . . . . 0.0 109.787 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -138.36 95.33 2.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.523 -0.735 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.505 ' CG ' HG13 ' A' ' 146' ' ' VAL . 49.0 t80 -81.36 169.83 16.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 ' NZ ' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -146.82 111.37 5.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.745 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 64.0 p -77.67 140.01 63.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.75 . . . . 0.0 109.064 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.11 163.28 29.43 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.75 1.395 . . . . 0.0 111.401 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -59.38 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.176 0.512 . . . . 0.0 111.478 -179.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 110' ' ' TYR . 5.9 tt0 -79.39 -171.5 2.77 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.54 155.92 39.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 110.649 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.796 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -100.62 160.61 26.4 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.702 -0.624 . . . . 0.0 109.8 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.58 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 48.0 Cg_endo -73.45 117.02 4.9 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.411 1.216 . . . . 0.0 110.777 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -113.97 -170.38 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.09 28.27 3.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 65.81 -68.51 0.12 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.452 -1.028 . . . . 0.0 110.75 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -56.57 -29.22 61.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 166' ' ' PRO . . . -57.61 -21.79 41.43 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.642 -0.661 . . . . 0.0 110.671 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.405 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 44.9 mtp180 -60.69 136.86 58.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 142.02 -173.52 23.64 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.0 p -91.6 137.99 31.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.623 -0.927 . . . . 0.0 110.335 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -128.23 115.07 17.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 110.271 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.484 ' O ' HD13 ' A' ' 177' ' ' ILE . 1.5 m120 -60.45 151.85 27.19 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.509 -0.744 . . . . 0.0 110.09 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.775 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 49.4 mm -131.51 97.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.463 -0.773 . . . . 0.0 110.42 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 133' ' ' TYR . 4.3 ttpt -82.4 102.44 11.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 109.733 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.4 p -109.34 137.1 47.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.725 . . . . 0.0 110.482 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.41 99.51 5.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.781 -0.575 . . . . 0.0 110.007 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -78.77 120.42 23.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.688 -0.633 . . . . 0.0 109.75 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.0 t -142.95 -164.77 1.92 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.53 -0.731 . . . . 0.0 110.736 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 13.0 p-10 -157.83 160.84 38.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.906 -0.496 . . . . 0.0 109.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.44 56.47 3.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.763 . . . . 0.0 109.964 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -131.09 -41.99 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 110.648 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -145.01 -77.65 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.578 -0.701 . . . . 0.0 110.931 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.6 t -150.76 -159.76 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.368 -0.832 . . . . 0.0 110.644 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.67 126.22 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.538 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 17.0 m-70 -73.48 -47.86 37.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 110.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.671 HD22 HG13 ' A' ' 71' ' ' VAL . 5.7 tp -168.39 152.21 5.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.424 -0.798 . . . . 0.0 110.232 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.3 t -148.43 152.15 36.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.692 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.572 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.4 p90 -142.97 -161.24 1.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.0 109.947 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.09 122.86 3.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.446 -0.784 . . . . 0.0 110.759 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.775 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 37.6 p-90 -132.28 149.31 52.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.601 -0.687 . . . . 0.0 109.713 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.21 152.3 22.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.549 -0.719 . . . . 0.0 111.303 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.548 HD21 ' OH ' ' A' ' 110' ' ' TYR . 25.7 tp -122.04 108.84 13.84 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.9 m -85.74 140.31 30.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.528 -0.733 . . . . 0.0 110.581 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.6 mm -119.72 160.51 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.752 -0.592 . . . . 0.0 109.651 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.13 -153.23 0.33 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.212 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -3.65 6.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.448 -0.783 . . . . 0.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -160.05 43.96 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -54.04 -23.11 12.44 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.239 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.04 47.2 0.91 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.589 -0.695 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.265 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.194 0.521 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -140.54 154.79 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 t -88.69 148.61 23.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.59 103.45 14.28 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.434 -0.791 . . . . 0.0 110.302 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -133.12 82.08 55.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 0.0 110.144 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.95 -51.16 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.364 1.192 . . . . 0.0 110.535 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 52.2 -167.62 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.292 -0.88 . . . . 0.0 110.825 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 35.1 m -144.52 52.82 1.9 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.567 -0.708 . . . . 0.0 110.415 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 67' ' ' VAL . 48.5 Cg_endo -74.18 106.62 2.26 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.292 1.154 . . . . 0.0 110.388 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 -62.13 1.77 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.611 -0.681 . . . . 0.0 110.062 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 123' ' ' VAL . 96.1 t -126.91 128.74 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.3 t -146.95 142.03 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.792 -0.567 . . . . 0.0 109.804 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.586 ' CG1' HD13 ' A' ' 90' ' ' LEU . 61.7 t -62.85 112.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 43.0 p -78.23 -35.53 48.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.0 111.062 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -159.31 176.89 11.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.367 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.1 tt -145.82 113.67 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.798 -0.564 . . . . 0.0 109.665 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 87' ' ' GLU . 4.1 m -109.8 164.55 12.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.445 -0.785 . . . . 0.0 110.571 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -139.23 101.67 4.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 79' ' ' CYS . 65.3 t -94.0 167.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.717 -0.614 . . . . 0.0 110.127 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -168.36 -162.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.759 . . . . 0.0 110.098 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.6 p -108.84 -40.65 4.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -122.62 35.12 4.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.09 165.02 25.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.547 -0.721 . . . . 0.0 110.263 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.4 Cg_endo -70.23 -26.8 25.01 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.385 1.203 . . . . 0.0 110.256 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.26 174.03 32.66 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.96 96.08 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.55 1.289 . . . . 0.0 110.293 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' PHE . 23.6 mt -64.8 106.24 1.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.629 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 76' ' ' THR . 2.2 mt-10 -99.24 135.08 41.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.586 -0.696 . . . . 0.0 110.652 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.536 HD22 ' HE1' ' A' ' 97' ' ' PHE . 10.8 mt -116.18 168.02 10.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.608 -0.682 . . . . 0.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -106.73 128.87 54.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.715 . . . . 0.0 110.111 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.586 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -128.07 50.24 2.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 110.078 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.7 p -141.0 -43.79 0.38 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.155 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.14 -92.01 2.03 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.68 98.79 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -1.021 . . . . 0.0 110.557 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -95.45 -36.92 11.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 0.0 110.089 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.36 -13.0 57.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 0.0 111.273 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 p -55.1 -28.01 49.31 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.545 ' CE2' HD13 ' A' ' 94' ' ' LEU . 28.7 m-85 -61.96 -39.47 92.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.46 -0.775 . . . . 0.0 109.985 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -57.92 -24.37 57.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.604 -0.685 . . . . 0.0 110.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -118.67 45.41 2.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.455 -0.778 . . . . 0.0 110.561 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -168.35 136.13 2.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.791 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.2 p -143.41 127.88 17.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.657 . . . . 0.0 109.544 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.714 ' CD1' HD22 ' A' ' 86' ' ' LEU . 11.9 m-85 -76.42 115.37 16.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.369 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.77 121.14 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 109.179 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 196' ' ' LEU . 1.0 OUTLIER -113.76 -159.31 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.618 -0.676 . . . . 0.0 110.3 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HB3' HG11 ' A' ' 108' ' ' VAL . 47.0 tttm -140.94 158.79 43.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.572 -0.705 . . . . 0.0 110.555 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' CG ' ' NH1' ' A' ' 172' ' ' ARG . 22.3 mt-10 -38.36 105.49 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 33.32 70.34 0.13 Allowed Glycine 0 N--CA 1.505 3.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.863 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 105' ' ' LYS . 33.0 m -90.83 147.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -1.14 . . . . 0.0 109.749 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.26 93.39 4.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 108.814 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 163' ' ' GLU . 31.8 p90 -113.45 146.31 39.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 111.894 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -108.38 157.49 18.35 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 113' ' ' LYS . 66.8 mt -116.66 164.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.855 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.633 ' CG ' HD11 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -142.67 87.15 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.87 -0.519 . . . . 0.0 109.612 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.55 150.92 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.411 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -127.02 153.02 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.705 -0.622 . . . . 0.0 109.739 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -172.09 159.32 4.9 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.576 -0.703 . . . . 0.0 110.576 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' A' ' 73' ' ' THR . 3.3 mtm180 -113.94 154.54 27.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -133.11 97.83 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -128.98 48.93 2.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.513 -0.742 . . . . 0.0 111.291 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -70.6 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.27 -0.894 . . . . 0.0 110.777 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -135.56 172.61 12.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.671 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.1 mt -80.35 108.76 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.726 -0.609 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 70' ' ' VAL . 93.7 t -83.61 86.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -78.13 59.29 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.677 -0.639 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.48 60.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.704 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD1' ' A' ' 116' ' ' PHE . 0.4 OUTLIER -70.25 128.67 37.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -1.058 . . . . 0.0 108.566 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -125.99 145.42 50.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.248 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.14 96.04 3.12 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -94.15 162.46 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.087 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 129' ' ' ILE . 4.3 tt0 -151.46 135.33 16.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.598 -0.688 . . . . 0.0 110.185 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 177' ' ' ILE . 13.6 m-70 -109.55 149.1 30.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.715 . . . . 0.0 109.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.483 HG22 HH22 ' A' ' 134' ' ' ARG . 0.4 OUTLIER -108.13 80.84 1.41 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.6 -0.687 . . . . 0.0 109.208 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 11.6 m-85 -86.05 140.37 30.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 111.071 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.699 HH11 HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -119.83 79.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.685 . . . . 0.0 110.399 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt 52.09 55.61 8.98 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.406 -0.809 . . . . 0.0 111.339 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.84 -19.33 52.3 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.1 t -98.73 89.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.181 -1.188 . . . . 0.0 109.829 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 5.1 pttm -66.92 122.73 18.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.575 -0.703 . . . . 0.0 110.562 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.699 HD12 HH11 ' A' ' 134' ' ' ARG . 1.8 mt -89.74 -54.03 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.15 -167.97 0.37 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.505 -0.747 . . . . 0.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HE2' ' CE1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -157.93 153.46 26.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.632 -0.668 . . . . 0.0 109.92 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.456 HG21 ' CZ ' ' A' ' 144' ' ' TYR . 8.5 m -118.29 146.1 44.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -125.19 118.4 25.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 142' ' ' THR . 29.2 m-85 -111.56 147.09 36.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.404 -0.81 . . . . 0.0 110.855 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.0 ttp -104.12 118.19 36.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.753 -0.592 . . . . 0.0 109.463 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 149' ' ' TYR . 49.1 t -79.87 -66.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.59 -0.694 . . . . 0.0 110.263 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.23 -148.87 20.17 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 92.5 p -108.59 136.64 47.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.543 -0.975 . . . . 0.0 110.427 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.552 ' HE1' HG12 ' A' ' 146' ' ' VAL . 23.3 m-85 -122.82 147.01 47.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 110.396 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.14 152.29 18.03 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.515 ' HA ' HG12 ' A' ' 118' ' ' VAL . 51.2 Cg_endo -75.5 -174.25 1.93 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.362 1.19 . . . . 0.0 110.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 52.01 70.11 0.59 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.5 -0.75 . . . . 0.0 111.079 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.1 -94.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.484 -0.76 . . . . 0.0 110.364 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -174.54 -155.17 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.838 -1.164 . . . . 0.0 109.897 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 88.73 6.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.91 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -59.75 -168.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.506 -0.746 . . . . 0.0 109.94 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.414 ' OE1' HD11 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -161.61 134.83 6.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.475 -0.766 . . . . 0.0 110.726 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 146' ' ' VAL . 29.9 t80 -107.09 156.86 18.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.633 HD11 ' CG ' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -137.93 114.0 10.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.446 -0.784 . . . . 0.0 110.595 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -78.61 154.53 78.69 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.21 154.96 72.11 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.628 1.331 . . . . 0.0 110.806 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 ttm -59.83 124.17 19.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.699 -0.626 . . . . 0.0 110.438 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.5 pt-20 -124.49 141.59 51.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.633 -0.667 . . . . 0.0 109.921 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.19 140.31 31.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.586 -0.696 . . . . 0.0 110.417 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -86.62 -179.27 1.34 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.637 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.7 Cg_endo -75.29 125.47 9.15 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.237 1.125 . . . . 0.0 110.297 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -115.26 -176.68 2.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.656 -0.653 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.93 153.98 19.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 9.2 ttm -60.19 -28.12 67.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.644 -0.915 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 26.2 4.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 110.116 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.31 22.46 8.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.529 -0.732 . . . . 0.0 110.387 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -100.03 147.9 25.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.363 -0.835 . . . . 0.0 109.94 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.83 179.97 16.77 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.6 p -81.14 140.76 34.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.67 -0.9 . . . . 0.0 110.761 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 13.4 m-85 -118.35 106.19 12.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.787 -0.571 . . . . 0.0 109.919 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -71.08 121.45 18.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.584 -0.697 . . . . 0.0 110.055 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 131' ' ' HIS . 26.6 mt -116.84 145.42 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -114.02 114.43 26.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.976 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.0 m -106.23 151.36 24.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.65 -0.656 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -149.12 93.73 2.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.495 ' CZ ' ' CD2' ' A' ' 116' ' ' PHE . 18.1 t80 -75.33 107.55 7.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.591 -0.693 . . . . 0.0 109.628 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 188' ' ' ASP . 75.8 p -121.71 168.49 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.524 -0.735 . . . . 0.0 110.38 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.691 ' HB2' HG13 ' A' ' 123' ' ' VAL . 7.0 p-10 -121.2 152.88 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.783 -0.573 . . . . 0.0 109.802 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.37 58.53 3.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 110.107 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -161.29 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.544 -0.722 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -112.04 -80.66 0.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.647 -0.658 . . . . 0.0 110.887 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.5 t -169.27 -154.16 0.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.282 -0.886 . . . . 0.0 110.297 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' A' ' 182' ' ' THR . 1.1 m-20 -78.32 108.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.378 -0.826 . . . . 0.0 110.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.414 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 25.8 m-70 -59.57 -55.12 38.45 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.471 -0.768 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 tp -168.56 153.87 6.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.5 t -148.26 155.73 41.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 110.142 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.526 ' CB ' HD11 ' A' ' 94' ' ' LEU . 23.1 p90 -148.6 -152.99 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -164.08 139.91 6.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 14.1 p-90 -147.89 147.82 30.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.559 -0.713 . . . . 0.0 110.213 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -92.73 148.88 21.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.503 -0.748 . . . . 0.0 111.224 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.783 HD21 HD12 ' A' ' 104' ' ' LEU . 49.6 tp -124.05 115.72 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.407 ' O ' HD13 ' A' ' 198' ' ' ILE . 96.0 m -87.41 152.49 22.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.477 -0.764 . . . . 0.0 110.947 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.488 HD13 ' CB ' ' A' ' 104' ' ' LEU . 49.8 mm -130.28 159.21 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -160.32 -158.51 0.63 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.284 -0.885 . . . . 0.0 111.243 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -64.31 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.61 -0.681 . . . . 0.0 111.096 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.59 103.67 3.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.0 110.93 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.58 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -72.95 -3.13 23.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.556 -0.715 . . . . 0.0 111.644 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -136.49 57.61 1.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.059 -1.026 . . . . 0.0 110.133 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.228 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.478 ' C ' HG22 ' A' ' 61' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.8 0.333 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG22 ' C ' ' A' ' 60' ' ' ALA . 19.7 m 38.4 -158.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 CA-C-O 121.022 0.439 . . . . 0.0 112.118 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.1 p 50.56 -166.84 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.353 -0.842 . . . . 0.0 111.002 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.13 -28.28 9.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.593 -0.692 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -118.79 85.11 27.1 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.281 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 173.12 14.34 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.398 1.209 . . . . 0.0 110.27 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -72.05 161.09 31.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.568 -0.708 . . . . 0.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.89 147.54 37.94 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.94 -174.49 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.398 1.21 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.487 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -82.77 -63.75 1.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.487 HG23 HD22 ' A' ' 69' ' ' ASN . 93.0 t -141.95 122.07 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.79 HG13 HD22 ' A' ' 190' ' ' LEU . 59.0 t -148.89 137.15 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.302 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.747 HG22 ' CD2' ' A' ' 181' ' ' PHE . 58.4 t -66.12 108.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.876 HG23 ' HA ' ' A' ' 116' ' ' PHE . 73.0 p -70.62 -62.63 1.32 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.607 -0.683 . . . . 0.0 110.543 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -145.07 167.9 21.6 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.774 . . . . 0.0 110.802 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.559 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -125.61 136.28 53.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.717 -0.615 . . . . 0.0 109.687 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 85' ' ' PRO . 92.4 m -125.82 149.17 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 110.638 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -133.9 103.66 5.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 109.947 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -94.14 166.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.616 -0.677 . . . . 0.0 110.178 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -167.25 -164.3 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.556 -0.715 . . . . 0.0 110.009 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -44.77 4.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 p -108.98 27.19 9.75 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.84 162.37 33.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.594 -0.691 . . . . 0.0 110.609 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 45.7 Cg_endo -71.78 -25.49 20.23 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.524 1.276 . . . . 0.0 110.078 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.03 176.22 33.89 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.65 ' HB2' HG23 ' A' ' 76' ' ' THR . 45.8 Cg_endo -71.63 104.45 1.6 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.567 1.298 . . . . 0.0 110.444 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 23.5 mt -64.88 108.75 1.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.655 -0.653 . . . . 0.0 109.634 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -86.77 139.66 30.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.657 -0.652 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -120.06 149.42 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 110.085 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.447 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.8 t0 -103.19 118.4 36.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.715 . . . . 0.0 110.222 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 192' ' ' TRP . 2.8 mt -128.98 50.04 2.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -96.93 -73.52 0.6 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.599 -0.688 . . . . 0.0 110.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -52.37 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.78 88.09 4.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.917 . . . . 0.0 110.195 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 96.1 mt -87.82 -25.23 23.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.541 -0.724 . . . . 0.0 110.405 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.85 -21.75 12.36 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.245 -0.909 . . . . 0.0 111.093 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.2 t -54.43 -22.6 13.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.347 -0.846 . . . . 0.0 111.127 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CE1' HD22 ' A' ' 88' ' ' LEU . 10.4 m-30 -61.95 -48.03 82.2 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.802 . . . . 0.0 109.943 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -59.51 -24.8 63.95 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.62 -0.675 . . . . 0.0 110.659 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -86.85 -26.42 24.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 0.0 110.509 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -132.76 129.86 39.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.643 -0.661 . . . . 0.0 110.379 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -106.99 -175.03 2.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.645 -0.659 . . . . 0.0 110.093 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 196' ' ' LEU . 2.6 m-85 -113.58 96.03 5.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.596 -0.69 . . . . 0.0 110.174 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.18 142.88 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 109.837 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 HD11 ' A' ' 196' ' ' LEU . 1.2 mt -157.32 172.51 18.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -90.06 157.57 17.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -20.04 -50.86 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.727 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -171.54 63.54 0.15 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' LYS . 23.3 m -75.37 137.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -1.025 . . . . 0.0 110.322 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.81 105.32 8.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.67 -0.644 . . . . 0.0 109.431 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 77' ' ' LEU . 18.1 p90 -121.56 171.07 9.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.317 -0.864 . . . . 0.0 111.512 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.9 mtt85 -117.18 145.61 43.75 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.61 139.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.417 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.28 90.59 3.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.695 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.6 mm -74.42 147.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.569 -0.707 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 m -130.49 134.72 47.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.876 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.6 p90 -154.61 160.67 41.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.441 -0.787 . . . . 0.0 111.093 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -108.29 131.44 54.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.327 0.584 . . . . 0.0 110.716 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 149' ' ' TYR . 93.5 t -120.23 93.1 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -129.35 50.23 2.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.348 -0.845 . . . . 0.0 111.569 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.12 -65.26 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 110.421 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.82 169.54 17.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.58 101.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.717 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 70' ' ' VAL . 60.7 t -79.9 75.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.65 -0.656 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -83.14 110.95 18.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.718 . . . . 0.0 110.387 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.47 30.16 2.51 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 0.7 OUTLIER -62.24 112.11 2.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.434 -1.039 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 163.71 12.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.594 -0.692 . . . . 0.0 110.936 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -138.13 112.08 8.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.73 -0.606 . . . . 0.0 109.64 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.41 161.29 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 0.0 110.034 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -167.42 117.98 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.546 -0.721 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -110.4 131.02 55.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.597 -0.689 . . . . 0.0 110.242 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 m -86.16 93.04 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.718 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 3.1 m-85 -78.19 127.44 32.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.718 . . . . 0.0 110.471 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.2 ttp180 -125.74 130.95 52.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.37 28.69 7.7 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.27 47.13 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.5 m -106.56 146.33 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.214 . . . . 0.0 110.707 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.61 138.76 40.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.597 -0.689 . . . . 0.0 110.126 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.85 -24.22 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -173.28 134.96 0.55 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.028 . . . . 0.0 110.829 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 175.57 7.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.627 -0.671 . . . . 0.0 109.438 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.3 m -154.26 144.7 22.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 111.1 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -115.15 122.51 46.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.93 130.59 56.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.442 -0.787 . . . . 0.0 111.23 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.48 119.01 17.11 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.74 HG12 ' OH ' ' A' ' 149' ' ' TYR . 6.4 t -79.7 -58.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.505 -0.747 . . . . 0.0 110.293 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.11 165.07 11.0 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.935 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 59.2 p -92.91 151.76 19.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.614 -0.933 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.74 ' OH ' HG12 ' A' ' 146' ' ' VAL . 12.7 m-85 -139.15 169.49 17.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.469 -0.769 . . . . 0.0 110.573 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.05 141.96 17.34 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.51 178.36 5.72 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.214 1.113 . . . . 0.0 110.777 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.06 71.32 0.5 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.54 -0.725 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -166.55 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.458 -0.776 . . . . 0.0 110.408 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.74 -153.94 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.028 -1.045 . . . . 0.0 110.026 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.28 168.85 10.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.427 -0.796 . . . . 0.0 110.02 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 32.2 m-85 -127.17 -176.58 3.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.666 -0.646 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -150.68 113.32 4.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.493 -0.754 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.517 ' HB2' HG13 ' A' ' 146' ' ' VAL . 35.2 t80 -87.24 168.51 13.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.529 -0.732 . . . . 0.0 110.022 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.07 109.8 4.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 0.0 110.738 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.8 p -83.33 151.13 62.07 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.392 -0.817 . . . . 0.0 109.121 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.72 -175.13 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.524 1.276 . . . . 0.0 110.892 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.0 ptm -56.64 145.1 29.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.653 -0.655 . . . . 0.0 110.915 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.04 93.92 2.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.718 -0.614 . . . . 0.0 109.731 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -63.91 121.83 15.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.727 ' HB3' ' HA2' ' A' ' 107' ' ' GLY . . . -57.43 175.12 0.27 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.724 -0.61 . . . . 0.0 110.234 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.0 Cg_endo -72.83 112.51 3.52 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.248 1.131 . . . . 0.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -172.82 2.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.886 -0.509 . . . . 0.0 110.544 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.34 31.67 1.8 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.5 mtp 63.71 -70.75 0.07 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.62 -0.929 . . . . 0.0 111.213 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -69.81 -7.03 36.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.179 -0.951 . . . . 0.0 111.71 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.54 -5.13 41.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.293 -0.879 . . . . 0.0 110.94 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 30.5 mtp180 -67.86 140.68 56.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 143.86 -174.65 24.16 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.6 p -91.49 124.46 35.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.605 -0.938 . . . . 0.0 110.211 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -112.11 112.87 24.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.358 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -62.59 143.32 57.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.592 -0.693 . . . . 0.0 109.801 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.772 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.5 mm -119.33 94.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.533 -0.729 . . . . 0.0 110.41 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 tttt -77.23 107.96 10.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.512 -0.743 . . . . 0.0 109.47 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 5.2 p -113.45 160.4 18.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.703 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -147.89 83.79 1.52 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.682 -0.636 . . . . 0.0 109.82 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.747 ' CD2' HG22 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -69.68 110.85 5.09 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.6 t -141.33 -168.21 2.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.521 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -99.94 -163.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.8 -53.24 60.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.28 -0.887 . . . . 0.0 110.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.23 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.829 . . . . 0.0 111.445 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.417 ' O ' ' HB ' ' A' ' 187' ' ' THR . 5.7 mmt180 -78.34 -43.81 26.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 186' ' ' ARG . 9.7 t 178.35 166.18 0.8 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.951 -0.468 . . . . 0.0 110.01 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.36 125.24 37.86 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 18.9 p80 -91.56 -17.69 25.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.474 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.79 HD22 HG13 ' A' ' 71' ' ' VAL . 43.5 tp -171.39 155.05 4.07 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.034 -1.041 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -164.96 140.27 5.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.72 -0.613 . . . . 0.0 109.677 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.506 ' CD1' HD21 ' A' ' 90' ' ' LEU . 14.7 p90 -146.95 -153.53 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.412 -0.805 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -167.16 127.33 1.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.701 -0.625 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 20.0 p-90 -130.63 145.94 52.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.25 152.1 23.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.681 -0.637 . . . . 0.0 110.989 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 104' ' ' LEU . 13.1 tp -123.75 92.06 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.734 -0.604 . . . . 0.0 109.544 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 87.8 m -67.73 129.5 40.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.571 -0.705 . . . . 0.0 110.186 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.1 mm -109.73 150.45 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.807 -0.558 . . . . 0.0 109.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -146.73 -153.01 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.665 -0.647 . . . . 0.0 109.949 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 -4.87 6.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.655 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -159.98 46.7 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.982 -1.074 . . . . 0.0 110.986 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.453 ' CH2' ' CB ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -56.06 -22.16 26.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.344 -0.848 . . . . 0.0 111.131 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.64 51.54 1.31 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -0.815 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.194 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.081 0.467 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.89 153.69 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.633 -0.667 . . . . 0.0 110.24 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.3 p -88.54 164.59 15.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 110.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.53 168.04 9.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.591 -0.693 . . . . 0.0 110.225 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -95.22 105.39 19.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.21 83.69 0.95 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.225 1.118 . . . . 0.0 110.463 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -121.59 52.22 1.26 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 110.127 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.14 156.14 38.05 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.333 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HG2' HG21 ' A' ' 71' ' ' VAL . 47.0 Cg_endo -72.9 -166.23 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.45 1.237 . . . . 0.0 110.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -98.09 -68.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 110.043 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 118' ' ' VAL . 84.6 t -115.82 134.52 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.582 -0.699 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG21 ' HG2' ' A' ' 68' ' ' PRO . 63.0 t -148.34 152.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.608 -0.683 . . . . 0.0 109.92 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.3 t -71.61 112.33 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.881 HG23 ' HA ' ' A' ' 116' ' ' PHE . 67.5 p -70.81 -51.3 27.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.306 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -151.3 179.77 8.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.2 tt -146.39 121.24 9.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.629 -0.669 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.6 m -109.75 163.42 13.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.514 -0.741 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -148.61 113.89 5.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.468 -0.77 . . . . 0.0 110.531 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.1 t -125.87 167.23 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.654 . . . . 0.0 109.817 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 78' ' ' VAL . 52.5 t -153.05 -71.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.554 -0.717 . . . . 0.0 110.315 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.0 p -171.89 -71.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.379 -0.826 . . . . 0.0 109.963 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 p -103.99 33.59 3.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.609 -0.682 . . . . 0.0 109.928 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -79.65 172.78 8.99 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 110.32 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.6 Cg_endo -72.22 -27.73 16.28 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.455 1.24 . . . . 0.0 110.046 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.57 170.44 25.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.2 Cg_endo -72.04 97.76 0.86 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.544 1.286 . . . . 0.0 110.292 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 1.5 mp -64.67 122.68 17.42 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.523 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.22 112.93 26.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 110.678 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.0 mt -95.26 131.23 41.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 5.4 t70 -75.64 135.25 40.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.704 . . . . 0.0 110.614 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HA ' HD21 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.61 54.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.619 -0.675 . . . . 0.0 109.71 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.7 p -130.21 49.84 2.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.649 . . . . 0.0 110.7 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.52 -55.62 0.74 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.26 64.32 0.56 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.592 -0.946 . . . . 0.0 110.073 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 90' ' ' LEU . 29.4 mt -95.14 -0.09 53.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 111.207 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.18 -24.37 58.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.106 -0.996 . . . . 0.0 110.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.77 -6.55 45.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.42 -0.8 . . . . 0.0 111.227 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 13.9 m-85 -81.28 -38.71 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -69.95 -20.2 63.34 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.511 -0.743 . . . . 0.0 110.858 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.37 38.25 3.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -168.96 151.62 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.447 -0.783 . . . . 0.0 110.55 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -128.76 -169.53 2.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.555 -0.716 . . . . 0.0 109.989 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD2' HD13 ' A' ' 77' ' ' LEU . 1.1 m-85 -125.17 111.57 15.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 109.93 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.22 147.47 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.547 -0.72 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -167.38 145.05 4.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.788 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.648 ' H ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -78.59 155.6 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.454 -0.779 . . . . 0.0 109.75 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -17.24 -87.59 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.736 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -134.81 67.29 0.55 Allowed Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.163 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.617 ' CG2' HD21 ' A' ' 104' ' ' LEU . 8.6 m -75.96 157.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.467 -1.02 . . . . 0.0 110.156 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -85.5 89.53 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.632 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 46.2 p90 -109.27 138.86 44.99 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.662 0.744 . . . . 0.0 112.095 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -105.94 164.98 11.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.35 150.01 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.218 -0.926 . . . . 0.0 111.216 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -125.42 108.01 11.23 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.7 153.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 0.0 110.522 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.3 m -131.02 140.95 50.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.806 -0.559 . . . . 0.0 109.582 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.881 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -164.47 147.58 9.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.469 -0.77 . . . . 0.0 110.505 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 161.56 17.91 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.439 -0.788 . . . . 0.0 111.195 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.988 HG22 HG22 ' A' ' 70' ' ' VAL . 63.1 t -133.08 117.23 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.779 -0.575 . . . . 0.0 109.593 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -128.66 46.73 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.995 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 -67.89 0.25 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -143.69 179.07 7.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.819 . . . . 0.0 110.562 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.0 mp -80.19 109.34 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.666 -0.646 . . . . 0.0 109.981 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 70' ' ' VAL . 57.5 t -91.46 83.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.9 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.5 p -85.07 107.78 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.621 -0.675 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.41 39.98 0.52 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -81.46 137.89 35.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -1.043 . . . . 0.0 109.957 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.631 ' HE2' HG23 ' A' ' 182' ' ' THR . 22.5 pttt -139.39 171.87 13.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -129.52 117.84 21.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 109.73 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE3' ' A' ' 127' ' ' LYS . 49.8 mm -91.32 165.74 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.736 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 129' ' ' ILE . 49.5 tt0 -168.29 124.05 1.0 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -113.95 117.82 32.44 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.731 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.6 m -71.89 84.58 0.95 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.717 -0.615 . . . . 0.0 109.921 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 138' ' ' LYS . 2.7 m-85 -87.41 136.39 32.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.497 -0.752 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.428 ' HD2' ' CE2' ' A' ' 175' ' ' TYR . 3.3 ttp180 -120.42 110.58 16.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.599 -0.688 . . . . 0.0 110.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 29.63 43.47 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 92.87 34.18 6.99 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 136' ' ' GLY . 62.6 t -149.21 82.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.959 . . . . 0.0 110.071 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 133' ' ' TYR . 2.4 ttpm? -62.29 121.87 14.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 140' ' ' ASP . 31.3 pt -104.32 -31.52 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.534 -0.729 . . . . 0.0 111.067 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.5 p30 -174.23 149.71 1.43 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.14 -0.975 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 150.71 51.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.64 . . . . 0.0 109.505 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.9 m -132.84 159.81 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 110.729 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.98 138.83 53.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.631 -0.668 . . . . 0.0 110.122 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -122.63 113.15 18.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.9 ttt -68.72 137.87 54.44 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.523 -0.736 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.456 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 60.6 t -98.11 -68.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.552 -0.717 . . . . 0.0 110.151 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.28 176.02 26.14 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.4 p -87.4 152.47 22.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.693 -0.887 . . . . 0.0 109.963 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.433 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . 81.3 m-85 -148.18 144.39 27.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 110.415 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.5 154.01 19.68 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.23 65.35 5.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.377 1.199 . . . . 0.0 110.474 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -170.93 37.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 110.337 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.698 ' HB3' ' OH ' ' A' ' 156' ' ' TYR . . . -144.31 15.02 1.65 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.522 -0.736 . . . . 0.0 111.06 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 54.66 -148.1 0.49 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.173 -0.954 . . . . 0.0 110.734 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.95 157.06 38.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.373 -0.829 . . . . 0.0 110.84 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.698 ' OH ' ' HB3' ' A' ' 153' ' ' ALA . 57.4 m-85 -115.87 177.45 4.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.737 -0.602 . . . . 0.0 109.669 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.95 92.84 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.51 -0.744 . . . . 0.0 110.355 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 28.5 t80 -80.81 168.23 19.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.009 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 111' ' ' ARG . 0.9 OUTLIER -154.4 100.63 2.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.395 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.426 HG22 ' HE2' ' A' ' 158' ' ' PHE . 81.0 p -76.02 155.87 84.39 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 109.252 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.76 153.02 76.91 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.615 1.324 . . . . 0.0 110.978 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.0 ptm -58.0 113.47 1.91 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.679 -0.638 . . . . 0.0 110.49 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.25 161.42 13.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.094 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -104.84 141.44 36.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.484 -0.76 . . . . 0.0 110.512 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -96.15 179.66 1.1 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.629 -0.67 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 41.8 Cg_endo -66.44 -153.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.201 1.106 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -107.0 -162.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.061 -1.024 . . . . 0.0 110.689 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 106' ' ' GLU . . . -98.86 -66.79 0.87 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 171' ' ' ALA . 6.6 mtt -60.79 145.94 47.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.959 . . . . 0.0 109.233 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER 66.93 -61.32 0.33 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.639 -0.663 . . . . 0.0 110.535 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -73.06 -2.85 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.4 -0.812 . . . . 0.0 111.695 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 150.36 48.93 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.918 -1.114 . . . . 0.0 110.136 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.56 -177.82 17.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.7 p -91.99 129.78 37.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.696 -0.885 . . . . 0.0 110.219 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.428 ' CE2' ' HD2' ' A' ' 134' ' ' ARG . 12.3 m-85 -108.01 101.12 10.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.594 -0.691 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.96 125.06 23.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.616 ' CD1' HD23 ' A' ' 196' ' ' LEU . 20.5 mt -115.96 132.14 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -0.851 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.8 106.51 17.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 110.118 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.4 m -99.09 140.6 33.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.646 -0.659 . . . . 0.0 109.728 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.44 90.07 2.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.595 -0.691 . . . . 0.0 110.393 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.494 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.7 t80 -64.38 131.66 47.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 109.648 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.631 HG23 ' HE2' ' A' ' 127' ' ' LYS . 5.9 t -171.0 -169.06 0.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -113.7 -164.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -57.5 11.14 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.293 -0.879 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.29 28.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.873 -0.517 . . . . 0.0 110.379 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -37.67 27.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 0.0 109.914 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.7 t -177.81 -167.43 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.675 -0.641 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -115.35 118.02 32.07 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.782 -0.574 . . . . 0.0 109.503 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.2 m-70 -75.07 -67.44 0.65 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.457 -0.777 . . . . 0.0 110.666 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.0 tp -165.74 160.29 17.06 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.461 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.8 p -155.94 144.91 20.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.586 -0.696 . . . . 0.0 110.403 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 30.1 p90 -138.7 -155.76 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.606 -0.684 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.46 129.31 7.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.323 -0.86 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.739 ' CZ3' HD21 ' A' ' 196' ' ' LEU . 4.4 p-90 -140.01 147.9 41.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 175' ' ' TYR . 4.9 m120 -99.31 154.97 17.76 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.756 0.789 . . . . 0.0 112.452 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.739 HD21 ' CZ3' ' A' ' 194' ' ' TRP . 0.9 OUTLIER -111.74 103.47 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -80.21 101.12 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.753 . . . . 0.0 110.434 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.93 145.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 109.689 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -142.6 -154.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.647 -0.658 . . . . 0.0 110.401 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -108.71 -32.46 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.758 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.11 93.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.761 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -77.21 -0.2 24.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.571 -0.706 . . . . 0.0 111.307 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -127.79 43.2 3.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.066 0.46 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.9 m -125.16 33.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.291 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.97 -66.61 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.543 -0.723 . . . . 0.0 110.265 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -164.16 -159.3 0.48 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.637 -0.665 . . . . 0.0 110.35 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -149.46 89.99 4.68 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.37 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.27 -30.46 15.72 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.181 1.095 . . . . 0.0 110.47 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.03 128.41 35.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.52 -0.738 . . . . 0.0 110.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.31 145.26 35.6 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.556 -0.715 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.92 -167.79 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.381 1.201 . . . . 0.0 110.635 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' A' ' 70' ' ' VAL . 1.3 t-20 -92.93 -66.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.712 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 123' ' ' VAL . 92.8 t -130.68 125.24 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.778 -0.577 . . . . 0.0 110.132 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -148.59 138.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.775 -0.578 . . . . 0.0 109.962 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.748 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -64.51 104.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 155' ' ' GLU . 66.4 p -70.8 -63.3 1.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.668 -0.645 . . . . 0.0 110.41 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -138.61 173.21 11.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.6 tt -142.85 124.92 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.648 -0.658 . . . . 0.0 109.559 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 85' ' ' PRO . 21.0 m -114.91 157.37 23.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.442 -0.786 . . . . 0.0 111.038 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mt -137.46 106.39 5.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.3 t -99.74 166.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 110.42 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -163.33 -154.49 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.842 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.1 p -115.03 -26.42 7.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.436 -0.79 . . . . 0.0 110.397 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.7 p -140.12 34.67 1.92 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.4 -0.812 . . . . 0.0 110.758 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.653 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.21 173.41 5.76 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.352 -0.843 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.0 Cg_endo -72.36 -26.52 17.17 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.286 1.15 . . . . 0.0 110.152 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.72 177.31 34.68 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -71.45 102.76 1.32 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.487 1.256 . . . . 0.0 110.317 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.657 HD22 ' CD1' ' A' ' 102' ' ' PHE . 37.5 mt -64.85 112.74 3.4 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.503 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -99.67 113.67 26.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.683 -0.636 . . . . 0.0 110.586 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.82 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.6 mt -98.75 137.45 37.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.604 -0.685 . . . . 0.0 109.739 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 14.6 t0 -86.57 128.61 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.506 -0.746 . . . . 0.0 110.679 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.748 HD22 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -128.52 51.44 2.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.466 -0.771 . . . . 0.0 109.982 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.6 p -115.16 -58.73 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.691 -0.631 . . . . 0.0 110.346 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.67 -57.25 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 75.64 0.96 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.548 -0.972 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 94' ' ' LEU . 6.5 mt -95.01 0.03 54.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 111.213 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -70.51 -33.14 70.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.037 -1.039 . . . . 0.0 110.659 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 m -57.47 -20.82 33.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.456 -0.777 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.82 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.7 m-85 -55.33 -42.2 73.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.246 -0.909 . . . . 0.0 110.388 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -63.59 -26.27 68.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 0.0 109.944 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 52.5 0.86 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.015 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -158.26 30.16 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.392 -0.817 . . . . 0.0 110.657 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.0 p -55.9 121.58 9.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.77 -0.581 . . . . 0.0 110.557 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.657 ' CD1' HD22 ' A' ' 86' ' ' LEU . 23.6 m-85 -85.21 122.73 29.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.544 -0.722 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.03 152.84 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.844 HD22 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -154.54 128.04 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.424 -0.798 . . . . 0.0 110.75 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 108' ' ' VAL . 24.3 tttm -60.57 146.34 45.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.105 0.955 . . . . 0.0 110.431 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.643 ' OE1' HG21 ' A' ' 198' ' ' ILE . 4.2 mm-40 -61.15 128.57 37.07 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.63 40.54 97.61 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.862 -0.524 . . . . 0.0 112.862 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.844 HG21 HD22 ' A' ' 104' ' ' LEU . 31.9 m -83.38 178.09 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 118.861 1.33 . . . . 0.0 110.044 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -120.27 96.38 5.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.455 ' HD2' HG23 ' A' ' 108' ' ' VAL . 52.7 p90 -118.93 157.54 27.49 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.887 0.851 . . . . 0.0 112.407 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -116.67 157.3 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 159' ' ' LEU . 71.8 mt -116.46 154.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -137.87 122.17 18.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.809 -0.557 . . . . 0.0 109.507 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 mm -106.54 147.09 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 110.648 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 m -127.42 134.83 49.86 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.557 ' CD2' ' HE1' ' A' ' 126' ' ' MET . 41.1 p90 -152.18 140.78 20.77 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.0 111.203 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -88.43 142.33 27.81 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.436 0.636 . . . . 0.0 110.946 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.96 95.49 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -129.41 48.27 2.39 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.0 111.687 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 -67.08 0.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.294 -0.879 . . . . 0.0 110.764 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -143.1 178.07 7.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.15 107.83 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 70' ' ' VAL . 59.5 t -95.9 82.02 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 p -84.64 113.4 21.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.667 -0.646 . . . . 0.0 110.438 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.68 37.07 0.8 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.557 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -79.51 145.32 33.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.498 -1.001 . . . . 0.0 109.797 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -143.82 141.23 30.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 110.958 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -109.0 109.05 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.4 mt -96.66 161.46 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.677 . . . . 0.0 110.117 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -159.34 118.9 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.69 -0.631 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 141' ' ' LYS . 17.8 m-70 -106.41 134.7 49.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.726 . . . . 0.0 109.899 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.654 HG22 HD11 ' A' ' 139' ' ' ILE . 3.8 m -90.11 113.42 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.646 -0.659 . . . . 0.0 109.981 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 2.3 m-85 -111.38 119.32 38.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.679 . . . . 0.0 109.947 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -120.88 129.14 53.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.656 -0.652 . . . . 0.0 110.348 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt 52.68 39.25 28.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.35 -0.844 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.88 30.43 72.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.5 t -143.11 119.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.997 . . . . 0.0 109.881 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -77.22 138.88 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.513 -0.742 . . . . 0.0 110.137 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.654 HD11 HG22 ' A' ' 132' ' ' THR . 0.1 OUTLIER -116.8 -26.87 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.492 -0.755 . . . . 0.0 110.555 179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -169.67 144.97 3.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HB2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -142.42 139.88 31.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.5 m -120.51 160.8 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.824 . . . . 0.0 111.061 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -126.21 73.81 1.4 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.088 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -62.89 141.67 58.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.708 . . . . 0.0 110.613 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 ttt -94.37 124.27 38.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 158' ' ' PHE . 26.3 t -79.75 -58.86 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.26 175.75 14.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.1 p -86.29 147.88 25.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.922 . . . . 0.0 109.853 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.432 ' OH ' HG12 ' A' ' 146' ' ' VAL . 67.3 m-85 -146.31 135.73 22.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.44 161.03 30.92 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.66 62.58 5.57 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.41 1.216 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -170.52 54.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.469 -0.77 . . . . 0.0 110.418 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.749 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -155.99 23.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.499 -0.751 . . . . 0.0 111.244 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 40.46 -150.16 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.862 -0.524 . . . . 0.0 112.269 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.699 ' HG2' HG21 ' A' ' 73' ' ' THR . 49.8 mt-10 -67.41 114.42 6.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.28 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.749 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 3.9 m-85 -73.37 -173.34 1.35 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.606 -0.684 . . . . 0.0 109.755 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.96 82.53 1.44 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.571 -0.706 . . . . 0.0 110.727 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.533 ' HB2' HG13 ' A' ' 146' ' ' VAL . 42.7 t80 -80.97 161.99 24.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.392 -0.817 . . . . 0.0 109.384 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER -150.51 117.54 5.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.952 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.5 p -81.05 156.7 71.9 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.434 -0.791 . . . . 0.0 108.877 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 166.3 20.03 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.711 1.374 . . . . 0.0 110.979 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 135.62 56.31 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.417 0.627 . . . . 0.0 110.948 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.64 127.49 42.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.639 . . . . 0.0 109.412 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -79.2 139.65 37.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.48 -0.762 . . . . 0.0 110.883 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.33 170.52 11.19 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.733 -0.605 . . . . 0.0 110.41 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.6 Cg_endo -71.37 132.76 21.35 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 O-C-N 123.434 1.228 . . . . 0.0 110.405 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 -171.83 2.08 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.653 -0.655 . . . . 0.0 110.571 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.55 -157.15 15.19 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.45 -38.91 6.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.626 -0.926 . . . . 0.0 109.573 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.734 ' O ' HD23 ' A' ' 170' ' ' LEU . 2.2 tt -86.68 -22.68 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.761 -0.587 . . . . 0.0 110.235 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HB3' ' OE2' ' A' ' 106' ' ' GLU . . . -55.5 -22.21 20.02 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -0.848 . . . . 0.0 110.778 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.426 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 40.2 mtp180 -62.22 147.6 47.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.86 . . . . 0.0 110.171 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 138.17 -171.95 23.15 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.6 p -96.26 137.06 35.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.6 -0.941 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.32 108.76 14.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.629 -0.669 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.76 131.71 42.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.442 -0.786 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.2 mt -121.27 147.99 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.32 -0.863 . . . . 0.0 110.725 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -112.23 111.01 21.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.686 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.438 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 3.1 m -103.39 125.0 49.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 110.135 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -113.92 114.55 26.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 110.315 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.442 ' CG ' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -96.11 130.54 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 109.938 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 t -156.2 -163.45 1.47 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.528 -0.733 . . . . 0.0 110.473 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' OD1' ' CD2' ' A' ' 189' ' ' HIS . 8.6 p-10 -164.47 -149.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.651 -0.655 . . . . 0.0 109.932 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -82.17 56.34 3.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.554 ' OD1' HG22 ' A' ' 187' ' ' THR . 54.6 p-10 -161.6 48.41 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.512 -0.743 . . . . 0.0 109.921 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 185' ' ' ASP . 1.8 mpt_? 3.9 65.63 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.554 HG22 ' OD1' ' A' ' 185' ' ' ASP . 8.8 t -144.62 -176.84 5.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.922 -0.486 . . . . 0.0 109.913 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.28 96.46 5.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 1.6 m-70 -60.14 -47.33 86.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 109.805 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.594 HD23 ' HB ' ' A' ' 72' ' ' VAL . 23.3 tp -170.89 107.81 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.709 -0.619 . . . . 0.0 109.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -113.31 131.0 56.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.629 -0.67 . . . . 0.0 110.124 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.585 ' CE2' HD21 ' A' ' 90' ' ' LEU . 25.1 p90 -133.92 -154.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.761 . . . . 0.0 109.938 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -167.91 130.74 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.629 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 16.6 p-90 -133.14 146.23 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.681 . . . . 0.0 109.829 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.75 149.25 21.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.695 -0.628 . . . . 0.0 110.627 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.783 HD11 HD12 ' A' ' 104' ' ' LEU . 22.3 tp -121.33 108.76 14.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.689 -0.632 . . . . 0.0 109.391 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.5 m -78.22 136.8 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.643 HG21 ' OE1' ' A' ' 106' ' ' GLU . 47.6 mm -111.1 151.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.712 -0.618 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.35 -160.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.659 -0.65 . . . . 0.0 109.721 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -119.62 -30.79 4.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -135.73 59.9 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 111.493 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.559 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -66.09 -11.3 47.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.305 -0.872 . . . . 0.0 111.338 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -157.02 51.22 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.02 . . . . 0.0 110.205 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.069 0.461 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -140.55 -83.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.585 -0.697 . . . . 0.0 110.387 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.472 ' H ' HG23 ' A' ' 61' ' ' VAL . 2.6 m 52.69 49.92 19.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.909 -1.12 . . . . 0.0 110.746 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.66 171.13 14.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.508 -0.745 . . . . 0.0 110.205 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.23 81.82 1.79 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.597 -0.689 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 -35.44 5.94 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.306 1.161 . . . . 0.0 110.432 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -168.07 107.78 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.1 92.3 7.63 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.544 -0.723 . . . . 0.0 109.845 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.92 179.99 4.81 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.456 1.24 . . . . 0.0 110.747 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.591 HD22 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -136.95 -64.94 0.56 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.651 -0.656 . . . . 0.0 109.758 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 70' ' ' VAL . 46.5 t -140.37 30.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.612 0.72 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.887 HG13 HD22 ' A' ' 190' ' ' LEU . 63.5 t -68.0 138.04 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.203 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.611 HG21 ' CZ3' ' A' ' 192' ' ' TRP . 67.5 t -63.07 124.39 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 116' ' ' PHE . 36.4 p -87.03 -63.5 1.3 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.258 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -135.99 172.16 13.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.357 -0.84 . . . . 0.0 111.119 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.08 124.51 14.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.712 -0.618 . . . . 0.0 109.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m -109.89 158.47 18.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.787 . . . . 0.0 110.455 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -142.3 103.22 4.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.229 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.0 t -105.53 166.95 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.497 -0.752 . . . . 0.0 110.34 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -160.45 -157.92 0.58 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.961 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -101.97 -29.41 11.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 0.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.4 p -138.17 41.78 2.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.675 -0.641 . . . . 0.0 110.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.449 ' CB ' ' CH2' ' A' ' 202' ' ' TRP . . . -90.39 163.43 31.06 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.592 -0.692 . . . . 0.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.27 -25.2 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.491 1.258 . . . . 0.0 110.244 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.04 167.57 25.84 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.44 100.07 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.515 1.271 . . . . 0.0 110.243 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.55 115.51 5.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.665 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -97.82 101.23 12.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.447 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -82.63 125.49 31.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.534 -0.729 . . . . 0.0 109.913 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.0 134.36 35.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.652 -0.655 . . . . 0.0 110.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.513 HD13 ' CG1' ' A' ' 72' ' ' VAL . 6.4 mt -135.27 55.15 1.9 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.66 -0.65 . . . . 0.0 109.923 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -106.34 -72.98 0.7 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.592 -0.692 . . . . 0.0 110.524 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.4 -77.99 0.78 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.05 92.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.451 -1.029 . . . . 0.0 110.41 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 94' ' ' LEU . 44.2 mt -92.34 -37.69 12.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.663 -0.648 . . . . 0.0 110.046 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -18.84 36.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.511 -0.743 . . . . 0.0 110.879 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.1 p -53.89 -22.51 10.15 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.299 -0.876 . . . . 0.0 111.153 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 88' ' ' LEU . 7.0 m-30 -60.84 -30.24 69.98 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 109.87 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -60.78 -26.7 67.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.672 . . . . 0.0 110.72 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.49 22.7 5.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.596 -0.69 . . . . 0.0 110.707 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -171.19 128.64 0.71 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 p -113.21 179.58 3.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.665 -0.647 . . . . 0.0 110.185 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 196' ' ' LEU . 7.1 m-85 -111.59 104.96 13.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.7 139.74 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.48 -0.762 . . . . 0.0 110.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -154.33 161.45 41.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.706 -0.621 . . . . 0.0 110.263 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.423 ' HB2' HG11 ' A' ' 108' ' ' VAL . 1.1 mtpm? -76.47 152.16 36.22 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.523 -0.735 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -20.61 -74.31 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.61 69.56 0.46 Allowed Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.415 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.651 HG21 HD22 ' A' ' 104' ' ' LEU . 33.9 m -80.27 -176.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.524 -0.986 . . . . 0.0 110.071 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.25 96.93 6.04 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.441 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 44.6 p90 -113.26 149.23 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.505 -0.747 . . . . 0.0 111.987 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HD3' HD21 ' A' ' 159' ' ' LEU . 2.5 ttt180 -107.32 155.48 19.93 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.2 mt -121.43 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.008 -1.058 . . . . 0.0 111.197 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -120.83 107.29 12.54 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.28 151.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.44 -0.787 . . . . 0.0 111.073 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -131.32 152.1 50.89 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.65 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.1 p90 -167.84 159.05 11.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 111.15 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -93.06 135.92 33.8 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.202 0.525 . . . . 0.0 111.377 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.06 85.2 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.21 48.38 2.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.535 -0.728 . . . . 0.0 111.998 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -68.51 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 171.51 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 0.0 110.586 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.96 108.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.666 -0.646 . . . . 0.0 110.264 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 70' ' ' VAL . 65.6 t -93.99 75.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.646 -0.658 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.44 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 69.8 p -64.68 82.81 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.657 -0.652 . . . . 0.0 110.358 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.92 49.38 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.45 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -79.78 120.7 24.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.257 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -132.88 148.2 52.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 111.1 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -125.38 113.37 17.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -114.47 146.71 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.625 -0.672 . . . . 0.0 110.511 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.67 141.83 43.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.556 -0.715 . . . . 0.0 110.08 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.815 ' O ' HG23 ' A' ' 177' ' ' ILE . 13.8 m-70 -101.07 164.72 11.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.684 . . . . 0.0 109.634 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.426 ' CG2' HD11 ' A' ' 139' ' ' ILE . 17.6 m -119.7 61.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.951 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.88 118.75 7.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.741 . . . . 0.0 110.417 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.603 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -120.92 138.26 54.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.619 -0.675 . . . . 0.0 110.017 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? 53.35 28.74 7.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.412 -0.805 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.37 -11.46 63.34 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.196 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.8 m -111.55 148.02 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.024 -1.28 . . . . 0.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.68 135.92 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.284 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.426 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -120.68 -26.26 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.496 -0.752 . . . . 0.0 111.049 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -176.3 146.02 0.62 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -133.67 143.13 48.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.535 -0.728 . . . . 0.0 109.76 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 129' ' ' ILE . 17.2 m -109.9 151.83 26.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.604 -0.685 . . . . 0.0 111.043 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -126.05 136.39 52.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.63 -0.669 . . . . 0.0 109.836 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -123.41 129.02 50.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.451 -0.781 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.7 ttm -91.75 107.97 19.58 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.845 HG12 ' CE1' ' A' ' 149' ' ' TYR . 61.8 t -79.68 -44.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.309 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.68 -173.82 19.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.44 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 31.9 m -84.84 126.32 33.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.604 -0.939 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.845 ' CE1' HG12 ' A' ' 146' ' ' VAL . 8.8 m-85 -113.51 131.46 56.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.725 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -118.19 145.09 18.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.81 142.77 35.97 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.382 1.201 . . . . 0.0 110.186 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -167.61 -39.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.566 -0.709 . . . . 0.0 110.774 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.6 -81.85 0.46 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 111.416 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.28 -136.31 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 110.424 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.78 166.01 22.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.887 -1.133 . . . . 0.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 33.5 m-85 -121.31 -175.99 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -133.78 114.96 13.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.447 -0.783 . . . . 0.0 111.019 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.615 ' CD1' HG13 ' A' ' 146' ' ' VAL . 34.4 t80 -100.41 159.97 14.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.725 . . . . 0.0 109.202 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.438 HD21 ' HD3' ' A' ' 111' ' ' ARG . 1.1 tt -149.81 118.79 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.459 -0.776 . . . . 0.0 110.946 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.6 p -89.78 156.41 47.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.564 -0.71 . . . . 0.0 109.094 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.53 169.53 12.58 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.652 1.343 . . . . 0.0 110.83 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 129.47 41.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.406 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 7.2 mm-40 -116.33 127.27 54.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.626 -0.671 . . . . 0.0 109.631 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -83.2 133.61 35.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.441 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -82.79 165.15 43.32 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.765 -0.585 . . . . 0.0 110.188 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.2 Cg_endo -73.2 123.69 8.97 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.401 1.211 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 169.2 8.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.654 -0.653 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 126.01 160.82 10.76 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.78 -43.54 97.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.969 . . . . 0.0 110.151 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -79.67 -27.35 40.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.647 -0.658 . . . . 0.0 110.216 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.97 -22.18 59.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.499 -0.751 . . . . 0.0 110.645 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -68.23 131.17 44.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.478 -0.764 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 151.71 179.4 27.34 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.2 p -87.44 130.16 34.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.524 -0.986 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.03 113.88 26.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 110.641 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.86 125.33 29.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.458 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 131' ' ' HIS . 17.7 mt -117.61 137.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.379 -0.825 . . . . 0.0 110.959 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -103.31 96.86 7.04 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.4 p -94.25 125.39 38.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.683 . . . . 0.0 110.671 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -127.6 96.83 4.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.681 . . . . 0.0 109.997 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -83.14 91.27 7.2 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.586 -0.696 . . . . 0.0 110.087 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.9 t -116.98 -171.77 2.09 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -94.19 -163.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.364 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.97 -53.29 59.05 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.243 -0.911 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.0 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.252 -0.905 . . . . 0.0 110.747 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.87 -35.69 32.32 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.902 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.9 t -178.41 -162.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.621 -0.674 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.07 120.01 38.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 16.3 m-70 -82.75 -73.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.779 . . . . 0.0 110.864 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.887 HD22 HG13 ' A' ' 71' ' ' VAL . 3.1 tp -156.05 151.19 26.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.669 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 t -153.86 139.69 18.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.663 . . . . 0.0 109.786 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.611 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 21.9 p90 -135.19 -153.57 0.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.99 132.01 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 17.0 p-90 -139.33 147.1 41.11 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.678 -0.639 . . . . 0.0 109.614 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.78 152.05 20.95 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.518 0.675 . . . . 0.0 111.26 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 102' ' ' PHE . 9.4 tp -126.16 91.54 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.3 m -67.9 137.2 55.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.608 -0.682 . . . . 0.0 110.436 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -114.53 145.3 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 109.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -144.16 -153.07 0.45 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 109.84 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -132.06 1.41 3.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.399 -0.813 . . . . 0.0 111.661 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -160.23 46.84 0.24 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.942 -1.099 . . . . 0.0 111.122 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.478 ' CH2' HD21 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -59.15 -18.63 37.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 111.197 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -152.47 48.24 0.75 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.219 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.113 0.482 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t -141.01 -51.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.568 -0.707 . . . . 0.0 109.975 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.9 m -82.53 164.49 20.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.256 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.35 -28.75 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 0.0 110.3 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -127.93 139.46 35.42 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.155 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.93 -51.86 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.23 1.121 . . . . 0.0 110.441 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -142.18 179.37 6.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.538 -0.726 . . . . 0.0 110.329 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.68 140.34 21.73 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 109.98 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.12 -165.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.256 1.135 . . . . 0.0 110.556 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.499 ' ND2' HG23 ' A' ' 70' ' ' VAL . 1.8 t-20 -98.15 -65.85 0.94 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.643 -0.66 . . . . 0.0 109.797 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 123' ' ' VAL . 93.3 t -141.92 117.76 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.507 0.67 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.0 t -139.66 144.05 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.899 -0.501 . . . . 0.0 109.775 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 90' ' ' LEU . 60.0 t -64.27 99.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 116' ' ' PHE . 82.1 p -70.83 -44.63 66.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.715 -0.616 . . . . 0.0 111.228 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -154.97 158.0 38.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.358 -0.839 . . . . 0.0 110.848 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 76' ' ' THR . 8.2 tt -119.32 152.57 36.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.724 -0.61 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.555 ' N ' HD23 ' A' ' 75' ' ' LEU . 19.5 m -139.77 152.64 46.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -0.765 . . . . 0.0 110.631 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -136.67 83.52 2.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.574 -0.704 . . . . 0.0 109.973 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.85 149.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.634 . . . . 0.0 110.14 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 94.8 m -146.07 -164.96 2.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.693 -0.629 . . . . 0.0 110.037 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.6 p -103.53 -76.9 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.775 . . . . 0.0 110.758 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 p -96.26 32.59 1.93 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.826 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.28 178.99 1.63 Allowed Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.652 -0.655 . . . . 0.0 110.087 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.771 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 46.6 Cg_endo -74.25 -26.85 12.1 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.342 1.18 . . . . 0.0 110.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 156.63 -179.42 32.48 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HB2' HG23 ' A' ' 76' ' ' THR . 46.0 Cg_endo -71.72 111.4 3.13 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.488 1.257 . . . . 0.0 110.416 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.938 HD22 ' CD1' ' A' ' 102' ' ' PHE . 13.8 mt -65.76 115.66 6.14 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.99 137.78 34.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.97 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 3.9 mt -132.71 119.67 20.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 0.0 109.717 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.49 141.95 50.17 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.599 HD21 ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -138.51 56.3 1.72 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.753 . . . . 0.0 110.059 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -105.99 -66.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.265 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.57 -46.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.91 65.15 1.94 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.574 -0.956 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.651 HD23 ' CE1' ' A' ' 97' ' ' PHE . 13.4 mt -84.19 0.1 50.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.575 -0.703 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.61 -27.29 64.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.054 -1.029 . . . . 0.0 110.787 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.8 m -65.42 -13.77 59.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.463 -0.773 . . . . 0.0 111.065 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.97 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 10.7 m-85 -72.19 -52.51 16.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.286 -0.883 . . . . 0.0 110.711 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -57.68 -20.24 32.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.521 -0.737 . . . . 0.0 111.007 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -115.0 44.96 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.4 -0.812 . . . . 0.0 110.393 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -168.66 146.55 4.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 p -150.98 131.39 13.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 109.82 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.938 ' CD1' HD22 ' A' ' 86' ' ' LEU . 15.1 m-85 -77.12 122.99 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.527 -0.733 . . . . 0.0 110.189 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.65 113.17 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 109.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.015 HD21 HG22 ' A' ' 108' ' ' VAL . 4.1 tt -113.62 156.81 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.657 ' N ' HD23 ' A' ' 104' ' ' LEU . 31.8 tttt -80.9 161.8 24.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -40.82 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 29.73 66.77 0.11 Allowed Glycine 0 N--CA 1.507 3.372 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.777 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.015 HG22 HD21 ' A' ' 104' ' ' LEU . 30.5 m -79.01 -160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.224 -1.162 . . . . 0.0 109.201 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.09 117.11 27.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.464 -0.773 . . . . 0.0 109.54 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.604 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 10.8 p90 -137.67 152.13 48.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.306 -0.872 . . . . 0.0 111.916 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -109.67 150.27 28.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.39 151.56 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.133 -0.979 . . . . 0.0 111.703 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HG3' HD23 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -126.24 93.28 3.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.989 HG21 ' CE2' ' A' ' 181' ' ' PHE . 47.8 mm -81.18 142.6 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.743 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.8 m -122.08 135.94 54.86 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.758 ' HA ' HG23 ' A' ' 73' ' ' THR . 15.5 p90 -153.06 145.34 23.95 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.333 -0.854 . . . . 0.0 111.158 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -88.52 128.25 35.55 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 70' ' ' VAL . 59.9 t -123.39 84.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.75 48.88 2.32 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 111.86 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -145.42 -66.32 0.31 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.237 -0.914 . . . . 0.0 110.904 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.74 168.92 17.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.339 -0.851 . . . . 0.0 110.412 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 18.2 mt -80.29 108.37 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.99 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.03 HG21 HG21 ' A' ' 70' ' ' VAL . 97.6 t -89.4 86.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 109.798 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.3 p -88.11 88.48 7.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.616 -0.677 . . . . 0.0 110.384 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 137.94 44.64 0.08 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -80.99 121.07 25.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 109.793 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -129.5 137.42 50.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.728 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.502 ' CD1' ' CD2' ' A' ' 181' ' ' PHE . 14.0 t80 -111.62 139.02 47.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.542 -0.723 . . . . 0.0 109.678 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 82.0 mt -136.79 144.45 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.541 -0.725 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.52 144.28 37.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.678 -0.639 . . . . 0.0 110.057 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 14.9 m-70 -117.23 116.92 28.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.596 -0.69 . . . . 0.0 110.156 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 139' ' ' ILE . 29.3 m -68.04 77.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 0.0 110.202 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 4.2 m-85 -76.39 125.99 30.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HD3' ' CE2' ' A' ' 175' ' ' TYR . 7.9 tpt180 -120.75 120.89 36.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt 52.89 38.59 27.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.488 -0.757 . . . . 0.0 110.754 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 72.8 35.56 58.47 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.5 t -147.1 109.14 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.955 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 4.9 pttm -63.02 128.9 37.99 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.637 -0.664 . . . . 0.0 110.232 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pt -115.53 -23.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.635 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.43 132.18 0.29 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.89 149.99 49.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.683 . . . . 0.0 109.634 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -127.56 154.89 44.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.514 -0.741 . . . . 0.0 110.838 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -126.01 121.44 33.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.63 -0.669 . . . . 0.0 110.052 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -110.99 145.7 37.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.703 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -92.08 119.33 31.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.634 -0.666 . . . . 0.0 109.228 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 58.9 t -79.58 -52.43 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 110.304 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.7 175.81 14.2 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 30.8 t -99.02 139.37 34.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.927 . . . . 0.0 110.063 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.492 ' HE2' HG12 ' A' ' 146' ' ' VAL . 47.0 m-85 -142.04 126.89 18.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.589 -0.694 . . . . 0.0 110.308 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.25 164.78 28.56 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.08 92.97 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.447 1.235 . . . . 0.0 110.342 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -169.49 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 0.0 110.447 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.778 ' HB3' ' CZ ' ' A' ' 156' ' ' TYR . . . -92.43 19.33 7.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.542 -0.724 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 156' ' ' TYR . 38.1 mt-10 56.2 -143.88 0.7 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.53 152.35 45.5 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.05 -1.031 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.778 ' CZ ' ' HB3' ' A' ' 153' ' ' ALA . 42.0 m-85 -116.13 -176.31 2.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 109.546 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -147.49 104.31 3.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.509 -0.744 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.531 ' HE2' HG22 ' A' ' 160' ' ' THR . 34.9 t80 -77.85 165.81 23.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -146.87 97.57 2.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.396 -0.815 . . . . 0.0 110.653 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.531 HG22 ' HE2' ' A' ' 158' ' ' PHE . 75.0 p -72.79 149.17 90.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.46 157.55 54.28 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.415 1.218 . . . . 0.0 110.702 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.71 93.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.606 -0.684 . . . . 0.0 110.976 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -79.87 167.71 20.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.416 -0.803 . . . . 0.0 109.862 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.69 123.32 48.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.504 -0.747 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -75.45 177.03 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.4 Cg_endo -73.45 127.73 12.09 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.298 1.157 . . . . 0.0 111.112 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 5.4 ptpp? -115.63 174.97 5.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 110.121 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.65 156.5 10.66 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 15.2 ttt -62.33 -46.61 87.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.734 -0.862 . . . . 0.0 109.998 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.3 tt -73.89 -26.42 60.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.668 -0.645 . . . . 0.0 110.182 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -57.93 -20.7 39.44 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.421 -0.799 . . . . 0.0 110.719 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 2.7 mtp-105 -58.5 125.22 22.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.304 -0.872 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.75 175.4 27.65 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.4 p -84.86 134.7 34.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.594 -0.945 . . . . 0.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 134' ' ' ARG . 32.3 m-85 -115.59 101.41 8.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.607 -0.683 . . . . 0.0 110.693 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -70.18 121.37 17.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.714 . . . . 0.0 109.112 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.516 HD12 ' CZ2' ' A' ' 194' ' ' TRP . 42.6 mt -110.09 126.61 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.53 -0.732 . . . . 0.0 110.99 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -87.4 92.52 9.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.685 -0.634 . . . . 0.0 109.879 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.403 ' OG ' ' CE2' ' A' ' 192' ' ' TRP . 3.0 p -84.98 140.94 30.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.658 -0.651 . . . . 0.0 110.674 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.82 83.62 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.64 -0.662 . . . . 0.0 109.892 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -78.26 128.66 34.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.668 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -162.72 -169.88 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.672 . . . . 0.0 110.52 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -104.03 -164.34 1.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.878 -0.514 . . . . 0.0 109.762 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -57.63 11.76 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.832 . . . . 0.0 110.228 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.36 27.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.76 -0.588 . . . . 0.0 110.467 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -36.31 26.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.755 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.55 -163.21 0.08 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.805 -0.559 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.35 110.99 20.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.384 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.48 -55.04 13.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.464 -0.773 . . . . 0.0 110.665 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.909 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -166.54 164.19 17.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 190' ' ' LEU . 17.6 p -168.23 134.73 1.99 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.853 -0.529 . . . . 0.0 109.576 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.599 ' CD2' HD21 ' A' ' 90' ' ' LEU . 14.5 p90 -147.0 -155.21 0.6 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 110.442 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -157.81 127.68 6.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.533 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 12.3 p-90 -134.79 146.21 49.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.697 -0.627 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.91 136.11 40.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.656 -0.653 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.748 HD21 HD13 ' A' ' 104' ' ' LEU . 6.7 tp -110.36 98.55 7.75 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 97.6 m -73.14 121.07 19.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.651 -0.656 . . . . 0.0 110.515 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' A' ' 104' ' ' LEU . 47.7 mm -90.24 149.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.592 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 -155.82 0.64 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 110.456 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -120.22 -21.3 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.504 -0.747 . . . . 0.0 111.268 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -155.04 81.71 1.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -79.74 3.21 20.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.478 -0.764 . . . . 0.0 111.501 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 44.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.086 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.104 0.478 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 62' ' ' SER . 57.4 t -81.36 166.92 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.487 -0.758 . . . . 0.0 109.909 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -104.52 34.84 2.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.509 -0.744 . . . . 0.0 110.247 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.12 5.94 5.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.79 63.07 9.85 Favored Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.977 -1.077 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.52 -84.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.203 1.107 . . . . 0.0 110.619 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 m120 51.95 -177.72 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.877 -1.139 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' VAL . 7.6 p -131.84 70.56 80.92 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.95 172.61 14.27 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.379 1.2 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -97.99 -60.62 1.52 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.632 -0.667 . . . . 0.0 109.898 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 123' ' ' VAL . 77.7 t -110.15 140.09 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.64 -0.662 . . . . 0.0 110.354 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HD22 ' A' ' 190' ' ' LEU . 72.3 t -149.43 144.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.731 -0.606 . . . . 0.0 109.616 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 HD13 ' A' ' 90' ' ' LEU . 57.4 t -68.4 100.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 117' ' ' ARG . 68.0 p -70.23 -44.46 68.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.596 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -159.29 173.92 15.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 76' ' ' THR . 9.7 tt -144.3 164.41 30.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.688 -0.632 . . . . 0.0 109.544 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.678 ' N ' HD23 ' A' ' 75' ' ' LEU . 27.4 m -151.55 163.01 39.98 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.432 -0.792 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -143.36 84.19 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.604 -0.685 . . . . 0.0 109.895 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.98 143.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.731 -0.606 . . . . 0.0 110.106 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 89.7 m -141.67 -163.13 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.592 -0.693 . . . . 0.0 110.077 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.9 p -110.53 -72.68 0.71 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.466 -0.772 . . . . 0.0 110.677 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -95.75 27.66 3.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.565 -0.709 . . . . 0.0 110.639 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.27 -176.52 0.65 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.9 Cg_endo -76.28 -25.04 10.32 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.311 1.163 . . . . 0.0 110.016 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.07 -177.08 30.91 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.484 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 91.55 0.65 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.556 1.292 . . . . 0.0 110.558 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.445 ' CB ' ' CE2' ' A' ' 102' ' ' PHE . 6.2 mt -64.83 111.41 2.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.696 . . . . 0.0 109.386 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.86 159.83 14.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.537 -0.727 . . . . 0.0 110.872 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.801 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.4 mt -132.18 128.16 37.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.722 -0.611 . . . . 0.0 109.912 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 133.46 40.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -132.09 51.79 2.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.3 p -123.82 -65.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.391 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.92 -53.18 0.21 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.99 71.97 0.4 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.541 -0.976 . . . . 0.0 110.158 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -93.71 -33.84 13.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.29 -26.99 65.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.591 -0.693 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.4 t -60.34 -23.68 64.44 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 110.472 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.801 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.3 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -73.63 -26.96 61.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.64 -0.663 . . . . 0.0 110.63 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -105.08 28.91 6.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.453 -0.779 . . . . 0.0 110.284 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -158.46 139.82 13.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.555 -0.716 . . . . 0.0 110.127 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -126.24 -175.8 3.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 110.4 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.7 m-85 -116.65 109.31 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.673 -0.642 . . . . 0.0 109.99 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.11 105.73 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -0.779 . . . . 0.0 109.793 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.071 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -122.43 158.62 29.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.627 -0.67 . . . . 0.0 110.077 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.683 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.2 tttt -87.22 161.56 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.472 -0.767 . . . . 0.0 110.385 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 105' ' ' LYS . 33.9 mt-10 -18.58 -71.63 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . -150.27 63.26 0.4 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.699 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.071 HG22 HD21 ' A' ' 104' ' ' LEU . 34.5 m -73.29 127.41 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.442 -1.034 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -71.71 94.77 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.6 p90 -109.49 154.87 22.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 111.838 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.3 131.1 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 76' ' ' THR . 62.1 mt -96.04 142.28 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.261 -0.9 . . . . 0.0 110.533 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -117.85 102.69 9.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.546 HG21 ' CE1' ' A' ' 181' ' ' PHE . 47.7 mm -88.11 127.92 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.755 . . . . 0.0 110.685 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -113.06 137.89 50.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 116' ' ' PHE . 19.5 p90 -151.05 174.84 12.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.347 -0.846 . . . . 0.0 110.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' CG ' HG21 ' A' ' 73' ' ' THR . 7.6 mmm-85 -127.64 150.83 49.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 111.322 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 151' ' ' PRO . 58.6 t -132.67 111.32 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -128.66 48.39 2.33 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.472 -0.767 . . . . 0.0 111.472 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -69.71 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.0 110.646 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -137.93 171.98 13.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.431 -0.793 . . . . 0.0 110.472 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 149' ' ' TYR . 86.9 mt -80.0 109.84 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.615 . . . . 0.0 109.966 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 70' ' ' VAL . 66.9 t -84.65 82.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.848 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 p -81.21 77.58 8.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.637 -0.664 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.97 46.08 0.04 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.623 ' HE3' ' CE2' ' A' ' 181' ' ' PHE . 1.3 tpp -79.54 137.68 37.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.546 -0.973 . . . . 0.0 109.489 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -126.11 158.15 36.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -134.31 109.9 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.4 mp -107.74 166.22 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.496 -0.753 . . . . 0.0 110.437 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.474 ' N ' HG22 ' A' ' 129' ' ' ILE . 7.8 mt-30 -154.96 127.89 8.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.665 -0.647 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 12.9 m-70 -110.32 117.19 32.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 139' ' ' ILE . 19.3 m -68.51 78.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 0.0 109.902 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 2.7 m-85 -78.25 105.1 9.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.191 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.533 ' O ' HG22 ' A' ' 137' ' ' VAL . 11.0 tpt180 -120.76 153.76 36.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.683 -0.636 . . . . 0.0 109.686 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 52.91 36.22 21.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.33 -0.857 . . . . 0.0 110.786 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.437 ' C ' HG13 ' A' ' 137' ' ' VAL . . . 63.32 23.91 66.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 134' ' ' ARG . 35.4 m -149.3 149.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.306 -1.114 . . . . 0.0 110.181 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 21.8 ttmt -80.1 136.31 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.0 110.247 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 132' ' ' THR . 1.1 pp -118.5 -25.19 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.456 -0.778 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -174.69 143.29 0.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.104 -0.998 . . . . 0.0 110.248 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 2.9 pttt -137.76 166.45 23.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.234 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 6.1 m -145.0 156.56 44.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.586 -0.696 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.91 132.65 52.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 110.335 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -123.08 121.92 37.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.566 -0.709 . . . . 0.0 110.576 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.406 ' O ' ' CZ ' ' A' ' 158' ' ' PHE . 23.6 mtp -65.15 122.08 16.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -0.786 . . . . 0.0 109.29 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 158' ' ' PHE . 48.8 t -79.27 -56.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 110.298 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 137.41 174.04 13.17 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 p -84.99 150.31 24.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.701 -0.882 . . . . 0.0 109.885 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.507 ' CE2' HG12 ' A' ' 146' ' ' VAL . 69.8 m-85 -146.7 161.32 40.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.357 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -110.07 154.55 16.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -72.64 -156.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.713 1.375 . . . . 0.0 110.321 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 25.4 mtp-105 73.09 51.23 0.14 Allowed 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.567 -0.708 . . . . 0.0 110.63 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 50.64 23.69 1.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.428 -0.795 . . . . 0.0 111.852 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 156' ' ' TYR . 1.5 tt0 -79.38 103.43 9.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.56 112.91 24.8 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.615 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 78.5 m-85 -96.75 -175.3 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.738 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -141.02 112.51 7.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.681 ' HB2' HG13 ' A' ' 146' ' ' VAL . 30.8 t80 -83.82 160.46 21.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.226 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.05 100.82 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 111.459 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 52.4 p -69.56 149.35 97.01 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.35 -179.45 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.591 1.311 . . . . 0.0 111.077 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptm -53.73 144.88 16.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.685 -0.634 . . . . 0.0 111.232 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.407 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 12.3 mt-10 -140.54 96.35 3.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.73 -0.606 . . . . 0.0 109.673 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.76 121.76 17.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.625 -0.672 . . . . 0.0 110.595 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -55.0 176.49 0.15 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.723 -0.611 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.762 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 45.6 Cg_endo -71.08 118.38 5.66 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.367 1.193 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 20.6 mttt -90.75 165.85 13.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.605 -0.684 . . . . 0.0 110.712 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.82 143.64 14.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.467 ' HA ' ' CD ' ' A' ' 172' ' ' ARG . 30.6 mtp -60.26 -42.24 94.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.521 -0.988 . . . . 0.0 109.511 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 170' ' ' LEU . 1.9 tm? -64.55 -22.23 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.869 -0.519 . . . . 0.0 109.938 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -92.72 23.06 4.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.82 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 169' ' ' MET . 45.9 mtm180 -100.37 176.85 5.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.257 -0.902 . . . . 0.0 110.029 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 105.63 -173.99 20.64 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.9 p -86.04 131.05 34.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.924 . . . . 0.0 110.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 134' ' ' ARG . 24.7 m-85 -116.67 108.5 15.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.688 -0.633 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -73.85 121.2 20.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.533 -0.73 . . . . 0.0 109.128 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.3 mt -110.09 129.61 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.4 -0.812 . . . . 0.0 111.061 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 108.54 20.41 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.698 -0.626 . . . . 0.0 109.729 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -113.16 135.15 54.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.53 ' CD ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.8 118.43 23.71 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.604 0.716 . . . . 0.0 110.361 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.623 ' CE2' ' HE3' ' A' ' 126' ' ' MET . 0.9 OUTLIER -91.41 94.64 9.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.535 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -116.82 -172.5 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 111.092 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -133.53 -172.0 2.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.88 -0.512 . . . . 0.0 109.904 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -96.52 26.11 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.499 -0.751 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 -76.34 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.523 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.622 ' HD2' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER 179.71 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.482 -0.761 . . . . 0.0 111.573 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.622 HG22 ' HD2' ' A' ' 186' ' ' ARG . 8.5 t -174.48 169.48 3.7 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.037 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.89 118.62 34.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.728 -0.607 . . . . 0.0 109.757 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -57.87 -50.79 72.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.483 -0.761 . . . . 0.0 110.697 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.678 HD22 HG13 ' A' ' 71' ' ' VAL . 4.0 tp -169.4 151.12 4.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 65.3 p -147.74 161.29 41.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.674 -0.641 . . . . 0.0 109.884 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CZ3' HG21 ' A' ' 72' ' ' VAL . 16.9 p90 -146.58 -156.23 0.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.766 . . . . 0.0 110.232 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.94 131.45 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.621 -0.674 . . . . 0.0 110.562 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.86 146.31 41.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.652 -0.655 . . . . 0.0 109.799 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.69 146.59 24.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.699 . . . . 0.0 111.079 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 102' ' ' PHE . 53.2 tp -116.23 97.43 6.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.4 m -72.11 111.9 7.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.473 -0.767 . . . . 0.0 110.081 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 48.5 mm -90.41 146.94 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.625 -0.672 . . . . 0.0 109.811 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -138.25 -156.91 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.684 -0.635 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -115.85 -24.31 8.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 110.72 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.79 94.89 1.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.611 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.821 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -84.95 12.19 8.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.606 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -153.65 40.1 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 110.18 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.116 179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.16 0.505 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.33 -26.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.712 . . . . 0.0 110.41 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p 50.19 -155.03 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.488 -0.758 . . . . 0.0 111.004 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.9 51.38 0.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.46 -0.775 . . . . 0.0 110.106 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -166.43 82.52 0.98 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.477 -0.764 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 46.6 Cg_endo -73.26 76.49 2.65 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.367 1.193 . . . . 0.0 110.353 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.27 48.21 22.57 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.421 -0.799 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 65' ' ' PRO . 61.5 t -128.37 99.91 23.53 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.25 170.89 18.05 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.302 1.159 . . . . 0.0 110.379 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -97.66 -65.32 0.97 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 123' ' ' VAL . 95.7 t -119.96 126.51 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.792 -0.567 . . . . 0.0 110.164 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 70' ' ' VAL . 64.5 t -149.02 132.55 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.832 -0.542 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.0 t -67.18 108.64 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.778 HG23 ' HA ' ' A' ' 116' ' ' PHE . 68.7 p -71.2 -62.05 1.54 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.66 . . . . 0.0 110.728 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -141.03 169.01 18.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.944 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.3 tt -130.64 124.49 31.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.648 -0.657 . . . . 0.0 109.744 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 112' ' ' ILE . 46.9 m -109.9 159.71 17.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -0.782 . . . . 0.0 110.486 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mt -139.76 84.15 1.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.539 -0.726 . . . . 0.0 109.978 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 79' ' ' CYS . 59.6 t -82.21 166.68 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.685 -0.634 . . . . 0.0 110.344 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -162.24 -152.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.607 -0.683 . . . . 0.0 109.847 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.04 -36.24 2.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 111.068 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -126.7 26.25 6.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.348 -0.845 . . . . 0.0 110.8 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.804 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.36 -175.51 0.54 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.403 -0.811 . . . . 0.0 110.235 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 48.7 Cg_endo -80.14 -30.97 1.91 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.313 1.165 . . . . 0.0 109.97 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.61 175.54 36.24 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.521 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 47.3 Cg_endo -72.4 104.67 1.73 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.521 1.274 . . . . 0.0 110.506 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.62 HD22 ' CD1' ' A' ' 102' ' ' PHE . 2.4 mp -69.41 112.42 5.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 109.493 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.72 146.53 23.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.629 -0.67 . . . . 0.0 110.749 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.934 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -132.42 153.88 50.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.667 . . . . 0.0 109.81 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.86 133.76 47.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.478 -0.764 . . . . 0.0 110.508 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -132.02 51.93 2.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.501 -0.75 . . . . 0.0 110.103 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.9 p -113.52 -69.57 0.85 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.94 -47.3 0.15 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -72.48 64.9 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.639 -0.919 . . . . 0.0 109.987 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -90.24 -23.16 21.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.397 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.37 -30.67 62.98 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.29 -0.881 . . . . 0.0 110.767 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 m -58.08 -20.23 38.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.486 -0.759 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -60.02 -30.39 69.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.92 -22.7 66.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.743 -0.598 . . . . 0.0 110.931 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -121.92 60.11 0.98 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.697 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.421 ' CG ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -170.61 125.03 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.374 -0.829 . . . . 0.0 110.363 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.4 p -135.04 127.18 29.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.62 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.8 m-85 -73.98 139.05 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.537 -0.727 . . . . 0.0 109.881 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.16 108.27 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.485 -0.76 . . . . 0.0 110.449 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 196' ' ' LEU . 58.0 mt -113.87 165.73 12.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.55 -0.718 . . . . 0.0 109.69 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 108' ' ' VAL . 15.1 tttm -94.46 160.93 14.43 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -18.28 -108.86 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -100.99 75.4 0.39 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.33 -1.481 . . . . 0.0 110.144 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 105' ' ' LYS . 34.3 m -85.26 143.76 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.536 -0.979 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -88.92 89.25 7.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' HE2' HD11 ' A' ' 112' ' ' ILE . 38.6 p90 -110.0 131.09 55.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 111.917 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.02 159.64 14.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 76' ' ' THR . 76.4 mt -126.2 145.3 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.053 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -118.06 102.35 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.432 HG21 ' HE2' ' A' ' 181' ' ' PHE . 48.1 mm -85.2 127.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.522 -0.736 . . . . 0.0 110.851 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.18 145.98 31.92 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.778 ' HA ' HG23 ' A' ' 73' ' ' THR . 27.8 p90 -162.43 149.16 13.25 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.363 -0.835 . . . . 0.0 111.009 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.476 ' HG3' HG21 ' A' ' 73' ' ' THR . 9.0 mtm180 -101.57 133.16 46.68 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.361 0.601 . . . . 0.0 111.282 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.06 96.43 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.52 48.64 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.344 -0.847 . . . . 0.0 111.742 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -146.76 -69.67 0.25 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.224 -0.923 . . . . 0.0 110.794 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.9 158.16 40.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 110.364 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.6 mt -80.19 102.9 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.565 -0.709 . . . . 0.0 109.999 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 70' ' ' VAL . 62.8 t -85.72 94.99 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.616 -0.677 . . . . 0.0 109.826 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.6 p -82.13 97.83 8.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.617 -0.677 . . . . 0.0 110.294 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.17 41.03 0.38 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.628 ' HE1' ' CD2' ' A' ' 116' ' ' PHE . 5.8 ttt -78.86 126.19 30.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.942 . . . . 0.0 109.78 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 146' ' ' VAL . 1.5 ptmm? -137.2 146.87 45.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HH ' ' HZ2' ' A' ' 192' ' ' TRP . 21.6 t80 -111.13 137.84 48.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -123.19 156.45 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.516 -0.74 . . . . 0.0 110.231 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -154.64 131.88 11.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.793 -0.567 . . . . 0.0 109.74 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.403 ' ND1' ' CB ' ' A' ' 141' ' ' LYS . 23.8 m-70 -110.64 131.56 54.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.547 -0.721 . . . . 0.0 110.098 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 31.3 m -81.87 67.3 7.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.615 -0.678 . . . . 0.0 109.837 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 6.4 m-85 -61.57 136.92 58.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.498 -0.751 . . . . 0.0 110.104 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -120.84 110.53 16.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.75 35.91 22.56 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.471 -0.768 . . . . 0.0 110.588 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.413 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.28 35.31 14.96 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.1 t -147.13 113.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -1.041 . . . . 0.0 110.143 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -67.64 123.92 21.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.649 -0.657 . . . . 0.0 110.189 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.65 -22.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.486 -0.759 . . . . 0.0 110.8 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -169.36 123.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 110.92 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.403 ' CB ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -130.86 154.15 48.36 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.697 . . . . 0.0 109.468 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.5 m -142.45 146.03 34.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.864 . . . . 0.0 111.176 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -109.33 120.51 42.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.695 -0.628 . . . . 0.0 109.462 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -104.37 117.68 34.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.443 -0.786 . . . . 0.0 110.946 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 124.9 23.92 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 21.7 t -90.53 -56.5 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 110.25 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' A' ' 149' ' ' TYR . . . 140.33 166.68 10.76 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 79.5 p -81.0 140.63 35.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.637 -0.92 . . . . 0.0 109.558 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 146' ' ' VAL . 43.9 m-85 -139.45 130.04 25.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.425 -0.797 . . . . 0.0 110.36 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.23 166.84 14.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.24 68.89 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.486 1.256 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.96 27.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.674 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.666 ' HB3' ' CE2' ' A' ' 156' ' ' TYR . . . -147.3 12.54 1.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 111.676 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 52.21 -145.08 0.57 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.956 -1.09 . . . . 0.0 111.09 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.1 122.4 20.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.39 -0.819 . . . . 0.0 110.948 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 153' ' ' ALA . 6.5 m-85 -84.17 -173.51 4.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.724 . . . . 0.0 109.911 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -153.9 104.45 2.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 22.3 t80 -85.18 162.61 19.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -140.44 87.1 2.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.403 -0.811 . . . . 0.0 111.305 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.416 HG22 ' HE2' ' A' ' 158' ' ' PHE . 65.5 p -67.19 148.27 98.83 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.37 -0.831 . . . . 0.0 108.965 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.26 157.73 60.57 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.392 1.206 . . . . 0.0 110.811 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.2 ptt? -54.61 108.67 0.41 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.574 -0.704 . . . . 0.0 110.659 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -88.55 155.97 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.38 -0.825 . . . . 0.0 110.296 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.73 137.7 44.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.284 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.628 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -94.16 172.15 6.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 110.323 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.628 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.0 Cg_endo -73.18 179.77 5.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.382 1.201 . . . . 0.0 110.529 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -170.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.439 -0.788 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.06 -44.14 0.09 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.7 mtt -56.2 -75.27 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.327 -1.102 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 171' ' ' ALA . 1.0 OUTLIER -77.64 -2.55 36.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.982 179.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.421 ' N ' HD23 ' A' ' 170' ' ' LEU . . . -124.26 28.75 6.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -0.946 . . . . 0.0 110.082 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 163.98 27.22 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.517 -0.739 . . . . 0.0 109.985 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.18 -167.78 14.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.1 p -107.23 130.46 54.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.663 -0.904 . . . . 0.0 110.661 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -103.61 129.72 50.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.671 -0.643 . . . . 0.0 109.954 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.8 OUTLIER -73.27 143.04 47.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.745 . . . . 0.0 109.851 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.831 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -121.43 130.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.51 -0.744 . . . . 0.0 110.199 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -110.92 98.89 7.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.534 -0.729 . . . . 0.0 109.307 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.451 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 10.0 m -100.82 133.66 44.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.648 -0.658 . . . . 0.0 110.422 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -139.54 90.51 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.706 -0.621 . . . . 0.0 109.39 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -75.77 116.47 16.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.837 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 t -129.1 -175.38 3.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.755 -0.59 . . . . 0.0 109.803 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 4.4 p30 -100.82 -152.52 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.01 -58.69 6.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.264 -0.898 . . . . 0.0 109.671 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.5 22.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.015 -0.428 . . . . 0.0 111.094 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' O ' ' HB ' ' A' ' 187' ' ' THR . 2.6 mtt180 -82.26 -43.59 17.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.861 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 186' ' ' ARG . 5.2 t 176.97 173.49 0.44 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.201 0.524 . . . . 0.0 110.197 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.59 115.75 30.12 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 181' ' ' PHE . 31.8 p80 -74.36 -15.21 60.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 0.0 111.31 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.1 tp -168.83 156.22 7.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.124 -0.985 . . . . 0.0 110.853 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.0 p -168.38 143.79 3.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.739 -0.6 . . . . 0.0 109.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.529 ' CE2' HD21 ' A' ' 90' ' ' LEU . 40.4 p90 -151.19 -156.15 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 110.095 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.6 132.88 3.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 111.085 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -139.33 165.44 27.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.79 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -102.19 159.68 15.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 111.291 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 104' ' ' LEU . 17.6 tp -129.48 109.75 11.31 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.1 m -85.28 130.11 34.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.696 . . . . 0.0 110.85 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.98 152.14 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.63 -0.669 . . . . 0.0 109.402 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -145.13 -151.83 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.0 110.605 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -107.43 -39.49 5.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 111.302 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -144.6 98.08 3.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.21 -0.931 . . . . 0.0 111.207 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.804 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -89.09 35.1 0.79 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.191 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -169.71 34.13 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.27 -0.894 . . . . 0.0 110.136 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.904 -1.045 . . . . 0.0 110.173 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.017 0.437 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.98 -50.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.607 -0.683 . . . . 0.0 109.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 18.8 p 48.9 58.14 5.65 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.644 -0.66 . . . . 0.0 111.337 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 62' ' ' SER . . . 60.55 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 55.38 76.9 0.46 Allowed Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.094 -1.003 . . . . 0.0 110.412 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.48 162.99 39.88 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.411 1.216 . . . . 0.0 110.536 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -167.69 38.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 109.973 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 67' ' ' VAL . 34.7 m -61.18 116.5 19.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.388 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.577 ' CG ' HG21 ' A' ' 71' ' ' VAL . 46.1 Cg_endo -71.39 -165.05 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.103 1.054 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.408 ' OD1' HG23 ' A' ' 70' ' ' VAL . 42.2 t-20 -82.17 -70.66 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 123' ' ' VAL . 94.3 t -130.06 112.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.623 . . . . 0.0 110.461 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG21 ' CG ' ' A' ' 68' ' ' PRO . 87.5 t -138.64 149.5 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.926 -0.484 . . . . 0.0 109.885 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.678 HG22 ' CD2' ' A' ' 181' ' ' PHE . 59.7 t -65.68 103.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.864 HG23 ' HA ' ' A' ' 116' ' ' PHE . 71.0 p -72.02 -35.94 69.55 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.146 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -167.31 173.09 9.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 110.4 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.5 tt -142.68 124.59 15.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.577 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 77' ' ' LEU . 24.5 m -109.7 167.19 10.33 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.56 -0.713 . . . . 0.0 110.843 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -147.03 80.98 1.54 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.62 -0.675 . . . . 0.0 109.39 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 85' ' ' PRO . 67.0 t -77.49 166.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 110.157 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.469 ' N ' HG12 ' A' ' 78' ' ' VAL . 1.2 m -161.17 -166.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.691 -0.63 . . . . 0.0 110.192 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.8 p -116.55 -33.13 4.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -124.17 20.21 9.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.708 . . . . 0.0 110.856 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.62 -174.83 0.47 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 110.131 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.5 Cg_endo -81.02 -30.87 1.51 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.27 1.142 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.19 173.17 34.36 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.89 -1.147 . . . . 0.0 110.55 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.715 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.3 Cg_endo -71.56 96.32 0.74 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.665 1.35 . . . . 0.0 110.372 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 3.6 mt -64.81 123.87 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.652 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 53.1 mt-10 -103.52 122.76 45.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.501 -0.749 . . . . 0.0 110.802 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -102.6 119.17 38.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.586 -0.696 . . . . 0.0 109.722 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -67.58 141.0 56.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.587 -0.695 . . . . 0.0 110.688 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -140.35 56.83 1.6 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.471 -0.768 . . . . 0.0 110.073 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.8 p -128.53 -56.22 1.23 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.684 -0.635 . . . . 0.0 110.3 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.89 -51.9 0.04 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.39 69.94 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.597 -0.943 . . . . 0.0 110.147 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 94' ' ' LEU . 10.9 mt -94.23 -22.69 18.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.51 -0.744 . . . . 0.0 110.579 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -22.17 12.88 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.373 -0.83 . . . . 0.0 111.08 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.26 63.38 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 0.0 110.548 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 5.5 m-85 -58.97 -60.34 4.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.362 -0.836 . . . . 0.0 110.667 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -13.45 47.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.482 -0.761 . . . . 0.0 111.231 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -86.36 -15.99 38.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.16 -0.962 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.68 162.23 34.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -132.4 167.74 19.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.444 ' CE2' HD13 ' A' ' 77' ' ' LEU . 3.9 m-85 -103.18 113.13 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.636 -0.665 . . . . 0.0 109.874 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 104' ' ' LEU . 60.4 t -88.89 117.27 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 110.787 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.673 ' HB3' HG21 ' A' ' 108' ' ' VAL . 37.0 mt -127.6 145.02 51.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.794 ' O ' HG13 ' A' ' 108' ' ' VAL . 26.9 tttm -65.21 142.08 58.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.213 -0.93 . . . . 0.0 108.848 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.0 pt-20 -57.13 110.64 0.87 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.404 -0.81 . . . . 0.0 111.523 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.2 39.73 3.68 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.762 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 105' ' ' LYS . 27.6 m -99.12 133.08 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.128 -1.219 . . . . 0.0 110.653 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -87.27 98.11 11.15 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' HD2' HG23 ' A' ' 108' ' ' VAL . 38.0 p90 -112.05 144.74 40.91 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.616 0.722 . . . . 0.0 111.611 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -106.55 150.87 25.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 76.8 mt -119.86 148.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.038 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 159' ' ' LEU . 25.3 ttpp -130.08 93.2 3.44 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 181' ' ' PHE . 44.4 mm -72.88 150.37 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.567 0.699 . . . . 0.0 110.652 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -124.82 145.22 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.864 ' HA ' HG23 ' A' ' 73' ' ' THR . 31.2 p90 -166.28 136.68 3.39 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.523 -0.735 . . . . 0.0 110.501 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -87.26 144.16 26.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.776 -0.578 . . . . 0.0 111.158 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 70' ' ' VAL . 61.5 t -131.03 83.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.577 -0.702 . . . . 0.0 109.415 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.34 48.7 2.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.515 -0.741 . . . . 0.0 111.738 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -147.79 -66.39 0.25 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.287 -0.883 . . . . 0.0 111.126 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.08 169.9 16.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.393 -0.817 . . . . 0.0 110.935 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 91.5 mt -78.4 124.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.63 . . . . 0.0 110.115 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.892 HG21 HG21 ' A' ' 70' ' ' VAL . 67.9 t -114.11 80.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.2 p -79.77 112.11 16.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.749 -0.595 . . . . 0.0 110.705 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.75 45.35 0.51 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.555 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 1.8 mmt -61.98 132.56 53.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -1.097 . . . . 0.0 109.098 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.16 148.76 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.923 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -133.96 87.4 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 109.533 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 130' ' ' GLN . 85.5 mt -81.46 169.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.648 . . . . 0.0 110.072 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.49 ' N ' HG22 ' A' ' 129' ' ' ILE . 33.1 tt0 -166.18 120.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.445 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.2 m-70 -103.4 124.88 49.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.0 110.083 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.452 ' CG2' HD11 ' A' ' 139' ' ' ILE . 41.7 m -85.25 68.32 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.373 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -65.96 154.31 39.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.425 -0.797 . . . . 0.0 110.201 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -130.72 86.29 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.598 -0.689 . . . . 0.0 110.602 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 53.63 61.96 2.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.381 -0.825 . . . . 0.0 110.857 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.76 36.58 57.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.01 146.95 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.991 . . . . 0.0 109.793 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.11 121.0 43.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pp -123.44 -26.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.759 . . . . 0.0 111.145 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -161.82 153.08 18.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.888 -1.133 . . . . 0.0 111.201 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HE3' ' CE1' ' A' ' 131' ' ' HIS . 5.9 ptmt -175.79 135.91 0.31 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.708 . . . . 0.0 109.229 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 143' ' ' ASP . 17.8 m -146.23 168.82 20.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 111.231 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 142' ' ' THR . 1.9 m-20 -108.39 151.0 26.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.723 -0.611 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -119.86 128.42 53.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.509 -0.744 . . . . 0.0 110.676 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 ttp -87.77 109.0 19.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.451 -0.781 . . . . 0.0 109.382 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.793 HG13 ' CD1' ' A' ' 158' ' ' PHE . 80.2 t -86.43 -71.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 110.709 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.59 -165.57 38.0 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.7 p -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.676 -0.896 . . . . 0.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.585 ' OH ' HG12 ' A' ' 146' ' ' VAL . 11.8 m-85 -126.22 -173.95 2.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.837 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.69 162.94 26.23 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.83 66.25 2.41 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.314 1.165 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 153' ' ' ALA . 0.7 OUTLIER -68.13 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.555 -0.716 . . . . 0.0 109.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 152' ' ' ARG . . . -178.35 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.005 -1.06 . . . . 0.0 110.709 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -94.02 -171.09 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.444 -0.785 . . . . 0.0 111.563 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.4 144.31 30.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.367 0.604 . . . . 0.0 110.601 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.489 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 60.4 m-85 -107.96 154.64 21.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -128.84 135.28 48.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.331 -0.856 . . . . 0.0 111.371 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.793 ' CD1' HG13 ' A' ' 146' ' ' VAL . 28.0 t80 -103.44 136.18 43.67 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -120.77 116.45 25.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 110.778 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.436 HG22 ' CE2' ' A' ' 158' ' ' PHE . 43.1 p -86.54 153.05 55.55 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 162.56 37.54 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.628 1.331 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.41 123.36 15.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.567 -0.708 . . . . 0.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.45 114.15 27.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.687 -0.633 . . . . 0.0 109.999 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -69.85 127.08 31.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.646 -0.658 . . . . 0.0 110.288 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -69.71 172.75 4.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.8 -0.562 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 44.2 Cg_endo -70.82 147.54 56.28 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 O-C-N 123.427 1.225 . . . . 0.0 110.131 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 35.7 mtmt -115.92 175.57 5.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.514 -0.741 . . . . 0.0 110.461 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 171' ' ' ALA . . . 103.57 147.17 17.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -52.74 43.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.541 -0.976 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 170' ' ' LEU . 9.2 tt -57.48 -27.93 62.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.463 -0.773 . . . . 0.0 110.34 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . -56.48 -23.29 38.25 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.465 -0.772 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 mtp-105 -67.71 126.98 31.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.511 -0.743 . . . . 0.0 109.9 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.32 177.88 28.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.9 p -91.8 135.81 33.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.918 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -128.56 114.68 17.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 110.054 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.98 148.4 47.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.768 . . . . 0.0 110.132 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.803 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.2 mm -124.09 101.67 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 0.0 110.172 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -91.67 104.0 16.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 14.9 m -113.88 142.94 45.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.516 -0.74 . . . . 0.0 110.939 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -123.49 95.28 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.777 -0.577 . . . . 0.0 109.455 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.678 ' CD2' HG22 ' A' ' 72' ' ' VAL . 6.6 t80 -80.61 73.56 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.711 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.1 t -116.56 -168.84 1.52 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.665 . . . . 0.0 109.319 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.16 -158.08 0.62 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.541 -0.725 . . . . 0.0 109.814 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.16 -60.15 3.79 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.38 -0.825 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -172.02 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.822 -0.549 . . . . 0.0 110.593 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -78.0 -35.29 50.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.297 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.6 t -176.35 -161.24 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.581 -0.7 . . . . 0.0 110.168 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -115.18 109.61 18.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.63 -0.669 . . . . 0.0 109.807 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -77.9 -67.76 0.7 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.451 -0.781 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.885 HD13 ' N ' ' A' ' 191' ' ' SER . 2.0 tm? -143.9 164.61 30.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 110.123 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.885 ' N ' HD13 ' A' ' 190' ' ' LEU . 7.4 t -168.82 135.38 1.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.448 ' CD2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -145.23 -172.83 3.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.65 125.88 7.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.523 -0.736 . . . . 0.0 110.513 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 10.0 p-90 -134.48 145.25 48.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.688 -0.633 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.62 146.79 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 104' ' ' LEU . 35.2 tp -120.28 94.37 4.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.731 -0.606 . . . . 0.0 109.793 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 103' ' ' VAL . 91.6 m -73.23 148.58 43.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.56 -0.712 . . . . 0.0 110.017 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 47.9 mm -124.27 135.95 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -128.76 -156.09 0.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.569 -0.707 . . . . 0.0 110.491 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -30.45 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 111.103 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -138.22 56.7 1.72 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.368 -0.832 . . . . 0.0 111.122 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.732 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -60.87 -16.04 37.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.0 111.327 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 35.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 110.455 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.186 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 61' ' ' VAL . 34.5 m -62.28 126.57 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.542 -0.724 . . . . 0.0 110.181 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.1 p -149.22 30.04 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.644 -0.66 . . . . 0.0 110.276 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 56.36 -86.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.705 -0.622 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.95 96.25 3.79 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 110.259 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.5 102.97 1.46 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.478 1.252 . . . . 0.0 110.375 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' C ' HG23 ' A' ' 67' ' ' VAL . 2.9 m120 52.86 -167.33 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.445 -0.784 . . . . 0.0 110.833 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 67' ' ' VAL . 63.3 t -146.95 59.9 5.37 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 110.052 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.96 171.21 17.97 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.314 1.165 . . . . 0.0 110.422 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -166.94 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.787 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 123' ' ' VAL . 93.1 t -125.04 111.45 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.628 . . . . 0.0 109.77 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.5 t -142.03 152.78 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.2 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 HD22 ' A' ' 90' ' ' LEU . 58.0 t -68.81 102.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.3 p -72.75 -53.57 11.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.597 -0.69 . . . . 0.0 110.065 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -150.02 165.68 31.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.74 -0.6 . . . . 0.0 110.001 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.689 ' HG ' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -127.06 165.21 19.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.728 -0.608 . . . . 0.0 109.685 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.573 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.4 m -155.04 156.13 35.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.59 -0.694 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -136.17 96.91 3.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.0 109.737 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 79' ' ' CYS . 57.5 t -74.26 167.88 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.852 -0.53 . . . . 0.0 110.188 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -171.7 -28.03 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.483 -0.761 . . . . 0.0 111.672 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 p 62.58 17.43 9.64 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -140.63 -46.55 0.41 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.507 -0.746 . . . . 0.0 109.224 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.938 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -59.34 -174.84 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.765 -0.584 . . . . 0.0 110.025 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.912 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 43.8 Cg_endo -73.11 -23.59 18.0 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.167 1.088 . . . . 0.0 110.345 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.66 176.73 40.21 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.83 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HB2' HG23 ' A' ' 76' ' ' THR . 43.9 Cg_endo -70.15 102.87 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.639 1.336 . . . . 0.0 110.452 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 30.5 mt -65.38 102.76 0.72 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -98.29 161.44 13.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.639 -0.663 . . . . 0.0 111.234 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.955 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 4.3 mt -130.94 167.53 18.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.822 -0.548 . . . . 0.0 109.959 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.419 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 11.0 t70 -111.05 131.22 55.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.578 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD22 HG11 ' A' ' 72' ' ' VAL . 1.5 mp -136.95 55.39 1.83 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 109.899 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -135.94 36.0 2.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.609 -0.682 . . . . 0.0 110.66 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.11 -86.65 0.22 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.97 81.18 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.694 -0.886 . . . . 0.0 110.197 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -95.12 -26.36 16.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.63 -0.669 . . . . 0.0 110.379 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -57.86 -26.64 62.34 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.443 -0.786 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -22.44 30.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.423 -0.798 . . . . 0.0 110.389 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.955 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 3.2 m-85 -56.47 -22.06 29.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.434 -0.791 . . . . 0.0 110.526 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -81.86 -20.18 39.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -0.783 . . . . 0.0 110.523 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -86.55 -22.15 26.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.935 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -132.4 134.81 45.59 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 110.689 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.3 p -105.83 -168.53 1.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.655 -0.653 . . . . 0.0 109.921 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.528 ' HB3' HD12 ' A' ' 196' ' ' LEU . 1.6 m-85 -116.98 96.62 5.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.42 108.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.715 -0.616 . . . . 0.0 109.854 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 196' ' ' LEU . 5.1 mt -113.87 -170.85 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.6 -0.687 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 31.1 tttm -134.64 157.23 47.15 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.994 0.902 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -47.54 124.46 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 45.51 60.18 4.35 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.905 -0.497 . . . . 0.0 113.097 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 104' ' ' LEU . 34.7 m -96.15 119.83 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.239 -1.153 . . . . 0.0 110.596 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.43 96.0 2.81 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.629 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.3 p90 -115.44 148.79 38.98 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.573 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -102.0 138.14 39.36 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HE1' ' A' ' 110' ' ' TYR . 42.2 mm -85.73 161.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.247 -0.908 . . . . 0.0 110.521 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -148.59 82.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.689 HD13 ' HG ' ' A' ' 75' ' ' LEU . 47.9 mm -75.15 143.78 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.708 -0.62 . . . . 0.0 110.49 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.07 132.21 54.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.722 ' HA ' HG23 ' A' ' 73' ' ' THR . 48.6 p90 -154.2 144.71 22.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.779 . . . . 0.0 111.082 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG3' HG21 ' A' ' 73' ' ' THR . 5.4 mtt180 -97.17 138.27 34.92 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.261 0.553 . . . . 0.0 110.858 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 70' ' ' VAL . 59.5 t -130.89 87.7 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.633 -0.667 . . . . 0.0 109.324 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.25 47.17 2.52 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.426 -0.796 . . . . 0.0 112.164 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HB3' ' A' ' 151' ' ' PRO . 2.8 ttt-85 -139.08 -64.09 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.34 160.95 37.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.479 -0.763 . . . . 0.0 110.277 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.79 112.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.839 HG21 HG21 ' A' ' 70' ' ' VAL . 58.0 t -101.58 120.74 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.583 -0.698 . . . . 0.0 109.599 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.6 p -116.84 114.87 24.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.455 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.99 30.77 2.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.611 ' SD ' HG11 ' A' ' 146' ' ' VAL . 3.2 ttt -63.45 120.06 10.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.402 -1.057 . . . . 0.0 109.625 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.22 156.22 25.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.409 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 35.0 t80 -132.16 101.06 5.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 130' ' ' GLN . 81.8 mt -94.27 165.67 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 110.295 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 129' ' ' ILE . 24.2 tt0 -158.84 134.66 8.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 0.0 110.023 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -113.96 118.23 33.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.681 -0.637 . . . . 0.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 m -75.42 74.59 2.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.533 -0.73 . . . . 0.0 109.781 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -62.27 154.64 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.518 -0.739 . . . . 0.0 110.515 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.486 ' CG ' HD11 ' A' ' 139' ' ' ILE . 11.9 ttp85 -120.22 39.26 3.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.703 -0.623 . . . . 0.0 110.27 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.46 61.34 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.253 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 149.45 -37.06 0.99 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 137' ' ' VAL . 9.1 p -157.88 127.18 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.968 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.38 131.34 50.68 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 134' ' ' ARG . 20.2 mt -89.79 -52.73 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.679 -0.638 . . . . 0.0 109.312 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -169.17 165.09 11.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 110.473 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.93 174.68 10.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.618 -0.676 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 m -154.65 146.25 23.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -102.38 137.46 40.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.578 -0.701 . . . . 0.0 110.109 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -120.97 129.94 53.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.431 -0.793 . . . . 0.0 110.537 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -80.44 112.5 17.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 109.389 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.611 HG11 ' SD ' ' A' ' 126' ' ' MET . 49.4 t -79.72 -67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.55 171.64 19.64 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.7 p -95.4 154.93 16.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.972 . . . . 0.0 110.02 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -147.92 128.04 13.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.366 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.55 153.21 28.49 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' A' ' 120' ' ' ARG . 49.9 Cg_endo -74.24 76.84 2.97 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.454 1.239 . . . . 0.0 110.435 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -169.0 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 110.34 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -142.44 -111.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 110.162 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -171.95 -148.65 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.593 -1.317 . . . . 0.0 109.739 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 91.13 1.03 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.461 -0.774 . . . . 0.0 110.114 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 22.7 m-85 -59.87 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.415 -0.803 . . . . 0.0 110.008 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.705 ' OE1' HD12 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -156.09 114.77 3.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.466 -0.771 . . . . 0.0 110.987 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.526 ' CG ' HG13 ' A' ' 146' ' ' VAL . 39.0 t80 -95.34 169.46 10.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.705 HD12 ' OE1' ' A' ' 157' ' ' GLU . 0.2 OUTLIER -154.1 124.9 7.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.858 . . . . 0.0 111.145 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.0 p -93.75 159.92 33.72 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.31 152.77 80.04 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.63 1.332 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -57.28 116.33 3.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.746 -0.596 . . . . 0.0 111.121 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -113.11 149.35 33.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.71 -0.619 . . . . 0.0 109.617 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.44 127.35 44.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.539 -0.726 . . . . 0.0 110.934 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -62.72 -176.06 0.14 Allowed Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.919 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 44.8 Cg_endo -73.6 127.7 11.95 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 O-C-N 123.066 1.035 . . . . 0.0 110.204 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -116.17 159.02 22.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 110.868 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.65 162.18 30.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -60.06 173.07 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -1.044 . . . . 0.0 109.556 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 tt 67.9 -60.65 0.4 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.372 -0.83 . . . . 0.0 110.625 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.919 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -52.08 -23.25 5.03 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.427 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 11.4 mtp180 -67.15 155.57 38.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.344 -0.847 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 132.23 -175.3 19.92 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -91.89 118.17 30.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.94 . . . . 0.0 110.363 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' A' ' 171' ' ' ALA . 55.3 m-85 -112.48 124.39 52.4 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.275 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 140.06 47.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.646 -0.659 . . . . 0.0 110.637 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.815 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 46.9 mm -113.53 94.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.647 -0.658 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 109.22 18.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.23 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.409 ' OG ' ' CE1' ' A' ' 128' ' ' TYR . 28.6 t -113.64 144.38 43.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.393 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.02 105.97 10.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.682 -0.637 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.455 ' CD2' HG23 ' A' ' 72' ' ' VAL . 1.7 t80 -81.62 132.63 35.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.72 -0.613 . . . . 0.0 109.852 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -171.03 -172.7 1.17 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.649 -0.657 . . . . 0.0 110.222 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -112.12 -154.37 0.54 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.738 -0.601 . . . . 0.0 109.524 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -59.32 5.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.92 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.753 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -81.64 -34.93 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.21 -166.91 0.15 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.686 -0.634 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.23 117.1 29.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.648 -0.658 . . . . 0.0 109.666 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.458 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 6.1 m-70 -68.9 -62.5 1.35 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.508 -0.745 . . . . 0.0 110.68 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.7 tp -168.43 159.53 10.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.382 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.2 t -153.71 138.53 17.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.53 -0.732 . . . . 0.0 110.196 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.41 ' CE2' HD21 ' A' ' 90' ' ' LEU . 19.0 p90 -142.02 -155.43 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 110.083 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -169.01 128.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.377 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.815 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 8.9 p-90 -130.45 145.0 51.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.613 -0.68 . . . . 0.0 109.982 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.44 158.83 28.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.474 0.654 . . . . 0.0 110.941 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 104' ' ' LEU . 21.9 tp -133.38 95.41 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 89.1 m -80.63 104.34 11.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.626 -0.672 . . . . 0.0 110.78 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 172' ' ' ARG . 47.3 mm -80.76 147.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -138.29 -158.83 0.89 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.424 -0.797 . . . . 0.0 110.809 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -53.13 4.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.691 -0.631 . . . . 0.0 110.928 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -147.1 94.06 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.0 110.818 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.938 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -74.97 -0.78 19.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.644 -0.66 . . . . 0.0 111.336 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.69 34.92 2.79 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 110.249 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.189 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.067 0.46 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.96 171.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.571 -0.706 . . . . 0.0 110.209 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.19 70.25 10.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.39 31.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.519 -0.738 . . . . 0.0 110.195 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.61 149.71 90.89 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.541 -0.725 . . . . 0.0 110.252 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.34 -175.54 1.82 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.353 1.186 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.99 126.45 34.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.584 -0.697 . . . . 0.0 110.151 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' HD2' ' A' ' 68' ' ' PRO . 8.6 p -113.32 143.63 29.68 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 67' ' ' VAL . 48.1 Cg_endo -73.91 177.39 8.2 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.298 1.157 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -104.82 -56.85 2.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.698 -0.626 . . . . 0.0 109.862 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.616 ' CG2' HG21 ' A' ' 123' ' ' VAL . 86.9 t -114.05 130.76 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.796 -0.565 . . . . 0.0 110.078 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.759 HG13 HD13 ' A' ' 190' ' ' LEU . 62.2 t -148.1 137.75 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.786 -0.572 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' CG1' HD13 ' A' ' 90' ' ' LEU . 57.5 t -69.44 106.74 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 116' ' ' PHE . 72.7 p -73.35 -58.37 3.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.728 -0.608 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.23 164.28 30.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.49 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -132.13 124.19 28.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.673 -0.642 . . . . 0.0 109.695 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 75' ' ' LEU . 23.3 m -109.87 152.04 26.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.754 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.61 114.19 9.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.612 -0.68 . . . . 0.0 110.149 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.2 t -113.44 165.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.712 . . . . 0.0 110.26 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.453 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -156.97 -156.64 0.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 109.956 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.1 p -97.38 -35.88 10.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 p -138.79 47.53 1.94 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.617 -0.677 . . . . 0.0 110.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -90.23 172.01 7.66 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.664 -0.647 . . . . 0.0 110.63 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.4 Cg_endo -72.4 -29.12 14.11 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.442 1.233 . . . . 0.0 109.855 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.38 175.12 33.07 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 76' ' ' THR . 44.9 Cg_endo -70.9 100.63 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.393 1.207 . . . . 0.0 110.204 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD13 ' CG ' ' A' ' 102' ' ' PHE . 53.1 mt -65.03 113.31 3.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.631 -0.668 . . . . 0.0 109.932 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.11 116.2 29.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.758 -0.589 . . . . 0.0 110.2 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -101.87 128.03 48.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.587 -0.696 . . . . 0.0 109.983 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.05 126.85 31.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.546 -0.721 . . . . 0.0 110.007 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.473 HD13 ' CG1' ' A' ' 72' ' ' VAL . 1.6 mt -129.76 52.21 2.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.624 -0.672 . . . . 0.0 110.062 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -101.37 -73.75 0.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.4 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.09 -42.66 0.32 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.33 77.66 8.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.689 -0.889 . . . . 0.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 86.9 mt -87.33 -20.87 26.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -13.71 36.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.236 -0.915 . . . . 0.0 111.477 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -6.2 39.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.06 -1.025 . . . . 0.0 111.567 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 88' ' ' LEU . 12.4 m-30 -75.27 -55.53 5.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -58.21 -17.55 19.79 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.489 -0.757 . . . . 0.0 111.407 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -86.0 -19.85 29.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.265 -0.897 . . . . 0.0 110.89 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.62 147.08 37.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.216 -0.928 . . . . 0.0 110.582 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 195' ' ' ASN . 0.7 OUTLIER -136.28 160.9 37.3 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.449 -0.782 . . . . 0.0 109.931 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.623 ' CG ' HD13 ' A' ' 86' ' ' LEU . 29.3 m-85 -90.98 166.08 13.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.99 128.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.621 -0.674 . . . . 0.0 110.426 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 196' ' ' LEU . 88.2 mt -129.5 164.62 23.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.63 -0.669 . . . . 0.0 109.686 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . 2.5 ttpt -77.2 166.54 23.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -29.24 -66.77 0.08 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.82 72.98 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 104' ' ' LEU . 32.7 m -88.0 139.12 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.412 -1.052 . . . . 0.0 110.661 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -85.32 95.98 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 48.5 p90 -109.68 135.93 49.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.533 -0.729 . . . . 0.0 111.745 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -89.2 157.39 18.28 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.89 132.56 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.422 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -115.36 121.48 42.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.88 146.82 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.506 0.669 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -129.37 133.29 47.32 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' THR . 33.4 p90 -154.73 157.98 38.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.383 -0.823 . . . . 0.0 110.847 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.76 129.46 56.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.51 110.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 109.351 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -128.53 48.23 2.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 111.382 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 -67.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.295 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.66 165.67 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.509 -0.745 . . . . 0.0 110.474 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.8 mt -69.12 106.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.691 -0.63 . . . . 0.0 109.974 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.616 HG21 ' CG2' ' A' ' 70' ' ' VAL . 59.9 t -84.83 95.02 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.653 -0.655 . . . . 0.0 109.966 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 94.1 p -88.87 74.97 8.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.322 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 153.63 53.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -82.69 151.38 26.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.988 . . . . 0.0 109.605 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -146.69 151.63 37.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.873 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -128.15 97.49 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.758 -0.588 . . . . 0.0 109.499 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.585 HG23 ' OD1' ' A' ' 143' ' ' ASP . 78.4 mt -96.23 134.6 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 110.055 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.405 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 18.5 tt0 -129.06 138.07 51.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.6 m-70 -113.6 138.39 50.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.444 -0.785 . . . . 0.0 110.089 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.7 m -96.6 85.92 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.707 -0.621 . . . . 0.0 109.824 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 138' ' ' LYS . 5.4 m-85 -89.84 129.26 36.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 110.398 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 137' ' ' VAL . 3.5 tmm_? -145.52 151.43 38.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 51.49 31.23 7.2 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.452 -0.78 . . . . 0.0 111.166 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.41 60.33 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.314 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.7 m -120.36 149.67 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.322 . . . . 0.0 110.398 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 16.7 tttp -85.66 119.76 26.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.62 HD11 ' HB3' ' A' ' 134' ' ' ARG . 95.9 mt -89.8 -67.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.56 -0.713 . . . . 0.0 109.914 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.73 157.45 6.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.506 -0.746 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 165.72 19.0 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.605 -0.684 . . . . 0.0 110.317 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.4 m -128.74 137.31 51.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.562 -0.711 . . . . 0.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 129' ' ' ILE . 72.4 m-20 -101.7 105.24 16.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.712 . . . . 0.0 110.077 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -96.2 148.07 23.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.75 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.05 117.2 33.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.718 HG13 ' CG ' ' A' ' 158' ' ' PHE . 48.1 t -80.86 -55.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.48 -0.762 . . . . 0.0 110.196 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.75 -179.69 17.68 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 22.3 m -89.65 151.29 21.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.66 -0.906 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.52 ' CE2' HG12 ' A' ' 146' ' ' VAL . 82.8 m-85 -148.3 129.55 14.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 0.0 110.369 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -82.03 152.08 30.95 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.71 90.24 0.95 Allowed 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.425 1.224 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 26.42 7.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.584 -0.698 . . . . 0.0 110.226 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 53.42 22.81 3.02 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.376 -0.827 . . . . 0.0 111.268 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -133.04 178.22 7.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.17 157.93 16.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.571 -0.705 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.1 m-85 -114.16 177.56 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.539 -0.726 . . . . 0.0 110.089 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -148.81 91.67 1.9 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.718 ' CG ' HG13 ' A' ' 146' ' ' VAL . 40.1 t80 -79.56 163.94 24.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.566 -0.709 . . . . 0.0 110.002 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -139.72 119.28 13.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.565 -0.709 . . . . 0.0 110.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.496 HG22 ' HE2' ' A' ' 158' ' ' PHE . 66.8 p -102.26 157.09 34.37 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.522 -0.736 . . . . 0.0 109.714 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.68 159.83 46.41 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.707 1.372 . . . . 0.0 110.997 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.38 149.87 27.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.408 0.623 . . . . 0.0 110.872 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.409 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 16.6 tt0 -129.24 106.44 8.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.712 -0.617 . . . . 0.0 109.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.09 126.0 26.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -74.31 173.09 7.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.793 -0.567 . . . . 0.0 110.003 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 48.5 Cg_endo -72.96 123.92 9.25 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.338 1.178 . . . . 0.0 110.362 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -118.12 -160.93 0.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 110.572 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.71 47.9 13.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 54.79 175.65 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.567 -0.961 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -61.38 0.32 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.285 -0.885 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -49.43 -24.66 2.09 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.382 -0.824 . . . . 0.0 111.407 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -58.74 128.35 36.78 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.18 -178.84 25.5 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.8 p -86.79 142.75 27.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.517 -0.99 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 38.1 m-85 -131.11 105.0 7.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.671 -0.643 . . . . 0.0 110.356 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -70.35 120.14 15.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.612 -0.68 . . . . 0.0 109.349 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 131' ' ' HIS . 44.8 mt -109.72 148.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.982 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -114.84 118.88 34.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.748 -0.595 . . . . 0.0 109.79 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 2.8 m -110.53 122.48 47.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.585 -0.697 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -111.01 103.62 12.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t80 -83.26 116.79 22.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.548 -0.72 . . . . 0.0 110.071 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.3 t -131.97 -155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.507 -0.746 . . . . 0.0 110.166 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 26.6 p-10 -161.81 -146.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.055 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.2 27.87 2.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 187' ' ' THR . 1.4 t70 -132.35 54.59 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.489 -0.757 . . . . 0.0 109.518 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 185' ' ' ASP . 0.0 OUTLIER 4.17 65.42 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 185' ' ' ASP . 8.0 t -144.63 -174.82 4.43 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.048 0.451 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.11 88.09 2.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -60.27 -40.62 91.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.522 -0.736 . . . . 0.0 109.973 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.759 HD13 HG13 ' A' ' 71' ' ' VAL . 5.2 tp -170.35 148.21 3.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 110.032 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -159.65 136.96 9.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.654 -0.654 . . . . 0.0 110.025 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.443 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 23.9 p90 -136.48 -157.39 0.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.613 -0.68 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.742 . . . . 0.0 110.55 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.544 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 18.1 p-90 -144.13 153.27 41.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.561 -0.712 . . . . 0.0 109.987 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 101' ' ' SER . 4.3 m-80 -94.34 153.49 17.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.536 -0.727 . . . . 0.0 111.042 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.544 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 23.5 tp -126.78 90.05 3.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.1 m -67.98 145.09 54.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.0 110.94 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.6 156.89 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.707 -0.621 . . . . 0.0 109.392 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -151.91 -153.27 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.493 -0.754 . . . . 0.0 110.068 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -129.88 -0.7 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 111.624 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -160.08 47.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.085 -1.01 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.579 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -57.44 -19.85 26.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.525 -0.734 . . . . 0.0 111.292 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 56.91 1.03 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.165 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.129 0.49 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.7 -26.02 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.75 . . . . 0.0 110.429 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 m 53.21 87.29 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.353 -0.842 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.21 -160.6 0.75 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.683 . . . . 0.0 110.152 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 t0 52.51 75.6 0.62 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.411 -0.806 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.364 1.191 . . . . 0.0 110.372 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.458 ' C ' HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER 55.04 174.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.544 -0.722 . . . . 0.0 110.697 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 66' ' ' ASN . 31.5 m -149.77 152.27 34.3 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 110.189 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.42 168.61 24.32 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.379 1.199 . . . . 0.0 110.271 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.548 ' ND2' HG23 ' A' ' 70' ' ' VAL . 1.9 t-20 -83.96 -77.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.506 -0.746 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 123' ' ' VAL . 96.2 t -134.33 119.2 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.624 -0.673 . . . . 0.0 110.338 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 190' ' ' LEU . 79.2 t -142.52 136.74 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG12 HD13 ' A' ' 90' ' ' LEU . 59.3 t -61.24 103.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.518 -0.739 . . . . 0.0 109.115 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.67 HG23 ' HA ' ' A' ' 116' ' ' PHE . 39.0 p -73.45 -56.37 5.14 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.889 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -141.99 168.35 19.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.812 . . . . 0.0 110.724 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.66 124.57 31.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.65 -0.657 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 85' ' ' PRO . 4.1 m -110.4 156.22 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.621 -0.674 . . . . 0.0 110.277 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.528 HD23 HG12 ' A' ' 112' ' ' ILE . 5.4 mt -139.55 82.2 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.577 -0.702 . . . . 0.0 109.879 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.49 143.93 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.725 -0.609 . . . . 0.0 110.088 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 72.2 m -140.82 -163.54 1.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.041 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 p -115.87 -72.42 0.69 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.4 p -95.87 24.9 5.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 110.615 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.93 ' HB2' ' CZ2' ' A' ' 202' ' ' TRP . . . -90.5 -177.38 0.77 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.509 -0.744 . . . . 0.0 110.29 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.2 Cg_endo -73.99 -23.59 15.97 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.359 1.189 . . . . 0.0 110.131 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.68 -175.46 29.67 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HB2' ' CG2' ' A' ' 76' ' ' THR . 45.0 Cg_endo -71.07 104.8 1.58 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.503 1.264 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.89 114.45 4.53 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.722 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -90.19 146.61 24.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.809 HD21 ' CE1' ' A' ' 97' ' ' PHE . 3.7 tt -128.08 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.575 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -94.52 127.35 40.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.517 -0.739 . . . . 0.0 110.161 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.673 HD13 HG12 ' A' ' 72' ' ' VAL . 2.9 mt -135.26 55.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.654 -0.654 . . . . 0.0 109.878 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -104.81 -73.63 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.728 -0.607 . . . . 0.0 110.474 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.22 -74.77 0.49 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.41 94.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.683 -0.893 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 61.0 mt -92.78 -33.41 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.492 -0.755 . . . . 0.0 110.149 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -57.57 -19.31 24.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.502 -0.749 . . . . 0.0 111.065 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.56 -24.5 5.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.16 -0.963 . . . . 0.0 111.263 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.809 ' CE1' HD21 ' A' ' 88' ' ' LEU . 8.1 m-85 -62.0 -19.24 62.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.507 -0.745 . . . . 0.0 110.309 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.9 -25.98 61.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -86.94 -25.24 24.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.494 -0.754 . . . . 0.0 110.855 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.35 151.47 51.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.392 -0.818 . . . . 0.0 110.619 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -123.81 -170.27 2.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.543 -0.723 . . . . 0.0 109.999 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.765 ' CZ ' HD12 ' A' ' 88' ' ' LEU . 6.5 m-85 -115.37 102.08 9.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.641 -0.662 . . . . 0.0 110.052 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.39 147.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.65 -0.656 . . . . 0.0 110.203 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.107 HD21 HG22 ' A' ' 108' ' ' VAL . 3.8 tt -159.34 148.17 18.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.664 -0.647 . . . . 0.0 109.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.651 ' HB3' HG11 ' A' ' 108' ' ' VAL . 63.7 tttt -83.54 158.29 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -39.96 107.5 0.07 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 32.24 68.64 0.14 Allowed Glycine 0 N--CA 1.506 3.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.736 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.107 HG22 HD21 ' A' ' 104' ' ' LEU . 21.5 m -88.78 167.55 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -1.141 . . . . 0.0 109.647 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.38 97.94 11.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.202 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.648 ' HE1' ' HB2' ' A' ' 165' ' ' ALA . 32.4 p90 -128.42 134.28 48.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.0 111.581 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -89.46 167.53 12.92 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.528 HG12 HD23 ' A' ' 77' ' ' LEU . 71.0 mt -125.35 137.94 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 0.0 110.358 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -115.68 109.34 17.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.645 -0.66 . . . . 0.0 109.541 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.801 HG21 ' CE2' ' A' ' 181' ' ' PHE . 49.0 mm -93.38 126.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.583 -0.698 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.9 p -108.59 148.55 30.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.67 ' HA ' HG23 ' A' ' 73' ' ' THR . 2.5 p90 -164.78 146.37 8.02 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.235 -0.916 . . . . 0.0 111.884 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -81.49 125.26 30.26 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.276 0.56 . . . . 0.0 110.748 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 70' ' ' VAL . 72.4 t -126.36 82.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.54 48.73 2.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.442 -0.786 . . . . 0.0 111.93 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -138.34 -65.97 0.5 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.104 -0.997 . . . . 0.0 111.089 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -142.67 175.98 9.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.393 -0.817 . . . . 0.0 110.86 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 82.6 mt -79.58 113.28 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 110.152 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 70' ' ' VAL . 74.3 t -95.76 88.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.664 -0.647 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 148' ' ' SER . 77.6 p -82.97 88.06 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.632 -0.668 . . . . 0.0 110.516 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.0 46.55 0.07 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.453 ' HE3' ' CE1' ' A' ' 116' ' ' PHE . 3.0 ttt -81.22 128.48 33.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.514 -0.992 . . . . 0.0 109.597 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -140.62 167.0 23.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.507 -0.745 . . . . 0.0 110.849 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -135.75 120.12 17.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.7 -0.625 . . . . 0.0 109.733 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 129' ' ' ILE . 5.3 mp -116.57 130.25 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.583 -0.698 . . . . 0.0 110.3 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -128.1 135.61 50.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.611 -0.681 . . . . 0.0 109.862 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.1 m-70 -104.2 114.64 29.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -70.68 77.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.698 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 138' ' ' LYS . 3.4 m-85 -80.79 141.99 34.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.985 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -119.35 -155.4 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.73 -0.606 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -64.66 81.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.58 -0.7 . . . . 0.0 110.608 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 60.9 23.73 61.75 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 136' ' ' GLY . 97.5 t -148.78 89.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -1.079 . . . . 0.0 109.982 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 149.84 49.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.726 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 140' ' ' ASP . 44.2 pt -118.89 -37.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.406 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.431 ' N ' HG13 ' A' ' 139' ' ' ILE . 2.6 t70 -175.86 167.2 3.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.0 -1.063 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.428 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -126.86 -168.3 1.85 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.427 HG22 ' CE2' ' A' ' 144' ' ' TYR . 34.4 m -159.74 126.96 4.61 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.554 ' OD1' HG23 ' A' ' 129' ' ' ILE . 1.5 m-20 -113.47 136.84 52.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CE2' HG22 ' A' ' 142' ' ' THR . 48.5 m-85 -123.17 127.44 48.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.576 -0.703 . . . . 0.0 110.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.7 tpp -81.18 106.01 12.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.598 -0.689 . . . . 0.0 109.34 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.85 HG12 ' CE1' ' A' ' 149' ' ' TYR . 40.8 t -79.96 -36.4 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.547 -0.721 . . . . 0.0 110.279 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.69 -176.87 16.81 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 124' ' ' SER . 3.1 t -82.52 135.73 35.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.599 -0.942 . . . . 0.0 110.03 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.85 ' CE1' HG12 ' A' ' 146' ' ' VAL . 9.3 m-85 -118.35 128.99 55.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.633 . . . . 0.0 110.939 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.79 153.05 16.91 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.79 85.14 1.36 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.369 1.194 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -62.28 1.48 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.67 127.01 0.9 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 111.17 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.03 -156.92 0.16 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.498 -0.751 . . . . 0.0 111.545 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.81 174.79 7.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.554 -0.716 . . . . 0.0 111.26 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.451 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 44.4 m-85 -119.31 -174.63 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.657 -0.652 . . . . 0.0 109.461 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.87 100.41 4.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.642 ' CD1' HG13 ' A' ' 146' ' ' VAL . 54.6 t80 -81.39 170.35 16.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.124 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 159' ' ' LEU . 2.8 tm? -155.68 109.42 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 110.513 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.407 HG22 ' HE2' ' A' ' 158' ' ' PHE . 54.8 p -75.6 146.88 81.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 109.168 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.43 -177.97 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.706 1.371 . . . . 0.0 111.021 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.5 mtm -58.37 145.17 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.482 0.658 . . . . 0.0 110.872 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.47 119.86 3.1 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.82 146.14 37.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.508 -0.745 . . . . 0.0 111.019 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -90.76 -178.09 0.88 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.748 -0.595 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.9 123.61 8.56 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.104 1.055 . . . . 0.0 110.355 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 171.36 7.78 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.459 -0.776 . . . . 0.0 110.539 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.84 161.91 11.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.1 mtt -62.99 -61.0 2.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.574 -0.956 . . . . 0.0 109.291 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -61.63 -29.76 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.725 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.9 -23.98 61.77 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.501 -0.749 . . . . 0.0 110.538 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -64.2 129.08 38.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.788 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.4 -177.94 30.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.6 p -86.72 133.99 33.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.949 . . . . 0.0 110.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -116.81 106.74 13.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.272 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.76 121.12 19.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.599 -0.688 . . . . 0.0 109.547 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 33.3 mt -111.81 124.33 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.451 -0.78 . . . . 0.0 110.89 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.406 ' CB ' ' HB2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -86.76 96.69 10.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.0 109.451 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 p -90.55 134.89 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.632 -0.667 . . . . 0.0 110.802 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -133.41 82.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.66 -0.65 . . . . 0.0 109.618 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 114' ' ' ILE . 4.0 t80 -79.1 111.84 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.617 -0.677 . . . . 0.0 110.06 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -136.19 -166.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.31 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -133.89 163.24 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.789 -0.569 . . . . 0.0 109.992 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.21 48.46 1.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 110.175 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.35 -54.22 0.19 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.602 -0.686 . . . . 0.0 110.722 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -94.72 -83.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.558 -0.714 . . . . 0.0 110.703 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 t -172.76 -165.02 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.211 -0.931 . . . . 0.0 110.386 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.46 108.15 0.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 110.003 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -65.92 -56.2 12.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.543 -0.723 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 71' ' ' VAL . 6.7 tp -168.3 142.85 3.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.584 -0.698 . . . . 0.0 110.356 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 81.0 p -142.63 147.75 36.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.532 -0.73 . . . . 0.0 109.989 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.449 ' CE2' HD21 ' A' ' 90' ' ' LEU . 16.4 p90 -144.68 -155.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.452 -0.78 . . . . 0.0 109.975 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -160.99 126.04 3.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.484 -0.76 . . . . 0.0 110.613 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.54 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 23.2 p-90 -133.29 147.55 51.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.589 -0.694 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.93 135.06 35.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 111.145 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.54 HD13 ' HZ3' ' A' ' 194' ' ' TRP . 27.4 tp -104.96 95.46 5.87 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 85.9 m -72.42 117.97 14.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.555 -0.716 . . . . 0.0 110.992 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 104' ' ' LEU . 48.3 mm -91.03 153.33 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -142.89 -167.63 2.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.394 -0.816 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 -46.66 6.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.704 -0.622 . . . . 0.0 110.568 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.89 106.27 4.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.452 -0.78 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.93 ' CZ2' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.33 36.56 0.88 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.607 -0.683 . . . . 0.0 111.285 179.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -169.37 37.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.316 -0.865 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.16 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.136 0.494 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.12 -25.91 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.371 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 p -155.31 42.48 0.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.461 -0.775 . . . . 0.0 110.135 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.52 96.59 0.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.591 -0.693 . . . . 0.0 110.213 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.61 149.11 42.52 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.593 -0.692 . . . . 0.0 110.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.04 -166.48 0.3 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.344 1.181 . . . . 0.0 110.357 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -90.97 -168.14 2.0 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.541 -0.724 . . . . 0.0 110.09 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 67' ' ' VAL . 35.6 m -119.02 64.23 6.61 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.547 -0.72 . . . . 0.0 110.376 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 149.31 53.32 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.248 1.13 . . . . 0.0 110.421 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.494 ' ND2' HG23 ' A' ' 70' ' ' VAL . 2.2 t-20 -123.47 -73.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.688 -0.633 . . . . 0.0 109.935 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 123' ' ' VAL . 59.2 t -138.87 135.34 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.434 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.551 ' CG1' HD22 ' A' ' 190' ' ' LEU . 76.8 t -147.73 142.1 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 0.0 109.582 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.729 ' HB ' HD23 ' A' ' 190' ' ' LEU . 62.1 t -63.02 105.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.1 p -70.52 -52.88 18.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 110.361 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 mtm105 -158.68 151.84 22.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.556 -0.715 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 76' ' ' THR . 4.3 tt -110.67 126.54 54.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.721 -0.612 . . . . 0.0 109.701 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.587 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.7 m -109.4 152.37 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.338 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.671 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -139.74 109.04 6.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.271 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.7 t -108.54 167.07 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.667 -0.645 . . . . 0.0 109.887 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -157.11 -158.38 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.532 -0.73 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 p -95.07 -34.48 12.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p -140.24 48.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.51 168.01 15.2 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 47.3 Cg_endo -73.2 -26.48 14.69 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.454 1.239 . . . . 0.0 110.07 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.07 169.13 28.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.97 103.04 1.41 Allowed 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.442 1.233 . . . . 0.0 110.209 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 102' ' ' PHE . 15.4 mt -64.7 116.16 5.98 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.756 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.83 106.04 17.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.395 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.509 HD22 ' CE1' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -84.98 127.97 34.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.666 -0.646 . . . . 0.0 109.938 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.28 122.6 25.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.569 -0.707 . . . . 0.0 110.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD13 ' CG1' ' A' ' 72' ' ' VAL . 3.9 mt -128.59 51.03 2.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 109.933 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -109.89 -70.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -60.88 0.15 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.93 88.66 0.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.6 -0.941 . . . . 0.0 110.316 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 92.1 mt -94.98 -25.93 16.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.378 -0.826 . . . . 0.0 110.5 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -52.35 -23.3 5.68 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -18.48 35.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.431 -0.793 . . . . 0.0 111.325 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.509 ' CE1' HD22 ' A' ' 88' ' ' LEU . 13.3 m-30 -61.96 -56.01 23.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.199 -0.938 . . . . 0.0 110.59 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.98 25.1 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.508 -0.745 . . . . 0.0 111.132 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -86.89 9.82 18.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 111.25 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -171.6 148.0 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.166 -0.959 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.2 p -125.3 159.41 31.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.539 -0.726 . . . . 0.0 109.781 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -82.15 117.97 22.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 110.261 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 199' ' ' LYS . 57.3 t -78.08 154.27 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.623 -0.673 . . . . 0.0 109.802 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 196' ' ' LEU . 1.7 mt -164.76 179.0 6.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.571 -0.706 . . . . 0.0 110.328 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -107.33 152.32 24.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.562 -0.711 . . . . 0.0 109.777 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -19.56 -69.44 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.798 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -143.26 74.21 0.33 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.922 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.643 HG21 HD22 ' A' ' 104' ' ' LEU . 33.4 m -88.47 -173.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 110.116 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -120.79 93.63 4.09 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.581 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 40.5 p90 -109.81 145.72 36.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.367 -0.833 . . . . 0.0 112.329 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 162' ' ' MET . 38.4 mtt85 -105.33 165.19 11.29 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 75' ' ' LEU . 68.2 mt -126.41 135.35 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 100.53 8.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.826 -0.546 . . . . 0.0 109.579 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' GLU . 46.2 mm -77.28 148.44 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.529 -0.732 . . . . 0.0 110.043 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -131.31 133.84 45.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 10.4 p90 -157.5 148.92 21.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 110.415 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.3 49.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.64 -0.662 . . . . 0.0 111.158 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 70' ' ' VAL . 57.4 t -115.01 99.04 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -129.2 47.97 2.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.41 -0.806 . . . . 0.0 111.608 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -145.09 -64.24 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.78 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -138.4 166.59 23.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.448 -0.783 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.91 102.78 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.673 -0.642 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.933 HG21 HG21 ' A' ' 70' ' ' VAL . 58.3 t -81.13 70.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.762 -0.586 . . . . 0.0 109.745 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.9 p -74.52 94.54 2.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.642 -0.661 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.98 42.11 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.517 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.4 ttt -72.28 140.79 48.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.973 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -136.58 159.61 41.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -135.27 97.89 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.39 133.37 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 109.728 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.412 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 28.0 tt0 -131.61 131.57 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.598 -0.688 . . . . 0.0 110.29 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.5 m-70 -107.97 123.62 48.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 0.0 109.792 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.9 m -83.32 105.57 14.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.538 -0.726 . . . . 0.0 110.047 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 138' ' ' LYS . 8.6 m-85 -96.32 140.19 31.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.52 -0.737 . . . . 0.0 109.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 112.32 18.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.737 . . . . 0.0 110.151 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.5 tptp 53.04 37.14 23.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.261 -0.899 . . . . 0.0 110.63 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 82.48 35.06 21.17 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.9 t -146.91 113.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.985 . . . . 0.0 110.13 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -64.12 127.71 32.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.567 -0.708 . . . . 0.0 110.116 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.542 HD12 ' OD2' ' A' ' 140' ' ' ASP . 2.8 pt -111.35 -26.05 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.56 -0.713 . . . . 0.0 110.655 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.542 ' OD2' HD12 ' A' ' 139' ' ' ILE . 3.2 p30 -174.43 151.19 1.53 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.455 ' CD ' ' CE1' ' A' ' 131' ' ' HIS . 15.7 pttm -147.72 149.69 32.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -143.32 155.03 44.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.343 -0.848 . . . . 0.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -100.74 113.8 27.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.18 100.33 12.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.451 -0.781 . . . . 0.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.9 ptp -61.63 116.19 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.757 . . . . 0.0 109.693 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.777 HG13 ' CG ' ' A' ' 158' ' ' PHE . 47.4 t -80.18 -51.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 0.0 110.286 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.89 178.33 18.68 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 77.6 p -93.37 152.35 19.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.525 -0.985 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -147.65 132.42 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 110.3 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -88.45 156.39 26.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.52 -171.5 1.13 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.411 1.216 . . . . 0.0 110.537 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 51.42 62.38 2.74 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.62 -0.675 . . . . 0.0 111.156 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -153.25 -94.5 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 110.273 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.34 -154.79 0.06 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.885 -1.135 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 73' ' ' THR . 32.7 tt0 -94.49 93.41 7.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.427 ' HB2' ' CE1' ' A' ' 116' ' ' PHE . 66.1 m-85 -59.92 177.54 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.731 -0.606 . . . . 0.0 110.298 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 12.3 mt-10 -146.75 110.15 4.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 110.314 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.777 ' CG ' HG13 ' A' ' 146' ' ' VAL . 42.3 t80 -76.85 163.27 26.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.731 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.58 116.99 15.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.517 -0.739 . . . . 0.0 110.687 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.2 p -100.51 145.99 31.26 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.12 171.6 8.71 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.755 1.397 . . . . 0.0 111.361 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.41 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 8.2 ptt? -59.73 118.37 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.821 -0.549 . . . . 0.0 111.073 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 1.0 OUTLIER -105.88 124.48 49.64 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.53 136.39 35.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.509 -0.744 . . . . 0.0 110.601 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 110' ' ' TYR . . . -90.06 171.15 9.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.737 -0.602 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.8 Cg_endo -72.92 129.31 14.14 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.369 1.194 . . . . 0.0 110.171 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -112.71 -178.09 3.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.601 -0.687 . . . . 0.0 110.75 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.68 138.01 8.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.2 ttm -58.98 -30.7 68.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.397 -1.061 . . . . 0.0 110.066 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 170' ' ' LEU . 4.4 mm? -69.37 -35.21 75.6 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 167' ' ' LYS . . . -88.04 -26.92 22.32 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.097 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -50.34 155.21 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 133.14 -156.5 22.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 p -104.51 132.45 50.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -1.001 . . . . 0.0 110.732 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -113.77 103.03 10.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.645 -0.659 . . . . 0.0 110.732 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -66.95 142.11 57.38 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 14.5 mt -132.94 154.99 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 103.19 8.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.785 -0.572 . . . . 0.0 109.845 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 192' ' ' TRP . 2.4 m -97.18 118.13 32.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.49 -0.756 . . . . 0.0 110.437 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.12 109.81 19.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 109.716 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 72' ' ' VAL . 1.4 t80 -86.54 154.45 21.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.696 -0.627 . . . . 0.0 110.623 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.4 t -167.76 -156.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.982 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.6 p-10 -164.7 -147.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.732 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -96.0 29.88 2.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 0.0 109.729 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 186' ' ' ARG . 2.6 t70 -138.93 59.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 185' ' ' ASP . 0.0 OUTLIER 4.23 67.47 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.0 t -142.94 168.99 18.4 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.892 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -105.56 101.06 10.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.502 -0.749 . . . . 0.0 110.215 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 7.9 m170 -60.35 -56.64 19.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.763 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 72' ' ' VAL . 17.7 tp -171.43 114.52 0.38 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.704 -0.622 . . . . 0.0 109.837 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -116.59 136.18 53.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.7 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 97' ' ' PHE . 27.1 p90 -134.28 -159.03 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.68 -0.638 . . . . 0.0 110.083 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -158.88 129.46 6.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 110.641 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 19.1 p-90 -143.55 147.95 35.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 0.0 109.976 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -99.09 146.07 26.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.566 -0.709 . . . . 0.0 110.939 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.749 HD11 HD12 ' A' ' 104' ' ' LEU . 43.0 tp -109.08 107.37 17.67 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 84.8 m -82.93 106.95 15.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 110.769 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.05 143.5 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.707 -0.621 . . . . 0.0 109.393 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.467 ' HD2' HG13 ' A' ' 103' ' ' VAL . 6.4 mttt -137.3 -160.25 1.04 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 110.027 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -19.48 8.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 111.055 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -152.54 60.87 0.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 110.952 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -62.43 -15.3 48.61 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.269 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.76 37.7 3.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.273 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.165 0.507 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.8 t 53.51 90.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.398 -0.814 . . . . 0.0 110.662 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.6 173.54 6.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.587 -0.696 . . . . 0.0 110.144 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.66 47.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.567 -0.708 . . . . 0.0 110.196 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 37.57 53.73 3.27 Favored Pre-proline 0 N--CA 1.51 2.558 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.33 -165.37 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.449 1.236 . . . . 0.0 110.43 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.9 176.91 0.36 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.586 -0.696 . . . . 0.0 110.147 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 68' ' ' PRO . 62.3 t -96.45 143.34 25.96 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.416 -0.802 . . . . 0.0 110.033 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 67' ' ' VAL . 49.2 Cg_endo -73.98 159.5 44.6 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.353 1.186 . . . . 0.0 110.431 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -168.04 -60.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.715 . . . . 0.0 110.278 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 123' ' ' VAL . 61.1 t -121.97 128.46 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 70' ' ' VAL . 69.7 t -148.96 139.62 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 181' ' ' PHE . 9.8 t -64.08 103.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 155' ' ' GLU . 65.9 p -69.95 -50.06 45.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.504 -0.748 . . . . 0.0 110.568 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -158.67 174.64 14.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.445 -0.784 . . . . 0.0 110.814 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.8 tt -140.65 123.77 16.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.722 -0.611 . . . . 0.0 109.643 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 85' ' ' PRO . 89.8 m -109.71 162.89 14.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.517 -0.739 . . . . 0.0 110.288 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -145.85 118.31 8.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 110.534 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.39 153.06 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.561 -0.712 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 t -147.16 25.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.569 -0.707 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 81' ' ' THR . 1.4 p 67.03 -61.19 0.34 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.533 -0.729 . . . . 0.0 110.977 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.4 ' N ' ' OG ' ' A' ' 80' ' ' SER . 20.1 p -98.97 30.97 3.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.159 -0.963 . . . . 0.0 109.964 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.19 165.98 21.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.691 -0.63 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 45.7 Cg_endo -71.74 -26.4 19.36 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.439 1.231 . . . . 0.0 110.221 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.11 165.86 25.22 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 76' ' ' THR . 47.1 Cg_endo -72.01 97.42 0.83 Allowed 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.466 1.245 . . . . 0.0 110.29 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 102' ' ' PHE . 20.3 mt -64.63 114.57 4.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.688 -0.632 . . . . 0.0 109.632 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -100.95 122.46 43.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.633 -0.667 . . . . 0.0 110.602 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.687 HD22 ' CE1' ' A' ' 97' ' ' PHE . 9.6 mt -97.6 166.17 11.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.702 -0.624 . . . . 0.0 109.88 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -109.96 126.58 54.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.527 -0.733 . . . . 0.0 110.478 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.659 HD13 HG12 ' A' ' 72' ' ' VAL . 1.7 mt -128.13 49.31 2.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.581 -0.699 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 p -133.67 51.69 2.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.32 -65.16 0.26 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.1 71.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.96 . . . . 0.0 110.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' O ' ' CD2' ' A' ' 97' ' ' PHE . 72.9 mt -90.08 -26.85 20.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.565 -0.709 . . . . 0.0 110.347 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.19 -22.05 15.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.25 -0.906 . . . . 0.0 111.074 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.8 p -58.23 -20.62 43.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 0.0 110.983 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' A' ' 88' ' ' LEU . 18.1 m-85 -58.37 -65.28 0.68 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.315 -0.866 . . . . 0.0 110.608 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -56.23 -20.73 19.55 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.525 -0.734 . . . . 0.0 111.207 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -86.93 11.65 12.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 111.323 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.76 143.13 2.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -133.16 137.07 46.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.66 . . . . 0.0 109.721 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 86' ' ' LEU . 22.5 m-85 -79.22 118.6 21.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -0.79 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.9 t -63.97 155.53 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.25 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 196' ' ' LEU . 2.1 mt -153.07 -171.38 3.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.756 . . . . 0.0 110.401 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.456 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.1 tttm -130.65 161.41 31.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.671 0.748 . . . . 0.0 109.857 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.81 106.37 0.06 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 37.28 69.42 0.3 Allowed Glycine 0 N--CA 1.503 3.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.698 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 104' ' ' LEU . 35.8 m -86.65 149.85 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.266 -1.137 . . . . 0.0 109.692 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -79.94 90.58 5.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.653 ' HE1' HD11 ' A' ' 112' ' ' ILE . 37.4 p90 -109.34 141.58 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.562 -0.711 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.49 163.49 13.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.638 -0.664 . . . . 0.0 109.344 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.653 HD11 ' HE1' ' A' ' 110' ' ' TYR . 45.0 mm -117.75 135.1 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.371 -0.831 . . . . 0.0 110.071 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -119.64 115.11 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 109.28 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 181' ' ' PHE . 43.3 mm -100.72 150.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 111.156 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.5 m -131.21 122.09 25.95 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.457 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 31.1 p90 -137.83 135.15 35.95 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.785 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.405 ' H ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -84.09 140.07 32.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 111.046 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.47 95.93 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.724 -0.61 . . . . 0.0 109.367 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -129.2 48.69 2.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 111.427 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.93 -68.7 0.18 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.25 -0.906 . . . . 0.0 110.849 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -136.82 174.7 10.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.82 . . . . 0.0 110.519 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 122' ' ' ILE . 4.3 mp -80.41 121.62 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.738 -0.601 . . . . 0.0 110.04 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 70' ' ' VAL . 63.0 t -103.8 77.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.692 -0.63 . . . . 0.0 109.531 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.4 p -81.47 84.95 6.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.59 -0.694 . . . . 0.0 110.666 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 145.68 44.55 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.457 ' CE ' ' CD2' ' A' ' 116' ' ' PHE . 3.0 mmm -73.76 148.56 42.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.446 -1.032 . . . . 0.0 109.627 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.24 136.16 36.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.447 -0.783 . . . . 0.0 110.941 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.417 ' CE1' ' OG ' ' A' ' 179' ' ' SER . 48.2 t80 -122.2 106.18 10.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.772 -0.58 . . . . 0.0 109.484 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 130' ' ' GLN . 80.5 mt -102.08 166.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 129' ' ' ILE . 2.8 tt0 -155.11 138.69 16.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.643 -0.661 . . . . 0.0 110.376 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 177' ' ' ILE . 11.1 m-70 -109.34 140.82 42.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.742 . . . . 0.0 109.645 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 m -103.43 78.83 1.64 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.454 -0.779 . . . . 0.0 110.062 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 131' ' ' HIS . 21.1 m-85 -90.57 120.13 31.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.704 ' HG2' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -140.43 142.42 35.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.518 -0.739 . . . . 0.0 110.491 179.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.0 OUTLIER 53.67 33.79 17.4 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 60.97 27.07 66.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 135' ' ' LYS . 57.4 t -128.03 112.55 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.435 -1.038 . . . . 0.0 109.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 113.65 5.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.575 -0.703 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.704 HD12 ' HG2' ' A' ' 134' ' ' ARG . 4.6 mt -90.21 -66.12 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.629 -0.669 . . . . 0.0 109.438 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.4 p30 -168.54 171.94 8.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.553 -0.717 . . . . 0.0 110.534 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -126.86 168.4 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.596 -0.69 . . . . 0.0 109.557 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.4 m -131.4 117.38 18.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.498 -0.752 . . . . 0.0 110.522 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.24 116.25 28.62 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 0.0 109.821 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -114.27 142.1 46.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 ttp -98.05 123.8 42.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.75 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 181' ' ' PHE . 45.7 t -80.0 -53.71 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.518 -0.739 . . . . 0.0 110.188 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.61 -173.36 21.22 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.9 p -93.35 145.9 24.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.946 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.657 ' CE2' HG12 ' A' ' 146' ' ' VAL . 84.2 m-85 -147.48 125.91 12.38 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.447 -0.783 . . . . 0.0 110.185 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.61 163.99 25.18 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 83.83 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.415 1.218 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.02 -66.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.618 -0.676 . . . . 0.0 110.17 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -169.87 132.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.489 -0.757 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 53.05 -157.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.403 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -101.22 171.06 7.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.58 -0.7 . . . . 0.0 111.031 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 41.3 m-85 -109.71 176.92 4.89 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -131.71 108.95 9.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.813 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 160' ' ' THR . 11.4 t80 -82.77 168.05 17.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 109.591 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.86 90.12 1.44 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.466 -0.771 . . . . 0.0 110.693 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 158' ' ' PHE . 37.6 p -76.76 158.11 81.09 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.483 -0.761 . . . . 0.0 109.327 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.59 158.42 50.05 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.699 1.368 . . . . 0.0 111.109 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -56.61 137.7 53.44 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.299 0.571 . . . . 0.0 111.156 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 3.1 tp10 -120.51 119.6 33.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.817 -0.552 . . . . 0.0 109.557 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.69 133.48 49.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -89.74 179.62 1.49 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.3 Cg_endo -72.21 123.75 9.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.192 1.101 . . . . 0.0 110.35 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -115.11 -175.2 2.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.557 -0.714 . . . . 0.0 110.462 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.31 18.83 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -59.5 -27.44 66.15 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -98.51 29.51 3.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 110.049 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.33 18.94 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.531 -0.731 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -100.13 132.89 45.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.392 -0.817 . . . . 0.0 110.0 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.7 177.88 23.31 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -84.95 126.23 33.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.724 -0.868 . . . . 0.0 110.747 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -107.33 115.87 30.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.582 -0.699 . . . . 0.0 109.883 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -75.08 122.86 24.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.593 -0.692 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.508 HD12 ' CH2' ' A' ' 194' ' ' TRP . 20.4 mt -116.31 152.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.762 . . . . 0.0 110.85 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.44 117.92 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.641 -0.662 . . . . 0.0 110.356 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 192' ' ' TRP . 17.5 t -114.23 163.15 15.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.343 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.15 108.13 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.776 -0.577 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.724 ' HD2' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -80.77 116.37 20.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.998 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.685 HG22 ' CB ' ' A' ' 188' ' ' ASP . 82.2 p -125.03 173.53 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.679 . . . . 0.0 109.861 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 189' ' ' HIS . 25.3 p-10 -145.33 179.4 7.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.678 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -96.46 55.67 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.487 -0.758 . . . . 0.0 110.211 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -135.68 -64.37 0.63 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.553 -0.717 . . . . 0.0 110.511 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.87 -76.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.652 -0.655 . . . . 0.0 110.843 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.0 t -156.1 -160.06 0.96 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.502 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.685 ' CB ' HG22 ' A' ' 182' ' ' THR . 5.8 p-10 -72.32 117.32 13.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.599 -0.688 . . . . 0.0 109.796 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 183' ' ' ASP . 88.9 m-70 -59.6 -44.62 93.34 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 110.531 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 15.8 tp -162.61 156.24 20.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.461 -0.774 . . . . 0.0 110.399 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.6 p -145.16 150.72 37.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.641 -0.662 . . . . 0.0 109.946 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.472 ' CE2' HD21 ' A' ' 90' ' ' LEU . 14.8 p90 -147.19 -153.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.574 -0.704 . . . . 0.0 110.391 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -169.09 140.26 2.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.528 -0.733 . . . . 0.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.653 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 49.7 p-90 -145.4 147.23 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.541 -0.724 . . . . 0.0 110.384 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -87.65 165.11 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.711 -0.618 . . . . 0.0 110.949 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 104' ' ' LEU . 24.8 tp -143.51 105.39 4.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.81 -0.557 . . . . 0.0 109.582 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.3 m -79.33 127.08 31.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.272 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.8 mm -99.78 159.48 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.652 -0.655 . . . . 0.0 109.662 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -150.59 -153.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.518 -0.739 . . . . 0.0 110.201 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -16.36 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.41 -0.806 . . . . 0.0 111.445 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -160.07 61.62 0.35 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.123 -0.985 . . . . 0.0 111.291 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -66.27 -11.63 51.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.385 -0.822 . . . . 0.0 111.712 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 29.57 6.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.119 -0.988 . . . . 0.0 110.927 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.443 179.456 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.039 0.447 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.32 166.36 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.621 -0.674 . . . . 0.0 110.285 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -164.04 -68.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.533 -0.729 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.98 -175.15 4.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.602 -0.686 . . . . 0.0 110.237 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.13 152.13 37.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.67 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.48 -165.73 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.426 1.224 . . . . 0.0 110.485 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.14 -168.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 67' ' ' VAL . 60.1 t 53.73 69.61 2.14 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.463 -0.773 . . . . 0.0 110.474 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.69 -165.5 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.052 0 O-C-N 123.429 1.226 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -73.88 -82.07 0.06 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.596 -0.69 . . . . 0.0 109.967 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 123' ' ' VAL . 68.4 t -135.72 133.71 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.628 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.3 t -137.31 155.42 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 90' ' ' LEU . 46.2 t -66.55 100.99 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.217 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 116' ' ' PHE . 55.2 p -70.81 -55.8 7.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.747 -0.596 . . . . 0.0 110.396 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -153.69 157.01 38.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.511 -0.743 . . . . 0.0 110.264 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 76' ' ' THR . 9.6 tt -125.31 161.28 27.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.606 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.725 ' N ' HD23 ' A' ' 75' ' ' LEU . 13.3 m -146.85 164.93 31.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.555 -0.715 . . . . 0.0 110.579 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 86' ' ' LEU . 2.6 mt -140.32 100.75 3.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.95 144.24 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.547 -0.72 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 m -150.03 -167.38 2.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.13 -76.21 0.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -0.775 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 p -94.99 36.82 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.397 -0.814 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.692 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -90.37 172.83 6.39 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.2 Cg_endo -71.29 -27.46 19.6 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.218 1.115 . . . . 0.0 109.87 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.58 -174.46 38.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -70.89 92.94 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.575 1.303 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' A' ' 102' ' ' PHE . 22.3 mt -64.32 104.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.56 159.68 15.56 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.118 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.927 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 5.0 mt -131.11 136.47 48.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.967 -0.458 . . . . 0.0 109.967 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.416 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 12.0 t70 -82.97 131.73 35.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -129.05 53.63 1.86 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 109.837 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 p -122.87 -58.37 1.66 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.517 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.67 -63.37 0.1 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.83 78.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.986 . . . . 0.0 110.292 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -95.37 -28.17 15.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 110.285 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.7 -31.14 69.31 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.571 -0.705 . . . . 0.0 110.932 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -57.9 -19.95 33.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.391 -0.818 . . . . 0.0 110.956 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.927 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 6.0 m-85 -62.71 -65.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.393 -0.817 . . . . 0.0 110.467 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -57.9 -20.15 34.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.0 110.942 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -22.41 26.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.409 -0.807 . . . . 0.0 110.748 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -129.91 132.44 46.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.277 -0.889 . . . . 0.0 110.569 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 p -115.24 148.05 39.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 109.841 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 m-85 -74.38 154.76 38.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.79 113.02 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 0.0 110.358 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.932 HD22 HG21 ' A' ' 108' ' ' VAL . 10.1 mt -113.7 -172.83 2.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.602 -0.686 . . . . 0.0 109.553 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.589 ' HB3' HG11 ' A' ' 108' ' ' VAL . 37.7 tttm -121.85 167.27 13.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.791 . . . . 0.0 109.756 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -42.01 108.93 0.11 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.24 69.24 0.43 Allowed Glycine 0 N--CA 1.502 3.068 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.259 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.932 HG21 HD22 ' A' ' 104' ' ' LEU . 34.4 m -93.77 142.83 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -1.142 . . . . 0.0 110.086 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.73 107.19 10.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.401 -0.812 . . . . 0.0 109.192 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.614 ' HE2' ' HB2' ' A' ' 165' ' ' ALA . 30.0 p90 -123.61 146.77 47.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.683 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -106.62 162.2 13.96 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.449 HG22 ' N ' ' A' ' 113' ' ' LYS . 70.2 mt -122.84 163.36 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 112' ' ' ILE . 14.0 ttmm -150.08 108.99 3.87 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' HD12 ' A' ' 75' ' ' LEU . 49.9 mm -98.02 146.73 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.54 -0.725 . . . . 0.0 110.807 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.36 145.51 51.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.639 -0.663 . . . . 0.0 109.639 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.533 ' HA ' HG23 ' A' ' 73' ' ' THR . 21.5 p90 -154.88 150.33 27.34 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 111.129 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.85 151.85 22.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.792 -0.568 . . . . 0.0 111.113 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 151' ' ' PRO . 57.7 t -133.91 99.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.674 -0.641 . . . . 0.0 109.554 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.71 48.75 2.34 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.386 -0.821 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -148.29 -77.78 0.16 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.185 -0.947 . . . . 0.0 110.841 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.83 -177.85 5.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 110.353 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 77.3 mt -74.15 106.05 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.819 HG21 HG21 ' A' ' 70' ' ' VAL . 57.6 t -80.22 76.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.662 -0.648 . . . . 0.0 109.908 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.2 98.59 7.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.449 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 128.48 40.83 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.548 ' CE ' HG11 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -78.27 124.44 28.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -1.054 . . . . 0.0 109.503 179.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -123.33 142.65 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.997 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -117.48 86.99 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 0.0 109.413 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 84.3 mt -79.06 140.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 110.044 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.7 137.6 29.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 177' ' ' ILE . 28.5 m-70 -107.05 154.96 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.74 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.537 ' O ' HD12 ' A' ' 139' ' ' ILE . 57.1 m -116.4 64.47 0.71 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -75.25 139.48 42.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.382 -0.824 . . . . 0.0 109.828 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NH1' HG11 ' A' ' 137' ' ' VAL . 3.4 ptt180 -120.68 -152.17 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.485 -0.76 . . . . 0.0 110.277 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -56.66 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.411 -0.806 . . . . 0.0 111.783 -178.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.58 13.34 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 121.514 -0.741 . . . . 0.0 111.584 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 135' ' ' LYS . 63.0 t -134.29 116.1 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 119.62 19.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.702 -0.624 . . . . 0.0 110.152 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.556 HG22 ' OD2' ' A' ' 140' ' ' ASP . 58.6 mt -89.62 -72.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.645 -0.659 . . . . 0.0 109.85 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.556 ' OD2' HG22 ' A' ' 139' ' ' ILE . 3.3 p30 -172.32 166.49 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.472 -0.767 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 157.74 42.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.271 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.2 m -125.24 143.69 50.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.562 -0.711 . . . . 0.0 110.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.57 75.47 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.631 -0.668 . . . . 0.0 109.892 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -64.72 146.43 54.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.455 -0.778 . . . . 0.0 110.685 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -106.74 123.67 48.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.641 -0.662 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.61 HG12 ' CE2' ' A' ' 149' ' ' TYR . 61.6 t -79.8 -55.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.544 -0.722 . . . . 0.0 110.015 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.92 176.6 14.48 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.9 p -86.72 151.06 23.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.626 -0.926 . . . . 0.0 110.091 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.61 ' CE2' HG12 ' A' ' 146' ' ' VAL . 88.4 m-85 -148.35 130.57 15.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.551 -0.718 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.54 157.16 32.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.675 ' HA ' HG12 ' A' ' 118' ' ' VAL . 48.5 Cg_endo -74.01 94.76 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.389 1.205 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -91.81 -78.23 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.559 -0.713 . . . . 0.0 109.91 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -172.6 -38.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -107.94 -161.8 0.79 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.0 110.672 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 168.81 9.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 30.0 m-85 -108.57 -178.47 3.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.773 -0.579 . . . . 0.0 109.649 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -138.86 99.51 3.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.931 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 146' ' ' VAL . 34.5 t80 -84.16 171.46 12.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.56 -0.713 . . . . 0.0 109.259 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.66 131.74 4.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 111.172 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.5 p -97.31 151.73 37.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.84 -170.16 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.714 1.376 . . . . 0.0 111.203 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.2 ptm -54.43 145.25 18.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 111.266 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 4.6 tt0 -144.5 84.21 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.68 -0.638 . . . . 0.0 109.636 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.67 135.46 55.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 110.692 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -88.83 179.99 1.45 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.611 -0.681 . . . . 0.0 109.816 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.4 Cg_endo -73.63 135.91 22.63 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.273 1.143 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 7.6 ptpp? -110.99 -179.33 3.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.713 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.08 156.35 18.94 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.1 ttp -61.44 -26.97 68.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.155 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.627 ' O ' HD23 ' A' ' 170' ' ' LEU . 1.5 tt -82.61 -24.76 33.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.568 -0.708 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -59.07 -25.42 63.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.431 -0.793 . . . . 0.0 110.52 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -60.5 123.85 18.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.426 -0.796 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 159.53 -179.84 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -95.1 135.63 36.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.66 -0.906 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.05 108.56 14.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 109.921 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -71.28 122.37 20.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.636 -0.665 . . . . 0.0 110.113 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 131' ' ' HIS . 36.3 mt -113.32 127.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -99.35 112.11 24.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.695 . . . . 0.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 4.0 m -105.65 130.06 53.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.634 -0.667 . . . . 0.0 110.217 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 99.68 6.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.605 -0.685 . . . . 0.0 110.183 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.46 ' C ' HG23 ' A' ' 182' ' ' THR . 2.0 t80 -75.57 121.38 22.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 0.0 109.835 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.46 HG23 ' C ' ' A' ' 181' ' ' PHE . 32.4 p -152.63 162.27 41.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -98.55 -162.32 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.597 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -58.42 8.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.65 24.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.857 -0.527 . . . . 0.0 110.741 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -37.66 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 109.405 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.6 t -179.18 -166.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.118 0.485 . . . . 0.0 109.969 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.41 115.24 26.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.626 . . . . 0.0 109.607 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.49 -59.94 3.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.739 . . . . 0.0 110.489 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.5 tp -167.61 170.55 11.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.449 -0.782 . . . . 0.0 110.484 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.7 t -163.85 125.29 2.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.725 -0.609 . . . . 0.0 109.872 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.606 ' CE2' HD21 ' A' ' 90' ' ' LEU . 20.5 p90 -140.16 -153.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.574 -0.704 . . . . 0.0 110.304 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.11 134.25 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 110.649 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 11.7 p-90 -138.36 146.95 42.92 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.674 -0.641 . . . . 0.0 109.893 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.66 141.3 29.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.628 -0.67 . . . . 0.0 111.181 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 104' ' ' LEU . 44.1 tp -108.84 108.83 19.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 96.4 m -88.47 122.08 31.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.771 . . . . 0.0 110.656 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 104' ' ' LEU . 49.9 mm -94.32 156.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 109.486 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -138.23 -162.33 1.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.748 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 -24.43 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 110.682 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -160.01 77.36 0.65 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.387 -0.821 . . . . 0.0 110.994 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.791 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -70.51 -7.03 40.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.452 -0.78 . . . . 0.0 111.693 179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -155.28 51.45 0.59 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.107 -0.995 . . . . 0.0 110.288 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.122 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.092 0.472 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 62' ' ' SER . 50.6 t 56.83 166.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.695 -0.628 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 61' ' ' VAL . 0.4 OUTLIER -96.15 110.31 22.6 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.832 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.97 -157.13 0.75 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.715 . . . . 0.0 110.143 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 t70 61.75 120.24 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.462 -0.774 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.01 -165.29 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 122.881 0.938 . . . . 0.0 110.487 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -59.79 125.14 22.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 68' ' ' PRO . 8.1 p -125.37 143.69 45.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.524 -0.735 . . . . 0.0 110.18 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -71.09 -163.89 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.288 1.151 . . . . 0.0 110.408 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.43 ' HB3' ' CB ' ' A' ' 120' ' ' ARG . 7.4 p-10 -132.97 18.69 4.12 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.426 -0.796 . . . . 0.0 111.419 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 70' ' ' VAL . 21.4 t -143.6 31.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 110.817 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.58 141.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.676 -0.64 . . . . 0.0 110.055 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 90' ' ' LEU . 58.5 t -63.73 125.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.637 -0.664 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.866 HG23 ' HA ' ' A' ' 116' ' ' PHE . 69.5 p -82.03 -58.92 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.903 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.58 155.42 26.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.454 ' HG ' HD13 ' A' ' 114' ' ' ILE . 4.5 tt -110.97 133.84 53.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.606 -0.684 . . . . 0.0 109.784 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -109.64 155.66 21.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.542 -0.724 . . . . 0.0 110.924 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -141.57 107.96 5.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.614 -0.679 . . . . 0.0 110.058 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 85' ' ' PRO . 60.3 t -121.79 160.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.972 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.8 t -147.27 -80.73 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -170.81 -45.49 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.346 -0.846 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 p -123.86 34.76 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 110.118 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -87.59 173.06 6.93 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.9 Cg_endo -72.29 -28.6 15.05 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.474 1.25 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.35 170.97 30.01 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 78' ' ' VAL . 46.0 Cg_endo -72.1 102.83 1.4 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.526 1.277 . . . . 0.0 110.188 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 8.2 mt -64.73 121.23 14.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 109.68 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.84 103.41 15.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.668 -0.645 . . . . 0.0 110.247 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.9 tt -80.2 119.82 23.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 110.176 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.47 129.42 37.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.717 HD13 HG11 ' A' ' 72' ' ' VAL . 6.0 mt -133.71 53.6 2.0 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.561 -0.712 . . . . 0.0 110.039 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.3 p -140.31 -43.53 0.41 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.656 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.11 -117.85 4.25 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 114.83 3.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.627 -0.925 . . . . 0.0 110.334 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mt -92.27 -30.46 15.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -66.13 -12.69 57.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.804 . . . . 0.0 111.096 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -56.45 -20.27 19.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.111 -0.993 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 88' ' ' LEU . 3.1 m-85 -67.99 -31.68 71.56 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.312 -0.868 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -61.49 -35.29 77.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 110.723 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -87.1 -25.2 24.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.61 126.26 46.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.468 -0.77 . . . . 0.0 110.477 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -115.38 159.77 20.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.784 ' HB2' HD12 ' A' ' 196' ' ' LEU . 11.3 m-85 -83.27 114.64 21.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.94 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.93 118.28 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.693 -0.63 . . . . 0.0 110.51 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 196' ' ' LEU . 82.1 mt -129.89 159.15 37.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.575 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 108' ' ' VAL . 18.9 tttt -85.9 169.02 13.67 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -39.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 165' ' ' ALA . . . 41.58 72.84 0.24 Allowed Glycine 0 N--CA 1.501 2.985 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.898 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 105' ' ' LYS . 33.1 m -86.5 125.77 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -1.037 . . . . 0.0 110.077 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.05 90.77 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.199 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.549 ' CD1' HD23 ' A' ' 77' ' ' LEU . 11.9 p90 -109.63 150.37 28.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.156 -0.965 . . . . 0.0 111.573 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -98.04 147.07 24.9 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.412 HD11 ' HE1' ' A' ' 110' ' ' TYR . 69.1 mt -111.04 132.56 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -115.38 98.63 6.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.782 -0.574 . . . . 0.0 109.559 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.496 HG21 ' CE1' ' A' ' 181' ' ' PHE . 42.4 mm -78.08 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.695 -0.628 . . . . 0.0 110.432 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.5 m -114.81 141.44 47.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.866 ' HA ' HG23 ' A' ' 73' ' ' THR . 12.9 p90 -153.87 144.65 22.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.415 -0.803 . . . . 0.0 110.968 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -87.17 132.53 33.84 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.246 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 151' ' ' PRO . 60.8 t -122.94 95.12 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -128.15 40.12 3.72 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.596 -0.841 . . . . 0.0 112.692 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -161.31 -67.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.08 -1.013 . . . . 0.0 110.919 179.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -124.38 166.07 16.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 110.911 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 123' ' ' VAL . 81.8 mt -72.97 165.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.263 0.554 . . . . 0.0 110.031 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 126' ' ' MET . 48.6 t -128.39 54.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.699 -0.625 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.92 104.95 2.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.661 -0.649 . . . . 0.0 110.35 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.14 46.27 0.95 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.537 ' HB2' HG12 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -87.6 132.27 34.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.599 -0.942 . . . . 0.0 109.486 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.22 164.55 17.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.478 -0.764 . . . . 0.0 111.019 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -136.43 102.06 4.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.861 -0.524 . . . . 0.0 109.748 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 130' ' ' GLN . 50.8 mm -82.27 164.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 0.0 109.994 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 129' ' ' ILE . 39.5 tt0 -167.96 117.71 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.775 ' O ' HG23 ' A' ' 177' ' ' ILE . 10.7 m170 -101.7 159.31 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.718 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.471 ' CG2' HD11 ' A' ' 139' ' ' ILE . 9.2 m -117.55 69.85 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.458 -0.777 . . . . 0.0 109.959 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 138' ' ' LYS . 19.7 m-85 -66.2 123.72 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.09 134.13 51.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 110.395 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm 52.69 28.15 5.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.21 -16.61 55.36 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 134' ' ' ARG . 34.6 m -106.02 156.24 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.118 -1.225 . . . . 0.0 110.576 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -86.37 134.34 33.72 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.676 . . . . 0.0 109.887 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.471 HD11 ' CG2' ' A' ' 132' ' ' THR . 1.1 pt -118.02 -25.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 110.956 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -175.79 144.45 0.63 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.225 -0.922 . . . . 0.0 110.537 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.64 152.44 50.43 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.7 m -136.27 153.45 51.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 111.374 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.69 116.37 26.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.43 114.69 29.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.981 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.4 ttt -74.64 120.07 19.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.702 HG13 ' CG ' ' A' ' 158' ' ' PHE . 51.3 t -79.64 -68.87 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.403 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.57 -163.23 29.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.2 p -104.77 148.04 27.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.659 -0.906 . . . . 0.0 110.256 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.485 ' CE2' HG12 ' A' ' 146' ' ' VAL . 89.8 m-85 -147.74 125.84 12.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.501 -0.75 . . . . 0.0 110.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.65 156.61 23.26 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.715 ' HA ' HG12 ' A' ' 118' ' ' VAL . 45.9 Cg_endo -71.36 94.13 0.67 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.406 1.214 . . . . 0.0 110.49 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -86.31 -67.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.681 . . . . 0.0 110.11 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.79 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.68 -152.29 0.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 110.634 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -99.97 168.05 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 116' ' ' PHE . 34.1 m-85 -111.46 -170.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.65 -0.656 . . . . 0.0 109.909 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.54 114.12 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.693 . . . . 0.0 110.43 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.702 ' CG ' HG13 ' A' ' 146' ' ' VAL . 37.7 t80 -89.64 164.73 14.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 109.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -135.75 117.41 14.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.531 -0.73 . . . . 0.0 110.656 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 158' ' ' PHE . 71.6 p -102.23 147.77 34.44 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.611 -0.68 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.21 -173.44 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.821 1.432 . . . . 0.0 111.735 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -52.67 140.67 22.82 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.472 0.653 . . . . 0.0 111.773 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 3.5 tp10 -138.42 82.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.61 137.18 58.0 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.541 0.686 . . . . 0.0 110.8 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -82.42 -178.7 1.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 45.4 Cg_endo -72.09 124.94 10.44 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.187 1.098 . . . . 0.0 110.198 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -115.26 178.96 4.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.571 -0.706 . . . . 0.0 110.662 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.44 150.83 10.66 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 5.8 ttt -59.59 -28.83 67.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.418 -1.049 . . . . 0.0 110.025 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 170' ' ' LEU . 0.2 OUTLIER -99.2 23.96 8.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.784 . . . . 0.0 110.325 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.41 24.61 7.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -98.59 131.45 44.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 110.009 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.33 -174.26 27.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.5 p -87.6 122.84 31.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.943 . . . . 0.0 110.659 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 19.4 m-85 -103.67 107.33 18.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -66.0 133.33 50.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.596 -0.69 . . . . 0.0 110.093 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 131' ' ' HIS . 15.7 mt -124.87 141.58 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.493 -0.755 . . . . 0.0 110.62 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -114.12 115.06 26.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.637 -0.664 . . . . 0.0 110.211 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.5 m -113.8 157.63 22.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 110.15 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.31 101.52 4.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.62 ' CD2' HG22 ' A' ' 72' ' ' VAL . 2.2 t80 -75.56 92.46 2.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.644 . . . . 0.0 110.096 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.7 t -127.28 179.75 5.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.274 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.34 -147.17 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.54 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -71.5 -39.7 70.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.988 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.91 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.819 -0.551 . . . . 0.0 111.575 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -51.8 13.66 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.271 -0.893 . . . . 0.0 111.824 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.1 t -175.58 -175.05 0.75 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.514 -0.741 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.84 116.52 28.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.715 -0.616 . . . . 0.0 109.413 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -57.65 -49.52 76.2 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.433 -0.792 . . . . 0.0 110.703 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.8 tp -168.35 158.91 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.5 -0.75 . . . . 0.0 110.463 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 140.28 22.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.92 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.535 ' CE2' HD21 ' A' ' 90' ' ' LEU . 15.3 p90 -146.52 -155.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.581 -0.699 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -161.68 130.23 4.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.688 -0.633 . . . . 0.0 110.169 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.519 ' CZ3' HD13 ' A' ' 196' ' ' LEU . 11.0 p-90 -137.49 145.96 43.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.498 -0.751 . . . . 0.0 110.066 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -90.13 155.88 18.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.511 0.672 . . . . 0.0 111.122 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 104' ' ' LEU . 15.3 tp -121.18 95.42 4.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.777 -0.577 . . . . 0.0 109.614 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -68.91 122.6 18.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.672 . . . . 0.0 110.304 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.7 mm -101.39 153.51 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 109.796 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -148.55 -157.09 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.615 -0.678 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -18.42 7.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.786 . . . . 0.0 111.355 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.8 73.73 1.08 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.0 111.079 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.782 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -73.59 -4.19 32.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.727 . . . . 0.0 111.569 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 37.51 4.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 110.25 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.334 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.137 0.494 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 36.0 m -112.86 -168.43 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.49 -0.756 . . . . 0.0 110.348 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -155.62 99.88 2.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 0.0 110.203 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 -58.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.561 -0.712 . . . . 0.0 110.22 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.98 161.98 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.938 -0.476 . . . . 0.0 110.689 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.84 -165.41 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.235 1.124 . . . . 0.0 110.385 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -60.47 -168.63 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.562 -0.711 . . . . 0.0 110.163 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 67' ' ' VAL . 9.1 p -148.35 69.5 10.54 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.21 135.89 25.74 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.327 1.172 . . . . 0.0 110.342 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' HG23 ' A' ' 70' ' ' VAL . 43.4 t-20 -77.32 -71.89 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 123' ' ' VAL . 90.6 t -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG23 ' C ' ' A' ' 70' ' ' VAL . 61.1 t -147.54 147.41 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.765 -0.584 . . . . 0.0 109.827 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG23 ' CD2' ' A' ' 181' ' ' PHE . 43.2 t -68.13 113.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.627 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 116' ' ' PHE . 32.8 p -77.29 -33.44 55.77 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.118 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -168.63 160.27 10.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.708 . . . . 0.0 110.324 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 75' ' ' LEU . 10.4 tt -128.29 134.75 48.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.655 -0.653 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.3 m -109.6 162.29 14.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.541 -0.724 . . . . 0.0 110.146 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.84 95.69 2.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.771 . . . . 0.0 110.195 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 85' ' ' PRO . 71.6 t -105.19 167.32 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.857 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 78' ' ' VAL . 40.8 t -159.55 -82.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.651 -0.656 . . . . 0.0 110.134 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -71.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.865 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 p -98.59 31.5 2.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.759 -0.588 . . . . 0.0 109.813 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.725 ' HB2' ' CH2' ' A' ' 202' ' ' TRP . . . -85.13 169.95 14.78 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.706 . . . . 0.0 110.088 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 44.7 Cg_endo -71.6 -27.44 18.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.393 1.207 . . . . 0.0 110.24 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.56 170.57 26.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HB3' HG22 ' A' ' 78' ' ' VAL . 44.9 Cg_endo -71.84 104.37 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.497 1.262 . . . . 0.0 110.192 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 102' ' ' PHE . 9.5 mt -64.91 128.48 35.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 109.817 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -103.55 113.17 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.681 -0.637 . . . . 0.0 110.323 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 102' ' ' PHE . 1.2 tt -100.01 105.71 17.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 110.154 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -65.69 137.71 57.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.689 -0.632 . . . . 0.0 109.729 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HA ' HD21 ' A' ' 94' ' ' LEU . 95.0 mt -135.6 56.8 1.82 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.753 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.0 p -115.75 -68.53 0.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.768 -0.582 . . . . 0.0 110.493 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.96 -58.18 0.18 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.45 74.81 0.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.969 . . . . 0.0 110.323 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 90' ' ' LEU . 18.2 mt -95.46 -22.38 17.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 0.0 110.805 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.43 -1.13 28.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.345 -0.847 . . . . 0.0 111.561 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 m -90.06 0.37 57.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.175 -0.953 . . . . 0.0 111.288 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.5 ' CZ ' HD23 ' A' ' 88' ' ' LEU . 51.8 m-85 -94.09 -32.22 13.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.114 -0.991 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -59.1 -19.72 47.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -88.07 -24.75 23.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 110.535 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.68 -179.88 3.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.429 -0.794 . . . . 0.0 110.54 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -167.31 142.88 4.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.536 -0.727 . . . . 0.0 110.146 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.641 ' HE2' HD12 ' A' ' 88' ' ' LEU . 29.5 m-85 -79.09 121.72 25.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.859 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.84 123.47 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 110.341 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.528 HD22 ' CZ3' ' A' ' 202' ' ' TRP . 55.0 mt -124.19 178.74 5.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.757 ' O ' HG13 ' A' ' 108' ' ' VAL . 19.7 tttm -104.2 150.97 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.815 0.817 . . . . 0.0 109.514 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 167' ' ' LYS . 3.6 pt-20 -50.63 124.5 11.0 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.56 48.99 72.77 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.626 -0.671 . . . . 0.0 113.343 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 105' ' ' LYS . 28.0 m -97.01 133.21 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.975 1.388 . . . . 0.0 109.678 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.44 94.77 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.75 ' HD2' HG23 ' A' ' 108' ' ' VAL . 40.8 p90 -118.32 142.03 47.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 0.0 111.361 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.19 163.37 12.86 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.612 -0.68 . . . . 0.0 109.176 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 82.5 mt -126.42 151.59 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.015 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.512 ' HE2' HD23 ' A' ' 159' ' ' LEU . 39.9 ttmt -128.91 117.9 21.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.699 -0.626 . . . . 0.0 109.468 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.14 144.98 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.758 . . . . 0.0 110.662 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -123.72 147.54 47.38 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.779 ' HA ' HG23 ' A' ' 73' ' ' THR . 34.1 p90 -168.37 161.29 11.89 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.572 ' HG3' HG21 ' A' ' 73' ' ' THR . 7.7 mtm180 -113.0 144.59 42.31 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.843 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 70' ' ' VAL . 57.8 t -125.79 98.89 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -128.7 49.01 2.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 0.0 111.046 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.03 -75.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 123' ' ' VAL . 3.7 tt0 -138.28 160.22 40.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.563 -0.711 . . . . 0.0 110.314 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.5 mt -63.57 104.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.74 -0.6 . . . . 0.0 109.921 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 70' ' ' VAL . 57.9 t -91.33 76.35 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.612 -0.68 . . . . 0.0 109.636 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.0 p -77.68 85.48 4.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 144.37 48.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.458 ' HE1' ' CE2' ' A' ' 181' ' ' PHE . 0.0 OUTLIER -85.12 131.05 34.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.558 -0.966 . . . . 0.0 109.481 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.5 162.34 25.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.63 -0.669 . . . . 0.0 111.051 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -136.38 108.28 7.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 77.2 mt -102.76 161.94 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -159.3 134.88 8.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.594 -0.691 . . . . 0.0 110.28 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 11.4 m-70 -111.23 130.68 55.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 84.3 m -84.33 72.59 10.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.849 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.41 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 4.4 m-85 -64.11 137.35 57.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 110.495 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 175' ' ' TYR . 14.8 ttm180 -120.91 107.76 13.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.634 . . . . 0.0 109.925 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 53.27 37.09 24.39 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.399 -0.813 . . . . 0.0 110.584 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 84.34 33.47 19.87 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 136' ' ' GLY . 59.7 t -147.24 111.41 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 126.47 28.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.73 -22.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.558 -0.714 . . . . 0.0 110.798 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -167.91 132.48 1.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.595 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.43 ' CE ' ' CE1' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -139.98 144.51 37.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 143' ' ' ASP . 28.2 m -132.42 164.72 25.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.494 -0.754 . . . . 0.0 110.744 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 142' ' ' THR . 1.5 m-20 -120.53 115.39 23.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.748 -0.595 . . . . 0.0 109.877 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.17 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 ttm -98.27 117.99 33.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.542 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.502 HG12 ' CE2' ' A' ' 149' ' ' TYR . 47.4 t -79.7 -63.21 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.443 -0.786 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 143.77 178.43 19.52 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.2 p -87.77 149.13 24.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.655 -0.909 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 146' ' ' VAL . 76.3 m-85 -147.82 132.57 17.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.333 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -92.95 159.5 24.57 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.13 94.22 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.399 1.21 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -116.51 23.35 12.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 110.6 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 52.49 23.64 2.64 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.339 -0.851 . . . . 0.0 111.213 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -126.97 169.15 13.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.573 -0.704 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -100.19 163.33 12.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.604 . . . . 0.0 110.398 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.474 ' CD2' ' CD1' ' A' ' 149' ' ' TYR . 64.2 m-85 -122.88 170.57 9.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.644 -0.66 . . . . 0.0 109.954 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -136.23 103.36 5.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.486 ' HB2' HG13 ' A' ' 146' ' ' VAL . 24.4 t80 -88.18 148.34 24.45 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 159' ' ' LEU . 3.4 tm? -133.53 111.3 10.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 110.641 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 158' ' ' PHE . 77.6 p -85.83 151.67 55.43 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.56 -0.712 . . . . 0.0 109.62 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.78 165.62 22.82 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.441 1.232 . . . . 0.0 111.093 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.3 mtm -54.64 168.63 0.26 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.714 -0.616 . . . . 0.0 110.755 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -155.55 140.2 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.741 -0.599 . . . . 0.0 109.775 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 129.9 42.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.591 -0.693 . . . . 0.0 110.974 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -77.93 178.56 2.09 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.612 -0.68 . . . . 0.0 110.25 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 46.3 Cg_endo -73.39 -173.12 1.2 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.448 1.236 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' GLU . 13.8 mmtt -78.39 -176.53 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.51 -0.744 . . . . 0.0 110.656 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.402 ' N ' ' CB ' ' A' ' 106' ' ' GLU . . . -95.18 -60.88 1.04 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 171' ' ' ALA . 12.2 mmt -60.9 141.7 56.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.564 -0.962 . . . . 0.0 109.44 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt 66.15 -64.27 0.22 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.673 -0.642 . . . . 0.0 110.393 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 166' ' ' PRO . . . -59.5 -17.83 35.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 111.177 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.15 27.78 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.082 -1.011 . . . . 0.0 110.285 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.63 177.88 15.13 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.7 p -88.19 134.21 33.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.544 -0.974 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 134' ' ' ARG . 15.9 m-85 -116.94 116.81 28.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.544 -0.722 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -61.66 145.82 51.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.827 HG21 ' CZ2' ' A' ' 194' ' ' TRP . 50.4 mm -125.18 108.23 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.502 -0.749 . . . . 0.0 110.361 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HD3' ' CE1' ' A' ' 133' ' ' TYR . 1.6 ttpt -88.2 95.61 10.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.493 -0.754 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 125.29 45.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.48 -0.762 . . . . 0.0 110.114 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -116.01 107.8 15.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.45 -0.782 . . . . 0.0 110.35 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.65 ' CD2' HG23 ' A' ' 72' ' ' VAL . 2.2 t80 -83.82 136.68 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.714 -0.616 . . . . 0.0 109.741 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.434 ' HA ' ' CD2' ' A' ' 189' ' ' HIS . 5.0 t -172.77 -173.58 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.557 -0.714 . . . . 0.0 110.42 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 6.6 p-10 -108.49 -155.5 0.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -171.56 27.65 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.937 -0.477 . . . . 0.0 110.642 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -79.18 -37.28 38.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.768 . . . . 0.0 110.283 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 t -177.19 -161.53 0.06 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.705 -0.622 . . . . 0.0 109.971 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -115.25 118.87 34.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.579 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 182' ' ' THR . 14.4 m-70 -73.23 -65.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.315 -0.866 . . . . 0.0 110.699 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.0 tp -168.42 151.49 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.797 . . . . 0.0 110.5 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.6 m -149.0 146.5 27.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.015 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -140.05 -162.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -154.44 121.89 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.401 -0.812 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.827 ' CZ2' HG21 ' A' ' 177' ' ' ILE . 30.5 p-90 -132.23 148.35 52.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.692 -0.63 . . . . 0.0 109.553 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.49 148.56 23.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.483 -0.76 . . . . 0.0 111.489 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.52 102.1 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -75.2 132.07 40.86 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.572 -0.705 . . . . 0.0 110.724 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.95 147.75 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.642 -0.661 . . . . 0.0 109.533 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.76 -159.08 0.96 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.694 -0.629 . . . . 0.0 110.129 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.58 -8.43 4.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.96 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -155.19 63.13 0.63 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.947 -1.095 . . . . 0.0 111.516 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.725 ' CH2' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -72.17 -6.77 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.263 -0.898 . . . . 0.0 111.241 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -162.21 47.92 0.17 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.134 -179.884 . . . . . . . . 0 0 . 1 stop_ save_